Citrus Sinensis ID: 009933
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 522 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.842 | 0.964 | 0.634 | 1e-177 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.733 | 0.905 | 0.622 | 1e-144 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.580 | 0.731 | 0.762 | 1e-138 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.687 | 0.728 | 0.5 | 3e-97 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.666 | 0.710 | 0.505 | 1e-94 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.590 | 0.751 | 0.549 | 3e-91 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.607 | 0.769 | 0.510 | 3e-90 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.582 | 0.713 | 0.540 | 1e-89 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.620 | 0.832 | 0.494 | 4e-89 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.557 | 0.683 | 0.557 | 8e-88 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 622 bits (1603), Expect = e-177, Method: Compositional matrix adjust.
Identities = 331/522 (63%), Positives = 370/522 (70%), Gaps = 82/522 (15%)
Query: 3 GCFPCFGSSNNKETGGGGGGGAVGAVKELNRKDSAKDGSIAQSHHV--NRVSS-----DK 55
GCF CF SS++++ LN D + G QS N +S +K
Sbjct: 2 GCFSCFDSSDDEK---------------LNPVDESNHGQKKQSQPTVSNNISGLPSGGEK 46
Query: 56 SKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLE 115
S+ K+E +P++ IAA TF FRELAAAT NF P+ LGEGGFGRVYKGRL+
Sbjct: 47 LSSKTNGGSKRELLLPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLD 106
Query: 116 STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175
STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLG
Sbjct: 107 STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLG 166
Query: 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235
SLEDHLHDLPPDKE LDWN RMKIAAGAAKGLE+LHDKANPPVIYRD KSSNILLDEGFH
Sbjct: 167 SLEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFH 226
Query: 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
PKLSDFGLAKLGP GDK+HVSTRVMGTYGYCAPEYAMTGQLT+KSDVYSFGVVFLELITG
Sbjct: 227 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 286
Query: 296 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ 355
RKAID+ P GE NLVAWARPLF DRRKF K+ADP L+GR+P R LYQALAVA+MC+QEQ
Sbjct: 287 RKAIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQ 346
Query: 356 AATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGR 415
AATRPLI DVVTAL+YLA+Q YDP+ + RNRD+R
Sbjct: 347 AATRPLIADVVTALSYLANQAYDPSK---------DDSRRNRDER--------------- 382
Query: 416 VGRHGSPSTHKNSPDYRKRSHPRDGSTGAEL-SRNETGGGSGRKWLGDDLERQESQRDSP 474
GA L +RN+ GGGSG K+ DLE E + DSP
Sbjct: 383 ---------------------------GARLITRNDDGGGSGSKF---DLEGSEKE-DSP 411
Query: 475 VNTGRARQSPRNRDLDRERAVAAAKVWGENWREKKRANAMGS 516
T R NRD++RERAVA AK+WGE+ REK+R + G+
Sbjct: 412 RETARI----LNRDINRERAVAEAKMWGESLREKRRQSEQGT 449
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 511 bits (1317), Expect = e-144, Method: Compositional matrix adjust.
Identities = 261/419 (62%), Positives = 303/419 (72%), Gaps = 36/419 (8%)
Query: 3 GCFPCFGSSN-----NKETGGGGGGGAVGAVKELNRKDSAKDGSIAQSHHVN---RVSSD 54
GCF C S+ NK+T +NRK S+A+S + + SSD
Sbjct: 2 GCFGCSKKSSKRSETNKDT-------------VINRKIVGGTTSVAKSDKRDDQTQPSSD 48
Query: 55 KSKSRNGSDPKKEPAIPKEPTAHI--------------AAQTFTFRELAAATKNFRPECL 100
+K D E + KE + AQTFTF+ELA AT NFR +C
Sbjct: 49 STKVSPYRDVNNEGGVGKEDQLSLDVKGLNLNDQVTGKKAQTFTFQELAEATGNFRSDCF 108
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LGEGGFG+V+KG +E QVVA+KQLDRNG+QG REF+VEVL LSL H NLV LIG+CA
Sbjct: 109 LGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCA 168
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+GDQRLLVYE+MP GSLEDHLH LP K+PLDWNTRMKIAAGAA+GLEYLHD+ PPVIY
Sbjct: 169 EGDQRLLVYEYMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIY 228
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 280
RDLK SNILL E + PKLSDFGLAK+GP GDKTHVSTRVMGTYGYCAP+YAMTGQLT KS
Sbjct: 229 RDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 288
Query: 281 DVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRG 340
D+YSFGVV LELITGRKAIDNT+ + NLV WARPLFKDRR FPKM DPLLQG+YP+RG
Sbjct: 289 DIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRG 348
Query: 341 LYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDD 399
LYQALA++AMC+QEQ RP++ DVV AL +LAS YDPN+ S+ S + PS R+RDD
Sbjct: 349 LYQALAISAMCVQEQPTMRPVVSDVVLALNFLASSKYDPNSPSSSSGK-NPSFHRDRDD 406
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1264), Expect = e-138, Method: Compositional matrix adjust.
Identities = 231/303 (76%), Positives = 263/303 (86%)
Query: 72 KEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL 131
KE T +IAAQTF+FRELA ATKNFR ECL+GEGGFGRVYKG+LE TG +VAVKQLDRNGL
Sbjct: 56 KEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGL 115
Query: 132 QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL 191
QGN+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYE+M GSLEDHL DL PD+ PL
Sbjct: 116 QGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPL 175
Query: 192 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251
DW+TR++IA GAA GLEYLHDKANPPVIYRDLK++NILLD F+ KLSDFGLAKLGPVGD
Sbjct: 176 DWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGD 235
Query: 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV 311
K HVS+RVMGTYGYCAPEY TGQLT KSDVYSFGVV LELITGR+ ID TRP E NLV
Sbjct: 236 KQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLV 295
Query: 312 AWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371
WA+P+FK+ +FP++ADP L+G +P + L QA+AVAAMCLQE+A RPL+ DVVTAL +
Sbjct: 296 TWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGF 355
Query: 372 LAS 374
L +
Sbjct: 356 LGT 358
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 356 bits (913), Expect = 3e-97, Method: Compositional matrix adjust.
Identities = 189/378 (50%), Positives = 237/378 (62%), Gaps = 19/378 (5%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKDSAKDGSIAQSHHVNRVSSDKSKSRN 60
M GC P + + G V ++ + + + D + Q VSS + S N
Sbjct: 55 MIGCIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQ------VSSTTTTS-N 107
Query: 61 GSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLES---- 116
P I +E + FTF +L +T+NFRPE LLGEGGFG V+KG +E
Sbjct: 108 AESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTA 167
Query: 117 -----TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171
TG VAVK L+ +GLQG++E+L E+ L L H NLV L+GYC + DQRLLVYEF
Sbjct: 168 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEF 227
Query: 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD 231
MP GSLE+HL PL W+ RMKIA GAAKGL +LH++A PVIYRD K+SNILLD
Sbjct: 228 MPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLD 284
Query: 232 EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 291
++ KLSDFGLAK P KTHVSTRVMGTYGY APEY MTG LT KSDVYSFGVV LE
Sbjct: 285 ADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 344
Query: 292 LITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMC 351
++TGR+++D RP GEHNLV WARP D+R+F ++ DP L+G + ++G + +AA C
Sbjct: 345 MLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQC 404
Query: 352 LQEQAATRPLIGDVVTAL 369
L RP + DVV AL
Sbjct: 405 LSRDPKIRPKMSDVVEAL 422
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (890), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 189/374 (50%), Positives = 238/374 (63%), Gaps = 26/374 (6%)
Query: 7 CFGSSNNKETGGGGGGGAVGAVKELNRKDSAKDGSIAQSHH--VNRVSSDKSKSRNGSDP 64
C S+++ ET VG+ +I QS+ V VSS + S N
Sbjct: 58 CASSTSDVETSLTLSTSTVGS-----------QSAIVQSNDQPVGPVSSTTTTS-NAESS 105
Query: 65 KKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLES-------- 116
P I +E + + F+F +L AT+NFRPE LLGEGGFG V+KG +E
Sbjct: 106 LSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 165
Query: 117 -TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175
TG VAVK L+ +GLQG++E+L E+ L L H NLV L+GYC + DQRLLVYEFMP G
Sbjct: 166 GTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 225
Query: 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235
SLE+HL PL W+ RMKIA GAAKGL +LH++A PVIYRD K+SNILLD ++
Sbjct: 226 SLENHLFR---RSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYN 282
Query: 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
KLSDFGLAK P KTHVSTRVMGTYGY APEY MTG LT KSDVYSFGVV LE++TG
Sbjct: 283 AKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
Query: 296 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ 355
R+++D RP GEHNLV WARP D+R+F ++ DP L+G + ++G + +AA CL
Sbjct: 343 RRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRD 402
Query: 356 AATRPLIGDVVTAL 369
+ RP + +VV L
Sbjct: 403 SKIRPKMSEVVEVL 416
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 3e-91, Method: Compositional matrix adjust.
Identities = 178/324 (54%), Positives = 218/324 (67%), Gaps = 16/324 (4%)
Query: 58 SRNGSDPKKEPAIPK------EPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYK 111
SR+ SD +P+ P+ P ++ FT EL TK+FRP+ +LGEGGFG VYK
Sbjct: 27 SRSVSD-LSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYK 85
Query: 112 GRLESTGQV------VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165
G ++ +V VAVK L++ GLQG+RE+L EV L L H NLV LIGYC + D R
Sbjct: 86 GYIDDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR 145
Query: 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 225
LLVYEFM GSLE+HL PL W+ RM IA GAAKGL +LH+ A PVIYRD K+
Sbjct: 146 LLVYEFMLRGSLENHL--FRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKT 202
Query: 226 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSF 285
SNILLD + KLSDFGLAK GP GD+THVSTRVMGTYGY APEY MTG LT +SDVYSF
Sbjct: 203 SNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSF 262
Query: 286 GVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQAL 345
GVV LE++TGRK++D TRP E NLV WARP D+RK ++ DP L+ +Y +R +A
Sbjct: 263 GVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKAC 322
Query: 346 AVAAMCLQEQAATRPLIGDVVTAL 369
++A CL + RPL+ DVV L
Sbjct: 323 SLAYYCLSQNPKARPLMSDVVETL 346
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 333 bits (853), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 170/333 (51%), Positives = 224/333 (67%), Gaps = 16/333 (4%)
Query: 62 SDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLES----- 116
++P+ E I + P ++FTF EL AAT+NFRP+ +LGEGGFG V+KG ++
Sbjct: 40 TNPRTEGEILQSPNL----KSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTA 95
Query: 117 ----TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172
TG V+AVK+L+++G QG++E+L EV L H NLV LIGYC + + RLLVYEFM
Sbjct: 96 SKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFM 155
Query: 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE 232
P GSLE+HL +PL W R+K+A GAAKGL +LH+ A VIYRD K+SNILLD
Sbjct: 156 PRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDS 214
Query: 233 GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 292
++ KLSDFGLAK GP GDK+HVSTR+MGTYGY APEY TG LT KSDVYS+GVV LE+
Sbjct: 215 EYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEV 274
Query: 293 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCL 352
++GR+A+D RPPGE LV WARPL ++RK ++ D LQ +Y M + +A CL
Sbjct: 275 LSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCL 334
Query: 353 QEQAATRPLIGDVVTALTYLASQTYDPNAASNL 385
+ RP + +VV+ L ++ QT + N+
Sbjct: 335 TFEIKLRPNMNEVVSHLEHI--QTLNEAGGRNI 365
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (847), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 173/320 (54%), Positives = 214/320 (66%), Gaps = 16/320 (5%)
Query: 64 PKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLEST------ 117
P+ E I P + FTF EL AT+NFRP+ LLGEGGFG V+KG ++ T
Sbjct: 56 PRTEGEILSSPNL----KAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASK 111
Query: 118 ---GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174
G VVAVK+L G QG++E+L EV L L H NLV L+GYC +G+ RLLVYEFMP
Sbjct: 112 PGSGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPK 171
Query: 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF 234
GSLE+HL +PL W RMK+A GAAKGL +LHD A VIYRD K++NILLD F
Sbjct: 172 GSLENHL--FRRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEF 228
Query: 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ KLSDFGLAK GP GDKTHVST+VMGT+GY APEY TG+LT KSDVYSFGVV LEL++
Sbjct: 229 NSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 288
Query: 295 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQE 354
GR+A+D ++ E +LV WA P D+RK ++ D L G+YP +G Y A ++A CL
Sbjct: 289 GRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNP 348
Query: 355 QAATRPLIGDVVTALTYLAS 374
A RP + +V+ L L S
Sbjct: 349 DAKLRPKMSEVLAKLDQLES 368
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 165/334 (49%), Positives = 223/334 (66%), Gaps = 10/334 (2%)
Query: 51 VSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVY 110
+S D SK + + P E + + F+ EL +AT+NFRP+ ++GEGGFG V+
Sbjct: 24 LSRDGSKGSSTASFSYMPRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVF 83
Query: 111 KGRLES---------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD 161
KG ++ TG V+AVK+L++ G QG+RE+L E+ L L H NLV LIGYC +
Sbjct: 84 KGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLE 143
Query: 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 221
+ RLLVYEFM GSLE+HL +PL WNTR+++A GAA+GL +LH+ A P VIYR
Sbjct: 144 EEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYR 202
Query: 222 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 281
D K+SNILLD ++ KLSDFGLA+ GP+GD +HVSTRVMGT GY APEY TG L++KSD
Sbjct: 203 DFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSD 262
Query: 282 VYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGL 341
VYSFGVV LEL++GR+AID +P GEHNLV WARP ++R+ ++ DP LQG+Y +
Sbjct: 263 VYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRA 322
Query: 342 YQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375
+ +A C+ A +RP + ++V + L Q
Sbjct: 323 LKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQ 356
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 8e-88, Method: Compositional matrix adjust.
Identities = 169/303 (55%), Positives = 208/303 (68%), Gaps = 12/303 (3%)
Query: 81 QTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLEST---------GQVVAVKQLDRNGL 131
+ FTF EL ATKNFR + LLGEGGFG V+KG ++ T G VVAVKQL G
Sbjct: 72 KAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGF 131
Query: 132 QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL 191
QG++E+L EV L L H NLV L+GYCA+G+ RLLVYEFMP GSLE+HL +PL
Sbjct: 132 QGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHL--FRRGAQPL 189
Query: 192 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251
W RMK+A GAAKGL +LH+ A VIYRD K++NILLD F+ KLSDFGLAK GP GD
Sbjct: 190 TWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGD 248
Query: 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV 311
THVST+V+GT+GY APEY TG+LT KSDVYSFGVV LELI+GR+A+DN+ E++LV
Sbjct: 249 NTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLV 308
Query: 312 AWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371
WA P D+RK ++ D L G+YP +G + A +A CL A RP + +V+ L
Sbjct: 309 DWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQ 368
Query: 372 LAS 374
L S
Sbjct: 369 LES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 522 | ||||||
| 255551669 | 516 | receptor serine-threonine protein kinase | 0.986 | 0.998 | 0.891 | 0.0 | |
| 225432364 | 528 | PREDICTED: serine/threonine-protein kina | 0.980 | 0.969 | 0.841 | 0.0 | |
| 449433375 | 514 | PREDICTED: serine/threonine-protein kina | 0.980 | 0.996 | 0.853 | 0.0 | |
| 356557829 | 587 | PREDICTED: serine/threonine-protein kina | 0.975 | 0.867 | 0.853 | 0.0 | |
| 356549075 | 513 | PREDICTED: serine/threonine-protein kina | 0.975 | 0.992 | 0.851 | 0.0 | |
| 357447401 | 507 | Protein kinase-like protein [Medicago tr | 0.965 | 0.994 | 0.845 | 0.0 | |
| 297736901 | 471 | unnamed protein product [Vitis vinifera] | 0.898 | 0.995 | 0.864 | 0.0 | |
| 15238886 | 513 | protein kinase family protein [Arabidops | 0.967 | 0.984 | 0.788 | 0.0 | |
| 297807881 | 513 | kinase family protein [Arabidopsis lyrat | 0.967 | 0.984 | 0.788 | 0.0 | |
| 116831497 | 514 | unknown [Arabidopsis thaliana] | 0.967 | 0.982 | 0.788 | 0.0 |
| >gi|255551669|ref|XP_002516880.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223543968|gb|EEF45494.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2457), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/523 (89%), Positives = 485/523 (92%), Gaps = 8/523 (1%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKDSAKDGSIAQSHHVNRVSSDKSKSRN 60
MGGCFPCFGSSN + T GGG A+KE+ +KDS K+GS+AQSHHV RVSSDKSKSRN
Sbjct: 1 MGGCFPCFGSSNKEGTDGGG------AIKEVAKKDSVKEGSVAQSHHVGRVSSDKSKSRN 54
Query: 61 GSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQ 119
GSDPKKEP IPK+ PTAHIAAQTFTFRELAAATKNFR ECLLGEGGFGRVYKGRLESTGQ
Sbjct: 55 GSDPKKEPTIPKDGPTAHIAAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGRLESTGQ 114
Query: 120 VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED 179
VVAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLED
Sbjct: 115 VVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLED 174
Query: 180 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239
HLHD P DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG+HPKLS
Sbjct: 175 HLHDFPSDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGYHPKLS 234
Query: 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299
DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI
Sbjct: 235 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 294
Query: 300 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 359
DNTR PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR
Sbjct: 295 DNTRAPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 354
Query: 360 PLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRH 419
PLIGDVVTALTYLASQTYDPN+A N SNRVGPSTPRNRDDR+ MADG DSPDEHGR G H
Sbjct: 355 PLIGDVVTALTYLASQTYDPNSA-NQSNRVGPSTPRNRDDRKGMADGLDSPDEHGRGGWH 413
Query: 420 GSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTGR 479
GSPST+KNSPDYR+R R+ ST +EL R+ETGGGSGRKW DD ERQ+SQR SPVNT R
Sbjct: 414 GSPSTYKNSPDYRRRDPMRESSTASELGRSETGGGSGRKWGLDDSERQDSQRGSPVNTSR 473
Query: 480 ARQSPRNRDLDRERAVAAAKVWGENWREKKRANAMGSFDGTDE 522
R++PRNRDLDRERAVA AKVWGENWREKKRANAMGSFDGT+E
Sbjct: 474 VRETPRNRDLDRERAVAEAKVWGENWREKKRANAMGSFDGTNE 516
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432364|ref|XP_002275431.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2349), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/536 (84%), Positives = 475/536 (88%), Gaps = 24/536 (4%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKDSAKDGSIAQSHHVNRVSSDKSKSRN 60
MGGCFPCFGSSN + G K++ +KDS KDGS AQSHHV RVSSDKSKSR+
Sbjct: 1 MGGCFPCFGSSNKEGNG---------VKKDVAKKDSVKDGSSAQSHHVTRVSSDKSKSRS 51
Query: 61 GSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQ 119
GSD KKEPA+PK+ PTAHIAAQTFTFRELAAATKNFRPE LLGEGGFGRVYKGRLESTGQ
Sbjct: 52 GSDSKKEPAVPKDGPTAHIAAQTFTFRELAAATKNFRPESLLGEGGFGRVYKGRLESTGQ 111
Query: 120 VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED 179
VVAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLED
Sbjct: 112 VVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLED 171
Query: 180 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239
HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA+PPVIYRDLKSSNILLDEG+HPKLS
Sbjct: 172 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKASPPVIYRDLKSSNILLDEGYHPKLS 231
Query: 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299
DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI
Sbjct: 232 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 291
Query: 300 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 359
DN R GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR
Sbjct: 292 DNNRAAGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 351
Query: 360 PLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRH 419
PLIGDVVTALTYLASQTYDPNAAS SNRVGPSTPR++DDRRS+ DG DSPD GR GR
Sbjct: 352 PLIGDVVTALTYLASQTYDPNAASAQSNRVGPSTPRSKDDRRSLPDGLDSPDNPGRGGRL 411
Query: 420 GSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQ--------- 470
GSPSTHKNSPD+R+R RD ST +L R+E GGSGRKW D+LERQESQ
Sbjct: 412 GSPSTHKNSPDFRRRDPLRDLSTATDLGRSEADGGSGRKWGLDELERQESQRDIPISAGR 471
Query: 471 -----RDSPVNTGRARQSPRNRDLDRERAVAAAKVWGENWREKKRANAMGSFDGTD 521
RD P+++GRAR++PRNRDLDRERAVA AKVWGENWREKKRAN +GSFDGT+
Sbjct: 472 ARDTERDIPISSGRARETPRNRDLDRERAVAEAKVWGENWREKKRANVVGSFDGTN 527
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433375|ref|XP_004134473.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] gi|449495476|ref|XP_004159852.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2314), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/524 (85%), Positives = 470/524 (89%), Gaps = 12/524 (2%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKDSAKDGSIAQSHHVNRVSSDKSKSRN 60
MGGCFPCFGSS+ G+ VKE +KD+AKDGS AQSHHV RV SDKSKSR+
Sbjct: 1 MGGCFPCFGSSDED--------GSSNGVKEATKKDTAKDGSTAQSHHVTRVGSDKSKSRS 52
Query: 61 GSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQ 119
SD KKEP I K+ TAHIAAQTFTFRELA ATKNFR ECLLGEGGFGRVYKGRLESTGQ
Sbjct: 53 VSDAKKEPTIQKDGTTAHIAAQTFTFRELATATKNFRSECLLGEGGFGRVYKGRLESTGQ 112
Query: 120 VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED 179
VVAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLED
Sbjct: 113 VVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLED 172
Query: 180 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239
HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG+HPKLS
Sbjct: 173 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGYHPKLS 232
Query: 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299
DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI
Sbjct: 233 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 292
Query: 300 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 359
DNTR PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR
Sbjct: 293 DNTRGPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 352
Query: 360 PLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRH 419
PLIGDVVTALTYLASQTYDPNAA++ SNR+G STPR RD+RRS DG DSPDE GR GR
Sbjct: 353 PLIGDVVTALTYLASQTYDPNAAASQSNRMGGSTPRARDERRSFPDGLDSPDERGR-GR- 410
Query: 420 GSPSTHKNSPDYRKRSHPRDGST-GAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTG 478
GSPS ++NSPDYRK+ R+ S G ELS+ +TGGGSGRKW D+LERQES RDSPV G
Sbjct: 411 GSPSNYRNSPDYRKKDFHRELSCGGTELSKIDTGGGSGRKWGLDELERQESLRDSPVYAG 470
Query: 479 RARQSPRNRDLDRERAVAAAKVWGENWREKKRANAMGSFDGTDE 522
RAR++PRNRDL+RERAVA AKVWGENWRE+KRANA GSFDG+ E
Sbjct: 471 RARETPRNRDLNRERAVAEAKVWGENWRERKRANAQGSFDGSQE 514
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557829|ref|XP_003547213.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2313), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/527 (85%), Positives = 476/527 (90%), Gaps = 18/527 (3%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKEL-NRKDSAKDGS---IAQSHHVNRVSSDKS 56
MGGCFPCFGSSN + +GG VKE+ NR S K+ + + QSHH +RV+SDKS
Sbjct: 74 MGGCFPCFGSSNKEGSGGV-------RVKEVPNRDSSFKEAAASVVPQSHHPSRVNSDKS 126
Query: 57 KSRNGSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLE 115
KSR+G+D KKE +PK+ PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLE
Sbjct: 127 KSRSGADTKKETPVPKDGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLE 186
Query: 116 STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175
+TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLG
Sbjct: 187 TTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLG 246
Query: 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235
SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG+H
Sbjct: 247 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGYH 306
Query: 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG
Sbjct: 307 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 366
Query: 296 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ 355
RKAIDNTR GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ
Sbjct: 367 RKAIDNTRAHGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ 426
Query: 356 AATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGR 415
AATRPLIGDVVTALTYLASQTYDPNAA N SNRVGPSTPR+RDDRRSMAD DSPD HGR
Sbjct: 427 AATRPLIGDVVTALTYLASQTYDPNAA-NQSNRVGPSTPRSRDDRRSMADSVDSPD-HGR 484
Query: 416 VGRHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSPV 475
+ GSPSTH+NSPD+RKR RD ST EL R +TGGGSGRKW DD ERQ+SQRDSPV
Sbjct: 485 L---GSPSTHRNSPDFRKRDS-RDPSTATELGRIDTGGGSGRKWGLDDYERQDSQRDSPV 540
Query: 476 NTGRARQSPRNRDLDRERAVAAAKVWGENWREKKRANAMGSFDGTDE 522
NT RAR++P NRDLDRERAVA AKVWGENWREKK+ANA+GSFD T++
Sbjct: 541 NTARARETPWNRDLDRERAVAEAKVWGENWREKKKANAVGSFDATND 587
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549075|ref|XP_003542923.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2292), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/526 (85%), Positives = 471/526 (89%), Gaps = 17/526 (3%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKDSA-KDGS--IAQSHHVNRVSSDKSK 57
MGGCFPCFGSSN + +GGG VKE+ KDS+ K+ + + QSH +RV+SDKSK
Sbjct: 1 MGGCFPCFGSSNKEGSGGGV------RVKEVPNKDSSFKEAASVVPQSHLPSRVNSDKSK 54
Query: 58 SRNGSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLES 116
SRNG+D KK+ +PK+ PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLES
Sbjct: 55 SRNGADIKKDTPVPKDGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLES 114
Query: 117 TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS 176
TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGS
Sbjct: 115 TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGS 174
Query: 177 LEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236
LEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG+HP
Sbjct: 175 LEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGYHP 234
Query: 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR
Sbjct: 235 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 294
Query: 297 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQA 356
KAIDNTR GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQA
Sbjct: 295 KAIDNTRAHGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQA 354
Query: 357 ATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRV 416
ATRPLIGDVVTALTYLASQTY+PNAA N SNRVGPSTPR RDDRRSMADG DSPD
Sbjct: 355 ATRPLIGDVVTALTYLASQTYEPNAA-NQSNRVGPSTPRIRDDRRSMADGVDSPDR---- 409
Query: 417 GRHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSPVN 476
R GSPSTH+NSPD+RKR RD S EL R + GGGSGRKW DD ERQESQRDSPVN
Sbjct: 410 -RLGSPSTHRNSPDFRKRDS-RDPSAATELGRIDIGGGSGRKWGLDDNERQESQRDSPVN 467
Query: 477 TGRARQSPRNRDLDRERAVAAAKVWGENWREKKRANAMGSFDGTDE 522
T R R++P NRDLDRERAVA AKVWGENWREKK+ANAMGSFD T++
Sbjct: 468 TARTRETPWNRDLDRERAVAEAKVWGENWREKKKANAMGSFDATND 513
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447401|ref|XP_003593976.1| Protein kinase-like protein [Medicago truncatula] gi|355483024|gb|AES64227.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2217), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/525 (84%), Positives = 468/525 (89%), Gaps = 21/525 (4%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKDSAKDGSIAQSHHVNRVSSDKSKSRN 60
MGGCFPCFGSSN ++T AVKE+++K+S K+ S+ QSHH RVSSDKSKS++
Sbjct: 1 MGGCFPCFGSSNKEDTN---------AVKEVSKKESFKEASLPQSHHPTRVSSDKSKSKS 51
Query: 61 GSDP--KKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLEST 117
SD +KE +PK+ TAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKG LEST
Sbjct: 52 VSDSKKEKEAPVPKDGATAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGCLEST 111
Query: 118 GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177
QVVAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSL
Sbjct: 112 KQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSL 171
Query: 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK 237
EDHLHDLPP+KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK
Sbjct: 172 EDHLHDLPPEKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK 231
Query: 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 297
LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK
Sbjct: 232 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 291
Query: 298 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA 357
AIDNTR GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA
Sbjct: 292 AIDNTRGHGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA 351
Query: 358 TRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVG 417
TRPLIGDVVTALTYLASQ +DPNAA N SNRVGPSTPR RDDRRSMAD DSPD
Sbjct: 352 TRPLIGDVVTALTYLASQAFDPNAA-NQSNRVGPSTPRLRDDRRSMADSVDSPDR----A 406
Query: 418 RHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSPVNT 477
R GSPST +NSPD RK RDG +ELSR +TGGGSGRKW DDLER +SQRDSPVNT
Sbjct: 407 RLGSPSTRRNSPDLRK----RDGRDPSELSRIDTGGGSGRKWGVDDLERHDSQRDSPVNT 462
Query: 478 GRARQSPRNRDLDRERAVAAAKVWGENWREKKRANAMGSFDGTDE 522
GRAR++PRNRDLDRERAVA A+VWGENWREKKR NA+GSFDGT+E
Sbjct: 463 GRARETPRNRDLDRERAVAEARVWGENWREKKRGNAVGSFDGTNE 507
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736901|emb|CBI26102.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2165), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/479 (86%), Positives = 432/479 (90%), Gaps = 10/479 (2%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKDSAKDGSIAQSHHVNRVSSDKSKSRN 60
MGGCFPCFGSSN + G K++ +KDS KDGS AQSHHV RVSSDKSKSR+
Sbjct: 1 MGGCFPCFGSSNKEGNG---------VKKDVAKKDSVKDGSSAQSHHVTRVSSDKSKSRS 51
Query: 61 GSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQ 119
GSD KKEPA+PK+ PTAHIAAQTFTFRELAAATKNFRPE LLGEGGFGRVYKGRLESTGQ
Sbjct: 52 GSDSKKEPAVPKDGPTAHIAAQTFTFRELAAATKNFRPESLLGEGGFGRVYKGRLESTGQ 111
Query: 120 VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED 179
VVAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLED
Sbjct: 112 VVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLED 171
Query: 180 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239
HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA+PPVIYRDLKSSNILLDEG+HPKLS
Sbjct: 172 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKASPPVIYRDLKSSNILLDEGYHPKLS 231
Query: 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299
DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI
Sbjct: 232 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 291
Query: 300 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 359
DN R GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR
Sbjct: 292 DNNRAAGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 351
Query: 360 PLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGRVGRH 419
PLIGDVVTALTYLASQTYDPNAAS SNRVGPSTPR++DDRRS+ DG DSPD GR GR
Sbjct: 352 PLIGDVVTALTYLASQTYDPNAASAQSNRVGPSTPRSKDDRRSLPDGLDSPDNPGRGGRL 411
Query: 420 GSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSPVNTG 478
GSPSTHKNSPD+R+R RD ST +L R+E GGSGRKW D+LERQESQRD P+ G
Sbjct: 412 GSPSTHKNSPDFRRRDPLRDLSTATDLGRSEADGGSGRKWGLDELERQESQRDIPIKIG 470
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238886|ref|NP_197362.1| protein kinase family protein [Arabidopsis thaliana] gi|334187748|ref|NP_001190331.1| protein kinase family protein [Arabidopsis thaliana] gi|91806876|gb|ABE66165.1| protein kinase family protein [Arabidopsis thaliana] gi|332005202|gb|AED92585.1| protein kinase family protein [Arabidopsis thaliana] gi|332005203|gb|AED92586.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2052), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/530 (78%), Positives = 444/530 (83%), Gaps = 25/530 (4%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKD-SAKDGSIAQSHHVNRVSSDKSKSR 59
M GC PCFGSS A K+ +K+ SAKDGS+ QSHH+ S DKSKSR
Sbjct: 1 MSGCLPCFGSSAKD-----------AASKDSVKKELSAKDGSVTQSHHI---SLDKSKSR 46
Query: 60 NGSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTG 118
G + KKE PKE PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLE+TG
Sbjct: 47 RGPEQKKELTAPKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTG 106
Query: 119 QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLE 178
Q+VAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYE+MPLGSLE
Sbjct: 107 QIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 166
Query: 179 DHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 238
DHLHDLPPDKEPLDW+TRM IAAGAAKGLEYLHDKANPPVIYRDLKSSNILL +G+HPKL
Sbjct: 167 DHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKL 226
Query: 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 298
SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA
Sbjct: 227 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 286
Query: 299 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 358
IDN R PGEHNLVAWARPLFKDRRKFPKMADP LQGRYPMRGLYQALAVAAMCLQEQAAT
Sbjct: 287 IDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAAT 346
Query: 359 RPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTP--RNRDDRRSMADGQ--DSPDEHG 414
RPLIGDVVTALTYLASQT+DPNA S ++R G P R RDDRRS+ DG DSP E
Sbjct: 347 RPLIGDVVTALTYLASQTFDPNAPSGQNSRSGSGPPFIRTRDDRRSLGDGSSLDSPAE-- 404
Query: 415 RVGRHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSP 474
R GSP+THKNSPDYR+R R+ +ETGGGSGRKW DLE QESQR SP
Sbjct: 405 TRSRLGSPATHKNSPDYRRRDMVRE-VNAGSEGGSETGGGSGRKWGLSDLEGQESQRGSP 463
Query: 475 VNTGR-ARQSPRNRDLDRERAVAAAKVWGENWREKKRA-NAMGSFDGTDE 522
+ GR +R +PRNRDLDRERAVA AKVWGENWRE+KRA N GSFD T++
Sbjct: 464 ASVGRSSRGTPRNRDLDRERAVAEAKVWGENWRERKRATNGPGSFDSTND 513
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297807881|ref|XP_002871824.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297317661|gb|EFH48083.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/530 (78%), Positives = 445/530 (83%), Gaps = 25/530 (4%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKD-SAKDGSIAQSHHVNRVSSDKSKSR 59
M GC PCFGSS A K+ +K+ SAKDGS+ QSHH+ S DKSKSR
Sbjct: 1 MSGCLPCFGSSAKD-----------AASKDSVKKELSAKDGSVTQSHHI---SLDKSKSR 46
Query: 60 NGSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTG 118
G + KKE A PKE PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLE+TG
Sbjct: 47 RGPEQKKELAAPKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTG 106
Query: 119 QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLE 178
Q+VAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYE+MPLGSLE
Sbjct: 107 QIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 166
Query: 179 DHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 238
DHLHDLPPDKEPLDW+TRM IAAGAAKGLEYLHDKANPPVIYRDLKSSNILL +G+HPKL
Sbjct: 167 DHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKL 226
Query: 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 298
SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA
Sbjct: 227 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 286
Query: 299 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 358
IDN R PGEHNLVAWARPLFKDRRKFPKMADP LQGRYPMRGLYQALAVAAMCLQEQAAT
Sbjct: 287 IDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAAT 346
Query: 359 RPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTP--RNRDDRRSMADGQ--DSPDEHG 414
RPLIGDVVTALTYLASQT+DPNA S ++R G P R RDDRRS+ DG DSP E
Sbjct: 347 RPLIGDVVTALTYLASQTFDPNAPSGQNSRSGSGPPFIRTRDDRRSLGDGSSLDSPAE-- 404
Query: 415 RVGRHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSP 474
R GSP+THKNSPDYR+R R+ +ETGGGSGRKW DLE Q+SQR SP
Sbjct: 405 TRSRLGSPATHKNSPDYRRRDMVRE-VNAGSEGGSETGGGSGRKWGLSDLEGQDSQRGSP 463
Query: 475 VNTGR-ARQSPRNRDLDRERAVAAAKVWGENWREKKRA-NAMGSFDGTDE 522
+ GR +R +PRNRDLDRERAVA AKVWGENWRE+KRA N GSFD T++
Sbjct: 464 ASVGRSSRGTPRNRDLDRERAVAEAKVWGENWRERKRATNGPGSFDSTND 513
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116831497|gb|ABK28701.1| unknown [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/530 (78%), Positives = 444/530 (83%), Gaps = 25/530 (4%)
Query: 1 MGGCFPCFGSSNNKETGGGGGGGAVGAVKELNRKD-SAKDGSIAQSHHVNRVSSDKSKSR 59
M GC PCFGSS A K+ +K+ SAKDGS+ QSHH+ S DKSKSR
Sbjct: 1 MSGCLPCFGSSAKD-----------AASKDSVKKELSAKDGSVTQSHHI---SLDKSKSR 46
Query: 60 NGSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTG 118
G + KKE PKE PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLE+TG
Sbjct: 47 RGPEQKKELTAPKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTG 106
Query: 119 QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLE 178
Q+VAVKQLDRNGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYE+MPLGSLE
Sbjct: 107 QIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 166
Query: 179 DHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 238
DHLHDLPPDKEPLDW+TRM IAAGAAKGLEYLHDKANPPVIYRDLKSSNILL +G+HPKL
Sbjct: 167 DHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKL 226
Query: 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 298
SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA
Sbjct: 227 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 286
Query: 299 IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 358
IDN R PGEHNLVAWARPLFKDRRKFPKMADP LQGRYPMRGLYQALAVAAMCLQEQAAT
Sbjct: 287 IDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAAT 346
Query: 359 RPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTP--RNRDDRRSMADGQ--DSPDEHG 414
RPLIGDVVTALTYLASQT+DPNA S ++R G P R RDDRRS+ DG DSP E
Sbjct: 347 RPLIGDVVTALTYLASQTFDPNAPSGQNSRSGSGPPFIRTRDDRRSLGDGSSLDSPAE-- 404
Query: 415 RVGRHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSP 474
R GSP+THKNSPDYR+R R+ +ETGGGSGRKW DLE QESQR SP
Sbjct: 405 TRSRLGSPATHKNSPDYRRRDMVRE-VNAGSEGGSETGGGSGRKWGLSDLEGQESQRGSP 463
Query: 475 VNTGR-ARQSPRNRDLDRERAVAAAKVWGENWREKKRA-NAMGSFDGTDE 522
+ GR +R +PRNRDLDRERAVA AKVWGENWRE+KRA N GSFD T++
Sbjct: 464 ASVGRSSRGTPRNRDLDRERAVAEAKVWGENWRERKRATNGPGSFDSTND 513
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 522 | ||||||
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.969 | 0.986 | 0.769 | 2.2e-208 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.852 | 0.975 | 0.615 | 3e-140 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.693 | 0.957 | 0.698 | 4.4e-132 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.697 | 0.879 | 0.618 | 2.5e-119 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.659 | 0.891 | 0.651 | 6.2e-117 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.572 | 0.705 | 0.705 | 1.5e-113 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.595 | 0.856 | 0.681 | 2.9e-112 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.626 | 0.840 | 0.641 | 9.7e-112 | |
| TAIR|locus:2075517 | 558 | AT3G02810 [Arabidopsis thalian | 0.752 | 0.704 | 0.535 | 4.3e-111 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.611 | 0.837 | 0.660 | 3.8e-110 |
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2015 (714.4 bits), Expect = 2.2e-208, P = 2.2e-208
Identities = 407/529 (76%), Positives = 433/529 (81%)
Query: 1 MGGCFPCFGSSNNKETXXXXXXXXXXXXKELNRKDSAKDGSIAQSHHVNRVSSDKSKSRN 60
M GC PCFGSS K+ KEL SAKDGS+ QSHH+ S DKSKSR
Sbjct: 1 MSGCLPCFGSSA-KDAASKDSVK-----KEL----SAKDGSVTQSHHI---SLDKSKSRR 47
Query: 61 GSDPKKEPAIPKE-PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQ 119
G + KKE PKE PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLE+TGQ
Sbjct: 48 GPEQKKELTAPKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQ 107
Query: 120 VVAVKQLDRNGLQGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLED 179
+VAVKQLDRNGLQGNREFLVE IGYCADGDQRLLVYE+MPLGSLED
Sbjct: 108 IVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLED 167
Query: 180 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239
HLHDLPPDKEPLDW+TRM IAAGAAKGLEYLHDKANPPVIYRDLKSSNILL +G+HPKLS
Sbjct: 168 HLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLS 227
Query: 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299
DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI
Sbjct: 228 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 287
Query: 300 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 359
DN R PGEHNLVAWARPLFKDRRKFPKMADP LQGRYPMRGLYQALAVAAMCLQEQAATR
Sbjct: 288 DNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATR 347
Query: 360 PLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTP--RNRDDRRSMADGQ--DSPDEHGR 415
PLIGDVVTALTYLASQT+DPNA S ++R G P R RDDRRS+ DG DSP E
Sbjct: 348 PLIGDVVTALTYLASQTFDPNAPSGQNSRSGSGPPFIRTRDDRRSLGDGSSLDSPAETR- 406
Query: 416 VGRHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDSPV 475
R GSP+THKNSPDYR+R R+ + G+E +ETGGGSGRKW DLE QESQR SP
Sbjct: 407 -SRLGSPATHKNSPDYRRRDMVREVNAGSE-GGSETGGGSGRKWGLSDLEGQESQRGSPA 464
Query: 476 NTGRA-RQSPRNRDLDRERAVAAAKVWGENWREKKRA-NAMGSFDGTDE 522
+ GR+ R +PRNRDLDRERAVA AKVWGENWRE+KRA N GSFD T++
Sbjct: 465 SVGRSSRGTPRNRDLDRERAVAEAKVWGENWRERKRATNGPGSFDSTND 513
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1372 (488.0 bits), Expect = 3.0e-140, P = 3.0e-140
Identities = 299/486 (61%), Positives = 335/486 (68%)
Query: 3 GCFPCFGSSNNKETXXXXXXXXXXXXKELNRKDSAKDGSIAQSHHV--NRVSS-----DK 55
GCF CF SS++++ LN D + G QS N +S +K
Sbjct: 2 GCFSCFDSSDDEK---------------LNPVDESNHGQKKQSQPTVSNNISGLPSGGEK 46
Query: 56 SKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLE 115
S+ K+E +P++ IAA TF FRELAAAT NF P+ LGEGGFGRVYKGRL+
Sbjct: 47 LSSKTNGGSKRELLLPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLD 106
Query: 116 STGQVVAVKQLDRNGLQGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLG 175
STGQVVAVKQLDRNGLQGNREFLVE IGYCADGDQRLLVYEFMPLG
Sbjct: 107 STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLG 166
Query: 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235
SLEDHLHDLPPDKE LDWN RMKIAAGAAKGLE+LHDKANPPVIYRD KSSNILLDEGFH
Sbjct: 167 SLEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFH 226
Query: 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
PKLSDFGLAKLGP GDK+HVSTRVMGTYGYCAPEYAMTGQLT+KSDVYSFGVVFLELITG
Sbjct: 227 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 286
Query: 296 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ 355
RKAID+ P GE NLVAWARPLF DRRKF K+ADP L+GR+P R LYQALAVA+MC+QEQ
Sbjct: 287 RKAIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQ 346
Query: 356 AATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDR--RSMADGQDSPDEH 413
AATRPLI DVVTAL+YLA+Q YDP S +R RNRD+R R + D
Sbjct: 347 AATRPLIADVVTALSYLANQAYDP---SKDDSR------RNRDERGARLITRNDDGGGSG 397
Query: 414 GRVGRHGSPSTHKNSPDYRKRSHPRDGSTGAELSRNETGGGSGRKWLGDDLERQESQRDS 473
+ GS ++SP R RD + ++ + G S R + RQ Q S
Sbjct: 398 SKFDLEGSEK--EDSPRETARILNRDINRERAVAEAKMWGESLR-----EKRRQSEQGTS 450
Query: 474 PVN-TG 478
N TG
Sbjct: 451 ESNSTG 456
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1295 (460.9 bits), Expect = 4.4e-132, P = 4.4e-132
Identities = 257/368 (69%), Positives = 283/368 (76%)
Query: 29 KELNRKDSAKDGSIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTA--HIAAQTFTFR 86
K R + ++G H ++R SSD S S + K + HI AQTFTF
Sbjct: 9 KSSGRNKTRRNGD----HKLDRKSSDCSVSTSEKSRAKSSLSESKSKGSDHIVAQTFTFS 64
Query: 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEXXXXXX 146
ELA AT+NFR ECL+GEGGFGRVYKG L ST Q A+KQLD NGLQGNREFLVE
Sbjct: 65 ELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLVEVLMLSL 124
Query: 147 XXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
IGYCADGDQRLLVYE+MPLGSLEDHLHD+ P K+PLDWNTRMKIAAGAAKG
Sbjct: 125 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIAAGAAKG 184
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
LEYLHDK PPVIYRDLK SNILLD+ + PKLSDFGLAKLGPVGDK+HVSTRVMGTYGYC
Sbjct: 185 LEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 244
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326
APEYAMTGQLTLKSDVYSFGVV LE+ITGRKAID++R GE NLVAWARPLFKDRRKF +
Sbjct: 245 APEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLFKDRRKFSQ 304
Query: 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLS 386
MADP+LQG+YP RGLYQALAVAAMC+QEQ RPLI DVVTAL+YLASQ +DP A
Sbjct: 305 MADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFDPLAQPVQG 364
Query: 387 NRVGPSTP 394
+ P TP
Sbjct: 365 SLFAPGTP 372
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1148 (409.2 bits), Expect = 2.5e-119, Sum P(2) = 2.5e-119
Identities = 232/375 (61%), Positives = 277/375 (73%)
Query: 34 KDSAKDGSIAQSHHVNRVSSDKSKSRNG---SDPKKEPAIPKEPTAHIAAQTFTFRELAA 90
+DS D S ++ V ++K+ N ++ K KE T +IAAQTF+FRELA
Sbjct: 17 RDS--DNSYRRNGEVTGRDNNKTHPENPKTVNEQNKNNDEDKEVTNNIAAQTFSFRELAT 74
Query: 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEXXXXXXXXXX 150
ATKNFR ECL+GEGGFGRVYKG+LE TG +VAVKQLDRNGLQGN+EF+VE
Sbjct: 75 ATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVLMLSLLHHK 134
Query: 151 XXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
IGYCADGDQRLLVYE+M GSLEDHL DL PD+ PLDW+TR++IA GAA GLEYL
Sbjct: 135 HLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALGAAMGLEYL 194
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
HDKANPPVIYRDLK++NILLD F+ KLSDFGLAKLGPVGDK HVS+RVMGTYGYCAPEY
Sbjct: 195 HDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEY 254
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330
TGQLT KSDVYSFGVV LELITGR+ ID TRP E NLV WA+P+FK+ +FP++ADP
Sbjct: 255 QRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPSRFPELADP 314
Query: 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVG 390
L+G +P + L QA+AVAAMCLQE+A RPL+ DVVTAL +L + P+ + ++ +
Sbjct: 315 SLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTA---PDGSISVPHYDD 371
Query: 391 PSTPRNRDDRRSMAD 405
P P D S+ D
Sbjct: 372 PPQP---SDETSVED 383
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1152 (410.6 bits), Expect = 6.2e-117, P = 6.2e-117
Identities = 228/350 (65%), Positives = 271/350 (77%)
Query: 29 KELNRKDSAKDGSIAQSHHV-NRVSS-DKSKSRNGSDPKK--EPAIPKEPTAHIAAQTFT 84
+ NR+ S++ SI N +++ D + S ++ I K +I+A FT
Sbjct: 13 RRFNRRSSSRQ-SIKDCIDAKNNITTFDNISFKTDSSRRRYISEEIAKLGKGNISAHIFT 71
Query: 85 FRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEXXXX 144
FREL ATKNF P+ LGEGGFGRVYKG++E+ QVVAVKQLDRNG QGNREFLVE
Sbjct: 72 FRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLVEVMML 131
Query: 145 XXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE-PLDWNTRMKIAAGA 203
+GYCADGDQR+LVYE+M GSLEDHL +L +K+ PLDW+TRMK+AAGA
Sbjct: 132 SLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAAGA 191
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
A+GLEYLH+ A+PPVIYRD K+SNILLDE F+PKLSDFGLAK+GP G +THVSTRVMGTY
Sbjct: 192 ARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGTY 251
Query: 264 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323
GYCAPEYA+TGQLT+KSDVYSFGVVFLE+ITGR+ ID T+P E NLV WA PLFKDRRK
Sbjct: 252 GYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDRRK 311
Query: 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373
F MADPLL+G+YP++GLYQALAVAAMCLQE+AATRP++ DVVTAL YLA
Sbjct: 312 FTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYLA 361
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1120 (399.3 bits), Expect = 1.5e-113, P = 1.5e-113
Identities = 211/299 (70%), Positives = 240/299 (80%)
Query: 80 AQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV 139
AQTFTF EL+ +T NF+ +C LGEGGFG+VYKG +E QVVA+KQLDRNG QG REF+V
Sbjct: 83 AQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIKQLDRNGAQGIREFVV 142
Query: 140 EXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 199
E IG+CA+G QRLLVYE+MPLGSL++HLHDLP K PL WNTRMKI
Sbjct: 143 EVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKI 202
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 259
AAGAA+GLEYLHD PPVIYRDLK SNIL+DEG+H KLSDFGLAK+GP G +THVSTRV
Sbjct: 203 AAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTRV 262
Query: 260 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 319
MGTYGYCAP+YA+TGQLT KSDVYSFGVV LELITGRKA DNTR +LV WA PLFK
Sbjct: 263 MGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPLFK 322
Query: 320 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD 378
DR+ F KM DPLL+G YP+RGLYQALA+AAMC+QEQ + RP+I DVV AL +LAS YD
Sbjct: 323 DRKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQPSMRPVIADVVMALDHLASSKYD 381
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 212/311 (68%), Positives = 246/311 (79%)
Query: 74 PTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG 133
P+ ++ A+ FTFRELA ATKNFR ECL+GEGGFGRVYKG+LE+ QVVAVKQLDRNGLQG
Sbjct: 26 PSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGLQG 85
Query: 134 NREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDW 193
REFLVE IGYCADGDQRLLVYE+MPLGSLEDHL DL P ++PLDW
Sbjct: 86 QREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDW 145
Query: 194 NTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253
NTR+KIA GAAKG+EYLHD+A+PPVIYRDLKSSNILLD + KLSDFGLAKLGPVGD
Sbjct: 146 NTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTL 205
Query: 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 313
HVS+RVMGTYGYCAPEY TG LT KSDVYSFGVV LELI+GR+ ID RP E NLV W
Sbjct: 206 HVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTW 265
Query: 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373
A P+F+D ++ ++ADPLL+G YP + L QA+AVAAMCL E+ RPL+ DV+TAL++L
Sbjct: 266 ALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSFLG 325
Query: 374 SQTYDPNAASN 384
+ + N SN
Sbjct: 326 ASSNSSNTGSN 336
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
Identities = 211/329 (64%), Positives = 259/329 (78%)
Query: 72 KEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL 131
KE +I A++F FRELA AT +FR E L+GEGGFGRVYKG++E TGQVVAVKQLDRNGL
Sbjct: 48 KESPKNIKAKSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDRNGL 107
Query: 132 QGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL 191
QGNREFLVE IGYC DGDQRLLV+EFMPLGSLEDHL D+ ++PL
Sbjct: 108 QGNREFLVEIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPL 167
Query: 192 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251
DWN+R++IA GAAKGLEYLH+KANPPVIYRD KSSNILL+ F KLSDFGLAKLG VGD
Sbjct: 168 DWNSRIRIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGD 227
Query: 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV 311
+VS+RV+GTYGYCAPEY TGQLT+KSDVYSFGVV LELITG++ ID TRP E NLV
Sbjct: 228 TQNVSSRVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLV 287
Query: 312 AWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371
WA+P+F++ +FP++ADPLLQG +P + L QA+A+AAMCLQE+ RPLI DVVTAL++
Sbjct: 288 TWAQPIFREPNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSF 347
Query: 372 LASQTYDPNAASNLSNRVGPSTPRNRDDR 400
++++T P+ + + + P +P+ +D+
Sbjct: 348 MSTETGSPSGLTGTA--LNPLSPKTVEDQ 374
|
|
| TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1057 (377.1 bits), Expect = 4.3e-111, Sum P(2) = 4.3e-111
Identities = 220/411 (53%), Positives = 281/411 (68%)
Query: 49 NRVSSDKSKSRNGSDPKKEPAIPKEPTAHI------AAQTFTFRELAAATKNFRPECLLG 102
N+ SS +++ + ++PK + E T I + + FTFRELA ATKNFR ECLLG
Sbjct: 12 NKKSSTTNETNDNNEPKPDDRRRAEETEEIEQSEGTSLKIFTFRELATATKNFRQECLLG 71
Query: 103 EGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEXXXXXXXXXXXXXXXIGYCADG 162
EGGFGRVYKG L+STGQVVAVKQLD++GL GN+EF E IGYCADG
Sbjct: 72 EGGFGRVYKGTLKSTGQVVAVKQLDKHGLHGNKEFQAEVLSLGQLDHPNLVKLIGYCADG 131
Query: 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 222
DQRLLVY+++ GSL+DHLH+ D +P+DW TRM+IA AA+GL+YLHDKANPPVIYRD
Sbjct: 132 DQRLLVYDYISGGSLQDHLHEPKADSDPMDWTTRMQIAYAAAQGLDYLHDKANPPVIYRD 191
Query: 223 LKSSNILLDEGFHPKLSDFGLAKLGP-VGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKS 280
LK+SNILLD+ F PKLSDFGL KLGP GDK +S+RVMGTYGY APEY G LTLKS
Sbjct: 192 LKASNILLDDDFSPKLSDFGLHKLGPGTGDKMMALSSRVMGTYGYSAPEYTRGGNLTLKS 251
Query: 281 DVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRG 340
DVYSFGVV LELITGR+A+D TRP E NLV+WA+P+F+D +++P MADP+L+ ++ RG
Sbjct: 252 DVYSFGVVLLELITGRRALDTTRPNDEQNLVSWAQPIFRDPKRYPDMADPVLENKFSERG 311
Query: 341 LYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD--PNAASNLSNR-VGPSTPRNR 397
L QA+A+A+MC+QE+A+ RPLI DV+ AL++L+ T D P LS + S +R
Sbjct: 312 LNQAVAIASMCVQEEASARPLISDVMVALSFLSMPTEDGIPTTVPILSFKDKSMSIALSR 371
Query: 398 DDRRSMADGQDSPDEHGRV----GRHGSPSTHKNSP---DYRKRSHPRDGS 441
D ++ + E + G S + K S +Y+K+ D S
Sbjct: 372 HDSNLVSPPPELATEDDKSSTSSGEESSLESEKESVSKNEYKKKHEEEDSS 422
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1088 (388.1 bits), Expect = 3.8e-110, P = 3.8e-110
Identities = 214/324 (66%), Positives = 254/324 (78%)
Query: 80 AQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV 139
A++FTF+ELAAAT+NFR LLGEGGFGRVYKGRL+S GQVVA+KQL+ +GLQGNREF+V
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIV 121
Query: 140 EXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 199
E IGYC GDQRLLVYE+MP+GSLEDHL DL ++EPL WNTRMKI
Sbjct: 122 EVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKI 181
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 259
A GAA+G+EYLH ANPPVIYRDLKS+NILLD+ F PKLSDFGLAKLGPVGD+THVSTRV
Sbjct: 182 AVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRV 241
Query: 260 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 319
MGTYGYCAPEYAM+G+LT+KSD+Y FGVV LELITGRKAID + GE NLV W+RP K
Sbjct: 242 MGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLK 301
Query: 320 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDP 379
D++KF + DP L+G+YP R L A+A+ AMCL E+A RP IGD+V AL YLA+Q+
Sbjct: 302 DQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRS- 360
Query: 380 NAASNLSNRVGPSTPRNRDDRRSM 403
+ A N+S+ PS +R RR +
Sbjct: 361 HEARNVSS---PSPEISRTPRRDL 381
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.1 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 522 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-60 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-55 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-39 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 3e-60
Identities = 75/195 (38%), Positives = 104/195 (53%), Gaps = 11/195 (5%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNLIGYC 159
LGEGGFG VY R + TG+ VA+K + + E L E+ +L L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
D + LV E+ GSL+D L + L + ++I +GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 220 YRDLKSSNILLDEG-FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-YAMTGQLT 277
+RDLK NILLD KL+DFGL+KL + + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 278 LKSDVYSFGVVFLEL 292
KSD++S GV+ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 3e-55
Identities = 82/234 (35%), Positives = 117/234 (50%), Gaps = 20/234 (8%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLV 153
+ LGEG FG+VY R + TG++VA+K + + ++ +RE L E+ +L L H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
L D D+ LV E+ G L D L E R LEYLH K
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE---AR-FYLRQILSALEYLHSK 116
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
+++RDLK NILLDE H KL+DFGLA+ + ++T V GT Y APE +
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 274 GQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDRRKFP 325
D++S GV+ EL+TG +PP G+ L+ + + K + FP
Sbjct: 171 KGYGKAVDIWSLGVILYELLTG-------KPPFPGDDQLLELFKKIGKPKPPFP 217
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 2e-53
Identities = 76/200 (38%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 101 LGEGGFGRVYKGRL----ESTGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG VYKG L E T VAVK L + EFL E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+G C G+ +V E+MP G L D L E L +++A AKG+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
++RDL + N L+ E K+SDFGL++ D + APE G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 276 LTLKSDVYSFGVVFLELITG 295
T KSDV+SFGV+ E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 5e-53
Identities = 80/199 (40%), Positives = 107/199 (53%), Gaps = 12/199 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 158
LG G FG VYK + + TG++VAVK L + ++ E+ +L L H N+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
D D LV E+ G L D+L PL + KIA +GLEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-T 277
I+RDLK NILLDE K++DFGLAK + + ++T V GT Y APE + G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 278 LKSDVYSFGVVFLELITGR 296
K DV+S GV+ EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-52
Identities = 71/199 (35%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 101 LGEGGFGRVYKGRLE----STGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG VYKG+L+ VAVK L + Q EFL E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+G C + + +V E+M G L +L + L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
I+RDL + N L+ E K+SDFGL++ D + APE G+
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179
Query: 276 LTLKSDVYSFGVVFLELIT 294
T KSDV+SFGV+ E+ T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 74/199 (37%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 101 LGEGGFGRVYKGRLE----STGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG VYKG L+ VAVK L + Q EFL E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+G C + + ++V E+MP G L D+L + L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
I+RDL + N L+ E K+SDFGL++ D V + APE G+
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180
Query: 276 LTLKSDVYSFGVVFLELIT 294
T KSDV+SFGV+ E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 77/209 (36%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 101 LGEGGFGRVYKGRLE---STGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLI 156
LGEG FG VYKG+L+ VAVK L + + R +FL E ++ L H N+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHL-----HDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
G C + + LV E+M G L D+L P+K L + A AKG+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST------RVMGTYGY 265
K ++RDL + N L+ E K+SDFGL++ D T R M
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM----- 174
Query: 266 CAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
APE G T KSDV+SFGV+ E+ T
Sbjct: 175 -APESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVL-----MLSLLH 148
+ LLG G FG VY + TG+++AVK ++ L G+ E +E L +LS L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQ 57
Query: 149 HSNLVNLIGYC--ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL--DWNTRMKIAAGAA 204
H N+V G + + + E++ GSL L EP+ + TR +
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQIL----- 111
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
+GL YLH +++RD+K +NIL+D KL+DFG AK + + V GT
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
+ APE + +D++S G +E+ TG+
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 154
F +G+GGFG VYK R + TG+ VA+K + + + + E+ +L H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
G D+ +V EF GSL+D L + L + + KGLEYLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR--VMGTYGYCAPEYAM 272
+I+RD+K++NILL KL DFGL+ + R ++GT + APE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSA-----QLSDTKARNTMVGTPYWMAPEVIN 170
Query: 273 TGQLTLKSDVYSFGVVFLELITGR 296
K+D++S G+ +EL G+
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 74/217 (34%), Positives = 110/217 (50%), Gaps = 20/217 (9%)
Query: 101 LGEGGFGRVYKGRLE----STGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG+V R + +TG+ VAVK L+ +G Q +F E+ +L L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 156 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G C R L+ E++P GSL D+L ++ ++ + ++ KG++YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST--RVMGTYGYCAPEYA 271
I+RDL + NIL++ K+SDFGLAK+ P + + Y APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 272 MTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGE 307
T + + SDV+SFGV EL T G + PP E
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP---SQSPPAE 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 83/271 (30%), Positives = 126/271 (46%), Gaps = 45/271 (16%)
Query: 101 LGEGGFGRVYKG----RLESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LG G FG VYKG E VA+K L + + N+E L E +++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+G C Q L+ + MPLG L D++ + K+ + + AKG+ YL +K
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+++RDL + N+L+ H K++DFGLAKL V +K + + + A E +
Sbjct: 130 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 276 LTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLV----------------------A 312
T KSDV+S+GV EL+T G K + +L+
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKC 247
Query: 313 W-----ARPLFKD-RRKFPKMA-DPLLQGRY 336
W +RP FK+ +F KMA DP RY
Sbjct: 248 WMIDAESRPTFKELINEFSKMARDP---QRY 275
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 72/202 (35%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 157
LG+G FG+V R + TG++ A+K L + + +E L E +LS ++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 158 YCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK-IAAGAAKGLEYLHDKA 214
+ A + LV E+ P G L HL E R + AA LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFYAAEIVLALEYLHSLG 113
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+IYRDLK NILLD H KL+DFGLAK + +T GT Y APE +
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLAPEVLLGK 168
Query: 275 QLTLKSDVYSFGVVFLELITGR 296
D +S GV+ E++TG+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-32
Identities = 77/216 (35%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEV-----LMLSLLH 148
++R LGEG FG VY R ++VA+K L L+ + + ++ SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVL-AKKLESKSKEVERFLREIQILASLNH 56
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
N+V L + D LV E++ GSLED L K PL + + I A LE
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALE 115
Query: 209 YLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKL----GPVGDKTHVSTRVMGTY 263
YLH K +I+RD+K NILLD G KL DFGLAKL G + + +GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 264 GYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGR 296
GY APE + + SD++S G+ EL+TG
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 77/244 (31%), Positives = 113/244 (46%), Gaps = 32/244 (13%)
Query: 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLI 156
L+G G FG VYKG TG VA+KQ+ ++ + + E+ +L L H N+V I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA---AGAAKGLEYLHDK 213
G D ++ E+ GSL + P E L +A +GL YLH++
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAYLHEQ 118
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
VI+RD+K++NIL + KL+DFG+A KL V V+GT + APE
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIE 172
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK----DRRKFPKMA 328
+ SD++S G +EL+TG PP ++L LF+ D P+
Sbjct: 173 MSGASTASDIWSLGCTVIELLTG-------NPP-YYDLNP-MAALFRIVQDDHPPLPEGI 223
Query: 329 DPLL 332
P L
Sbjct: 224 SPEL 227
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 77/204 (37%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 100 LLGEGGFGRVYKGRLE----STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LG+G FG V R + +TG+VVAVK+L + + R+F E+ +L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 156 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G C +R LV E++P GSL D+L +E LD + A+ KG+EYL K
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYGYCAPEY 270
++RDL + NIL++ K+ DFGL K+ P DK + R G + Y APE
Sbjct: 128 R---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APES 182
Query: 271 AMTGQLTLKSDVYSFGVVFLELIT 294
+ ++ SDV+SFGVV EL T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLV-EVLMLSLLHHSN 151
+ +G+G FG+VY R +S G++ +K++D + + + RE + EV +L L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
++ + + +V E+ G L + + +P + L+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-- 269
+ +++RD+K NI L KL DFG++K+ + ++ V+GT Y +PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175
Query: 270 ----YAMTGQLTLKSDVYSFGVVFLELITGRKA 298
Y KSD++S G V EL T +
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-31
Identities = 68/202 (33%), Positives = 111/202 (54%), Gaps = 8/202 (3%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
+ F E LG G FG V++G ++ +V A+K L + L ++F EV L L H +L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
++L C+ G+ ++ E M GSL L P+ + L + + +A A+G+ YL +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
+ I+RDL + NIL+ E K++DFGLA+L + + ++S+ Y + APE A
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 273 TGQLTLKSDVYSFGVVFLELIT 294
G + KSDV+SFG++ E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 154
LGEG FG+VYKG L + VA+K L N + EF E ++S L H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEPLDWNTRMKIAAG 202
L+G C +++E++ G L + L P K LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 262
A G+EYL ++ ++RDL + N L+ EG K+SDFGL++ D V ++ +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 292
+ PE + G+ T +SD++SFGVV E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQ-----VVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVN 154
LGEG FG+V+ G +VAVK L R+ F E +L+ H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHL--HD--------LPPDKEPLDWNTRMKIAAGAA 204
G C +GD ++V+E+M G L L H L + ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
G+ YL A+ ++RDL + N L+ K+ DFG+++ D V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ PE M + T +SDV+SFGVV E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 68/201 (33%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 159
+G+G FG V G GQ VAVK L + + FL E +++ L H NLV L+G
Sbjct: 13 TIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
G+ +V E+M GSL D+L + + ++ A +G+EYL +K +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEKN---FV 124
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAK---LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 276
+RDL + N+L+ E K+SDFGLAK G K V + APE +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKF 176
Query: 277 TLKSDVYSFGVVFLELIT-GR 296
+ KSDV+SFG++ E+ + GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 74/211 (35%), Positives = 107/211 (50%), Gaps = 16/211 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V+ G T +V AVK L + G FL E ++ L H LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ + +V E+M GSL D L + + L + +AA A+G+ YL + I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLK 279
RDL + NIL+ E K++DFGLA+L + T + + APE A G+ T+K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184
Query: 280 SDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309
SDV+SFG++ E++T GR PG N
Sbjct: 185 SDVWSFGILLTEIVTYGR-----VPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 101 LGEGGFGRV----YKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNL 155
LGEG FG+V Y + TG++VAVK L R Q N + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 156 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G C++ + L+ E++PLGSL D+L K L+ + A +G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAM 272
I+RDL + N+LLD K+ DFGLAK P G + + V + A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 273 TGQLTLKSDVYSFGVVFLELIT 294
+ + SDV+SFGV EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 32/265 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGY 158
+G+G FG V+K ++ +V A+KQ+D + + E + E +L+ L S ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
D + +V E+ G L L PL + + GL +LH K +
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 278
++RD+KS N+ LD + K+ D G+AKL + D T+ + ++GT Y +PE
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 279 KSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY-P 337
KSDV++ GVV E TG+ D +N A +++G + P
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD------ANNQGALIL--------------KIIRGVFPP 220
Query: 338 MRGLY-QALA-VAAMCLQEQAATRP 360
+ +Y Q LA + CL + RP
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 63/226 (27%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLV--EVLMLSLL-H 148
+F+ ++GEG F V + + T + A+K LD+ L + + V E +L+ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
H ++ L D + V E+ P G L ++ LD AA LE
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALE 116
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVM------- 260
YLH K +I+RDLK NILLD+ H K++DFG AK L P
Sbjct: 117 YLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 261 ----------GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
GT Y +PE SD+++ G + +++TG+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVK--QLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG- 157
LG+G G VYK R + TG++ A+K +D + ++ L E+ L +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVVKCYGA 67
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
+ +G+ +V E+M GSL D L + EP+ IA KGL+YLH K +
Sbjct: 68 FYKEGEIS-IVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTKRH-- 120
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPE------Y 270
+I+RD+K SN+L++ K++DFG++K L D+ + T V GT Y +PE Y
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESY 177
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGR 296
+ +D++S G+ LE G+
Sbjct: 178 SY------AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 69/204 (33%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 100 LLGEGGFGRVYKGR-LESTGQV--VAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNL 155
LG+G FG V +G S G+V VAVK L + L +FL E ++ L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLD--WNTRMKIAAGAAKGLEYLHDK 213
G ++V E PLGSL D L + + ++IA G+ YL K
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLESK 116
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST---RVMGTYGYCAPEY 270
I+RDL + NILL K+ DFGL + P + +V +V + +CAPE
Sbjct: 117 R---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171
Query: 271 AMTGQLTLKSDVYSFGVVFLELIT 294
T + SDV+ FGV E+ T
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 69/208 (33%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQ--LDRNGLQGN---REFLVEVLMLSLLHHSNLVN 154
LLG G FG VY+G G AVK+ L +G G ++ E+ +LS L H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
+G + D + E +P GSL L EP+ +I GLEYLHD+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN 122
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-----GTYGYCAPE 269
++RD+K +NIL+D KL+DFG+AK V G+ + APE
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPE 171
Query: 270 YAM-TGQLTLKSDVYSFGVVFLELITGR 296
G L +D++S G LE+ TG+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLLHHSNLVNL 155
+GEG +G+VYK R + TG++VA+K++ ++ +E + E+ +L L H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 156 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK-------- 205
+ +V+E+M HDL L + +K K
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD--------HDL----TGLLDSPEVKFTESQIKCYMKQLLE 111
Query: 206 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265
GL+YLH +++RD+K SNIL++ KL+DFGLA+ + T + T Y
Sbjct: 112 GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWY 167
Query: 266 CAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 296
PE + + + D++S G + EL G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 27/204 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+GEG G VYK +TG+ VA+K++ + N+E ++ E+L++ H N+V+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWN-TRMK---IAAGAA---KGLEYLHD 212
GD+ +V E+M GSL D + N RM IA +GLEYLH
Sbjct: 85 LVGDELWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ VI+RD+KS NILL + KL+DFG A+L K + V+GT + APE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYWMAPEVI 188
Query: 272 MTGQLTLKSDVYSFGVVFLELITG 295
K D++S G++ +E+ G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 104 GGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIGYCA 160
G +GRV+ + +STG + A+K + + + + L E +LS +V L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 161 DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
G + L LV E++P G L L ++ LD + A LEYLH + +I
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLH---SNGII 115
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS------TRVMGTYGYCAPEYAMT 273
+RDLK NIL+D H KL+DFGL+K+G V + +++ R++GT Y APE +
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 274 GQLTLKSDVYSFGVVFLELITG 295
+ D +S G + E + G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM-LSLLHHSNLVNLIGY- 158
LG G G V K TG+++AVK + N ++L L +LH N ++G+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 159 --CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+ + E+M GSL+ L + + KIA KGL YLH+K
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHK- 121
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM--------GTYGYCAP 268
+I+RD+K SNIL++ KL DFG VS +++ GT Y AP
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAP 168
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELITGR 296
E ++KSD++S G+ +EL TGR
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIG 157
LG+GGFG V ++++TG++ A K+LD+ L +G + L E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 158 YCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKA 214
D LV M G L+ H+ P E R AA GLE+LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA-----RAIFYAAQIICGLEHLHQRR 115
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
++YRDLK N+LLD+ + ++SD GLA G K GT GY APE
Sbjct: 116 ---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGE 169
Query: 275 QLTLKSDVYSFGVVFLELITGR 296
D ++ G E+I GR
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 68/206 (33%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIG 157
++G G VY + VA+K++D Q + + L EV +S +H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA---GAAKGLEYLHDKA 214
GD+ LV ++ GSL D+ P IA KGLEYLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTH-VSTRVMGTYGYCAPEYAM 272
I+RD+K+ NILL E K++DFG+ A L GD+T V +GT + APE M
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VM 178
Query: 273 TGQ--LTLKSDVYSFGVVFLELITGR 296
K+D++SFG+ +EL TG
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V++G +T V AVK L + G ++FL E ++ L H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ +V E M GSL ++L L + +AA A G+ YL + I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKL-------GPVGDKTHVSTRVMGTYGYCAPEYAMT 273
RDL + N+L+ E K++DFGLA++ G K + + APE A+
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK--------WTAPEAALY 178
Query: 274 GQLTLKSDVYSFGVVFLELIT-GR 296
+ ++KSDV+SFG++ E++T GR
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 62/200 (31%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 102 GEGGFGRVYKGRLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLLHHSNLVNLIGY 158
G+G FG+V + T ++ A+K +++ R L E +L L+H LVNL
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKANPP 217
D + LV + + G L HL E ++K LEYLH K
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWICEIVLALEYLHSKG--- 120
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 277
+I+RD+K NILLDE H ++DF +A T T GT GY APE +
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYS 177
Query: 278 LKSDVYSFGVVFLELITGRK 297
+ D +S GV E + G++
Sbjct: 178 VAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 74/242 (30%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 154
F LGEG +G VYK + TGQVVA+K + +E + E+ +L +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA---GAAKGLEYLH 211
G +V E+ GS+ D + + L T +IAA KGLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTL---TEEEIAAILYQTLKGLEYLH 116
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEY 270
I+RD+K+ NILL+E KL+DFG++ +L K + V+GT + APE
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEV 170
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGR------------KAIDNTRPPGEHNLVAWARPLF 318
K+D++S G+ +E+ G+ I N PP + W+ P F
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWS-PEF 229
Query: 319 KD 320
D
Sbjct: 230 ND 231
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 101 LGEGGFGRVYKGRLE--STGQV---VAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 154
LG+G FG VY+G + G+ VA+K + + ++ EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------PLDWNTRMKIAAGAAKGLE 208
L+G + G L+V E M G L+ +L P+ E P +++AA A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
YL K ++RDL + N ++ E K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELIT 294
E G T KSDV+SFGVV E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 32/209 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGN--REFLVEVLMLSLLHHSNLVN 154
LGEG +G VYK R + TG++VA+K++ + G+ R E+ +L L H N+V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELKHPNIVK 62
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
L+ + LV+E+ + L+ +L P PL N I +GL Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+++RDLK NIL++ KL+DFGLA+ + +T+ + V+ T Y APE
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPE----- 168
Query: 275 QLTLKS-------DVYSFGVVFLELITGR 296
+ L S D++S G +F E+ITG+
Sbjct: 169 -ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 65/197 (32%), Positives = 94/197 (47%), Gaps = 8/197 (4%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNLIGY 158
+G+G FG VYKG L+ +V AVK + FL E +L H N+V LIG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
C +V E +P GSL L K L ++++ AA G+EYL K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 278
I+RDL + N L+ E K+SDFG+++ G T + APE G+ T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 279 KSDVYSFGVVFLELITG 295
+SDV+S+G++ E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 90/284 (31%), Positives = 132/284 (46%), Gaps = 47/284 (16%)
Query: 100 LLGEGGFGRVYKGRL-ESTGQVV--AVKQLDR-NGLQGNREFLVEVLMLSLLHHSNLVNL 155
++G+G FG VY G L +S GQ + AVK L+R L+ +FL E +++ H N+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 156 IGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG--AAKGLEYLHD 212
+G C + L+V +M G L + + P + I G AKG+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRS--ETHNP---TVKDLIGFGLQVAKGMEYL-- 114
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK------LGPVGDKTHVSTRVMGTYGYC 266
A+ ++RDL + N +LDE F K++DFGLA+ V + T V +
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH-NLVAWARPLFKDRRKFP 325
A E T + T KSDV+SFGV+ EL+T R A PP + L + RR
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT-RGA-----PPYPDVDSFDITVYLLQGRR--- 220
Query: 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP----LIGDV 365
LLQ Y LY+ V C + RP L+ +
Sbjct: 221 -----LLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGY 158
+GEG +G VYK R + TG++VA+K++ + L E+ +L L+H N++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
LV+EFM D + + L + +GL + H +
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHG--I 119
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYGYCAPEYAMT-G 274
++RDLK N+L++ KL+DFGLA+ PV TH V TR Y APE +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 275 QLTLKSDVYSFGVVFLELITGR 296
+ D++S G +F EL++ R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-25
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G +G VY+G + VAVK L + ++ EFL E ++ + H NLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
++ EFM G+L D+L + +++ ++ + +A + +EYL K I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKL-------GPVGDKTHVSTRVMGTYGYCAPEYAMT 273
RDL + N L+ E K++DFGL++L G K + + APE
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPESLAY 179
Query: 274 GQLTLKSDVYSFGVVFLELIT 294
+ ++KSDV++FGV+ E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG+V+ E +VAVK L ++F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE-----------PLDWNTRMKIAAGAA 204
G C +G L+V+E+M G L L PD + L + IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
G+ YL A+ ++RDL + N L+ +G K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ PE + + T +SD++SFGVV E+ T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 73/226 (32%), Positives = 110/226 (48%), Gaps = 23/226 (10%)
Query: 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTG----QVVAVKQL-DRNGLQGNREFLVEV 141
EL + F E LGE FG++YKG L G Q+VA+K L D N Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 142 LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------------K 188
+++ LHH N+V L+G +++E++ G L + L P K
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 189 EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248
LD + IA A G+EYL ++ +++DL + NIL+ E H K+SD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
D V + + + PE M G+ + SD++SFGVV E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 65/202 (32%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIG 157
LG GGFGRV +++S + A+K + + + + E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 158 YCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
Y D++ +Y E+ G L L D + D T A EYLH++
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+IYRDLK N+LLD + KL DFG AK G KT GT Y APE +
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNK 167
Query: 275 QLTLKSDVYSFGVVFLELITGR 296
D +S G++ EL+TGR
Sbjct: 168 GYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 66/198 (33%), Positives = 96/198 (48%), Gaps = 15/198 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIG 157
LG G FGRV R + +G+ A+K L + + ++ L E +L + H LVNL G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
D LV E++P G L HL + P R AA LEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPV-ARF-YAAQVVLALEYLHSLD--- 121
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 277
++YRDLK N+LLD + K++DFG AK V +T+ + GT Y APE ++
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAPEIILSKGYG 176
Query: 278 LKSDVYSFGVVFLELITG 295
D ++ G++ E++ G
Sbjct: 177 KAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 79/292 (27%), Positives = 121/292 (41%), Gaps = 51/292 (17%)
Query: 99 CLLGEGGFGRVYKGRLESTGQVVAVKQ-LDRNGLQGNREF-LVEVLMLSLLHHSNLVNLI 156
++GEG +G V K R ++TG++VA+K+ + + ++ L EV +L L H N+VNL
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 157 GYCADGDQRLLVYEFMP---LGSLEDHLHDLPPDK-EPLDWNTRMKIAAGAAKGLEYLHD 212
+ LV+E++ L LE LPPD W + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHS 118
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
+I+RD+K NIL+ E KL DFG A+ + ++ V T Y APE
Sbjct: 119 HN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE--- 171
Query: 273 TGQLTLKS-------DVYSFGVVFLELITGR----------------KAIDNTRPPGEHN 309
L + DV++ G + EL+ G K + P H
Sbjct: 172 ---LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP--SHQ 226
Query: 310 LVAWARPLFKDRRKFPKMADP-LLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
+ + P F FP+ + P L+ RYP + AL CL+ R
Sbjct: 227 ELFSSNPRFA-GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLV-EVLMLSLLHHSNLVNLIGY 158
+G+G FG V K R +S G+++ K++D + + ++ LV EV +L L H N+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 159 CADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
D + L V E+ G L + +++ ++ +I L H++++P
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 217 P--VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEYA 271
V++RDLK +NI LD + KL DFGLAK+ KT+V GT Y +PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYMSPEQL 182
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR 296
KSD++S G + EL
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 101 LGEGGFGRVYKGR---LESTGQ--VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG+V+ L T +VAVK L L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK------EPLDWNTR------MKIAAGA 203
G C DGD ++V+E+M G L L PD +P + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
A G+ YL A+ ++RDL + N L+ K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 264 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ PE M + T +SDV+SFGV+ E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 7e-23
Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 18/215 (8%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLD---RNGLQGNREFLV---EVLMLSLLHHSNLV 153
+LG+G +G VY G L + GQ++AVKQ++ N L +E+ EV +L L H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
+G C D + + EF+P GS+ L+ P EP+ +I G A YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK----LGPVGDKTHVSTRVMGTYGYCAPE 269
V++RD+K +N++L KL DFG A+ +G G +++ + GT + APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 304
KSD++S G E+ TG+ + +
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 49/289 (16%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV------EVLMLSLLHHSNLV 153
L+GEG +G V K + + TGQ+VA+K+ L+ + +V E+ ML L H NLV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDH--LHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
NLI + LV+EF+ DH L DL LD + K +G+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEY 270
+ +I+RD+K NIL+ + KL DFG A+ L G+ V T + T Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPEL 171
Query: 271 AMTGQLTLKS-DVYSFGVVFLELITGRKAIDNTRPPGEH-------------NLVAWARP 316
+ ++ D+++ G + E++TG PG+ NL+ +
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG-----EPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226
Query: 317 LFKDRRKFPKMADPLLQGRYPMRGLY-----QALAVAAMCLQEQAATRP 360
+F+ F M P ++ P+ + L +A CL+ RP
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 9e-23
Identities = 72/198 (36%), Positives = 109/198 (55%), Gaps = 12/198 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V+ G +V AVK L + G FL E ++ L H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ + +V E+M GSL D L D + L + +AA A G+ Y+ ++ N I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYI-ERMN--YIH 125
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYAMTGQLTLK 279
RDL+S+NIL+ +G K++DFGLA+L + D + + + + APE A+ G+ T+K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 280 SDVYSFGVVFLELIT-GR 296
SDV+SFG++ EL+T GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 79/273 (28%), Positives = 117/273 (42%), Gaps = 39/273 (14%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLV 153
F +G+G FG VYK + T QVVA+K +D + E + E+ LS +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE-PLDWNTRMKIAAGAAKGLEYLHD 212
G G + ++ E+ GS D L K LD I GLEYLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEYLHE 116
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCAPE 269
+ I+RD+K++NILL E KL+DFG++ G T ++ +GT + APE
Sbjct: 117 EG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPE 168
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDRRKFPKM 327
K+D++S G+ +EL G PP H + R LF PK
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG-------EPPLSDLHPM----RVLF----LIPKN 213
Query: 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
P L+G + + ++CL + RP
Sbjct: 214 NPPSLEGNKFSKPFKDFV---SLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQ---VVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNL 155
+G G FG V +GRL+ G+ VA+K L + G +FL E ++ H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G +++ E+M GSL+ L +D + + G A G++YL +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCA 267
++RDL + NIL++ K+SDFGL++ + D T T G + A
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGGKIPIRWTA 176
Query: 268 PEYAMTGQLTLKSDVYSFGVVFLELIT 294
PE + T SDV+SFG+V E+++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V+ G VA+K L + G FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMGYYNGH-TKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ ++ E+M GSL D L P+ L N + +AA A+G+ ++ K I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY--GYCAPEYAMTGQLTL 278
RDL+++NIL+ E K++DFGLA+L + + R + + APE G T+
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 279 KSDVYSFGVVFLELIT-GR 296
KSDV+SFG++ E++T GR
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 101 LGEGGFGRVYKG--RLESTGQV-VAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNLI 156
LG G FG V KG ++S +V VAVK L + + +EFL E +++ L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
G C G+ +LV E PLG L +L P + + ++ A G+ YL K
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 269
++RDL + N+LL K+SDFG+++ G + +T T G + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPE 168
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT 294
G+ + KSDV+S+GV E +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V+ G+ V A+K + R G +F+ E ++ L H NLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDV-AIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+V E+M G L ++L + K L + + + + +EYL I+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 277
RDL + N L+ E K+SDFGLA+ V D + S+ GT + PE + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFS 179
Query: 278 LKSDVYSFGVVFLELITGRK 297
KSDV+SFGV+ E+ + K
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLD-RNGLQGNREFLV-EV-LMLSLLHHS 150
+F+ LG+G +G VYK + S Q A+K++D + Q RE V E+ ++ S+ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP- 59
Query: 151 NLVNLIGY---CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207
N+I Y DG++ +V E+ P G L + ++ + +I +GL
Sbjct: 60 ---NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 267
+ LH++ +++RDLKS+NILL K+ D G++K+ K +++ +GT Y A
Sbjct: 117 QALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMA 169
Query: 268 PEYAMTGQLTLKSDVYSFGVVFLELITGR 296
PE + KSD++S G + E+ T
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 69/221 (31%), Positives = 104/221 (47%), Gaps = 39/221 (17%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL-------DRNGLQGNREFLVEVLMLSL 146
+ LGEG + VYK R + TG++VA+K++ ++G+ N L E+ +L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQE 58
Query: 147 LHHSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHD-----LPPDKEPLDWNTRMKI 199
L H N++ L+ + + LV+EFM LE + D P D + T
Sbjct: 59 LKHPNIIGLLDVFGH--KSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT---- 111
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDK-TH-VS 256
+GLEYLH +++RDLK +N+L+ KL+DFGLA+ G K TH V
Sbjct: 112 ----LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 257 TRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 296
TR Y APE + D++S G +F EL+
Sbjct: 165 TRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 100 LLGEGGFGRVYKG----RLESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 154
LLG G FG V+KG +S VA+K + DR+G Q +E +L + L H+ +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP---LDWNTRMKIAAGAAKGLEYLH 211
L+G C G LV + PLGSL DH+ +P L+W ++ AKG+ YL
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ +++R+L + NILL +++DFG+A L DK + + + A E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 272 MTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPP 305
+ G+ T +SDV+S+GV E+++ G + RP
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 73/208 (35%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 99 CLLGEGGFGRVYKGRLESTGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+GEG +G V+K R TGQ+VA+K+ + + L E+ ML L H NLVNLI
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 157 GYCADGDQRLLVYEFMPLGSLEDH--LHDLPPDKEP--LDWNTRMKIAAGAAKGLEYLHD 212
+ LV+E+ DH L++L +K P + + KI + + + H
Sbjct: 67 EVFRRKRKLHLVFEYC------DHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCH- 117
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKT-HVSTRVMGTYGYCAPE 269
K N I+RD+K NIL+ + KL DFG A++ GP D T +V+TR Y APE
Sbjct: 118 KHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE 170
Query: 270 YAMTGQLTLKS--DVYSFGVVFLELITG 295
+ G DV++ G VF EL+TG
Sbjct: 171 L-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 66/203 (32%), Positives = 107/203 (52%), Gaps = 16/203 (7%)
Query: 101 LGEGGFGRV----YKGRLESTGQVVAVKQLD-RNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG+V Y ++TG+ VAVK L +G + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 156 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G C + L+ EF+P GSL+++L P +K ++ ++K A KG++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR--VMGTYGYCAPEYA 271
++RDL + N+L++ K+ DFGL K DK + + + + + APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 272 MTGQLTLKSDVYSFGVVFLELIT 294
+ + + SDV+SFGV EL+T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIG 157
++G G FG V+ R ++ ++V +KQ+ + + E +L LL H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
+ ++V E+ P G+L +++ L + L + ++ +A L ++H K
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVHTK 120
Query: 214 ANPPVIYRDLKSSNILLDEGFHP---KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
+++RDLK+ NILLD+ H K+ DFG++K+ + K+ T V+GT Y +PE
Sbjct: 121 L---ILHRDLKTQNILLDK--HKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPEL 172
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 305
KSD+++ G V EL + ++A + P
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-22
Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 27/301 (8%)
Query: 79 AAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL-DRNGLQGNREF 137
+++ T ++ ++ K E ++ G G YKG+ G VK++ D N + +
Sbjct: 679 VSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS--- 732
Query: 138 LVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM 197
E+ + L H N+V LIG C L++E++ +L + L +L W R
Sbjct: 733 --EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRR 783
Query: 198 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257
KIA G AK L +LH + +P V+ +L I++D P L L L K +S+
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842
Query: 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317
Y APE T +T KSD+Y FG++ +EL+TG+ D ++V WAR
Sbjct: 843 ------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYC 895
Query: 318 FKDRRKFPKMADPLLQGRYPM--RGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375
+ D DP ++G + + + + +A C RP DV+ L +
Sbjct: 896 YSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954
Query: 376 T 376
+
Sbjct: 955 S 955
|
Length = 968 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 24/225 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI-GYC 159
LG+G FG+VYK + + TG A K + + +F+VE+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
+ +L+ EF G+L+ + +L + L + + L +LH VI
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VI 125
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-- 277
+RDLK+ NILL KL+DFG++ + + +GT + APE
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 278 ---LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 319
K+D++S G+ +EL PP H+ + R L K
Sbjct: 184 PYDYKADIWSLGITLIELAQM-------EPP--HHELNPMRVLLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 73/272 (26%), Positives = 108/272 (39%), Gaps = 34/272 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQ-LDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 159
LGEG G V K RL++TG + A+K ++ L E+ + +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 160 ADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRM------KIAAGAAKGLEYLH 211
D + E+ GSL+ K+ R+ KIA KGL YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEY 270
+ +I+RD+K SNILL KL DFG++ +L T GT Y APE
Sbjct: 123 SRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPER 174
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAI--DNTRPPGEHNLVAWARPLFKDRRKFPKMA 328
++ SDV+S G+ LE+ R + P G L+++ P++
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-----NMPNPELK 229
Query: 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
D G + CL++ RP
Sbjct: 230 DEPGNGIKWSEEFKDFIKQ---CLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQ--LDRNGLQG---NREFLV----EVLMLSLLHHS 150
L+G G FG VY G S+G+++AVKQ L R L E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
N+V +G D D + E++P GS+ L++ +E L N +I KGL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-----LGPVGDKTHVSTRVMGTYGY 265
H++ +I+RD+K +NIL+D K+SDFG++K + + G+ +
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 266 CAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
APE T K+D++S G + +E++TG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 101 LGEGGFGRVYKGRLESTGQV-------VAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNL 152
+G+G FGRV++ R + G + VAVK L + +F E +++ H N+
Sbjct: 13 IGQGAFGRVFQAR--APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------------DKEPLDWN 194
V L+G CA G L++E+M G L + L P + PL
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 195 TRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254
++ IA A G+ YL ++ ++RDL + N L+ E K++DFGL++ D
Sbjct: 131 EQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
S + PE + T +SDV+++GVV E+ +
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-21
Identities = 72/206 (34%), Positives = 115/206 (55%), Gaps = 12/206 (5%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
++ R + LG+G FG V+ G T +V A+K L + G FL E ++ L H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
V L ++ + +V EFM GSL D L + D + L + +AA A G+ Y+ +
Sbjct: 64 VPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYI-E 119
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYA 271
+ N I+RDL+++NIL+ + K++DFGLA+L + D + + + + APE A
Sbjct: 120 RMN--YIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 272 MTGQLTLKSDVYSFGVVFLELIT-GR 296
+ G+ T+KSDV+SFG++ EL+T GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 100 LLGEGGFGRVYKGRL-----ESTGQV-VAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNL 152
LG G FG VY+G +G + VAVK L + Q +EFL E ++S +H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP---LDWNTRMKIAAGAAKGLEY 209
V L+G C + + ++ E M G L +L D ++ L + I AKG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHP-----KLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
L I+RDL + N L+ E + K+ DFGLA+ D +
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ APE + G+ T +SDV+SFGV+ E++T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 6e-21
Identities = 68/198 (34%), Positives = 107/198 (54%), Gaps = 18/198 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+GEG FG V +G E TGQ VAVK + + + FL E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ +V E M G+L + L + ++ + A+G+EYL K +++
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLESKK---LVH 123
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVG-DKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
RDL + NIL+ E K+SDFGLA++G +G D + + + + APE + + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 280 SDVYSFGVVFLELIT-GR 296
SDV+S+GV+ E+ + GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG+V+ E +VAVK L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK---------EPLDWNTRMKIAAGAAKG 206
G C +GD ++V+E+M G L L PD L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
+ YL A+ ++RDL + N L+ E K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELIT 294
PE M + T +SDV+S GVV E+ T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 1e-20
Identities = 71/206 (34%), Positives = 112/206 (54%), Gaps = 12/206 (5%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
++ R E LG+G FG V+ G T +V A+K L + G FL E ++ L H L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
V L ++ + +V E+M GSL D L + L + +AA A G+ Y+ +
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYV-E 119
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYA 271
+ N ++RDL+++NIL+ E K++DFGLA+L + D + + + + APE A
Sbjct: 120 RMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 272 MTGQLTLKSDVYSFGVVFLELIT-GR 296
+ G+ T+KSDV+SFG++ EL T GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 70/207 (33%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM----LSLLHHS-NLVN 154
+G G G+VYK R + TG V+AVKQ+ R G N+E +LM + H +V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
GY + E M + D L L + P+ + K+ K L YL +K
Sbjct: 79 CYGYFITDSDVFICMELM--STCLDKL--LKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEY--- 270
VI+RD+K SNILLD + KL DFG++ +L V K TR G Y APE
Sbjct: 135 G--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK--TRSAGCAAYMAPERIDP 188
Query: 271 -AMTGQLTLKSDVYSFGVVFLELITGR 296
+ +++DV+S G+ +EL TG+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 38/275 (13%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSN 151
++ P +LG+G FG R +V K+++ L + R+ L E+++LSLL H N
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLED---HLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
++ + D + L+ E+ G+L D ++E + W ++A +
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA-----VS 115
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
Y+H KA +++RD+K+ NI L + KL DFG++K+ +G + ++ V+GT Y +P
Sbjct: 116 YIH-KAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSP 170
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328
E + KSD+++ G V EL+T ++ D T P NLV
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV---------------- 211
Query: 329 DPLLQGRY-PMRGLYQA--LAVAAMCLQEQAATRP 360
++QG Y P+ +Y + +++ LQ+ RP
Sbjct: 212 -KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLD--RNGLQGNREFLVEVL-----MLSLLHHSNL 152
LG G F Y+ R TG ++AVKQ+ RN +E +VE L +++ L+H ++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 153 VNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+ ++G C D L V E+M GS+ L KE + N ++ +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLH 120
Query: 212 DKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLA-KLGPVGDKT-HVSTRVMGTYGYCAP 268
+ +I+RD+K +N+L+D G +++DFG A +L G +++GT + AP
Sbjct: 121 ENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELITGR 296
E Q DV+S G V +E+ T +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 70/226 (30%), Positives = 113/226 (50%), Gaps = 15/226 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+G+G G VY +TGQ VA+KQ++ Q +E ++ E+L++ H N+VN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
GD+ +V E++ GSL D + + D+ + R + A LE+LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LEFLHSNQ---VI 137
Query: 220 YRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 278
+RD+KS NILL KL+DFG A++ P K + ++GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 279 KSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW-ARPLFKDRRK 323
K D++S G++ +E++ G N P L+A P ++ K
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 11/208 (5%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+G G FG V+ G +V A+K + R G +F+ E ++ L H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ LV+EFM G L D+L + T + + +G+ YL VI+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 280
RDL + N L+ E K+SDFG+ + + D+ ST + +PE + + KS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 281 DVYSFGVVFLELIT-GRKAIDNTRPPGE 307
DV+SFGV+ E+ + G+ +N R E
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYEN-RSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 67/217 (30%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY- 158
++GEG +G+VYK R + TGQ+VA+K +D E E +L +SN N+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILR--KYSNHPNIATFY 69
Query: 159 --------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK------IAAGAA 204
+ DQ LV E GS+ D + L R+K I
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL------RKKGKRLKEEWIAYILRETL 123
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTY 263
+GL YLH+ VI+RD+K NILL + KL DFG+ A+L + + GT
Sbjct: 124 RGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTP 177
Query: 264 GYCAPE-----YAMTGQLTLKSDVYSFGVVFLELITG 295
+ APE +SDV+S G+ +EL G
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 13/207 (6%)
Query: 100 LLGEGGFGRVYKGRLESTGQVV----AVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVN 154
+LG G FG VYKG G+ V A+K L+ G + N EF+ E L+++ + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
L+G C +L V + MP G L D++H+ K+ + + AKG+ YL ++
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+++RDL + N+L+ H K++DFGLA+L +K + + + A E
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 275 QLTLKSDVYSFGVVFLELIT-GRKAID 300
+ T +SDV+S+GV EL+T G K D
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLLHHSNLVNL 155
+GEG +G VYKGR + TGQ+VA+K++ L+ E + E+ +L L H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+ L++EF+ + L+ +L LP + +D +G+ + H +
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQY-MDAELVKSYLYQILQGILFCHSRR- 121
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
V++RDLK N+L+D KL+DFGLA+ G V T + T Y APE +
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 276 L-TLKSDVYSFGVVFLELITGR 296
+ D++S G +F E+ T +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 55/196 (28%), Positives = 85/196 (43%), Gaps = 17/196 (8%)
Query: 104 GGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF----LVEVLMLSLLHHSNLVNLIGYC 159
G FG VY + STG A+K L ++ + + +M+ + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
D LV E++ G + L P DW + A G+E LH + +I
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAK--QYIAEVVLGVEDLHQRG---II 119
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
+RD+K N+L+D+ H KL+DFGL++ G + + +GT Y APE +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKM 173
Query: 280 SDVYSFGVVFLELITG 295
SD +S G V E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 69/209 (33%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQ--LDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 158
+G G FG+VY TG+++AVK+ + N + +E E+ +L LL H NLV Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV---KY 64
Query: 159 CADGDQRLLVYEFMPL---GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
R VY FM G+LE+ L LD + +GL YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHG- 119
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRV---MGTYGYCAPEYA 271
+++RD+K +NI LD KL DFG A L + T + V GT Y APE
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN--NTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 272 MTGQLTLK---SDVYSFGVVFLELITGRK 297
G+ +D++S G V LE+ TG++
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL--DRNGLQGNRE---FLVEVLMLSLLH 148
N+R LLG+G FGRVY TG+ +AVKQ+ D + + +E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 149 HSNLVNLIGYCADGDQRLLVY-EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207
H +V G C D+ L ++ E+MP GS++D L E + TR K +G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TR-KYTRQILEGV 117
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYC 266
EYLH +++RD+K +NIL D + KL DFG +K L + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 305
+PE K+DV+S G +E++T +PP
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT-------EKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 73/198 (36%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIG 157
+G G FG VY R T +VVA+K++ +G Q N ++ + EV L L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
LV E+ LGS D L K+PL I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLH---SHE 135
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--YAM-TG 274
I+RD+K+ NILL E KL+DFG A L + +GT + APE AM G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVILAMDEG 189
Query: 275 QLTLKSDVYSFGVVFLEL 292
Q K DV+S G+ +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 94 NFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQL---DRNGLQGNREFLVEVLMLS 145
N + LG G FG V+ + E +V VK L LQ EF E+ M
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFR 63
Query: 146 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-----HDLPPDKEPLDWNTRMKIA 200
L H N+V L+G C + + ++ E+ LG L+ L D PL ++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 201 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 260
A G+++L +N ++RDL + N L+ K+S L+K + + +
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNAL 179
Query: 261 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ APE + KSDV+SFGV+ E+ T
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 73/246 (29%), Positives = 107/246 (43%), Gaps = 43/246 (17%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQ--LDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIG 157
+G G +G VYK R +TG++VA+K L+ + E + E+ ML H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIA---AGAAKGLEYLHDK 213
D+ +V E+ GSL+D P E IA KGL YLH+
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ-------IAYVCRETLKGLAYLHET 120
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCAPEY 270
I+RD+K +NILL E KL+DFG++ T + +GT + APE
Sbjct: 121 G---KIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEV 172
Query: 271 A---MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF---KDRRKF 324
A G K D+++ G+ +EL + + + P R LF K
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP---------MRALFLISKSNFPP 223
Query: 325 PKMADP 330
PK+ D
Sbjct: 224 PKLKDK 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 158
+GEG G V+K + TG+ VA+K++ L+G + L E+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
G +LV E+MP L + L D PL KG+ Y+H +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---I 120
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LT 277
++RDLK +N+L+ K++DFGLA+L + S +V T Y APE +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYD 179
Query: 278 LKSDVYSFGVVFLELITGR 296
D+++ G +F EL+ G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 7e-20
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 100 LLGEGGFGRVYKGRL---ESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVN 154
+LGEG FG V +G+L + + VAVK + + + EFL E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 155 LIGYCADGDQR------LLVYEFMPLGSLEDHLH----DLPPDKEPLDWNTRMKIAAGAA 204
LIG C + +++ FM G L L P+K PL T +K A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIA 123
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD---KTHVSTRVMG 261
G+EYL +N I+RDL + N +L E ++DFGL+K GD + ++ +
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV- 179
Query: 262 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ A E T KSDV++FGV E+ T
Sbjct: 180 --KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 101 LGEGGFGRVYKGR---LESTGQV--VAVKQLDRNGLQGNREFLV-EVLMLSLL-HHSNLV 153
LG G FG+V + L + V VAVK L RE L+ E+ ++S L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP-LDWNTRMKIAAGAAKGLEYLHD 212
NL+G C G L++ E+ G L + L +E L + + AKG+ +L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPE 269
K I+RDL + N+LL G K+ DFGLA+ + D +V + R+ + APE
Sbjct: 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMAPE 213
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT 294
T +SDV+S+G++ E+ +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 9e-20
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLL-HHSNLVNL 155
+LG+G FG+V+ L+ T Q A+K L ++ + + + +VE +LSL H L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 156 IGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
YC + V E++ G L H+ D AA GL++LH K
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK 115
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
++YRDLK NILLD H K++DFG+ K +GD + GT Y APE +
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLG 170
Query: 274 GQLTLKSDVYSFGVVFLELITGR 296
+ D +SFGV+ E++ G+
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 66/201 (32%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
+LG+G FG+V RL+ +G++ AVK L ++ + + + + E +LSL + + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 157 GYCADGDQRLL-VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKA 214
C RL V EF+ G L H+ E R + AA L +LHDK
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEITSALMFLHDKG 116
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+IYRDLK N+LLD H KL+DFG+ K G KT ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEM 171
Query: 275 QLTLKSDVYSFGVVFLELITG 295
D ++ GV+ E++ G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 69/212 (32%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM--------LSL 146
FR +LG G FG+V + TG++ A+K L + + E VE LM +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 147 LHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK 205
H LVNL C + + V E+ G L H+H + + AA
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVL 112
Query: 206 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMGTY 263
GL+YLH+ ++YRDLK N+LLD K++DFGL K +G GD+T ST GT
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGTP 165
Query: 264 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
+ APE T D + GV+ E++ G
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 29/229 (12%)
Query: 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTG-----QVVAVKQL-DRNGLQGNREFLVE 140
E+ +T F E LGE FG+VYKG L T Q VA+K L D+ EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 141 VLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---------DK--- 188
+M S L H N+V L+G +++ + L + L P DK
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 189 ---EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245
EP D+ + I A G+E+L ++ V+++DL + N+L+ + + K+SD GL +
Sbjct: 119 STLEPADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
D + + + +PE M G+ ++ SD++S+GVV E+ +
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 101 LGEGGFGRVYKG-RLESTGQ----VVAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVN 154
LGEG FG+V K G+ VAVK L N R+ L E +L ++H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHL--------------------HDLPPDKEPLDWN 194
L G C+ LL+ E+ GSL L + PD+ L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 195 TRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254
+ A ++G++YL A +++RDL + N+L+ EG K+SDFGL++ D
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
++ + A E T +SDV+SFGV+ E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 64/196 (32%), Positives = 100/196 (51%), Gaps = 12/196 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V+ G ++ +V AVK L + G + FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ ++ E+M GSL D L K L + +A A+G+ Y+ K I+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIH 126
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY--GYCAPEYAMTGQLTL 278
RDL+++N+L+ E K++DFGLA+ V + + R + + APE G T+
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 279 KSDVYSFGVVFLELIT 294
KSDV+SFG++ E++T
Sbjct: 184 KSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM-----LSLL-HHSNLV 153
+LG+G FG+V L+ T ++ AVK L ++ + + + VE M L+L H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 154 NLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLH 211
L C RL V E++ G L H+ EP R + AA GL++LH
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLH 113
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
++ +IYRDLK N+LLD H K++DFG+ K G +G T ++ GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE-I 167
Query: 272 MTGQLTLKS-DVYSFGVVFLELITGR 296
++ Q + D ++ GV+ E++ G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 65/201 (32%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLL-HHSNLVNL 155
+LG+G FG+V L+ G+ AVK L ++ + + + +VE +L+L + L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+ V EF+ G L H+ D K D AA GL++LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+IYRDLK N++LD H K++DFG+ K GD ++ GT Y APE +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172
Query: 276 LTLKSDVYSFGVVFLELITGR 296
T D +SFGV+ E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 48/229 (20%)
Query: 98 ECL--LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-F----LVEVLMLSLLHHS 150
E L + EG +G VY+ R + TG++VA+K+L ++ +E F L E+ +L L H
Sbjct: 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHP 64
Query: 151 NLVNL--IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK--IAAGAAK- 205
N+V + + ++ D+ +V E++ HDL K ++ MK K
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVE--------HDL---KSLME---TMKQPFLQSEVKC 110
Query: 206 -------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 258
G+ +LHD +++RDLK+SN+LL+ K+ DFGLA+ G T+
Sbjct: 111 LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQ 165
Query: 259 VMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELIT------GRKAID 300
++ T Y APE + + + D++S G +F EL+T G+ ID
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 73/220 (33%), Positives = 110/220 (50%), Gaps = 22/220 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSN---LV 153
++G GGFG VY R TG++ A+K LD+ + QG L E +MLSL+ + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+ D+ + + M G L HL H + +KE + T + + GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
++ V+YRDLK +NILLDE H ++SD GLA K H S +GT+GY APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 272 MTGQLTLKS-DVYSFGVVFLELITGRKAIDNTRPPGEHNL 310
G S D +S G + +L+ G + +H +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 73/206 (35%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSN--LVN 154
++G GGFG VY R TG++ A+K LD+ + QG L E +MLSL+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 155 LIGYCADGDQRL-LVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKI-AAGAAKGLEYL 210
+ Y +L + + M G L HL H + + E M+ AA GLE++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGLEHM 113
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
H++ V+YRDLK +NILLDE H ++SD GLA K H S +GT+GY APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166
Query: 271 AMTGQLTLKS-DVYSFGVVFLELITG 295
G S D +S G + +L+ G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 25/238 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE----------FLVEVLMLSLLHH 149
L+G+G +GRVY +TG+++AVKQ++ R E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
N+V +G+ + + E++P GS+ L +E L ++ +GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAY 123
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
LH K +++RDLK+ N+L+D K+SDFG++K + + G+ + APE
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 270 YAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325
+ + K D++S G V LE+ GR RP + +A L R P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIAAMFKLGNKRSAPP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 69/205 (33%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSN 151
FR +LG+GGFG V ++ +TG++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+VNL D LV M G L+ H++++ + + AA GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ +YRDLK NILLD+ H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR 296
+ TL D + G + E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIG 157
LG+GGFG V ++++TG++ A K+LD+ L+ G + L+E +L ++ +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 158 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
Y + L LV M G L+ H++++ + L+ + +A G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 276
++YRD+K N+LLD+ + +LSD GLA G T+ GT GY APE
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171
Query: 277 TLKSDVYSFGVVFLELITGR 296
+ D ++ G E++ GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 78/263 (29%), Positives = 118/263 (44%), Gaps = 32/263 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+G+G FG VYKG T +VVA+K +D + E + E+ +LS + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
G + ++ E++ GS D L PL+ I KGL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSERK---I 123
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
+RD+K++N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 280 SDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY--P 337
+D++S G+ +EL G + P R LF PK + P L+G+Y P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHP---------MRVLF----LIPKNSPPTLEGQYSKP 228
Query: 338 MRGLYQALAVAAMCLQEQAATRP 360
+ +A CL + RP
Sbjct: 229 FKEFVEA------CLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 101 LGEGGFGRVYKG-----RLESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 154
LG G FG VY+G ++ VAVK L + Q +FL+E L++S +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---PLDWNTRMKIAAGAAKGLEYLH 211
LIG + R ++ E M G L+ L + P E L + A AKG +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 212 DKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
+ I+RD+ + N LL G K++DFG+A+ R M + P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 269 EYAMTGQLTLKSDVYSFGVVFLEL 292
E + G T K+DV+SFGV+ E+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 99 CLLGEGGFGRVYKGRLESTG-----QVVAVKQLDRNGLQGN-REFLVEVLMLSLL-HHSN 151
LGEG FG+V K VAVK L + + + + + E+ M+ ++ H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLH------------DLPPDKEPLDWNTRMKI 199
++NL+G C +V E+ G+L D L D P +E L +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 259
A A+G+E+L K I+RDL + N+L+ E K++DFGLA+ D +T
Sbjct: 138 AYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 260 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ APE T +SDV+SFGV+ E+ T
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+GEG +G VY+ R ++G++VA+K++ +R+G+ + L E+ +L L H N+V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLRHPNIVELK 72
Query: 157 GYCADGDQR---LLVYEF--MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
G LV E+ L SL D++ P + + +GL+YLH
Sbjct: 73 EVVV-GKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQLLRGLQYLH 125
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-- 269
+ +I+RDLK SN+LL + K++DFGLA+ G T + T Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAPELL 180
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGR 296
T T D+++ G + EL+ +
Sbjct: 181 LGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 67/193 (34%), Positives = 97/193 (50%), Gaps = 9/193 (4%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGY 158
LLG+G FG V+KG L+ V AVK + Q + +FL E +L H N+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
C QR +Y M L D L L K+ L +K A AA G+ YL K
Sbjct: 61 CT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 278
I+RDL + N L+ E K+SDFG+++ G + + + + APE G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 279 KSDVYSFGVVFLE 291
+SDV+S+G++ E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 72/207 (34%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIG 157
+G G FG VY T +VVAVK++ +G Q N ++ + EV L L H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
LV E+ LGS D L K+PL I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 274
+I+RD+K+ NILL E KL+DFG A K+ + +GT + APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 275 QLTLKSDVYSFGVVFLELITGRKAIDN 301
Q K DV+S G+ +EL + + N
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 7e-19
Identities = 78/263 (29%), Positives = 122/263 (46%), Gaps = 32/263 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+G+G FG V+KG T +VVA+K +D + E + E+ +LS + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
+ ++ E++ GS D L + PLD I KGL+YLH + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSEKK---I 123
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
+RD+K++N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 280 SDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY--P 337
+D++S G+ +EL G PP H+ + + LF PK P L+G Y P
Sbjct: 182 ADIWSLGITAIELAKG-------EPP--HSELHPMKVLF----LIPKNNPPTLEGNYSKP 228
Query: 338 MRGLYQALAVAAMCLQEQAATRP 360
++ +A CL ++ + RP
Sbjct: 229 LKEFVEA------CLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 98 ECLLGEGGFGRVYKGRLESTGQVV--AVKQLDRNGLQGN-REFLVEVLMLSLL-HHSNLV 153
E ++GEG FG+V + ++ G + A+K L + + R+F E+ +L L HH N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEPLDWNTRMKIAA 201
NL+G C + + E+ P G+L D L L D L ++ A+
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 261
A G++YL +K I+RDL + N+L+ E K++DFGL++ G++ +V + MG
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMG 178
Query: 262 TYG--YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ A E T KSDV+SFGV+ E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 67/195 (34%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 158
+G G FG V+ GRL + VAVK R L + +FL E +L H N+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
C Q+ +Y M L D L L + L +++ AA G+EYL K
Sbjct: 62 CT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT--YGYCAPEYAMTGQL 276
I+RDL + N L+ E K+SDFG+++ D + ST M + APE G+
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 277 TLKSDVYSFGVVFLE 291
+ +SDV+SFG++ E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIG 157
LG+GGFG V ++ +TG++ A K+L++ L +G +VE +L+ +H +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
LV M G L H++++ + A GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 277
+IYRDLK N+LLD + ++SD GLA + D + GT G+ APE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 278 LKSDVYSFGVVFLELITGR 296
D ++ GV E+I R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 81/307 (26%), Positives = 135/307 (43%), Gaps = 53/307 (17%)
Query: 101 LGEGGFGRVYKGRLESTGQV----------------VAVKQLDRNGLQGNR-EFLVEVLM 143
LGEG FG V+ + + + VAVK L + + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 144 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEP----------- 190
LS L N++ L+G C D D ++ E+M G L L H L +E
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 191 --LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248
+ +++ + +A A G++YL ++ ++RDL + N L+ E K++DFG+++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE- 307
GD + R + + A E + G+ T SDV++FGV E++ K +P GE
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE----QPYGEL 245
Query: 308 --HNLVAWARPLFKDRRKFPKMADPLLQGRYPM--RGLYQALAVAAMCLQEQAATRPLIG 363
++ A F+D+ + + R P +GLY+ + C RP
Sbjct: 246 TDEQVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELM---LQCWSRDCRERPSFS 296
Query: 364 DVVTALT 370
D+ LT
Sbjct: 297 DIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 66/215 (30%), Positives = 111/215 (51%), Gaps = 19/215 (8%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQ----VVAVKQL-DRNGLQGNREFLVEVLMLSLLHH 149
F+ +LG G FG VYKG G+ VA+K+L + + N+E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH---DLPPDKEPLDWNTRMKIAAGAAKG 206
++ L+G C +L + + MP G L D++ D + L+W ++ AKG
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
+ YL ++ +++RDL + N+L+ H K++DFGLAKL +K + + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAID 300
A E + T +SDV+S+GV EL+T G K D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 77/284 (27%), Positives = 128/284 (45%), Gaps = 39/284 (13%)
Query: 100 LLGEGGFGRVYKGRLESTGQ---VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNL 155
++G G FG V++G L+ G+ VA+K L + R +FL E ++ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
G +++ E+M G+L+ +L D + ++ G A G++YL D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDMN- 127
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGYCAPEYAM 272
++RDL + NIL++ K+SDFGL+++ P G T ++ + APE
Sbjct: 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIA 183
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK-DRRKFPKMADPL 331
+ T SDV+SFG+V E+++ GE RP + + K +
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSF----------GE-------RPYWDMSNHEVMKAINDG 226
Query: 332 LQGRYPM---RGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372
+ PM +YQ + C Q+ A RP D+V L L
Sbjct: 227 FRLPAPMDCPSAVYQLM---LQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSN 151
FR +LG+GGFG V ++ +TG++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V+L D LV M G L+ H++++ D + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLH 119
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ ++YRDLK NILLD+ H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVV 173
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR 296
+ T D + G + E+I G+
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 100 LLGEGGFGRVYKGRLESTG--QVVAVKQLDRNGLQGN-REFLVEVLMLSLL-HHSNLVNL 155
++GEG FG+V K R++ G A+K++ + + R+F E+ +L L HH N++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEPLDWNTRMKIAAGA 203
+G C L E+ P G+L D L L D L + AA
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
A+G++YL K I+RDL + NIL+ E + K++DFGL++ G + +V + MG
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 173
Query: 264 G--YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ A E T SDV+S+GV+ E+++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 70/221 (31%), Positives = 106/221 (47%), Gaps = 45/221 (20%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLV----EVLMLSLLHHSNLVNL 155
+GEG +G+VYK R + TG++VA+K++ L +E F + E+ +L L+H N+VNL
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 156 IGYCADGDQRL----------LVYEFMP---LGSLEDHLHDLPPD------KEPLDWNTR 196
D L LV+E+M +G LE L D K+ L+
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE---- 127
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 256
GL Y H K ++RD+K SNILL+ KL+DFGLA+L + +
Sbjct: 128 ---------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 257 TRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 296
+V+ T Y PE + + + DV+S G + EL T +
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+GEG G V +STG+ VAVK++D Q RE L EV+++ H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM---KIAA---GAAKGLEYLHDK 213
GD+ +V EF+ G+L D + +TRM +IA K L +LH +
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
VI+RD+KS +ILL KLSDFG V + ++GT + APE
Sbjct: 135 G---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 274 GQLTLKSDVYSFGVVFLELITGRKAIDNTRP 304
+ D++S G++ +E++ G N P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 101 LGEGGFGRVY------------KGRLESTGQ--VVAVKQLDRNGLQGNR-EFLVEVLMLS 145
LGEG FG V+ +G E GQ +VAVK L + + R +FL E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 146 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED------------HLHDLPPDKEPLDW 193
L + N++ L+G C D ++ E+M G L H +++P +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS----VSI 128
Query: 194 NTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253
+ +A A G++YL A+ ++RDL + N L+ + K++DFG+++ GD
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ R + + A E + G+ T SDV++FGV E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSN 151
FR +LG+GGFG V ++ +TG++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V+L D LV M G L+ H++ + + + + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ ++YRDLK NILLD+ H ++SD GLA P G + RV GT GY APE
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR 296
+ T D ++ G + E+I G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 72/272 (26%), Positives = 114/272 (41%), Gaps = 29/272 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V+ G+ + +V A+K + G +F+ E ++ L H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+V EFM G L L+ L + L + + + +G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYAMTGQLTLK 279
RDL + N L+ K+SDFG+ + V D + S+ + PE + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 280 SDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPM 338
SDV+SFGV+ E+ T G+ + + N R PK+A
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEK-----KSNYEVVEMISRGFRLYRPKLAS--------- 227
Query: 339 RGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370
V C E+ RP +++ A+T
Sbjct: 228 ---MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 50/218 (22%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF--------LVEVLML-SLLHHSN 151
LG+G FG VY R + TG++VA+K++ ++F L EV L L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE--PLDWNTRMKIAAGAAKGLEY 209
+V L + D+ V+E+M E +L+ L D++ P + I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK----THVSTRVMGTYGY 265
+H K +RDLK N+L+ K++DFGLA+ + + +VSTR Y
Sbjct: 115 IH-KHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WY 164
Query: 266 CAPEYAMTGQLTLKSDVYS-------FGVVFLELITGR 296
APE + L+S YS G + EL T R
Sbjct: 165 RAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSN 151
FR +LG+GGFG V ++ +TG++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V+L D LV M G L+ H++++ D + AA GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ ++YRDLK NILLD+ H ++SD GLA P G+ V RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR 296
+ T D + G + E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 100 LLGEGGFGRVYKGRLESTG--QVVAVKQLDRNGLQGN-REFLVEVLMLSLL-HHSNLVNL 155
++GEG FG+V K R++ G A+K++ + + R+F E+ +L L HH N++NL
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEPLDWNTRMKIAAGA 203
+G C L E+ P G+L D L L D L + AA
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
A+G++YL K I+RDL + NIL+ E + K++DFGL++ G + +V + MG
Sbjct: 134 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 185
Query: 264 G--YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ A E T SDV+S+GV+ E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-18
Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+G+G G V+ +TGQ VA+KQ++ Q +E ++ E+L++ L + N+VN +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
GD+ +V E++ GSL D + + D+ + R + A LE+LH AN VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA-----LEFLH--AN-QVI 137
Query: 220 YRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 278
+RD+KS N+LL KL+DFG A++ P +++ ST V GT + APE
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 279 KSDVYSFGVVFLELITGRKAIDNTRP 304
K D++S G++ +E++ G N P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 77/261 (29%), Positives = 117/261 (44%), Gaps = 28/261 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+G+G FG V+KG T QVVA+K +D + E + E+ +LS + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
G + ++ E++ GS D L P D+ T +K KGL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDE--FQIATMLK---EILKGLDYLHSEKK---I 123
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
+RD+K++N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 280 SDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMR 339
+D++S G+ +EL G + P R LF PK P L G +
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHP---------MRVLF----LIPKNNPPTLTGEFSKP 228
Query: 340 GLYQALAVAAMCLQEQAATRP 360
++ A CL + + RP
Sbjct: 229 --FKEFIDA--CLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 68/198 (34%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIG 157
+G G FG VY R +VVA+K++ +G Q N ++ + EV L L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
LV E+ LGS D L K+PL + GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 274
+I+RD+K+ NILL E KL DFG A + + +GT + APE + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEG 189
Query: 275 QLTLKSDVYSFGVVFLEL 292
Q K DV+S G+ +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM-LSLLHHSN---LVNLI 156
LG G G V K + TG V+A K + + ++L L ++H +V+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 157 G-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
G + + + + EFM GSL+ P+ KIA +GL YL++
Sbjct: 70 GAFLNENNI-CMCMEFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+++RD+K SNIL++ KL DFG++ G + + ++ +GT Y +PE G+
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS--IADTFVGTSTYMSPERIQGGK 178
Query: 276 LTLKSDVYSFGVVFLELITGR 296
T+KSDV+S G+ +EL G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 100 LLGEGGFGRVYKGRLESTGQ----VVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVN 154
+LG G FG VYKG G+ VA+K L N + N+E L E +++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLH---DLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
L+G C +L V + MP G L D++ D ++ L+W ++ AKG+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ +++RDL + N+L+ H K++DFGLA+L + + + + + A E
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 272 MTGQLTLKSDVYSFGVVFLELIT-GRKAID 300
+ + T +SDV+S+GV EL+T G K D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 63/198 (31%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
LGEG + VYKGR +TG++VA+K++ + +G + E+ ++ L H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
++ +LV+E+M L+ ++ D + LD NT KG+ + H+ V+
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
+RDLK N+L+++ KL+DFGLA+ + T + V T Y AP+ + +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYST 180
Query: 280 S-DVYSFGVVFLELITGR 296
S D++S G + E+ITGR
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 8e-18
Identities = 69/198 (34%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIG 157
+G G FG VY R T +VVA+K++ +G Q N ++ + EV L + H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
LV E+ LGS D L K+PL I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 274
+I+RD+K+ NILL E KL+DFG A + + +GT + APE + G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199
Query: 275 QLTLKSDVYSFGVVFLEL 292
Q K DV+S G+ +EL
Sbjct: 200 QYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 80/289 (27%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 101 LGEGGFGRVYKG---RLESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+G G FG+V G R S +VV VK+L FL EV L+H N++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHD------LPPDKEPLDWNTRMKIAAGAAKGLEYL 210
G C + LLV EF PLG L+++L K+ ++A A GL +L
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD-----VLQRMACEVASGLLWL 116
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
H +A+ I+ DL N L K+ D+GLA D + APE
Sbjct: 117 H-QAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 271 A-------MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP-PGEHNLVAWARPLFKDRR 322
+ T KS+++S GV EL T +P P + + + +
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVLKQVVREQDI 228
Query: 323 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371
K PK P L +Y R Y+ + + TRP +V LTY
Sbjct: 229 KLPK---PQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 14/206 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+G+G G VY +TGQ VA++Q++ Q +E ++ E+L++ + N+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
GD+ +V E++ GSL D + + D+ + R + A LE+LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LEFLHSNQ---VI 138
Query: 220 YRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 278
+RD+KS NILL KL+DFG A++ P K + ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 279 KSDVYSFGVVFLELITGRKAIDNTRP 304
K D++S G++ +E+I G N P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQ-----VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 154
LG+G FG VY+G + + VA+K ++ R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------PLDWNTRMKIAAGAAKGLE 208
L+G + G L++ E M G L+ +L L P+ E P +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
YL+ AN ++RDL + N ++ E F K+ DFG+ + D + + + +P
Sbjct: 134 YLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELIT 294
E G T SDV+SFGVV E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
+LG+G FG+V + T ++ A+K L ++ + + + +VE +L+L + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 157 GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
C RL V E++ G L H+ + KEP + AA A GL +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFFLHSKG- 121
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTG 274
+IYRDLK N++LD H K++DFG+ K G KT TR GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQ 176
Query: 275 QLTLKSDVYSFGVVFLELITGRKAID 300
D ++FGV+ E++ G+ D
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 33/210 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLLHHSNLVNL 155
+GEG +G VYK R + TG++VA+K++ L+ E + E+ +L L+H N+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 156 --IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA---GAAKGLEY 209
+ + + +L LV+EF+ L L+ ++ D PL I + +G+ Y
Sbjct: 64 LDVVHS---ENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LG-PVGDKTHVSTRVMGTYGYCA 267
H V++RDLK N+L+D KL+DFGLA+ G PV TH V+ T Y A
Sbjct: 115 CHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRA 167
Query: 268 PEYAMTG-QLTLKSDVYSFGVVFLELITGR 296
PE + Q + D++S G +F E++ R
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 12/209 (5%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQ--LDRNGLQGNREFLVEVLMLSLLHHSN 151
NF+ +GEG +G VYK R + TG+VVA+K+ LD + E+ +L L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V L+ ++ LV+EF+ L+ + P PL +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCH 117
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
V++RDLK N+L++ KL+DFGLA+ V +T+ V T Y APE
Sbjct: 118 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 172
Query: 272 MTGQL-TLKSDVYSFGVVFLELITGRKAI 299
+ + + D++S G +F E++T R+A+
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 101 LGEGGFGRVYKGRLESTGQV-VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 159
LG G FG V G+ GQ VA+K + + G EF+ E ++ L H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWR--GQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
+V E+M G L ++L + +P +++ +G+ YL K I
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESKQ---FI 122
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQL 276
+RDL + N L+D+ K+SDFGL++ V D + S+ +G+ + PE + +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKF 178
Query: 277 TLKSDVYSFGVVFLELIT 294
+ KSDV++FGV+ E+ +
Sbjct: 179 SSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 13/234 (5%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+GEG G V ++S+G++VAVK++D Q EV+++ H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
GD+ +V EF+ G+L D + ++E + + K L LH + VI+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQG---VIH 139
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 280
RD+KS +ILL KLSDFG V + ++GT + APE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 281 DVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334
D++S G++ +E++ G N P ++ R + K P L+G
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKNLHKVSPSLKG 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHS 150
+F +LG+G FG+V + T ++ A+K L ++ + + + +VE +L+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 151 NLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
+ + C RL V E++ G L H+ + KEP + AA + GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFF 116
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAP 268
LH + +IYRDLK N++LD H K++DFG+ K V V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAP 170
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELITGRKAID 300
E D +++GV+ E++ G+ D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 70/233 (30%), Positives = 106/233 (45%), Gaps = 41/233 (17%)
Query: 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSL 146
+++ LGEG FG VYK R TG+VVA+K++ +++G L E+ +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILKK 63
Query: 147 LHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 201
L H N+V LI + +R VY P HDL L N +K+
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-----HDL----SGLLENPSVKLTE 114
Query: 202 GAAK--------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL------- 246
K G+ YLH+ +++RD+K++NIL+D K++DFGLA+
Sbjct: 115 SQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 247 --GPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 296
G G T T ++ T Y PE + + T D++ G VF E+ T R
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+G+G FG V G + G VAVK + + + FL E +++ L HSNLV L+G
Sbjct: 14 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 161 DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
+ L +V E+M GSL D+L + L + +K + + +EYL +AN +
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL--EANN-FV 124
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 278
+RDL + N+L+ E K+SDFGL K D + + + APE + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFST 178
Query: 279 KSDVYSFGVVFLELIT-GR 296
KSDV+SFG++ E+ + GR
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+GEG G V + TG+ VAVK++D Q EV+++ HH N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
GD+ +V EF+ G+L D + ++E + + + L YLH++ VI+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQG---VIH 141
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 280
RD+KS +ILL KLSDFG V + ++GT + APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 281 DVYSFGVVFLELITGRKAIDNTRP 304
D++S G++ +E+I G N P
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 159
+LG+G +G VY R ST +A+K++ + + E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
++ + E +P GSL L L +++ + + T+ + +GL+YLHD
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDNQ- 128
Query: 216 PPVIYRDLKSSNILLD--EGFHPKLSDFG----LAKLGPVGDKTHVSTRVMGTYGYCAPE 269
+++RD+K N+L++ G K+SDFG LA + P + GT Y APE
Sbjct: 129 --IVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINP------CTETFTGTLQYMAPE 179
Query: 270 YAMTGQ--LTLKSDVYSFGVVFLELITGR 296
G +D++S G +E+ TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V+ +V AVK + + G FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ ++ EFM GSL D L K+PL + +A A+G+ ++ + I+
Sbjct: 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYAMTGQLTLK 279
RDL+++NIL+ K++DFGLA++ + D + + + APE G T+K
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 280 SDVYSFGVVFLELIT-GR 296
SDV+SFG++ +E++T GR
Sbjct: 184 SDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSL-LHHSNLVNL 155
+LG+G FG+V L+ T + A+K L ++ + + + +VE +L+L H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 156 IGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
+C + V E++ G L H+ D AA GL++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
+IYRDLK N+LLD+ H K++DFG+ K G+ ++ GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 274 GQLTLKSDVYSFGVVFLELITGR 296
+ D +SFGV+ E++ G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 14/206 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+G+G G VY +TGQ VA+KQ++ Q +E ++ E+L++ + N+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
GD+ +V E++ GSL D + + D+ + R + A L++LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LDFLHSNQ---VI 137
Query: 220 YRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 278
+RD+KS NILL KL+DFG A++ P +++ ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 279 KSDVYSFGVVFLELITGRKAIDNTRP 304
K D++S G++ +E++ G N P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 101 LGEGGFGRVY--------KGRLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSN 151
LG+G FG VY KG E+ VAVK ++ + L+ EFL E ++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETR---VAVKTVNESASLRERIEFLNEASVMKGFTCHH 70
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------PLDWNTRMKIAAGAAK 205
+V L+G + G L+V E M G L+ +L L P+ E P +++AA A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 206 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265
G+ YL+ K ++RDL + N ++ F K+ DFG+ + D + + +
Sbjct: 131 GMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 266 CAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
APE G T SD++SFGVV E+ +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLHHS 150
+ +G G FGRV+ R + A+K + + L+ + E +L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 151 NLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
++ L + + DQR L + E++P G L +L + +T + A+ LE
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALE 115
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
YLH K ++YRDLK NILLD+ H KL+DFG AK + D+T + GT Y AP
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYLAP 167
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELITG 295
E + D ++ G++ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---------LVEVLMLSLLHHS 150
+G G +G V + TG+ VA+K++ + F L E+ +L L H
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 151 NLVNLIGYCADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK-IAAGAA 204
N++ L+ +V E M E LH + +PL + ++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYFLYQIL 113
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG-----PVGDKT-HVSTR 258
+GL+YLH AN VI+RDLK SNIL++ K+ DFGLA+ G T +V TR
Sbjct: 114 RGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 259 VMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGR 296
Y APE ++ T D++S G +F EL+T +
Sbjct: 171 W-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 101 LGEGGFGRVY-------KGRLESTGQ---------VVAVKQLDRNGLQGNR-EFLVEVLM 143
LGEG FG V+ + E +VAVK L + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 144 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------DLPPDKEPLDWNTR 196
LS L N+ L+G C ++ E+M G L L L + + L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 256
+ +A A G+ YL + ++RDL + N L+ + + K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 257 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
R + A E + G+ T KSDV++FGV E++T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 73/209 (34%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 100 LLGEGGFGRVY---KGRLESTGQVVAVKQL--------DRNGLQGNREFLVEVLMLSLLH 148
+LG+G FG+V+ K GQ+ A+K L DR + R+ L EV +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56
Query: 149 HSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKG 206
H +V L Y + +L L+ +F+ G L L KE + +K A A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALA 110
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
L++LH +IYRDLK NILLDE H KL+DFGL+K +K S GT Y
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELITG 295
APE T +D +SFGV+ E++TG
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 100 LLGEGGFGRVYKG---RLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNL 155
+GEG FG VY+G E+ VAVK RE FL E ++ H ++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
IG + + +V E PLG L +L +K LD + + + + L YL K
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTG 274
++RD+ + N+L+ KL DFGL++ + D+++ +++ + APE
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFR 183
Query: 275 QLTLKSDVYSFGVVFLELI 293
+ T SDV+ FGV E++
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 98 ECLLGEGGFGRVYKGRLESTG---QVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNL 152
E ++G G FG V +GRL+ G VA+K L ++G + R+FL E ++ H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
++L G +++ EFM G+L+ L + + + G A G++YL +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSE 124
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYGYCAPE 269
++RDL + NIL++ K+SDFGL++ T +G + APE
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT 294
+ T SDV+S+G+V E+++
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 65/201 (32%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLLHHSNLVNLIG 157
LG G FGRV + + TG+ A+K L + ++ + E +L L H +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHD---LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
D ++ + EF+ G L HL P D A EYLH K
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-------YHAELVLAFEYLHSKD 138
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+IYRDLK N+LLD H K++DFG AK V D+T + GT Y APE +
Sbjct: 139 ---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLAPEVIQSK 190
Query: 275 QLTLKSDVYSFGVVFLELITG 295
D ++ GV+ E I G
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 69/216 (31%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL--DRNGLQGNRE---FLVEVLMLSLLH 148
N+R LLG+G FGRVY TG+ +AVKQ+ D + ++E E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 149 HSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
H +V G D +R L E MP GS++D L E N K +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE----NVTRKYTRQILEG 118
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK------LGPVGDKTHVSTRVM 260
+ YLH +++RD+K +NIL D + KL DFG +K L G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----VT 170
Query: 261 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
GT + +PE K+D++S G +E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 101 LGEGGFGRVY--KGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 158
+GEG FG++Y K + +S V+ L + ++ EV++L+ + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
+ + +V E+ G L ++ L + + L W ++ + GL+++HD+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDRK 121
Query: 215 NPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
+++RD+KS NI L + G KL DFG+A+ + D ++ +GT Y +PE
Sbjct: 122 ---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQN 176
Query: 274 GQLTLKSDVYSFGVVFLELIT 294
K+D++S G V EL T
Sbjct: 177 RPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQL-DRNGLQGNREFL--VEVLMLSLLHHSNLVNLI 156
+G G FG V K + +G ++AVK++ + + L ++V+M S S+ ++
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS----SDCPYIV 66
Query: 157 GYCA----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIAAGAAKGLEYL 210
+ +GD + E M + SL D + + + KIA K L YL
Sbjct: 67 KFYGALFREGDC-WICMELMDI-SL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
K +I+RD+K SNILLD + KL DFG++ G + D TR G Y APE
Sbjct: 124 --KEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI-AKTRDAGCRPYMAPER 178
Query: 271 AMTGQLT---LKSDVYSFGVVFLELITGR 296
++SDV+S G+ E+ TG+
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 72/220 (32%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLVNLIGY 158
L+G G +G+VYKGR TGQ+ A+K +D G + E E+ ML HH N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 159 CAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
DQ LV EF GS+ D + + + +W I +GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 129
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTR--VMGTYGYCAPE 269
VI+RD+K N+LL E KL DFG+ A+L D+T V R +GT + APE
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPE 181
Query: 270 YAMTGQ-----LTLKSDVYSFGVVFLELITGRKAIDNTRP 304
+ KSD++S G+ +E+ G + + P
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVK----QLDRNGLQGNREFLVEVLMLSLLH-- 148
+ P +G G +G VYK R +G VA+K Q + +GL + + EV +L L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST--VREVALLKRLEAF 59
Query: 149 -HSNLVNLIGYCADG--DQRL---LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 202
H N+V L+ CA D+ LV+E + L +L +PP P + T +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKDLMRQ 116
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS-TRVMG 261
+GL++LH +++RDLK NIL+ G KL+DFGLA++ ++ T V+
Sbjct: 117 FLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVV 169
Query: 262 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 292
T Y APE + D++S G +F E+
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQ----------------VVAVKQLDRNGLQGNR-EFLVEVLM 143
LGEG FG V+ E + +VAVK L + + R +FL E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 144 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLD-------WNTR 196
+S L N++ L+ C D ++ E+M G L L P + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 256
+ +A A G++YL ++ ++RDL + N L+ + + K++DFG+++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 257 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
R + + + E + G+ T SDV++FGV E++T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQV--VAVKQLD-----RNGLQGNREFLVEVLMLSLLHHSNLV 153
LGEG FG V +G+L + VAVK + R+ ++ +FL E + + H N++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHPNVM 63
Query: 154 NLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIAAGAAK 205
LIG C + +++ FM G L L P T+M K A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 206 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265
G+EYL K+ I+RDL + N +L+E + ++DFGL+K GD +
Sbjct: 124 GMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 266 CAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
A E T KSDV+SFGV E+ T
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 71/233 (30%), Positives = 104/233 (44%), Gaps = 58/233 (24%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL-D--RNGLQGNREFLVEVLMLS-LLH 148
+ + LG+G +G V+K T +VVA+K++ D RN R F E++ L L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD 65
Query: 149 HSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA--- 203
H N+V L+ A+ D+ + LV+E+M E LH + I A
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAV--------------IRANILED 106
Query: 204 ----------AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL---GPVG 250
K L+Y+H N VI+RDLK SNILL+ KL+DFGLA+
Sbjct: 107 VHKRYIMYQLLKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 296
+ V T + T Y APE + L S Y+ GV + E++ G+
Sbjct: 164 PENPVLTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 101 LGEGGFGRVYKGRLESTG---------QVVAVKQLDRNGLQGNREFLV-EVLMLSLL-HH 149
LGEG FG+V R E+ G VAVK L N + L+ E+ ++ L+ H
Sbjct: 20 LGEGCFGQVV--RAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------DLPPD-----KEPLDWNTRM 197
N++NL+G C ++ E+ G+L + L D D +E L + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 198 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257
A A+G+EYL + I+RDL + N+L+ E K++DFGLA+ D ++
Sbjct: 138 SCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ APE T +SDV+SFG++ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 70/222 (31%), Positives = 105/222 (47%), Gaps = 30/222 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRN-GLQGNREFLVE--VLMLSLLHHSNLVNLIG 157
LG G +G V K R TG ++AVK++ Q + L++ + M S+ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYG 67
Query: 158 YC-ADGDQRLLVYEFMPL--GSLED-----HLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
+GD V+ M + SL+ + L ++ L KIA K LEY
Sbjct: 68 ALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEY 118
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
LH K + VI+RD+K SN+L++ KL DFG++ G + D T G Y APE
Sbjct: 119 LHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKTIDAGCKPYMAPE 173
Query: 270 Y---AMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 307
+ + +KSDV+S G+ +EL TGR D+ + P +
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 38/285 (13%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLH 148
NF+ E +G+G F VYK G+VVA+K++ + + ++ L E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLD----WNTRMKIAAGAA 204
H N++ + + ++ +V E G L + K + W +++ +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS--- 117
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
LE++H K +++RD+K +N+ + KL D GL + KT + ++GT
Sbjct: 118 -ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPY 171
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK- 323
Y +PE KSD++S G + E+ A+ + + NL + L K K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYS----LCKKIEKC 223
Query: 324 -FPKMADPLLQGRY--PMRGLYQALAVAAMCLQEQAATRPLIGDV 365
+P PL Y +R L + C+ RP I V
Sbjct: 224 DYP----PLPADHYSEELRDL------VSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 41/261 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLIG 157
+G G +G VYK R +TG++ A+K + L+ +F V E++M+ HSN+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
D+ + EF GSL+D H PL + ++ +GL YLH K
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 274
++RD+K +NILL + H KL+DFG++ + +GT + APE A G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 275 QLTLKSDVYSFGVVFLELITGRKAI--------------DNTRPPGEHNLVAWAR----- 315
D+++ G+ +EL + + N +PP + + W+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF 244
Query: 316 ---PLFKDRRKFPKMADPLLQ 333
L K+ +K P A+ LLQ
Sbjct: 245 VKMALTKNPKKRP-TAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 74/269 (27%), Positives = 124/269 (46%), Gaps = 39/269 (14%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-----EVLMLSLLHHSNLVN 154
L+G G +G VY+G+ TG+VVA+K ++ + + V EV +LS L S N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 155 LIGYCA---DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+ Y G + ++ E+ GS+ + P ++ + R + A L+Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA-----LKYIH 118
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
VI+RD+K++NIL+ + KL DFG+A L + + + +GT + APE
Sbjct: 119 ---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEVI 173
Query: 272 MTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330
G+ K+D++S G+ E+ TG PP ++ V F+ PK P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG-------NPP--YSDV----DAFRAMMLIPKSKPP 220
Query: 331 LLQGRYPMRGLYQALAVAAMCLQEQAATR 359
L+ + L + + A CL E+ R
Sbjct: 221 RLEDNGYSKLLREFV---AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL--DRNGLQGNRE---FLVEVLMLSLLH 148
N+R LLG G FG VY TG+ +AVKQ+ D + + ++E E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 149 HSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
H +V G D +++ L E+MP GS++D L E N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE----NVTRRYTRQILQG 118
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK------LGPVGDKTHVSTRVM 260
+ YLH +++RD+K +NIL D + KL DFG +K + G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----VT 170
Query: 261 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
GT + +PE K+DV+S +E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 68/204 (33%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 101 LGEGGFGRVYKGRLES---TGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLI 156
+G G FG+V G + S QVV VK+L + +Q +FL E L HSNL+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
G C + LLV EF PLG L+ +L + D T ++A A GL +LH K N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNN 120
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA--MT 273
I+ DL N LL K+ D+GL+ D ++ + APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 274 GQL-----TLKSDVYSFGVVFLEL 292
G L T +S+V+S GV EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 19/195 (9%)
Query: 117 TGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIGYCADGDQRLL-VYEFM 172
TG VA+K L + + + F E + + L+H N+V L+ L V+E++
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL-- 230
P +L + L L ++ L H++ +++RDLK NI++
Sbjct: 62 PGRTLREVLAA----DGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 231 -DEGFHPKLSDFGLAKLGP-VGD----KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYS 284
H K+ DFG+ L P V D +T V+GT YCAPE +T SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 285 FGVVFLELITGRKAI 299
+G++FLE +TG++ +
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 57/198 (28%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG-YC 159
LG+G FG+VYK + + TG + A K ++ + +++VE+ +L+ +H +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
DG +++ EF P G+++ + +L D+ + ++ I + L+YLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLEL--DRGLTEPQIQV-ICRQMLEALQYLHSMK---II 132
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-- 277
+RDLK+ N+LL KL+DFG++ + S +GT + APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDT 190
Query: 278 ---LKSDVYSFGVVFLEL 292
K+D++S G+ +E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 33/210 (15%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQ----LDRNGLQGN--REFLVEVL-MLSLLHHSNL 152
+GEG +G VYK R +TG+ VA+K+ L G+ + RE + +L L H N+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPNI 63
Query: 153 VNLIGYCA--DGDQRL---LVYEFMPLGSLEDHLHDLPP---DKEPLDWNTRMKIAAGAA 204
V L+ C D+ L LV+E + L +L P E + R +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLL----- 117
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
+G+++LH +++RDLK NIL+ K++DFGLA+ + T V+ T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLW 171
Query: 265 YCAPEYAMTGQLTLKS--DVYSFGVVFLEL 292
Y APE + Q + + D++S G +F EL
Sbjct: 172 YRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLHHSN 151
++P +G G +G V +G+ VA+K++ + + L E+ +L H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 152 LVN----LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207
++ L AD +V + M E LH + +PL +GL
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL---GPVGDKT----HVSTRVM 260
+Y+H AN VI+RDLK SN+L++E ++ DFG+A+ P K +V+TR
Sbjct: 121 KYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR-- 175
Query: 261 GTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAI 299
Y APE ++ + T D++S G +F E++ GR+ +
Sbjct: 176 ---WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 65/200 (32%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVE-VLMLSLLHHSNLVNLI 156
+G+G FG+V + ++ G+ AVK L + + +E + E ++L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKAN 215
D+ V +++ G L HL EP R + AA A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSLN- 116
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+IYRDLK NILLD H L+DFGL K G KT ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 276 LTLKSDVYSFGVVFLELITG 295
D + G V E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 101 LGEGGFGRVYKGRLESTG---------QVVAVKQLDRNGLQGNREFLV-EVLMLSLL-HH 149
LGEG FG+V E+ G VAVK L + + + LV E+ M+ ++ H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRM 197
N++NL+G C ++ E+ G+L ++L P E + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 198 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257
A+G+EYL A+ I+RDL + N+L+ E K++DFGLA+ D +T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ APE T +SDV+SFGV+ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM-LSLLHHSNLVNLIGYC 159
LG+G +G VYK TG +A+K++ L+ + +++M L +LH + ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR---LELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 160 ADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
VY E+M GSL D L+ E + + +I KGL++L ++ N
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEY----A 271
+I+RD+K +N+L++ KL DFG++ L KT++ G Y APE
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGG 177
Query: 272 MTGQLT--LKSDVYSFGVVFLELITGR 296
T ++SDV+S G+ LE+ GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLHHS 150
+ +P +G G FG V R + TGQ VA+K++ + + R + E+ +L L H
Sbjct: 14 DLQP---VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHE 69
Query: 151 NLVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
N+++L + + + V E + LH L + PL+ +GL+Y
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL-----GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKY 123
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
+H V++RDLK SNIL++E K+ DFGLA++ +VSTR Y APE
Sbjct: 124 VHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPE 175
Query: 270 YAMTGQ-LTLKSDVYSFGVVFLELITGR 296
+T Q ++ D++S G +F E++ G+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 17/198 (8%)
Query: 101 LGEGGFGRVYKG--RLESTGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
LG G FG V KG +++ + + VAVK L D N E L E ++ L + +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
G C + + +LV E LG L L +K + N ++ + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQK---NKHVTEKNI-TELVHQVSMGMKYLEETN-- 115
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTY--GYCAPEYAMT 273
++RDL + N+LL + K+SDFGL+K LG D+ + + G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 274 GQLTLKSDVYSFGVVFLE 291
+ + KSDV+SFGV+ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 78/288 (27%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQ---VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHH 149
+ E ++G G FG V GRL+ G+ VA+K L + R +FL E ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKGL 207
N+++L G ++V E+M GSL+ L HD L + + G A G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGM 119
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYG 264
+YL D ++RDL + NIL++ K+SDFGL+++ + D + G
Sbjct: 120 KYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIR 174
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324
+ APE + T SDV+S+G+V E+++ RP E + + + + R
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSY-----GERPYWEMSNQDVIKAIEEGYRLP 229
Query: 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372
M P L+Q + C Q+ RP +V+ L L
Sbjct: 230 APMDCPA--------ALHQLM---LDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL--DRNGLQGNRE---FLVEVLMLSLLH 148
N+R LLG+G FGRVY TG+ +A KQ+ D + ++E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 149 HSNLVNLIGYCADGDQRLLV--YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
H +V G D ++ L E+MP GS++D L E + TR K +G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV---TR-KYTRQILEG 118
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGY 265
+ YLH +++RD+K +NIL D + KL DFG +K + R V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 266 CAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
+PE K+DV+S G +E++T +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 64/194 (32%), Positives = 91/194 (46%), Gaps = 45/194 (23%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE--F----LVEVLMLSLLHHSNLVN 154
+G+G FG V+K R + T Q+VA+K++ L N + F L E+ +L LL H N+VN
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 155 LIGYC---ADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK- 205
LI C A R LV+EF HDL L N +K K
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCE--------HDLA----GLLSNKNVKFTLSEIKK 123
Query: 206 -------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK---LGPVGDKTHV 255
GL Y+H +++RD+K++NIL+ + KL+DFGLA+ L
Sbjct: 124 VMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 256 STRVMGTYGYCAPE 269
+ RV+ T Y PE
Sbjct: 181 TNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLVNLIGY 158
++G G +G+VYKGR TGQ+ A+K +D + E +E+ ML HH N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 159 ------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
DQ LV EF GS+ D + + + DW I +GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTR--VMGTYGYCAPE 269
VI+RD+K N+LL E KL DFG+ A+L D+T V R +GT + APE
Sbjct: 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPE 191
Query: 270 YAMTGQ-----LTLKSDVYSFGVVFLELITGRKAIDNTRP 304
+ +SD++S G+ +E+ G + + P
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 95 FRPECLLGEGGFGRVYKGRL----ESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLH 148
LL EG FGR++ G L + V VK + + +Q L E +L L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLS 66
Query: 149 HSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHD--LPPDKEPLDWNTR--MKIAAGA 203
H N++ ++ C DG+ ++Y +M G+L+ L L P +T+ + +A
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGP-----VGDKTHVST 257
A G+ YLH + VI++D+ + N ++DE K++D L++ L P +GD +
Sbjct: 127 ACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ M A E + + + SDV+SFGV+ EL+T
Sbjct: 184 KWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 66/239 (27%), Positives = 111/239 (46%), Gaps = 29/239 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG+G FG+VYK + + TG + A K +D + +++VE+ +L+ H N+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ ++ EF G+++ + +L + PL + + L YLH+ +I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIH 126
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCAPEYAMTGQ-- 275
RDLK+ NIL KL+DFG++ T R +GT + APE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 276 ---LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK-DRRKFPKMADP 330
K+DV+S G+ +E+ PP H+ + R L K + + P +A P
Sbjct: 182 DRPYDYKADVWSLGITLIEMA-------QIEPP--HHELNPMRVLLKIAKSEPPTLAQP 231
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQV--VAVKQLDRNGLQGN-REFLVEVLMLSLL-HHSN 151
LGEG FG+V E +V VAVK L + + + + + E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHL---------HDLPPDKEP---LDWNTRMKI 199
++NL+G C ++ E+ G+L ++L + P + P L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 259
A A+G+EYL A+ I+RDL + N+L+ E K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 260 MGTYG-----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
T G + APE T +SDV+SFGV+ E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 71/242 (29%), Positives = 98/242 (40%), Gaps = 51/242 (21%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVL----MLSLLH 148
K+F+ LLG+G GRV+ RL+ TG++ A+K LD+ + R + VL +L+ L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLD 59
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI------AAG 202
H L L LV ++ P G L L P K + AA
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGK-------CLSEEVARFYAAE 111
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV------- 255
LEYLH ++YRDLK NILL E H LSDF L+K V
Sbjct: 112 VLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 256 -----------------STRVM---GTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELIT 294
S R GT Y APE ++G D ++ G++ E++
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLY 227
Query: 295 GR 296
G
Sbjct: 228 GT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 66/208 (31%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 100 LLGEGGFGRVYKGRLES---TGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVN 154
+LG+G FG V + +L+S + Q VAVK L D EFL E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 155 LIGYC--ADGDQRL----LVYEFMPLGSLEDHLHDLPPDKEP--LDWNTRMKIAAGAAKG 206
LIG + RL ++ FM G L L +EP L T ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
+EYL K I+RDL + N +L+E ++DFGL+K GD +
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELIT 294
A E T SDV++FGV E++T
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 101 LGEGGFGRVYKG--RLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIG 157
LG G FG V KG ++ VA+K L + R E + E ++ L + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
C + + +LV E G L L K+ + + +++ + G++YL K
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTY--GYCAPEYAMTG 274
++RDL + N+LL + K+SDFGL+K LG D ++ R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 275 QLTLKSDVYSFGVVFLELIT-GRKAIDNTRPP 305
+ + +SDV+S+G+ E + G+K + P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVK--QLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 158
LG G G VYK T +++AVK LD ++ ++ + E+ +L ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
++ + EFM GSL D +P E + +IA KGL YL + +
Sbjct: 68 FFVENRISICTEFMDGGSL-DVYRKIP---EHV----LGRIAVAVVKGLTYLW---SLKI 116
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 277
++RD+K SN+L++ KL DFG++ +L KT+V GT Y APE Q
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYG 171
Query: 278 LKSDVYSFGVVFLELITGR 296
+ SDV+S G+ F+EL GR
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSL-LHHSNLVNL 155
+LG+G FG+V L+ T +V A+K L ++ + + + + E +L+L H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
D+ V E++ G L + D AA L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
VIYRDLK NILLD H KL+DFG+ K G + T +T GT Y APE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 276 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 307
D ++ GV+ E++ G +PP E
Sbjct: 173 YGPSVDWWALGVLMYEMMAG-------QPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 93 KNFRPECLLGEGGFGRVYKGR-LESTGQVVAVK----QLDRNGLQGNREFLVEVL-MLSL 146
+ + +GEG +G+V+K R L++ G+ VA+K Q G+ + V VL L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 147 LHHSNLVNLIGYCA----DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 201
H N+V L C D + +L LV+E + L +L +P P + T +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTE--TIKDMMF 117
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 261
+GL++LH V++RDLK NIL+ KL+DFGLA++ T V+
Sbjct: 118 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 171
Query: 262 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
T Y APE + D++S G +F E+ +
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
+GEG G V R + +G+ VAVK +D Q RE L EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
G++ ++ EF+ G+L D + ++E + + + L YLH + VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQG---VI 139
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
+RD+KS +ILL KLSDFG + ++GT + APE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 280 SDVYSFGVVFLELITG 295
D++S G++ +E++ G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 40/212 (18%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVN- 154
++GEG FGR + ++ Q A+K++ + ++ +R+ E ++L+ + H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 155 ------------LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 202
++ YC GD + ++ L P+ L W +M +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDL---------MQKIKLQRGKLFPEDTILQWFVQMCL--- 111
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 262
G++++H+K V++RD+KS NI L + KL DFG A+L + + +GT
Sbjct: 112 ---GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL--LTSPGAYACTYVGT 163
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
Y PE KSD++S G + EL T
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 34/228 (14%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVA-------VKQLDRNGLQGNREFLVEVLMLSL 146
+F LG G G V K +G ++A +K RN Q RE L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRE-------LKV 52
Query: 147 LHHSNLVNLIGY----CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 202
LH N ++G+ +DG+ + + E M GSL+ L E + KI+
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENI----LGKISIA 107
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 262
+GL YL +K +++RD+K SNIL++ KL DFG++ G + D ++ +GT
Sbjct: 108 VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 161
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 310
Y +PE T++SD++S G+ +E+ GR I PP L
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP---PPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 101 LGEGGFGRVYKGRLESTG---------QVVAVKQLDRNGLQGNREFLV-EVLMLSLL-HH 149
LGEG FG+V E+ G VAVK L + + LV E+ M+ ++ H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEPLDWNTRM 197
N++NL+G C ++ E+ G+L ++L P +E L + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 198 KIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257
A A+G+EYL A+ I+RDL + N+L+ E K++DFGLA+ D +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ APE T +SDV+SFGV+ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
LLG+G FG+V R ++TG+ A+K L + + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKAN 215
D+ V E+ G L HL +E + R + A LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
V+YRD+K N++LD+ H K++DFGL K G + D + T GT Y APE
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 276 LTLKSDVYSFGVVFLELITGR 296
D + GVV E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQ-VVAVKQLDRNGL---QGNRE-------FLVEVLML-SLL 147
LG G FG VYK R ++ GQ ++A+K+++ + + RE + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 148 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLD----WNTRMKIAAGA 203
H N+V + D+ +V + + L +H + L K+ WN +++
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
L YLH + +++RDL +NI+L E ++DFGLAK K T V+GT
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTI 177
Query: 264 GYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
Y PE K+DV++FG + ++ T
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 39/224 (17%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLD---RNGLQGNREFLVEV-LMLSLLHHSNLVNLI 156
+GEG F V K + TG+ A+K + ++ Q N L E+ + L H N++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 157 GYCADGDQ-RL-LVYEFMPLGSLEDHLHDLPPD-KEPLDWNTRMKIAAGAAKGLEYLHDK 213
D RL LV+E M + +L++L K PL K L+++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK----THVSTRVMGTYGYCAPE 269
+ +RD+K NIL+ + KL+DFG + + K ++STR Y APE
Sbjct: 120 G---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTR-----WYRAPE 168
Query: 270 YAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRP--PGEHNL 310
+T G K D+++ G VF E+++ P PG + L
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS-------LFPLFPGTNEL 205
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGYC 159
LGEG + VYKGR + T +VA+K++ +G + EV +L L H+N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
LV+E++ L+ +L D ++ + +GL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VL 126
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTL 278
+RDLK N+L++E KL+DFGLA+ + KT+ + V T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 279 KSDVYSFGVVFLELITGR 296
+ D++ G +F E+ TGR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN-----REFLVEVLMLSLLHHSNLV 153
LGEG + VYKGR + TGQ+VA+K++ +G RE +L L H+N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIV 66
Query: 154 NLIGYCADGDQRLLVYEFM--PLGS-LEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
L LV+E++ L ++D L N R+ + +GL Y
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRLFLFQ-LLRGLAYC 119
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
H + V++RDLK N+L+ E KL+DFGLA+ V KT+ + V T Y P+
Sbjct: 120 HQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDV 174
Query: 271 AM-TGQLTLKSDVYSFGVVFLELITGR 296
+ + + + D++ G +F E+ TGR
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 24/234 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIG 157
+G+GG+G+V+ + + TG++VA+K++ ++ L R L E +L+ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
D + L E++P G L++L + + M A A L Y+H
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH---- 124
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
RDLK N L+D H KL+DFGL+K G T+ ++ V+G+ Y APE
Sbjct: 125 -----RDLKPENFLIDASGHIKLTDFGLSK----GIVTYANS-VVGSPDYMAPEVLRGKG 174
Query: 276 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH-NLVAWA----RPLFKDRRKF 324
D +S G + E + G + P NL W RP++ D R
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN 228
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
+LG+G FG+V + T ++ A+K L ++ + + + +VE +L+L + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 157 GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
C RL V E++ G L + + KEP + AA A GL +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFFLHSKG- 121
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAK---LGPVGDKTHVSTRVMGTYGYCAPEYAM 272
+IYRDLK N++LD H K++DFG+ K V KT GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-----GTPDYIAPEIIA 174
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAID 300
D ++FGV+ E++ G+ +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGYC 159
LGEG + V+KGR + T +VA+K++ +G + EV +L L H+N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
LV+E++ L+ ++ D + + +GL Y H + V+
Sbjct: 74 HTDKSLTLVFEYLD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VL 126
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTL 278
+RDLK N+L++E KL+DFGLA+ V KT+ + V T Y P+ + + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 279 KSDVYSFGVVFLELITGR 296
+ D++ G +F E+ +GR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
LLG+G FG+V R +++G+ A+K L + + E L E +L H L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKAN 215
D+ V E++ G L HL +E + R + A L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
++YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 276 LTLKSDVYSFGVVFLELITGR 296
D + GVV E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 66/200 (33%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
LLG+G FG+V R ++TG+ A+K L + + E L E +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
D+ V E+ G L HL E R A L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIVSALGYLHSCD-- 115
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 276
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 277 TLKSDVYSFGVVFLELITGR 296
D + GVV E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
LLG+G FG+V + ++TG+ A+K L + + E L E +L H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKAN 215
D+ V E+ G L HL +E + R + A L+YLH + N
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 276 LTLKSDVYSFGVVFLELITGR 296
D + GVV E++ GR
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 67/232 (28%), Positives = 91/232 (39%), Gaps = 49/232 (21%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE----FLVEVLMLSLLHHSNLVNL 155
++G G FG V+ R + TGQV A+K L R R E +L+ +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 156 IGYCADGDQRLL--VYEFMPLGSLEDHL---HDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
Y + D+ L V E+MP G L + L P + R IA L+ +
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET------ARFYIAELVL-ALDSV 117
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT----------------- 253
H I+RD+K NIL+D H KL+DFGL K
Sbjct: 118 HKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 254 -----HVSTRVM-----GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
H RV GT Y APE L+ D +S GV+ E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQ--LDRNGLQGNREFLVEVLMLSLLHHSNLVNL--I 156
+GEG +G VYK R T + +A+K+ L++ + E+ +L + H N+V L +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 157 GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIAAGAAKGLEYLHDK 213
+ ++RL LV+E++ L L+ H+ D PD N R+ +G+ Y H
Sbjct: 70 VHS---EKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 214 ANPPVIYRDLKSSNILLDEGFHP-KLSDFGLAK-LG-PVGDKTHVSTRVMGTYGYCAPEY 270
V++RDLK N+L+D + KL+DFGLA+ G PV TH T Y APE
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEI 174
Query: 271 AM-TGQLTLKSDVYSFGVVFLELITGR 296
+ + + D++S G +F E++ +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVK----QLDRNGLQGNREFLVEVLMLSLLHHSN-LVNL 155
+GEG +G+VYK R ++TG++VA+K ++D G+ L E+ +L +L S +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 156 IGY----CADGDQRL-LVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
+ +G L LV+E++ L D P PL T KG+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG--RPLPAKTIKSFMYQLLKGVA 124
Query: 209 YLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLG--PVGDKTHVSTRVMGTYGY 265
+ H V++RDLK N+L+D + K++D GL + PV TH + T Y
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWY 177
Query: 266 CAPEYAMTG-QLTLKSDVYSFGVVFLELITG 295
APE + + D++S G +F E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 66/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFL-----VEVLMLSLLHHSNLVNL 155
+G+G FG+VY+ R + T ++ A+K L + + +E +L+ +LL S +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 156 IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDK 213
+ + D L LV ++M G L HL KE R K A LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ-----KEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
++YRDLK NILLD H L DFGL+K +KT + GT Y APE +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLD 170
Query: 274 GQ-LTLKSDVYSFGVVFLELITG 295
+ T D +S GV+ E+ G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 158
+GEG FG+ + + G+ +K+++ + + E EV +LS + H N+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
+ +V ++ G L ++ L P+ + LDW ++ +A L+++HD+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK 121
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+++RD+KS NI L + KL DFG+A++ + ++ +GT Y +PE
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENR 176
Query: 275 QLTLKSDVYSFGVVFLELITGRKAID 300
KSD+++ G V E+ T + A +
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 51/219 (23%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLHHSNLVNLIG 157
+G G +G+V TG+ VA+K+L R + + R + E+ +L + H N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 158 YCADGDQRLLVYEFMPLGSLED--------HLHDLPPDKEPLDWNTRMK----------- 198
F P SLED HL D N +K
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGA-------DLNNIVKCQKLSDDHIQF 122
Query: 199 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 258
+ +GL+Y+H A +I+RDLK SNI ++E K+ DFGLA+ +V+TR
Sbjct: 123 LVYQILRGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
Query: 259 VMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 296
Y APE + D++S G + EL+TG+
Sbjct: 180 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF-LVEVLMLSLLHHSNLVNLIGY 158
++G G + +V RL+ Q+ A+K + + + + + V+ S+ L+G
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 159 --CADGDQRL-LVYEFMPLGSLEDHLH---DLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
C RL LV E++ G L H+ LP + AA L +LH+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-------YAAEICIALNFLHE 114
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYGYCAPEY 270
+ +IYRDLK N+LLD H KL+D+G+ K LGP GD T + GT Y APE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPEI 167
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAID 300
+ D ++ GV+ E++ GR D
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF-LVEVLMLSLLHHSNLVNLIGY 158
++G G + +V L+ T ++ A+K + + + + + V+ SN L+G
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 159 --CADGDQRL-LVYEFMPLGSLEDHLH---DLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
C + RL V EF+ G L H+ LP + + R +A + L +LH+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEE------HARF-YSAEISLALNFLHE 114
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYGYCAPEY 270
+ +IYRDLK N+LLD H KL+D+G+ K + P GD T + GT Y APE
Sbjct: 115 RG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT---STFCGTPNYIAPEI 167
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAID 300
D ++ GV+ E++ GR D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLIG 157
+G G +G VYK R TG++ AVK + L+ +F + E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA---AGAAKGLEYLHDKA 214
++ + E+ GSL+D H P E ++IA +GL YLH K
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-------LQIAYVCRETLQGLAYLHSKG 126
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-- 272
++RD+K +NILL + KL+DFG+A + +GT + APE A
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 273 -TGQLTLKSDVYSFGVVFLEL 292
G D+++ G+ +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 100 LLGEGGFGRVYKGRL---ESTGQVVAVKQLDRNGLQGNRE----FLVEVLMLSLLHHSNL 152
+LG+GG+G+V++ R TG++ A+K L + + N++ E +L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDW-NTRMKIAAGAAKGLEYLH 211
V+LI G + L+ E++ G L HL ++E + +T + + LE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALEHLH 117
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGYCAPEY 270
+ +IYRDLK NILLD H KL+DFGL K G TH GT Y APE
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEI 171
Query: 271 AMTGQLTLKSDVYSFGVVFLELITG---------RKAID 300
M D +S G + +++TG +K ID
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 65/202 (32%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEV-LMLSLLHHSNLVNL 155
++G+G FG+V + + G+ AVK L + + +E + E ++L + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKA 214
++ V +F+ G L HL EP R + AA A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLH--- 113
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGYCAPEYAMT 273
+ ++YRDLK NILLD H L+DFGL K G D T T GT Y APE
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRK 170
Query: 274 GQLTLKSDVYSFGVVFLELITG 295
D + G V E++ G
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 8/202 (3%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLHHS 150
NFR E +G G F VY+ G VA+K++ D + + + E+ +L L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
N++ + ++ +V E G L + K + T K LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
H + V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 271 AMTGQLTLKSDVYSFGVVFLEL 292
KSD++S G + E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 101 LGEGGFGRVYKGRL--ESTGQVVAVKQLDRNGL----QGNR---EFLVEVLMLSLLHHSN 151
LG+G F +YKG L +S +V Q L +R F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
LV L G C D+ ++V E++ G L+ LH + L W ++ +A A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 212 DKANPPVIYRDLKSSNILL-----DEGFHP--KLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
DK +++ ++ NIL+ +EG+ P KLSD G+ V + R+
Sbjct: 119 DKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 265 YCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 307
+ APE GQ LT+ +D +SFG LE+ + + +T E
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 65/230 (28%), Positives = 111/230 (48%), Gaps = 21/230 (9%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
+F LG G G V K + + +G ++A K + R ++ L +LH N
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR--ELQVLHECNS 62
Query: 153 VNLIGYC----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
++G+ +DG+ + + E M GSL+ L + E + K++ +GL
Sbjct: 63 PYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLA 117
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
YL +K +++RD+K SNIL++ KL DFG++ G + D ++ +GT Y +P
Sbjct: 118 YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSP 171
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA-WARPL 317
E +++SD++S G+ +EL GR I PP L A + RP+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP---PPDAKELEAIFGRPV 218
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF-LVEVLMLSLLHHSNLVNLIGY 158
++G G + +V RL+ T ++ A+K + + + + + V+ SN L+G
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 159 --CADGDQRLL-VYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
C + RL V E++ G L H+ P++ ++ + +A L YLH++
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHER 115
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGYCAPEYAM 272
+IYRDLK N+LLD H KL+D+G+ K G GD T + GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILR 169
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAID 300
D ++ GV+ E++ GR D
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 47/229 (20%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLD----RNGLQGNREF----------LVEVLMLSL 146
LGEG +G+V K TG++VA+K++ N + +R+ L E+ +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 147 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK------IA 200
+ H N++ L+ +GD LV + M DL K+ +D R+ I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA--------SDL---KKVVDRKIRLTESQVKCIL 125
Query: 201 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-------LGPVGDKT 253
GL LH ++RDL +NI ++ K++DFGLA+ +
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 254 HVSTRVMGTYG-----YCAPEYAM-TGQLTLKSDVYSFGVVFLELITGR 296
+ R T Y APE M + D++S G +F EL+TG+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGYC 159
LGEG + V+KGR + T +VA+K++ +G + EV +L L H+N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 160 ADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
LV+E++ L D+ +L + + +GL Y H +
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNL------MSMHNVKIFMFQLLRGLSYCHKRK--- 123
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQL 276
+++RDLK N+L++E KL+DFGLA+ V KT+ + V T Y P+ + + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181
Query: 277 TLKSDVYSFGVVFLELITGR 296
+ D++ G + E+ TGR
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 79/253 (31%), Positives = 114/253 (45%), Gaps = 29/253 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 157
+G+G FG+V + R T ++ A+K + + + E L E +L+ ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKANP 216
++ LV F+ G L HL +E +R + A LE LH K N
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ-----REGRFDLSRARFYTAELLCALENLH-KFN- 113
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 276
VIYRDLK NILLD H L DFGL KL D + GT Y APE +
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGY 170
Query: 277 TLKSDVYSFGVVFLELITGRKAIDNTRPP-GEHNLVAWARPLFKDRRKFP----KMADPL 331
T D ++ GV+ E++TG PP + N+ R + ++ +FP + A L
Sbjct: 171 TKAVDWWTLGVLLYEMLTG-------LPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDL 223
Query: 332 LQG---RYPMRGL 341
L G R P R L
Sbjct: 224 LIGLLSRDPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGYC 159
LGEG + VYKG+ + G++VA+K + +G + E +L L H+N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 160 ADGDQRLLVYEFMPLG---SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+ LV+E++ ++ H L P+ N ++ + +GL Y+H +
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPE------NVKLFLFQ-LLRGLSYIHQRY-- 123
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQ 275
+++RDLK N+L+ + KL+DFGLA+ V T+ + V T Y P+ + + +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTE 180
Query: 276 LTLKSDVYSFGVVFLELITGRKA 298
+ D++ G +F+E+I G A
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 62/279 (22%), Positives = 113/279 (40%), Gaps = 30/279 (10%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLHHS 150
NF+ E +G G F VY+ + VA+K++ + + ++ + E+ +L L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
N++ + + ++ +V E G L + K + T K +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
H + V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330
KSD++S G + E + A P + D+ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLFSLCQK 219
Query: 331 LLQGRY---PMRGLYQAL-AVAAMCLQEQAATRPLIGDV 365
+ Q Y P + L + +MC+ RP IG V
Sbjct: 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 68/268 (25%), Positives = 107/268 (39%), Gaps = 87/268 (32%)
Query: 102 GEGGFGRVYKGRLE--STGQVVAVKQLDRNGLQGN-------REFLVEVLMLSLLHHSNL 152
G G +GRVYK + + G+ A+K+ + Q RE + +L L H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHENV 64
Query: 153 VNLIGYC-ADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDW--------NTRMKIAAG 202
V+L+ D+ + L++++ HDL W R+ I
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAE--------HDL--------WQIIKFHRQAKRVSIPPS 108
Query: 203 AAK--------GLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAKL--GP 248
K G+ YLH V++RDLK +NIL+ E K+ D GLA+L P
Sbjct: 109 MVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 249 V-----GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGRKAIDNT 302
+ D V+ T Y APE + + K+ D+++ G +F EL+T
Sbjct: 166 LKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-------- 211
Query: 303 RPPGEHNLVAWARPLFKDRRKFPKMADP 330
P+FK R K ++P
Sbjct: 212 -----------LEPIFKGREAKIKKSNP 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 13/216 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYC 159
LGEG + VYKG GQ+VA+K + +G + E +L L H+N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
+ V+E+M L ++ P P +N R+ + +GL Y+H + ++
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGGLHP--YNVRLFMFQ-LLRGLAYIHGQH---IL 125
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
+RDLK N+L+ KL+DFGLA+ + +T+ S V T Y P+ + G
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGATDYS 182
Query: 280 S--DVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 313
S D++ G +F+E++ G+ A E W
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 94 NFRPECLLGEGGFGRVYKGRLES---TGQVVAVKQLDRNGLQGNREFL----VEVLMLSL 146
NF +LG G +G+V+ R G++ A+K L + + + E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 147 LHHSN-LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 204
+ LV L Y D +L L+ +++ G L HL+ E R+ IA
Sbjct: 61 VRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAE-IV 115
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMGT 262
L++LH +IYRD+K NILLD H L+DFGL+K L ++ + GT
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGT 169
Query: 263 YGYCAPEYAMTGQLTLKS--DVYSFGVVFLELITG 295
Y APE G D +S GV+ EL+TG
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 83/274 (30%), Positives = 122/274 (44%), Gaps = 34/274 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLVNLIG-- 157
+G+G +G+VYK + G + AVK LD + E E +L SL +H N+V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 158 YCAD---GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
Y AD G Q LV E GS+ + + L + LD I GA GL++LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--- 145
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
N +I+RD+K +NILL KL DFG+ A+L + + S +GT + APE
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPEVIAC 202
Query: 274 GQ-----LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328
Q + DV+S G+ +EL G + + P + LF K P+
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---------VKTLF----KIPRNP 249
Query: 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362
P L +P + + CL + RP +
Sbjct: 250 PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSV 281
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 108 RVYKGRLESTGQVVAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166
+YKG + ++ + G + E+ L + +N++ + G+ D L
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 167 ----LVYEFMPLGSLEDHLHDLPPDKEP-LDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 221
L+ E+ G L + L DKE L + T++ +A KGL L+ N P Y+
Sbjct: 95 PRLSLILEYCTRGYLREVL-----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 222 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 281
+L S + L+ E + K+ GL K+ +V+ V +Y ++ + T+K D
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS---EYTIKDD 204
Query: 282 VYSFGVVFLELITGRKAIDN 301
+YS GVV E+ TG+ +N
Sbjct: 205 IYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEV-LMLSLLHHSNLVNL 155
++G+G FG+V + +S G AVK L + + +E + E ++L L H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKA 214
++ V +++ G L HL EP R + AA A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSLN 116
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+IYRDLK NILLD H L+DFGL K G ++T ++ GT Y APE
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 275 QLTLKSDVYSFGVVFLELITG 295
D + G V E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 56/216 (25%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLD-RNGLQGNREFL-VEVLMLSLLHHSNLVN---- 154
+G+G +G V R + G+ +K+L+ RN + R+ E +LS L H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 155 ----------LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 204
++G+C GD +Y L++ L P+ + ++W ++ +A
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
L+YLH+K +++RDLK+ N+ L K+ D G+A++ + ++ +++ ++GT
Sbjct: 115 --LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 300
Y +PE KSDV++ G E+ T + A +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+GEG +G V+K + T ++VA+K++ D G+ + L E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+ LV+E+ L+ + D +D KGL + H
Sbjct: 66 DVLHSDKKLTLVFEYCD-QDLKKYFDSCNGD---IDPEIVKSFMFQLLKGLAFCHSHN-- 119
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 276
V++RDLK N+L+++ KL+DFGLA+ + + + S V+ T Y P+ +L
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFGAKL 176
Query: 277 TLKS-DVYSFGVVFLEL 292
S D++S G +F EL
Sbjct: 177 YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 86 RELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLM 143
+L ++F ++G G FG V R +S+ QV A+K L + + + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE--E 93
Query: 144 LSLLHHSN---LVNLIGYCADGDQRLL--VYEFMPLGSLEDHL--HDLPPDKEPLDWNTR 196
++ H+N +V L + A D + L V E+MP G L + + +D+P W R
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----W-AR 145
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHV 255
A L+ +H I+RD+K N+LLD+ H KL+DFG K+ G
Sbjct: 146 FYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRC 200
Query: 256 STRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVFLELITG 295
T V GT Y +PE + G + D +S GV E++ G
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHH 149
K+F + L+G G FG V R ++TG + A+K + ++ L F E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
+ L D D LV E+ P G L L L ++ D + A +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG-LAKLGPVGDKTHVSTRVMGTYGYCAP 268
+H ++RD+K N+L+D H KL+DFG A+L +K S +GT Y AP
Sbjct: 118 VHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIAP 172
Query: 269 EYAMT------GQLTLKSDVYSFGVVFLELITGR 296
E T G ++ D +S GV+ E+I GR
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLHHSNLVNL- 155
+GEG +G V + TG VA+K++ + R L E+ +L H N++ +
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-TFCQRT-LREIKILRRFKHENIIGIL 69
Query: 156 -----IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
+ + D +V E M E L+ L + + + + + +GL+Y+
Sbjct: 70 DIIRPPSFESFNDV-YIVQELM-----ETDLYKLIKTQHLSNDHIQYFLYQ-ILRGLKYI 122
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY----GYC 266
H AN V++RDLK SN+LL+ K+ DFGLA+ + D H T + Y Y
Sbjct: 123 H-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTGFLTEYVATRWYR 176
Query: 267 APEYAMTGQLTLKS-DVYSFGVVFLELITGR 296
APE + + K+ D++S G + E+++ R
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 37/225 (16%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN----REFLVEVLMLSLLHHSNLVNL 155
L+G+GG G VY + VA+K++ R L N + FL E + + L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 156 IGYCADGDQRLLVYEFMP------LGSLEDHLHDLPPDKEPLDWNTRMK----IAAGAAK 205
C+DGD VY MP L SL + + L T + I
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 206 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-------------KLGPVGDK 252
+EY+H K V++RDLK NILL + D+G A +
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 253 THVST---RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
T +++GT Y APE + + +D+Y+ GV+ +++T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 73/252 (28%), Positives = 112/252 (44%), Gaps = 28/252 (11%)
Query: 94 NFRPECLLGEGGFGRVYKGRLES---TGQVVAVKQLDRNGL----QGNREFLVEVLMLSL 146
NF +LG G +G+V+ R S +G++ A+K L + + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 147 LHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA-A 204
+ S + + Y D +L L+ +++ G L HL KE ++I +G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIYSGEIV 115
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
LE+LH +IYRD+K NILLD H L+DFGL+K D+ + GT
Sbjct: 116 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIE 171
Query: 265 YCAPEYAMTGQLTLKS--DVYSFGVVFLELITGRK--AIDNTRPPGEHNLVA-WARPLFK 319
Y AP+ G D +S GV+ EL+TG +D GE N A +R + K
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD-----GEKNSQAEISRRILK 226
Query: 320 DRRKFPKMADPL 331
+P+ L
Sbjct: 227 SEPPYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQ---VVAVKQLDRNGLQGN--REFLVEVLMLSLL 147
K+ + E +LG G FG + +G L+ + VA+ L R G R FL E L L
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQF 63
Query: 148 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207
HSN+V L G G+ ++V E+M G+L+ L + L M + G A G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGM 120
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG--- 264
+YL + +++ L + +L++ K+S F + DK+ M
Sbjct: 121 KYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVL 173
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ APE + SDV+SFG+V E+++
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLHHSNLVNL 155
L+ G +G VY R + T Q A+K++++ L Q + F VE +L+ + +V++
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66
Query: 156 IGYCADGDQRLL--VYEFMPLG---SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
+C+ +R L V E++ G +L ++ LP D RM A LEYL
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM------ARMYFAE-TVLALEYL 117
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-------STR----- 258
H N +++RDLK N+L+ H KL+DFGL+K+G + T++ TR
Sbjct: 118 H---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 259 -VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
V GT Y APE + D ++ G++ E + G
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 74/244 (30%), Positives = 105/244 (43%), Gaps = 27/244 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLVNLIG-- 157
+G+G +G+V+K + G AVK LD + E E +L +L H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 158 YCAD---GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
Y D GDQ LV E GS+ D + E ++ I A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--- 141
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY-AMT 273
I+RD+K +NILL KL DFG++ + +GT + APE A
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 274 GQL----TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK-DRRKFPKMA 328
QL + DV+S G+ +EL G + + P R LFK R P +
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP---------MRALFKIPRNPPPTLH 250
Query: 329 DPLL 332
P L
Sbjct: 251 QPEL 254
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 70/259 (27%), Positives = 111/259 (42%), Gaps = 36/259 (13%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF----LVEVLMLSLLHHSNLVNL 155
++GEG +G V K R + T ++VA+K+ + + N E L E+ ML L N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 156 IGYCADGDQRLLVYEFMP---LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
+ LV+E++ L LE+ + +PP+K R I K + + H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK------VRSYIYQ-LIKAIHWCHK 118
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
+++RD+K N+L+ KL DFG A+ G + T + T Y +PE +
Sbjct: 119 ND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLL 174
Query: 273 TGQLTLKSDVYSFGVVFLE------LITGRKAIDNTRP--------PGEHNLVAWARPLF 318
D++S G + E L G ID P E + ++ P F
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234
Query: 319 KDRRKFPKMADP-LLQGRY 336
R FP + P L+ RY
Sbjct: 235 HGLR-FPAVNHPQSLERRY 252
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEV-LMLSLLHHSNLVNL 155
++G+G FG+V R ++ + AVK L + + +E + E ++L + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKA 214
D+ V +++ G L HL +E R + AA A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
++YRDLK NILLD H L+DFGL K + T ++ GT Y APE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171
Query: 275 QLTLKSDVYSFGVVFLELITG 295
D + G V E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 148
+ P +G G +G V + T + VA+K++ N + R L E+ +L L
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLD 62
Query: 149 HSNLVNLIGYCADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 203
H N++ + + +VYE M + LH + + L +
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQL 117
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
+GL+Y+H AN V++RDLK SN+LL+ K+ DFGLA+ +K T + T
Sbjct: 118 LRGLKYIH-SAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTR 172
Query: 264 GYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAI 299
Y APE + + T DV+S G +F EL+ GRK +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQV-------VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
LG+G F +++KG G V +K LD++ + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G C GD+ ++V E++ GSL+ +L + + W ++++A A L +L DK
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 214 ANPPVIYRDLKSSNILL------DEGFHP--KLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265
+ + ++ + N+LL G P KLSD G++ V K + R+ +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI--TVLPKEILLERI----PW 170
Query: 266 CAPEYAMTGQ-LTLKSDVYSFGVVFLELITG 295
PE Q L+L +D +SFG E+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLHHSNL 152
++ + ++G+G +G V TG+ VA+K+++ + L E+ +L LL H ++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 153 VNLIGYCADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207
V + +R +V+E M E LH + + L + L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS-TRVMGTYGYC 266
+Y+H AN V +RDLK NIL + K+ DFGLA++ T + T + T Y
Sbjct: 117 KYIH-TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 267 APEY--AMTGQLTLKSDVYSFGVVFLELITGR 296
APE + + T D++S G +F E++TG+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC- 159
LG G G V+K + +G ++A K + R ++ L +LH N ++G+
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR--ELQVLHECNSPYIVGFYG 70
Query: 160 ---ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+DG+ + + E M GSL+ L E + K++ KGL YL +K
Sbjct: 71 AFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK- 124
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 276
+++RD+K SNIL++ KL DFG++ G + D ++ +GT Y +PE
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHY 179
Query: 277 TLKSDVYSFGVVFLELITGRKAIDNTRPP 305
+++SD++S G+ +E+ GR I PP
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPI----PP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 101 LGEGGFGRVYKGRLESTG-QVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
LG G FGRV ++ VA+K+ +++ + ++ E +L+ ++H VNL
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHD---LPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G D LV EF+ G L P D AA EYL
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-------YAAQIVLIFEYLQSL 150
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
++YRDLK N+LLD+ K++DFG AK+ V +T+ + GT Y APE +
Sbjct: 151 N---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTYT---LCGTPEYIAPEILLN 202
Query: 274 GQLTLKSDVYSFGVVFLELITG 295
+D ++ G+ E++ G
Sbjct: 203 VGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH 149
+ K+++ ++G G FG VY+ T + VA+K++ ++ NRE L+ + L+H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNH 118
Query: 150 SNLVNLIGY----CADGDQRLL----VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 201
N++ L Y C +++ + V EF+P ++ ++ + L +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-KLSDFGLAK--LGPVGDKTHVSTR 258
+ L Y+H K + +RDLK N+L+D H KL DFG AK L +++ +R
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 259 VMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITG 295
Y APE + T D++S G + E+I G
Sbjct: 235 F-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 10/204 (4%)
Query: 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLHHSNLV 153
RP +G G FG V+ G+ VA+K++ L + E+ ML H N++
Sbjct: 6 RP---IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
+ + ++ ++ LH + +PL + +GL+YLH
Sbjct: 63 SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH-S 121
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
A +++RD+K N+L++ K+ DFGLA++ + H++ V+ Y Y APE M
Sbjct: 122 AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMG 178
Query: 274 GQ-LTLKSDVYSFGVVFLELITGR 296
+ T D++S G +F EL+ R
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 32/225 (14%)
Query: 84 TFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVE 140
T E+ ++ + +G G +G V TG VA+K+L R + L R + E
Sbjct: 9 TIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-E 64
Query: 141 VLMLSLLHHSNLVNLIG-YCADG--DQRLLVYEFMP-----LGSLEDHLHDLPPDKEPLD 192
+ +L + H N++ L+ + D D+ Y MP LG L H E L
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLS 116
Query: 193 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252
+ + KGL+Y+H +I+RDLK N+ ++E K+ DFGLA+
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173
Query: 253 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 296
+V TR Y APE + T D++S G + E++TG+
Sbjct: 174 GYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLHHSNLVNL 155
+G G +G V + TG+ VA+K+L R + + R + E+ +L + H N++ L
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGL 79
Query: 156 I-----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDK-EPLDWNTRMKIAAGAAKGLE 208
+ D Q LV +M + H L DK + L + GL+
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLK 131
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
Y+H +I+RDLK N+ ++E K+ DFGLA+ +V TR Y AP
Sbjct: 132 YIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAP 183
Query: 269 EYAMTG-QLTLKSDVYSFGVVFLELITGR 296
E + D++S G + E++TG+
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 33/209 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV------EVLMLSLLHHSNLVN 154
+G G G VYK TG++ A+K + GN E V E+ +L ++H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 155 LIGYCADGDQRLLVYEFMPLGSLED-HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
+ ++ EFM GSLE H+ D E + +I +G A YLH +
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIAD-----EQFLADVARQILSGIA----YLHRR 187
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAM 272
+++RD+K SN+L++ + K++DFG+++ L D + S +GT Y +PE
Sbjct: 188 H---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERIN 241
Query: 273 T----GQLT-LKSDVYSFGVVFLELITGR 296
T G D++S GV LE GR
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 28/195 (14%)
Query: 117 TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLIGYCADGDQRLLVYEFMPL 174
T Q +K L ++ L+++ H N+V L Y D LV +
Sbjct: 17 TQQTFILKGLRKSSEYSRER-------LTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69
Query: 175 GSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE 232
G L H+ P++ W M +A L+ LH + ++ RDL +NILLD+
Sbjct: 70 GKLWSHISKFLNIPEECVKRWAAEMVVA------LDALHREG---IVCRDLNPNNILLDD 120
Query: 233 GFHPKLSDFG-LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 291
H +L+ F +++ D V YCAPE + T D +S G + E
Sbjct: 121 RGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVGGISEETEACDWWSLGAILFE 174
Query: 292 LITGRKAIDNTRPPG 306
L+TG K + P G
Sbjct: 175 LLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 42/236 (17%)
Query: 84 TFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVE 140
T E+ +N P +G G +G V TG VAVK+L R + + R + E
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-E 66
Query: 141 VLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED-------------HLHDLPPD 187
+ +L + H N++ L+ F P SLE+ L+++
Sbjct: 67 LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 114
Query: 188 KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247
++ D + + I +GL+Y+H + +I+RDLK SN+ ++E K+ DFGLA+
Sbjct: 115 QKLTDDHVQFLIYQ-ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170
Query: 248 PVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 302
+V+TR Y APE + D++S G + EL+TGR T
Sbjct: 171 DDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 101 LGEGGFGRVY-----KGRLESTGQV---VAVKQLDRN-GLQGNREFLVEVLMLSLLHHSN 151
LG+G FG VY K E +V + V +L+ N +Q N E +LS L H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V + D ++ E+ L+ L +L + L N + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ +++RDLK+ NI L K+ DFG+++L + ++T GT Y +PE
Sbjct: 124 QRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 272 MTGQLTLKSDVYSFGVVFLEL 292
KSD++S G + E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 86 RELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLM 143
R+L +++ ++G G FG V R +ST +V A+K L + + + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 144 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAA 201
+ +S V + Y D+ L +V E+MP G L + + + P+K + + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG----LAKLGPVGDKTHVST 257
A + ++H RD+K N+LLD+ H KL+DFG + K G V T V
Sbjct: 156 DAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 204
Query: 258 RVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVFLELITG 295
GT Y +PE + G + D +S GV E++ G
Sbjct: 205 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 86 RELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVL 142
R+L +++ ++G G FG V R +S+ +V A+K L + + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 143 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKI 199
+++ + +V L +CA D + L V E+MP G L + + + P+K + + +
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTR 258
A A + +H RD+K N+LLD+ H KL+DFG K+ G T
Sbjct: 154 ALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTA 203
Query: 259 VMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVFLELITG 295
V GT Y +PE + G + D +S GV E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 41/217 (18%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDR---------NGLQGNREFLV--EVLMLSLLH 148
++G G FG V ++++TGQV A+K L++ + R+ LV + ++ LH
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 149 HS-----NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 203
++ NL ++ Y GD L+ +F ED L P D + M +A +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL---PEDMARF-YLAEMVLAIDS 117
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
L Y+H RD+K N+LLD+ H +L+DFG + L + D T S +GT
Sbjct: 118 VHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTP 167
Query: 264 GYCAPEY--AM---TGQLTLKSDVYSFGVVFLELITG 295
Y +PE AM G+ + D +S GV E++ G
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 70/253 (27%), Positives = 112/253 (44%), Gaps = 27/253 (10%)
Query: 94 NFRPECLLGEGGFGRVYKGRLES---TGQVVAVKQLDRNGL----QGNREFLVEVLMLSL 146
NF +LG G +G+V+ R + TG++ A+K L + L + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 147 LHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA- 204
+ S + + Y + +L L+ +++ G + HL+ E ++ +G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGEII 115
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK--LGPVGDKTHVSTRVMGT 262
LE+LH ++YRD+K NILLD H L+DFGL+K L ++T+ GT
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGT 169
Query: 263 YGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGRKAIDNTRPPGEHNLVA-WARPLFKD 320
Y APE K+ D +S G++ EL+TG GE N + +R + K
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT---LEGERNTQSEVSRRILKC 226
Query: 321 RRKFPKMADPLLQ 333
FP P Q
Sbjct: 227 DPPFPSFIGPEAQ 239
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 63/256 (24%), Positives = 101/256 (39%), Gaps = 74/256 (28%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---------QGNREFLVEVLM 143
+F ++G G FG V + + TG + A+K+L ++ + + R+ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 144 LSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKI 199
+ +V L Y + D + L+ E++P G + L D ++E TR I
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYI 107
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG-DKTHVST- 257
A ++ +H K I+RD+K N+LLD H KLSDFGL G K+H +
Sbjct: 108 AE-TILAIDSIH-KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEF 159
Query: 258 ---------------------------------RVM-----GTYGYCAPEYAMTGQLTLK 279
R + GT Y APE + +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219
Query: 280 SDVYSFGVVFLELITG 295
D +S GV+ E++ G
Sbjct: 220 CDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 25/221 (11%)
Query: 101 LGEGGFGRVYKGRL--ESTGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLIG 157
+G G FG+V + ++ V VK+L N + EFL + +L H N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 158 YCADGDQRLLVYEFMPLGSLEDHL---HDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
C + LLV+E+ LG L+ +L + + L ++A A G+ ++H K
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-KH 118
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA--- 271
N ++ DL N L K+ D+G+ D + APE
Sbjct: 119 N--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 272 ----MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH 308
+T + T S+V++ GV EL +N P H
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL------FENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLHH 149
+N +P +G G G V TGQ VA+K+L R N R + VLM L++H
Sbjct: 19 QNLKP---IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNH 74
Query: 150 SNLVNLIGYCADGDQRL-------LVYEFMPLGSLEDHLH-DLPPDKEPLDWNTRMKIAA 201
N++ L+ + L LV E M +L + DL D E + + +
Sbjct: 75 KNIIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDL--DHERMSYLLYQMLC- 129
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 261
G+++LH + +I+RDLK SNI++ K+ DFGLA+ G ++ V+
Sbjct: 130 ----GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVT 180
Query: 262 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
Y Y APE + D++S G + E+I G
Sbjct: 181 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 40/229 (17%)
Query: 84 TFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR--NGLQGNREFLVEV 141
T E+ +N P +G G +G V Q VAVK+L R L R E+
Sbjct: 9 TVWEVPERYQNLTP---VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYREL 65
Query: 142 LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED-------------HLHDLPPDK 188
+L + H N++ L+ F P S+E+ L+++ +
Sbjct: 66 RLLKHMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQ 113
Query: 189 EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248
+ D + + I +GL+Y+H +I+RDLK SN+ ++E ++ DFGLA+
Sbjct: 114 KLSDEHVQFLIYQ-LLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD 169
Query: 249 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 296
+V+TR Y APE + D++S G + EL+ G+
Sbjct: 170 DEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 70/260 (26%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGN--REFLVEV-LMLSLLHHSNL 152
LG G FG+V + ++ + VAVK L + G + + + E+ +++ + HH N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIGHHLNV 73
Query: 153 VNLIGYCADGDQRLLV-YEFMPLGSLEDHL----HDLPPDKEPLDWNTRMKIAAGAAKGL 207
VNL+G C L+V E+ G+L ++L P + MK G + L
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 208 --------------------------EYLHDKANPPV----------------------- 218
E + P+
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK 193
Query: 219 -IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYAMTG 274
I+RDL + NILL E K+ DFGLA+ D +V R+ + APE
Sbjct: 194 CIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPESIFDK 250
Query: 275 QLTLKSDVYSFGVVFLELIT 294
T +SDV+SFGV+ E+ +
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 41/217 (18%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDR---------NGLQGNREFLV--EVLMLSLLH 148
++G G FG V +L++ +V A+K L++ + R+ LV + ++ LH
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 149 HS-----NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 203
++ NL ++ Y GD L+ +F ED L P+ + M IA +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAEMVIAIDS 117
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
L Y+H RD+K NIL+D H +L+DFG + L + D T S+ +GT
Sbjct: 118 VHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTP 167
Query: 264 GYCAPEY--AM---TGQLTLKSDVYSFGVVFLELITG 295
Y +PE AM G+ + D +S GV E++ G
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 18/219 (8%)
Query: 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH 148
A+ + L G GRV+ V +K G +G L+E ++L ++
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI----GQKGTT--LIEAMLLQNVN 115
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD-LPPDKEPLDWNTRMKIAAGAAKGL 207
H +++ + G +V L L+ L PL + + I +GL
Sbjct: 116 HPSVIRMKDTLVSGAITCMV-----LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGL 170
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 267
YLH + +I+RD+K+ NI +++ + D G A+ PV + + GT A
Sbjct: 171 RYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNA 224
Query: 268 PEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 306
PE + K+D++S G+V E++ I P
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 37/98 (37%), Positives = 56/98 (57%), Gaps = 9/98 (9%)
Query: 206 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK---LGPVGDKTHVSTRVMGT 262
GL+Y+H AN V++RDLK N+L++ K+ DFGLA+ P + + T + T
Sbjct: 117 GLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 263 YGYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGRKAI 299
Y APE ++ Q K+ DV+S G + EL+ GRK +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 35/151 (23%), Positives = 55/151 (36%), Gaps = 17/151 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLV-NLIG 157
LL G RVY L + + +K +RE EV +L LL V ++
Sbjct: 5 LLKGGLTNRVY--LLGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPKVLA 60
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217
L+ E++ G D + + + A+ L LH
Sbjct: 61 SGESDGWSYLLMEWIE-GETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLV 109
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248
+ + DL NIL+D+G + D+ A GP
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 36/159 (22%)
Query: 104 GGFGRVYKGRLESTGQVVAVK----------------QLDRNGLQGNREFLVEVLMLSLL 147
G FG+VY GR ++ ++ AVK Q +R+ L ++ + L SL
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 148 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207
+N+ LV E++ G ++ LH E +K + A L
Sbjct: 75 SANNV-------------YLVMEYLIGGDVKSLLHIYGYFDEE----MAVKYISEVALAL 117
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246
+YLH +I+RDLK N+L+ H KL+DFGL+K+
Sbjct: 118 DYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 36/242 (14%)
Query: 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL 146
+L + + RP LG G G V+ + VAVK++ Q + L E+ ++
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRR 58
Query: 147 LHHSNLVNLIGYCADGDQRL--------------LVYEFMPLGSLEDHLHDLPPDKEPLD 192
L H N+V + L +V E+M E L ++ ++ PL
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVL-EQGPLS 112
Query: 193 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAK-LGP-V 249
+GL+Y+H AN V++RDLK +N+ ++ E K+ DFGLA+ + P
Sbjct: 113 EEHARLFMYQLLRGLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169
Query: 250 GDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH 308
K ++S ++ + Y +P ++ T D+++ G +F E++TG+ G H
Sbjct: 170 SHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-----PLFAGAH 223
Query: 309 NL 310
L
Sbjct: 224 EL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 32/215 (14%)
Query: 100 LLGEGGFGR--VYKGRLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVN 154
L+G+ V+ + + T +VAVK+++ + + + E++ L H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA---AGAAKGLEYLH 211
+ + +V M GS ED L P+ P + IA L+Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIH 118
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA--------KLGPVGDKTHVSTRVMGTY 263
K I+R +K+S+ILL LS + + V D S + +
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-- 173
Query: 264 GYCAPEY---AMTGQLTLKSDVYSFGVVFLELITG 295
+ +PE + G KSD+YS G+ EL G
Sbjct: 174 -WLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 63/236 (26%), Positives = 99/236 (41%), Gaps = 41/236 (17%)
Query: 75 TAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGL 131
+ +A TFT K ++ +G G G V G VAVK+L R N
Sbjct: 9 SVQVADSTFT------VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT 62
Query: 132 QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL 191
R + E+++L ++H N+++L+ F P SLE+ D+ E +
Sbjct: 63 HAKRAYR-ELVLLKCVNHKNIISLLNV------------FTPQKSLEE-FQDVYLVMELM 108
Query: 192 DWN-----------TRMK-IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239
D N RM + G+++LH +I+RDLK SNI++ K+
Sbjct: 109 DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 165
Query: 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
DFGLA+ + T + T Y APE + D++S G + EL+ G
Sbjct: 166 DFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 41/217 (18%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDR---------NGLQGNREFLV--EVLMLSLLH 148
++G G FG V +++ T ++ A+K L++ + R LV + ++ LH
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 149 HS-----NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 203
++ L ++ Y GD L+ +F ED L P+ + M +A +
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYIAEMVLAIHS 117
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
L Y+H RD+K N+LLD H +L+DFG + L D T S+ +GT
Sbjct: 118 IHQLHYVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTP 167
Query: 264 GYCAPEY--AM---TGQLTLKSDVYSFGVVFLELITG 295
Y +PE AM G+ + D +S GV E++ G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 72/262 (27%), Positives = 101/262 (38%), Gaps = 71/262 (27%)
Query: 100 LLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSN 151
+LG G FG+V + +S+ VAVK L + L+ L + L+H H N
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKI-LIHIGNHLN 72
Query: 152 LVNLIGYCADGDQRLLV-YEFMPLGSLEDHLHD-----LP-PDKEPLDW----------N 194
+VNL+G C + L+V EF G+L + L P +K P
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 195 TRMKIAAGAAKGLEYLHDK-----ANPP-------------------------------- 217
+I AG A L NPP
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 218 --VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYAM 272
I+RDL + NILL E K+ DFGLA+ D +V S R+ + APE
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIF 249
Query: 273 TGQLTLKSDVYSFGVVFLELIT 294
T +SDV+SFGV+ E+ +
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 31/83 (37%), Positives = 45/83 (54%)
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 277
+I+RD+KS+NILL KL DFG +K+ V GT Y APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 278 LKSDVYSFGVVFLELITGRKAID 300
K+D++S GV+ EL+T ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 99 CLLGEGGFGRVYKGRLESTG--QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
C +G G +G VYK + + + A+KQ++ G+ + E+ +L L H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQ 64
Query: 157 G-YCADGDQRL-LVYEFMPLGSLEDHLHDL----------PPDKEPLDWNTRM--KIAAG 202
+ + D+++ L++++ HDL +K+P+ M +
Sbjct: 65 KVFLSHSDRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAK-----LGPVGDKT 253
G+ YLH AN V++RDLK +NIL+ E K++D G A+ L P+ D
Sbjct: 117 ILDGIHYLH--AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 254 HVSTRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELIT 294
V T+ Y APE + + K+ D+++ G +F EL+T
Sbjct: 174 PVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 43/222 (19%)
Query: 99 CLLGEGGFGRVYKGRLE--STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
C +G G +G VYK + + + A+KQ++ G+ + E+ +L L H N+++L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQ 64
Query: 157 G-YCADGDQRL-LVYEFMPLGSLEDHLHDL----------PPDKEPLDWNTRM--KIAAG 202
+ + D+++ L++++ HDL +K+P+ M +
Sbjct: 65 KVFLSHADRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAK-----LGPVGDKT 253
G+ YLH AN V++RDLK +NIL+ E K++D G A+ L P+ D
Sbjct: 117 ILDGIHYLH--AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 254 HVSTRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVFLELIT 294
V T+ Y APE + + K+ D+++ G +F EL+T
Sbjct: 174 PVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 19/182 (10%)
Query: 114 LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173
E+ G + +KQ D ++ V ML + S ++ D R Y+
Sbjct: 171 FENKGDYMDMKQAD------TTQY---VPMLEIKEASKYSDIQRSNYD---RPASYKGSN 218
Query: 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG 233
+++ L D E L + A+G+E+L A+ ++RDL + N+LL +G
Sbjct: 219 DSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQG 273
Query: 234 FHPKLSDFGLAKLGPVGDKTHVST-RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 292
K+ DFGLA+ + D +VS + APE T SDV+S+G++ E+
Sbjct: 274 KIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
Query: 293 IT 294
+
Sbjct: 333 FS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 71/270 (26%), Positives = 106/270 (39%), Gaps = 84/270 (31%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNREFLVEVL--MLSLLHHSNLV 153
LG G FG+V + +T + VAVK L L+ L ++ + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 154 NLIG--------------YCADGDQRLLVY------EFMPLGSL-------EDHLHDLPP 186
NL+G +C G+ L Y EF+P + + D+
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGN--LSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132
Query: 187 D-KEPLDWNTRMKIAAGA--------------------------------------AKGL 207
D K LD T + +A + AKG+
Sbjct: 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGM 192
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV---STRVMGTYG 264
E+L A+ I+RDL + NILL E K+ DFGLA+ D +V R+
Sbjct: 193 EFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLK 246
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ APE T++SDV+SFGV+ E+ +
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 52/256 (20%)
Query: 78 IAAQTFTFRELAAATKNFRPECLLGEGGFGRV---YKGRLESTGQVVAVKQLDR---NGL 131
I TFT + +N +P +G G G V Y LE VA+K+L R N
Sbjct: 15 IGDSTFT---VLKRYQNLKP---IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQT 65
Query: 132 QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL 191
R + E++++ ++H N++ L+ F P SLE+ D+ E +
Sbjct: 66 HAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSLEE-FQDVYIVMELM 111
Query: 192 DWN-----------TRMK-IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239
D N RM + G+++LH +I+RDLK SNI++ K+
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299
DFGLA+ G ++ V+ Y Y APE + D++S G + E+I G
Sbjct: 169 DFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 300 DNTRPPGEHNLVAWAR 315
PG ++ W +
Sbjct: 226 -----PGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 188 KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KL 246
PL + I + L YLH + +I+RD+K+ NI LDE + L DFG A KL
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 292
D GT +PE K+D++S G+V E+
Sbjct: 236 DAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 13/113 (11%)
Query: 187 DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246
D+ LD + + AKG+ +L K I+RDL + NILL G K+ DFGLA+
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR- 262
Query: 247 GPVGDKTHVSTRVMGTYG-----YCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
D + S V+ + APE T +SDV+S+G++ E+ +
Sbjct: 263 ----DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 35/113 (30%), Positives = 62/113 (54%), Gaps = 11/113 (9%)
Query: 186 PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245
D PLD + ++ ++ A+G+++L K I+RD+ + N+LL +G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 246 LGPVGDKTHVSTRVMGT----YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ D +V V G + APE T++SDV+S+G++ E+ +
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 63/207 (30%), Positives = 88/207 (42%), Gaps = 34/207 (16%)
Query: 109 VYKGRLESTGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHSNLVNLIGYCADGDQ 164
VY R TG +V V+ D E L EV++ H N++ G
Sbjct: 16 VYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73
Query: 165 RLLVYEFMPLGSLEDHLHDLPPD--KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 222
++ FM GS L P+ E L N I GA +GL YLH I+R+
Sbjct: 74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRN 126
Query: 223 LKSSNILLDEGFHPKLSDFGLAKLGPV---GDKTHV-------STRVMGTYGYCAPEYA- 271
+K+S+IL+ LS GL+ L + G K V ST V+ + +PE
Sbjct: 127 IKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLR 181
Query: 272 --MTGQLTLKSDVYSFGVVFLELITGR 296
+ G +KSD+YS G+ EL TGR
Sbjct: 182 QDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 28/163 (17%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---------QGNREFLVEVLML 144
+F ++G+G FG V + + TG++ A+K L ++ + + R+ L E
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE---- 57
Query: 145 SLLHHSN---LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 201
S+ +V+L D L+ EF+P G L L E + TR +A
Sbjct: 58 -----SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAE 109
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244
+E +H I+RD+K NIL+D G H KLSDFGL+
Sbjct: 110 -CVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 59/246 (23%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---------QGNREFLVEVLML 144
+F ++G G FG V + + TG + A+K L + + + R+ LVE
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA--- 58
Query: 145 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAG 202
+ +V + D L+ EF+P G + L D ++ + +A
Sbjct: 59 ---DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA---------------KLG 247
A L ++H RD+K N+LLD H KLSDFGL
Sbjct: 116 AIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 248 PVGD------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVF 289
P D + ++ +GT Y APE M D +S GV+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 290 LELITG 295
E++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST-RVMGT 262
A G+E+L A+ ++RDL + N+L+ EG K+ DFGLA+ + D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLP 304
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ APE T SDV+SFG++ E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 59/245 (24%), Positives = 90/245 (36%), Gaps = 55/245 (22%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---------QGNREFLVEVLM 143
++F ++G G FG V + + TG V A+K L + + + R+ LVE
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 144 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 203
L + V + D L+ EF+P G + L K+ L A
Sbjct: 61 LWV------VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAET 110
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT---------- 253
++ +H I+RD+K N+LLD H KLSDFGL +T
Sbjct: 111 VLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 254 -----------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 290
++ +GT Y APE M D +S GV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 291 ELITG 295
E++ G
Sbjct: 228 EMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 44/229 (19%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLHH 149
+N +P +G G G V + VA+K+L R N R + E++++ ++H
Sbjct: 20 QNLKP---IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWN-----------TRMK 198
N+++L+ F P SLE+ D+ E +D N RM
Sbjct: 76 KNIISLLNV------------FTPQKSLEE-FQDVYLVMELMDANLCQVIQMELDHERMS 122
Query: 199 -IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257
+ G+++LH +I+RDLK SNI++ K+ DFGLA+ G ++
Sbjct: 123 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 177
Query: 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELI------TGRKAID 300
V+ Y Y APE + D++S G + E++ GR ID
Sbjct: 178 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 29/77 (37%), Positives = 43/77 (55%)
Query: 218 VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 277
+++RDLKS+NI L KL DFG +K V++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 278 LKSDVYSFGVVFLELIT 294
K+D++S GV+ EL+T
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 5e-06
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR--EFLVEVLMLSLLHHSNLVNLIG- 157
+G G FG V+ + + T + K + GL+ + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 158 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+ +Q+L ++ EF G L ++ ++ + + I L Y H+ +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 217 P----VIYRDLKSSNILLDEGFH-----------------PKLSDFGLAKLGPVGDKTHV 255
P V++RDLK NI L G K+ DFGL+K + H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 256 STRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVFLELITGR 296
+GT Y +PE + T KSD+++ G + EL +G+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQ-----VVAVKQLDRNGLQGNREFLV-EVLMLSLL-HHSNLV 153
LG G FG+V + G+ VAVK L + RE L+ E+ +LS L H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHL 181
NL+G C G L++ E+ G L + L
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 64/268 (23%), Positives = 98/268 (36%), Gaps = 64/268 (23%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLD------RNG---LQGNREFLVEVLMLSLLHHSN 151
+G G FG V R T + A+K L RN ++ R+ L E +
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA------DNEW 62
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V L D D V +++P G + L L +E L R IA +E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCAIESVH 118
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGL---------------------------- 243
I+RD+K NIL+D H KL+DFGL
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 244 --AKLGPVGDKTHVSTRV-----------MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 290
+++ K R +GT Y APE + T D +S GV+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 291 ELITGRKA-IDNTRPPGEHNLVAWARPL 317
E++ G+ + +T + ++ W L
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 101 LGEGGFGRVYKGRL--------ESTGQVVAVKQLDRNGLQGNRE----FLVEVLMLSLLH 148
LG G ++Y G L + +K + + +R+ F M+ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
H ++V L G C + ++V EF+ G L+ +H + L + K+A A L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALS 119
Query: 209 YLHDKANPPVIYRDLKSSNILL-DEGFHPKLSDFGLAKLGPVGDKTHVSTR--VMGTYGY 265
YL DK +++ ++ + NILL EG + F KL G V +R + +
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECVERIPW 174
Query: 266 CAPEYAM-TGQLTLKSDVYSFGVVFLEL 292
APE + L++ +D +SFG E+
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 32/88 (36%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 101 LGEGGFGRV-----YKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLL-HHSNLV 153
LG G FG+V Y VAVK L + RE L+ E+ +LS L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHL 181
NL+G C G L++ E+ G L + L
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 32/89 (35%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 101 LGEGGFGRVYK----GRLESTGQV-VAVKQLDRNGLQGNREFLVEVL--MLSLLHHSNLV 153
LG G FGRV + G S + VAVK L ++ L+ L M L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLH 182
NL+G C G ++ E+ G L D+LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 47/196 (23%), Positives = 78/196 (39%), Gaps = 32/196 (16%)
Query: 128 RNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV---YEFMPLGSLEDHLHDL 184
+ G + + E+L L L+H N++ + ++ Y+F + D
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE--AF 258
Query: 185 PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244
PL TR I +EY+HDK +I+RD+K NI L+ L DFG A
Sbjct: 259 DWKDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 245 ----------KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
G VG S ++ GYC ++T D++S G++ L++++
Sbjct: 315 MPFEKEREAFDYGWVGTVATNSPEILAGDGYC--------EIT---DIWSCGLILLDMLS 363
Query: 295 GR--KAIDNTRPPGEH 308
D PG+
Sbjct: 364 HDFCPIGDGGGKPGKQ 379
|
Length = 501 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 61/258 (23%), Positives = 93/258 (36%), Gaps = 67/258 (25%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---------QGNREFLVEVLMLSLLHHSN 151
LG G FG V R T + A+K L + + + R+ L E +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEW 62
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V L D D V +++P G + L + E L R IA +E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIAELTC-AVESVH 118
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA--------------------------- 244
I+RD+K NIL+D H KL+DFGL
Sbjct: 119 KMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 245 ------------KLGPV---GDKTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFG 286
+L P+ + H ++ ++GT Y APE + T D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 287 VVFLELITGRKAIDNTRP 304
V+ E++ G+ P
Sbjct: 236 VILYEMLVGQPPFLAQTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 28/177 (15%)
Query: 143 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE----PLDWNTRMK 198
++S + H +L + G C G + ++V EF+ G L+ L KE P+ W ++
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-----KEKGRVPVAW--KIT 121
Query: 199 IAAGAAKGLEYLHDKANPPVIYRDLKSSNIL-----LDEGFHP--KLSDFGLAKLGPVGD 251
+A A L YL DK +++ ++ + NIL L EG P KLSD G++ +
Sbjct: 122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSR 177
Query: 252 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 307
+ V R+ + APE G L+ +D +SFG LE+ + R P E
Sbjct: 178 EERVE-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 60/251 (23%), Positives = 101/251 (40%), Gaps = 49/251 (19%)
Query: 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL 146
++ +T+ F+ LLGEG FG+V + + AVK + RN + R+ +E+ +
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVK-IVRNVPKYTRDAKIEIQFMEK 181
Query: 147 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLE-------DHLHDLPPDKEP--LDW---- 193
+ AD R PL ++ H+ + P P LDW
Sbjct: 182 VRQ----------ADPADRF------PLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH 225
Query: 194 ---NTR--MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG-----------FHPK 237
+ R +I L+Y H + + +++ DLK NIL++ P
Sbjct: 226 GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 297
+ LG D+ H T ++ T Y +PE + +D++S G + EL TG K
Sbjct: 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG-K 342
Query: 298 AIDNTRPPGEH 308
+ +T EH
Sbjct: 343 LLYDTHDNLEH 353
|
Length = 467 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 10/106 (9%)
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK---LSDFGLAKLGPVGDKT 253
+ I + ++YLH+ +I+RD+K+ NI ++ HP L DFG A PV
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGDVCLGDFGAACF-PVDINA 237
Query: 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299
+ GT APE D++S G+V E+ T ++
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 63/250 (25%), Positives = 93/250 (37%), Gaps = 67/250 (26%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL------DRNGL---QGNREFLVEVLMLSLLHHSN 151
LG G FG V T + A+K L +RN + + R+ L E +
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA------DNEW 62
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V L D D V +++P G + L + E L R IA +E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVH 118
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA---------------------KLGP-- 248
I+RD+K NIL+D H KL+DFGL + P
Sbjct: 119 KMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 249 ---------VGD----------KTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFG 286
GD K H ++ ++GT Y APE + T D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 287 VVFLELITGR 296
V+ E++ G+
Sbjct: 236 VILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 100 LLGEGGFGRVYKGR---LESTGQV--VAVKQLDRNGLQGNREFLVEVL--MLSLLHHSNL 152
+LG G FG+V +G L + V VAVK L ++ L+ L M L H N+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLH 182
VNL+G C ++ E+ G L ++LH
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 522 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.52 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.42 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.28 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.28 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.2 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.01 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.97 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.96 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.85 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.79 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.74 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.6 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.45 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.4 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.14 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.97 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.93 | |
| PLN02236 | 344 | choline kinase | 96.91 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.68 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.65 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.65 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.55 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.52 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.36 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.32 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.28 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.26 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.95 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.87 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.66 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.63 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.37 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.34 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=437.98 Aligned_cols=291 Identities=59% Similarity=0.987 Sum_probs=257.8
Q ss_pred ccccccHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEE
Q 009933 79 AAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 158 (522)
Q Consensus 79 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~ 158 (522)
....|++.++..+|++|....+||+|+||.||+|.... +..||||++.........+|..|+.+|.+++|||||+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56789999999999999999999999999999999975 58999998876543315569999999999999999999999
Q ss_pred EEcCC-eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcee
Q 009933 159 CADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK 237 (522)
Q Consensus 159 ~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vk 237 (522)
|.+.+ +.+||||||++|+|.++|+..... +++|..+++|+.++|+||+|||....++|||||||++|||||++++.|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999873222 899999999999999999999999888999999999999999999999
Q ss_pred eeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 238 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
|+|||+++..+.. .....+...||.+|+|||++..+..+.++|||||||+|+||+||+.+.+...+....+++.|++..
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999865431 222222117999999999999999999999999999999999999999987777777899999888
Q ss_pred hhcccCCCCcCCcccc-CCCCh-HHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 318 FKDRRKFPKMADPLLQ-GRYPM-RGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
+.+. .+.+++|+.+. ..++. .++..+..++.+|++.+|..||+|.+|+++|+.+..
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 8876 78999999987 67775 788999999999999999999999999999966543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=413.34 Aligned_cols=251 Identities=28% Similarity=0.442 Sum_probs=215.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
..|...++||+|+|++||.+++..+|+.||+|+|.+..+ ...+.+.+||+|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 569999999999999999999988999999999987543 33467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|+|..++|..+++. ..++++.+++.+++||+.||.|||+.+ |||||||..||||+++.+|||+|||||..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999975 688999999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. +...+.||||.|+|||++....++..+||||+|||||.||+|++||+...-.+..+ .+......+
T Consensus 171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~------~Ik~~~Y~~----- 237 (592)
T KOG0575|consen 171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN------KIKLNEYSM----- 237 (592)
T ss_pred cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH------HHHhcCccc-----
Confidence 32 34457899999999999999999999999999999999999999998542211111 111111222
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
|........+||..+|+.+|.+|||+.+|+..=-
T Consensus 238 -------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 238 -------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred -------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 2223457789999999999999999999997543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=399.59 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=210.2
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-------hHHHHHHHHHHHhCCCCCcceeEEEEEcCC
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-------NREFLVEVLMLSLLHHSNLVNLIGYCADGD 163 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-------~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~ 163 (522)
..+.|.+.+.||+|+||.|-+|..+.||+.||||+|++..... ...+.+|+++|++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3567889999999999999999999999999999997643322 233579999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---Cceeeee
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG---FHPKLSD 240 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~---~~vkL~D 240 (522)
..||||||+.||+|.+++-. +..+.+.....+++||+.||.|||++| |+||||||+||||..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999976 567888888999999999999999999 9999999999999654 8899999
Q ss_pred ecceeeCCCCCCCcceecccCCccccChhhhhcCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 241 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 241 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
||+|+... ......+.|||+.|.|||++.+.. |..++|+||||||||-+|+|..||.......
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----------- 388 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----------- 388 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----------
Confidence 99999754 334567899999999999998764 3458899999999999999999998543321
Q ss_pred hhcccCCCCcCCccccCCCC------hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRYP------MRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~------~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.+.+.++.+.|. .+...+.++||.+||..||+.|||+.|+|+.=+
T Consensus 389 --------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 389 --------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred --------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 111112222221 234568889999999999999999999988544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=392.34 Aligned_cols=243 Identities=28% Similarity=0.390 Sum_probs=207.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|+++++||+|+||+||+++.++|++.||+|++++..... .+....|..+|..++||+||.++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999999999999999998765433 35578899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
+||+.||.|..+|+. ...+++..+..++..|+.||.|||+++ ||||||||+|||||.+|+|+|+||||++..-
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999986 678999999999999999999999999 9999999999999999999999999999632
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
. ......++|||+.|||||++....|+..+|+|||||++||||+|..||.... ...+...+..... ...
T Consensus 177 ~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k~---~~~ 245 (357)
T KOG0598|consen 177 K--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGKL---PLP 245 (357)
T ss_pred c--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCcC---CCC
Confidence 2 2234456899999999999999999999999999999999999999997642 2333333333321 111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCC
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP 360 (522)
+. -......+|+..+|+.||++|.
T Consensus 246 p~--------~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 PG--------YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred Cc--------cCCHHHHHHHHHHhccCHHHhc
Confidence 11 1235677999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=390.87 Aligned_cols=203 Identities=32% Similarity=0.496 Sum_probs=184.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
..+|.+.+.||.|+|++||+|+++.++..||||.|.+..+. ..+.+..|+.+|+.++|||||.|++++...+.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45799999999999999999999999999999999877543 2345688999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC------Cceeeeeecc
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG------FHPKLSDFGL 243 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~------~~vkL~DFGl 243 (522)
|||.||+|.+||+. .+.+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999987 568999999999999999999999999 9999999999999654 5689999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 304 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~ 304 (522)
|+.+.. .....+.||++.|||||+++..+|+.|+|+||+|+|||+|++|+.||+...+
T Consensus 162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 997653 3355679999999999999999999999999999999999999999986543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=389.02 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=213.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-eeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-QRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-~~~lV~E 170 (522)
.+.+.+..||+|..|+||+++++.|++.+|+|+|..+. ....+++.+|+++|+..+||+||.+|+.|.... ..+|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34566788999999999999999999999999995432 233467899999999999999999999999998 5999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||++|+|.+++.. .+.+++....+|+.+|++||.|||+ .+ ||||||||+||||+..|.|||||||.+..+..
T Consensus 159 YMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999987 3779999999999999999999996 66 99999999999999999999999999987533
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. ...+++||..|||||.+.+..|+.++||||||++|+||.+|+.||....+. -.+.......+..+. .+
T Consensus 232 S----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll~~Iv~~p--pP---- 300 (364)
T KOG0581|consen 232 S----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELLCAIVDEP--PP---- 300 (364)
T ss_pred h----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHHHHHhcCC--CC----
Confidence 2 456788999999999999999999999999999999999999999764221 111222111111111 01
Q ss_pred ccccCCCCh-HHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 330 PLLQGRYPM-RGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 330 ~~l~~~~~~-~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.+|. ....++..++..||++||.+||++.+++++=.-..
T Consensus 301 -----~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 301 -----RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred -----CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 1122 24468889999999999999999999998654433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=382.77 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=215.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEE-EEEcCCe-eEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIG-YCADGDQ-RLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~-~~~~~~~-~~lV 168 (522)
.+|+++++||.|+||+||++.+..+|..||.|.|....+.. .+....|+.+|++|+|||||++++ .|.+..+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 46899999999999999999999999999999998654443 346788999999999999999999 4555555 8999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA-NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||..|+|..+|+.++..+..+++..+++++.|++.||..||.+- ...|+||||||.||||+.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999998888899999999999999999999999842 122999999999999999999999999999975
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
. .........+|||.||+||++....|+.+|||||+||++|||+.-+.||.+. ++......+-.. .++.
T Consensus 179 ~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg--d~~~- 247 (375)
T KOG0591|consen 179 S--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG--DYPP- 247 (375)
T ss_pred c--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC--CCCC-
Confidence 3 3334556789999999999999999999999999999999999999999865 333322221111 1111
Q ss_pred CCccccCCCC-hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 328 ADPLLQGRYP-MRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 328 ~d~~l~~~~~-~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.| .-.+..+..||..|+..||+.||+...++..+..
T Consensus 248 --------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 --------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 12 3456789999999999999999986555555543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=392.83 Aligned_cols=260 Identities=35% Similarity=0.527 Sum_probs=212.0
Q ss_pred CcccceecccCceEEEEEEECCCCcE-EEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCC-eeEEEEe
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQV-VAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGD-QRLLVYE 170 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~-vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-~~~lV~E 170 (522)
+.+.+.||.|+||+||++.+. |+. ||||++....... ...|.+|+.+|.+|+|||||+|+|+|.+.. .++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 444556999999999999998 556 9999997654333 458999999999999999999999999987 7999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DFGla~~~~~ 249 (522)
||++|+|.++++.. .+..+++..++.|+.||++||.|||+++. ||||||||+||||+.++ ++||+|||+++....
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999763 46789999999999999999999999863 89999999999999998 999999999986432
Q ss_pred CCCCcceecccCCccccChhhhh--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.. ...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+. .... ....-..+..
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~-~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVAS-AVVVGGLRPP---- 266 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHH-HHHhcCCCCC----
Confidence 21 2233468999999999999 569999999999999999999999999876441 1111 1001111111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccCC
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD 378 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~ 378 (522)
.+......+..|+.+||+.||..||++.+|+..|+.+......
T Consensus 267 --------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 267 --------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred --------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1112335778899999999999999999999999988765543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=371.13 Aligned_cols=265 Identities=27% Similarity=0.369 Sum_probs=213.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
+.|+.+.++|+|+||+||+|+++.||+.||||++..... ...+-.++|+.+|++|+|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 358888899999999999999999999999999965432 223456899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||+. ++.+-|..+ ...++...+.+++.|++.|+.|||+++ +|||||||+||||+.++.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9987 554555442 466889999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh--------hhhhhcc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA--------RPLFKDR 321 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~--------~~~~~~~ 321 (522)
.....+..+.|.+|+|||++.+ .+|+..+|||++||++.||++|+..|.+....+...++... ..++...
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 3446678899999999999998 68999999999999999999999999877654443333211 2223322
Q ss_pred cCC-----CCcCCcc-ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 322 RKF-----PKMADPL-LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 322 ~~~-----~~~~d~~-l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.-+ ++.-++. +...|| ..+..+++|+..||+.||++|++.++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 222 2222211 112232 23447889999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=384.30 Aligned_cols=256 Identities=26% Similarity=0.346 Sum_probs=215.6
Q ss_pred HHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhC-CCCCcceeEEEEEcCCe
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~ 164 (522)
....++|..++.||+|+|++|++|+.+.+++.||||++.+.-+. ....+..|-.+|.+| .||.|++||..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999999999999999999765332 224467899999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
+|+|+||+++|+|.++|++ .+.|++..++.++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999988 488999999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCC---------cce--ecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHh
Q 009933 245 KLGPVGDKT---------HVS--TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 313 (522)
Q Consensus 245 ~~~~~~~~~---------~~~--~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~ 313 (522)
+.+...... ... ..++||..|++||+|.....+..+|||+||||||+||.|..||....+.. .
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------i 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------I 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------H
Confidence 976433222 111 45899999999999999999999999999999999999999998653321 1
Q ss_pred hhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 314 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+.++.-...++.-+. ..+.+||.+.|..||.+|+++++|-++.
T Consensus 296 FqkI~~l~y~fp~~fp------------~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 FQKIQALDYEFPEGFP------------EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHhcccCCCCCC------------HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1222232223333222 5667999999999999999999887754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=362.95 Aligned_cols=238 Identities=30% Similarity=0.408 Sum_probs=209.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||.|+||+|.+++++.+|..||+|++++...- ..+...+|..+|+.+.||+++++++.|.+.+++|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 35799999999999999999999999999999999876543 334567899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||++||.|+.+++. .+++++..++.++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999987 578999999999999999999999999 9999999999999999999999999999742
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
. ...+.||||.|+|||++....|+.++|+|+|||++|||+.|..||....+ ......+......++..+
T Consensus 196 ~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~v~fP~~f 264 (355)
T KOG0616|consen 196 G-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGKVKFPSYF 264 (355)
T ss_pred C-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCcccCCccc
Confidence 2 25578999999999999999999999999999999999999999987755 222333444444555555
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCC
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATR 359 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~R 359 (522)
.+ .+.+|+...|+.|-.+|
T Consensus 265 s~------------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 SS------------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CH------------HHHHHHHHHHhhhhHhh
Confidence 44 55689999999999988
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=381.86 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=216.4
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC----c-cchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG----L-QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ 164 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~----~-~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~ 164 (522)
....|.+.+.||+|+||+|+.|.+..++..||||++++.. . ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3578999999999999999999999999999999887641 1 23345668999999999 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-Cceeeeeecc
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG-FHPKLSDFGL 243 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~-~~vkL~DFGl 243 (522)
+||||||+.||+|++++.. ..++.+.++.++++||+.||+|||+.+ |+||||||+||||+.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999976 578999999999999999999999999 9999999999999999 9999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LT-LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~-~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
+.... .......+.+||+.|+|||++.+.. |+ .++|||||||+||.|++|..||+.. +.......+....
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRKIRKGE 239 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHHHhcCC
Confidence 99753 2223456789999999999999977 86 7899999999999999999999873 2222233334444
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
..++..+. ...+..|+.+||..||.+|+++.+|+ .-..+.
T Consensus 240 ~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 240 FKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred ccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 44444432 35778999999999999999999999 443333
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=386.64 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=214.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-c--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-L--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.-|++++.||.|+-|.|.+|++..||+.+|||+|.+.. . .....+.+|+.||+.+.||||+.+|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34889999999999999999999999999999997652 2 12346789999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++|.|+++|.. +++|++.++.+++.||+.|+.|||..+ |+||||||+|+|||..++|||+|||+|.+-..
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999977 789999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.....+.||.|.|.+||++++..|. .++||||+|||||.||||+.||++. ++......+-...-.++.
T Consensus 165 ---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV~~G~f~MPs-- 233 (786)
T KOG0588|consen 165 ---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKVQRGVFEMPS-- 233 (786)
T ss_pred ---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHHHcCcccCCC--
Confidence 2345678999999999999999985 7899999999999999999999843 333322222222222222
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
....++.+||.+||..||++|.|++||+++-..
T Consensus 234 ----------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 234 ----------NISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred ----------cCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 223567799999999999999999999997643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=372.50 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=210.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcC--CeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~~l 167 (522)
.+.|+.+++||+|+||.||+|++..+|+.||+|++..+.... .....+||.||++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356889999999999999999999999999999998765332 34567899999999999999999988776 68999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|+|||+. +|.-++.. ..-.|++.++..|+.||+.||+|||..+ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999987 88877764 3457999999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh-----hhhhcc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR-----PLFKDR 321 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~-----~~~~~~ 321 (522)
...... ..+..+-|.+|+|||++.+. .|+.++|+||+||||.||++|+..|.+....+....+--.- ..|. .
T Consensus 269 ~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~ 346 (560)
T KOG0600|consen 269 TPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-V 346 (560)
T ss_pred cCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-c
Confidence 544333 35667789999999999976 79999999999999999999999998765433332221110 0011 1
Q ss_pred cCCC--CcCCccccCCCCh-------HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFP--KMADPLLQGRYPM-------RGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~--~~~d~~l~~~~~~-------~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..++ ..+.+.. .|.. ......++|+..+|..||.+|.|+.++|..
T Consensus 347 ~kLP~~~~~kp~~--~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 347 SKLPHATIFKPQQ--PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCcccccCCCC--cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111 1111111 1111 112367889999999999999999998763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=377.34 Aligned_cols=266 Identities=25% Similarity=0.326 Sum_probs=216.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHH--HHHHHHHHHhCC-CCCcceeEEEEEcCC-eeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE--FLVEVLMLSLLH-HSNLVNLIGYCADGD-QRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~--~~~E~~~L~~l~-hpnIv~l~~~~~~~~-~~~l 167 (522)
-++|.+.+.||.|+||.||+|+...++..||||.+++.-.. .++ -++|+..|++|+ |||||+|.+++.+.+ .+||
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 46899999999999999999999999999999999765332 333 468999999999 999999999998888 9999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||||+. +|+++++.. ...|++..++.|+.||++||+|+|.+| ++||||||+|||+.....|||+|||+|+..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999975 999999873 688999999999999999999999999 999999999999999999999999999964
Q ss_pred CCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh-----hh--
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL-----FK-- 319 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~-----~~-- 319 (522)
. .....+..+.|.+|+|||++.. +-|+.+.|||++|||++||.+-+..|.+....+....+-.+..- +.
T Consensus 161 ~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 R---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred c---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 3 3335577889999999999874 57999999999999999999999999877654333222111000 00
Q ss_pred ------cccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 320 ------DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 320 ------~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
-.-.++.+....+..-++. ...++++||.+||++||.+|||+.+++++-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0112222222222222232 567899999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=376.79 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=209.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|+++++||+|+||.||+|+-+.||.+||+|++++..+.. .+.+..|-.+|....+|+||+||..|++.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 367999999999999999999999999999999998875543 34567899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||++||++..+|.. ...|++..+..++.+++.||+.||+.| ||||||||+|+|||..|+|||+||||+.-+.
T Consensus 220 MEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999977 689999999999999999999999999 9999999999999999999999999985211
Q ss_pred C----------------------CCCC------c-----------------ceecccCCccccChhhhhcCCCCcchhhH
Q 009933 249 V----------------------GDKT------H-----------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVY 283 (522)
Q Consensus 249 ~----------------------~~~~------~-----------------~~~~~~gt~~y~APE~l~~~~~~~~sDVw 283 (522)
. .+.. . .....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 0000 0 01125799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcc-hHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC-
Q 009933 284 SFGVVFLELITGRKAIDNTRPPGEH-NLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL- 361 (522)
Q Consensus 284 SlGvll~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs- 361 (522)
||||||||||.|.+||....+...- .++.|...+. ++.-. ....+..+||.+||. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-----fP~~~----------~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-----FPEEV----------DLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----CCCcC----------cccHHHHHHHHHHhc-CHHHhcCc
Confidence 9999999999999999877664332 3444542221 11111 112678899999999 9999985
Q ss_pred --HHHHHH
Q 009933 362 --IGDVVT 367 (522)
Q Consensus 362 --~~evl~ 367 (522)
++||-+
T Consensus 437 ~G~~EIK~ 444 (550)
T KOG0605|consen 437 KGAEEIKK 444 (550)
T ss_pred ccHHHHhc
Confidence 555543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=386.06 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=209.6
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCC-CCCcceeEEEEEcCCee
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLH-HSNLVNLIGYCADGDQR 165 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~ 165 (522)
...++|.++++||+|+||+|+++..+.+++.||||++++..+-. .+..+.|..|+...+ ||+++.++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999999999999999999876533 355678999988886 99999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
|+||||+.||++..+.+ ...+++..+..|+..|+.||+|||+++ |||||||.+|||||.+|++||+||||++
T Consensus 445 ~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999655554 378999999999999999999999999 9999999999999999999999999999
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
.... ....+.++||||.|||||++.+..|+.++|+|||||+|||||.|+.||.+....
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------- 574 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------- 574 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------------
Confidence 7442 223567899999999999999999999999999999999999999999865331
Q ss_pred CcCCcccc--CCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 009933 326 KMADPLLQ--GRYPMRGLYQALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 326 ~~~d~~l~--~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 362 (522)
+++|.++. -.||.-...+.+.|+.++|..+|++|.-+
T Consensus 575 e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11222221 13566667889999999999999999855
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=346.25 Aligned_cols=267 Identities=27% Similarity=0.368 Sum_probs=213.6
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.+|..+++||+|.||.||+|++..+|+.||||+|+..+..+ .....+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888999999999999999999999999999998654432 3567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||+. +|+..|++ ....++..++..++.++++||+|||.+. |+||||||.|+||+++|.+||+|||+++.....
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9975 99999976 4678999999999999999999999999 999999999999999999999999999986554
Q ss_pred CCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh-----hhhh-----
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR-----PLFK----- 319 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~-----~~~~----- 319 (522)
+. ..+..+-|.+|+|||++++. .|+..+||||.|||+.||+.|..-|.+....+....+-.+. ..|.
T Consensus 155 ~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Cc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 43 33444789999999999975 79999999999999999999988887654422222211110 0001
Q ss_pred -cccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 320 -DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 320 -~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
+...+.....+.+..-+ .......++|+..+|..||.+|+++.|++++=
T Consensus 233 pdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 11111111112222222 23445679999999999999999999998854
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=360.12 Aligned_cols=264 Identities=26% Similarity=0.361 Sum_probs=215.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch-HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.+.|++.++||.|.-++||+|+...+++.||||++..+..... ..+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 5789999999999999999999999999999999986654443 778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC-
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV- 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~- 249 (522)
||.+|++.+.++... ...+++..+..|++++++||.|||.+| .||||||+.||||+++|.|||+|||.+.....
T Consensus 105 fMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999998743 445999999999999999999999999 99999999999999999999999998765432
Q ss_pred CCCCcce-ecccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 250 GDKTHVS-TRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 250 ~~~~~~~-~~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
++..... ..++||++|||||+++. ..|+.|+|||||||+..||.+|..||..+.+.... . .+-....+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l------~tLqn~pp~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--L------LTLQNDPPT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--H------HHhcCCCCC
Confidence 2222222 56789999999999764 47999999999999999999999999887653211 1 111111222
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..-..+...-.......+.++|..||+.||.+|||+.++++.
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111111112233578899999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=373.05 Aligned_cols=248 Identities=31% Similarity=0.416 Sum_probs=217.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|.+.+.||+|+||+||+|+.+.+.+.||||.|.+..... .+.+.+|++|++.|+|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47888999999999999999999999999999998764433 3568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.| +|+.+|.. .+.++++.+..|+.+++.||.|||+.. |+|||+||.||||+.++.+|+||||+++...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~-- 151 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS-- 151 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc--
Confidence 9977 99999976 688999999999999999999999999 9999999999999999999999999999743
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
..+.+.+.+.|||.|||||++.+..|+..+|+||||||+|||++|+.||... .+...+..+..+...
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v~------- 218 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPVK------- 218 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCCC-------
Confidence 3455677889999999999999999999999999999999999999999643 233333344444322
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+|......+..++...|..||.+|.+..+++.+
T Consensus 219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -----CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 233456788999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=362.67 Aligned_cols=259 Identities=29% Similarity=0.421 Sum_probs=207.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC--eeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~--~~~lV~ 169 (522)
..+|...+.||+|+||+||++.+..+|..+|||.+........+.+.+|+.+|..|+|||||+++|...... .++|+|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 356888899999999999999999999999999997664333566889999999999999999999755444 689999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCceeeeeecceeeCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGP 248 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~~~ 248 (522)
||+++|+|.+++... ...|++..++.++.||++||.|||+++ ||||||||+||||+. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999873 227999999999999999999999999 999999999999999 7999999999998654
Q ss_pred C-CCCCcceecccCCccccChhhhhcCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 249 V-GDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 249 ~-~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
. ...........||+.|||||++..+. ...++|||||||++.||+||+.||... ... ..+...+... ...+
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~---~~~~~~ig~~-~~~P- 242 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEE---AEALLLIGRE-DSLP- 242 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cch---HHHHHHHhcc-CCCC-
Confidence 2 11122234578999999999999632 335999999999999999999999764 111 1111111111 1122
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.+|........+++..|++.+|+.|||+.++|...-.
T Consensus 243 --------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 --------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred --------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1222233577799999999999999999999997653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=373.14 Aligned_cols=258 Identities=31% Similarity=0.459 Sum_probs=211.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
..+.+++.||+|-||.||.|.++. ...||+|.++... ...+.|.+|+.+|++|+|+|||+++++|..++.+|||||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 345667889999999999999974 4589999997653 34578889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
+.|+|.+||+. .....+...+.+.++.|||+|++||++++ +|||||...||||+++..+||+||||++.. ..+.
T Consensus 284 ~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~ 357 (468)
T KOG0197|consen 284 PKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI-GDDE 357 (468)
T ss_pred ccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc-CCCc
Confidence 99999999986 45677899999999999999999999999 999999999999999999999999999943 2222
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
........-...|.|||.+..+.++.+||||||||+||||+| |+.|+......+. +.. +.... .+
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev---~~~----le~Gy---Rl---- 423 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV---LEL----LERGY---RL---- 423 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH---HHH----HhccC---cC----
Confidence 222333334668999999999999999999999999999998 7788765433211 111 11111 12
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..|..+...+.+|+..||+.+|++|||++.+...|+.+...
T Consensus 424 ---p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 424 ---PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 22333456778899999999999999999999999887543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=373.00 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=215.9
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
.|.....||+|..|.||.+....+++.||||++........+-+++|+.+|+.++|+|||.+++.|..++.+|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 58888899999999999999999999999999988877777889999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
||+|.|.+.. ..+++.++..|+++++.||+|||.++ |||||||.+||||+.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 354 GGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999976 55999999999999999999999999 99999999999999999999999999987544332
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ 333 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 333 (522)
.....+|||+|||||++....|++++||||||++++||+-|+.||-+..+.-...++. ... .+++
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~ng--~P~l------ 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNG--TPKL------ 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------hcC--CCCc------
Confidence 4466899999999999999999999999999999999999999997654422211111 111 0111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+......|.+++.+||+.|+++|+++.|+|++
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1233345678899999999999999999999984
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=367.09 Aligned_cols=264 Identities=27% Similarity=0.413 Sum_probs=206.1
Q ss_pred hcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcC-C
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADG-D 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~-~ 163 (522)
.++|++.++||+|+||.||+|.+ ..+++.||||++..... .....+..|+.+|..+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999985 23457899999975432 2235688999999999 899999999988764 4
Q ss_pred eeEEEEeecCCCChhhhhccCCC---------------------------------------------------------
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPP--------------------------------------------------------- 186 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------------- 186 (522)
.+++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68999999999999999865211
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccc
Q 009933 187 -DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265 (522)
Q Consensus 187 -~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y 265 (522)
...++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0235888999999999999999999998 999999999999999999999999999864322211112234467889
Q ss_pred cChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHH
Q 009933 266 CAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQA 344 (522)
Q Consensus 266 ~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 344 (522)
+|||++.+..++.++|||||||+||||++ |..||....... .+.. .+...... . .+......+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~~~~-~---------~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ----RLKDGTRM-R---------APENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH----HHhcCCCC-C---------CCCCCCHHH
Confidence 99999999999999999999999999997 999997643211 1111 11111100 0 111223567
Q ss_pred HHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 345 LAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 345 ~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.61 Aligned_cols=251 Identities=29% Similarity=0.388 Sum_probs=217.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
...|+..++||+|+||.||+|.+..+++.||||++..+...+ .+++..|+.+|..++++||.++|+.|..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345778899999999999999999999999999998765443 4678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||.||++.+.|+. ...+.+..+..|+++++.||.|||.++ .+|||||+.||||..+|.+||+|||.+......
T Consensus 92 y~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999976 455588889999999999999999999 999999999999999999999999999875543
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.. ...+++||+.|||||++.+..|+.++||||||++.+||++|..|+....+..- --.+++-..|
T Consensus 165 ~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------------lflIpk~~PP 229 (467)
T KOG0201|consen 165 VK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------------LFLIPKSAPP 229 (467)
T ss_pred hh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------------EEeccCCCCC
Confidence 33 22568999999999999988999999999999999999999999988766211 1123444555
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.+.+ ...+.+++..||..||+.||++.++|+.
T Consensus 230 ~L~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDF----SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccccc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 555433 3668899999999999999999999874
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=358.48 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=213.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHH---HHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~---~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
..+|++.+.||+|+||+|-++.....|+.||||.|+++.+.+.+. +.+|++||+.|+||||+.+|++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 468999999999999999999998899999999999887776654 67899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||..+|.|+||+.. .+.|++.+++.|+.||+.|+.|||.++ |+|||||.+|||||.++++||+||||+-++.
T Consensus 132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999977 678999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
. ....+++||++-|.+||++.+.+|. +.+|-|||||+||.|+.|..||++... ..++..+ ... ..
T Consensus 205 ~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQI---s~G-----aY 270 (668)
T KOG0611|consen 205 D---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQI---SRG-----AY 270 (668)
T ss_pred c---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHh---hcc-----cc
Confidence 2 3356789999999999999999885 789999999999999999999986522 2222211 111 11
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
..|. ......-||.+||-.+|++|.|+.+|...-
T Consensus 271 rEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 271 REPE--------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cCCC--------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111 123455799999999999999999998765
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.05 Aligned_cols=269 Identities=23% Similarity=0.290 Sum_probs=214.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEc--CCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~~l 167 (522)
.++|+.++.|++|+||.||+|+++.|++.||+|+++.+.... --.-++||.+|.+++|||||.+..+.+- -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 456899999999999999999999999999999997653111 1245789999999999999999998764 357999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||||+. +|..++... .++|...++..++.|++.||+|||... |+|||||++|+|++..|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 9999987 999999874 378999999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh-----hhhhc-
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR-----PLFKD- 320 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~-----~~~~~- 320 (522)
... ....+..+-|.+|+|||++.+. .|+.+.|+||+|||+.|||+++..|.+....+..+.+-... .+|..
T Consensus 228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 443 3456778889999999999976 69999999999999999999999998876644443321110 01111
Q ss_pred -------ccCCCCcCCccccCCCChH-HHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 321 -------RRKFPKMADPLLQGRYPMR-GLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 321 -------~~~~~~~~d~~l~~~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
...+.+.....+...++.. -...-++|+..+|..||.+|.|+.+.|+.=
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 1112222233333344333 235677899999999999999999998753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=358.82 Aligned_cols=246 Identities=30% Similarity=0.390 Sum_probs=204.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+|..++||||+++++++...+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999975422 23356788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999976 457899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+. .....+......++.
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~~p~--- 236 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAGRLKFPN--- 236 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCcCCCC---
Confidence 1 22457999999999999999999999999999999999999999754221 111111111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~ 368 (522)
.....+.+||..||+.||.+||+ +.+|+.+
T Consensus 237 ---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 ---------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 12245779999999999999996 5776654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=353.13 Aligned_cols=247 Identities=25% Similarity=0.305 Sum_probs=204.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 468999999999999999999999999999999965432 23456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999976 457899999999999999999999999 99999999999999999999999999986422
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~------ 216 (291)
T cd05612 154 -----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAGKLE------ 216 (291)
T ss_pred -----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcC------
Confidence 122357999999999999989999999999999999999999999754321 111111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTAL 369 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~L 369 (522)
++......+.+||.+||+.||.+||+ +.++++.-
T Consensus 217 ------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 217 ------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 11122346789999999999999995 77777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=362.02 Aligned_cols=264 Identities=30% Similarity=0.450 Sum_probs=215.3
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCC
Q 009933 86 RELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD 163 (522)
Q Consensus 86 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~ 163 (522)
.++....+.+.+...||.|.||+||+|++.. .||||++...... ..+.|.+|+.+|++-+|.||+-+.|||....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4555556677888999999999999999974 4999999876543 3467999999999999999999999999887
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
. .||+-+|.|.+|+.+|+.. ...|+....+.|++||++|+.|||.++ |||||||..||||.+++.|||+||||
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 7 9999999999999999873 467999999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
+................|...|||||+++. .+|++.+||||||||+|||+||..||........ ++..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI---------ifmV 605 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI---------IFMV 605 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe---------EEEe
Confidence 987544433333444568889999999984 4799999999999999999999999983322111 1111
Q ss_pred ccC--CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 321 RRK--FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 321 ~~~--~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
.+- .+.+... .......+.+|+..||..++++||.+.+|+..|+.+..
T Consensus 606 GrG~l~pd~s~~------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 606 GRGYLMPDLSKI------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccccCccchhh------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111 1111111 11344678899999999999999999999999988764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.95 Aligned_cols=255 Identities=28% Similarity=0.354 Sum_probs=210.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch---HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.+.|++++.||.|.-|+||+|++..++..+|+|++++..+... .....|-+||+.++||+++.||..|+.++..|||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 4568899999999999999999999999999999988765543 3456799999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
||||+||+|..+++. +....+++..++.++.+|+.||+|||.+| ||+|||||+||||-++|+|.|+||.|+..+.
T Consensus 156 meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999987 45678999999999999999999999999 9999999999999999999999999975421
Q ss_pred C---------------------------------CCCC---------------------cceecccCCccccChhhhhcC
Q 009933 249 V---------------------------------GDKT---------------------HVSTRVMGTYGYCAPEYAMTG 274 (522)
Q Consensus 249 ~---------------------------------~~~~---------------------~~~~~~~gt~~y~APE~l~~~ 274 (522)
. .... ..+..++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1 0000 011236799999999999999
Q ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhccc
Q 009933 275 QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQE 354 (522)
Q Consensus 275 ~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~ 354 (522)
..+.++|+|+|||+|||||.|..||.+....... ..++.....++.. ......+.+||.+.|.+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl------~NIv~~~l~Fp~~----------~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL------RNIVGQPLKFPEE----------PEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH------HHHhcCCCcCCCC----------CcchhHHHHHHHHHhcc
Confidence 9999999999999999999999999876442221 1111222222211 13456788999999999
Q ss_pred CcCCCCC----HHHHHH
Q 009933 355 QAATRPL----IGDVVT 367 (522)
Q Consensus 355 dP~~RPs----~~evl~ 367 (522)
||.+|.- +.||-+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999997 666654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=356.89 Aligned_cols=243 Identities=28% Similarity=0.337 Sum_probs=199.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 175 (522)
++||+|+||.||+|.+..+++.||||+++.... .....+..|+.+|..++||||++++++|...+..||||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcc
Q 009933 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV 255 (522)
Q Consensus 176 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 255 (522)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 99999875 467899999999999999999999999 999999999999999999999999998753211 112
Q ss_pred eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCC
Q 009933 256 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 335 (522)
Q Consensus 256 ~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 335 (522)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ......+......
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~~------------ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEIR------------ 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCCCC------------
Confidence 3346799999999999999999999999999999999999999965321 1111111111111
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 336 YPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 336 ~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
++......+.+||.+||+.||++|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1222345678999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=347.06 Aligned_cols=253 Identities=29% Similarity=0.421 Sum_probs=205.2
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+|..++|+||+.++++|.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378889999999999999999999999999998754322 23457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999888642 2346899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. ......||..|+|||++.+..|+.++|||||||++|+|++|+.||...........+ ...+....
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~--------- 221 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV--DRRVKEDQ--------- 221 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH--HHHhhccc---------
Confidence 1 223457899999999999999999999999999999999999999865432111111 10000000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~ 368 (522)
..++......+.+|+.+||+.||++||+ +.++++.
T Consensus 222 ---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1122233457789999999999999997 7787764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=347.97 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=204.9
Q ss_pred hcCCcccceecccCceEEEEEEECC----------------CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcce
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES----------------TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVN 154 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~----------------~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~ 154 (522)
.++|++.+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+.+|..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578999999999999999998643 3457999999764322 2356889999999999999999
Q ss_pred eEEEEEcCCeeEEEEeecCCCChhhhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 009933 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219 (522)
Q Consensus 155 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ii 219 (522)
++++|.+.+..+|||||+.+++|.+++..... ....+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999864211 1134788899999999999999999999 99
Q ss_pred ecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh--CCC
Q 009933 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT--GRK 297 (522)
Q Consensus 220 HrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt--G~~ 297 (522)
|+||||+||||+.++.+||+|||++................++..|+|||++....++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986433332222233456789999999998899999999999999999987 556
Q ss_pred CCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 298 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 298 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
||..... ..........+......... ..+......+.+|+.+||+.+|++||++.+|++.|+
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7764322 12222221111111000000 011122357889999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=357.85 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=207.7
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+..|+.+|..++||||+++++++...+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 469999999999999999999999999999999975422 23456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999975 457899999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch-HHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN-LVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 328 (522)
......||+.|+|||++.+..++.++|||||||++|||++|..||.......... +..|. .....+...
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~ 223 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-----ETLQRPVYD 223 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-----ccccCCCCC
Confidence 2234679999999999999999999999999999999999999997543211111 11110 000001111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
++. ......+.+|+.+||+.+|.+||++.+|++.-
T Consensus 224 ~~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 224 DPR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred ccc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 100 12345778999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=353.83 Aligned_cols=261 Identities=26% Similarity=0.350 Sum_probs=208.7
Q ss_pred HHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--------------cchHHHHHHHHHHHhCCCCCcce
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--------------QGNREFLVEVLMLSLLHHSNLVN 154 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--------------~~~~~~~~E~~~L~~l~hpnIv~ 154 (522)
....++|++.+.||.|.||+|-+|++..+++.||||+|.+... ...+.+.+||.+|++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3446789999999999999999999999999999999976322 12357889999999999999999
Q ss_pred eEEEEEcC--CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 009933 155 LIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE 232 (522)
Q Consensus 155 l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~ 232 (522)
|+++..+. +.+|||+|||..|.+...-- ....+++.++++|+.+++.||+|||.++ ||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 99998764 68999999999888765432 2334999999999999999999999999 999999999999999
Q ss_pred CCceeeeeecceeeCCCCC---CCcceecccCCccccChhhhhcCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 009933 233 GFHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVFLELITGRKAIDNTRPP 305 (522)
Q Consensus 233 ~~~vkL~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~----~~~~sDVwSlGvll~eLltG~~Pf~~~~~~ 305 (522)
+|+|||+|||.+.....+. ........+|||.|+|||+..++. -+.+.||||+||+||-||.|+.||....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-- 323 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-- 323 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--
Confidence 9999999999998653221 111223478999999999988742 2468899999999999999999997542
Q ss_pred CcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 306 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.......+.++.-.++. ..+....+.+||.++|++||++|.++.+|..+....
T Consensus 324 ----~~~l~~KIvn~pL~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 324 ----ELELFDKIVNDPLEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred ----HHHHHHHHhcCcccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 22222223333222222 123456788999999999999999999998887643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=346.54 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=212.6
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEc--cCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc-----C
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLD--RNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD-----G 162 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~--~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-----~ 162 (522)
.....|...+.||+|+||.|+.+.++.+|+.||||+|. .......+...+|+.+|+.++|+||+.+++.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34566777899999999999999999999999999997 3444455778899999999999999999999865 4
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
+.+|+|+|+| ..+|...|+. ...|+...+..+++||++||+|+|+.+ |+||||||.|+|++.+..+||+|||
T Consensus 99 ~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 5789999999 4589998876 455999999999999999999999999 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh-------
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA------- 314 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~------- 314 (522)
+|+...........+..+-|.+|.|||++.. ..|+.+.||||+||||.|||+|+..|.+........++...
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 9997643323334467888999999999875 47999999999999999999999999877543333222211
Q ss_pred ----------hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 315 ----------RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 315 ----------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+..+. .++.....-+...++ ......++|+.+||..||.+|+|++|.|+.
T Consensus 251 ~l~~i~s~~ar~yi~---slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIK---SLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHH---hCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111 111111111111122 334578899999999999999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=345.19 Aligned_cols=267 Identities=23% Similarity=0.281 Sum_probs=204.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||+||+|+++.+++.||||++..... .....+.+|+.+++.++||||++++++|...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 469999999999999999999999999999999975432 223567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.++.|..+... ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998766655432 356899999999999999999999998 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh-hhh-------hhccc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA-RPL-------FKDRR 322 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~-~~~-------~~~~~ 322 (522)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .++ +....
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 21 1223456899999999999889999999999999999999999999764321111111000 000 00000
Q ss_pred CCCCcCCccccC------CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 323 KFPKMADPLLQG------RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 323 ~~~~~~d~~l~~------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.+.....+.... .+.......+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000110111100 011112356889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=353.85 Aligned_cols=267 Identities=23% Similarity=0.304 Sum_probs=208.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||.||++++..++..||+|++..... .....+.+|+.+|+.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999999999999999976432 223568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+. |+|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999976 4568999999999999999999998532 999999999999999999999999998754221
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh-hhhhcccCCC----
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR-PLFKDRRKFP---- 325 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~---- 325 (522)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +..... ..........
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccC
Confidence 1234568999999999999899999999999999999999999996533211 111000 0000000000
Q ss_pred ------------------------CcCCccccC---CC-ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 326 ------------------------KMADPLLQG---RY-PMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 326 ------------------------~~~d~~l~~---~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.+.+..... .. .......+.+||.+||+.||++||++.+|++....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 000000000 00 01234578899999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.67 Aligned_cols=240 Identities=27% Similarity=0.331 Sum_probs=196.3
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
||+|+||+||+|.+..+++.||||++.... ......+..|+.+|..++||||++++++|...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999997532 22335577899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence 999975 457899999999999999999999999 999999999999999999999999999853221 12234
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 337 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 337 (522)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ............. ++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~~~------------~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEPLR------------FP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCC------------CC
Confidence 56799999999999999999999999999999999999999975321 1222222222111 11
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 338 MRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 338 ~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
......+.+|+.+||+.||++||++..+.+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 222356789999999999999986543333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=344.97 Aligned_cols=266 Identities=23% Similarity=0.327 Sum_probs=203.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|++.++||.|+||+||+|.+..+++.||||+++..... ....+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5699999999999999999999999999999999754322 234677899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 999988652 345789999999999999999999999 9999999999999999999999999998643222
Q ss_pred CCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh--------hhhhccc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR--------PLFKDRR 322 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~ 322 (522)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... +......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 1 2234568999999999875 468999999999999999999999997654322111110000 0000000
Q ss_pred CCCCcCCccccCC----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 323 KFPKMADPLLQGR----YPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 323 ~~~~~~d~~l~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.+.....+..... ........+.+||.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0011111100000 00112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.94 Aligned_cols=243 Identities=27% Similarity=0.347 Sum_probs=200.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 175 (522)
++||+|+||.||++.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++...+..||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975432 22356778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcc
Q 009933 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV 255 (522)
Q Consensus 176 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 255 (522)
+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99998865 457899999999999999999999999 999999999999999999999999998753221 112
Q ss_pred eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCC
Q 009933 256 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 335 (522)
Q Consensus 256 ~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 335 (522)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~~~------------ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEDIK------------ 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCCcc------------
Confidence 23467999999999999989999999999999999999999999753221 111111111111
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 336 YPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 336 ~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
++......+.+||.+||+.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1222335678999999999999997 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=360.02 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=205.3
Q ss_pred hcCCcccceecccCceEEEEEEECCC-----CcEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST-----GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~ 164 (522)
.++|++.+.||+|+||.||+|.+..+ +..||||++...... ....+.+|+.+|+.+ +|+|||+++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35799999999999999999986433 357999999754322 235678899999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCC-----------------------------------------------------------
Q 009933 165 RLLVYEFMPLGSLEDHLHDLP----------------------------------------------------------- 185 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------------- 185 (522)
.++|||||++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999985421
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceec
Q 009933 186 -------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 258 (522)
Q Consensus 186 -------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 258 (522)
....++++..+++|+.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++..............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01235788999999999999999999998 99999999999999999999999999986433221111222
Q ss_pred ccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCC
Q 009933 259 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 337 (522)
Q Consensus 259 ~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 337 (522)
..++..|+|||++....++.++|||||||++|||++ |+.||....... ..... ..... ... .+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~----~~~~~---~~~-------~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKM----VKRGY---QMS-------RP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHH----HHccc---Ccc-------CC
Confidence 345678999999998899999999999999999997 999997543211 11111 11100 000 01
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 338 MRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 338 ~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
......+.+|+.+||+.||++||++.+|+++|+.+
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=350.43 Aligned_cols=243 Identities=28% Similarity=0.357 Sum_probs=198.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 175 (522)
++||+|+||.||++.+..+++.||+|++..... .....+..|+.+|+.++||||++++++|...+..||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345678999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcc
Q 009933 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV 255 (522)
Q Consensus 176 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 255 (522)
+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 99998865 457899999999999999999999999 9999999999999999999999999987532211 12
Q ss_pred eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCC
Q 009933 256 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR 335 (522)
Q Consensus 256 ~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 335 (522)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+......
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~---~~~~~~~~~------------ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---ELILMEEIR------------ 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHhcCCCC------------
Confidence 23467999999999999999999999999999999999999999754221 111 111111111
Q ss_pred CChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 336 YPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 336 ~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
++......+.+||.+||+.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1222335678999999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=338.42 Aligned_cols=269 Identities=25% Similarity=0.320 Sum_probs=207.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCC-cceeEEEEEcCC------
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSN-LVNLIGYCADGD------ 163 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpn-Iv~l~~~~~~~~------ 163 (522)
..|...++||+|+||+||+|+.+.+|+.||+|++...... ......+|+.+|+.|+|+| ||.|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4577778899999999999999999999999999765432 2245678999999999999 999999998887
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.++|||||++. +|..++.........++...++.++.||+.||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 88999999965 999999875543356777899999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh-----h
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP-----L 317 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~-----~ 317 (522)
|+...... ...+..++|.+|+|||++.+. .|+...||||+|||++||++++..|.+.........+-.... .
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99654332 235667889999999999987 799999999999999999999999987655211111100000 0
Q ss_pred hhcccCCCCcCCccccCCC-Ch-------HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRY-PM-------RGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~-~~-------~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
|.....++..-. .+.... +. .......+++.+||+.+|.+|.|+..++++
T Consensus 245 Wp~v~~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000000000000 000000 00 011367889999999999999999999986
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=367.88 Aligned_cols=262 Identities=24% Similarity=0.278 Sum_probs=213.2
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEE-EEc------C
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGY-CAD------G 162 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~-~~~------~ 162 (522)
...++++.+.|-+|||+.||+|.+...+..||+|++-.......+.+.+||++|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3567899999999999999999999877999999987666666778899999999998 9999999993 221 1
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
-+++|+||||.||.|.|++..... ..|++.++++|+.++++||.+||.. .+||||||||-+||||..+++.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 367899999999999999986433 3499999999999999999999998 5889999999999999999999999999
Q ss_pred ceeeCCCCCCCc--ce-----ecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 009933 243 LAKLGPVGDKTH--VS-----TRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA 312 (522)
Q Consensus 243 la~~~~~~~~~~--~~-----~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~ 312 (522)
.+.-........ .. -...-|+.|+|||.+. +...+.|+|||+|||+||-|+....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 997532221110 00 0123589999999885 567899999999999999999999999865331
Q ss_pred hhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 313 WARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 313 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.+++-.....-...+...|.+||..||+.||.+||++-+|+..+-.++..
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 22222222222246778999999999999999999999999999877543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=327.27 Aligned_cols=268 Identities=25% Similarity=0.319 Sum_probs=218.5
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-----ee
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-----QR 165 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-----~~ 165 (522)
..++|++.++||+|||+.||+++...++..||+|+|.....++.+..++|++..++++||||++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 3578999999999999999999999999999999998887777888999999999999999999999875543 48
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
||+++|...|+|.+.+......+..+++.+++.|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999987777789999999999999999999999984 689999999999999999999999999997
Q ss_pred eCCCCCCCcc-------eecccCCccccChhhhhc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh
Q 009933 246 LGPVGDKTHV-------STRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 246 ~~~~~~~~~~-------~~~~~gt~~y~APE~l~~---~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~ 315 (522)
..+..-.... -.....|..|+|||++.. ...+.++|||||||+||+|+.|..||+..-..+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-------- 249 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-------- 249 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--------
Confidence 6432111110 112347889999999874 3578999999999999999999999974322111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.....+....+...-.......+.+||..||+.||.+||++.+++..+..+.
T Consensus 250 ------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 ------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0001111111211112235678999999999999999999999999998763
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=369.68 Aligned_cols=255 Identities=22% Similarity=0.261 Sum_probs=208.6
Q ss_pred CCcccceecccCceEEEEEEECCC-CcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 94 NFRPECLLGEGGFGRVYKGRLEST-GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~-g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
.|.+.++||+|+||.||+|....+ +..||+|.+..........+..|+.+|+.++|||||+++++|...+.+||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 489999999999999999999877 7889999876554444456788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++|+|.+++........++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988654344567899999999999999999999998 99999999999999999999999999986543322
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.... . .+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~--~----~~-- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGK--Y----DP-- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC--C----CC--
Confidence 2233456799999999999999999999999999999999999999965322 11111111110 0 00
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
++......+.+||.+||+.+|++||++.+++..
T Consensus 291 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 ---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111223568899999999999999999999763
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=359.00 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=205.3
Q ss_pred hcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~ 164 (522)
.++|++.+.||+|+||+||+|.+ ..++..||||+++.... ...+.+.+|+.+|..+ +||||++++++|.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999974 34567899999975432 2345688899999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC----------------------------------------------------------
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPP---------------------------------------------------------- 186 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------------- 186 (522)
.++|||||++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864210
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 187 -------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 187 -------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1135789999999999999999999998 999999999999999999999999999864332221
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+. ..... .. .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~----~~~~~--~~-~--- 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI----KEGYR--ML-S--- 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH----HhCcc--CC-C---
Confidence 11222345678999999999999999999999999999998 88888654221 1122211 11100 00 0
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
+......+.+||.+||+.||++||++.+|++.|+.
T Consensus 339 ----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 ----PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11112467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=354.39 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=202.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.++||+|+||+||+|++..+++.||||++..... .....+..|+.+|..++||||++++++|.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 479999999999999999999999999999999975422 22345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999976 457999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCc------------------------------------ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHH
Q 009933 250 GDKTH------------------------------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELI 293 (522)
Q Consensus 250 ~~~~~------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLl 293 (522)
..... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 111346999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC---HHHHHHH
Q 009933 294 TGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL---IGDVVTA 368 (522)
Q Consensus 294 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~~evl~~ 368 (522)
+|..||....... .. ..+......+ .... .......+.+||.+|+. +|.+|++ +.++++.
T Consensus 234 ~G~~Pf~~~~~~~---~~---~~i~~~~~~~-~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQE---TY---RKIINWKETL-QFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHH---HH---HHHHcCCCcc-CCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999997543211 11 1111111000 0000 00123567789999997 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=342.76 Aligned_cols=245 Identities=21% Similarity=0.363 Sum_probs=199.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEc----CCeeEEEEee
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRLLVYEF 171 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 171 (522)
..||+|+++.||+|.+ +|+.||||+++...... .+.+.+|+.+|.+++|||||++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999998 48999999997654333 3567799999999999999999999876 3578999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
+++|+|.+++.. ...+++...+.++.|++.||.|||+. + ++||||||+|||+++++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999976 45789999999999999999999985 6 889999999999999999999999999854321
Q ss_pred CCCcceecccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.....|+..|+|||++.+ ..|+.++|||||||++|||++|+.||...... .+.. .+......+
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~---~i~~~~~~~---- 241 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYD---LIINKNNSL---- 241 (283)
T ss_pred -----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHhcCCCC----
Confidence 123468899999999976 68999999999999999999999999754321 1111 111111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
..+......+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 242 ------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 ------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111223456889999999999999999999999998765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=341.15 Aligned_cols=265 Identities=23% Similarity=0.327 Sum_probs=202.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999999989999999999754322 23456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 588888765 2356889999999999999999999999 999999999999999999999999998753222
Q ss_pred CCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc--------
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR-------- 321 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------- 321 (522)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..........+...
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccch
Confidence 1 12234568999999999875 45889999999999999999999999754321 11111110000000
Q ss_pred cCCCCcCCccccCCCC---------hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 322 RKFPKMADPLLQGRYP---------MRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~---------~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
...+.+....+....+ ......+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000000 011245779999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.00 Aligned_cols=266 Identities=23% Similarity=0.350 Sum_probs=199.4
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC-----CeeE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQRL 166 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~-----~~~~ 166 (522)
+|++.++||+|+||.||+|.+..++..||||++.... ......+.+|+.+|+.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999999999999999986432 22335678999999999999999999988643 2579
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+|||||. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689998865 456899999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCC-cceecccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHh---------h
Q 009933 247 GPVGDKT-HVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW---------A 314 (522)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~---------~ 314 (522)
....... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. .
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 4222111 12234679999999999876 6789999999999999999999999975432111100000 0
Q ss_pred hhhhhcc-----cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 315 RPLFKDR-----RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 315 ~~~~~~~-----~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+.... ..+.......+...++ .....+.+|+.+||+.||++||++.+|++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 0000000000000000 122457799999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.03 Aligned_cols=247 Identities=24% Similarity=0.323 Sum_probs=202.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCC-cEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTG-QVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g-~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|.+.+.||+|+||.||+|.+..++ ..||||++..... .....+..|+.+|..++||||++++++|.+...+|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 356999999999999999999976554 6899999865322 233567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999976 457899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||....+. .....+......
T Consensus 182 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~~~---- 246 (340)
T PTZ00426 182 DT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGIIY---- 246 (340)
T ss_pred CC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCCCC----
Confidence 22 123467999999999999989999999999999999999999999754321 111111111111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
++......+.++|.+||+.||++|+ +++++++.
T Consensus 247 --------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 --------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1112234577999999999999995 78887764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.25 Aligned_cols=259 Identities=32% Similarity=0.500 Sum_probs=208.7
Q ss_pred cCCcccceecccCceEEEEEEECCCC-----cEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTG-----QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g-----~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
++|++.+.||+|+||.||+|.+...+ ..||+|.+...... ....+.+|+.+|..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46889999999999999999986544 67999998754322 2356889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 009933 167 LVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF 234 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~ 234 (522)
++|||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975321 1156889999999999999999999999 99999999999999999
Q ss_pred ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHh
Q 009933 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAW 313 (522)
Q Consensus 235 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~ 313 (522)
.++|+|||++......+.........+++.|+|||++.+..++.++|||||||++|||++ |..||...... .+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986433332223334557889999999998899999999999999999998 99999754321 11111
Q ss_pred hhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 314 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
+ ... .... .+......+.+|+.+||+.+|++||++.+|+++|+.
T Consensus 239 i----~~~-~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 I----RSR-QLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcC-CcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 111 0111 122334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=343.75 Aligned_cols=243 Identities=28% Similarity=0.392 Sum_probs=197.2
Q ss_pred ceecccCceEEEEEEEC---CCCcEEEEEEEccCCc----cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 99 CLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~----~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++||+|+||.||++.+. .+++.||||+++.... .....+..|+.+|+.++||||++++++|..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999873 4688999999975322 2234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999975 456888999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......+
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~~~~------- 219 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGKLNL------- 219 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCCC-------
Confidence 122346799999999999998999999999999999999999999975422 11111111111111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
+......+.+||.+||+.+|++|| ++.+++..
T Consensus 220 -----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 -----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 112235678999999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=345.25 Aligned_cols=261 Identities=27% Similarity=0.472 Sum_probs=206.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcE----EEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQV----VAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~----vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
..+|++.+.||+|+||+||+|.+..++.. ||||+++.... ...+.+..|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 35699999999999999999998665554 89999865432 3346788899999999999999999999764 578
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999999762 346889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..............++..|+|||++....++.++|||||||++|||++ |..||...... .+.. .......++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~~ 231 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKGERLP 231 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHhCCCCCC
Confidence 543322212222334678999999999999999999999999999998 99999754221 1111 111111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.+......+.+|+.+||+.+|++||++.+|+..|..+....
T Consensus 232 ----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 232 ----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 01112346789999999999999999999999998875433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=343.40 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=206.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-----eeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-----QRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-----~~~l 167 (522)
-.|...+++|.|+||.||+|....+++.||||++-.+. +.-.+|+++|+.+.|||||+|+.+|.... +..|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35778899999999999999999999999999985443 23346999999999999999999886432 4468
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-Cceeeeeecceee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG-FHPKLSDFGLAKL 246 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~-~~vkL~DFGla~~ 246 (522)
|||||+. +|.++++.+...+..++...+.-+..||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 999999876666788898999999999999999999998 9999999999999865 9999999999998
Q ss_pred CCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh--------
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL-------- 317 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~-------- 317 (522)
...+... .....|..|+|||++.+. .|+.+.||||.|||+.||+-|+..|.+....+ +++..+..+
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence 6554433 345678999999999975 79999999999999999999999998754322 222211110
Q ss_pred --hhc---ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 --FKD---RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 --~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
++. ...++.+....+..-+......++++|+.++|+.+|.+|.++.+++.+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 000 111222222221111333445688999999999999999999999863
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=348.87 Aligned_cols=243 Identities=27% Similarity=0.346 Sum_probs=198.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 175 (522)
++||+|+||+||++.+..+++.||||++..... .....+..|+.++..++||||++++++|...+.+||||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345678999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 176 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
+|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 99998865 4578999999999999999999997 67 9999999999999999999999999987532211 1
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~~~~----------- 214 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEIR----------- 214 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcCCCC-----------
Confidence 223457999999999999999999999999999999999999999654221 111111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
++......+.+|+.+||+.||++|+ ++.++++.
T Consensus 215 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 -FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1122235678999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.60 Aligned_cols=254 Identities=23% Similarity=0.280 Sum_probs=200.1
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.|++.+.||+|+||+||+|++..+++.||||++..... .....+..|+.+|..++||||++++++|.+.+.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58899999999999999999999999999999975432 223467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999976 456899999999999999999999999 999999999999999999999999997532100
Q ss_pred CC---------------------------------------------CcceecccCCccccChhhhhcCCCCcchhhHHH
Q 009933 251 DK---------------------------------------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSF 285 (522)
Q Consensus 251 ~~---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSl 285 (522)
.. .......+||+.|+|||++.+..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 001123579999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHH--hcccCcCCCCCHH
Q 009933 286 GVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAM--CLQEQAATRPLIG 363 (522)
Q Consensus 286 Gvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~--cl~~dP~~RPs~~ 363 (522)
||++|||++|..||....+.... . .+......+ .+ . ........+.+||.+ |+..++..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~--~----~i~~~~~~~-~~-~------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ--L----KVINWENTL-HI-P------PQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH--H----HHHcccccc-CC-C------CCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999999754321111 0 000000000 00 0 001123567788877 4456666799999
Q ss_pred HHHHH
Q 009933 364 DVVTA 368 (522)
Q Consensus 364 evl~~ 368 (522)
+|+..
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=345.65 Aligned_cols=245 Identities=28% Similarity=0.412 Sum_probs=197.0
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHH---HhCCCCCcceeEEEEEcCCeeEEE
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLML---SLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L---~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
|++.+.||+|+||.||+|.+..+++.||||+++.... ...+.+..|+.++ ..++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6788999999999999999999999999999975421 2234566666554 566799999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988864 57999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.. .......+|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~~----- 219 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDEVR----- 219 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-----
Confidence 21 11223467999999999999999999999999999999999999999754221 111111111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 367 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~ 367 (522)
++......+.+||.+||+.||.+|| ++.++++
T Consensus 220 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 -------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1122235678999999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=343.53 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=200.9
Q ss_pred CCcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCc----cchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQR 165 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~----~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~ 165 (522)
+|++.+.||+|+||+||+++.. .+++.||+|++.+... ...+.+..|+.+|..++ |+||+.+++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999999874 4689999999965322 22345778999999995 99999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999975 456899999999999999999999999 9999999999999999999999999997
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
........ .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ ...+......
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~~~~- 229 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKCDPP- 229 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhcCCCC-
Confidence 54322211 22346799999999999865 4789999999999999999999999754332221111 1111111111
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
++......+.+|+.+||+.||++|| ++.++++.
T Consensus 230 -----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 -----------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -----------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1112235677999999999999999 67777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.42 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=205.8
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CC-----CcceeEEEEEcCCeeEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HS-----NLVNLIGYCADGDQRLL 167 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hp-----nIv~l~~~~~~~~~~~l 167 (522)
+|.++++||+|+||.|.+|.+..|++.||||+|+... .-..+...|+.+|..|+ |. |||+++++|...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 5788999999999999999999999999999997543 33455677999999998 43 89999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCceeeeeeccee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE--GFHPKLSDFGLAK 245 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~--~~~vkL~DFGla~ 245 (522)
|+|++. .+|+++|+. .....|+...++.|+.||+.||.+||+.+ |||+||||+||||.+ ...|||+|||.+.
T Consensus 266 VfELL~-~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhh-hhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999995 599999987 34566999999999999999999999999 999999999999954 3479999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh----------
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR---------- 315 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~---------- 315 (522)
.... .....+-+..|+|||+|.+.+|+.+.||||||||++||++|...|.+....+....+..+.
T Consensus 340 ~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 340 FESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6322 1225667889999999999999999999999999999999998888776533332221110
Q ss_pred -----hhhhcccCCCCcCC--------------c-----cccCCCC-----------hHHHHHHHHHHHHhcccCcCCCC
Q 009933 316 -----PLFKDRRKFPKMAD--------------P-----LLQGRYP-----------MRGLYQALAVAAMCLQEQAATRP 360 (522)
Q Consensus 316 -----~~~~~~~~~~~~~d--------------~-----~l~~~~~-----------~~~~~~l~~Li~~cl~~dP~~RP 360 (522)
..+.....++.... . ......| ...-..+++++.+||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 01111000000000 0 0111111 12345789999999999999999
Q ss_pred CHHHHHHHH
Q 009933 361 LIGDVVTAL 369 (522)
Q Consensus 361 s~~evl~~L 369 (522)
|..+.+.+-
T Consensus 495 tp~qal~Hp 503 (586)
T KOG0667|consen 495 TPAQALNHP 503 (586)
T ss_pred CHHHHhcCc
Confidence 999998753
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=337.78 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=200.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
||+|+||+||++.+..+++.||||++....... ...+..|+.+|+.++|+||++++++|......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999997543322 24567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9888654444567999999999999999999999999 99999999999999999999999999976433221 223
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 337 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 337 (522)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............ .++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~------------~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRILNDSV------------TYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhcccCC------------CCc
Confidence 457899999999999999999999999999999999999999754322111 111111111100 122
Q ss_pred hHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 338 MRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 338 ~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
......+.+|+..||+.||++|| ++.+++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 23345788999999999999999 66777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.33 Aligned_cols=252 Identities=26% Similarity=0.325 Sum_probs=206.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|.+.+.||+|+||+||+|.+..+++.||||++..... .....+..|+.+|..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 479999999999999999999999999999999975422 23456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999976 367899999999999999999999998 99999999999999999999999999986433
Q ss_pred CC---------------------------CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 009933 250 GD---------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 302 (522)
Q Consensus 250 ~~---------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~ 302 (522)
.. .........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001223456999999999999999999999999999999999999999765
Q ss_pred CCCCcchHHHhhhhhhh--cccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC-HHHHHHH
Q 009933 303 RPPGEHNLVAWARPLFK--DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-IGDVVTA 368 (522)
Q Consensus 303 ~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~evl~~ 368 (522)
.... ....+.. ....++.. ......+.+||.+||+ +|.+||+ +.+|++.
T Consensus 234 ~~~~------~~~~i~~~~~~~~~p~~----------~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQE------TYNKIINWKESLRFPPD----------PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHH------HHHHHhccCCcccCCCC----------CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 3211 1111111 10011110 0123567889999998 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=348.99 Aligned_cols=203 Identities=28% Similarity=0.369 Sum_probs=178.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||+||+|.+..+++.||||++..... .....+..|+.++..++|+||+++++++.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478999999999999999999999999999999975322 22345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999976 467999999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCC---------------------------------cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCC
Q 009933 250 GDKT---------------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296 (522)
Q Consensus 250 ~~~~---------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~ 296 (522)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0112457999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 009933 297 KAIDNT 302 (522)
Q Consensus 297 ~Pf~~~ 302 (522)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=340.31 Aligned_cols=242 Identities=28% Similarity=0.422 Sum_probs=194.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHh-CCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSL-LHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||+||+|.+..+++.||||+++.... .....+..|..++.. ++||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975422 223345566666665 4799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999999875 457899999999999999999999998 9999999999999999999999999998643222 2
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~----------- 214 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILNDRPH----------- 214 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCC-----------
Confidence 23456799999999999998999999999999999999999999975432 1111111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHH-HHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIG-DVVT 367 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-evl~ 367 (522)
++......+.+|+.+||+.+|++||++. ++++
T Consensus 215 -~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 -FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1122235677999999999999999875 4433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=350.93 Aligned_cols=254 Identities=22% Similarity=0.249 Sum_probs=200.6
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+|..++|+||++++++|.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 369999999999999999999999999999999965322 22355778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999976 456889999999999999999999999 99999999999999999999999999752210
Q ss_pred CC-----------------------------------------CCcceecccCCccccChhhhhcCCCCcchhhHHHHHH
Q 009933 250 GD-----------------------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 288 (522)
Q Consensus 250 ~~-----------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvl 288 (522)
.. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCC---CHHHH
Q 009933 289 FLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP---LIGDV 365 (522)
Q Consensus 289 l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP---s~~ev 365 (522)
+|||++|+.||....+..... .+......+ .+ .........+.++|.+|+ .+|.+|+ ++.++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~------~i~~~~~~~-~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQL------KVINWETTL-HI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHH------HHhccCccc-cC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999997654321111 000000000 00 001112345677888876 5999999 88888
Q ss_pred HHH
Q 009933 366 VTA 368 (522)
Q Consensus 366 l~~ 368 (522)
+..
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=335.62 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=204.9
Q ss_pred hcCCcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++..... ....+.+|+.+|..++||||+++++++...+..+|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457899999999999999999875 34678999999764322 23568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||||+.++.++|+|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999752 357899999999999999999999999 999999999999999999999999987653
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
..... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...... ......
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~----~~~~~~-- 227 (266)
T cd05064 158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAV----EDGFRL-- 227 (266)
T ss_pred cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----HCCCCC--
Confidence 21111 11112335678999999999999999999999999999875 99999754321 111111 111100
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+......+.+++..||+.+|.+||++.+|++.|..+
T Consensus 228 --------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112335678899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=345.40 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=196.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.+|+..+.||+|+||+||+|.+..+++.||||++...... ....+.+|+.+|+.++|+||++++++|...+.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4577788999999999999999999999999999654322 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+.. .+.+..+..++.||+.||.|||+.+ |+||||||+||||++++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986542 3456788899999999999999999 9999999999999999999999999998643211
Q ss_pred CCcceecccCCccccChhhhhc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.......||..|+|||++.. ..++.++|||||||++|||++|+.||..........+.. ..... ..
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~---~~- 293 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICMS---QP- 293 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhcc---CC-
Confidence 12234579999999998753 234568999999999999999999997432211111111 00000 00
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
+ ..+......+.+||.+||+.||++||++.||++.-
T Consensus 294 ---~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 294 ---P----EAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ---C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0 01112335788999999999999999999998853
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.01 Aligned_cols=200 Identities=26% Similarity=0.374 Sum_probs=177.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||.||++.+..++..+|+|++..... .....+.+|+.+|+.++||||++++++|...+..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999999999999999999876432 223568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|+.+++|.+++.. ...+++..+..++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999975 45688999999999999999999975 5 99999999999999999999999999875322
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 302 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~ 302 (522)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 123356899999999999889999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=344.59 Aligned_cols=239 Identities=29% Similarity=0.411 Sum_probs=194.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||+||+|.++.+++.||||++..... .....+..|+.++..+ +||||+++++++...+.+||||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975421 2334567788888776 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999999875 457899999999999999999999999 999999999999999999999999998753221 11
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~----------- 214 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEVV----------- 214 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCCC-----------
Confidence 23446799999999999998999999999999999999999999975422 1111111221111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIGD 364 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e 364 (522)
++......+.+|+.+||+.||++||++.+
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11122356789999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=346.67 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=216.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch--HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~--~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
..-|.+++.||+|.|.+|-++++.-||..||||+|++..+... ..+..|+..|+.++|||||+||++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3458899999999999999999999999999999998776554 46789999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-cCCCceeeeeecceeeCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL-DEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl-d~~~~vkL~DFGla~~~~ 248 (522)
|+-++|+|+|||.+ ..+.+.+..+.+++.||+.||.|||... ||||||||+||++ ..-|-|||+|||++-.+.
T Consensus 97 ELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999976 3577999999999999999999999999 9999999999877 667899999999998755
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.+. ..++.||+..|.|||++.+..|+ +++||||||||||-|++|+.||+..... ..+..+
T Consensus 171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTmI 231 (864)
T KOG4717|consen 171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTMI 231 (864)
T ss_pred Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhhh
Confidence 443 45678999999999999999997 5789999999999999999999855332 223333
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
+|... ..|.....++.+||..||..||++|.+.++|+..-
T Consensus 232 mDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 232 MDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred hcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 33322 24455678999999999999999999999998643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=321.23 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=213.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++++.||+|-||.||+|+.+.++-.||+|++-+..+ ....++.+|++|-+.|+||||+++|+||.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4679999999999999999999999999999999976543 2346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
+||...|+|+..|.. .....+++.....++.|++.||.|||..+ ||||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999985 23567889999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.....+.|||..|.+||...+..++..+|+|++|++.||+|.|..||....... ....+....-.
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkrI~k~~~~----- 240 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKRIRKVDLK----- 240 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHHHHHcccc-----
Confidence 223456899999999999999999999999999999999999999998654111 11111121111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+|........+||.+|+..+|.+|.+..|++..-.
T Consensus 241 -------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 241 -------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred -------CCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 12223357789999999999999999999987654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=343.67 Aligned_cols=242 Identities=28% Similarity=0.407 Sum_probs=197.7
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCC-CcceeEEEEEcCCeeEEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHS-NLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hp-nIv~l~~~~~~~~~~~lV~ 169 (522)
+|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+..|+.++..+.|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58899999999999999999999999999999975422 2335577899999999765 5888999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ..+.....
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~i~~~~~------- 218 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF---QSIMEHNV------- 218 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHcCCC-------
Confidence 21 1233467999999999999999999999999999999999999999754221 111 11111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 362 (522)
.++......+.+|+.+||+.||.+|++.
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122233567899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.41 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=200.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|.+.+.||+|+||+||++.+..+++.||||++..... .....+.+|+.+|..++||||++++++|.+...+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 468999999999999999999999999999999865322 22345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999975 467899999999999999999999999 99999999999999999999999999863211
Q ss_pred CCCC---------------------------------------------cceecccCCccccChhhhhcCCCCcchhhHH
Q 009933 250 GDKT---------------------------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYS 284 (522)
Q Consensus 250 ~~~~---------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDVwS 284 (522)
.... ......+||+.|+|||++.+..|+.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCC---CC
Q 009933 285 FGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR---PL 361 (522)
Q Consensus 285 lGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~R---Ps 361 (522)
|||+||||++|..||........ . ..+......+ .+.+ .......+.+||.+||+ +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~---~---~~i~~~~~~~-~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHET---Y---RKIINWRETL-YFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHH---H---HHHHccCCcc-CCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999999975432111 1 1111100000 0000 00123567889999998 67665 58
Q ss_pred HHHHHHHH
Q 009933 362 IGDVVTAL 369 (522)
Q Consensus 362 ~~evl~~L 369 (522)
+.+++..-
T Consensus 299 ~~~~l~hp 306 (377)
T cd05629 299 AHEIKSHP 306 (377)
T ss_pred HHHHhcCC
Confidence 88888753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=345.36 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=198.3
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||.||+|.+..+++.||||+++..... ....+..|+.++..+ +||||++++++|.....+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999764322 234577899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999998865 467999999999999999999999999 999999999999999999999999998742111 11
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC--cchHHHhhhhh-hhcccCCCCcCCcc
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG--EHNLVAWARPL-FKDRRKFPKMADPL 331 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~d~~ 331 (522)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+.... ......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-------- 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--------
Confidence 2334679999999999999999999999999999999999999997433221 11111222111 111111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCC------HHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPL------IGDVVT 367 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs------~~evl~ 367 (522)
++......+.+||.+||+.||.+||+ +.++++
T Consensus 224 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 ----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12222356789999999999999997 556654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=360.07 Aligned_cols=267 Identities=21% Similarity=0.271 Sum_probs=197.3
Q ss_pred HHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC------CCcceeEEEEEc
Q 009933 88 LAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH------SNLVNLIGYCAD 161 (522)
Q Consensus 88 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h------pnIv~l~~~~~~ 161 (522)
+....++|++.++||+|+||+||+|.+..+++.||||+++... .....+..|+.++..++| .+|+.++++|..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445678999999999999999999999899999999996432 223345567777776654 458899998876
Q ss_pred C-CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCC-----
Q 009933 162 G-DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGF----- 234 (522)
Q Consensus 162 ~-~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~----- 234 (522)
. .++|||||++ +++|.+++.. ...+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 5 5789999988 7789998865 4679999999999999999999998 47 99999999999998665
Q ss_pred -----------ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 009933 235 -----------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 303 (522)
Q Consensus 235 -----------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~ 303 (522)
.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999876421 12345679999999999999999999999999999999999999997654
Q ss_pred CCCcchHHHhhh-----------------hhhhcccCCCCcCCcc-----ccCC-C-ChHHHHHHHHHHHHhcccCcCCC
Q 009933 304 PPGEHNLVAWAR-----------------PLFKDRRKFPKMADPL-----LQGR-Y-PMRGLYQALAVAAMCLQEQAATR 359 (522)
Q Consensus 304 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~d~~-----l~~~-~-~~~~~~~l~~Li~~cl~~dP~~R 359 (522)
.......+.... .++.....+....++. .... . .......+.+||.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 322111111100 0000000000000000 0000 0 00112457799999999999999
Q ss_pred CCHHHHHHH
Q 009933 360 PLIGDVVTA 368 (522)
Q Consensus 360 Ps~~evl~~ 368 (522)
||+.|++++
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999974
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=337.00 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=207.7
Q ss_pred hcCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
..+|.+.+.||+|+||.||+|.+.. ++..||||+++..... ....+.+|+.+|+.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999998743 3678999999765433 346788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 009933 166 LLVYEFMPLGSLEDHLHDLP----------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~ 235 (522)
++||||+++++|.+++.... .....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997531 22345889999999999999999999998 999999999999999999
Q ss_pred eeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhh
Q 009933 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~ 314 (522)
+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...... ..+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH
Confidence 99999999975432222122233446788999999999999999999999999999998 99998654321 111111
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
. . ..... .+......+.+|+.+||+.+|++||++.||++.|+
T Consensus 238 ~----~-~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T----Q-GRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H----c-CCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 0 00000 11122356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=345.11 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=194.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||+||+|.+..+++.||+|++++... .....+..|+.++..+ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976432 2234567788888776 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence 999998865 457999999999999999999999999 999999999999999999999999998753211 11
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--chHHHhhhh-hhhcccCCCCcCCcc
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE--HNLVAWARP-LFKDRRKFPKMADPL 331 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~d~~ 331 (522)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .....+... +......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------- 223 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------- 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC--------
Confidence 22346799999999999999999999999999999999999999964322111 111122111 1111111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 362 (522)
++......+.+|+.+||+.||++||++
T Consensus 224 ----~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 ----IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 222334567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=366.33 Aligned_cols=257 Identities=25% Similarity=0.313 Sum_probs=208.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCC------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------ 163 (522)
.++|.+.++||+|+||+||+|.+..+++.||||++...... ....+..|+.+|..++|+||++++..+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 56899999999999999999999999999999999765432 2345778999999999999999988775432
Q ss_pred --eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 164 --QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 164 --~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
.+++||||+++|+|.+++.........+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence 368999999999999999764445567999999999999999999999998 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
|+++..............+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ...........
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~~~ 261 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLAGR 261 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCC
Confidence 999865433222233456799999999999999999999999999999999999999975321 11111111110
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. .+ .+......+.+|+.+||+.+|.+||++.+++.+
T Consensus 262 --~----~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 --Y----DP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --C----CC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 01 112233578899999999999999999999874
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=344.07 Aligned_cols=243 Identities=27% Similarity=0.384 Sum_probs=197.4
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||.||+|++..+++.||||++..... .....+..|+.++..+ +||||++++++|...+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999976422 2234567788888866 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 999999865 457899999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~~~----------- 214 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDDVL----------- 214 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC-----------
Confidence 233467999999999999989999999999999999999999999754321 111111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCC-------CHHHHHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRP-------LIGDVVTA 368 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RP-------s~~evl~~ 368 (522)
++......+.+|+..||+.||++|| ++.++++.
T Consensus 215 -~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 -YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1111235678999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=332.12 Aligned_cols=262 Identities=21% Similarity=0.336 Sum_probs=211.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.+|++.+.||+|+||.||+|++..+++.||||.+..... .....+..|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 579999999999999999999998999999998865322 22345788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999998654444566899999999999999999999998 99999999999999999999999999886432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. .......+++.|+|||++.+..++.++||||||+++|||++|+.||...... ...+...+... ..+.
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~--~~~~--- 227 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQC--DYPP--- 227 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhcC--CCCC---
Confidence 21 1122356889999999999888999999999999999999999998643221 11111111100 0111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
. ........+.+|+.+||+.+|++||++.+|++.|+.+.
T Consensus 228 -~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 -L----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -C----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1 11123356889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.24 Aligned_cols=252 Identities=23% Similarity=0.251 Sum_probs=197.6
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.|++.++||+|+||+||+|++..+++.||||++..... .....+..|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999975422 223467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999975 356889999999999999999999999 999999999999999999999999997532100
Q ss_pred C---------------------------------------------CCcceecccCCccccChhhhhcCCCCcchhhHHH
Q 009933 251 D---------------------------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSF 285 (522)
Q Consensus 251 ~---------------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSl 285 (522)
. ........+||+.|+|||++.+..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC---H
Q 009933 286 GVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL---I 362 (522)
Q Consensus 286 Gvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~ 362 (522)
||+||||++|+.||....+... .. .+......+. .+ ........+.++|.+|+ .+|++|++ +
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~--~~----~i~~~~~~~~---~p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLET--QM----KVINWQTSLH---IP-----PQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHH--HH----HHHccCCCcC---CC-----CcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999999975432111 00 0111000000 00 00112345667777766 49999997 7
Q ss_pred HHHHH
Q 009933 363 GDVVT 367 (522)
Q Consensus 363 ~evl~ 367 (522)
.+|+.
T Consensus 300 ~ei~~ 304 (382)
T cd05625 300 DEIKA 304 (382)
T ss_pred HHHhc
Confidence 77664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=346.60 Aligned_cols=254 Identities=26% Similarity=0.307 Sum_probs=204.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|.+.+.||+|+||+||+|.+..+++.||||+++.... .....+..|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 469999999999999999999999999999999975432 23345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999762 357999999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCCcceecccCCccccChhhhh------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAM------TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~------~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
... .......||+.|+|||++. ...++.++|||||||++|||++|..||...... .....+.....
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~- 226 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQR- 226 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCC-
Confidence 221 1223457999999999987 456789999999999999999999999754321 11111111110
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..... ........+.+|+..||+ +|++||++.+++..
T Consensus 227 ~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00000 011223567889999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=337.51 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=209.6
Q ss_pred hcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.++|.+.+.||+|+||+||++.+ ..++..+|+|.+..........+..|+.+|..++||||++++++|......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35789999999999999999986 2345679999987654444567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcee
Q 009933 167 LVYEFMPLGSLEDHLHDLP---------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK 237 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vk 237 (522)
+||||+++++|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999997532 12235899999999999999999999999 99999999999999999999
Q ss_pred eeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhh
Q 009933 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 238 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~--- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC--- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---
Confidence 999999985432222112223445778999999998899999999999999999998 899986543211 1111
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
+... .... . +......+.+|+.+||+.+|.+||++.+|+..|+.+..
T Consensus 235 i~~~--~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQG--RVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcC--CcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111 0000 0 11122468899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=370.94 Aligned_cols=264 Identities=29% Similarity=0.468 Sum_probs=219.3
Q ss_pred hcCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
..+....+.||+|.||+||+|+... ....||||.++..... ..++|.+|+++|..|+|||||+|+|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3455667889999999999999742 3468999999876555 567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPD----------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~ 235 (522)
|||+|||..|+|.+||...... ..+|+..+.+.|+.|||.|+.||-++. +|||||...|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 9999999999999999753221 234889999999999999999999999 999999999999999999
Q ss_pred eeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhh
Q 009933 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~ 314 (522)
|||+||||++.....+.........-..+|||||.|+.++|+.+||||||||+|||+++ |+.||...... ..+..+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---EVIe~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---EVIECI 718 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---HHHHHH
Confidence 99999999997666666555544455789999999999999999999999999999998 88888765332 222222
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+.. -..|......+..|+..||+..|++||+++||-.+|+.+...
T Consensus 719 ----~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 719 ----RAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ----HcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 22211 123444557888999999999999999999999999986543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=353.35 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=215.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch--HHHHHHHHHHHhCCCCCcceeEEEEEcCCe-eEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGYCADGDQ-RLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~--~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~-~~lV~ 169 (522)
++|..+++||+|+||.+++++++.+++.|++|.|........ +....|+.++++++|||||.+++.|+.++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 579999999999999999999999999999999976554332 356889999999999999999999999888 99999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
+||+||+|.+.|... ...-++++.+..|+.||+.||.|||++. |+|||||+.|||++.+..|||.|||+++....
T Consensus 84 ~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999999873 3567999999999999999999999888 99999999999999999999999999998654
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. .....++||+.||.||++.+.+|+.|+|||||||++|||++-+.+|...... ..+..+... ...
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~~~------~~~ 224 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKINRG------LYS 224 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHhhc------cCC
Confidence 33 2445688999999999999999999999999999999999999999765321 111111111 112
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+......+..||..||+.+|..||++.++|.+
T Consensus 225 -----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 -----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2344566788899999999999999999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=335.55 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=196.7
Q ss_pred cCCcccceecccCceEEEEEEECC-CCcEEEEEEEccCCccc--hHHHHHHHHHHHhC---CCCCcceeEEEEE-----c
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLES-TGQVVAVKQLDRNGLQG--NREFLVEVLMLSLL---HHSNLVNLIGYCA-----D 161 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~-~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l---~hpnIv~l~~~~~-----~ 161 (522)
++|++.+.||+|+||+||+|.+.. +++.||||+++...... ...+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 47889999987543222 23456677777665 6999999999985 2
Q ss_pred CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
...+++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 5999998752 2345899999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH-HHhhhhhhhc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL-VAWARPLFKD 320 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~-~~~~~~~~~~ 320 (522)
|++...... .......||+.|+|||++....++.++|||||||++|||++|..||........... ...... ..
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~-~~- 229 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PG- 229 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CC-
Confidence 999864322 223346789999999999988999999999999999999999999976543211111 100000 00
Q ss_pred ccCCCC---cCCccccC--C-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 321 RRKFPK---MADPLLQG--R-----YPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 321 ~~~~~~---~~d~~l~~--~-----~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
....+. +....+.. . ........+.+|+.+||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 00000000 0 00112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=342.72 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=197.7
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
+|++.+.||+|+||.||+|.+..+++.||||++.+.... ....+..|..++..+ +|++|+.+++++...+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999764321 223456678888777 5899999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+.....
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~---~i~~~~~------- 218 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIMEHNV------- 218 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCC-------
Confidence 11 1223467999999999999999999999999999999999999999754321 1111 1111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 362 (522)
.++......+.+|+.+||+.+|.+|++.
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1222234577899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=349.47 Aligned_cols=256 Identities=22% Similarity=0.271 Sum_probs=205.1
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
..++|++.++||+|+||.||++.+..+++.||||++..... .....+..|+.+++.++||||+++++++.+...+||
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 35679999999999999999999999999999999965322 223457789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999865 45888999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
.... .......+||+.|+|||++... .++.++|||||||++|||++|+.||...... .....+......
T Consensus 193 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~ 265 (370)
T cd05596 193 DANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNS 265 (370)
T ss_pred cCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCc
Confidence 3221 1122346799999999998753 4789999999999999999999999754321 111111111111
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTAL 369 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~evl~~L 369 (522)
+ .+. ........+.+||..||+.+|.+ |+++.+|+..-
T Consensus 266 ~-~~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 266 L-TFP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred C-CCC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0 000 01123467889999999999988 99999998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=346.97 Aligned_cols=253 Identities=27% Similarity=0.295 Sum_probs=213.6
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~ 166 (522)
....|++.+.||.|.||.||+|+.+.+|+.+|+|+|.+..... ...+.+|+.+|+.|. |||||.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3567999999999999999999999999999999998765543 357899999999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC----CCceeeeeec
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE----GFHPKLSDFG 242 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~----~~~vkL~DFG 242 (522)
+|||+|.||.|++.|... .+++..+..++.||+.++.|||+.+ |+||||||+|||+.. ++.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999873 3999999999999999999999999 999999999999943 3579999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhccc
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 322 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 322 (522)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...........+ .....
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i------~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI------LRGDF 255 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH------HcCCC
Confidence 9998544 33556789999999999999999999999999999999999999999876432221111 11111
Q ss_pred CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 323 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 323 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.++ +-......+.++|..||..||..|+++.++|++
T Consensus 256 ---~f~~~-----~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ---DFTSE-----PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCCCC-----CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 112334678899999999999999999999983
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=330.94 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=207.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
.+|.+.+.||+|+||.||+|.+..+++.||+|++..+. .....+.+|+.+|+.++|+||++++++|.....+++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888899999999999999999889999999987543 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++... ....+++..++.++.|++.+|.|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999652 2356899999999999999999999998 99999999999999999999999999986433211
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||...... .+.. .+ ... .
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~---~~-~~~--~------- 222 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE---LL-EKG--Y------- 222 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HH-HCC--C-------
Confidence 1 1112234568999999998899999999999999999998 88998653211 1111 11 100 0
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
....+......+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 223 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011122335788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.94 Aligned_cols=263 Identities=19% Similarity=0.188 Sum_probs=200.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
..+|++.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.|+|||||+++++|......++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3579999999999999999999999999999997542 3467899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+. ++|.+++.. ...+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 689888865 456899999999999999999999998 9999999999999999999999999997532211
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc----chHHHhhhhhhhc-ccCCC-
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE----HNLVAWARPLFKD-RRKFP- 325 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~----~~~~~~~~~~~~~-~~~~~- 325 (522)
........||+.|+|||++.+..|+.++|||||||++|||++|..||........ ...+......... ...++
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1123346799999999999998999999999999999999999988754321110 0001000000000 00000
Q ss_pred ----------------CcCCccccCCCC--hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 326 ----------------KMADPLLQGRYP--MRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 326 ----------------~~~d~~l~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
....+.....+. ......+.+||.+||+.||.+|||+.|+++.-
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 000000000000 01234678899999999999999999998743
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=358.85 Aligned_cols=265 Identities=25% Similarity=0.322 Sum_probs=200.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcC--------C
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--------D 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--------~ 163 (522)
..+|++.++||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++|||||+++++|... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999999899999999985432 3345799999999999999999887432 2
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeeec
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDFG 242 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DFG 242 (522)
.+++||||+++ +|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999975 788877654445678999999999999999999999999 99999999999998654 79999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh--
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK-- 319 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~-- 319 (522)
+++...... ......||+.|+|||++.+. .|+.++|||||||+||||++|..||........ +......+-.
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPT 291 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCC
Confidence 998643322 22345789999999998764 699999999999999999999999976533211 1111100000
Q ss_pred ------c-----ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 320 ------D-----RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 320 ------~-----~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
. ...++......+...++......+.+||.+||+.||.+|||+.+++..-
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 0 0001111111111112223345788999999999999999999998753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=335.23 Aligned_cols=253 Identities=29% Similarity=0.412 Sum_probs=204.4
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
+|++.++||+|+||+||++.+..+++.||||++...... ....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488899999999999999999989999999999754322 22456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999988652 2356899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. ......|++.|+|||++.+..++.++|||||||++|||++|..||......... ......+....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~--------- 221 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EEVERRVKEDQ--------- 221 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HHHHHHhhhcc---------
Confidence 2 123357899999999999889999999999999999999999999754321111 01111111100
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
..++......+.+||.+||+.||++|| ++.++++.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112222345678999999999999999 77788665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=333.02 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=210.9
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
...+|++.++||.|+||.||+|.+.. +..+|+|++..........+..|+.+|+.++|+||+++++++......++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34579999999999999999999987 89999999987665556778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999762 3456899999999999999999999998 999999999999999999999999999764321
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. .......++..|+|||++....++.++|||||||++|+|++ |+.||..... ........ .. .. .
T Consensus 158 ~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~---~~-~~--~--- 223 (261)
T cd05148 158 V--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT---AG-YR--M--- 223 (261)
T ss_pred c--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH---hC-Cc--C---
Confidence 1 11223346778999999998899999999999999999998 8999965431 11111111 10 00 0
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+......+.++|.+||+.+|.+||++.+|++.|+.+
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 -----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 01122235678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=348.42 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=202.9
Q ss_pred HHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
....++|++.+.||+|+||.||++.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 3345789999999999999999999999999999999965321 2234577899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999965 35889999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
....... ......+||+.|+|||++... .++.++|||||||+||+|++|+.||...... .....+....
T Consensus 191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~ 263 (370)
T cd05621 191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHK 263 (370)
T ss_pred ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC
Confidence 6432211 122356799999999999764 3789999999999999999999999754221 1111111111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~evl~~ 368 (522)
..+ .+. ........+.+++..||+.++.+ |+++.+++++
T Consensus 264 ~~~-~~p-------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 NSL-NFP-------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccc-CCC-------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111 000 01122356778899999865544 8899999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=335.86 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=204.4
Q ss_pred hhcCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~ 164 (522)
..++|++.+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999998742 356899999864322 234568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceee
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPD------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 238 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL 238 (522)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ |+|+||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999999753221 234678889999999999999999998 999999999999999999999
Q ss_pred eeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhh
Q 009933 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 239 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~--- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFV--- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence 99999875432222111222345778999999998899999999999999999999 68888654221 111111
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
... .... .+......+.+|+.+||+.+|++||++.++++.|+
T Consensus 235 ~~~--~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 MEG--GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HcC--CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111 0111 11122356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=339.62 Aligned_cols=238 Identities=26% Similarity=0.348 Sum_probs=192.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHH-HHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVL-MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~-~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||+||+|.+..+++.||||++...... ....+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999999999999999999754221 2234445544 56789999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 999999875 467899999999999999999999999 999999999999999999999999998753221 12
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+......+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~---------- 215 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKPLRL---------- 215 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCCCCC----------
Confidence 23456799999999999999999999999999999999999999975421 11111111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIG 363 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 363 (522)
+......+.+||.+||+.||.+||++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 --KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111235678999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.43 Aligned_cols=242 Identities=28% Similarity=0.422 Sum_probs=197.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||+||+|.+..+++.||||++++... .....+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975422 2234567788888887 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999999876 457999999999999999999999999 9999999999999999999999999987532211 1
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+......
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~~~~----------- 214 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILEDEVR----------- 214 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCC-----------
Confidence 22345799999999999999999999999999999999999999975421 1111111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCH-----HHHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLI-----GDVVT 367 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~-----~evl~ 367 (522)
++......+.+||.+||+.||++||++ .+++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 112223567899999999999999999 66655
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=328.89 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=198.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+|+.++||||++++++|......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 369999999999999998899999999865432 2345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999864 2346899999999999999999999998 9999999999999999999999999987533211111111
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY 336 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 336 (522)
....+..|+|||.+.+..++.++|||||||++|||++ |..||...... ...... ... ... ..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~----~~~--~~~--------~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAI----EQG--VRL--------PC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHH----HcC--CCC--------CC
Confidence 1123457999999998899999999999999999998 88888643221 111111 000 000 11
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 337 PMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 337 ~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+......+.+|+.+||+.+|++||++.+|+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1222357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=326.40 Aligned_cols=262 Identities=23% Similarity=0.359 Sum_probs=212.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 579999999999999999999998999999999864322 22456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999999765444567899999999999999999999999 99999999999999999999999999876432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... +.......+... ....+.
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~--~~~~~~- 229 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEKC--DYPPLP- 229 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhcC--CCCCCC-
Confidence 21 112335688999999999988999999999999999999999999964421 111111111110 011110
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.......+.++|.+||..+|++||++.+|+++|+.+.
T Consensus 230 -------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 -------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0123356789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.06 Aligned_cols=241 Identities=29% Similarity=0.445 Sum_probs=194.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHh-CCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSL-LHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||.||+|.++.+++.||||+++.... .....+..|..++.. ++||||+++++++.+.+.+||||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999975421 223456677777765 4899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999999865 457899999999999999999999999 9999999999999999999999999987432211 2
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.. .+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~---~~~~~~~~----------- 214 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFE---SIRVDTPH----------- 214 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCCC-----------
Confidence 234567999999999999999999999999999999999999999754221 1111 11111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHH-HHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIG-DVV 366 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-evl 366 (522)
++......+.+|+.+||+.||++||++. +++
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 -YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1112235678999999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=323.50 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=209.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc----cch----HHHHHHHHHHHhCC-CCCcceeEEEEEcC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL----QGN----REFLVEVLMLSLLH-HSNLVNLIGYCADG 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~----~~~----~~~~~E~~~L~~l~-hpnIv~l~~~~~~~ 162 (522)
...|...++||.|..++|.++.++.+|..+|+|+|..... +.. +.-..|+.||+++. ||+|+.+.++|+..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 4568888999999999999999999999999999964321 111 33457999999985 99999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
..+++|+|.|+.|.|+|+|.. .-.+++....+|+.|++.|+.|||..+ ||||||||+|||+|++.+|||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 999999999999999999976 678999999999999999999999999 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
+++.+..+. .....||||+|+|||.+... .|+..+|+|++|||||.||.|..||..... .-..+.
T Consensus 169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------mlMLR~ 239 (411)
T KOG0599|consen 169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------MLMLRM 239 (411)
T ss_pred eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HHHHHH
Confidence 999876554 44678999999999998743 688899999999999999999999975321 111111
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
++...- ++-.+.. .+......+||.+||+.||.+|.|++|+|.+-
T Consensus 240 ImeGky---qF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 240 IMEGKY---QFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHhccc---ccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 222211 1111111 13345678999999999999999999999854
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=345.34 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=205.4
Q ss_pred hcCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCcceeEEEEEc-CC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCAD-GD 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~-~~ 163 (522)
.++|++.++||+|+||.||+|.+.. +++.||+|+++..... ....+..|+.++..+ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4579999999999999999997533 4578999999754322 234577899999999 79999999998865 45
Q ss_pred eeEEEEeecCCCChhhhhccCCCC--------------------------------------------------------
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPD-------------------------------------------------------- 187 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~-------------------------------------------------------- 187 (522)
.+++||||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999998642110
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCcccc
Q 009933 188 -KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266 (522)
Q Consensus 188 -~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 266 (522)
...+++..+..++.||+.||.|||+.+ |+||||||+||||++++.+||+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999998 9999999999999999999999999998643322221222345677899
Q ss_pred ChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHH
Q 009933 267 APEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQAL 345 (522)
Q Consensus 267 APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 345 (522)
|||++.+..++.++|||||||+||||++ |..||....... .+.. .+..... .. .+......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~--~~--------~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGTR--MR--------APEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccCC--CC--------CCccCCHHHH
Confidence 9999999999999999999999999998 999997532211 1111 1111110 00 1112235688
Q ss_pred HHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 346 AVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 346 ~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
+|+.+||+.+|++||++.+|+++|..+..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=352.09 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=206.9
Q ss_pred hcCCcccceecccCceEEEEEEECCC-----CcEEEEEEEccCCcc-chHHHHHHHHHHHhCC-CCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST-----GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~ 164 (522)
.++|.+.++||+|+||.||+|.+... +..||||++...... ..+.+.+|+.+|..+. |||||+++++|.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 56899999999999999999997432 346999999754322 2356889999999996 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC----------------------------------------------------------
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPP---------------------------------------------------------- 186 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------------- 186 (522)
.|||||||++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864210
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 009933 187 ----------------------------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE 232 (522)
Q Consensus 187 ----------------------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~ 232 (522)
....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0135788899999999999999999998 999999999999999
Q ss_pred CCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 009933 233 GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLV 311 (522)
Q Consensus 233 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~ 311 (522)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||....... .+.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence 99999999999986433222222233456788999999999899999999999999999997 999987542211 111
Q ss_pred HhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 312 AWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 312 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.. ....... ..+......+.+|+.+||+.+|++||++.+|+++|+.+.
T Consensus 351 ~~----~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NK----IKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH----HhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 10 1111000 011122356889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=335.51 Aligned_cols=263 Identities=27% Similarity=0.443 Sum_probs=210.9
Q ss_pred cCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+..........+.+|+.+++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888899999999999999863 2456799999876655555678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 009933 168 VYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~ 235 (522)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999965321 2245899999999999999999999999 999999999999999999
Q ss_pred eeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhh
Q 009933 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~ 314 (522)
++|+|||++................++..|+|||++.+..++.++|||||||++|||+| |..||....... ....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence 99999999975433222222234456889999999999999999999999999999999 999986543211 1111
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.... ..... +......+.+|+.+||+.+|++||++.+|+++|+.+...
T Consensus 238 ---~~~~-~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 ---ITQG-RVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ---HhCC-CCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111 01110 111235678999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.81 Aligned_cols=241 Identities=29% Similarity=0.434 Sum_probs=194.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHh-CCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSL-LHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
+.||+|+||+||+|.+..+++.||||+++.... .....+..|..++.. ++||||+++++++.+.+.++|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976421 223445667777775 5899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999975 356889999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.... ......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i---~~~~~~----------- 214 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSI---RMDNPC----------- 214 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCCCC-----------
Confidence 233467999999999999989999999999999999999999999754321 111111 111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHH-HHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIG-DVV 366 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-evl 366 (522)
++......+.+|+.+||+.+|++||++. +++
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1111235678999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=350.28 Aligned_cols=240 Identities=28% Similarity=0.402 Sum_probs=203.1
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
++-||.|+.|.||+|+.+ ++.||||+++. .-..+|+-|++|+||||+.|.|+|...-.+|||||||..|-|
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 456999999999999997 78999999853 123478899999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
...|+. ..+++......|..+||.|+.|||.+. |||||||.-||||..+..|||+|||.++..... ....
T Consensus 200 ~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 200 YEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 999987 678999999999999999999999998 999999999999999999999999999864322 2334
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 337 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 337 (522)
.++||..|||||++.+.+.+.|+|||||||||||||||..||.+-.... + +|... ...|.-..|
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I-----IwGVG-------sNsL~LpvP 333 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I-----IWGVG-------SNSLHLPVP 333 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e-----EEecc-------CCcccccCc
Confidence 5789999999999999999999999999999999999999997542211 1 11211 122223344
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 338 MRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 338 ~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+...|.-|++.||+..|..||++.+|+.+|...
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 45557788899999999999999999999999754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.68 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=207.2
Q ss_pred hcCCcccceecccCceEEEEEEECCC---CcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.+.||+|+||+||+|.+..+ ...||||+++..... ....+..|+.+++.++||||+++++++......++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 45799999999999999999998643 458999998754322 23568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||||++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999752 347899999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.............+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... .+.... ......+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~~- 228 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV----EDGYRLP- 228 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCCCCC-
Confidence 42222212222345678999999998899999999999999999998 99998654221 111111 1110000
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.+......+.+|+.+||+.+|++||++.+|++.|..+
T Consensus 229 ---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112235678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=328.38 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=205.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.++..++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999999989999999999765444456678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999865 457899999999999999999999998 9999999999999999999999999998643221
Q ss_pred CCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.... ..+. . . .+.
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~-----~-~---~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMS-----K-S---NFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeee-----c-C---CCC
Confidence 1122356889999999885 345788999999999999999999998644321110 0000 0 0 000
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+.+. ........+.+|+.+||+.+|++||++.+|++.|
T Consensus 228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01110 0112235788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=328.49 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=211.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.+|++.+.||.|+||.||++.+..+++.||||.+..... .....+.+|+.+++.++|+||++++++|...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468889999999999999999988899999998865322 22356788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998754444567899999999999999999999999 99999999999999999999999999876432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. .......++..|+|||++.+..++.++||||||+++|+|++|..||...... .......+. ....
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-------~~~~ 225 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-------QCDY 225 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhh-------cCCC
Confidence 22 1223456889999999999888999999999999999999999999643221 111111110 0000
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
+.+ ........+.+|+.+||+.+|++|||+.+|++++..+.
T Consensus 226 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 100 01123357889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=331.89 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=203.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCc----EEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQ----VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
++|++.+.||+|+||+||+|.+..+++ .+++|.+...... ...++..|+.++..+.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 468889999999999999999977666 4777777533221 2346777888999999999999999875 456789
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|+||+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999975 2356899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.............++..|+|||++.+..++.++|||||||++|||++ |..||....+.. +... +......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCcC--
Confidence 43332222334557789999999998899999999999999999998 999997543211 1111 1111111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..+. .....+..++.+||..+|+.||++.|+++.|..+..
T Consensus 231 -~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 -AQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -CCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 112456789999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.07 Aligned_cols=244 Identities=25% Similarity=0.331 Sum_probs=196.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||+||+|.+..+++.||||+++..... ....+..|+.++..+ +||||+.+++++...+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999764322 234577899988888 599999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence 999998865 457999999999999999999999999 999999999999999999999999998752211 12
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc-ccCCCCcCCcccc
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD-RRKFPKMADPLLQ 333 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~l~ 333 (522)
.....+||+.|+|||++.+..++.++|||||||+||+|++|..||.............+....... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------- 221 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR---------- 221 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------
Confidence 234567999999999999999999999999999999999999999754332222222222111111 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPLIG 363 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 363 (522)
++......+.+++.+||+.||++|+++.
T Consensus 222 --~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 --IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1112235677999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=340.54 Aligned_cols=239 Identities=29% Similarity=0.356 Sum_probs=194.4
Q ss_pred ceecccCceEEEEEEE---CCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 99 CLLGEGGFGRVYKGRL---ESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~---~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
+.||+|+||.||++.+ ..+++.||||++...... ....+..|+.+|..++||||++++++|.....+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999987 357899999999754322 23456789999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~ 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--E 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--C
Confidence 9999999965 457899999999999999999999999 999999999999999999999999998753222 1
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ 333 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 333 (522)
.......||+.|+|||++....++.++|||||||++|||++|+.||..... ......+......+
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~~~~--------- 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAKLGM--------- 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCCCCC---------
Confidence 223346799999999999988899999999999999999999999975422 11111111111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPLIGD 364 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e 364 (522)
+......+.+||.+||+.||++||++.+
T Consensus 218 ---p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 ---PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122356779999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=326.79 Aligned_cols=253 Identities=27% Similarity=0.345 Sum_probs=205.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-----chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-----GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-----~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
++|.+.+.||+|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999989999999998654321 22457889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||+++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999876 356889999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCCcc-eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
........ .....++..|+|||++.+..++.++|||||||++|+|++|+.||....... ..... ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~---~~~-~~~-- 225 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIFKI---ATQ-PTN-- 225 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHHHH---hcc-CCC--
Confidence 32211111 123567889999999999889999999999999999999999997542210 01000 000 000
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..++......+.+++.+||..+|.+||++.+|++.
T Consensus 226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11122233567899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.20 Aligned_cols=242 Identities=26% Similarity=0.322 Sum_probs=193.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHH-HHHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEV-LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~-~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
+.||+|+||+||+|++..+++.||+|++..... .....+..|. .+++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999975322 1123344444 457889999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence 999999975 456888999999999999999999999 999999999999999999999999998753221 11
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~----------- 214 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPLQ----------- 214 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCcC-----------
Confidence 234567999999999999999999999999999999999999999754221 111111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
++......+.+|+.+||+.+|.+||++.+.+.
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 -LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11122356789999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.97 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=206.2
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEc
Q 009933 85 FRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCAD 161 (522)
Q Consensus 85 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~ 161 (522)
+.++....++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+..|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 34445556899999999999999999999999999999999964321 223457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
...+|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999865 45888999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
|++....... .......+||+.|+|||++... .++.++|||||||++|||++|..||..... ......+
T Consensus 187 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i 259 (371)
T cd05622 187 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKI 259 (371)
T ss_pred CceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence 9998643221 1122356799999999999754 378999999999999999999999975422 1111111
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTALT 370 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~evl~~L~ 370 (522)
......+ .+.+ .......+.+||..||..++.+ |+++.+|++...
T Consensus 260 ~~~~~~~-~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 260 MNHKNSL-TFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HcCCCcc-cCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1111111 0000 1123456778999999844433 779999988653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.50 Aligned_cols=259 Identities=30% Similarity=0.455 Sum_probs=204.5
Q ss_pred cCCcccceecccCceEEEEEEEC----CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLE----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~----~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
+.|++.+.||+|+||+||+|.+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46888999999999999999863 3567899999975332 223568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 009933 168 VYEFMPLGSLEDHLHDLPP-------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF 234 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~ 234 (522)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853210 1235789999999999999999999999 99999999999999999
Q ss_pred ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHh
Q 009933 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAW 313 (522)
Q Consensus 235 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~ 313 (522)
.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...... .+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986433322222233446778999999998889999999999999999998 88898654221 11111
Q ss_pred hhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 314 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
. .... ... .+......+.+++.+||+.+|++||++.+|++.|..
T Consensus 239 ~----~~~~-~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQ-LLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCC-cCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 1111 000 111123567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=335.79 Aligned_cols=263 Identities=29% Similarity=0.423 Sum_probs=208.4
Q ss_pred hhcCCcccceecccCceEEEEEEECCC-----CcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCC
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLEST-----GQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD 163 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~ 163 (522)
..++|++.+.||+|+||.||++.+... ...+|+|.+..... .....+.+|+.++..+ +|+||++++++|....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 356789999999999999999998643 37899999875422 2234578899999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLP------------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD 231 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld 231 (522)
.+++||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ |+|+||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 9999999999999999996421 23457899999999999999999999998 99999999999999
Q ss_pred CCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchH
Q 009933 232 EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNL 310 (522)
Q Consensus 232 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~ 310 (522)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~ 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---L 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---H
Confidence 999999999999986433222222222335678999999998899999999999999999998 989986542211 1
Q ss_pred HHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 311 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.. ........ ..+......+.+|+.+||+.+|++|||+.+|++.|+.+.
T Consensus 244 ~~----~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FK----LLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH----HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 11111100 112223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=327.93 Aligned_cols=258 Identities=27% Similarity=0.387 Sum_probs=203.3
Q ss_pred CcccceecccCceEEEEEEECCC---CcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCe-----
Q 009933 95 FRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ----- 164 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~----- 164 (522)
|.+.+.||+|+||.||+|.+..+ +..||||+++..... ....+..|+.+|+.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999998653 478999999754322 23568899999999999999999998876554
Q ss_pred -eEEEEeecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 165 -RLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 165 -~~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
.++||||+++++|..++.... .....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999985432 22346899999999999999999999998 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||...... .+..+. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~---~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL---RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcC
Confidence 99986533322211222335678999999988899999999999999999999 88888654321 111111 111
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.. . ..+......+.+++.+||+.||++||++.+|++.|+.+
T Consensus 232 -~~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 -NR-L---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -CC-C---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0 01122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.61 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=205.6
Q ss_pred CCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... .....+..|+.+|+.++||||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999999743 235799998875432 223568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009933 168 VYEFMPLGSLEDHLHDLPP--------------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 227 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~N 227 (522)
||||+.+++|.+++..... ....+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999864211 1245889999999999999999999998 9999999999
Q ss_pred eeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 009933 228 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPG 306 (522)
Q Consensus 228 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~ 306 (522)
|||++++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999975432222111223345778999999988889999999999999999998 99999654321
Q ss_pred cchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 307 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.+..+. ..... ...+......+.+|+.+||+.+|++||++.+|++.|+.+.
T Consensus 237 --~~~~~~----~~~~~----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 --RLFNLL----KTGYR----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --HHHHHH----hCCCC----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111111 11000 0111223357889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.13 Aligned_cols=264 Identities=24% Similarity=0.359 Sum_probs=203.0
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-----eeE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-----QRL 166 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-----~~~ 166 (522)
+|++.+.||+|+||+||++.+..+++.||||++.... ......+.+|+.+|+.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4888999999999999999999899999999986432 223456789999999999999999999998776 789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 588888754 467999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh-----------
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA----------- 314 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~----------- 314 (522)
...... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+......+...
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 433221 122345688999999999874 5899999999999999999999999765432211111100
Q ss_pred -----hh-hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 315 -----RP-LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 315 -----~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.. +.......+. ..... .........+.+||.+||+.||++||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 232 ACEGARAHILRGPHKPPS-LPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred hhHHHHHHHHhCCCCCCc-hHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00 0000000000 00000 01112245788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.83 Aligned_cols=259 Identities=28% Similarity=0.426 Sum_probs=207.0
Q ss_pred hcCCcccceecccCceEEEEEEECCC-----CcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST-----GQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|.+.+.||+|+||.||++.+... +..||+|.+..... .....+.+|+.+|..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46799999999999999999998643 47899999865432 3345688899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPD------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~ 239 (522)
++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999753321 234788999999999999999999998 9999999999999999999999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
|||+++...............++..|+|||.+....++.++|||||||++|||++ |..||...... ....+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHh---
Confidence 9999875433322222233456789999999998899999999999999999998 89998653221 1121111
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
... ... .+......+.+|+.+||+.+|++|||+.+|++.|+
T Consensus 236 -~~~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGG-HLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCC-CCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 110 011 11122457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=325.92 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=205.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||.||+|.+.. ++.||||.++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4679999999999999999999864 6789999997544 2356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||++.......
T Consensus 83 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999762 2356899999999999999999999999 9999999999999999999999999998754211
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.. .......+..|+|||++....++.++|||||||++|||++ |+.||...... .+.... ......
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~------ 223 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQV----DQGYRM------ 223 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCCCC------
Confidence 11 1111223457999999998899999999999999999999 99999654221 111111 110000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+......+.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 ----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01112335788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=330.70 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=207.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCC----------------cEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcce
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTG----------------QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVN 154 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g----------------~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~ 154 (522)
..+|++.+.||+|+||.||+|.+..++ ..||+|++...... ....+..|+.+|..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457999999999999999999886533 56899998765332 3456888999999999999999
Q ss_pred eEEEEEcCCeeEEEEeecCCCChhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009933 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 227 (522)
Q Consensus 155 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~N 227 (522)
++++|..+...++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976321 1236899999999999999999999998 9999999999
Q ss_pred eeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCC
Q 009933 228 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT--GRKAIDNTRPP 305 (522)
Q Consensus 228 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt--G~~Pf~~~~~~ 305 (522)
||++.++.++|+|||++................+++.|+|||++....++.++|||||||++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986433332222334556789999999998899999999999999999998 6677754321
Q ss_pred CcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 306 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
..........+......... ..+......+.+|+.+||+.||++||++.+|++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11222221111111100000 011122357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=330.65 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=204.5
Q ss_pred hcCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999976 6788999998654322 234688899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---ceeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPP---DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF---HPKLS 239 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~---~vkL~ 239 (522)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999975321 1235899999999999999999999998 99999999999998654 59999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...... .+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~---~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFV---T 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---H
Confidence 9999986422211111112234568999999999899999999999999999997 99999754321 111111 1
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.. .. ..++......+.+|+.+||+.+|++||++.+|++.|+
T Consensus 236 ~~-~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GG-GR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cC-Cc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 00 0111222357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=337.35 Aligned_cols=242 Identities=26% Similarity=0.390 Sum_probs=196.9
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~ 169 (522)
+|+..++||+|+||+||+|.+..+++.||||++..... .....+..|+.++..+. |++|+++++++...+.+||||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47888999999999999999999999999999975422 22345677888888886 577888999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999865 467999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+. ..+......
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~---~~i~~~~~~------ 219 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELF---QSIMEHNVS------ 219 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCCCC------
Confidence 11 122345699999999999998999999999999999999999999975432 1111 111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 362 (522)
++......+.+|+.+||+.+|.+|++.
T Consensus 220 ------~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ------YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 122233567899999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.54 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=199.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||+||+|.+..+++.||||++.... ......+..|+.++..++||||++++++|.+.+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46899999999999999999999999999999997532 122356778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999975 467899999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCC---------------------------------cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCC
Q 009933 250 GDKT---------------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296 (522)
Q Consensus 250 ~~~~---------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~ 296 (522)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC---HHHHHH
Q 009933 297 KAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL---IGDVVT 367 (522)
Q Consensus 297 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~~evl~ 367 (522)
.||....+... ...+......+ .+.+. ......+.+||.+|+. +|.+|++ +.+|++
T Consensus 234 ~Pf~~~~~~~~------~~~i~~~~~~~--~~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQET------YRKVMNWKETL--VFPPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHH------HHHHHcCCCce--ecCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99976533211 11111100000 00100 0123466778888764 9999996 455544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=336.12 Aligned_cols=238 Identities=26% Similarity=0.340 Sum_probs=191.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHH-HHHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEV-LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~-~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||.||+|++..+++.||||++.+.... ....+..|. .+++.++||||++++++|.+.+..||||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999754221 223344554 467889999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999988865 456889999999999999999999999 999999999999999999999999998753221 12
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~------------ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHKPL------------ 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcCCC------------
Confidence 23446799999999999998999999999999999999999999975421 111111111111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIG 363 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 363 (522)
.++......+.+++.+||+.+|.+||+..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11222345788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=331.24 Aligned_cols=251 Identities=34% Similarity=0.543 Sum_probs=195.2
Q ss_pred ccceecccCceEEEEEEEC----CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 97 PECLLGEGGFGRVYKGRLE----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 97 ~~~~LG~G~fG~Vy~~~~~----~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+.+.||.|.||.||+|.+. ..+..|+||.++.... .....+.+|+.+|++++||||++++++|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999997 4467899999965332 2357889999999999999999999999988889999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++|+|.++|... ....+++..++.|+.||+.||.|||+.+ |+|++|+++||||++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999872 3467999999999999999999999998 9999999999999999999999999998753222
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.............|+|||++....++.++||||||+++|||++ |+.||..... .. ....+ ...... .
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~---~~~~~-~~~~~~-~---- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EE---IIEKL-KQGQRL-P---- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HH---HHHHH-HTTEET-T----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc---ccccc-cccccc-e----
Confidence 2222233456789999999999999999999999999999999 6788765411 11 11111 111111 0
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+......+.+||..||..+|++||++.+|++.|
T Consensus 226 -----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111235677999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.27 Aligned_cols=242 Identities=28% Similarity=0.354 Sum_probs=205.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHH---HHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~---~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
-++|..+++||+|.||+|.+|+.+.+++.||||++++..+....+ -+.|-.+|+..+||++..|...|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467999999999999999999999999999999998876554443 45688999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||..||.|+-+|.. ...+++..++.+-..|+.||.|||+.+ ||+||||.+|+|||.+|+|||+|||+++...
T Consensus 247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999976 578999999999999999999999998 9999999999999999999999999998632
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.......++||||.|+|||++....|+.++|+|.+||+||||++|+.||.+..... ...-++.....
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k------LFeLIl~ed~k----- 386 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK------LFELILMEDLK----- 386 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH------HHHHHHhhhcc-----
Confidence 22334567999999999999999999999999999999999999999997542211 11111112122
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCC
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP 360 (522)
+|.....+...|+...|..||++|.
T Consensus 387 -------FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 -------FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -------CCccCCHHHHHHHHHHhhcChHhhc
Confidence 3333445677899999999999996
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=326.73 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=205.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.++||+|+||.||+|.+. ++..||+|.+..... ..+.+..|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 467999999999999999999976 467899999865432 356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999999752 2456888999999999999999999998 9999999999999999999999999998643221
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.. ......++..|+|||++....++.++|||||||++|+|++ |..||...... ....... ..... +
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~~-----~ 224 (261)
T cd05072 158 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQ----RGYRM-----P 224 (261)
T ss_pred ee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHH----cCCCC-----C
Confidence 11 1122345678999999998899999999999999999998 99999653221 1111111 10000 1
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.. ......+.+|+.+||..+|++||++.+|++.|+.+
T Consensus 225 ~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 RM-----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CC-----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00 11224678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=327.03 Aligned_cols=258 Identities=27% Similarity=0.375 Sum_probs=199.8
Q ss_pred CcccceecccCceEEEEEEECCCCc--EEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC------Ce
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQ--VVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------DQ 164 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~--~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------~~ 164 (522)
|.+.++||+|+||.||+|.+..++. .||||.++... ....+.+..|+.+|+.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999977665 69999986542 22345678899999999999999999987532 24
Q ss_pred eEEEEeecCCCChhhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 165 RLLVYEFMPLGSLEDHLHDL--PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
.++||||+.+++|.+++... ......+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987421 122345899999999999999999999998 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
++................+++.|+|||++....++.++|||||||++|||++ |..||...... .+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~----~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYL----RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HcC
Confidence 9986433222111122345778999999999899999999999999999999 78888653221 111111 111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
... . .+......+.+||.+||+.+|++||++.+|++.|+.+
T Consensus 231 ~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL-K---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC-C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 0 1112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=331.46 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=204.3
Q ss_pred cCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.+|++.+.||+|+||.||+|.+.. .+..||||+++...... ...+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 347888999999999999999754 35789999997543222 356788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 009933 167 LVYEFMPLGSLEDHLHDLP------------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF 234 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~ 234 (522)
+++||+.+++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985311 11245888999999999999999999999 99999999999999999
Q ss_pred ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHh
Q 009933 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAW 313 (522)
Q Consensus 235 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~ 313 (522)
.+||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||..... ..+...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEM 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999886433322222233456789999999998899999999999999999998 7788865322 111111
Q ss_pred hhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 314 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
. .... .. .++......+.+|+..||+.+|++||++.+|+..|+.
T Consensus 239 i---~~~~--~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 I---RNRQ--VL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H---HcCC--cC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 1110 00 1122233567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=331.54 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=208.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
..+|++.+.||.|+||.||++.+..+++.||||.+..........+.+|+.+++.+.|+||++++++|......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35799999999999999999999889999999999876666667788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999864 45889999999999999999999999 9999999999999999999999999987533221
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+... +..+ .... ....
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~----~~~~--~~~~---- 236 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLI----ATNG--TPEL---- 236 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHH----hcCC--CCCC----
Confidence 112335688999999999988899999999999999999999999975432111 1100 0000 0000
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+......+.+|+.+||..+|++||++.+|+..
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0112223567889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.40 Aligned_cols=241 Identities=26% Similarity=0.336 Sum_probs=193.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHH-HHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVL-MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~-~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||+||+|.+..+++.||||++..... .....+..|.. +++.++||||++++++|...+..||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999965421 22234455554 57789999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999998865 467899999999999999999999999 999999999999999999999999998753221 11
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~~----~------- 214 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKPL----V------- 214 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCCc----c-------
Confidence 234567999999999999999999999999999999999999999754221 11111111110 0
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 366 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl 366 (522)
.+......+.+++.+||+.+|.+||++.+.+
T Consensus 215 -~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 215 -LRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 1112235677999999999999999886443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=328.46 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=204.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCc----EEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQ----VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
..+|++.++||+|+||+||+|.+..++. .||||++...... ....+..|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 4578999999999999999999876666 4899998654322 34568889999999999999999999975 4578
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
++|||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999752 356899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+..+.. .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE----KGERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CCCcCC
Confidence 543222111122234678999999998899999999999999999998 88998654221 1111111 111100
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
.+......+.+++.+||+.||+.||++.+++..|..+..
T Consensus 232 ----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 232 ----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011223567899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=367.02 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=203.2
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEc--CCee
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQR 165 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~ 165 (522)
....+|++.+.||+|+||+||+|.+..++..||+|++...... ....+..|+.+|..|+|||||+++++|.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3457899999999999999999999999999999999754332 23568889999999999999999998855 3578
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCceeecC---------
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN----PPVIYRDLKSSNILLDE--------- 232 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~----~~iiHrDLKp~NILld~--------- 232 (522)
||||||+.+++|.++|.........+++..++.|+.||+.||.|||+.+. .+|||+||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997644445679999999999999999999998431 23999999999999964
Q ss_pred --------CCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 009933 233 --------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDNT 302 (522)
Q Consensus 233 --------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLltG~~Pf~~~ 302 (522)
...+||+|||++....... .....+||+.|+|||++.. ..++.++||||||||||||+||..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3358999999998643221 2234579999999999864 45889999999999999999999999643
Q ss_pred CCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 303 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.. ....... +... +.+. + ......+.+||..||+.+|.+||++.++|.
T Consensus 247 ~~-----~~qli~~-lk~~---p~lp---i-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-----FSQLISE-LKRG---PDLP---I-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-----HHHHHHH-HhcC---CCCC---c-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 22 1111111 1111 1100 0 012356889999999999999999999985
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.55 Aligned_cols=265 Identities=21% Similarity=0.224 Sum_probs=203.6
Q ss_pred hcCCcccceecccCceEEEEEEEC--CCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE--STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
..+|.+.+.||+|+||.||+|... .++..||||.+... ....+|+.+|+.++|||||+++++|......|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999864 34678999988543 33567999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|++. ++|.+++.. ...+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++.....
T Consensus 166 e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9995 589888844 467999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc-ccCCCCc-
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD-RRKFPKM- 327 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~- 327 (522)
...........||+.|+|||++....|+.++|||||||+||||++|+.||...........+..+...+.. ...++..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 33322334567999999999999999999999999999999999999999765443222111111110000 0000000
Q ss_pred ----------CCccccCCCC-------hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 328 ----------ADPLLQGRYP-------MRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 328 ----------~d~~l~~~~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
........+. ......+.++|.+||+.||++||++.+++.+=
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000000 01124677899999999999999999998864
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=324.74 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=201.7
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
++|++.+.||+|+||.||++.++. +..+|+|.+.... .....+..|+.+|+.++||||++++++|......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 468889999999999999999864 5689999986543 23467888999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999998752 246899999999999999999999999 99999999999999999999999999875422211
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
. ......++..|+|||++....++.++||||||+++|||++ |+.||..... ........ .. . ....+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~---~~-~---~~~~~- 223 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMIS---RG-F---RLYRP- 223 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH---CC-C---CCCCC-
Confidence 1 1112235668999999998899999999999999999999 8999865422 11121111 11 0 00111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
......+.+|+.+||+.+|++||++.+|++.|
T Consensus 224 ------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 ------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11224678999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=327.73 Aligned_cols=271 Identities=28% Similarity=0.413 Sum_probs=205.0
Q ss_pred cCC-cccceecccCceEEEEEEE----CCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcC--Ce
Q 009933 93 KNF-RPECLLGEGGFGRVYKGRL----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQ 164 (522)
Q Consensus 93 ~~y-~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~ 164 (522)
++| ++.+.||+|+||+||++.. ..++..||+|++..... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8889999999999988653 34678999999976532 2345678899999999999999999988653 46
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.++||||+.+++|.+++.. ..+++.+++.++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence 8999999999999999965 45999999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 245 KLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 245 ~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
.......... ......++..|+|||++....++.++|||||||++|||++|..||...... .............. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~ 232 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTV-VR 232 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccch-hh
Confidence 8654322111 112234567799999999889999999999999999999999998653221 01111111000000 00
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
+...++.......+......+.+|+..||+.+|++||++.+|++.|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 01111111111122233467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=327.91 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=197.1
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
||+|+||.||++.++.+++.||+|++...... ....+..|+++|+.++||||+++++++....+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999653322 223456799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 9988652 2345889999999999999999999999 9999999999999999999999999998643221 223
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 337 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 337 (522)
...|+..|+|||++.+..++.++|||||||++|||++|+.||........ ............ + ... .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~--~-~~~----~---- 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE--V-KFE----H---- 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc--c-ccc----c----
Confidence 45689999999999988999999999999999999999999975432111 111111111110 0 000 0
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 338 MRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 338 ~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
......+.+|+..||+.||++||++.|+++.+
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 11234678999999999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=324.31 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=204.0
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchH--HHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR--EFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~--~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
|++.+.||+|+||+||++.+..+++.||+|++......... ....|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67889999999999999999999999999999876544332 2356999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.+++|.+++.. ...+++..++.++.||+.||.+||+.+ |+|+||||+|||++.++.++|+|||++... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 99999999973 467899999999999999999999999 999999999999999999999999999853 112
Q ss_pred CcceecccCCccccChhhhh-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 THVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~-~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
........++..|+|||++. ...++.++||||||+++|+|++|..||...... +............ .....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~-----~~~~~ 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKRP-----LPSSS 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHTH-----HHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhccccc-----ccccc
Confidence 22334567899999999998 788999999999999999999999999865111 1111111100000 00000
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
. ........+.+|+..||+.||++||++.++++
T Consensus 224 ~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 Q---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp T---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00001267889999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=329.10 Aligned_cols=265 Identities=24% Similarity=0.381 Sum_probs=202.5
Q ss_pred cCCcccceecccCceEEEEEEECCC--------------CcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLEST--------------GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIG 157 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~--------------g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~ 157 (522)
.+|++.+.||+|+||.||+|.+..+ ...||||+++..... ....+.+|+++|..++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987543 235899999754322 2346889999999999999999999
Q ss_pred EEEcCCeeEEEEeecCCCChhhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 009933 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPP--------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 229 (522)
Q Consensus 158 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NIL 229 (522)
++......++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999864211 1124788999999999999999999999 999999999999
Q ss_pred ecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCCc
Q 009933 230 LDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT--GRKAIDNTRPPGE 307 (522)
Q Consensus 230 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt--G~~Pf~~~~~~~~ 307 (522)
+++++.+||+|||++................++..|+|||++....++.++|||||||++|+|++ +..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 99999999999999976433222222223345778999999998899999999999999999998 5567654322
Q ss_pred chHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 308 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
...+......+.......... .+......+.+||.+||+.+|++||++.+|++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111111100000000 01112357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=333.63 Aligned_cols=266 Identities=25% Similarity=0.377 Sum_probs=203.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|.+.+.||+|+||.||+|++..+++.||||+++..... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5799999999999999999999999999999999754322 234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 888888652 345889999999999999999999999 9999999999999999999999999997533222
Q ss_pred CCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh--------hhhhccc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR--------PLFKDRR 322 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~ 322 (522)
.......+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||................ +.+....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12233467899999999875 468999999999999999999999997654322211111000 0000000
Q ss_pred -----CCCCcC-CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 323 -----KFPKMA-DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 323 -----~~~~~~-d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.++... .+.+. ........+.+||.+||+.||.+|||+.|++..-
T Consensus 237 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 237 EFKNYNFPKYKPQPLIN--HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhhcCccCCCchhh--hccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 000000 00000 0011234678999999999999999999998843
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=319.34 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=208.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++-+.||+|.|+.||++.+..+|+.+|+|+|.... ..+.+++.+|+.|-+.|+|||||+|.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 567899999999999999999999999999999986543 235678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCceeeeeecceee
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKL 246 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld---~~~~vkL~DFGla~~ 246 (522)
|+|.|++|..-|-. ...+++..+-.+++||+.+|.|+|.++ |||||+||+|+||- ..--+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999877754 366888899999999999999999999 99999999999993 445699999999997
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.. ........+|||+|||||++...+|+..+|||+.|||||-||.|..||.+.... .....+......++.
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~------rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYEQIKAGAYDYPS 233 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH------HHHHHHhccccCCCC
Confidence 65 233445678999999999999999999999999999999999999999864221 111112222111111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
+.. ........+|+.+||..||++|.|+.|.|..-
T Consensus 234 ---~~w-----~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 234 ---PEW-----DTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred ---ccc-----CcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 111 11235677999999999999999999987643
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=325.21 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=205.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCc---EEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQ---VVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|+..++||+|+||.||+|.+..++. .+|||.++.... ...+.+..|+.++..++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578889999999999999999976554 799999875432 234568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999865 2356899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCCcce-ecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 248 PVGDKTHVS-TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 248 ~~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
......... .....+..|+|||++....++.++|||||||++|||++ |..||...... ...... ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~i----~~~~~~~ 230 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKAI----NDGFRLP 230 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHH----hcCCCCC
Confidence 332211111 11223457999999998899999999999999999997 99999643221 111111 1111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.+......+.+|+.+||+.+|++||++.+|++.|..+
T Consensus 231 ----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112335678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.08 Aligned_cols=264 Identities=21% Similarity=0.223 Sum_probs=200.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.|+|+|||++++++......+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3479999999999999999999999999999996432 3456899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+. ++|.+++... ...+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 6898888652 347999999999999999999999999 9999999999999999999999999998653322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-CC----cchHHHhhhhhhhcccCCCC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP-PG----EHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~-~~----~~~~~~~~~~~~~~~~~~~~ 326 (522)
.........||+.|+|||++.+..++.++||||||||||||++|..++..... .. ...+...+.........+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 22223346799999999999999999999999999999999998876543221 11 11111111110000000110
Q ss_pred cCCc------------cccCCCCh-------HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 327 MADP------------LLQGRYPM-------RGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 327 ~~d~------------~l~~~~~~-------~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.... .....+.. .....+.+||.+||+.||.+|||+.|||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 00000000 112357789999999999999999999875
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=323.22 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=205.0
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
+|++.+.||+|+||.||++.+..+++.||+|.++... ....+.+..|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5888999999999999999999999999999986532 233456788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 999999988642 2456889999999999999999999999 9999999999999999999999999998643221
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ......+... ....
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~--~~~~------ 219 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQG--SYKP------ 219 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcC--CCCC------
Confidence 122345689999999999988999999999999999999999999975321 1111111111 0110
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.+|+.+||+.||++||++.+|+..
T Consensus 220 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=334.25 Aligned_cols=264 Identities=27% Similarity=0.390 Sum_probs=206.8
Q ss_pred cCCcccceecccCceEEEEEEECC-------CCcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCC
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLES-------TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD 163 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~ 163 (522)
++|.+.+.||+|+||.||++.+.. +...+|+|.++.... .....+..|+.++..+ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 569999999999999999998743 235799999975432 2335678899999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD 231 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld 231 (522)
..|+||||+.+++|.+++..... ....+++.+++.++.||+.||+|||+.+ |+|+||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999975321 1235889999999999999999999998 99999999999999
Q ss_pred CCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchH
Q 009933 232 EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNL 310 (522)
Q Consensus 232 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~ 310 (522)
.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence 999999999999875432221111222234568999999998899999999999999999998 8888864321
Q ss_pred HHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 311 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
......+ ..... . ..+......+.+|+.+||+.+|.+||++.+|++.|..+....
T Consensus 249 ~~~~~~~-~~~~~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 EELFKLL-KEGHR-M---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHH-HcCCC-C---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 11100 0 111223357788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=326.06 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=205.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|.+.+.||+|+||.||+|.+..+++.||||+++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35788999999999999999999989999999999766544455678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT- 159 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence 999999999865 457899999999999999999999999 999999999999999999999999998764321
Q ss_pred CCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
........|+..|+|||++. ...++.++|||||||++|+|++|..||....+.... .... ... ..
T Consensus 160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~~~----~~~-----~~ 227 (267)
T cd06645 160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMT----KSN-----FQ 227 (267)
T ss_pred -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hhhh----ccC-----CC
Confidence 11223457899999999985 456889999999999999999999998654332111 0000 000 00
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.+.. .......+.++|.+||+.+|++||++.+|+++
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 011110 00122457899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=327.91 Aligned_cols=253 Identities=29% Similarity=0.417 Sum_probs=203.7
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.|++.++||+|+||.||++.+..+++.||||.+....... ...+..|+.+++.++|+||+.+++++.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999999999999999987543322 2346789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999998642 2346899999999999999999999998 999999999999999999999999999764322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............. ..... .. .
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~---~~----~ 222 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE---VQ----E 222 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh---hh----h
Confidence 2 1223468999999999999899999999999999999999999997543221111110 00000 00 0
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~ 368 (522)
.++......+.+|+..||+.||++||+ +.+++++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111222356789999999999999999 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=338.98 Aligned_cols=266 Identities=23% Similarity=0.290 Sum_probs=200.9
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-----
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD----- 163 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~----- 163 (522)
..++|++.+.||+|+||.||++.+..+++.||||++.... ......+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999999999999999996542 223456788999999999999999999986543
Q ss_pred -eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 164 -QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 164 -~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
.+|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999975 67776642 4788999999999999999999999 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc------------hH
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH------------NL 310 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~------------~~ 310 (522)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+
T Consensus 169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 99753221 1223457899999999999999999999999999999999999999754321100 00
Q ss_pred HH----hhhhhhhcccCCC-----CcCCcccc---CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 311 VA----WARPLFKDRRKFP-----KMADPLLQ---GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 311 ~~----~~~~~~~~~~~~~-----~~~d~~l~---~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.. ............. ......+. ..........+.+||.+||+.||++|||+.|++..-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00 0000011100000 00000000 000111235678999999999999999999998854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.83 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=201.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|++.++||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|..++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 368889999999999999999999999999999975432 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|..+. .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999986542 4678889999999999999999999 999999999999999999999999999754221
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH-NLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.....+||..|+|||++.+..++.++|||||||++|+|++|+.||......... ............. ...+
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~--- 220 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVL--- 220 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCC---
Confidence 223457899999999999889999999999999999999999999753322111 1111111111110 0000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
. .......+.+|+.+||+.+|++||++.+++...
T Consensus 221 -~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 -P----VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred -C----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0 111234678999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=345.37 Aligned_cols=245 Identities=27% Similarity=0.408 Sum_probs=206.6
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCChhh
Q 009933 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED 179 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ 179 (522)
+||+|+||+||.|++..|...+|||.|........+-+..|+.+.+.|+|.|||+++|.|.+++++-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999999999999999987666666778899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCceeeeeecceeeCCCCCCCcce
Q 009933 180 HLHDLPPDKEPL--DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVS 256 (522)
Q Consensus 180 ~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~ 256 (522)
+|.. .=+++ .+..+-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||.++.+... ....
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~T 733 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCT 733 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Cccc
Confidence 9976 23566 78888999999999999999999 99999999999995 5789999999999875332 2344
Q ss_pred ecccCCccccChhhhhcC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 257 TRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 257 ~~~~gt~~y~APE~l~~~--~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.++.||..|||||++..+ .|+.++|||||||++.||.||++||-....+... .++. .+.+ ...
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkV--GmyK-----vHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKV--GMYK-----VHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhh--ccee-----cCC
Confidence 567899999999999876 6999999999999999999999999755433211 0110 0111 112
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
..|.+...++..+|.+|+.+||.+||++.++|.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 345566678889999999999999999999986
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=327.55 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=196.5
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhC---CCCCcceeEEEEEc-----CC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLL---HHSNLVNLIGYCAD-----GD 163 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l---~hpnIv~l~~~~~~-----~~ 163 (522)
+|++.+.||+|+||+||+|.+..+++.||||.++...... ...+.+|+.+++.+ +||||++++++|.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999999999999999997543221 23456677776655 69999999998864 34
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
..++||||+.+ +|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999975 898888652 2345899999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch-HHHhhhhh----h
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN-LVAWARPL----F 318 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~-~~~~~~~~----~ 318 (522)
+....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.......... +....... +
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98643221 2234568999999999999899999999999999999999999996543221111 11110000 0
Q ss_pred hcccCC-CCcCCcccc---CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 319 KDRRKF-PKMADPLLQ---GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 319 ~~~~~~-~~~~d~~l~---~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.....+ .....+... ..........+.+|+.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 000000000 0001122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=331.40 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=203.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCc--EEEEEEEccCC-ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQ--VVAVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~--~vAvK~i~~~~-~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV 168 (522)
++|++.++||+|+||.||+|.+..++. .+++|.++... ....+.+..|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999977664 46888886422 22345688899999999 799999999999999999999
Q ss_pred EeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCce
Q 009933 169 YEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
|||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ |+|+||||+||||++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965221 1235889999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhh
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 315 (522)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||...... .+..
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~--- 229 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYE--- 229 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---
Confidence 999999986421110 1111223457999999998899999999999999999997 99999654321 1111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.+... . .. ..+......+.+|+.+||+.+|.+||++.+|++.|..+....
T Consensus 230 ~~~~~---~----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KLPQG---Y----RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHhcC---C----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11110 0 00 011122356789999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.90 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=206.1
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|.+.+.||+|+||.||+|.+..+++.|++|.+..... .....+..|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 47888999999999999999999999999999875432 2345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999762 2457899999999999999999999998 9999999999999999999999999988643322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... ... ...+.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~---~~~--~~~~~----- 220 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILK---IIR--GVFPP----- 220 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---HHc--CCCCC-----
Confidence 122345688999999999998999999999999999999999999975431 111111 111 01111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.+++.+||+.+|++||++.+|++.
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 ----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=329.52 Aligned_cols=265 Identities=25% Similarity=0.423 Sum_probs=203.5
Q ss_pred cCCcccceecccCceEEEEEEECC----------------CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCccee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLES----------------TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNL 155 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~----------------~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l 155 (522)
++|++.+.||+|+||.||++.+.. +...||||++...... ....+..|+.+|+.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 569999999999999999986532 3457999999754322 33578899999999999999999
Q ss_pred EEEEEcCCeeEEEEeecCCCChhhhhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 009933 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNI 228 (522)
Q Consensus 156 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NI 228 (522)
++++...+..++||||+.+++|.+++...... ...+++..+..++.||+.||.|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999999763221 134788899999999999999999999 99999999999
Q ss_pred eecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 009933 229 LLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT--GRKAIDNTRPPG 306 (522)
Q Consensus 229 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt--G~~Pf~~~~~~~ 306 (522)
|++.++.++|+|||++................+++.|++||+.....++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999975433222112223345678999999988899999999999999999998 667886443211
Q ss_pred cchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 307 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.+......+..... ....+ .+......+.+|+.+||+.||++||++.+|++.|+
T Consensus 242 ---~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 ---VIENTGEFFRDQGR--QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHhhccc--cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111111100 00000 11122357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=332.11 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=205.8
Q ss_pred hcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~ 164 (522)
.++|.+.+.||+|+||.||++.+ ..++..||||+++.... ...+.+.+|+.+++.+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 45799999999999999999986 23456899999875432 2235688999999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.++||||+.+++|.+++... ....+++.+++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999752 2234899999999999999999999998 999999999999999999999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
................++..|+|||++....++.++|||||||++|||++ |..||....... ...... .....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~~~----~~~~~ 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYKLI----KEGYR 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHHHH----HcCCc
Confidence 86433221111223346778999999999899999999999999999998 999987543211 111111 11100
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
. ..+......+.+|+.+||..+|++||++.+|++.|..+
T Consensus 263 --~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 --M--------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --C--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 01111235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=336.47 Aligned_cols=256 Identities=23% Similarity=0.273 Sum_probs=198.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||+||++.+..+++.||||++.+... .....+..|+.++..++|+||+.++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 479999999999999999999999999999999965321 22345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999652 356899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCcceecccCCccccChhhhhc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
... ......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||..... ......+......+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~ 227 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHF 227 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence 221 12233569999999999973 4578899999999999999999999975322 11111111111100
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcC--CCCCHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA--TRPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~--~RPs~~evl~~ 368 (522)
.+ .+. .......+.+|+.+||..+++ .|+++.++++.
T Consensus 228 -~~-~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 -QF-PPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -cC-CCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 000 011234667788887765443 37899888876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=327.77 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=208.7
Q ss_pred hcCCcccceecccCceEEEEEEECC----CCcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEc-CCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES----TGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~----~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-~~~~ 165 (522)
.++|++.++||+|+||.||+|.+.. ++..|++|++.... ......+.+|+.+|+.++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5689999999999999999999875 35889999986432 2234567889999999999999999998766 4678
Q ss_pred EEEEeecCCCChhhhhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPD----KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
++++||+.+++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999764322 156899999999999999999999998 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....+. .+..+.. .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK----D 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH----c
Confidence 99985433222222223446778999999998899999999999999999999 99999754321 1222111 1
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
...+. . +......+.+++.+||+.+|++||++.+|+..|+.+..
T Consensus 235 ~~~~~---~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYRLA---Q-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCC---C-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11100 0 11122467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=327.76 Aligned_cols=265 Identities=30% Similarity=0.434 Sum_probs=203.7
Q ss_pred hcCCcccceecccCceEEEEEEE----CCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc--CCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~ 165 (522)
.++|++.+.||+|+||.||++.. ..++..||||++..........+.+|+.+|+.++||||+++++++.. ...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35789999999999999999984 45688999999976654555678899999999999999999998754 3468
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||||++++.+||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 9999999999999999652 346899999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCCcc-eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc---------hHHHhhh
Q 009933 246 LGPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH---------NLVAWAR 315 (522)
Q Consensus 246 ~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~---------~~~~~~~ 315 (522)
.......... .....++..|+|||++.+..++.++|||||||++|||++|..++......... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 6543222111 11122345699999999889999999999999999999988765432110000 0000000
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
........+ ..+......+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011110000 01122335788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=331.68 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=208.4
Q ss_pred hcCCcccceecccCceEEEEEEEC-------CCCcEEEEEEEccCC-ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE-------STGQVVAVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~ 162 (522)
..+|.+.+.||+|+||.||+|++. .++..||+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 567889999999999999999852 234579999986542 23345688999999999 799999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
...++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999975321 1245888999999999999999999999 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~ 309 (522)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999986543322222233446778999999998899999999999999999998 7888864321
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+...+ ...... ..+......+.+|+.+||+.+|.+||++.+|++.|..+..-
T Consensus 246 -~~~~~~~-~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 -EELFKLL-KEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHHHHH-HcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 111100 01122345788899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.13 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=207.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||.|+||.||++.+..+++.||||.+........+.+..|+.+++.++|+||++++++|......++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999999889999999999876555567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.. ..+++.++..++.|++.+|.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999865 46889999999999999999999998 9999999999999999999999999987643222
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+...... ..... .+..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~--~~~~---- 235 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--TPEL---- 235 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC--CCCC----
Confidence 1 12345688999999999988899999999999999999999999965433111000 00000 0000
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+......+.+|+.+||+.+|++||++.+|+..
T Consensus 236 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 ---QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223457789999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=339.59 Aligned_cols=265 Identities=23% Similarity=0.278 Sum_probs=201.0
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcC------
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG------ 162 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------ 162 (522)
..++|++.+.||+|+||.||++.+..+++.||||++..... .....+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999999998999999999975422 2335677899999999999999999988654
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
...|+||||+.+ +|.+++.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 67777643 4788999999999999999999999 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH-H---------
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-A--------- 312 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~-~--------- 312 (522)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99853221 1223457899999999999989999999999999999999999999754321110000 0
Q ss_pred ------hhhhhhhcccCCCCc-----C-Ccccc--CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 313 ------WARPLFKDRRKFPKM-----A-DPLLQ--GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 313 ------~~~~~~~~~~~~~~~-----~-d~~l~--~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..............+ . +.... ..........+.+||.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000110000000 0 00000 00111223567899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.09 Aligned_cols=268 Identities=22% Similarity=0.280 Sum_probs=206.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|++.+.||+|+||.||++.+..++..||+|.+...... ....+.+|++++..++||||++++++|...+.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3689999999999999999999999999999998754222 234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999976 3668999999999999999999998 46 999999999999999999999999998753221
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC------
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF------ 324 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 324 (522)
......++..|+|||++.+..++.++|||||||++|+|++|+.||.........................
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 1234568999999999988889999999999999999999999996443211111110000000000000
Q ss_pred ----------CCcCCcccc---CCCCh-HHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 325 ----------PKMADPLLQ---GRYPM-RGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 325 ----------~~~~d~~l~---~~~~~-~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
....+.... ...+. .....+.+|+.+||+.+|++||++.+|+.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 000000000 00000 123468899999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=328.11 Aligned_cols=258 Identities=28% Similarity=0.474 Sum_probs=205.0
Q ss_pred cCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.+|...++||+|+||.||++... .++..+|+|.+..........+.+|+.+++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56888899999999999999753 3467899999876554555678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCce
Q 009933 168 VYEFMPLGSLEDHLHDLPP-----------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999975321 1135889999999999999999999999 9999999999999999999
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhh
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 315 (522)
||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~-- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IEC-- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HHH--
Confidence 9999999975433222112223345788999999999999999999999999999998 8999865432111 111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
. ...... . .+......+.+|+.+||+.||.+||++.+|++.|+
T Consensus 237 -~-~~~~~~-~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 -I-TQGREL-E---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -H-HcCccC-C---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 010000 0 01112245779999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=345.34 Aligned_cols=263 Identities=27% Similarity=0.396 Sum_probs=206.3
Q ss_pred hcCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCC-CCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~ 164 (522)
.++|.+.++||+|+||.||+|++. .++..||||+++..... ..+.+..|+.+|..+. |||||+++++|.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 456888999999999999999964 34568999999754322 2346889999999998 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC----------------------------------------------------------
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPP---------------------------------------------------------- 186 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------------- 186 (522)
.+|||||+.+|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999965321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 187 ------------------------------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 187 ------------------------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
....+++..++.|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1134678889999999999999999998 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~ 309 (522)
++++.+||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||........
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-- 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-- 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--
Confidence 9999999999999986432221111223457789999999998889999999999999999998 8899865422111
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
+.. .......+ ..+......+.+|+.+||+.+|.+||++.+|+..|+.+.
T Consensus 351 ~~~----~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYN----AIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHH----HHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111 01110000 011223357889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=327.47 Aligned_cols=267 Identities=27% Similarity=0.350 Sum_probs=209.7
Q ss_pred cccHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEE
Q 009933 82 TFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCA 160 (522)
Q Consensus 82 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~ 160 (522)
.+.++.+....++|++.+.||+|+||.||+|.+..+++.+|||++.... .....+..|+.++..+ +||||++++++|.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3555666677899999999999999999999999999999999986532 2235677899999999 6999999999884
Q ss_pred -----cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 009933 161 -----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235 (522)
Q Consensus 161 -----~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~ 235 (522)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 345789999999999999988654334567899999999999999999999998 999999999999999999
Q ss_pred eeeeeecceeeCCCCCCCcceecccCCccccChhhhhc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH
Q 009933 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 310 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~ 310 (522)
+||+|||++....... .......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+... +
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~ 238 (286)
T cd06638 163 VKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--L 238 (286)
T ss_pred EEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--H
Confidence 9999999998643221 12233568999999999853 4578999999999999999999999975432111 1
Q ss_pred HHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 311 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
... ... .......+ ......+.+|+.+||+.+|++||++.+|++.+
T Consensus 239 ~~~----~~~--~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FKI----PRN--PPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hhc----ccc--CCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 100 000 00111111 11224688999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.96 Aligned_cols=253 Identities=29% Similarity=0.422 Sum_probs=202.8
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.|+..++||+|+||+||++.+..+++.||+|++....... ...+.+|+.+|+.++|+||+.+++++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3778899999999999999999999999999997643322 2346789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999988652 2346999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||.......... .+.........
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~~~~~~~~~~~-------- 222 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--EVDRRVLETEE-------- 222 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhhhcccc--------
Confidence 1 1234568999999999998899999999999999999999999997543211111 11111111100
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~ 368 (522)
.++......+.+|+..||+.+|++||+ +.+++..
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 011222346789999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=329.27 Aligned_cols=264 Identities=26% Similarity=0.414 Sum_probs=205.9
Q ss_pred hhcCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~ 164 (522)
..++|++.+.||+|+||.||+|.++. .+..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999997652 355899999864432 223457789999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceee
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPD------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 238 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL 238 (522)
.++||||+++|+|.+++...... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753211 234567888999999999999999998 999999999999999999999
Q ss_pred eeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhh
Q 009933 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 239 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... +
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~---~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKF---V 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---H
Confidence 99999885433222212222345778999999998899999999999999999998 78888643221 11111 1
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
... . ... .+......+.+|+.+||+.+|++||++.++++.|.....
T Consensus 235 ~~~-~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 235 MDG-G-YLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HcC-C-CCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 111 0 000 111123578899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=320.29 Aligned_cols=252 Identities=33% Similarity=0.470 Sum_probs=205.9
Q ss_pred ceecccCceEEEEEEECCC---CcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
+.||+|+||.||+|.+... +..|+||++....... ...+..|+.++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999865 8899999997654433 56788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 175 GSLEDHLHDLPPD-----KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 175 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999874222 367999999999999999999999998 99999999999999999999999999987544
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
...........++..|+|||.+....++.++|||||||++|+|++ |..||...... .+.... .. .. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~---~~-~~---~-- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYL---RK-GY---R-- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH---Hc-CC---C--
Confidence 332222334567889999999998899999999999999999999 68999765221 111111 11 00 0
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
...+......+.+++.+||+.+|.+||++.+|+..|+
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0112222467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=331.94 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=203.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcE--EEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQV--VAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~--vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+..... .....+.+|+.++..+ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 35789999999999999999999777754 57777654322 2335678899999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 009933 168 VYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~ 235 (522)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999975321 1236889999999999999999999998 999999999999999999
Q ss_pred eeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhh
Q 009933 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~ 314 (522)
+||+|||++....... ......++..|+|||++....++.++|||||||++|||+| |..||...... .....
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~- 235 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK- 235 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHH-
Confidence 9999999986321110 1111224567999999988889999999999999999998 99999643221 11111
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
. ...... ..+......+.+|+.+||+.+|++||++.++++.|..+....
T Consensus 236 --~-~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 236 --L-PQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred --H-hcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 000000 011112346789999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=321.97 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=201.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
.+|++.+.||+|+||.||++.++ ++..+|||++..... ....+..|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 45888999999999999999986 467899999865433 3456888999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999752 246899999999999999999999999 99999999999999999999999999976432111
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..... ... . ..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~--~----~~- 220 (256)
T cd05059 156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESV----SAG--Y----RL- 220 (256)
T ss_pred -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHH----HcC--C----cC-
Confidence 11111223457999999999899999999999999999999 789987543211 11111 000 0 00
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
..+......+.+|+.+||+.+|++||++.+|++.|
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 ---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01112345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.76 Aligned_cols=194 Identities=24% Similarity=0.353 Sum_probs=169.1
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
...+|++.+.||+|+||.||+|.+..+++.||+|+.... ....|+.+|+.++||||++++++|......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999999999988999999985432 23568999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+. ++|.+++.. ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++......
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 588888864 2467899999999999999999999999 999999999999999999999999999753211
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 300 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~ 300 (522)
.......||+.|+|||++.+..|+.++|||||||++|||+++..++.
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12234569999999999999999999999999999999999766553
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.90 Aligned_cols=264 Identities=27% Similarity=0.359 Sum_probs=201.3
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|++.+.||+|+||.||+|.+..++..||||++...... ....+..|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 488899999999999999999989999999998654322 235678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+. ++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 97 58988886532 2356899999999999999999999998 999999999999999999999999999754322
Q ss_pred CCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh--------------
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP-------------- 316 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~-------------- 316 (522)
........+++.|+|||++.+. .++.++|||||||++|+|+||+.||........ +......
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchh
Confidence 1122334578899999998754 578999999999999999999999975432111 0000000
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.......+.......+.. ........+.+||.+||+.||++|||+.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000001111110000 01112356779999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=324.23 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=201.5
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcC------C
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADG------D 163 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~------~ 163 (522)
+...|++.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.++..+ +|+||++++++|... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567899999999999999999999999999999997543 3345678899999998 699999999998753 4
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.+|+||||+.+++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 689999999999999998752 2356899999999999999999999998 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhh
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
+....... .......|++.|+|||++. ...|+.++|||||||++|||++|..||....+... ... ..
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~-~~ 229 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFL-IP 229 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHH-Hh
Confidence 98643211 1223466899999999986 33688899999999999999999999964422111 100 00
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
. ....... .......+.+|+.+||+.+|.+||++.+|++
T Consensus 230 ~--~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 R--NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred c--CCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 0001111 1112346789999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.07 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=195.9
Q ss_pred eecccCceEEEEEEE--CCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCC
Q 009933 100 LLGEGGFGRVYKGRL--ESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~--~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 175 (522)
.||+|+||.||+|.+ ..++..+|||+++..... ..+.+..|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 456789999998654322 2456889999999999999999999885 45678999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc-
Q 009933 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH- 254 (522)
Q Consensus 176 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~- 254 (522)
+|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||.|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999965 356899999999999999999999999 9999999999999999999999999998643322111
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcccc
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ 333 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 333 (522)
......++..|+|||++....++.++|||||||++|||++ |..||...... .+.... ..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i----~~~~~-~-------- 217 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMI----ESGER-M-------- 217 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HCCCC-C--------
Confidence 1122234578999999988889999999999999999998 99999754221 111111 11110 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
..+......+.+||.+||+.||++||++.+|++.|+.
T Consensus 218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1112233567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=321.61 Aligned_cols=255 Identities=29% Similarity=0.429 Sum_probs=202.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||.||+|.+..+ ..||||++..... ....+..|+.+++.++||||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 45799999999999999999998764 5699999975432 3457889999999999999999999875 4568999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999752 2346789999999999999999999998 9999999999999999999999999998643322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.. ......++..|+|||++....++.++|||||||++|+|++ |..||....... ... ..... ...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~---~~~~~-~~~------ 222 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD---QVERG-YRM------ 222 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHH---HHhcC-CCC------
Confidence 11 1122346678999999988899999999999999999999 788886542211 111 11000 000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+......+.+|+.+|++.+|++||++.++++.|+..
T Consensus 223 ----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=324.15 Aligned_cols=257 Identities=27% Similarity=0.459 Sum_probs=204.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCc---EEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQ---VVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
..|++.+.||+|+||.||+|.+..++. .||||++.... ......+..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458899999999999999999976654 69999987542 22345788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++... ...+++.+++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998752 356899999999999999999999998 9999999999999999999999999987643
Q ss_pred CCCCCcceeccc---CCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 249 VGDKTHVSTRVM---GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 249 ~~~~~~~~~~~~---gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
............ .+..|+|||++....++.++|||||||++|||++ |..||...... ....+... . ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~---~-~~~ 230 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQ---D-YRL 230 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc---C-CcC
Confidence 322111111111 2457999999998899999999999999999886 99999654321 12222110 0 000
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
+ .+......+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 231 ~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 P----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0112234678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=336.79 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=203.2
Q ss_pred hcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCcceeEEEEEcC-C
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADG-D 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~-~ 163 (522)
.++|++.++||+|+||+||+|.+ ..+++.||||+++..... ....+..|+.+|..+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999985 345789999999754322 235678899999999 689999999988654 5
Q ss_pred eeEEEEeecCCCChhhhhccCCC---------------------------------------------------------
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPP--------------------------------------------------------- 186 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------------- 186 (522)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceeccc
Q 009933 187 ------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 260 (522)
Q Consensus 187 ------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 260 (522)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0134788899999999999999999999 9999999999999999999999999998643222111112234
Q ss_pred CCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChH
Q 009933 261 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMR 339 (522)
Q Consensus 261 gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 339 (522)
+++.|+|||++....++.++|||||||++|+|++ |..||....... .+... ....... . .+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~----~~~~~~~-~---------~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR----LKEGTRM-R---------APDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHH----HhccCCC-C---------CCCC
Confidence 5678999999998899999999999999999997 889986542211 11111 1111100 0 0111
Q ss_pred HHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 340 GLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 340 ~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
....+.+++..||+.+|++||++.+|++.|+.+..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=346.77 Aligned_cols=262 Identities=29% Similarity=0.427 Sum_probs=209.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCc---E-EEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQ---V-VAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~---~-vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~ 164 (522)
.++..+.++||+|.||.||+|..+..+. . ||||..+... .....+|++|+++|++++|||||++||++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4556667899999999999999965422 3 8999987522 3445689999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
++||||+|.||+|.++|+.. ...++..+.+.++.+.+.||+|||+++ +|||||...|+|++.++.+||+||||+
T Consensus 236 l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999873 336999999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCCccee-cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhccc
Q 009933 245 KLGPVGDKTHVST-RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRR 322 (522)
Q Consensus 245 ~~~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 322 (522)
+...... ... ...-...|+|||.+....|+.++|||||||++||+++ |..||...... .+..++ .....
T Consensus 310 ~~~~~~~---~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI---~~~~~ 380 (474)
T KOG0194|consen 310 RAGSQYV---MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI---VKNGY 380 (474)
T ss_pred cCCccee---eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---HhcCc
Confidence 8643111 111 1224579999999999999999999999999999999 78888765332 111111 11111
Q ss_pred CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccCC
Q 009933 323 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD 378 (522)
Q Consensus 323 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~ 378 (522)
....+......+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 381 ----------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 ----------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 0111223345677888999999999999999999999998766543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=318.95 Aligned_cols=254 Identities=27% Similarity=0.359 Sum_probs=208.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
++|++.+.||.|+||.||+|.+..+++.+++|++..........+..|+.+++.++||||+++++++.....++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57999999999999999999998889999999998765555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.+++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999875 2257899999999999999999999998 9999999999999999999999999987643211
Q ss_pred CcceecccCCccccChhhhhcC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 253 THVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~---~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.......++..|+|||++... .++.++|||||||++|+|++|+.||....+... ..... .. . +..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~----~~--~---~~~ 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLIS----KS--N---FPP 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH----hc--c---CCC
Confidence 122345688899999999876 889999999999999999999999975432111 11100 00 0 001
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
+.+ .........+.+|+.+||+.+|..||++.+|+.
T Consensus 224 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 112234467889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=336.94 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=199.3
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcC-----
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG----- 162 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~----- 162 (522)
...++|.+.+.||.|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.++||||++++++|...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 346789999999999999999999999999999999975422 2234577899999999999999999988543
Q ss_pred -CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 163 -DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 163 -~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
...|++||++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 7799888754 56999999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh---
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL--- 317 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~--- 317 (522)
|++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +..+....
T Consensus 163 g~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 235 (343)
T cd07878 163 GLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTP 235 (343)
T ss_pred ccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCC
Confidence 99986432 1234568999999999987 4789999999999999999999999975432110 10000000
Q ss_pred ----h----hc-----ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 ----F----KD-----RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ----~----~~-----~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+ .. ...++......+...+ ......+.+|+.+||+.||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 0000000000000000 0112346799999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.98 Aligned_cols=254 Identities=30% Similarity=0.449 Sum_probs=202.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 357899999999999999999886 467799999976443 3467889999999999999999999885 4568999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999999752 2356899999999999999999999998 9999999999999999999999999998643322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.. ......++..|+|||++....++.++|||||||++|+|++ |..||...... ...... ......
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~------ 222 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQV----ERGYRM------ 222 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCCCC------
Confidence 11 1122335678999999988899999999999999999999 88899653221 111111 110000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
..+......+.+|+.+||+.+|.+|||+.++++.|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122233578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.40 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=207.4
Q ss_pred hcCCcccceecccCceEEEEEEECC-------CCcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES-------TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~ 162 (522)
..+|.+.+.||+|+||.||+|.+.. ....||+|.++.... .....+..|+.+++.+ +||||++++++|...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3578899999999999999998632 345799999875432 2335678899999999 599999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
...++||||+++++|.+++..... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999975321 1245899999999999999999999998 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~ 309 (522)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---E 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999986432221111122234567999999998899999999999999999999 88888654221 1
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
+.... ..... . ..+......+.+|+.+||+.+|++||++.+|++.|..+.....
T Consensus 245 ~~~~~----~~~~~-~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 245 LFKLL----REGHR-M---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHHH----HcCCC-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 11111 11100 0 0112223567799999999999999999999999998865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.96 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=201.0
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC------
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------ 162 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------ 162 (522)
..++|++.+.||+|+||.||++.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999999999999999997532 22335678899999999999999999987543
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
...|+||||+.+ +|.+++.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 78777743 4788999999999999999999999 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH----------
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA---------- 312 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~---------- 312 (522)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99853221 12234578999999999999999999999999999999999999997543211110000
Q ss_pred ------hhhhhhhcccCCCC-----cCCccc---cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 313 ------WARPLFKDRRKFPK-----MADPLL---QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 313 ------~~~~~~~~~~~~~~-----~~d~~l---~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...........+.. +....+ ...........+.+||.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000011110000 000000 000111123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=332.21 Aligned_cols=265 Identities=26% Similarity=0.382 Sum_probs=207.2
Q ss_pred hcCCcccceecccCceEEEEEEECCC-------CcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST-------GQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-------g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~ 162 (522)
..+|++.+.||+|+||.||+|.+... ...||+|.+..... .....+..|+.++.++ +||||++++++|...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 45789999999999999999986432 23689998875422 2345788999999999 799999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
...++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 999999999999999999975321 2345888999999999999999999998 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~ 309 (522)
+.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 9999999999999986433222111222334568999999999999999999999999999998 8888865321
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
..+...+. .... .. .+......+.+|+.+||+.+|++||++.+|++.|..+....
T Consensus 243 -~~~~~~~~-~~~~-~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 -EELFKLLK-EGHR-MD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -HHHHHHHH-cCCC-CC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111111 1100 00 11123357889999999999999999999999999886433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=320.95 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=201.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
++|++.+.||+|+||+||++.+.. +..+|||.+..... ....+.+|+.++..++||||++++++|......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 458889999999999999998864 45699999875433 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||.|||++.++.+||+|||++........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999752 236899999999999999999999999 99999999999999999999999999886432211
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..... +..... ..
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~---~~~~~~---~~---- 221 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEK---VSQGLR---LY---- 221 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH---HhcCCC---CC----
Confidence 11112335678999999998889999999999999999998 99998654321 11111 111100 00
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 ----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112367889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=317.09 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=202.5
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---------hHHHHHHHHHHHhCCCCCcceeEEEEEcCCe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---------NREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---------~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~ 164 (522)
+|.+...||.|+||.||+|.+..+++.||+|.+....... .+.+..|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999998889999999986543322 1457789999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+|||+++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999976 356889999999999999999999998 999999999999999999999999998
Q ss_pred eeCCCCCCC----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 245 KLGPVGDKT----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 245 ~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
......... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAI---FKIGE- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHH---HHHhc-
Confidence 865321110 1112345888999999999889999999999999999999999999753221 000 00000
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
...+. .+......+.+++.+||+.+|.+||++.+|++
T Consensus 227 ------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ------NASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------cCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00111 11223357789999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.78 Aligned_cols=259 Identities=26% Similarity=0.458 Sum_probs=204.6
Q ss_pred hcCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||.||+|.+. .++..||||++..... .....+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999974 3578999999875432 2235688899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009933 166 LLVYEFMPLGSLEDHLHDLPP------------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 227 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~N 227 (522)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999974211 1235788999999999999999999998 9999999999
Q ss_pred eeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 009933 228 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPG 306 (522)
Q Consensus 228 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~ 306 (522)
||++.++.++|+|||++.................+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875432221111222345677999999998899999999999999999998 88888643221
Q ss_pred cchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 307 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
...... .... ... .+......+.+|+.+||+.+|++||++.||++.|+
T Consensus 240 --~~~~~~----~~~~-~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 --EVIYYV----RDGN-VLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred --HHHHHH----hcCC-CCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111111 1111 100 11122357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=318.87 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=198.6
Q ss_pred ceecccCceEEEEEEECCCC---cEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTG---QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g---~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||.||+|.+..++ ..||+|.+...... ....+..|+.+++.+.|+||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999886544 78999999765442 3457889999999999999999999876 4568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..++.++.|++.+|.|||..+ |+|+||||+|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999976 347899999999999999999999998 9999999999999999999999999998643322211
Q ss_pred c-eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 255 V-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 255 ~-~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
. .....++..|+|||.+....++.++|||||||++|+|++ |..||..... ..+..+... ... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~----~~~---~----- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES----GER---L----- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc----CCc---C-----
Confidence 1 111223567999999998899999999999999999998 9999975432 122222211 110 0
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+......+.+||.+||+.+|++||++.+|++.|+.+
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01112235778999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.02 Aligned_cols=256 Identities=20% Similarity=0.235 Sum_probs=199.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||+||++++..+++.||||++.+... .....+..|+.++..++|+||+.+++++.+.+..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999965321 22344778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCCcceecccCCccccChhhhhc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
... ......+||+.|+|||++.. ..++.++|||||||+||+|++|+.||...... .....+......+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~ 227 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF 227 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc
Confidence 221 12234579999999999875 46889999999999999999999999754221 1111111111000
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~evl~~ 368 (522)
. +...+ ......+.+|+.+||..++.+ |+++.+++++
T Consensus 228 -~-~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 -Q-FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -c-CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 01101 112356788999999876544 4578877764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=322.52 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=204.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.+.|++.+.||.|+||.||+|.+..+++.|++|++..........+..|+.+++.++||||++++++|..+..+++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 35799999999999999999999999999999999766555566788899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|..++.. ....+++..+..++.||+.+|.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999988754 2356899999999999999999999998 999999999999999999999999998753221
Q ss_pred CCcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
........+++.|+|||++. ...++.++|||||||++|+|++|..||...... ..+.. ..... .+.
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~~~--~~~ 234 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK----IAKSE--PPT 234 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHH----HhcCC--Ccc
Confidence 11223456889999999985 345788999999999999999999998654321 01111 11100 000
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.. .+......+.+|+.+||+.+|++||++.+|++.
T Consensus 235 ~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 LS-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CC-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 111223467899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.97 Aligned_cols=256 Identities=21% Similarity=0.244 Sum_probs=199.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.++||+|+||.||++.++.+++.||+|++.+... .....+..|+.++..++|+||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999999999999999999964221 12234778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
.. .......+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+......+
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~ 227 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERF 227 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccc
Confidence 21 11223457999999999986 34688999999999999999999999975422 11111111111110
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~evl~~ 368 (522)
. +... .......+.+|+.+||..++.+ |+++.+++++
T Consensus 228 ~--~p~~-----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 Q--FPAQ-----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c--CCCc-----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0000 0122356778899988665444 6889988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=327.25 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=207.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
.+|++.+.||.|+||.||++.+..+++.||||.+..........+.+|+.+++.++||||++++++|......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999999899999999997665555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++.. ..+++.++..++.|++.+|.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999865 46899999999999999999999999 99999999999999999999999999875432221
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+... ... +.... .....
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~~---~~~~~--~~~~~---- 236 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYL---IATNG--TPELQ---- 236 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH---HHhcC--CcccC----
Confidence 12335688999999999988899999999999999999999999975432111 110 11100 00100
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.+||.+||..||.+||++.+|+..
T Consensus 237 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111223467789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=321.93 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=206.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCc----EEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQ----VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
..+|++.+.||+|+||.||+|.+..++. .||+|.+...... ....+.+|+.++..++||||++++++|.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3568899999999999999999876654 5899988765432 34568889999999999999999999987 7889
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||||+.+++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999752 345899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..............++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.... .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~- 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLL----EKGERL- 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHH----hCCCCC-
Confidence 543222111122224568999999988899999999999999999998 99999754321 111111 111100
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..+......+.+++.+||..+|+.||++.++++.|..+..
T Consensus 231 ---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 ---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111122467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=318.30 Aligned_cols=249 Identities=29% Similarity=0.414 Sum_probs=200.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEE-cCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA-DGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 171 (522)
++|++.+.||+|+||.||++... +..||+|.++... ....+.+|+.+++.++|+||+++++++. .....++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 47899999999999999999875 7889999986542 3456889999999999999999999764 55678999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999752 2345889999999999999999999998 9999999999999999999999999988532211
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
....++..|+|||++....++.++|||||||++|+|++ |+.||..... ..+.... ... . ..
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~---~~~-~--~~---- 218 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV---EKG-Y--KM---- 218 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---hcC-C--CC----
Confidence 22334668999999998899999999999999999998 9999864321 1111111 110 0 00
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+......+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11112235678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=318.12 Aligned_cols=250 Identities=30% Similarity=0.476 Sum_probs=204.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||.|+||.||+|... ++.||||.+..... ....+..|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457899999999999999999986 78999999976543 456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999762 2236899999999999999999999999 9999999999999999999999999998642211
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.....+..|+|||++....++.++|||||||++|+|++ |..||...... .+..... .... .
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~-~----- 218 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVE----KGYR-M----- 218 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----cCCC-C-----
Confidence 12334668999999998899999999999999999997 99998644221 1111111 1000 0
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
..+......+.+||.+||..+|++||++.+|++.|+.
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 ----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111223578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.84 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=205.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCC---cEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTG---QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.++..... ....+..|+.+|..++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357899999999999999999986444 37999998754322 23568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++... ...+++.+++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999999752 346899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCcc-eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 248 PVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 248 ~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
........ .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ....... .....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~~~~~~ 229 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE----EGYRLP 229 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh----CCCcCC
Confidence 33221111 111223568999999998899999999999999999886 99999754321 1111111 100010
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.+......+.+++.+|++.+|.+||++.+|++.|..+
T Consensus 230 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 ----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111235678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=315.46 Aligned_cols=250 Identities=28% Similarity=0.369 Sum_probs=206.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
++|++.+.||.|+||.||+|.+..+++.|++|.+..... ...+.+|+.+++.++|+||+++++++.....+|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 679999999999999999999998899999999975432 567899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999864 2467899999999999999999999998 99999999999999999999999999986433221
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
......++..|+|||++.+..++.++|||||||++|+|++|+.||....+.... .. . .....+.+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~-------~----~~~~~~~~ 219 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FM-------I----PNKPPPTL 219 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hh-------h----ccCCCCCC
Confidence 223355889999999999889999999999999999999999999754321110 00 0 00000001
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
. .+......+.++|.+||+.+|++||++.+|++
T Consensus 220 ~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 S--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 11122356889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=323.34 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=203.0
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
.|++.+.||.|+||.||++.+..++..+++|.+..........+.+|+.+++.++||||++++++|......++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36788899999999999999999999999999976554455678889999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+++|..++.. ...++++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++...... .
T Consensus 86 ~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~ 157 (282)
T cd06643 86 GGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 157 (282)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--c
Confidence 9999998764 2357899999999999999999999999 999999999999999999999999998753221 1
Q ss_pred cceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 254 HVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.......++..|+|||++. ...++.++|||||||++|+|++|+.||....+.. ..... .... ...+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~----~~~~--~~~~~ 229 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKI----AKSE--PPTLA 229 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHH----hhcC--CCCCC
Confidence 1223456899999999984 3457889999999999999999999986532210 11111 1110 00111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+......+.+||.+||+.+|.+||++.+|++.-
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 230 -------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 1112235788999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=324.52 Aligned_cols=264 Identities=24% Similarity=0.352 Sum_probs=202.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|.+.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5799999999999999999999989999999999754322 234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5899888652 346889999999999999999999999 9999999999999999999999999997533222
Q ss_pred CCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh-----------
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK----------- 319 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 319 (522)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........ .......+.
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhh
Confidence 1 12234578899999998754 578899999999999999999999975432111 111000000
Q ss_pred cccCCCCcCCccccCC----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 320 DRRKFPKMADPLLQGR----YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 320 ~~~~~~~~~d~~l~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....+.....+..... ........+.+||.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000000000 011223467899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=317.23 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=203.4
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEc-CCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-~~~~~lV~E 170 (522)
.|++.+.||+|+||.||++.+..+++.||||++..... ...+.+..|+.+++.++|+||+++++.+.. ...+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999998899999999975432 233567889999999999999999998864 446799999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++... ....+++.+++.++.||+.+|.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999752 2356899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. .......+++.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+... .+..
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~--~~~~---- 221 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEG--KLPP---- 221 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc--CCCC----
Confidence 1 122345689999999999998999999999999999999999999974321 1111111111 1111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.+|+.+||+.+|++||++.+++++
T Consensus 222 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112233578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=322.02 Aligned_cols=261 Identities=24% Similarity=0.359 Sum_probs=209.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||+||++.+..+++.||+|++..... .....+.+|+++++.++||||+++++++.....+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 3578899999999999999999998999999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|+++++|.+++.. ...+++..+..++.+++.+|.|||+ .+ |+|+||||+|||+++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999999865 3578999999999999999999997 46 99999999999999999999999999865321
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc-----chHHHhhhhhhhcccCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE-----HNLVAWARPLFKDRRKF 324 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~ 324 (522)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..+..+.........
T Consensus 157 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (284)
T cd06620 157 S----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-- 230 (284)
T ss_pred h----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--
Confidence 1 12235689999999999888999999999999999999999999985543211 111222222221110
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
+.+. .......+.+|+.+||+.||++||++.||+++...+.
T Consensus 231 -----~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 231 -----PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -----CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000 0012356889999999999999999999999765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=320.90 Aligned_cols=256 Identities=29% Similarity=0.364 Sum_probs=194.0
Q ss_pred ceecccCceEEEEEEEC--CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCC
Q 009933 99 CLLGEGGFGRVYKGRLE--STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~--~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 175 (522)
+.||+|+||.||+|.+. .++..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 3456799999875432 22346888999999999999999999999999999999999999
Q ss_pred ChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 176 SLEDHLHDLPP-DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 176 sL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
+|.+++..... ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 1235677788899999999999999999 9999999999999999999999999987533222211
Q ss_pred ceecccCCccccChhhhhcC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 255 VSTRVMGTYGYCAPEYAMTG-------QLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~-------~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
......++..|+|||++... .++.++|||||||++|||++ |..||....... ...+. ... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~--~~~---~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT--VRE---QQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH--hhc---ccCC
Confidence 22334578889999998642 35789999999999999996 999997543221 11111 001 1111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+..+.+.. .....+.+|+.+|+ .+|++||++.+|+..|+
T Consensus 230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222211 12245678999998 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.14 Aligned_cols=241 Identities=26% Similarity=0.318 Sum_probs=188.9
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhC---CCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLL---HHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
||+|+||+||+|++..+++.||||++....... ...+..|..++..+ +||||+.++++|......||||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999996532221 22344566666654 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999999865 467899999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred ceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcccc
Q 009933 255 VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ 333 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 333 (522)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+......++ ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~---~~--- 219 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGKVRFP---KN--- 219 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCCCCCC---Cc---
Confidence 23346799999999999764 589999999999999999999999975322 111111111111111 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCC----HHHHHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPL----IGDVVT 367 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~evl~ 367 (522)
.....+.+|+.+||+.||++||+ +.++++
T Consensus 220 -----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 -----VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11246678999999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=319.53 Aligned_cols=267 Identities=27% Similarity=0.337 Sum_probs=204.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+..|+.+++.++|+||++++++|......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468999999999999999999998899999999865432 223567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|..++.. ...+++..++.++.||+.+|.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888887654 356899999999999999999999998 999999999999999999999999999865332
Q ss_pred CCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH-HHhhhhhhh-------cc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL-VAWARPLFK-------DR 321 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~-~~~~~~~~~-------~~ 321 (522)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........... ......+.. ..
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1223457889999999876 4688999999999999999999999975543221111 111100000 00
Q ss_pred cCCCCcCCccccCCCCh-----HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPM-----RGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~-----~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.....+..+......+. .....+.+|+.+||+.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000001111111111 123568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=319.12 Aligned_cols=250 Identities=27% Similarity=0.369 Sum_probs=206.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
..|+..+.||.|+||.||+|.+..++..||||++..... .....+..|+.+++.+.|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 457788899999999999999988899999999875432 3345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999999864 46889999999999999999999998 9999999999999999999999999997643322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......++..|+|||++.+..++.++|||||||++|||++|..||....+...... . .....+
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------~-------~~~~~~- 219 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL------I-------PKNNPP- 219 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh------h-------hcCCCC-
Confidence 122334688899999999988899999999999999999999999975432111000 0 000001
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
..+......+.+|+.+||+.+|++||++.+++..-
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 220 ---TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred ---CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 12223446788999999999999999999998864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=318.31 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=203.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.++||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.+++.++|+||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 467999999999999999999976 478899999975543 3467889999999999999999999874 4578999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+++... ....+++.++..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999998652 3456899999999999999999999998 9999999999999999999999999998643221
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. .......++..|+|||++....++.++|||||||++|||++ |+.||....... ..... ...... .
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~~-~---- 223 (260)
T cd05067 157 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNL----ERGYRM-P---- 223 (260)
T ss_pred c-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----HcCCCC-C----
Confidence 1 11223345678999999998899999999999999999999 999997543211 11111 111000 0
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.+......+.+++.+||..+|++||++++|+..|+.
T Consensus 224 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=315.66 Aligned_cols=248 Identities=29% Similarity=0.400 Sum_probs=199.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
++||.|+||.||++.+.. ++.||+|++...... ....+..|+.+++.++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999987 999999998765443 346788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
.+++... ...+++..++.++.+++.+|.|||+++ |+|+||||+||||+.++.+||+|||++.............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9998652 346889999999999999999999998 9999999999999999999999999998543211111111
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY 336 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 336 (522)
...++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..... ..... ...
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~----~~~~~----------~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERI----ESGYR----------MPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHH----hcCCC----------CCC
Confidence 2233567999999998899999999999999999999 788886543211 11111 00000 011
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 337 PMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 337 ~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+......+.+|+.+||+.+|.+||++.+|++.|+
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1222357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=317.60 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=203.8
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
..++++....+||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34566666778999999999999999889999999998766556677899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCceeeeeecceee
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPL--DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKL 246 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~ 246 (522)
||+++++|.+++... ...+ ++..+..++.||+.||.|||+.+ |+|+||||+|||++. .+.++|+|||++..
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999752 2334 78889999999999999999998 999999999999976 67999999999876
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
...... ......+++.|+|||++.... ++.++|||||||++|+|++|+.||....... ...+.........
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~-- 231 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKIHP-- 231 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhccCC--
Confidence 432221 122345889999999987643 7899999999999999999999996432211 1111111111100
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.++......+.+|+.+||+.+|.+||++.+|+..
T Consensus 232 ----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 232 ----------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1122233567899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=322.92 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=214.2
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
|.++.+||+|+||.||++.++.+|+.+|||++..+ .+.+++..|+.+|+++..|++|++|+.|.....+|||||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 67788999999999999999999999999998654 4568899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
|++.|.+.. ...+|++.++..++...+.||+|||... -||||||..||||+.+|+.||+|||.+-.+. +...
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMA 184 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMA 184 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhHH
Confidence 999999875 4678999999999999999999999998 8999999999999999999999999997643 2333
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
...++.||+.|||||++..-.|+.++||||||++..||..|+.||.+-.+.-. ++. ++.-..|.+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------IFM----IPT~PPPTF-- 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------IFM----IPTKPPPTF-- 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------eEe----ccCCCCCCC--
Confidence 34568899999999999999999999999999999999999999986554211 111 122222322
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..|......+-+++..||-..|++|.|+.+++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2455566789999999999999999999888764
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=320.05 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=196.5
Q ss_pred ceecccCceEEEEEEECCCCc--EEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQ--VVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~--~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||.||+|.+..++. .+++|.+..... .....+..|+.++.++ +||||++++++|......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987775 468888864322 2335688899999999 799999999999999999999999999
Q ss_pred CChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 175 GSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 175 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
++|.+++..... ....+++..++.++.||+.||+|||+.+ |+|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 1235889999999999999999999998 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||...... ..... +.. .
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~---~~~-~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK---LPQ-G 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHH---HhC-C
Confidence 98632111 01111223567999999988899999999999999999997 99999643221 11111 100 0
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
... ..+......+.+|+.+||+.+|.+||++.++++.|..+.
T Consensus 228 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 011112346789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=320.00 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=206.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|++.+.||.|+||.||+|.+..+++.||||++.... ......+..|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999999999999999997653 23345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.. .++++..++.++.||+.+|.|||+.+ |+|+||+|+|||+++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999975 37899999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......+++.|+|||++.+..++.++|||||||++|+|+||..||....+.. .... +... ..+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~~---~~~~-------~~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLFL---IPKN-------NPPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHHH---hhhc-------CCCC
Confidence 12234568889999999998889999999999999999999999997543211 1100 0000 1111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+... .....+.+++.+||..+|++||++.++++.
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 023467889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=360.83 Aligned_cols=263 Identities=31% Similarity=0.445 Sum_probs=211.3
Q ss_pred hcCCcccceecccCceEEEEEEECCC-C----cEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST-G----QVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-g----~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
..+.++.+.||+|.||.||.|....- + ..||||.+.+.. .+...+|++|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 34566778899999999999998543 2 249999997653 45567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPD---KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
+|++|||.+|+|..||++.... ...|+..+.+.|+.|||+|+.||++++ +|||||...|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999874221 356889999999999999999999999 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
||+.....+........+-...|||||.+..+.++.|+|||||||+|||++| |..||.......... .+....
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC
Confidence 9995433333333222233568999999999999999999999999999999 788887654422111 111221
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
. + ..|..+...+.+|+..||+.+|++||++..|++.+..+..
T Consensus 922 -R---L-------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 -R---L-------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred -c---c-------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 1 1 1222334566799999999999999999999998877643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=325.58 Aligned_cols=200 Identities=26% Similarity=0.382 Sum_probs=163.6
Q ss_pred cceecccCceEEEEEEEC--CCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc--CCeeEEEEeecC
Q 009933 98 ECLLGEGGFGRVYKGRLE--STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMP 173 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~ 173 (522)
.++||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.++||||++++++|.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999975 367899999996543 23457789999999999999999999854 456899999996
Q ss_pred CCChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCceeeeeecce
Q 009933 174 LGSLEDHLHDLP-----PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLA 244 (522)
Q Consensus 174 ggsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl----d~~~~vkL~DFGla 244 (522)
++|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 48888875321 11235899999999999999999999999 9999999999999 45678999999999
Q ss_pred eeCCCCCCC-cceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 009933 245 KLGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTR 303 (522)
Q Consensus 245 ~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~ 303 (522)
......... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 864322111 122346789999999999874 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=327.96 Aligned_cols=265 Identities=19% Similarity=0.214 Sum_probs=196.9
Q ss_pred ccceeccc--CceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 97 PECLLGEG--GFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 97 ~~~~LG~G--~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
+.++||+| +|++||++.+..+++.||||+++..... ....+..|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7899999999999999999999764322 2345678999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998652 2345899999999999999999999999 99999999999999999999999986543211110
Q ss_pred -C----cceecccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh---c--
Q 009933 253 -T----HVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK---D-- 320 (522)
Q Consensus 253 -~----~~~~~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---~-- 320 (522)
. .......++..|+|||++.+ ..|+.++|||||||++|||++|+.||........ .......... +
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCcccccccc
Confidence 0 01112346778999999976 4689999999999999999999999975432110 0000000000 0
Q ss_pred ----------------------ccCCC---CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 ----------------------RRKFP---KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ----------------------~~~~~---~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..... ..........+.......+.+|+.+||+.||++|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000 0000000001111234578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=319.87 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=205.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||.|+||.||++.+..++..||+|++..........+..|+.+++.++||||+++++++......|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35699999999999999999999888999999999765544556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ...+++..++.++.|++.+|.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999998652 356999999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCcceecccCCccccChhhhhc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.......+++.|+|||++.. ..++.++|||||||++|+|++|+.||....... .+.. +.... .+.
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~~~--~~~ 227 (280)
T cd06611 158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLK----ILKSE--PPT 227 (280)
T ss_pred --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHH----HhcCC--CCC
Confidence 12234568999999999853 357789999999999999999999997543211 1111 11100 000
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+. .+......+.+++..||+.+|.+||++.+|++.
T Consensus 228 ~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 LD-------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cC-------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 111223467899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=315.52 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=207.1
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|+..++||.|+||.||.+.+..+++.+++|.+..... .....+.+|+.+|+.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999999999999999999865432 3345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ....+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999999762 2356899999999999999999999998 9999999999999999999999999998653322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
. ......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+... .+...
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~--~~~~~---- 221 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQG--NYTPV---- 221 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcC--CCCCC----
Confidence 1 223456899999999998888999999999999999999999999653221 111111111 11111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
+......+.+++.+||+.+|.+||++.++++.+
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 012235688999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=316.58 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=195.6
Q ss_pred eecccCceEEEEEEEC--CCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCC
Q 009933 100 LLGEGGFGRVYKGRLE--STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~--~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
.||+|+||.||+|.+. ..+..||||++...... ..+.+.+|+.+++.++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999875 44567999999754322 23568899999999999999999998864 57899999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcc-
Q 009933 177 LEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV- 255 (522)
Q Consensus 177 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~- 255 (522)
|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999864 2357899999999999999999999998 99999999999999999999999999975433222111
Q ss_pred eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 256 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 256 ~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....+++.|+|||++....++.++|||||||++|+|++ |..||....... ..... ..... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~----------~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFI----EQGKR----------L 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCCC----------C
Confidence 111223578999999988889999999999999999996 999997543211 11111 11110 0
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+......+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11222346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=321.74 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=203.6
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
.|+..+.||+|+||.||+|.+..++..||||.+..... .....+..|+.+++.++||||++++++|......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46777889999999999999988899999999875432 23356889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999998854 56889999999999999999999998 9999999999999999999999999997643221
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
.......++..|+|||++.+..++.++|||||||++|||++|..||....+... ..+ .. ....+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~~------~~~~~~~ 221 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----IP------KNSPPTL 221 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----hh------cCCCCCC
Confidence 112234688899999999988999999999999999999999999864432111 100 00 0011111
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.......+.++|.+||+.+|++||++.+|+.+-
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 112335678999999999999999999999854
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=316.38 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=205.8
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEc--CCeeEEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLVY 169 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~~lV~ 169 (522)
+|++.+.||.|+||.||++.+..++..||+|++...... ..+.+..|+.+++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 488899999999999999999999999999999754332 23467889999999999999999998764 45679999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-----DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-----~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
||+++++|.+++.........+++..++.++.||+.||.||| +.+ |+|+||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765444578999999999999999999999 777 999999999999999999999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
....... .......+++.|+|||++....++.++||||||+++|+|++|..||..... ..+.... ... ..
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~---~~~--~~ 227 (265)
T cd08217 158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKI---KEG--KF 227 (265)
T ss_pred ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHH---hcC--CC
Confidence 8654322 112345689999999999988899999999999999999999999975431 1111111 110 01
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. ..+......+.+|+.+||+.+|++||++.+|+++
T Consensus 228 ~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 R---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 1122334678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=356.77 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=207.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.++||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999999999999999999754322 2346889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 170 EFMPLGSLEDHLHDLPP-------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
||++|++|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 1234667788999999999999999998 9999999999999999999999999
Q ss_pred ceeeCCCCCC----------------CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 009933 243 LAKLGPVGDK----------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 306 (522)
Q Consensus 243 la~~~~~~~~----------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~ 306 (522)
++........ .......+||+.|+|||++.+..++.++|||||||++|||+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986421110 001123569999999999999999999999999999999999999997532211
Q ss_pred cchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHHHhhhc
Q 009933 307 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-LIGDVVTALTYLASQ 375 (522)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~evl~~L~~l~~~ 375 (522)
. .+.. ..... ....+ .......+.+++.+||+.||++|| +++++++.|+.+...
T Consensus 239 i----~~~~-~i~~P----~~~~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 I----SYRD-VILSP----IEVAP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred h----hhhh-hccCh----hhccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 0000 00000 00000 011224577899999999999996 677888888776543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=321.55 Aligned_cols=264 Identities=30% Similarity=0.456 Sum_probs=206.0
Q ss_pred cCCcccceecccCceEEEEEEECC----CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEc--CCee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLES----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQR 165 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~----~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~ 165 (522)
..|++.+.||+|+||.||++.+.. ++..||||++...... ....+..|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 457888999999999999999753 4789999999765443 35678999999999999999999999987 5688
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999762 236899999999999999999999998 9999999999999999999999999998
Q ss_pred eCCCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc--------hHHHhhhh
Q 009933 246 LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH--------NLVAWARP 316 (522)
Q Consensus 246 ~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~--------~~~~~~~~ 316 (522)
......... ......++..|+|||.+....++.++|||||||++|||++|..||......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 754222111 111233556799999999889999999999999999999999998643221100 00111111
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.+...... ..+......+.+|+.+||+.+|++||++.+|+++|+.+
T Consensus 238 ~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111100 01112225688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=321.72 Aligned_cols=267 Identities=27% Similarity=0.375 Sum_probs=205.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+..|+.+++.++|+||++++++|...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368999999999999999999998999999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.++.|..++.. ...+++.++..++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998766665543 356899999999999999999999998 999999999999999999999999999865433
Q ss_pred CCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh-hh-------hhhcc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA-RP-------LFKDR 321 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~-~~-------~~~~~ 321 (522)
.. .......++..|+|||++... .++.++||||||+++|+|++|+.||............... .. .+...
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 22 122345688999999999888 8899999999999999999999999754322111110000 00 00000
Q ss_pred c-----CCCCcCCc-cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 322 R-----KFPKMADP-LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 322 ~-----~~~~~~d~-~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
. .+....++ .+...++......+.+||.+||..+|++||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00000000 0011122223567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=324.90 Aligned_cols=260 Identities=29% Similarity=0.471 Sum_probs=204.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCc----EEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQ----VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
..+|+..+.||+|+||.||+|.+..++. .||+|.+...... ....+..|+.++..++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 4568889999999999999999877775 4788888654322 234678899999999999999999998754 467
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+|+||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999875 2346889999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..............++..|+|||++.+..++.++|||||||++|||++ |..||..... .....+. .....++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~ 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLL----EKGERLP 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCCCC
Confidence 433222212223345778999999998899999999999999999997 8999865421 1122221 1111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
. +......+.+++..||..+|++||++.+|++.|..+...
T Consensus 232 ~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 Q----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 111224678899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=320.37 Aligned_cols=252 Identities=29% Similarity=0.432 Sum_probs=199.0
Q ss_pred ceecccCceEEEEEEECCCC------cEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 99 CLLGEGGFGRVYKGRLESTG------QVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g------~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+.||+|+||.||+|.+.... ..||||.+..... .....+.+|+.+|+.++||||++++++|......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999986433 6899998865432 3345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-----ceeeeeecc
Q 009933 172 MPLGSLEDHLHDLPP---DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-----HPKLSDFGL 243 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-----~vkL~DFGl 243 (522)
+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975321 2245789999999999999999999998 99999999999998877 899999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhccc
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRR 322 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 322 (522)
+................++..|+|||++.+..++.++|||||||++|+|++ |..||...... ...... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH----hcCC
Confidence 975433222222223345788999999999999999999999999999998 99998643221 111111 0000
Q ss_pred CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 323 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 323 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.+ ..+......+.+||.+||+.+|.+||++.+|++.|+
T Consensus 231 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 111223356789999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=315.75 Aligned_cols=255 Identities=29% Similarity=0.445 Sum_probs=205.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||.||++.+.. +..||||.+..... ....+..|+.+++.++|+||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 5689999999999999999999864 67899999976443 346788999999999999999999999998999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||||++++.+||+|||++.......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999762 2346899999999999999999999998 9999999999999999999999999988643211
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
........++..|+|||.+.+..++.++|||||||++|+|++ |+.||...... ...... ... +...
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~---~~~---~~~~--- 224 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQV---ERG---YRMP--- 224 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcC---CCCC---
Confidence 111112234568999999998899999999999999999999 99999654221 111111 110 0000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 -----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011113467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=322.93 Aligned_cols=265 Identities=27% Similarity=0.353 Sum_probs=208.7
Q ss_pred ccHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEc
Q 009933 83 FTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCAD 161 (522)
Q Consensus 83 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~ 161 (522)
+++.++....++|.+.+.||+|+||.||++.+..+++.+|+|++.... .....+..|+.++..+ +||||++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445566667889999999999999999999999999999999996542 2245677899999988 79999999999875
Q ss_pred C-----CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCce
Q 009933 162 G-----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 162 ~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
. ...++||||+++++|.++++........+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999999998754444567899999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhhcC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV 311 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~ 311 (522)
||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||....+. ..+.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 9999999886432221 12234688999999998643 3688999999999999999999999754321 1111
Q ss_pred HhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 312 AWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 312 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+. .. ....+.+ +......+.+||.+||+.+|++||++.+|++.
T Consensus 244 ~~~----~~--~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIP----RN--PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHh----cC--CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 00 0111111 12233568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=315.56 Aligned_cols=253 Identities=30% Similarity=0.446 Sum_probs=201.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
.+|++...||+|+||.||++.+..+ ..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 5688999999999999999998754 469999886543 23466888999999999999999999875 45689999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.+++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999752 2345889999999999999999999998 99999999999999999999999999986432221
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
. ......++..|+|||++....++.++|||||||++|+|++ |..||...... ....+. ... ...
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~--~~~----- 222 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQV----ERG--YRM----- 222 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcC--CCC-----
Confidence 1 1122345678999999998899999999999999999999 88998754221 111111 110 000
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
..+......+.+|+.+||..+|++||++.+|++.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=317.04 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=201.8
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc----------chHHHHHHHHHHHhCCCCCcceeEEEEEcCC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ----------GNREFLVEVLMLSLLHHSNLVNLIGYCADGD 163 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~----------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~ 163 (522)
+|.+.+.||.|+||.||+|.+..+++.||||.++..... ..+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578889999999999999999888999999988542111 1235678999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999976 357899999999999999999999998 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
+................|+..|+|||++.... ++.++||||||+++|+|++|..||...... .... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~-~~~~~- 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMF-KLGNK- 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHH-Hhhcc-
Confidence 97643221111223456889999999988654 889999999999999999999999643221 1110 00000
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. ....+... ........+.+++..||+.+|..||++.+|++.
T Consensus 228 ~-~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 R-SAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-cCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 01111111 111234678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=317.95 Aligned_cols=255 Identities=27% Similarity=0.347 Sum_probs=190.1
Q ss_pred eecccCceEEEEEEECC--CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCC
Q 009933 100 LLGEGGFGRVYKGRLES--TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~--~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
.||+|+||.||+|.... ....+|+|.+...... ....+.+|+.+++.++|+||++++++|.....+++||||+++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3457888887644322 23467889999999999999999999999999999999999999
Q ss_pred hhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcc
Q 009933 177 LEDHLHDLPPD-KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV 255 (522)
Q Consensus 177 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 255 (522)
|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999763322 234567888999999999999999999 99999999999999999999999999875322221111
Q ss_pred eecccCCccccChhhhhc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 256 STRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 256 ~~~~~gt~~y~APE~l~~-------~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||....+.. ..... +... ...+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~--~~~~---~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQV--VREQ---DIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH--hhcc---CccC
Confidence 223345678999999753 356889999999999999999 778886542211 11110 0111 1111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
..+.+ +......+.+++..|+ .||++||++.+|++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22222 1223355667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=319.95 Aligned_cols=264 Identities=20% Similarity=0.244 Sum_probs=199.6
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+..|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488899999999999999999999999999999654322 234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+. ++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 4888887642 356899999999999999999999999 9999999999999999999999999998543221
Q ss_pred CCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh-----------hhh
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP-----------LFK 319 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~-----------~~~ 319 (522)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||....... ........ ...
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhh
Confidence 112334578899999998765 47899999999999999999999875332211 11100000 000
Q ss_pred cccCCCC--cCCcccc-CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 320 DRRKFPK--MADPLLQ-GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 320 ~~~~~~~--~~d~~l~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....... ....... ..........+.+||.+||+.||.+|||+.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 0000000 00111234577899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=330.59 Aligned_cols=249 Identities=30% Similarity=0.406 Sum_probs=208.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
+.|+.-++||+|+||.||-++.+.||+.||+|++.+..+. .....++|..||.+++.++||.+-..|+..+.+||||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4688889999999999999999999999999999765433 2345688999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
..|+||+|.-+|.... ...+++..++.++.+|+.||++||... ||+|||||+|||||+.|+|+|+|+|||...+.
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999998743 357999999999999999999999999 99999999999999999999999999997665
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
+.. ....+||.+|||||++.+..|+...|+|||||+||||+.|+.||.....-....-+ -+....+
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv--drr~~~~--------- 405 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV--DRRTLED--------- 405 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH--HHHHhcc---------
Confidence 443 33458999999999999999999999999999999999999999754332111001 0111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 363 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 363 (522)
..+|+..-+.++..|+...|+.||++|.-..
T Consensus 406 ---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 406 ---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ---hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1235555567788999999999999997443
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=316.08 Aligned_cols=250 Identities=30% Similarity=0.443 Sum_probs=200.1
Q ss_pred ceecccCceEEEEEEECC-CC--cEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLES-TG--QVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~-~g--~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||.||+|.+.. .+ ..||||.+..... ...+.+..|+.+++.++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 33 3699999987665 445678899999999999999999999988 889999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976321 56899999999999999999999998 9999999999999999999999999998754322111
Q ss_pred -ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 255 -VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 255 -~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
......++..|+|||++....++.++|||||||++|+|++ |..||...... ..... +....... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~---~~~~~~~~---~---- 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKK---IDKEGERL---E---- 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHhcCCcC---C----
Confidence 1123457789999999998899999999999999999998 99998643221 11111 11111000 0
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.+......+.+|+.+||+.+|++||++.+|++.|.
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=324.70 Aligned_cols=254 Identities=29% Similarity=0.373 Sum_probs=204.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||+||+|.+..+++.||||.+...... ....+..|+++|..++|+||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3689999999999999999999988999999999765433 3356788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998752 2457899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCC---------------------------cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 009933 250 GDKT---------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNT 302 (522)
Q Consensus 250 ~~~~---------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~ 302 (522)
.... .......||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111346889999999999989999999999999999999999999754
Q ss_pred CCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC----HHHHHH
Q 009933 303 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL----IGDVVT 367 (522)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~evl~ 367 (522)
.... .+. ........+.. .......+.+|+.+||+.+|++||+ +.+++.
T Consensus 236 ~~~~--~~~----~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDE--TFS----NILKKEVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHH--HHH----HHhcCCccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3211 111 11111111100 0113467889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=320.64 Aligned_cols=267 Identities=27% Similarity=0.361 Sum_probs=203.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+|+.++||||++++++|......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999999999988999999998654322 23567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.++... ...+++..++.++.||+.+|.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888887654 345899999999999999999999998 999999999999999999999999999864332
Q ss_pred CCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch-HHHhhhhhhh-------cc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN-LVAWARPLFK-------DR 321 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~-------~~ 321 (522)
. .......++..|+|||++.+. .++.++|||||||++|||++|+.||.......... +..+...+.. ..
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 222345688999999998753 57889999999999999999999986543211100 0110000000 00
Q ss_pred cCCCCcCCccccC-----CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQG-----RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+..+..+.... .........+.+|+.+||+.+|++||++.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000 0011224578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.73 Aligned_cols=245 Identities=29% Similarity=0.397 Sum_probs=203.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||.||++.+..+++.||||++..... .....+.+|+++|+.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468999999999999999999998999999999975432 23356788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|.||||+.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999976 367899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .............
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~------ 216 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEGKVR------ 216 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCCcc------
Confidence 2 2345689999999999888899999999999999999999999975431 1111111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 367 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~ 367 (522)
++......+.+++.+||+.+|.+|+ ++++++.
T Consensus 217 ------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 ------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1112235677999999999999999 6667764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.19 Aligned_cols=263 Identities=26% Similarity=0.429 Sum_probs=203.5
Q ss_pred cCCcccceecccCceEEEEEEE----CCCCcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC--Cee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRL----ESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQR 165 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~ 165 (522)
..|++.+.||+|+||.||++.+ ..++..||+|.++... ......+.+|+.+|+.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999985 4568899999987543 22345688999999999999999999998775 568
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998652 246899999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCC-cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC---------CCcchHHHhhh
Q 009933 246 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP---------PGEHNLVAWAR 315 (522)
Q Consensus 246 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~---------~~~~~~~~~~~ 315 (522)
........ .......++..|+|||++.+..++.++|||||||++|||+++..|+..... ........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV- 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-
Confidence 64332211 111234567789999999988999999999999999999998766432110 0000111111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
......... ..+......+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 237 ~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111110 01112346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.03 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=197.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-----chHHHHHHHHHHHhCCCCCcceeEEEEEc--CCee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-----GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQR 165 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-----~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~ 165 (522)
.+|+..+.||+|+||.||++.+..++..||+|++...... ....+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4799999999999999999999989999999998654221 22457789999999999999999998875 3678
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
+++|||+++++|.+++.. ...+++...+.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999975 356889999999999999999999998 9999999999999999999999999987
Q ss_pred eCCCCCC-CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 246 LGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 246 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
....... ........++..|+|||++.+..++.++|||||||++|+|++|+.||....... ... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--~~~----~~~~~---- 224 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--AIF----KIATQ---- 224 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--HHH----HHhcC----
Confidence 5432111 111123458899999999998889999999999999999999999997542210 000 00000
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
...+ .++......+..++ .||..+|++||++.+|+.
T Consensus 225 --~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 --PTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0011 11222223455566 788899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=314.45 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=203.8
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
+|+..++||+|+||.||++.+..+++.||+|++...... ....+..|+.+|+.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588899999999999999999999999999999753311 23567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeeecceee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKL 246 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DFGla~~ 246 (522)
||||+.+++|.+++.. ..++++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999975 357899999999999999999999999 99999999999998775 599999999876
Q ss_pred CCCCCC--CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 247 GPVGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 247 ~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
...... ........++..|+|||++.+..++.++|||||||++|+|++|..||............ ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~---- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASA---- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhcc----
Confidence 433211 11122356889999999998888999999999999999999999999654322111111 000000
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
......+......+.+++.+||+.+|.+||++.+++.
T Consensus 227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011122233467889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=320.14 Aligned_cols=240 Identities=25% Similarity=0.423 Sum_probs=191.3
Q ss_pred ceecccCceEEEEEEECCCCc-------EEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 99 CLLGEGGFGRVYKGRLESTGQ-------VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~-------~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+.||.|+||.||+|.+..++. .||+|.+........+.+..|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999999865443 4888888655444456788899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--------eeeeeecc
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH--------PKLSDFGL 243 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~--------vkL~DFGl 243 (522)
+.+|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++|+|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999752 346899999999999999999999999 999999999999977665 68999998
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR-KAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
+..... .....+++.|+|||++.+. .++.++|||||||++|+|++|. .||....+.. ... .....
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~----~~~~~ 221 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQ----FYEDR 221 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHH----HHHcc
Confidence 864321 1235678899999999864 5899999999999999999995 5554332211 010 11111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
. .++......+.+|+.+||+.+|++||++.+|++.|
T Consensus 222 ~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 H------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred c------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1 11222335688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=320.31 Aligned_cols=239 Identities=25% Similarity=0.405 Sum_probs=188.9
Q ss_pred eecccCceEEEEEEECCC------------------------CcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCccee
Q 009933 100 LLGEGGFGRVYKGRLEST------------------------GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 155 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~~------------------------g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l 155 (522)
+||+|+||.||+|....+ ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999985321 24589999875544444678889999999999999999
Q ss_pred EEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-
Q 009933 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF- 234 (522)
Q Consensus 156 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~- 234 (522)
+++|......+|||||+++++|..++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999864 2456899999999999999999999998 99999999999997543
Q ss_pred ------ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCC
Q 009933 235 ------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELI-TGRKAIDNTRPPG 306 (522)
Q Consensus 235 ------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLl-tG~~Pf~~~~~~~ 306 (522)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3899999988642211 12357788999998875 56899999999999999995 6899987543321
Q ss_pred cchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 307 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.. .+ +.....++ ......+.+||.+||+.+|++||++.+|++.|
T Consensus 230 ~~---~~----~~~~~~~~------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KE---RF----YEKKHRLP------------EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH---HH----HHhccCCC------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 11 11111111 11123678999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=314.76 Aligned_cols=252 Identities=27% Similarity=0.328 Sum_probs=199.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-----cchHHHHHHHHHHHhCCCCCcceeEEEEEcC--Cee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQR 165 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-----~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~ 165 (522)
.+|++.++||+|+||.||++.+..++..||||++..... .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999864321 1234677899999999999999999998764 567
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+++++|.+++.. ...+++..++.++.||+.+|.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999875 345888999999999999999999999 9999999999999999999999999987
Q ss_pred eCCCCCCC-cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 246 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 246 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
........ .......++..|+|||++.+..++.++|||||||++|+|++|+.||...... .... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~-~~~~~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAIF-KIATQP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHHH-HHhcCC---
Confidence 54321111 1122356889999999999888999999999999999999999999643211 1110 000000
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.. ...+......+.+++.+|+. +|+.||++.+|++.
T Consensus 226 ---~~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 ---TN----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---CC----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 01 11233344577889999995 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=311.38 Aligned_cols=247 Identities=29% Similarity=0.419 Sum_probs=196.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
++||+|+||.||+|... ++..||+|.+....... ...+.+|+.+++.++||||++++++|......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36999999999999975 58899999987553322 34688899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
.+++... ...+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++........ ....
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 152 (250)
T cd05085 80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSG 152 (250)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCC
Confidence 9998652 345889999999999999999999998 99999999999999999999999999875322111 1111
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY 336 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 336 (522)
...++..|+|||++....++.++|||||||++|+|++ |..||...... ...... ..... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~----~~~~~----------~~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQV----EKGYR----------MSC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCCC----------CCC
Confidence 2234667999999998899999999999999999998 99999654221 111111 11000 011
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 337 PMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 337 ~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+......+.+|+.+||+.+|++||++.+|++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1223467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.35 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=203.9
Q ss_pred hcCCcccceecccCceEEEEEEECCC---CcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|.+.++||+|+||.||+|.+... ...||||.+.... ....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688999999999999999998543 3569999886544 2334578899999999999999999999876 55789
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999752 345899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
..... ...+...++..|+|||.+....++.++|||||||++|||++ |..||....... ..... .....+ .
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~----~~~~~~-~ 228 (270)
T cd05056 158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGRI----ENGERL-P 228 (270)
T ss_pred ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH----HcCCcC-C
Confidence 33211 11122334568999999988889999999999999999996 999997543221 11111 111100 0
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
.+......+.+|+.+|+..+|.+||++.+++..|..+..
T Consensus 229 ---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 ---------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111223578889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.77 Aligned_cols=256 Identities=29% Similarity=0.407 Sum_probs=204.1
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCC------
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD------ 163 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~------ 163 (522)
.+++|++.+.||.|+||.||+|.+..+++.|++|++..... ....+..|+.+++.+ +|+||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35789999999999999999999998899999999876543 346788999999998 6999999999997644
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.+++||||+++++|.+++.........+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 589999999999999998764434567999999999999999999999998 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhh
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
+....... .......|+..|+|||++.. ..++.++|||||||+||+|++|..||...... ..+.. ..
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh
Confidence 87643211 12234568899999999864 34778999999999999999999999643221 11111 11
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.. .... + ..+......+.+||.+||..||++|||+.+|++
T Consensus 232 ~~--~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RN--PPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cc--CCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 0011 1 111223457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=319.24 Aligned_cols=260 Identities=28% Similarity=0.400 Sum_probs=203.7
Q ss_pred cHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEc-
Q 009933 84 TFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCAD- 161 (522)
Q Consensus 84 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~- 161 (522)
+..++......|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|+||++++++|..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34444556678999999999999999999999899999999986543 2335677899999988 69999999999853
Q ss_pred -----CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCce
Q 009933 162 -----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 162 -----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
...+|+||||+.+++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 46789999999999999999752 2345888899999999999999999999 9999999999999999999
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV 311 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~ 311 (522)
+|+|||++....... .......|++.|+|||++. ...++.++|||||||++|||++|..||....+.......
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 999999987532211 1123356899999999986 346888999999999999999999999654321111100
Q ss_pred HhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 312 AWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 312 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.. .....+ .. ......+.+||.+||+.||.+||++.+|++
T Consensus 239 -------~~-~~~~~~----~~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -------PR-NPPPKL----KS----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------hh-CCCCCC----cc----cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000000 01 122357889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=318.78 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=198.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHH-HHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLM-LSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~-L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||.||++.+..+++.||||+++.... .....+..|+.+ ++.++||||+++++++......|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468999999999999999999999999999999976432 223345556654 667789999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|++ ++|.+++.........+++..++.++.||+.||.|||++ + ++|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 589888865444456799999999999999999999987 7 99999999999999999999999999886422
Q ss_pred CCCCcceecccCCccccChhhhhc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
. ...+...++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..... ..... ...
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~-~~~~~--~~~ 226 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQLK-QVVEE--PSP 226 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHHH-HHHhc--CCC
Confidence 1 11233568899999998864 45788999999999999999999999643221 01110 00110 001
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.. . .....+.++|.+||..+|++||++.+|++.
T Consensus 227 ~~~~----~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 QLPA----E----KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCc----c----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 1 123568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=310.36 Aligned_cols=248 Identities=28% Similarity=0.411 Sum_probs=202.6
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-----cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-----~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
+|+..+.||+|+||+||+|.+..++..|+||.+..... ...+.+..|+.+++.++|+||+++++++.....+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999988899999999865432 1335688899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999976 346889999999999999999999999 9999999999999999999999999988643
Q ss_pred CCCCCcceecccCCccccChhhhhcCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... ......++..|++||.+.... ++.++|||||||++|+|++|+.||...... .....+ .. ......
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~----~~-~~~~~~- 222 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKI----GR-SKELPP- 222 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHH----Hh-cccCCC-
Confidence 322 223456889999999998766 899999999999999999999999754311 111110 00 001111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.+......+.+++.+||+.+|.+||++.+++.
T Consensus 223 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 --------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11122356778999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.16 Aligned_cols=238 Identities=26% Similarity=0.436 Sum_probs=191.9
Q ss_pred ceecccCceEEEEEEECCCC----------cEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 99 CLLGEGGFGRVYKGRLESTG----------QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g----------~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.+|+.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999998766 35888887654332 5778899999999999999999999988 778999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-------ceeeeee
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-------HPKLSDF 241 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-------~vkL~DF 241 (522)
|||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999762 236899999999999999999999998 99999999999999887 7999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhh
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
|++..... .....++..|+|||++... .++.++|||||||++|+|++ |..||....... ...+.
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~---- 219 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY---- 219 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH----
Confidence 99986422 1234567789999999876 78999999999999999999 577776543211 11111
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
..... .+......+.+|+.+||..+|.+||++.+|++.|
T Consensus 220 ~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 220 QDQHR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hcCCC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 01000 0111126788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=315.04 Aligned_cols=262 Identities=26% Similarity=0.335 Sum_probs=207.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcC--CeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~~lV~ 169 (522)
++|+..+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+++++.++||||++++++|... ..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 368889999999999999999998999999999975432 2345688999999999999999999998654 4689999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.........+++..+..++.||+.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988654444567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC--CcchHHHhhhhhhhcccCCCCc
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... ....+..+.... ....+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-----PNPEL 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-----Cchhh
Confidence 21 12345788999999999889999999999999999999999999865331 112222222110 00111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+... ........+.+|+.+||+.+|.+||++.||++.-
T Consensus 229 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 229 KDEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred ccCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 11100 0012345688999999999999999999998844
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=322.70 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=202.5
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
.|.....||+|+||.||++.+..++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 44455679999999999999988899999999976554555678899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 9999998854 45889999999999999999999998 9999999999999999999999999987532221
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ 333 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 333 (522)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...... ..+ .+.+.
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~------~~~----~~~~~ 239 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRIR------DNL----PPRVK 239 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH------hcC----CCccc
Confidence 12233568999999999988899999999999999999999999997532211 111000 001 11111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. .......+.+++..||+.+|.+||++.+|++.
T Consensus 240 ~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 D--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 11123467789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=319.00 Aligned_cols=264 Identities=26% Similarity=0.314 Sum_probs=202.2
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-----chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-----GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-----~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
+|.+.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488889999999999999999988999999999765433 234567899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 88999999762 137999999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh-------hhc
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL-------FKD 320 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~-------~~~ 320 (522)
... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..+|........ +......+ +..
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhh
Confidence 322 12233456888999999865 4678999999999999999999777765432111 11100000 000
Q ss_pred ccCCCCcCCccccCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 RRKFPKMADPLLQGRYP-----MRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...+............+ ......+.+||.+||+.+|++||++.+|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000010000000111 1234678899999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.82 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=200.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||.|+||.||+|.++.+++.||||.+...... ....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36799999999999999999999988999999999754322 22456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+ +|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9975 999988652 346899999999999999999999998 999999999999999999999999998753221
Q ss_pred CCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc--------c
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD--------R 321 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------~ 321 (522)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+......+.. .
T Consensus 157 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 157 S--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred C--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhh
Confidence 1 11223346889999999875 4689999999999999999999999965431111 01000000000 0
Q ss_pred cC--------CCCcCCccccCCC-ChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 322 RK--------FPKMADPLLQGRY-PMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 322 ~~--------~~~~~d~~l~~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.. ........+.... .......+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000000000000 0111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.98 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=203.8
Q ss_pred CCcccceecccCceEEEEEEECC-CCcEEEEEEEccCCc----------cchHHHHHHHHHHHh-CCCCCcceeEEEEEc
Q 009933 94 NFRPECLLGEGGFGRVYKGRLES-TGQVVAVKQLDRNGL----------QGNREFLVEVLMLSL-LHHSNLVNLIGYCAD 161 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~-~g~~vAvK~i~~~~~----------~~~~~~~~E~~~L~~-l~hpnIv~l~~~~~~ 161 (522)
+|++.+.||+|+||.||+|.+.. +++.+|||.+..... .....+..|+.++.. ++||||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48888999999999999999987 678999999864321 112346678887765 789999999999999
Q ss_pred CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCceeeee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSD 240 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~D 240 (522)
.+..++||||+++++|.+++.........+++..++.++.|++.+|.|||+ .+ |+|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986544445679999999999999999999996 56 99999999999999999999999
Q ss_pred ecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 241 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 241 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..... ......+...
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVEA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhhc
Confidence 99998643322 23445689999999999988899999999999999999999999864322 1111111111
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
. . .+.... .....+.+||.+||+.||++||++.||.++|.
T Consensus 229 ~--~----~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 V--Y----EPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c--C----CcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 0 111111 12356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=313.47 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=200.6
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
+|++.+.||.|+||.||+|... +++.+|||.+...... ....+.+|+.+|+.++|+||++++++|.+....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4788999999999999999875 6889999998653211 12457889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++.. ...+++..+..++.||+.+|.|||+.+ |+|+||+|+|||+++++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999965 356889999999999999999999998 999999999999999999999999998753
Q ss_pred CCCC----CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 248 PVGD----KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 248 ~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
.... .........|+..|+|||++.+..++.++|||||||++|+|++|..||........ ... . ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~-~---~~~~~~ 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFY-I---GAHRGL 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHH-h---hhccCC
Confidence 2111 11122345689999999999988899999999999999999999999975422111 000 0 000001
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.+. .+......+.++|.+||+.+|.+||++.+++.
T Consensus 227 ~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPR---------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC---------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 11123356789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=341.92 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=211.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
+.|.+...||.|+||+||++..+.++-..|.|+|........+.++.||+||..+.||+||+|++.|..++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34777888999999999999999999999999998777677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.||-++..+..+ ...|++.++..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+.... ..
T Consensus 112 ~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--ST 183 (1187)
T ss_pred CCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hH
Confidence 999999888763 578999999999999999999999999 9999999999999999999999999986421 12
Q ss_pred CcceecccCCccccChhhhhc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 253 THVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
......++|||+|||||+.++ .+|+.++|||||||+|.||..+.+|.....+ ......+-+. ..+.+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaKS--ePPTL 255 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKS--EPPTL 255 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhhc--CCCcc
Confidence 223456889999999999875 4799999999999999999999988654322 2111111111 11222
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+. |-.....|.+|+.+||..||..||++.+|+++
T Consensus 256 lq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 LQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22 23455678899999999999999999999864
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=311.20 Aligned_cols=258 Identities=28% Similarity=0.380 Sum_probs=207.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|++.+.||.|+||+||+|....++..+|+|++..... .....+.+|+.+|+.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 478999999999999999999988899999999975432 2446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975211 246899999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCc--ceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 252 KTH--VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 252 ~~~--~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... ......|+..|+|||++... .++.++|||||||++|+|++|+.||....... .+...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~---~-------- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQN---D-------- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcC---C--------
Confidence 221 22345689999999999877 78999999999999999999999997543321 11111110 0
Q ss_pred CccccCCC-ChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 329 DPLLQGRY-PMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 329 d~~l~~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.+.+.... .......+.+|+.+||+.+|++||++.+|+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00111000 1123467789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=316.87 Aligned_cols=264 Identities=24% Similarity=0.324 Sum_probs=203.6
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|++.+.||.|+||.||+|.+..+++.||||++..... .....+..|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58899999999999999999998899999999976542 2235788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+ +++|.+++... ...+++.+++.++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998752 356999999999999999999999999 9999999999999999999999999998654332
Q ss_pred CCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc--------cc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD--------RR 322 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~ 322 (522)
. .......++..|+|||++.+. .++.++|||||||++|+|++|..+|....... ........+.. ..
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhcc
Confidence 1 122345689999999998754 46899999999999999999987776433211 11111000000 00
Q ss_pred CCCC---cCCcccc----CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 323 KFPK---MADPLLQ----GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 323 ~~~~---~~d~~l~----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.. +..+... ..........+.+||.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0000000 00001223678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.79 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=201.7
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
.+|++.+.||.|+||.||++.+.. +..+|||.+..... ....+..|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 468889999999999999999864 67899999875433 3457889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.+++|.+++.. ....+++..++.++.|++.+|.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999865 2346889999999999999999999998 99999999999999999999999999986432211
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.. .+... .....+.
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~---~~~~~----~~~~~~~ 224 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVE---TINAG----FRLYKPR 224 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHH---HHhCC----CCCCCCC
Confidence 11112335678999999998899999999999999999998 8999865322 11111 11110 0111111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.....+.+|+.+||+.+|++||++.+|++.|
T Consensus 225 -------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 -------LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1235688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.36 Aligned_cols=252 Identities=32% Similarity=0.458 Sum_probs=202.0
Q ss_pred CcccceecccCceEEEEEEECCCC----cEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTG----QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g----~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
|++.+.||.|+||.||++.+...+ ..||+|++...... ....+..|+.+|..++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999999998766 89999999765433 4567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999997621 122899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
...... ....+++.|+|||.+....++.++|||||||++|+|++ |..||..... ..+.... .... ...
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~---~~~~--~~~-- 224 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL---KKGY--RLP-- 224 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---hcCC--CCC--
Confidence 322111 12336789999999988889999999999999999998 7788765211 1111111 1110 000
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+......+.+++.+||..+|++|||+.++++.|
T Consensus 225 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111335788899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.35 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=202.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|++.+.||+|+||.||++.+..++..||+|.+..... .....+.+|+.+|..++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 368899999999999999999998999999999865421 2235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
+++++|..++... .....+++..+..++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 9999999988652 1234789999999999999999999974 6 999999999999999999999999998753221
Q ss_pred CCCcceecccCCccccChhhhhcC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~------~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....... ........... ..
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~--~~ 227 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVDG--DP 227 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhhc--CC
Confidence 12234588899999998543 35889999999999999999999996532211 11111111110 00
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
. ..+......+.+||.+||+.+|++||++.+++..-
T Consensus 228 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 228 P---------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred C---------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 0 11222345678999999999999999999998854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.28 Aligned_cols=251 Identities=20% Similarity=0.333 Sum_probs=204.9
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|++.+.||+|+||.||++.+..+++.||||.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58899999999999999999998999999999875432 2335688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999998651 2346789999999999999999999998 9999999999999999999999999998643221
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ......... ....
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~--~~~~----- 220 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRG--SYPP----- 220 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcC--CCCC-----
Confidence 1122345888999999999888999999999999999999999999643221 111111111 0100
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.++|.+||+.+|++||++.+|++.
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112234568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=320.42 Aligned_cols=199 Identities=26% Similarity=0.380 Sum_probs=162.5
Q ss_pred cceecccCceEEEEEEECC--CCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc--CCeeEEEEeecC
Q 009933 98 ECLLGEGGFGRVYKGRLES--TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMP 173 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~ 173 (522)
..+||+|+||+||+|.+.. ++..||+|.+.... ....+.+|+.+|+.++||||++++++|.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999754 56889999997543 23467789999999999999999999854 567899999996
Q ss_pred CCChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCceeeeeecce
Q 009933 174 LGSLEDHLHDLP-----PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLA 244 (522)
Q Consensus 174 ggsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl----d~~~~vkL~DFGla 244 (522)
+ +|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 8888775321 12235889999999999999999999999 9999999999999 56779999999999
Q ss_pred eeCCCCCCC-cceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 009933 245 KLGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNT 302 (522)
Q Consensus 245 ~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~ 302 (522)
+........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 864332211 112345689999999999764 5899999999999999999999999744
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.08 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=204.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||.||++.+..+++.||||.+..... .....+..|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468999999999999999999999999999999976532 22346778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999965 356899999999999999999999998 99999999999999999999999999874211
Q ss_pred CCC-------------CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh
Q 009933 250 GDK-------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 250 ~~~-------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
... ........++..|+|||.+....++.++|||||||++|||++|..||...... .+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 100 00112245788999999999889999999999999999999999999743221 11111
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
....... .+.... .....+.+||.+||+.+|++||++.++++.|+.
T Consensus 228 ~~~~~~~-----~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDIE-----WPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcccC-----CCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111000 111100 122457899999999999999998777766653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=308.38 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=209.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|++.+.||+|+||.||+|.+..+++.|+||++..... .....+..|+.++..++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368899999999999999999999999999999976543 3356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
+++++|.+++.. ...+++..++.++.||+.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999976 3678999999999999999999999 88 999999999999999999999999999864332
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.. ......++..|+|||.+....++.++||||||+++|+|++|..||.............+.. .. .. +
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~--~~-----~ 221 (264)
T cd06623 154 LD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DG--PP-----P 221 (264)
T ss_pred CC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cC--CC-----C
Confidence 21 1224568899999999999899999999999999999999999997654322222222211 10 00 1
Q ss_pred cccCCCChH-HHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 331 LLQGRYPMR-GLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. .+.. ....+.++|..||..+|+.||++.+|++.
T Consensus 222 ~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 S----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 1111 33678899999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.46 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=191.2
Q ss_pred eecccCceEEEEEEECCC--CcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCC
Q 009933 100 LLGEGGFGRVYKGRLEST--GQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~~--g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
.||+|+||+||++..... ...+++|.+..... .....+.+|+.+++.++||||++++++|......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999976432 24567777765432 334678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcce
Q 009933 177 LEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 256 (522)
Q Consensus 177 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 256 (522)
|.+++.........+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999764333345677788899999999999999998 999999999999999999999999998642221111122
Q ss_pred ecccCCccccChhhhhc-------CCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 257 TRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVFLELITG-RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 257 ~~~~gt~~y~APE~l~~-------~~~~~~sDVwSlGvll~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
....++..|+|||++.. ..++.++|||||||++|||+++ ..||...... ... ...+.. ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~---~~~~~~--~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVL---NHVIKD--QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHhh--cccccC
Confidence 34567889999999853 2457899999999999999974 6677543221 111 111111 112223
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
++.+... ....+.+|+..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333222 2346777899999 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=312.84 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=203.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.+.|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4679999999999999999998754 5679999886542 234578889999999999999999999887 778999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999752 2456788999999999999999999998 9999999999999999999999999998643221
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. .......++..|+|||++....++.++|||||||++|+|++ |..||...... .+..+. ......
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~------ 222 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYRM------ 222 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCCCCC------
Confidence 1 11122345678999999998889999999999999999999 89999754221 111111 111000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.87 Aligned_cols=265 Identities=27% Similarity=0.398 Sum_probs=218.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch-HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.+...+.++||+|-||.|.+|.... +..||||.++....... .+|..|+++|.+|+|||||.|+++|..++.+++|+|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 4556788899999999999999874 69999999987654444 789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||++|+|.+|+..... ..+.-.....|+.||+.|++||.+.+ +|||||.+.|+|+|.++++||+|||+++-+..+
T Consensus 616 YmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999987321 22455566789999999999999998 999999999999999999999999999987777
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT--GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
+........+-...|||||.+..++++.++|||+||++|||+++ ...||..... .+.+.-...++.....-.-+.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcceecc
Confidence 77777667777899999999999999999999999999999864 7788865432 233333333333322111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.|.-+...+.+|+.+||..+.++||++++|...|+..
T Consensus 768 -------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 -------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2223446778999999999999999999999999864
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.56 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=203.7
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
.|.....||+|+||.||++.+..+++.||||++..........+.+|+.++..++||||++++++|..++..++||||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 34455679999999999999988899999999976554555678899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-- 171 (297)
T cd06659 102 GGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-- 171 (297)
T ss_pred CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--
Confidence 9999998754 56899999999999999999999998 9999999999999999999999999987532221
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ 333 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 333 (522)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....+. ....... ... .+...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~---~~~-------~~~~~ 238 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLR---DSP-------PPKLK 238 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh---ccC-------CCCcc
Confidence 1123456899999999999889999999999999999999999999754321 1111110 000 00000
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
........+.+++.+||+.+|.+||++.+|++.--
T Consensus 239 --~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 239 --NAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred --ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 01112345778999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.11 Aligned_cols=240 Identities=23% Similarity=0.361 Sum_probs=189.0
Q ss_pred ceecccCceEEEEEEECCC------------CcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 99 CLLGEGGFGRVYKGRLEST------------GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~------------g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
+.||+|+||.||+|..... ...|++|++..........+..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986422 2358999887654444457888999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-------eeee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH-------PKLS 239 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~-------vkL~ 239 (522)
+||||+++++|..++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. ++|+
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999998864 2356899999999999999999999998 999999999999976654 8999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhh-cCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCCcchHHHhhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELI-TGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDVwSlGvll~eLl-tG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
|||++..... .....++..|+|||++. ...++.++|||||||++|||+ +|..||........ . ..
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~----~~ 221 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---E----RF 221 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---H----HH
Confidence 9999875321 12345788999999987 467899999999999999998 57777764322110 0 00
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.... .... ......+.+||.+||+.||.+||++.+|++.|
T Consensus 222 ~~~~---~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 YEGQ---CMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HhcC---ccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1110 0011 11234678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=319.60 Aligned_cols=271 Identities=23% Similarity=0.299 Sum_probs=202.1
Q ss_pred CCcccceecccCceEEEEEEECC--CCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC--CeeE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLES--TGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRL 166 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~--~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~~ 166 (522)
.|++.+.||+|+||.||+|.+.. +++.||||.+.... ......+.+|+.++..++||||++++++|.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48889999999999999999988 78999999997643 22335678899999999999999999999988 8899
Q ss_pred EEEeecCCCChhhhhccCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC----CCceeeeee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDK-EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE----GFHPKLSDF 241 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~----~~~vkL~DF 241 (522)
+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 7777775433222 37899999999999999999999999 999999999999999 999999999
Q ss_pred cceeeCCCCCC-CcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc-------hHHH
Q 009933 242 GLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH-------NLVA 312 (522)
Q Consensus 242 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~-------~~~~ 312 (522)
|++........ ........+++.|+|||++.+. .++.++|||||||++|+|++|+.||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986433221 1112345678999999988764 5889999999999999999999999755432210 0000
Q ss_pred hhhhh----------hhcccCCCCcCCccccCCCC---------h--HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 313 WARPL----------FKDRRKFPKMADPLLQGRYP---------M--RGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 313 ~~~~~----------~~~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....+ +..........+......++ . .....+.+++.+||+.||++|||+.+|+.+
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 00000000000000011111 0 233568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=336.90 Aligned_cols=246 Identities=32% Similarity=0.416 Sum_probs=205.9
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
-|..++.||.|+||.||-+++..+.+.||||++.....+ ...+++.|+..|.+|+|||+|.+.++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 477788899999999999999999999999999765443 34678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||- |+-.|+|.- .+.++.+.++..|+.+.+.||.|||+.+ .||||||..||||++.|.|||+|||.+.+..
T Consensus 107 YCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 107 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 995 577777754 3578999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
....++|||+|||||++. .+.|+-++|||||||+-.||.-.++|+.+...... +..+ ...
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYHI----------AQN 240 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI----------AQN 240 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHHH----------Hhc
Confidence 234688999999999986 46899999999999999999999999875533211 1111 111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
-.|.+. ..+....|..++..||+.-|.+|||.++++..
T Consensus 241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 122222 23445678999999999999999999988764
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=318.19 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=206.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
++|.+.+.||.|+||.||++.+..++..||+|.+........+.+.+|+.+++.++||||++++++|...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67999999999999999999998889999999997655455567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999865 45789999999999999999999999 99999999999999999999999999875433221
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
......+++.|+|||++....++.++|||||||++|+|++|+.||........... ...... +.+
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~-------~~~ 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGT-------PEL 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCC-------CCC
Confidence 22334688999999999888899999999999999999999999975433211100 000000 000
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
..+......+.++|.+||+.+|++||++.+++.+-
T Consensus 236 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 236 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 01112234677899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=315.63 Aligned_cols=267 Identities=23% Similarity=0.315 Sum_probs=200.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
+++|.+.+.||+|+||.||+|.+..++..||||++....... ...+.+|+.+|+.++|+||+++++++......|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 578999999999999999999999889999999997543322 3457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 688777654 1345788899999999999999999998 999999999999999999999999998753222
Q ss_pred CCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh-h-----hhhcccC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR-P-----LFKDRRK 323 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~-~-----~~~~~~~ 323 (522)
.. ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........-...|.. . .+.....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 11 12234578999999998754 58899999999999999999999997543311100000000 0 0000000
Q ss_pred CCCcCCccccCCCC---------hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 324 FPKMADPLLQGRYP---------MRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 324 ~~~~~d~~l~~~~~---------~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
++...........+ ......+.+|+.+|++.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 01111110000000 012356778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=312.27 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=192.4
Q ss_pred ceecccCceEEEEEEECC---CCcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEE-cCCeeEEEEeecC
Q 009933 99 CLLGEGGFGRVYKGRLES---TGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCA-DGDQRLLVYEFMP 173 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~---~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~-~~~~~~lV~E~~~ 173 (522)
++||+|+||.||+|.+.. ....||||.+.... ......+..|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998743 34679999985432 233457788999999999999999999875 4556899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999752 244677888999999999999999998 999999999999999999999999999753221110
Q ss_pred --cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 254 --HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG-RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 254 --~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.......++..|+|||++....++.++|||||||++|||++| ..||..... ..+.... .... .. .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~---~~~~-~~-~---- 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYL---LQGR-RL-L---- 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---hcCC-CC-C----
Confidence 011233457789999999988999999999999999999995 455643221 1112111 1110 00 0
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
. +......+.+|+..||+.+|++||++.+|++.|+.+.
T Consensus 223 -~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 -Q----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 0111246789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=315.35 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=203.4
Q ss_pred cCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
++|++...||+|+||.||+|+.+. +.+.|++|.+...... ....+..|+.+|+.++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578999999999999999999753 3567999998654333 3457889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPD-----KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
+||||+++++|.+++...... ...+++..++.++.||+.+|.|||+.+ |+|+||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999763211 126899999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
|++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .++... ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~---~~~ 234 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL---QAG 234 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH---HcC
Confidence 99874322111 11223346778999999988889999999999999999999 78888643221 111111 000
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.+. .. .+......+.+++.+||+.+|++||++.+++..|+
T Consensus 235 --~~~-~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 --KLE-LP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --CcC-CC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 00 01112256889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.03 Aligned_cols=264 Identities=26% Similarity=0.323 Sum_probs=200.7
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|++.+.||.|+||.||+|++..+++.||||++..... .....+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 58899999999999999999998999999999865432 2235688899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+. ++|.+++... ....+++..++.++.||+.||+|||+.+ |+|+||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 5899988652 2456899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCcceecccCCccccChhhhhcCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh--------------
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP-------------- 316 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~-------------- 316 (522)
.......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||....... .+......
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhH
Confidence 1123345788999999887654 6889999999999999999999997543211 11110000
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+......+.......+.. ........+.++|.+||+.||++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000111111111000 001122456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=312.02 Aligned_cols=248 Identities=27% Similarity=0.337 Sum_probs=204.6
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58899999999999999999998999999999976432 234678889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+++|.+++.. ...+++..+..++.||+.+|.|||+.+ |+|+||+|+|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999976 357899999999999999999999998 999999999999999999999999999864332
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. ......|+..|+|||++....++.++||||||+++|+|++|..||..........+... ......
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~-------- 219 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK---QETADV-------- 219 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH---hccccc--------
Confidence 1 22345688899999999988899999999999999999999999986543211111110 000111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCH--HHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLI--GDVV 366 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~--~evl 366 (522)
.++......+.++|.+||+.||.+||++ .|++
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 ----LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112223678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.99 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=205.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|+..+.||.|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.....+++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 367888999999999999999998999999999976543 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
+.+++|.+++... ...+++..+..++.||+.+|.|||+ .+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999762 2678999999999999999999999 88 999999999999999999999999998753211
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. .....++..|+|||++.+..++.++|||||||++|+|++|..||........ ............. .+
T Consensus 155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~-------~~ 222 (265)
T cd06605 155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEP-------PP 222 (265)
T ss_pred H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcCC-------CC
Confidence 1 1126688999999999998999999999999999999999999975432111 1122221111110 00
Q ss_pred cccCCCChH-HHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 331 LLQGRYPMR-GLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. .+.. ....+.++|..||..+|++||++.+++..
T Consensus 223 ~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 R----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 1111 33568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=329.39 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=202.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV 168 (522)
...|+++++||.||-+.||++.... .+.||+|++.... .+...-|.+|+.+|.+|+ |.+||+||+|-..++.+|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4569999999999999999999864 5677877765432 223456899999999997 99999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||=+ .+|..+|... ...++.-.++.+..||+.++.++|.++ |||.||||.|+|+-. |.+||+|||+|....
T Consensus 439 mE~Gd-~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eeccc-ccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99864 4999999762 222332388999999999999999999 999999999999975 589999999999876
Q ss_pred CCCCCcceecccCCccccChhhhhcCC-----------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQ-----------LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~-----------~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
.....-.....+||+.||+||.+.... .+.++||||||||||+|+.|+.||.... +..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~------ 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI------ 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH------
Confidence 665555667789999999999997543 4578999999999999999999996431 111
Q ss_pred hhcccCCCCcCCccccCCCChHH-HHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRG-LYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.++..+.+|....+|+.-- ...+++++..||+.||++||++.+||+.
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2334555554444444322 2338999999999999999999999873
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=309.50 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=203.5
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|++.+.||+|+||.||++.+..+++.+|||.+..... .....+..|+.+|+.++||||+++++++......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58899999999999999999998999999999976533 2345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-CceeeeeecceeeCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG-FHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~-~~vkL~DFGla~~~~~~ 250 (522)
+++++|.+++... ....+++..++.++.|++.+|.|||+++ |+|+||+|+|||++.+ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999752 2345899999999999999999999998 9999999999999754 46899999999865332
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. ......++..|+|||.+....++.++|||||||++|+|++|+.||....... ........ ....+
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~~--~~~~~--- 221 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMSG--TFAPI--- 221 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHhc--CCCCC---
Confidence 2 1223568899999999998889999999999999999999999997543211 11111110 01111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+......+.+++.+||+.+|.+||++.+++..
T Consensus 222 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11223567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=311.31 Aligned_cols=247 Identities=29% Similarity=0.460 Sum_probs=198.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
++|++.+.||+|+||.||++.. +++.||+|++.... ....+.+|+.++..++||||+++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4689999999999999999875 57889999986542 345788999999999999999999998764 579999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999752 2346889999999999999999999998 999999999999999999999999999863221
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
......+..|+|||++.+..++.++|||||||++|+|++ |..||....... .... ....... .
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~-~----- 217 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKEC----VEKGYRM-E----- 217 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH----HhCCCCC-C-----
Confidence 112234568999999998899999999999999999998 999987543211 1111 1111000 0
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.+......+.+|+.+||+.+|+.||++.+|++.|+.
T Consensus 218 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 ----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111223567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.49 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=203.9
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|.+.+.||+|+||.||++.+..+++.||||+++..... ....+..|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999999888999999999766543 456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.. ...+++..++.|+.|++.||.|||+.+ |+|+||+|+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999975 345889999999999999999999999 9999999999999999999999999998653322
Q ss_pred CCcc--eecccCCccccChhhhhcCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 252 KTHV--STRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 252 ~~~~--~~~~~gt~~y~APE~l~~~~---~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.... .....++..|+|||++.... ++.++|||||||++|+|++|+.||...... ........ ......++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~--~~~~~~~~~ 229 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVG--AGHKPPIPD 229 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHh--cCCCCCCCc
Confidence 2111 11356788999999998766 889999999999999999999999754211 11110000 010001110
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.......+.+++.+||+.+|.+||++.+++.
T Consensus 230 ----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 ----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0112356678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=312.45 Aligned_cols=258 Identities=27% Similarity=0.387 Sum_probs=200.3
Q ss_pred CcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCC------
Q 009933 95 FRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 163 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------ 163 (522)
|.+.++||+|+||.||+|.+. .+++.||||++..+.. ...+.+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999864 3578999999975432 23456888999999999999999999886542
Q ss_pred eeEEEEeecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
..++++||+.+++|.+++.... .....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 12235789999999999999999999998 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
|+++...............+++.|++||.+....++.++|||||||++|+|++ |+.||..... ..+..+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH---cC
Confidence 99986433222112223345678999999998899999999999999999999 8888864422 12222211 00
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+. .+......+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 232 -~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 -NRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 1112335788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=311.01 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=202.3
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCC---CCCcceeEEEEEcCCeeEEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~---hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.|++.+.||.|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.++ ||||++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 57888999999999999999998999999999875432 33456888999999997 999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ..+++..++.++.||+.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999865 37899999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... ......|+..|+|||.+... .++.++|||||||++|+|++|..||........ .... . ...
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~----~------~~~ 218 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLI----P------KSK 218 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhcc----c------cCC
Confidence 321 22345689999999998754 578999999999999999999999975432111 0000 0 000
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.+... .....+.+++.+||+.||++||++.+++..
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111110 123578899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=332.24 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=213.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch--HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~--~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
...|.+.+.||+|.|++|.++++..++..||||+|++...+.. +.+.+|+++|..|+|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4679999999999999999999999999999999988765443 45789999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+|.|++++.. ...+.+..+..++.|++.+++|||+++ |||||||.+||||+.+.++||+|||++.++.
T Consensus 135 eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence 99999999999987 466777899999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCcceecccCCccccChhhhhcCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
......+.+|++.|.|||++.+..|. +.+|+||+|++||.|+.|..||++... ..+-
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------------------k~Lr 264 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------------------KELR 264 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------------cccc
Confidence 33455678999999999999998874 799999999999999999999985422 2223
Q ss_pred CccccCCC--ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 329 DPLLQGRY--PMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 329 d~~l~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
++.+.+.| +.-...++-+||.++|-.+|.+|+++.+|.+.-
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 33333322 222345677899999999999999999987643
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=314.82 Aligned_cols=266 Identities=25% Similarity=0.354 Sum_probs=202.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcC--CeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~~lV 168 (522)
++|++.+.||.|+||.||+|.+..+++.+|||.++...... ...+.+|+.++..++||||+++++++... ...|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999999899999999997543222 23467899999999999999999999877 899999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+ +|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 999988652 236899999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH-Hhh-------hhhhh
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-AWA-------RPLFK 319 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~-~~~-------~~~~~ 319 (522)
... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||...........+ ... +..+.
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 322 122334578899999998764 4689999999999999999999999754332111100 000 00000
Q ss_pred c----c-cCCCCcCCccccCCCChH-HHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 320 D----R-RKFPKMADPLLQGRYPMR-GLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 320 ~----~-~~~~~~~d~~l~~~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
. . ..........+...++.. ....+.+||..||+.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0 000111111111222222 3456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=311.91 Aligned_cols=248 Identities=27% Similarity=0.362 Sum_probs=202.8
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
-|++.+.||.|+||.||+|.+..++..||||++..... .....+.+|+.++..++||||++++++|..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 47788899999999999999988899999999865432 22356788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++.. ..+++..+..++.|++.+|.|||+.+ |+|+||+|+|||++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999864 46889999999999999999999998 99999999999999999999999999876433221
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+... . .+.+
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~--~-----~~~~ 221 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPKN--N-----PPTL 221 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhcC--C-----CCCC
Confidence 122356888999999998888999999999999999999999999643221 111111010 0 0111
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+......+.+++.+||+.+|.+||++.+++..
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223567889999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=310.49 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=203.2
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
.|...+.||+|+||.||++.+..+++.++||++........+.+.+|+.+++.++||||+++++++...+..++|+||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 45556799999999999999988899999999875544445668899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+++|.+++.. ..+++..+..++.||+.+|.|||+.+ |+|+||+|+|||++.++.++|+|||++.......
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 9999999865 46889999999999999999999999 9999999999999999999999999887533221
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ 333 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 333 (522)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||....+. .....+.... .+.+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~~-------~~~~~ 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDNL-------PPKLK 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhcC-------CCCCc
Confidence 1223356899999999999888999999999999999999999999653321 1111111110 01110
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 011123568899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=340.11 Aligned_cols=271 Identities=20% Similarity=0.228 Sum_probs=190.8
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCC-cEEEEEEE--------------cc---CCccchHHHHHHHHHHHhCCCCC
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTG-QVVAVKQL--------------DR---NGLQGNREFLVEVLMLSLLHHSN 151 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g-~~vAvK~i--------------~~---~~~~~~~~~~~E~~~L~~l~hpn 151 (522)
...++|++.+.||+|+||+||+|..+... ..+++|.+ .+ ........+.+|+.+|..++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998875322 22222211 10 11112345788999999999999
Q ss_pred cceeEEEEEcCCeeEEEEeecCCCChhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 152 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
||++++++...+..|+|+|++. ++|.+++.... ..........++.|+.||+.||.|||+++ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999995 57877775421 11223345677889999999999999999 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA-IDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~P-f~~~~~~~~~~ 309 (522)
+.++.+||+|||++........ ......+||+.|+|||++.+..|+.++|||||||+||||++|..+ |..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999986533221 122346799999999999999999999999999999999998854 43322211122
Q ss_pred HHHhhhhhhhcccCCCC-------------------cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 310 LVAWARPLFKDRRKFPK-------------------MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~-------------------~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+......+......++. .+...+.. ......+.++|.+||+.||++||++.|++.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN---LGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh---cCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 22111110000000100 00000000 0112356778999999999999999999874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.84 Aligned_cols=265 Identities=24% Similarity=0.289 Sum_probs=201.6
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC------
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------ 162 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------ 162 (522)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986532 22335677899999999999999999988644
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
...|+||||+.+ +|.+++.. .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999964 88888754 2888999999999999999999998 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH-----------
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV----------- 311 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~----------- 311 (522)
++....... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998643221 123346789999999999999999999999999999999999999754321110000
Q ss_pred -Hh----hhhhhhccc-----CCCCcCCc----cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 312 -AW----ARPLFKDRR-----KFPKMADP----LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 312 -~~----~~~~~~~~~-----~~~~~~d~----~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.. ......... .+..+... ......+......+.+||.+||+.||++||++.++|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000000 00011111 00001111234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.13 Aligned_cols=267 Identities=25% Similarity=0.358 Sum_probs=201.8
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
+|++.+.||.|+||.||+|++..+++.||||++...... ....+..|+.+++.++|+||++++++|...+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588999999999999999999999999999999765433 2356778999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.+ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 85 8988886532 2346899999999999999999999998 9999999999999999999999999997532211
Q ss_pred CcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH-HHhhh-h---hhhcccCCCC
Q 009933 253 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL-VAWAR-P---LFKDRRKFPK 326 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~-~~~~~-~---~~~~~~~~~~ 326 (522)
.......++..|++||++.+. .++.++|||||||++|+|++|+.||........... ..... + .+..-.....
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 112234578899999998764 578999999999999999999999975433211110 00000 0 0000000000
Q ss_pred cCCcccc------CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 327 MADPLLQ------GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 327 ~~d~~l~------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
....... ..+.......+.+++.+||+.||.+||++.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0011122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=313.88 Aligned_cols=267 Identities=24% Similarity=0.287 Sum_probs=199.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCC-CCCcceeEEEEEcCCe-----
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ----- 164 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~----- 164 (522)
++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999999999999999998654322 2356788999999995 6999999999987665
Q ss_pred eEEEEeecCCCChhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCceeeeeec
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPD-KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFG 242 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-~~~vkL~DFG 242 (522)
.|+||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 898888653222 356899999999999999999999999 999999999999998 8899999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc-
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD- 320 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 320 (522)
++....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ +......+...
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 988542211 11223356889999998875 4579999999999999999999999975432211 11100000000
Q ss_pred ccC------------CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 RRK------------FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ~~~------------~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
... ........+. .........+.+||.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0000000000 0001233567899999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=301.68 Aligned_cols=253 Identities=27% Similarity=0.355 Sum_probs=207.4
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcC--CeeEEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLLVY 169 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~~lV~ 169 (522)
+|.+.+.||+|+||.||+|.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47888999999999999999998899999999976543 3356788999999999999999999999988 8999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+++|.+++.. ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999976 238999999999999999999999998 99999999999999999999999999987544
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
...........++..|+|||.+....++.++||||||+++|+|++|..||..... .......+.. .....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-~~~~~---- 223 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS-SGEPP---- 223 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc-cCCCc----
Confidence 3321112345688999999999988899999999999999999999999976541 1111111110 00111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.++......+.++|.+||+.+|.+||++.+++..
T Consensus 224 -----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 -----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1122224678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=314.25 Aligned_cols=257 Identities=24% Similarity=0.337 Sum_probs=198.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|...+.||+|+||.||++.+..+++.||||++...... ....+..|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 3566778899999999999999999999999999754332 3456788999999996 9999999999999999999999
Q ss_pred ecCCCChhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 171 FMPLGSLEDHLHDL-PPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 171 ~~~ggsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|+.. +|.++.... ......+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 665544321 11236799999999999999999999975 7 9999999999999999999999999987532
Q ss_pred CCCCCcceecccCCccccChhhhhcC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
... ......|+..|+|||++... .++.++|||||||++|+|++|+.||..... ...........
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~----- 226 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG----- 226 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC-----
Confidence 211 12234688999999999876 689999999999999999999999975431 11111111110
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+.+...........+.+|+.+||+.+|++||++.+|+..
T Consensus 227 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 --DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111111112344678899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=360.62 Aligned_cols=265 Identities=29% Similarity=0.498 Sum_probs=213.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
...|...++||+|+||.||+|.+..++..||||++..... ....|+.++++++|||||+++++|.+....|+||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 3567888899999999999999988899999999864322 123468899999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++|+|.++++. ++|..+..|+.||+.||+|||....++|+||||||+|||++.++..++. |+......
T Consensus 765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 999999999953 7899999999999999999995544449999999999999998888875 66554321
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
......+|+.|+|||++.+..|+.++|||||||++|||+||+.||+... .....++.|.+..+... ....++++.
T Consensus 834 ---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 908 (968)
T PLN00113 834 ---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDC-HLDMWIDPS 908 (968)
T ss_pred ---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCcc-chhheeCcc
Confidence 1122368899999999999999999999999999999999999995432 22345666665443332 234455555
Q ss_pred ccC--CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 332 LQG--RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 332 l~~--~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
+.. ..+.++...+.+|+.+||+.+|++||++.+|++.|+.+....
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 543 234566778899999999999999999999999999875433
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=304.29 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=209.3
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|.+.+.||.|+||.||++.+..++..||+|++..... .....+..|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58889999999999999999998899999999976544 3445688899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.........+++..+..++.+|+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999874434578999999999999999999999998 9999999999999999999999999998643322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.......|++.|+|||.+....++.++||||||+++|+|++|..||...... ......... ....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~--~~~~----- 222 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKG--QYPP----- 222 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcC--CCCC-----
Confidence 2233456889999999999888999999999999999999999999754321 111111111 1111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.+++.+||..+|++||++.++++.
T Consensus 223 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 ----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111223577899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.15 Aligned_cols=244 Identities=28% Similarity=0.365 Sum_probs=191.2
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHh---CCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSL---LHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~---l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
+||+|+||.||++.+..+++.||||.+....... ...+..|..++.. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999899999999997543221 1233445444443 479999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|||++......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 9999999865 457999999999999999999999999 999999999999999999999999998753221
Q ss_pred cceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
......|+..|+|||.+.. ..++.++|||||||++|+|++|..||..........+... .... .
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~~--------~--- 215 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTV--------N--- 215 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hhcC--------C---
Confidence 1123468999999999874 5689999999999999999999999975433221111110 0000 0
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTAL 369 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~L 369 (522)
...+......+.++|.+||+.||++|| ++++++++.
T Consensus 216 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 216 -VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred -cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 011222335778999999999999999 598888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=303.54 Aligned_cols=251 Identities=21% Similarity=0.349 Sum_probs=203.4
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|.+.+.||.|+||.||++.++.++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58889999999999999999999999999999976432 2345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeeecceeeCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKLGPVG 250 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DFGla~~~~~~ 250 (522)
+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999752 2345899999999999999999999998 99999999999998875 4699999998764322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
........|++.|+|||++....++.++|||||||++|+|++|..||..... ..+....... .+...
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~--~~~~~--- 222 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG--YFAPI--- 222 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc--cCCCC---
Confidence 1122334689999999999888899999999999999999999999864321 1122111111 11111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+......+.+++.+||+.+|++||++.+|+..
T Consensus 223 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.36 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=216.8
Q ss_pred cCCcccceecccCceEEEEEEECCCC---cEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTG---QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
....++++||.|.||.||+|+++..| ..||||.++....+ ...+|+.|+.||-++.||||++|.|+........||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34678899999999999999998766 46999999764333 346799999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
.|||++|+|+.||+. +.+.|++.++.-+++.|+.|++||-+++ +|||||...||||+.+...|++||||++++.
T Consensus 709 TEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999987 3466999999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcceecccC--CccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 249 VGDKTHVSTRVMG--TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 249 ~~~~~~~~~~~~g--t~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..... ..+..-| ...|.|||.+...+++.++|||||||+|||.++ |..||.+.... +.+.-+ ++.-
T Consensus 783 dd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIkaI----e~gy--- 851 (996)
T KOG0196|consen 783 DDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAI----EQGY--- 851 (996)
T ss_pred cCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHHHHH----Hhcc---
Confidence 43322 2222222 469999999999999999999999999999886 99998765432 222111 1111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.-..|.++...|.+|++.|||+|-.+||.+.+|+.+|..+..+.
T Consensus 852 -------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 852 -------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred -------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 22234556678999999999999999999999999999987554
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.97 Aligned_cols=270 Identities=25% Similarity=0.336 Sum_probs=198.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCC------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------ 163 (522)
.++|++.+.||+|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999999999999999998654322 2234567999999999999999999987654
Q ss_pred --eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 164 --QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 164 --~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
..++||||+.+ +|.+++.. ....+++.+++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 45999999964 88888764 2346899999999999999999999998 999999999999999999999999
Q ss_pred cceeeCCCCCCC--cceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh-
Q 009933 242 GLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL- 317 (522)
Q Consensus 242 Gla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~- 317 (522)
|++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999764322211 112334578899999988764 4788999999999999999999999765432211111111000
Q ss_pred ----hhcccC--------CCCcCCccccCCC-ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 ----FKDRRK--------FPKMADPLLQGRY-PMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ----~~~~~~--------~~~~~d~~l~~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+..... ++......+...+ +......+.+||.+||+.||.+||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0000000000000 00123456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=306.11 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=196.6
Q ss_pred HHHHHhhcCCccccee--cccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcC
Q 009933 86 RELAAATKNFRPECLL--GEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 162 (522)
Q Consensus 86 ~~~~~~~~~y~~~~~L--G~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~ 162 (522)
.+.....++|++.+.+ |.|+||.||++.++.++..+|+|++........ |+.....+ +||||++++++|...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677887776 999999999999999999999999875432211 22222222 699999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDF 241 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DF 241 (522)
+..++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+|+||||+|||++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999976 348999999999999999999999999 99999999999999888 9999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
|++...... ....++..|+|||++.+..++.++|||||||++|+|++|..||...... ......+.... ...
T Consensus 155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~~ 226 (267)
T PHA03390 155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-QKK 226 (267)
T ss_pred ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-ccc
Confidence 998764221 2245889999999999989999999999999999999999999744321 11222222111 000
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC-HHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-IGDVVT 367 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~evl~ 367 (522)
.. ........+.++|.+||+.+|.+||+ ++++++
T Consensus 227 ---~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ---LP---------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---CC---------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 11123357889999999999999995 688875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=297.32 Aligned_cols=251 Identities=29% Similarity=0.419 Sum_probs=206.7
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
.|++.+.||.|+||.||++.+..+++.+++|++..........+.+|+.+++.++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47888999999999999999988899999999977654456778899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+++|.+++... ...+++..+..++.|++.+|.|||..+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998762 257899999999999999999999988 99999999999999999999999999986543321
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ 333 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 333 (522)
.....++..|+|||++....++.++||||||+++|+|++|..||........ .... .. .........
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~---~~--~~~~~~~~~--- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFKI---AT--NGPPGLRNP--- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHH---Hh--cCCCCcCcc---
Confidence 2345688999999999988899999999999999999999999975432111 1000 00 111111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+.++|.+||+.||++||++.+|++.
T Consensus 221 ----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 ----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ----cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1113568899999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.50 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=212.5
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 87 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
+++-...+.....+||-|-||.||.|.++...-.||||.++.+.+ ..++|+.|+.+|+.++|||+|+|+++|..+-.+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 333334456667789999999999999998889999999987654 4688999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
||+|||.+|+|.+||.+. +...++....+.++.||..|++||..++ +|||||...|+|+.++..|||+||||+++
T Consensus 340 IiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999873 4566788888999999999999999999 99999999999999999999999999997
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..... ........-.+-|.|||-+....++.|+|||+|||+|||+.| |-.||.+-. +.+ +-.++...
T Consensus 415 MtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSq-VY~LLEkg---- 482 (1157)
T KOG4278|consen 415 MTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQ-VYGLLEKG---- 482 (1157)
T ss_pred hcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHH-HHHHHhcc----
Confidence 53322 212222233568999999999999999999999999999998 666775431 111 11112221
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..-.-|..+...+.+|+..||++.|.+||++.||-++|+.+
T Consensus 483 ------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 483 ------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 11122333446788999999999999999999999999765
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.89 Aligned_cols=265 Identities=22% Similarity=0.311 Sum_probs=199.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-----ee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-----QR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-----~~ 165 (522)
.++|++.++||+|+||.||+|.+..+++.||||++..... .....+..|+.+++.++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5789999999999999999999999999999999964322 23356778999999999999999999876543 57
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+.+ +|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 999999964 88888754 56999999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCC-CcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc--
Q 009933 246 LGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR-- 321 (522)
Q Consensus 246 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 321 (522)
....... ........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 6432211 111233568999999998765 468999999999999999999999996532211 111110000000
Q ss_pred cCCCCcCCcc-------c--cCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPL-------L--QGRYP-----MRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~-------l--~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+..+.+.. + ....+ ......+.+|+.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 0 00000 1123568899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=308.30 Aligned_cols=259 Identities=25% Similarity=0.303 Sum_probs=196.3
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCC-CCCcceeEEEEEcC--CeeEEEEe
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADG--DQRLLVYE 170 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~--~~~~lV~E 170 (522)
|++.+.||+|+||.||+|.+..+++.||||+++..... .......|+.++..+. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67889999999999999999989999999998754222 2234457888888885 99999999999987 88999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+. ++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 4888887652 357899999999999999999999999 999999999999999 99999999999864322
Q ss_pred CCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh----------
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK---------- 319 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---------- 319 (522)
. ......++..|+|||++.. ..++.++|||||||++|||++|..||......+ .+.+......
T Consensus 153 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 P---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred C---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence 1 1233567899999998754 457889999999999999999999997643311 1111111000
Q ss_pred -cccC----CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 320 -DRRK----FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 320 -~~~~----~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.... ++......+. .........+.+||.+||+.+|++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLR-KLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHH-HHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 0000000000 0011235688999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=308.21 Aligned_cols=263 Identities=27% Similarity=0.351 Sum_probs=200.4
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
|++.+.||.|++|.||+|.+..++..||||++...... ....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999989999999999754322 2356788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
. ++|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68999987622 246899999999999999999999998 99999999999999999999999999975432211
Q ss_pred CcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh--------------h
Q 009933 253 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP--------------L 317 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~--------------~ 317 (522)
......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........ +...... .
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhc
Confidence 12233568899999988764 578999999999999999999999975432111 1111000 0
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+......... .........+.++|.+||+.+|.+||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000001111111000 0111223578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=308.57 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=199.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.+++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999999989999999998654322 23567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~~~~ 249 (522)
|+. ++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||+|+|||++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5888887542 2234678889999999999999999998 999999999999985 56799999999975432
Q ss_pred CCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH-Hhhh----hhhhcccC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-AWAR----PLFKDRRK 323 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~-~~~~----~~~~~~~~ 323 (522)
. ........+++.|+|||++.+. .++.++|||||||++|+|+||..||............ .+.. ..+.....
T Consensus 156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 1 1122334678899999998764 5789999999999999999999999764332111100 0000 00000000
Q ss_pred C-------CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 324 F-------PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 324 ~-------~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+ +......+. .........+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000000 0011223467899999999999999999999873
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=306.04 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=207.0
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|++.+.||+|+||.||++.+..+++.+|||.+...... ....+..|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588899999999999999999989999999999764332 234677899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.........+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998764444567899999999999999999999999 999999999999999999999999999865433
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...... .+... .. ...+..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~---~~--~~~~~~----- 220 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYK---VQ--RGKYPP----- 220 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---Hh--cCCCCC-----
Confidence 222345889999999999989999999999999999999999999754321 11111 00 011111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 ----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112334678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=312.18 Aligned_cols=270 Identities=24% Similarity=0.345 Sum_probs=201.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcC--CeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~~l 167 (522)
.++|++.+.||+|+||.||+|.+..+++.||+|+++...... ...+.+|+.+++.++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999999999999999997543222 23456799999999999999999998765 56899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+.+ +|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999965 888888652 356899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH-hhh----hhhhcc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA-WAR----PLFKDR 321 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~-~~~----~~~~~~ 321 (522)
..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+. ... ..+...
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 43221 1223346788999999875 468899999999999999999999997543322111110 000 000000
Q ss_pred cCCCCcCCcccc-CCCC------hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 322 RKFPKMADPLLQ-GRYP------MRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 322 ~~~~~~~d~~l~-~~~~------~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
..++......+. ..+. ......+.+||.+||+.||++||++.+|+..-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 000000000000 0000 012456778999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=303.38 Aligned_cols=243 Identities=28% Similarity=0.367 Sum_probs=198.5
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
||.|+||.||+|.+..+++.||||++...... ....+..|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999988999999999764332 235688899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999976 345899999999999999999999998 9999999999999999999999999998654322 123
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 337 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 337 (522)
...++..|++||++....++.++||||||+++|+|++|..||...... ............ ....++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~----------~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGN----------GKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccC----------CCCCCC
Confidence 356889999999998888999999999999999999999999765421 111111111000 001122
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q 009933 338 MRGLYQALAVAAMCLQEQAATRPL-----IGDVVT 367 (522)
Q Consensus 338 ~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~ 367 (522)
......+.+++.+||+.+|++||+ +.|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 222457889999999999999999 777766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=307.11 Aligned_cols=245 Identities=29% Similarity=0.399 Sum_probs=195.2
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
||+|+||+||+|.+..+++.||+|++..... .....+..|+.+|+.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999998999999999975432 2234567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
.+++... ....+++..++.++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 9999752 2246899999999999999999999999 999999999999999999999999998754321 1122
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 337 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 337 (522)
...++..|+|||++.+..++.++|||||||++|+|++|+.||............. ........ .++
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~------------~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLEMAV------------EYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hccccccc------------cCC
Confidence 3457889999999998889999999999999999999999997543321111110 00011000 112
Q ss_pred hHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q 009933 338 MRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 367 (522)
Q Consensus 338 ~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~ 367 (522)
......+.++|.+||+.+|.+|| ++.+++.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 22245678999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=304.57 Aligned_cols=251 Identities=24% Similarity=0.269 Sum_probs=201.0
Q ss_pred hhcCCccc-ceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEc----CCe
Q 009933 91 ATKNFRPE-CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCAD----GDQ 164 (522)
Q Consensus 91 ~~~~y~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~----~~~ 164 (522)
++++|.+. ++||-|-.|+|..|.++.|++.+|+|++. +.....+|+++.-.. .|||||.++++|++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 46777775 57999999999999999999999999984 334556788775555 49999999998865 357
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCceeeeee
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDF 241 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld---~~~~vkL~DF 241 (522)
+++|||.|+||.|+..+++ .....+++.++..|+.||..||.|||+.+ |.||||||+|+|.. .+-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 7899999999999999987 33567999999999999999999999999 99999999999995 4567999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
|+|+.... .....+.+-||+|+|||++....|+..+|+||+||++|.||+|..||....-....
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais------------- 272 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------- 272 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-------------
Confidence 99996432 22345577899999999999999999999999999999999999999754321110
Q ss_pred cCCCCcCCccccC--CCChHH----HHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 322 RKFPKMADPLLQG--RYPMRG----LYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 322 ~~~~~~~d~~l~~--~~~~~~----~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+-+-..+..+ .||..+ +....++|..+|..+|.+|.|+.+++..-.
T Consensus 273 ---pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 273 ---PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred ---hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 0111111111 234333 346778999999999999999999987543
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=298.85 Aligned_cols=248 Identities=29% Similarity=0.431 Sum_probs=205.2
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|++.+.||+|+||.||++.+..+++.|+||.+..... .....+.+|++++..++|+||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 48889999999999999999998899999999977654 3446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+++.. ...+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999876 367899999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
. ......++..|+|||.+....++.++||||||+++|+|++|..||..... ......... .....
T Consensus 154 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~---~~~~~----- 218 (254)
T cd06627 154 K--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRIVQ---DDHPP----- 218 (254)
T ss_pred c--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc---cCCCC-----
Confidence 2 12335688999999999888889999999999999999999999975431 111110000 11111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.+......+.+++.+||..+|++||++.+++.
T Consensus 219 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 ----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11122356779999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.38 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=207.9
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..+.|+..+.||.|+||.||++.+..++..|++|++..... ....+..|+.+++.++|+||++++++|......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45678999999999999999999998899999999976543 45678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999862 137999999999999999999999998 999999999999999999999999998754322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. .......++..|++||++.+..++.++|||||||++|+|++|+.||....+... ... .... .......
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~----~~~~--~~~~~~~- 238 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFL----ITTK--GIPPLKN- 238 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHhc--CCCCCcc-
Confidence 1 122334578899999999988899999999999999999999999865422110 110 0010 0111111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+......+.+||.+||+.+|..||++.+|+...-
T Consensus 239 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 239 ------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred ------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 1112356788999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=313.48 Aligned_cols=250 Identities=31% Similarity=0.407 Sum_probs=200.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.+.|.+.+.||+|+||+||+|.+..+++.||||++...... ....+.+|+.+++.++||||++++++|...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35689999999999999999999888999999998654322 234678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 577777753 1346899999999999999999999998 9999999999999999999999999987643
Q ss_pred CCCCCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
.. ....+++.|+|||++. ...++.++||||||+++|||++|..||........ .... ... ...
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~~---~~~--~~~ 232 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI---AQN--DSP 232 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHHH---hcC--CCC
Confidence 21 2346888999999885 35688999999999999999999999865422111 1000 000 000
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
... +......+.+|+.+||+.+|++||++.+|+....
T Consensus 233 ~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 233 TLS--------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CCC--------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 100 1122356889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=315.76 Aligned_cols=273 Identities=21% Similarity=0.274 Sum_probs=210.8
Q ss_pred ccHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC--CC----CcceeE
Q 009933 83 FTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH--HS----NLVNLI 156 (522)
Q Consensus 83 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~--hp----nIv~l~ 156 (522)
+.+......+++|.+..+||+|+||.|..+.+..++..||||+++.-. .-.+..+.|+++|.++. -| -+|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 444445555889999999999999999999999999999999996422 22344567999999995 23 378899
Q ss_pred EEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-----
Q 009933 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD----- 231 (522)
Q Consensus 157 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld----- 231 (522)
+||...++.|||+|.+ |-+++++|.. +...+++...++.|+.||+.+++|||+.. ++|.||||+|||+.
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceE
Confidence 9999999999999998 6699999987 45678899999999999999999999999 99999999999993
Q ss_pred ---------------CCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCC
Q 009933 232 ---------------EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296 (522)
Q Consensus 232 ---------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~ 296 (522)
.+..|+|+|||.+...... .+.++.|..|.|||++.+-.++..+||||+||||+||.||.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 1346899999999973322 24577899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHHhhh--------------hhhhcccCC-----------C---CcCCcccc-CCCChHHHHHHHHH
Q 009933 297 KAIDNTRPPGEHNLVAWAR--------------PLFKDRRKF-----------P---KMADPLLQ-GRYPMRGLYQALAV 347 (522)
Q Consensus 297 ~Pf~~~~~~~~~~~~~~~~--------------~~~~~~~~~-----------~---~~~d~~l~-~~~~~~~~~~l~~L 347 (522)
..|......+...+...+. ..+... .+ . +...++-. -.....+..+|++|
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 9998776433322221110 000000 00 0 00000000 01122456689999
Q ss_pred HHHhcccCcCCCCCHHHHHHH
Q 009933 348 AAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 348 i~~cl~~dP~~RPs~~evl~~ 368 (522)
+..||..||.+|+|+.|++..
T Consensus 386 l~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHccCccccccHHHHhcC
Confidence 999999999999999999874
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.81 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=199.4
Q ss_pred cccceecccCceEEEEEEECCCCcEEEEEEEccCC----ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe--eEEEE
Q 009933 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG----LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ--RLLVY 169 (522)
Q Consensus 96 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~--~~lV~ 169 (522)
+...+||+|+|-+||+|.|..+|..||--.++... ....+.|..|+.+|+.|+|||||++|+++.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999999999999876654322 2233678999999999999999999999987655 78999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCceeeeeecceeeCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGP 248 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~~~ 248 (522)
|++..|+|..|+++ ...++...+..|++||++||.|||++ .|||||||||.+||||+. .|.|||+|+|||.+..
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999987 46788889999999999999999998 589999999999999964 6899999999999743
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc--ccCCCC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD--RRKFPK 326 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 326 (522)
.. ....++|||.|||||+.. ..|+..+||||||++|+||+|+..||..+..+... .+.+... ...+.+
T Consensus 198 ~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI-----YKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 198 KS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI-----YKKVTSGIKPAALSK 267 (632)
T ss_pred cc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH-----HHHHHcCCCHHHhhc
Confidence 21 233478999999999877 79999999999999999999999999876543221 1111111 112233
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+-|| ++.+||.+||.. .++|||+.|+|..
T Consensus 268 V~dP------------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 VKDP------------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cCCH------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3333 556899999999 9999999999873
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=306.92 Aligned_cols=266 Identities=23% Similarity=0.295 Sum_probs=201.4
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC--CeeEEEEe
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLLVYE 170 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~~lV~E 170 (522)
|++.+.||.|+||.||+|.+..+++.||||++.... ......+..|+.+++.++|+||+++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999999889999999997653 22335678899999999999999999999888 89999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++ +|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||+|+|||+++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 898888652 257899999999999999999999998 999999999999999999999999999865433
Q ss_pred CCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH-Hhhhhhhhcc-cCCC--
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-AWARPLFKDR-RKFP-- 325 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~-~~~~-- 325 (522)
.. .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+ .......... ..+.
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 11233457889999998765 46889999999999999999999999755432111111 0000000000 0000
Q ss_pred ---------CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 326 ---------KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 326 ---------~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+...+.......+.+++.+||+.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000001111124578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=303.83 Aligned_cols=251 Identities=25% Similarity=0.302 Sum_probs=199.7
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-----ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC--Cee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-----LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQR 165 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~ 165 (522)
.+|++.++||+|+||.||++.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999885321 12234678899999999999999999998764 468
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999865 356889999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCC-CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 246 LGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 246 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
....... ........++..|+|||++.+..++.++|||||||++|+|++|+.||...... ...... ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~~--~~ 226 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFKI----ATQ--PT 226 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHHH----HcC--CC
Confidence 5422111 11122356899999999999888999999999999999999999999753221 111110 000 00
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
. ..++......+.+++.+||+ +|..||++.+++.
T Consensus 227 ~--------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 K--------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred C--------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0 11222334678899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=301.29 Aligned_cols=244 Identities=24% Similarity=0.306 Sum_probs=190.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHH-HHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLM-LSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~-L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
+.||.|+||.||+|.+..+++.||||++....... ...+..|..+ +..++|+||+++++++...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999999889999999997543222 1233445444 4455899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999975 356899999999999999999999998 99999999999999999999999999875322
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .. ...............
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~~~~~~~~~~~------ 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AV---FDNILSRRINWPEEV------ 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHhcccCCCCcc------
Confidence 22346889999999998888999999999999999999999999643221 11 111111110001100
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.......+.+++.+||+.+|++||++.++.+.|
T Consensus 217 --~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 --KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred --cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 112235688999999999999999776554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=302.51 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=198.6
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
||.|+||.||++.+..+++.|+||++..... .....+.+|+.++..++||||+++++.+......|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999976543 2345688899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC-----
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK----- 252 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~----- 252 (522)
.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||+|+|||+++++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999976 247899999999999999999999999 99999999999999999999999999886433211
Q ss_pred -CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 253 -THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 253 -~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
........++..|+|||++....++.++||||||+++|+|++|..||...... .....+.......+...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~--- 224 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILNGKIEWPEDV--- 224 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCcCCCccc---
Confidence 11223456788999999999888999999999999999999999999754321 11111111111111000
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.....+.+++.+||+.+|++||++..+.+.|+
T Consensus 225 -------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 -------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01357789999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=315.38 Aligned_cols=269 Identities=25% Similarity=0.296 Sum_probs=200.7
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcC--Cee
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADG--DQR 165 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~--~~~ 165 (522)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..+ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567999999999999999999998889999999985431 22334577899999999 999999999998654 468
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 499998865 37889999999999999999999998 9999999999999999999999999998
Q ss_pred eCCCCCCC---cceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc-
Q 009933 246 LGPVGDKT---HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD- 320 (522)
Q Consensus 246 ~~~~~~~~---~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 320 (522)
........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....+......+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65332211 12234568999999998765 46789999999999999999999999654332111100000000000
Q ss_pred ------ccCCCCcCCccccC------CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 ------RRKFPKMADPLLQG------RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ------~~~~~~~~d~~l~~------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+++..... .........+.++|.+||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 0001134578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=315.27 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=201.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC-----Ce
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~-----~~ 164 (522)
..+|.+.+.||+|+||+||++.+..+++.||||.+.... ......+..|+.+|+.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999999999999999987532 22334577899999999999999999988654 35
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.||||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 689888865 467999999999999999999999998 999999999999999999999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc---
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD--- 320 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~--- 320 (522)
....... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||...... ............
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 230 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSE 230 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCCh
Confidence 8643221 12234567889999999875 46899999999999999999999999654211 001000000000
Q ss_pred --------c------cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 --------R------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 --------~------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. ..+.......+.. ........+.+||.+||+.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 0000000000000 011234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=345.22 Aligned_cols=259 Identities=27% Similarity=0.313 Sum_probs=211.0
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcC
Q 009933 86 RELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADG 162 (522)
Q Consensus 86 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~ 162 (522)
.++....++|.++++||+|+||.|.+++++.++++||+|++.+... ....-|..|-.+|..-+.+-|+.++..|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4555566789999999999999999999999999999999977332 3345688899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
.++|||||||+||+|..++..+ .++++..+++++..|+.||.-||+.| +|||||||+|||||..|+|||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999773 48999999999999999999999999 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
.|-... .+..-.+...+|||.|++||++.. +.|+..+|+||+||++||||.|..||... .++.-...+
T Consensus 221 sClkm~-~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KI 293 (1317)
T KOG0612|consen 221 SCLKMD-ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKI 293 (1317)
T ss_pred hHHhcC-CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHH
Confidence 987643 233444566789999999999963 56999999999999999999999999743 333322223
Q ss_pred hhc--ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC---HHHHHHHH
Q 009933 318 FKD--RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL---IGDVVTAL 369 (522)
Q Consensus 318 ~~~--~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~~evl~~L 369 (522)
+.. .-.|+.. .+.+....+||.+.+. +|+.|.. +++|-.+.
T Consensus 294 m~hk~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 294 MNHKESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hchhhhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 322 1122211 1234567778887665 5777877 87776644
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=308.52 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=199.7
Q ss_pred ccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCC
Q 009933 97 PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 97 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
....||+|+||.||++.+..+++.||||++..........+.+|+.+++.++|+||++++++|...+..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 34679999999999999998999999999865544445668899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcce
Q 009933 177 LEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 256 (522)
Q Consensus 177 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 256 (522)
|.+++.. ..+++..+..++.|++.+|.|||+.+ |+|+||+|+||++++++.++|+|||++....... ...
T Consensus 104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~ 173 (292)
T cd06657 104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR 173 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccc
Confidence 9998754 46889999999999999999999998 9999999999999999999999999987543221 122
Q ss_pred ecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCC
Q 009933 257 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRY 336 (522)
Q Consensus 257 ~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 336 (522)
....|++.|+|||++....++.++|||||||++|+|++|..||...... ..+..... .++..+.. +
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~------~~~~~~~~-~---- 239 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD------NLPPKLKN-L---- 239 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh------hCCcccCC-c----
Confidence 3356889999999998888999999999999999999999999753221 11111110 01111100 0
Q ss_pred ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 337 PMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 337 ~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+.+++.+||+.+|.+||++.+|+..
T Consensus 240 -~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 -HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred -ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0122456789999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.36 Aligned_cols=257 Identities=16% Similarity=0.178 Sum_probs=188.4
Q ss_pred hcCCcccceecccCceEEEEEEECCC---CcEEEEEEEccCCccchH-----------HHHHHHHHHHhCCCCCcceeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGLQGNR-----------EFLVEVLMLSLLHHSNLVNLIG 157 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~~~~~~-----------~~~~E~~~L~~l~hpnIv~l~~ 157 (522)
.++|.+.++||+|+||+||+|.+..+ +..+|+|+.......... ....++..+..+.|+||+.+++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999999876 667788765433211111 1122334456678999999999
Q ss_pred EEEcCC----eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 009933 158 YCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG 233 (522)
Q Consensus 158 ~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~ 233 (522)
++.... ..++++|++. .++.+.+.. ....++..+..|+.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 776543 3467888874 367776654 234578889999999999999999998 9999999999999999
Q ss_pred CceeeeeecceeeCCCCCCC-----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 009933 234 FHPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH 308 (522)
Q Consensus 234 ~~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~ 308 (522)
+.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999864322111 1112346999999999999999999999999999999999999999865322111
Q ss_pred h-H--HHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 309 N-L--VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 309 ~-~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
. . ..+...+......+ ......+.+++..|++.+|++||++.+|++.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKIKI-------------KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhhhhcc-------------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 0 11111111110000 11135688999999999999999999999876
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=312.29 Aligned_cols=251 Identities=30% Similarity=0.407 Sum_probs=200.5
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.|...+.||+|+||.||++.+..++..||||++...... ....+..|+.+++.++||||++++++|......+||||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 477888999999999999999888999999999754322 23467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+ +|.+++.. ...++++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 106 YCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 9975 78777754 2456899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.....|++.|+|||++. ...++.++|||||||++|+|++|+.||........ +..+ .... ....
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~----~~~~--~~~~ 244 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI----AQNE--SPTL 244 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHH----Hhcc--CCCC
Confidence 12346889999999984 45688999999999999999999999865321110 1111 1110 0000
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
. .......+.+|+.+||+.+|.+||++.+|++.+..+.
T Consensus 245 ~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 Q--------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred C--------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0 1112346789999999999999999999998776543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=312.98 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=195.9
Q ss_pred ceeccc--CceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEG--GFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G--~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
..||+| +||+||++.+..+++.||||++...... ..+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 9999999999999999999998754322 235678899999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC-CC
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD-KT 253 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~-~~ 253 (522)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+||+.+....... ..
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987632 345889999999999999999999998 9999999999999999999999998654321110 00
Q ss_pred cc----eecccCCccccChhhhhcC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh----------
Q 009933 254 HV----STRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL---------- 317 (522)
Q Consensus 254 ~~----~~~~~gt~~y~APE~l~~~--~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~---------- 317 (522)
.. .....++..|+|||++.+. .++.++|||||||++|+|++|..||....... .+.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 00 0112345679999999763 57899999999999999999999997543211 111000000
Q ss_pred ------hhcc---------------cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 318 ------FKDR---------------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 318 ------~~~~---------------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
+... .....+....+....+......+.+|+.+||+.||++|||+.++++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000 000011111111122234556889999999999999999999998744
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=315.13 Aligned_cols=271 Identities=22% Similarity=0.302 Sum_probs=203.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEc----CCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~----~~~~ 165 (522)
..+|++.+.||.|+||.||+|.+..+++.||||++.... ......+..|+.+|+.++||||++++++|.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999999999999999997542 2234567789999999999999999998753 3568
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 589998865 456999999999999999999999998 9999999999999999999999999997
Q ss_pred eCCCCCCC--cceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh-----h
Q 009933 246 LGPVGDKT--HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP-----L 317 (522)
Q Consensus 246 ~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~-----~ 317 (522)
........ .......++..|+|||++.. ..++.++|||||||++|+|++|+.||...........+..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 64322211 11234578999999999865 4689999999999999999999999975433211111000000 0
Q ss_pred hhc--ccCCCCcCCccc-cCCC-----ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 318 FKD--RRKFPKMADPLL-QGRY-----PMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 318 ~~~--~~~~~~~~d~~l-~~~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+.. ...+....+... .... .......+.++|.+||+.+|.+||++.+++..-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 000 000000000000 0000 0123467889999999999999999999988544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.62 Aligned_cols=243 Identities=28% Similarity=0.362 Sum_probs=191.1
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHH---HHHhCCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVL---MLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~---~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
+||+|+||.||++.+..+++.||||++....... ...+..|.. ++....||||+.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999889999999997653321 122334433 4445679999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 9999998865 457999999999999999999999998 999999999999999999999999998753221
Q ss_pred cceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
......|+..|+|||++.+. .++.++|||||||++|+|++|+.||............ ...... ..
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~--------~~-- 216 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTM--------AV-- 216 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhhcc--------CC--
Confidence 12234689999999999754 6899999999999999999999999765332211111 000000 00
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
.++......+.+++.+||..+|.+|| ++.++++.
T Consensus 217 --~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11122246788999999999999999 89999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=314.72 Aligned_cols=242 Identities=27% Similarity=0.397 Sum_probs=204.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchH---HHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~---~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~l 167 (522)
..+|..+.+||+|+||+|.++..+.+.+.||||+++++.+.... --+.|-.+|.... -|+++++..+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 35688899999999999999999999999999999887654332 3456888888775 6789999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+.||+|--+|++. +.+.+..+..++..|+-||-|||+++ ||+||||.+|||||.+|+|||+|||+++..
T Consensus 428 VMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999874 56777789999999999999999999 999999999999999999999999999974
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
..... ...+++|||.|+|||++...+|+..+|+|||||+|||||.|+.||++....+ ..+.+....
T Consensus 501 i~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------lF~aI~ehn------ 566 (683)
T KOG0696|consen 501 IFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQAIMEHN------ 566 (683)
T ss_pred ccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHcc------
Confidence 44332 3457899999999999999999999999999999999999999998753311 111122221
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCC
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP 360 (522)
-.||...+.+...|+...|..+|.+|.
T Consensus 567 ------vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ------VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 125666667889999999999999996
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=304.68 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=204.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV 168 (522)
++|.+.+.||.|+||.||++.+..+++.||||++..... .....+..|+.++..+. |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 478999999999999999999998999999999976332 22356788999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999976 347999999999999999999999999 9999999999999999999999999988643
Q ss_pred CCCCC------------------cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH
Q 009933 249 VGDKT------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 310 (522)
Q Consensus 249 ~~~~~------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~ 310 (522)
..... .......++..|+|||++....++.++|||||||++|+|++|+.||..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH
Confidence 32211 112234578999999999988899999999999999999999999975531 111
Q ss_pred HHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCH----HHHHH
Q 009933 311 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI----GDVVT 367 (522)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~----~evl~ 367 (522)
. ......... ++......+.+||.+||+.+|.+||++ .+++.
T Consensus 231 ~---~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 F---QKILKLEYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H---HHHHhcCCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 111111111 111223567899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.63 Aligned_cols=269 Identities=27% Similarity=0.347 Sum_probs=200.3
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCC----
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD---- 163 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~---- 163 (522)
...++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+..|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999998899999999975432 22345678999999999999999999987655
Q ss_pred ------eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcee
Q 009933 164 ------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK 237 (522)
Q Consensus 164 ------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vk 237 (522)
.+++||||+++ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999976 77777754 2356899999999999999999999998 99999999999999999999
Q ss_pred eeeecceeeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh-h
Q 009933 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA-R 315 (522)
Q Consensus 238 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~-~ 315 (522)
|+|||++........ .......++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+... .
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999986433221 112233467889999988653 5789999999999999999999999754321111111100 0
Q ss_pred -hh---hhcccCCCCc--CC------ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 316 -PL---FKDRRKFPKM--AD------PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 316 -~~---~~~~~~~~~~--~d------~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
+. +..-...... .+ ..+...+ ......+.+|+.+||+.+|.+||++.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000000000 00 0000000 012356889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=304.21 Aligned_cols=263 Identities=26% Similarity=0.319 Sum_probs=202.1
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ....+..|+.+|+.++|+||+++++++......++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 66788999999999999999888999999998765433 3456788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
.+ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 88888865 2357899999999999999999999999 9999999999999999999999999998754332
Q ss_pred CcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh--hhhhhccc-------
Q 009933 253 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA--RPLFKDRR------- 322 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~------- 322 (522)
.......++..|+|||.+.+. .++.++|||||||++|+|++|+.||............... ........
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 122335678899999999876 7899999999999999999999999754331111100000 00000000
Q ss_pred ----CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 323 ----KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 323 ----~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.++....... ..........+.++|..||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000000 0011123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=299.13 Aligned_cols=267 Identities=24% Similarity=0.352 Sum_probs=206.9
Q ss_pred cHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcC
Q 009933 84 TFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADG 162 (522)
Q Consensus 84 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~ 162 (522)
+|.++...+. ++||+|+|+.|-.+....+|..||||+|.+........+.+|++++...+ |+||+.|+++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3455544443 68999999999999999999999999999887667778999999999987 99999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---ceeee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF---HPKLS 239 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~---~vkL~ 239 (522)
..+|||||.|.||.|..+|++ ...+++.++.++.++|+.||.|||.++ |.||||||+|||..+.. -||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999987 578999999999999999999999999 99999999999995543 48999
Q ss_pred eecceeeCCCCCC-----CcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 009933 240 DFGLAKLGPVGDK-----THVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN 309 (522)
Q Consensus 240 DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~ 309 (522)
||.+..-...... +....+.+|+..|||||+.. ...|+.++|.||||||||.||+|..||.+.-..+.
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC-- 299 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC-- 299 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--
Confidence 9988753222111 11223567999999999874 23689999999999999999999999986543211
Q ss_pred HHHhhhhhhhcccCCCCcCCccccC--CCChHH----HHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQG--RYPMRG----LYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~----~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.|-+...- +.--..++..+..+ ++|.++ ..+..+||...|..|+.+|.++..++.
T Consensus 300 --GWdrGe~C-r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 --GWDRGEVC-RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred --CccCCCcc-HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11100000 00000111222222 244433 346678999999999999999888876
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=298.05 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=201.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-ccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++.+.+..||.|+.|.|++++.+.+|..+|||.+.+.. .+....++..+.++.+.+ +|+||+.+|||..+...+|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 44556678999999999999999999999999997754 334466777777776665 9999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
.|. ..+..+++.. ..++++..+-++...++.||.||.++.. |||||+||+|||||+.|+|||||||++-.+...
T Consensus 172 lMs-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHH-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecc
Confidence 984 3556666542 4679999999999999999999998764 999999999999999999999999999764332
Q ss_pred CCCcceecccCCccccChhhhhc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
...+...|-+.|||||.+.- ..|+.++|||||||+|+||.||+.||......-+ .+ ..++++ .+..
T Consensus 246 ---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~l---tkvln~---ePP~ 314 (391)
T KOG0983|consen 246 ---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VL---TKVLNE---EPPL 314 (391)
T ss_pred ---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HH---HHHHhc---CCCC
Confidence 23455679999999999874 3799999999999999999999999987644211 11 111111 1122
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
++... .....+.+++..||+.|+.+||.+.++++.-
T Consensus 315 L~~~~------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 315 LPGHM------GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred CCccc------CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 22211 1346788999999999999999999998854
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.54 Aligned_cols=269 Identities=26% Similarity=0.337 Sum_probs=198.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcC-------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADG------- 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------- 162 (522)
.++|++.+.||.|+||.||+|.+..+++.||||++....... ...+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999986543222 24567899999999999999999987543
Q ss_pred -CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 163 -DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 163 -~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
..+++||||+.+ +|..++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 346999999965 77777654 2357999999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCCC---------cceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 009933 242 GLAKLGPVGDKT---------HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV 311 (522)
Q Consensus 242 Gla~~~~~~~~~---------~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~ 311 (522)
|++......... ...+...+++.|+|||++.+. .++.++|||||||++|||++|+.||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999754322111 112334678899999988754 5889999999999999999999999754332111111
Q ss_pred Hhh-hh----hhhcccCCCCcCCccccCCCC-------hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 312 AWA-RP----LFKDRRKFPKMADPLLQGRYP-------MRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 312 ~~~-~~----~~~~~~~~~~~~d~~l~~~~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
... .. .+.....+....+.......+ ......+.++|.+||+.+|.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 00 000000011111000000011 112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.96 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=199.0
Q ss_pred CCcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCc----cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~----~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~ 165 (522)
+|++.+.||.|+||.||+|.+. .+|..||+|++..... ...+.+..|+.+|..+ +|+||+.++++|..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4888999999999999999984 4689999999975322 2235677899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999975 456889999999999999999999998 9999999999999999999999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
....... .......|+..|+|||++... .++.++|||||||++|+|++|..||........ ...+..........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~ 230 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEPP 230 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccCCC
Confidence 6432221 122245689999999998753 478899999999999999999999974322111 11112111111111
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
++......+.+|+.+||+.+|++|| ++.+++..
T Consensus 231 ------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 ------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1222335677999999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=301.36 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=204.5
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch---HHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLL-HHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~ 166 (522)
..++|.++++||+|+|.+|.+++++.|.+.||+|++++.-..+. .-++.|..+...- +||++|-+..+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 35789999999999999999999999999999999987544333 3356677777665 6999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+|.||++||+|--+++. ...|+++.++.+...|+.||.|||+.+ ||+||||.+|||||..|+|||+|+|+++.
T Consensus 328 fvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999888876 578999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--CCCcchHHHh-hhhhhhcccC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR--PPGEHNLVAW-ARPLFKDRRK 323 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~--~~~~~~~~~~-~~~~~~~~~~ 323 (522)
.. .......+++|||.|.|||++.+..|...+|+|+|||+|+||+.|+.||+--. .++ .+...+ .+.++...-.
T Consensus 401 ~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-~ntedylfqvilekqir 477 (593)
T KOG0695|consen 401 GL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-MNTEDYLFQVILEKQIR 477 (593)
T ss_pred CC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-cchhHHHHHHHhhhccc
Confidence 32 22334567999999999999999999999999999999999999999998432 222 222222 2333333222
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 361 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs 361 (522)
+ |.........++..-|..||++|.-
T Consensus 478 i------------prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 I------------PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred c------------cceeehhhHHHHHHhhcCCcHHhcC
Confidence 2 2222345567889999999999863
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=299.76 Aligned_cols=262 Identities=26% Similarity=0.344 Sum_probs=196.7
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhC---CCCCcceeEEEEEcCCe-----
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLL---HHSNLVNLIGYCADGDQ----- 164 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l---~hpnIv~l~~~~~~~~~----- 164 (522)
|++.+.||.|+||.||+|.+..+++.||||++....... ...+..|+.++..+ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999997543221 23456777777665 59999999999988776
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.+++|||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8999886522 236899999999999999999999998 999999999999999999999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh-cccC
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK-DRRK 323 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~ 323 (522)
....... ......++..|+|||++.+..++.++|||||||++|+|++|..||....... .+......... ....
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence 8653322 1123457889999999999899999999999999999999999987543211 11111100000 0000
Q ss_pred CC-------CcCCccccC---CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 324 FP-------KMADPLLQG---RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 324 ~~-------~~~d~~l~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.. ......... .........+.++|.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 000000000 001123356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.86 Aligned_cols=269 Identities=23% Similarity=0.295 Sum_probs=200.2
Q ss_pred hcCCc-ccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--------------hHHHHHHHHHHHhCCCCCcceeE
Q 009933 92 TKNFR-PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--------------NREFLVEVLMLSLLHHSNLVNLI 156 (522)
Q Consensus 92 ~~~y~-~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--------------~~~~~~E~~~L~~l~hpnIv~l~ 156 (522)
.++|. +.++||.|+||+||+|.+..+++.||||++....... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35665 4578999999999999999899999999986543222 12467899999999999999999
Q ss_pred EEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCce
Q 009933 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 157 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
+++...+..++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999997 599998865 456899999999999999999999999 9999999999999999999
Q ss_pred eeeeecceeeCCCCC------------CCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 009933 237 KLSDFGLAKLGPVGD------------KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTR 303 (522)
Q Consensus 237 kL~DFGla~~~~~~~------------~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~ 303 (522)
+|+|||++....... .........+++.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999997643110 01111233568899999998764 47899999999999999999999997654
Q ss_pred CCCcchH-HHhhhhh----hhcccCCC------CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 304 PPGEHNL-VAWARPL----FKDRRKFP------KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 304 ~~~~~~~-~~~~~~~----~~~~~~~~------~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
....... ....... +.....++ ......+.. ........+.++|.+||+.+|++||++.+++..-
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 3211110 0000000 00000000 000000000 0012235688999999999999999999998744
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.96 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=199.4
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEeec
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
|.+.+.||.|+||+||+|.+..+++.|+||++...... ......+|+..+..++ |+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67888999999999999999888999999998654321 2234557899999999 999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
+++|.+++... ....+++..++.++.||+.+|.|||+.+ |+|+||+|+|||+++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 77999988762 1347899999999999999999999998 9999999999999999999999999998643221
Q ss_pred CcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH-HHhhhh----hhhccc----
Q 009933 253 THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL-VAWARP----LFKDRR---- 322 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~-~~~~~~----~~~~~~---- 322 (522)
......++..|+|||++.. ..++.++||||||+++|+|++|+.||........... ..+... .+.+..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1233568889999998854 4688999999999999999999999975533211100 000000 000000
Q ss_pred ----CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 323 ----KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 323 ----~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.......+. .+.......+.+||.+||+.+|++||++.||+..
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 0111124578899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=304.74 Aligned_cols=259 Identities=21% Similarity=0.241 Sum_probs=192.3
Q ss_pred CceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCChhhhhc
Q 009933 105 GFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH 182 (522)
Q Consensus 105 ~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~ 182 (522)
+++.||.++...+++.||||++.... ......+..|+.+++.++|+||++++++|...+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 45566666666689999999997652 2334578899999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC-----Cccee
Q 009933 183 DLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK-----THVST 257 (522)
Q Consensus 183 ~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~-----~~~~~ 257 (522)
.. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||.+........ .....
T Consensus 92 ~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 TH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 52 2346889999999999999999999999 99999999999999999999999998875422111 11112
Q ss_pred cccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh----hhh------cccCCC
Q 009933 258 RVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP----LFK------DRRKFP 325 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~----~~~------~~~~~~ 325 (522)
...++..|+|||++.. ..|+.++|||||||++|||++|..||....... .+...... .+. ......
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcC
Confidence 3457788999999876 358899999999999999999999997543211 11110000 000 000000
Q ss_pred C----cCCccc----cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 326 K----MADPLL----QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 326 ~----~~d~~l----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
. ..++.. ...+.......+.+|+..||+.||++||++.++++.-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0 000000 01122233457889999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=317.30 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=210.4
Q ss_pred cCCcccceecccCceEEEEEEECCC----CcEEEEEEEccC-CccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLEST----GQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~----g~~vAvK~i~~~-~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
....+.++||+|-||.||+|.+..- .-.||||..+.+ ..++.+.|+.|..+|+.++|||||+|+|+|.+ ...||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 3345567899999999999998432 345899998774 44556789999999999999999999999986 57899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||+++.|.|..||+. ++..|+......++.||+.+|.|||+.. +|||||...|||+.....|||+|||+++..
T Consensus 468 vmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999986 4677999999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
........ +...-..-|||||.+.-..++.++|||-|||+|||+|. |.+||..-...+... .++..
T Consensus 542 ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnG----- 608 (974)
T KOG4257|consen 542 EDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENG----- 608 (974)
T ss_pred cccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCC-----
Confidence 55444332 23444678999999999999999999999999999986 999998654322110 01111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
-.-..|..+...+..|+.+||.++|.+||.+.+|...|..+..
T Consensus 609 -----eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 -----ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1123445556677899999999999999999999999987654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.48 Aligned_cols=256 Identities=26% Similarity=0.319 Sum_probs=200.9
Q ss_pred CCcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCc----cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~----~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~ 165 (522)
+|++.+.||+|+||.||++.+. .+++.||||++..... .....+..|+.++..+ +||||+++++++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999864 4578899999875322 2234577899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+.+++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++|+||+|.|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999865 356899999999999999999999998 9999999999999999999999999987
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
........ ......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||........ ..............
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 230 (288)
T cd05583 154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSKPP 230 (288)
T ss_pred cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccCCC
Confidence 64332211 122356889999999987654 78899999999999999999999964322111 11111111111111
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
. +......+.+++.+||+.+|++|||+.++.+.|..
T Consensus 231 ~------------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 F------------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred C------------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1 11122467789999999999999999888777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=312.15 Aligned_cols=267 Identities=24% Similarity=0.311 Sum_probs=203.7
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-----eeE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-----QRL 166 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-----~~~ 166 (522)
+|++.+.||.|+||.||+|.+..+++.||||++.... ....+.+..|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999998889999999997643 233457889999999999999999999998775 789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 489888865 348999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCC-cceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh-----
Q 009933 247 GPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK----- 319 (522)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~----- 319 (522)
....... .......++..|+|||++.+. .++.++|||||||++|+|++|..||...........+.-......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 5433210 112345678999999999887 889999999999999999999999976543111110000000000
Q ss_pred --cccCCCCcCCcccc------CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 320 --DRRKFPKMADPLLQ------GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 320 --~~~~~~~~~d~~l~------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
........+..... ..........+.+||.+||+.+|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000000 00011123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.11 Aligned_cols=254 Identities=26% Similarity=0.313 Sum_probs=205.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
+-+|.....||.|.||.||.|.+.++|...|+|-|.-.... ....+.+|+.+|..|+|||||++|++=.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44677788999999999999999999999999988654332 2356788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||.+|+|.+.+.. ..-.++.....+..|++.||.|||+++ ||||||||.||||+.+|.||++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999976 455677778889999999999999999 99999999999999999999999999987544
Q ss_pred CCCC--cceecccCCccccChhhhhcC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 250 GDKT--HVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 250 ~~~~--~~~~~~~gt~~y~APE~l~~~---~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
...+ ......+||+.|||||++.+. ....++||||||||+.||+||+.||........ .....-....
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----IMy~V~~gh~--- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----IMYHVAAGHK--- 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----HHhHHhccCC---
Confidence 3211 112357899999999999864 356789999999999999999999976533211 1111111111
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+|......-.++|.+||+.||+.|-++.+|++.
T Consensus 1460 ---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12333445667799999999999999888777764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.62 Aligned_cols=268 Identities=23% Similarity=0.317 Sum_probs=198.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcC---------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--------- 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--------- 162 (522)
..+|.+.+.||.|+||.||+|.+..+++.||||++........+.+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999999999999999999776655567788999999999999999999876543
Q ss_pred -----CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCce
Q 009933 163 -----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHP 236 (522)
Q Consensus 163 -----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~v 236 (522)
...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 589888854 46899999999999999999999999 99999999999997 45678
Q ss_pred eeeeecceeeCCCCCCC-cceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh
Q 009933 237 KLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~ 314 (522)
||+|||++......... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999764221111 11123457889999998764 46888999999999999999999999755332111110000
Q ss_pred hhhhh--cccC----CCCcCC-ccccCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 315 RPLFK--DRRK----FPKMAD-PLLQGRYP-----MRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 315 ~~~~~--~~~~----~~~~~d-~~l~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+... .... +..... .......+ ......+.+|+..||+.||.+||++.+|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 0000 000000 00000000 1123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.96 Aligned_cols=254 Identities=29% Similarity=0.395 Sum_probs=210.0
Q ss_pred CCcccceecccCceEEEEEEECCCC---cEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTG---QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
...+.++||+|.||.|++|.+...+ ..||||++...... ....|++|+.+|.+|+|+|+++|||+..+ ..+.|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3456788999999999999996532 36999999876655 45789999999999999999999999987 7788999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|++++|+|.+.|++ .....|.......++.||+.|+.||..++ +|||||...||||-....|||+||||.+.+..
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999987 45677888999999999999999999999 99999999999998899999999999998766
Q ss_pred CCCCccee-cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 250 GDKTHVST-RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 250 ~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
++...... ...-...|+|||.+....++.++|||+|||+||||+| |+.||-+........ .
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~-----------------~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK-----------------N 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH-----------------h
Confidence 55444332 2334568999999999999999999999999999998 778987664422211 1
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+|..-.-.-+..+...+.+++..||..+|++||++..|.+.+-
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1111111234556788999999999999999999999985553
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.86 Aligned_cols=270 Identities=23% Similarity=0.306 Sum_probs=203.1
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC
Q 009933 85 FRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG 162 (522)
Q Consensus 85 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~ 162 (522)
..++....++|.+.+.||+|+||.||++.+..+++.||||++.... ....+.+.+|+.++..++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4456667899999999999999999999998899999999997542 22235677899999999999999999988643
Q ss_pred ------CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCce
Q 009933 163 ------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 163 ------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
...|++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3467888887 7799888764 46899999999999999999999999 9999999999999999999
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH-Hhh
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-AWA 314 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~-~~~ 314 (522)
||+|||++..... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+ ...
T Consensus 160 kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999875321 1234568899999999876 46889999999999999999999999654321111100 000
Q ss_pred h----hhh---hcc------cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 315 R----PLF---KDR------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 315 ~----~~~---~~~------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
. .+. ... ..+.......+. .........+.+||.+||+.||.+||++.+++..-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0 000 000 000000000000 00011235678999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.69 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=200.8
Q ss_pred HHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEc-CCee
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQR 165 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-~~~~ 165 (522)
..++++|++.+.||.|+||.||++.+..+++.||||++..... .....+..|+.++..++||||++++++|.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3467899999999999999999999999999999999865322 234567789999999999999999999865 5678
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||+|.|||+++++.++|+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999999 5689888864 46888899999999999999999999 9999999999999999999999999987
Q ss_pred eCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch-HHH--------hhh
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN-LVA--------WAR 315 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~-~~~--------~~~ 315 (522)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.. +..
T Consensus 157 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 5321 1123457889999998866 578999999999999999999999997543211100 000 000
Q ss_pred hhhhcccCCCCcCCcc-ccCCCCh-----HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 316 PLFKDRRKFPKMADPL-LQGRYPM-----RGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~-l~~~~~~-----~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+... .. ..++... .....+. .....+.++|.+||+.+|++||++.+++..
T Consensus 232 ~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSE-NT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccch-hh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00 0000000 0011111 123578899999999999999999999775
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=322.12 Aligned_cols=271 Identities=26% Similarity=0.352 Sum_probs=203.7
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC------CeeE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------DQRL 166 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------~~~~ 166 (522)
.|...+.||+|+||.||+++++.+|+.||||.+.... ....+...+|+++|++|+|+|||+++++=+.. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3566788999999999999999999999999997643 33456788999999999999999999875543 3568
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--C--CCceeeeeec
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD--E--GFHPKLSDFG 242 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld--~--~~~vkL~DFG 242 (522)
+|||||.||+|...|.. +.+...|++.+.+.++.+++.||.|||+++ ||||||||.||++- + .-..||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999987 455677999999999999999999999999 99999999999992 2 3346999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhh-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
.|+....+. ..+.++||..|++||++. ...|+..+|.|||||++|+.+||..||-....+-...-+.|.. ..+..
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~-~tkkp 245 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI-ITKKP 245 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh-hccCC
Confidence 999754333 567789999999999998 4789999999999999999999999997665543222222211 01111
Q ss_pred cCCCCcCCcccc------CCC--C----hHHHHHHHHHHHHhcccCcCCCC--CHHHHHHHHHHh
Q 009933 322 RKFPKMADPLLQ------GRY--P----MRGLYQALAVAAMCLQEQAATRP--LIGDVVTALTYL 372 (522)
Q Consensus 322 ~~~~~~~d~~l~------~~~--~----~~~~~~l~~Li~~cl~~dP~~RP--s~~evl~~L~~l 372 (522)
..+.....+..+ ..+ + ......+-..+..+|..+|.+|- .+.++...+..+
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 111111111111 111 1 12234556677888888888887 555544444443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.04 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=198.9
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCC----
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD---- 163 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~---- 163 (522)
...++|++.+.||+|+||.||++.+..++..||||++...... ....+..|+.+|+.++||||++++++|....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999999999999999998653221 2345778999999999999999999987654
Q ss_pred --eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 164 --QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 164 --~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 7799888754 56899999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch-HHH-------
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN-LVA------- 312 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~-~~~------- 312 (522)
|++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +..
T Consensus 163 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99985322 1223467889999999876 468899999999999999999999997543211000 000
Q ss_pred -hhhhhhhc-----ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 313 -WARPLFKD-----RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 313 -~~~~~~~~-----~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
+...+... ...++......+. .........+.++|.+||+.||++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 0000000000000 001122346889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.03 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=200.5
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-----cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-----~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
+|.+.+.||+|+||.||++.+..++..+++|+++.... .....+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48889999999999999999987777777777654221 2233566789999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998764445567999999999999999999999998 999999999999976 569999999987643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... .......|++.|+|||.+....++.++||||||+++|+|++|..||.... ........... ..+.
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~--~~~~-- 224 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG--PTPS-- 224 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC--CCCC--
Confidence 221 12234568889999999988889999999999999999999999996432 11111111111 1111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.++|.+||+.+|++||++.++++.
T Consensus 225 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 -------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 122334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.65 Aligned_cols=261 Identities=22% Similarity=0.332 Sum_probs=195.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCC------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------ 163 (522)
..+|.+.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.+++.++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999888999999999754221 2345788999999999999999999987543
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.+++|+||+.. +|..++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999964 7776652 35889999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh------
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP------ 316 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~------ 316 (522)
+..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 164 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 875322 1123467889999999876 4689999999999999999999999975432111110000000
Q ss_pred --hhhcc------cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 317 --LFKDR------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 317 --~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..... ..++......+...+ ......+.+||.+||+.||++||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000000000000000 0123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=307.23 Aligned_cols=266 Identities=22% Similarity=0.262 Sum_probs=195.5
Q ss_pred CCcccceecccCceEEEEEEECCC--CcEEEEEEEccCCc--cchHHHHHHHHHHHhC-CCCCcceeEEEEEcC----Ce
Q 009933 94 NFRPECLLGEGGFGRVYKGRLEST--GQVVAVKQLDRNGL--QGNREFLVEVLMLSLL-HHSNLVNLIGYCADG----DQ 164 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~--g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~----~~ 164 (522)
+|++.+.||+|+||.||++.+..+ +..||||++..... .....+..|+.++..+ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488899999999999999999887 88999999864321 2235677899999999 599999999875432 45
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.++++||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999985 589998865 467899999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCC--cceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH---------
Q 009933 245 KLGPVGDKT--HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA--------- 312 (522)
Q Consensus 245 ~~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~--------- 312 (522)
......... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.............
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 864322111 11234578999999998876 468999999999999999999999997543211100000
Q ss_pred hhhhhhhcc-----cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 313 WARPLFKDR-----RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 313 ~~~~~~~~~-----~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+...+.... ..+.......+.. ........+.+|+.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0000000000000 001123578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.67 Aligned_cols=245 Identities=31% Similarity=0.434 Sum_probs=196.2
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
|...+.||+|+||+||+|.+..+++.|+||++...... ....+..|+.+++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999999989999999999754332 224577899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+. ++|.+++.. ...++++.+++.++.||+.+|.|||+.+ |+|+||+|+|||++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 96 578887754 2356899999999999999999999999 9999999999999999999999999986422
Q ss_pred CCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
......|+..|+|||++. ...++.++|||||||++|+|++|..||........ ... ... ...+...
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~~---~~~--~~~~~~~ 241 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH---IAQ--NDSPTLQ 241 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHH---HHh--cCCCCCC
Confidence 122456889999999984 45688999999999999999999999875432111 111 000 0111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+ .....+.+|+.+||+.+|.+||++.+++..
T Consensus 242 ~~--------~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 SN--------EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cc--------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 112457789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=299.34 Aligned_cols=275 Identities=22% Similarity=0.258 Sum_probs=203.4
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCc----EEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEc-CC
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQ----VVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GD 163 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-~~ 163 (522)
....|+....||+|+||.||+|..++++. .+|||+++.... -......+|+.+++.|+||||+.|..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34579999999999999999997765433 789999975421 223567889999999999999999999877 78
Q ss_pred eeEEEEeecCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----Cceee
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPP-DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG----FHPKL 238 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~----~~vkL 238 (522)
.++|++||.+. +|+..|+-... ....++...+..|+.||+.|+.|||++. |+||||||.||||..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999987 89988864322 2356899999999999999999999999 9999999999999766 99999
Q ss_pred eeecceeeCCCCCCCc-ceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc------chH
Q 009933 239 SDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE------HNL 310 (522)
Q Consensus 239 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~------~~~ 310 (522)
+|||+++++...-... ....++-|.+|.|||++.+. .|+.+.|||++|||+.||||-+..|........ .+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999865443332 23456789999999999976 699999999999999999999988865432111 111
Q ss_pred HHhhhhhhh--------cccCCCCcCC---ccccCCCChH-----------HHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 311 VAWARPLFK--------DRRKFPKMAD---PLLQGRYPMR-----------GLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 311 ~~~~~~~~~--------~~~~~~~~~d---~~l~~~~~~~-----------~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+..+-.++. +-..+++..+ ..-...+..- .....++|+..+|+.||.+|.|+++.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111111111 0011111100 0000001110 01136789999999999999999999886
Q ss_pred H
Q 009933 369 L 369 (522)
Q Consensus 369 L 369 (522)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 5
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=301.48 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=197.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||.||+|.+..+++.||||+++..... ....+..|+.++..+. |+||++++++|......|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 46789999999999999999999988999999999764322 3345667777666665 999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
||+. ++|.+++... ...+++..+..++.||+.||.|||+ .+ |+|+||+|+|||+++++.+||+|||++....
T Consensus 94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9985 4777777552 3478999999999999999999997 47 9999999999999999999999999987542
Q ss_pred CCCCCcceecccCCccccChhhhhcCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
... ......++..|+|||++.... ++.++|||||||++|+|++|+.||...... .... ....... .
T Consensus 167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~~~~~~~--~ 236 (296)
T cd06618 167 DSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVL---TKILQEE--P 236 (296)
T ss_pred CCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHH---HHHhcCC--C
Confidence 211 122345788999999987553 889999999999999999999999653211 0111 1111111 0
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
..+.. .......+.+|+.+||+.||.+||++.+++....
T Consensus 237 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 237 PSLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 11100 0012356889999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=309.88 Aligned_cols=257 Identities=27% Similarity=0.368 Sum_probs=200.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch-------HHHHHHHHHHHhCCCCCcceeEEEEE-cCCe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN-------REFLVEVLMLSLLHHSNLVNLIGYCA-DGDQ 164 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~-------~~~~~E~~~L~~l~hpnIv~l~~~~~-~~~~ 164 (522)
++|-++.+||+|+|+.||++.+....+.||||+-..+..... +...+|..|.+.|.||.||++|+||. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 457888999999999999999988899999998754422211 23568999999999999999999985 5567
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCceeeeee
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDF 241 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl---d~~~~vkL~DF 241 (522)
+|-|+|||+|.+|+-||+. ..-+++.+++.|+.||+.||.||.+. .+||||-||||.|||| +..|.|||+||
T Consensus 543 FCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 8999999999999999987 56789999999999999999999988 5889999999999999 45688999999
Q ss_pred cceeeCCCCCCC-----cceecccCCccccChhhhhcC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 009933 242 GLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA 312 (522)
Q Consensus 242 Gla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~----~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~ 312 (522)
||+++....... .......||.+|++||+|.-+ ..+.++||||+|||+|+.|.|++||..... .++++.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh
Confidence 999975433222 234557799999999998744 468899999999999999999999986533 122222
Q ss_pred hhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 009933 313 WARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 366 (522)
Q Consensus 313 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl 366 (522)
+- .+++... +....-+-...+..++|.+||++.-++|..+.++.
T Consensus 696 eN-TIlkAtE---------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 EN-TILKATE---------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hh-chhccee---------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11 1111100 00001112235677899999999999998766654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=332.02 Aligned_cols=147 Identities=30% Similarity=0.428 Sum_probs=133.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|.+.++||+|+||+||+|.+..+++.||||++....... ...+..|+.++..++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999999999999999997643322 25678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
|||+.+++|.+++.. ...+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999975 356889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=304.03 Aligned_cols=250 Identities=30% Similarity=0.397 Sum_probs=198.7
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
..|...+.||+|+||.||+|++..++..||||.+..... .....+..|+.+++.++|+||+++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 347778889999999999999998899999999864322 22346778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+. ++|.+++.. ....+++..+..++.|++.+|.|||+.+ ++|+||+|+|||++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 588877753 2356899999999999999999999998 99999999999999999999999999876422
Q ss_pred CCCCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.....+++.|+|||++. ...++.++|||||||++|+|++|..||........ ...+. . ...+.
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~----~--~~~~~ 233 (308)
T cd06634 168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA----Q--NESPA 233 (308)
T ss_pred ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHHHh----h--cCCCC
Confidence 12346889999999985 34688899999999999999999999865422111 01111 0 01111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.. .......+.+||.+||+.+|++||++.+|+.....
T Consensus 234 ~~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 234 LQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred cC--------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 11 11223567899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=336.67 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=194.4
Q ss_pred HHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEc------
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCAD------ 161 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~------ 161 (522)
.....+|+.+.+||+||||.||+++.+-+|+.||||+|.... ......+.+|+..|++|+|||||++|..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 445678999999999999999999999999999999997653 2223568899999999999999998832210
Q ss_pred --------------------------------------------------------------------------------
Q 009933 162 -------------------------------------------------------------------------------- 161 (522)
Q Consensus 162 -------------------------------------------------------------------------------- 161 (522)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeeEEEEeecCCCChhhhhccCCCCCCCC-CHHHHHHHHHHHHHHH
Q 009933 162 -------------------------G--------DQRLLVYEFMPLGSLEDHLHDLPPDKEPL-DWNTRMKIAAGAAKGL 207 (522)
Q Consensus 162 -------------------------~--------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l-~~~~~~~i~~qi~~~L 207 (522)
+ ..+||-||||+..+|.+++.. +... .....++++++|+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHH
Confidence 0 125788999998888888766 2222 4678899999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC----------------CCCCCcceecccCCccccChhhh
Q 009933 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP----------------VGDKTHVSTRVMGTYGYCAPEYA 271 (522)
Q Consensus 208 ~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~APE~l 271 (522)
.|+|+++ ||||||||.|||||++..|||+|||++.... .+......+..+||.-|+|||++
T Consensus 711 aYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999999 9999999999999999999999999998611 01111123567899999999999
Q ss_pred hcC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHH
Q 009933 272 MTG---QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVA 348 (522)
Q Consensus 272 ~~~---~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li 348 (522)
.+. .|+.|+|+|||||||+||+. ||..... -...... +. ...++.. ..+.......-..+|
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-----Ra~iL~~-LR-~g~iP~~------~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-----RASILTN-LR-KGSIPEP------ADFFDPEHPEEASLI 851 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHH-----HHHHHHh-cc-cCCCCCC------cccccccchHHHHHH
Confidence 865 49999999999999999995 5654311 1111111 11 1111111 123334445667899
Q ss_pred HHhcccCcCCCCCHHHHHH
Q 009933 349 AMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 349 ~~cl~~dP~~RPs~~evl~ 367 (522)
.++++.||.+|||+.|+|.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999875
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=296.97 Aligned_cols=263 Identities=28% Similarity=0.376 Sum_probs=201.3
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
|++.+.||+|+||.||+|....+++.||+|++.... ......+..|+.+++.++|+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999999999999999997653 222356778999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
. ++|.+++... ...+++..++.++.|++.+|.|||+.+ |+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 5999999762 146899999999999999999999998 99999999999999999999999999986433221
Q ss_pred CcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch-HHHhh-------hhhhh----
Q 009933 253 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN-LVAWA-------RPLFK---- 319 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~-~~~~~-------~~~~~---- 319 (522)
......++..|+|||++... .++.++|||||||++|||++|..||.......... +.... +..+.
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 22334567889999999876 78999999999999999999999997543211110 00000 00000
Q ss_pred cccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 320 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 320 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
....++..........++ .....+.++|..||+.+|++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000111111111100010 11357899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.66 Aligned_cols=237 Identities=32% Similarity=0.413 Sum_probs=194.9
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
||.|+||.||++.+..+++.||+|++...... ....+..|+.+++.++|+||+++++++..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999765432 234678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCccee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 257 (522)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999976 346899999999999999999999998 9999999999999999999999999998643321 1233
Q ss_pred cccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCC
Q 009933 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 337 (522)
Q Consensus 258 ~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 337 (522)
...++..|++||.+.+..++.++|+||||+++|+|++|..||..... ..... ........ ++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~~~~~------------~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILKDPLR------------FP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhcCCCC------------CC
Confidence 45688999999999988899999999999999999999999965432 11111 11111111 11
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHH
Q 009933 338 MRGLYQALAVAAMCLQEQAATRPLIGD 364 (522)
Q Consensus 338 ~~~~~~l~~Li~~cl~~dP~~RPs~~e 364 (522)
......+.+++.+||..||+.||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 112356789999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.20 Aligned_cols=208 Identities=26% Similarity=0.327 Sum_probs=180.1
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
|..++.||-|+||.|.++.-.+|...||+|.+.+...-. ...+..|-.||..-..+-||+||..|.+.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 666778999999999999999999999999997654322 23466799999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC---
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP--- 248 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~--- 248 (522)
++||++-.+|.. .+-|.+..+++++..|.+||++.|..| +|||||||+|||||.+|+|||+|||||.-+.
T Consensus 711 IPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999976 578999999999999999999999999 9999999999999999999999999985321
Q ss_pred ------CCCCCc-------------------------------ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHH
Q 009933 249 ------VGDKTH-------------------------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLE 291 (522)
Q Consensus 249 ------~~~~~~-------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~e 291 (522)
.++... .....+||+.|+|||++....|+..||+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 111000 0112579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCcch
Q 009933 292 LITGRKAIDNTRPPGEHN 309 (522)
Q Consensus 292 LltG~~Pf~~~~~~~~~~ 309 (522)
||.|+.||-...+.+.+.
T Consensus 864 m~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQY 881 (1034)
T ss_pred HhhCCCCccCCCCCccee
Confidence 999999998877765544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.40 Aligned_cols=243 Identities=26% Similarity=0.295 Sum_probs=198.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
+..|.+...||.|+|+.|..+.+..+++..++|+|.+.. .+..+|+.++... +||||+++.+.|.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888888999999999999999999999999997652 2233466555544 69999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-cCCCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL-DEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl-d~~~~vkL~DFGla~~~~~ 249 (522)
++.|+.|.+.+.. .+....++..|+.+|+.++.|||+++ ||||||||+|||+ ++.++++|+|||.++....
T Consensus 397 ~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999999998876 22233778889999999999999999 9999999999999 6999999999999987433
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. ....+-|..|.|||++....|+.+|||||||++||+||+|+.||...... .++...
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~---------------- 525 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTR---------------- 525 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHh----------------
Confidence 2 22345688999999999999999999999999999999999999865432 111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+..+.+....+....+|+.+||+.||.+||++.++...-.
T Consensus 526 -i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 526 -IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred -hcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 1111122334467889999999999999999999977544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=308.06 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=199.9
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe----
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ---- 164 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~---- 164 (522)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999999899999999986532 2233557789999999999999999998866554
Q ss_pred --eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 165 --RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 165 --~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
.++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 6699999865 56999999999999999999999998 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc-
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD- 320 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 320 (522)
++...... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||........ +.........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~ 235 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNLVGTP 235 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCC
Confidence 99864221 2334678899999998753 678999999999999999999999975433111 1100000000
Q ss_pred ------c----------cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 ------R----------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ------~----------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. ..+.....+.+.. ........+.+||.+||+.+|++|||+.+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0000000000000 001124578899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=320.12 Aligned_cols=256 Identities=29% Similarity=0.424 Sum_probs=213.7
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEc-----CC
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCAD-----GD 163 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~-----~~ 163 (522)
.-++-|++.+.||.|.||.||+++.+.+++.+|||++.... ...+++..|.+||+.+. |||++.+|++|.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34567999999999999999999999999999999997654 34567788999999875 9999999999854 57
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
++|||||||.+|+..|+++... ...+.|..+..|++.++.||.+||... +||||||-.||||+.++.|||+|||+
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeee
Confidence 8999999999999999999865 788999999999999999999999998 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhh
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
+..+... .....+.+||+.|||||++... .|+..+|+||||++..||--|..|+.+..+. +.++
T Consensus 170 SaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------raLF 238 (953)
T KOG0587|consen 170 SAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------RALF 238 (953)
T ss_pred eeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------hhhc
Confidence 9864322 1223457899999999999754 5788999999999999999999999876552 1122
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.. +. +|-..-.-+.....+|.++|..||..|.+.||++.++|++
T Consensus 239 ~I----pR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 LI----PR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cC----CC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 21 11 2222222355677899999999999999999999998863
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.77 Aligned_cols=247 Identities=26% Similarity=0.340 Sum_probs=201.6
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCC
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 175 (522)
.++||.|-||+||-|.++.+|+.||||+|++-... ....+.+|+.||+.++||.||.|.-.|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 57899999999999999999999999999875443 345688999999999999999999999999999999999965
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---CceeeeeecceeeCCCCCC
Q 009933 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG---FHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 176 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~---~~vkL~DFGla~~~~~~~~ 252 (522)
++.++|.. ..++.|++.....++.||+.||.|||.++ |+|+||||+||||.+. -.+||||||+|++.+...
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 55555543 45788999999999999999999999999 9999999999999543 469999999999865432
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
....++|||.|+|||++++..|+..-|+||.|||+|--|+|..||..... ..+.++-+...+.
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyP------------- 784 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYP------------- 784 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccC-------------
Confidence 34568899999999999999999999999999999999999999975432 1111211111100
Q ss_pred cCCCCh-HHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 333 QGRYPM-RGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 333 ~~~~~~-~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.-|. +.....++||...|+..-.+|-++...+...+
T Consensus 785 --p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 785 --PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred --CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 0111 22356789999999999999999987776543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.33 Aligned_cols=269 Identities=31% Similarity=0.460 Sum_probs=210.0
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHh--CCCCCcceeEEEEEcCC----eeEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL--LHHSNLVNLIGYCADGD----QRLL 167 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~--l~hpnIv~l~~~~~~~~----~~~l 167 (522)
...+.++||+|.||.||+|... ++.||||++.. +..+.|..|-.|.+. ++|+||++++++-.... .++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4566778999999999999996 69999999964 456778888888776 56999999999876655 8999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCceeecCCCceeeeee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK------ANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
|+||.+.|+|.+||+. ..++|....+|+..|++||+|||+. .+++|+|||||..||||..+++..|+||
T Consensus 286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999986 6899999999999999999999974 3678999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcC-CCC-----cchhhHHHHHHHHHHHhCCCCCCCCCCCCcch--H---
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLT-----LKSDVYSFGVVFLELITGRKAIDNTRPPGEHN--L--- 310 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~-----~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~--~--- 310 (522)
|+|..+.........-..+||.+|||||++.+. .+. .+.||||+|.|||||++.-..+.. .+..... +
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAE 439 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHH
Confidence 999987765555455568899999999999864 232 368999999999999998765542 1111111 0
Q ss_pred ------HHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 311 ------VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 311 ------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
+.-.+.+.-..+..+.+.+..... ..+..+.+.+..||..||+-|.|+.=+.+++..+.....
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 011111111112223443433332 346678899999999999999999999999998765544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.20 Aligned_cols=220 Identities=24% Similarity=0.237 Sum_probs=178.6
Q ss_pred cCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCChhhhhcc
Q 009933 104 GGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD 183 (522)
Q Consensus 104 G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~ 183 (522)
|.||.||++++..+++.||+|++.... .+..|...+....||||+++++++...+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999997543 233455555566799999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCc
Q 009933 184 LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263 (522)
Q Consensus 184 ~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~ 263 (522)
...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 346899999999999999999999999 999999999999999999999999987653221 22344677
Q ss_pred cccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHH
Q 009933 264 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQ 343 (522)
Q Consensus 264 ~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 343 (522)
.|+|||++....++.++|||||||++|||++|..||....... .... . ...+......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~---~-------~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT---T-------LNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc---c-------cCCcccCCHH
Confidence 8999999988889999999999999999999998875321100 0000 0 0111122356
Q ss_pred HHHHHHHhcccCcCCCCCH
Q 009933 344 ALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 344 l~~Li~~cl~~dP~~RPs~ 362 (522)
+.+||.+||+.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 7899999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=310.37 Aligned_cols=253 Identities=27% Similarity=0.322 Sum_probs=213.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
..++++...||-|+||.|-++..+.....+|+|++++..+.+ .+.+..|-.+|..++.|+||++|-.|.+..++|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345677778999999999999998666669999998765433 34577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
||-|-||.|+..|.+ .+.++...+.+++.-+++|++|||+++ ||+|||||+|+|||.+|-+||.|||+|+...
T Consensus 499 mEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999987 688999999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.+. .+-++||||.|.|||++.+...+.++|.|||||++||||+|..||....+....+++--....
T Consensus 572 ~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------- 637 (732)
T KOG0614|consen 572 SGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------- 637 (732)
T ss_pred cCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------
Confidence 554 345689999999999999999999999999999999999999999987765544433211111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTALT 370 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~L~ 370 (522)
-.+|........+||.+.+..+|.+|.- +.+|-.+-+
T Consensus 638 -----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 638 -----IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred -----hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 1233344466779999999999999985 667766554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=267.47 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=200.1
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+|...++||+|.||+||+++...+++.||+|.++.+... .....++|+.+|+.|+|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 567778999999999999999999999999998764322 234678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
|.. .|..|.... ++.++.+.+..++.|+++||.|+|+++ ++||||||.|+||+.+|.+||+|||+++.....-
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 964 888887653 577999999999999999999999999 9999999999999999999999999999754332
Q ss_pred CCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcc--cCCCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDR--RKFPKM 327 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 327 (522)
......+-|.+|.+|.++.+. -|+...|+||.|||+.||.. |+..|.+....+....+-|......+. ..+.++
T Consensus 156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 223344569999999999986 58899999999999999987 555565543322222121211111111 011122
Q ss_pred CCccccCCCCh---------HHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 328 ADPLLQGRYPM---------RGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 328 ~d~~l~~~~~~---------~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.|-..-.-|+. +....-.+|+...|.-+|..|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22111111221 11123346888889999999999988765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=293.00 Aligned_cols=261 Identities=24% Similarity=0.333 Sum_probs=199.6
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-hHHHHHHHHHHHh-CCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSL-LHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~-l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.+.+-+..||.|+||+|++-.++.+|+.+|||+|+..+.+. ..+++.|.+...+ -++||||++||.+..+..+||.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34555677999999999999999999999999998776533 3467778776554 469999999999999999999999
Q ss_pred ecCCCChhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDL-PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
+|+- +|..+.+.. ...+..+++..+-.|..-.+.||.||...-+ ||||||||+|||||..|.|||||||++-.+..
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9954 766554321 1234678999999999999999999998654 99999999999999999999999999875321
Q ss_pred CCCCcceecccCCccccChhhhhcC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
....+.-.|-..|||||.+... .|+.+|||||||++|||+.||+.|+..+.. .+.+....+..+. +.+
T Consensus 221 ---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdp---p~l 290 (361)
T KOG1006|consen 221 ---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDP---PIL 290 (361)
T ss_pred ---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCC---Cee
Confidence 1122445688899999999743 599999999999999999999999976532 1111112222221 111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
..+. -.......+..+|.-||.+|-..||.+.+++++--
T Consensus 291 ~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 291 LFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred cCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 1111 11234578899999999999999999999987543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=309.02 Aligned_cols=258 Identities=30% Similarity=0.450 Sum_probs=211.5
Q ss_pred CcccceecccCceEEEEEEECCCC----cEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTG----QVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g----~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.+..++||.|+||+||+|.+--.| -+||||++.... .....+++.|+.+|..|.||||++|+++|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 455678999999999999994434 468999886543 345678999999999999999999999998765 88999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
+||++|+|.||++. .+..+.....+.|..||++||.|||++. +|||||-..||||.+-.++||+|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987 4577888999999999999999999998 99999999999999999999999999998755
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
...........-.+-|||-|.+....|+.++|||||||++||||| |..|++.....+..++ ++....+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~geRL---- 919 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKGERL---- 919 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------HhccccC----
Confidence 444333333334568999999999999999999999999999998 8899887654333222 2222221
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.-|+.....+..++.+||..|+..||+++++...+.+.+...
T Consensus 920 ------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 920 ------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 123344567888999999999999999999999998775443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=283.18 Aligned_cols=268 Identities=25% Similarity=0.355 Sum_probs=206.0
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHh--CCCCCcceeEEEEEcC----C
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL--LHHSNLVNLIGYCADG----D 163 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~--l~hpnIv~l~~~~~~~----~ 163 (522)
....+..+.+.||+|.||.||+|.+. |+.||||++.. .++..+.+|.+|.+. |+|+||+.|++.-..+ .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc--CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 44567888999999999999999998 89999999964 345677788888775 6899999999875443 3
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCceeecCCCceee
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-----KANPPVIYRDLKSSNILLDEGFHPKL 238 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-----~~~~~iiHrDLKp~NILld~~~~vkL 238 (522)
++|||.+|.+.|||+|||.. ..++.+..++++..++.||++||. +|+|.|.|||||..||||..++..-|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 78999999999999999976 779999999999999999999996 47888999999999999999999999
Q ss_pred eeecceeeCCCCC--CCcceecccCCccccChhhhhcCC----C--CcchhhHHHHHHHHHHHhC----------CCCCC
Q 009933 239 SDFGLAKLGPVGD--KTHVSTRVMGTYGYCAPEYAMTGQ----L--TLKSDVYSFGVVFLELITG----------RKAID 300 (522)
Q Consensus 239 ~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~----~--~~~sDVwSlGvll~eLltG----------~~Pf~ 300 (522)
+|+|||....... ........+||..|||||++...- + -..+||||||+|+||+.-. +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999998644331 112234578999999999997531 1 2368999999999999753 24665
Q ss_pred CCCCCCcchHHHhhhhhhhcccCCCCcCCcccc-CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 301 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ-GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
+.-+.+.. +......+. +.+ +.|.+. .....+.+..+.+|+..||..+|.-|.|+--|-+.|..+..
T Consensus 438 d~Vp~DPs-~eeMrkVVC-----v~~-~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSDPS-FEEMRKVVC-----VQK-LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCCCC-HHHHhccee-----ecc-cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 44332221 111111000 011 112221 22345678899999999999999999999999999988763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=267.86 Aligned_cols=239 Identities=32% Similarity=0.431 Sum_probs=195.0
Q ss_pred CceEEEEEEECCCCcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCChhhhhcc
Q 009933 105 GFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD 183 (522)
Q Consensus 105 ~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~ 183 (522)
+||.||+|.+..+++.+|+|++....... ...+..|+.+++.++|+||+++++++......++||||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997665444 57889999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCc
Q 009933 184 LPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263 (522)
Q Consensus 184 ~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~ 263 (522)
...+++..++.++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||++....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 233899999999999999999999998 9999999999999999999999999998754332 223456888
Q ss_pred cccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHH
Q 009933 264 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQ 343 (522)
Q Consensus 264 ~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 343 (522)
.|++||.+....++.++||||||+++|+|++|..||..... ......+. ...... ..... ......
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~---~~~~~~---~~~~~------~~~~~~ 216 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKI---GKPKPP---FPPPE------WKISPE 216 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHH---hccCCC---Ccccc------ccCCHH
Confidence 99999999988899999999999999999999999965311 11111111 111000 00000 002357
Q ss_pred HHHHHHHhcccCcCCCCCHHHHHH
Q 009933 344 ALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 344 l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=279.40 Aligned_cols=275 Identities=24% Similarity=0.377 Sum_probs=206.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-c-hHHHHHHHHHHHhCCCCCcceeEEEEEc--------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-G-NREFLVEVLMLSLLHHSNLVNLIGYCAD-------- 161 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~-------- 161 (522)
...|+...+||+|.||.||+|+.+++++.||+|++-.++.. . -...++|+.+|..|+|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 34577778899999999999999999999999977432211 1 2456789999999999999999988743
Q ss_pred CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
...+||||.+|+. +|.-+|.. ....++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 2358999999976 88888765 2467899999999999999999999998 999999999999999999999999
Q ss_pred cceeeCCCCCCC--cceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh--
Q 009933 242 GLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP-- 316 (522)
Q Consensus 242 Gla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~-- 316 (522)
|+++.+...+.. ...+..+-|.+|++||.+.+. .|+++.|||..||||.||+|+.+-|..........+++..-.
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 999764332221 123455679999999999875 799999999999999999999998887654333333332110
Q ss_pred ---hhhcccCC---CCc-CCccccCCCCh--HHH------HHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 317 ---LFKDRRKF---PKM-ADPLLQGRYPM--RGL------YQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 317 ---~~~~~~~~---~~~-~d~~l~~~~~~--~~~------~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.|..-..+ ..+ +.|+..+.+.. +.+ ...++|+..+|..||.+|+.+.+++..--...
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 11110111 011 01222222211 122 26789999999999999999999998765543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=263.59 Aligned_cols=211 Identities=26% Similarity=0.335 Sum_probs=176.0
Q ss_pred HHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeE
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~ 166 (522)
....+.......||+|+||.|-+.++..+|...|+|.+...-. +.....+.|+.+.... .+|++|.+||.+..+...+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 3344555666789999999999999999999999999975422 2334567788776554 5999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
|.||.|.. +|..|..+.......+++..+-+|+..++.||.|||++-+ |||||+||+||||+.+|.|||||||++-.
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEccccccee
Confidence 99999965 9998887777778899999999999999999999999854 99999999999999999999999999976
Q ss_pred CCCCCCCcceecccCCccccChhhhhc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 305 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~ 305 (522)
+...- ..+-..|-..|||||.+.. ..|+.++||||||++++||.+++.||+....+
T Consensus 199 L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 199 LVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred ehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 43211 1122457788999999863 37999999999999999999999999876543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.78 Aligned_cols=263 Identities=21% Similarity=0.240 Sum_probs=172.7
Q ss_pred hhcCCcccceecccCceEEEEEEECCC----CcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEE------EE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLEST----GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY------CA 160 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~----g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~------~~ 160 (522)
..++|.+.++||+|+||.||+|++..+ +..||||++..... .+.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999988 89999999864321 1111111 1222222333322221 24
Q ss_pred cCCeeEEEEeecCCCChhhhhccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 009933 161 DGDQRLLVYEFMPLGSLEDHLHDLPP----------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 224 (522)
Q Consensus 161 ~~~~~~lV~E~~~ggsL~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLK 224 (522)
....++|||||+.+++|.+++..... ......+..+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56788999999999999999865210 0011223456789999999999999998 9999999
Q ss_pred CCceeecC-CCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcC----------------------CCCcchh
Q 009933 225 SSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG----------------------QLTLKSD 281 (522)
Q Consensus 225 p~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------------------~~~~~sD 281 (522)
|+||||+. ++.+||+|||+++...... .......++++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 6899999999998543222 2233456789999999976432 2445679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCC-------CCcchHHHhhhhhhhcccCCCCcCCccccCCC--ChHHHHHHHHHHHHhc
Q 009933 282 VYSFGVVFLELITGRKAIDNTRP-------PGEHNLVAWARPLFKDRRKFPKMADPLLQGRY--PMRGLYQALAVAAMCL 352 (522)
Q Consensus 282 VwSlGvll~eLltG~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~Li~~cl 352 (522)
|||||||||||+++..+++.... .....+..|..... ....+.+...+ .........+||.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE-------PRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc-------cccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999997765432100 00001111211100 00000000000 0001123458999999
Q ss_pred ccCcCCCCCHHHHHHH
Q 009933 353 QEQAATRPLIGDVVTA 368 (522)
Q Consensus 353 ~~dP~~RPs~~evl~~ 368 (522)
+.||++|||+.+++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.28 Aligned_cols=265 Identities=21% Similarity=0.287 Sum_probs=200.6
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-----C---CCcceeEEEEEc---
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----H---SNLVNLIGYCAD--- 161 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-----h---pnIv~l~~~~~~--- 161 (522)
.+|.+.++||.|.|++||+|.+..+.+.||+|+++... .-.+..+.||.+|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68999999999999999999999999999999996532 23455678999999884 2 369999999964
Q ss_pred -CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-------
Q 009933 162 -GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG------- 233 (522)
Q Consensus 162 -~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~------- 233 (522)
+.++|||+|++ |.+|..+|.. .....++...+..|++||+.||.|||.... |||-||||+||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhh
Confidence 56999999999 7799999976 345678999999999999999999999864 9999999999998300
Q ss_pred --------------------------------------------------------------------------------
Q 009933 234 -------------------------------------------------------------------------------- 233 (522)
Q Consensus 234 -------------------------------------------------------------------------------- 233 (522)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 009933 234 -------------------------------------------------------------------------------F 234 (522)
Q Consensus 234 -------------------------------------------------------------------------------~ 234 (522)
.
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC----CcchH
Q 009933 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP----GEHNL 310 (522)
Q Consensus 235 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~----~~~~~ 310 (522)
.|||+|||-|+.. ...++.-+-|..|+||||+.+..|+..+||||++|++|||+||...|+...-. ++..+
T Consensus 392 ~vKIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 392 RVKIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eEEEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 1455555555431 11233445678899999999999999999999999999999999999754321 11111
Q ss_pred HH-----------------hhhhhhhcccCCCCcC-------Ccccc--CCCChHHHHHHHHHHHHhcccCcCCCCCHHH
Q 009933 311 VA-----------------WARPLFKDRRKFPKMA-------DPLLQ--GRYPMRGLYQALAVAAMCLQEQAATRPLIGD 364 (522)
Q Consensus 311 ~~-----------------~~~~~~~~~~~~~~~~-------d~~l~--~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e 364 (522)
.. +.+.+++.+..+..+- ...|. ..++.+...+|.+++.-||+.+|++|||+.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 11 1122222222222111 11121 2456778889999999999999999999999
Q ss_pred HHHH
Q 009933 365 VVTA 368 (522)
Q Consensus 365 vl~~ 368 (522)
+|+.
T Consensus 547 cl~h 550 (590)
T KOG1290|consen 547 CLKH 550 (590)
T ss_pred HhcC
Confidence 9873
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.92 Aligned_cols=263 Identities=28% Similarity=0.436 Sum_probs=206.3
Q ss_pred hhcCCcccceecccCceEEEEEEECC-------CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCC-CCCcceeEEEEEc
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLES-------TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCAD 161 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~ 161 (522)
..++..+.+.||+|.||.|++|.... ....||||.++..... +.+.+..|+++|..+. |+||+.++++|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34555667799999999999998631 1457999999765433 4467889999999985 9999999999999
Q ss_pred CCeeEEEEeecCCCChhhhhccCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLP---P-------DK--EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 229 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NIL 229 (522)
...+++|+||+..|+|.+|+.... . .. ..++..+.+.++.||+.|++||++.. +|||||...|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999998743 0 01 23899999999999999999999998 999999999999
Q ss_pred ecCCCceeeeeecceeeCCCCCCCcceecccC--CccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 009933 230 LDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG--TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPG 306 (522)
Q Consensus 230 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~ 306 (522)
|.++..+||+|||+++.....+.... ....+ ...|||||.+....|+.++|||||||+||||+| |..||.+...
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-- 527 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-- 527 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence 99999999999999996433332221 11122 346999999999999999999999999999998 7788865211
Q ss_pred cchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 307 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
...+..+ +..... + ..|..+..++.+|+..||+.+|++||++.++++.|....
T Consensus 528 ~~~l~~~----l~~G~r---~-------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 528 TEELLEF----LKEGNR---M-------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHH----HhcCCC---C-------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1112221 222211 1 123334567889999999999999999999999998853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=274.62 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=200.7
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccC--CccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-----eeEE
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN--GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-----QRLL 167 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-----~~~l 167 (522)
.+..+.||-|.||.||.+.+..+|+.||+|++..- ++...+.+.+|+.+|..++|.|++..++...... .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45568899999999999999999999999998532 2334467889999999999999999988765443 4678
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|+|+|.. +|...|-. ...++.+.+.-+++||++||+|||+.+ |+||||||.|+|++.+..+||||||+++.-
T Consensus 135 ~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 8898853 67666644 678999999999999999999999999 999999999999999999999999999974
Q ss_pred CCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh----------
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP---------- 316 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~---------- 316 (522)
...+. ...+..+-|.+|.|||++++. .|+.+.||||.|||+.|||-.+..|....+....+++.-...
T Consensus 207 e~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 43333 234455678999999999986 699999999999999999999999987766444333321100
Q ss_pred -------hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 317 -------LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 317 -------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
++....+ ...+..+..-..+.....+.+.++..+|..||.+|.+.++.+..+
T Consensus 286 CEGAk~H~LR~~~k-~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLR-APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCC-CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0000000 000111111111223344667788899999999999988887655
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=290.11 Aligned_cols=263 Identities=21% Similarity=0.282 Sum_probs=182.5
Q ss_pred hhcCCcccceecccCceEEEEEEEC----------------CCCcEEEEEEEccCCccch--------------HHHHHH
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLE----------------STGQVVAVKQLDRNGLQGN--------------REFLVE 140 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~----------------~~g~~vAvK~i~~~~~~~~--------------~~~~~E 140 (522)
..++|++.++||+|+||+||+|.+. ..++.||||++........ +....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3678999999999999999999752 2356799999865432211 223457
Q ss_pred HHHHHhCCCCCc-----ceeEEEEEc--------CCeeEEEEeecCCCChhhhhccCCC--------------------C
Q 009933 141 VLMLSLLHHSNL-----VNLIGYCAD--------GDQRLLVYEFMPLGSLEDHLHDLPP--------------------D 187 (522)
Q Consensus 141 ~~~L~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~--------------------~ 187 (522)
+.++.+++|.++ +.++++|.. ....+|||||+.+++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777787876654 677777753 3568999999999999999874211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccC
Q 009933 188 KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 267 (522)
Q Consensus 188 ~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~A 267 (522)
...+++..+..++.||+.+|.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123567889999999999999999998 999999999999999999999999999753222111 1112335789999
Q ss_pred hhhhhcCC--------------------C--CcchhhHHHHHHHHHHHhCCC-CCCCCCCCCc------chHHHhhhhhh
Q 009933 268 PEYAMTGQ--------------------L--TLKSDVYSFGVVFLELITGRK-AIDNTRPPGE------HNLVAWARPLF 318 (522)
Q Consensus 268 PE~l~~~~--------------------~--~~~sDVwSlGvll~eLltG~~-Pf~~~~~~~~------~~~~~~~~~~~ 318 (522)
||++.... | ..+.||||+|||+|+|++|.. ||........ ..+..|.. ..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YK 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hc
Confidence 99886432 1 234799999999999999885 6653221110 11111211 00
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCc---CCCCCHHHHHHH
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQA---ATRPLIGDVVTA 368 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP---~~RPs~~evl~~ 368 (522)
.....+ . ..........+|+.+||..+| .+|+|+.|+|++
T Consensus 458 ~~~~~~----~------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQKYDF----S------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccCCCc----c------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000000 0 011223567889999999766 689999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=282.04 Aligned_cols=198 Identities=24% Similarity=0.350 Sum_probs=174.7
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch--------HHHHHHHHHHHhCC---CCCcceeEEEEEc
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--------REFLVEVLMLSLLH---HSNLVNLIGYCAD 161 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~--------~~~~~E~~~L~~l~---hpnIv~l~~~~~~ 161 (522)
..|..++.||+|+||.|++|.++.+...|+||.|.+..+-.. -.+-.|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458999999999999999999999999999999976543211 12456999999998 9999999999999
Q ss_pred CCeeEEEEeec-CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeee
Q 009933 162 GDQRLLVYEFM-PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSD 240 (522)
Q Consensus 162 ~~~~~lV~E~~-~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~D 240 (522)
.+++||+||.- ++.+|+++|.. +..+++.++..|++||+.|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999985 66799999975 678999999999999999999999999 99999999999999999999999
Q ss_pred ecceeeCCCCCCCcceecccCCccccChhhhhcCCCC-cchhhHHHHHHHHHHHhCCCCCCC
Q 009933 241 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDN 301 (522)
Q Consensus 241 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDVwSlGvll~eLltG~~Pf~~ 301 (522)
||.+.... ......++||..|.|||++.+..|- ..-|||+||++||.++....||.+
T Consensus 714 fgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998643 2345678899999999999998885 567999999999999999998853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=280.71 Aligned_cols=278 Identities=22% Similarity=0.250 Sum_probs=211.5
Q ss_pred ccccHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC------CCcce
Q 009933 81 QTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH------SNLVN 154 (522)
Q Consensus 81 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h------pnIv~ 154 (522)
..|.+.-.+..-.+|.+....|+|-|++|..|.+..-|..||||+|..+... ...=+.|+++|++|+. -|+++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 4455555666778899999999999999999999988999999999765432 2344679999999973 48999
Q ss_pred eEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-
Q 009933 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG- 233 (522)
Q Consensus 155 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~- 233 (522)
|+-.|...+++|||||-+. .+|.+.|+.+..+ -.|....+..++.||+.||..|...+ |+|.||||+|||+++.
T Consensus 499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHhhhcceeEEEehhhh-chHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 9999999999999999984 5999999986443 45788899999999999999999988 9999999999999875
Q ss_pred CceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHh
Q 009933 234 FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 313 (522)
Q Consensus 234 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~ 313 (522)
..+||||||.|........ +.+.-+..|.|||++.+..|+...|+||.||+||||.||+..|.+......+-+.--
T Consensus 574 ~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 4579999999986543332 223345679999999999999999999999999999999999987654322211100
Q ss_pred h-----hhh----------hhc--------------c--cCCCCcCCc------ccc--CCCCh---HHHHHHHHHHHHh
Q 009933 314 A-----RPL----------FKD--------------R--RKFPKMADP------LLQ--GRYPM---RGLYQALAVAAMC 351 (522)
Q Consensus 314 ~-----~~~----------~~~--------------~--~~~~~~~d~------~l~--~~~~~---~~~~~l~~Li~~c 351 (522)
+ ..+ |.. + ..+...+.| .|. ..++. ..+.+|.+|+..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 0 000 000 0 000111111 111 12333 3456788999999
Q ss_pred cccCcCCCCCHHHHHHH
Q 009933 352 LQEQAATRPLIGDVVTA 368 (522)
Q Consensus 352 l~~dP~~RPs~~evl~~ 368 (522)
|..||++|.++.+.|.+
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999998763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=242.73 Aligned_cols=212 Identities=37% Similarity=0.558 Sum_probs=185.6
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCChhh
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED 179 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ 179 (522)
||+|.+|.||++.+..+++.++||++...... ....+.+|+.+++.+.|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999765432 24678899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCceeeeeecceeeCCCCCCCcceec
Q 009933 180 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTR 258 (522)
Q Consensus 180 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~ 258 (522)
++... ...+++..++.++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||++........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99762 146889999999999999999999998 999999999999999 89999999999986533221 1233
Q ss_pred ccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCC
Q 009933 259 VMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYP 337 (522)
Q Consensus 259 ~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 337 (522)
..+...|++||.+... .++.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578899999999887 888999999999999999
Q ss_pred hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 338 MRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 338 ~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4667899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=290.75 Aligned_cols=247 Identities=27% Similarity=0.355 Sum_probs=188.9
Q ss_pred CcccceecccCceE-EEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEeec
Q 009933 95 FRPECLLGEGGFGR-VYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 95 y~~~~~LG~G~fG~-Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
|...+++|.|+.|+ ||+|... ++.||||.+-.. ......+|+..|+.-. |||||++|+.-.+....||+.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 55567899999985 8999997 899999988432 2345678999999885 999999999989999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCceeeeeecceeeC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-----GFHPKLSDFGLAKLG 247 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-----~~~vkL~DFGla~~~ 247 (522)
.. +|.+++...............+.++.|++.||++||+.+ ||||||||.||||+. ...++|+|||+++..
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 65 999999762111111111456789999999999999998 999999999999965 357899999999986
Q ss_pred CCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 248 PVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG-RKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 248 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..+...- ......||-+|+|||++....-+.++||||||||+|+.++| .+||...-... ..++.....+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCcccee
Confidence 5543321 12456799999999999998888899999999999999996 79997542210 11111111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.+.. . .++ ...+||.+|+..+|..||++.+|+.
T Consensus 734 ~L~~-~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLEP-L------PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eecc-C------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 0 011 6779999999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=284.18 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=208.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++...+|.|+||.||+++++.+++..|+|+++.....+..-+..|+-+++..+|||||.+++.+...+.++|+|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35799999999999999999999999999999999988777778888999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
|.+|+|.+..+- .+++++.++..+++..++||+|||+++ -+|||||-.|||+++.|.+||+|||.+-.+..
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 999999998876 688999999999999999999999999 89999999999999999999999999865322
Q ss_pred CCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh-cccCCCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK-DRRKFPKM 327 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 327 (522)
.-.....+.||++|||||+.. .+.|...||||++|+...||---+.|.....+... ..++. ....-+.+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-------l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-------LFLMTKSGFQPPTL 237 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-------HHHhhccCCCCCcc
Confidence 111234578999999999874 56899999999999999999877766543322111 01111 11111111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
-|+ -.....|.+|++.||..+|++||+++.+|.
T Consensus 238 kDk-------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 123456789999999999999999987765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=247.37 Aligned_cols=260 Identities=18% Similarity=0.263 Sum_probs=199.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCC--eeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGD--QRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~--~~~lV 168 (522)
.++|++.+.+|+|-|+.||.|....+.+.++||+++.- ..+.+.+|+.||..|. ||||++|++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46899999999999999999999888999999999753 3567899999999998 999999999987754 56799
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCceeeeeecceeeC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLG 247 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~~ 247 (522)
+||+.+.+...+. ..|+..++..++.+++.||.|||++| |+|||+||.|++||. .-.++|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999887766654 45777889999999999999999999 999999999999985 457999999999976
Q ss_pred CCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc-----c
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD-----R 321 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-----~ 321 (522)
..+... ...+.+..|--||++-.. .|+..-|+|||||+|..|+..+.||...... -.+++..+..+-.+ -
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHH
Confidence 544432 334567789999998764 6889999999999999999999999754331 22333332211100 0
Q ss_pred cCCCCcCCccccC---CCCh-------------HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQG---RYPM-------------RGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~---~~~~-------------~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....-.+++.+.. ..+. -...+.++|+...|..|-.+|+|+.|....
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0001112221111 1110 113578899999999999999999998763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=257.56 Aligned_cols=271 Identities=25% Similarity=0.385 Sum_probs=217.6
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEECCC-----CcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEE
Q 009933 85 FRELAAATKNFRPECLLGEGGFGRVYKGRLEST-----GQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGY 158 (522)
Q Consensus 85 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~ 158 (522)
..++.....++++..++-+|.||.||.|.+... .+.|-+|.++.... -....++.|..+|..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 345666667899999999999999999977532 34466676654322 223567889999999999999999998
Q ss_pred EEc-CCeeEEEEeecCCCChhhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 009933 159 CAD-GDQRLLVYEFMPLGSLEDHLHDL----PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG 233 (522)
Q Consensus 159 ~~~-~~~~~lV~E~~~ggsL~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~ 233 (522)
+.+ ....++++.++.-|+|..||... ......++..+...++.|++.|++|||+++ |||.||...|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 754 46778899999999999999832 223456778889999999999999999999 9999999999999999
Q ss_pred CceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 009933 234 FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVA 312 (522)
Q Consensus 234 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~ 312 (522)
..|||+|=.+++-+...+.............||+||.+.+..|+.++|||||||+||||+| |+.|+..-.|.+...+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-- 510 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-- 510 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--
Confidence 9999999999998777777766666667889999999999999999999999999999998 8889876555433222
Q ss_pred hhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 313 WARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 313 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
+++...+.+ |..+..++..++.-||...|++||++++++.-|.++-.+
T Consensus 511 -----lkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 511 -----LKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -----HhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 223322221 223456788999999999999999999999999877544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=256.36 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=200.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccC--CccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN--GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------ 163 (522)
..+|.-++.+|.|.- .|.-+.+..+++.||+|++... +....+...+|+.++..++|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 567888889999999 8888999889999999988543 2334466788999999999999999999986543
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
..|+|||||. .+|...++ ..++-..+..|+.|++.|++|||+.+ |+||||||+||++..++.+||.|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 5699999995 49999886 35777889999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh--------
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR-------- 315 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~-------- 315 (522)
++.. +.....+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+... +-+|.+
T Consensus 165 ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 165 ARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLGTP 236 (369)
T ss_pred hccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhcCC
Confidence 9853 222345667889999999999999999999999999999999999999874322 222211
Q ss_pred -------------hhhhcc-----cCCCCcC-CccccC--CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 316 -------------PLFKDR-----RKFPKMA-DPLLQG--RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 316 -------------~~~~~~-----~~~~~~~-d~~l~~--~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...... ..+.+.+ |..+.. +.+......+.+|+.+||..+|++|.++.++|.+
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000 0011111 111111 1112334567789999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=247.88 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=194.1
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEE-EEcCCeeEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGY-CADGDQRLLV 168 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~-~~~~~~~~lV 168 (522)
..+.|.+.+.||+|-||.+.+|.++.+.+.+++|.+.+. .....+|.+|...--.|. |.||+.-|++ |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 356799999999999999999999999999999999754 344578888887655554 9999999884 6777888999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-c-CCCceeeeeecceee
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL-D-EGFHPKLSDFGLAKL 246 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl-d-~~~~vkL~DFGla~~ 246 (522)
+||++.|+|.+-+.. ..+-+....+++.|+++||.|||+++ +||||||.+|||| + +...|||||||+.+.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999998865 55788889999999999999999999 9999999999999 3 344899999999875
Q ss_pred CCCCCCCcceecccCCccccChhhhhcC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
... ......-+..|.+||+.... ...+.+|||.||||+|..|||+.||+..... ...+..|..-.-...
T Consensus 173 ~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 173 VGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQWLKRKN 246 (378)
T ss_pred cCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHHhcccC
Confidence 221 11223346679999987642 3467899999999999999999999843222 222233321111111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
..++..+.+. ...++.+..+-|..++++|--+.++.++...
T Consensus 247 ~~~P~~F~~f---------s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 247 PALPKKFNPF---------SEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred ccCchhhccc---------CHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 2233333332 2467788899999999999766666665543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=241.72 Aligned_cols=199 Identities=35% Similarity=0.464 Sum_probs=174.9
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecC
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
|.+.+.||.|+||.||++.+..+++.+|||.+...... ....+..|+..+..++|+||+++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778999999999999999988999999999876544 56778899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEP-LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
+++|.+++... .. +++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999762 23 889999999999999999999998 99999999999999999999999999987543321
Q ss_pred CcceecccCCccccChhhh-hcCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 009933 253 THVSTRVMGTYGYCAPEYA-MTGQLTLKSDVYSFGVVFLELITGRKAIDN 301 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l-~~~~~~~~sDVwSlGvll~eLltG~~Pf~~ 301 (522)
. ......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 154 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 A-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1 22345678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=248.49 Aligned_cols=269 Identities=25% Similarity=0.350 Sum_probs=199.5
Q ss_pred HHHhhcCCcccceecccCceEEEEEEECC---CCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCC
Q 009933 88 LAAATKNFRPECLLGEGGFGRVYKGRLES---TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGD 163 (522)
Q Consensus 88 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~ 163 (522)
+....+.|.++++||+|+|++||++.+.. ..+.||+|.|.... ....+..|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 33445779999999999999999999976 68899999997643 3456889999999996 999999999999999
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCceeeeeec
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFG 242 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~vkL~DFG 242 (522)
+..+||||++.....+++.. ++..++..+++.++.||.++|.+| ||||||||.|+|.+ ..+.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999998888855 567899999999999999999999 99999999999996 45678999999
Q ss_pred ceeeC-----------------CC--C-----------------------CCCcceecccCCccccChhhhhcC-CCCcc
Q 009933 243 LAKLG-----------------PV--G-----------------------DKTHVSTRVMGTYGYCAPEYAMTG-QLTLK 279 (522)
Q Consensus 243 la~~~-----------------~~--~-----------------------~~~~~~~~~~gt~~y~APE~l~~~-~~~~~ 279 (522)
++... .. + ..........||++|.|||++... ..+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 99710 00 0 000001124599999999999864 57889
Q ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCCCc--chHHH---------hh--h-h--hhh---------cccCCCCc-CCcccc
Q 009933 280 SDVYSFGVVFLELITGRKAIDNTRPPGE--HNLVA---------WA--R-P--LFK---------DRRKFPKM-ADPLLQ 333 (522)
Q Consensus 280 sDVwSlGvll~eLltG~~Pf~~~~~~~~--~~~~~---------~~--~-~--~~~---------~~~~~~~~-~d~~l~ 333 (522)
+||||.|||++-+++++.||........ ..++. .+ . . ++. ....+..+ ......
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 9999999999999999999965432111 11110 00 0 0 000 00111111 111111
Q ss_pred CCCC------h-H-HHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 334 GRYP------M-R-GLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 334 ~~~~------~-~-~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...+ . + ....+++|+.+||..||.+|.++++.|++
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1110 0 1 12378899999999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-28 Score=276.43 Aligned_cols=197 Identities=16% Similarity=0.235 Sum_probs=140.7
Q ss_pred hCCC-CCcceeEEEE-------EcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 009933 146 LLHH-SNLVNLIGYC-------ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPP 217 (522)
Q Consensus 146 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 217 (522)
.++| .||+.++++| .....++++|||+ +++|.++|.. ....+++.+++.|+.||+.||.|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 5888888887 3334677889988 5599999964 2356999999999999999999999999
Q ss_pred eEecCCCCCceeecC-------------------CCceeeeeecceeeCCCCCC--------------CcceecccCCcc
Q 009933 218 VIYRDLKSSNILLDE-------------------GFHPKLSDFGLAKLGPVGDK--------------THVSTRVMGTYG 264 (522)
Q Consensus 218 iiHrDLKp~NILld~-------------------~~~vkL~DFGla~~~~~~~~--------------~~~~~~~~gt~~ 264 (522)
||||||||+||||+. ++.+||+|||+++....... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566666666653210000 000112468999
Q ss_pred ccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHH
Q 009933 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQA 344 (522)
Q Consensus 265 y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 344 (522)
|||||++.+..|+.++|||||||+||||++|..||..... .+..+... .+.+.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~----------~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR----------VLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh----------hcChhh-----hhcCHHH
Confidence 9999999999999999999999999999998887642110 00011000 001100 1112345
Q ss_pred HHHHHHhcccCcCCCCCHHHHHHH
Q 009933 345 LAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 345 ~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..++.+||+.+|.+||++.+|++.
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 688899999999999999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=227.95 Aligned_cols=264 Identities=20% Similarity=0.204 Sum_probs=199.8
Q ss_pred CCcccceecccCceEEEEEEECCCC-cEEEEEEEccCCccchHHHHHHHHHHHhCCC----CCcceeEEEE-EcCCeeEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTG-QVVAVKQLDRNGLQGNREFLVEVLMLSLLHH----SNLVNLIGYC-ADGDQRLL 167 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g-~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h----pnIv~l~~~~-~~~~~~~l 167 (522)
+|.+.+.||+|+||.||+|.+..++ ..+|+|............+..|+.+|..+.. .++..+++.. ......||
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999998764 6789998765433333367778888888873 6899999999 57788999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-----Cceeeeeec
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG-----FHPKLSDFG 242 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~-----~~vkL~DFG 242 (522)
||+.+ |.+|.++..... ...++..++..|+.|++.+|++||+.| +|||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 889999886643 578999999999999999999999999 9999999999999654 469999999
Q ss_pred cee--eCCCCCCC----c-c-eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh
Q 009933 243 LAK--LGPVGDKT----H-V-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 243 la~--~~~~~~~~----~-~-~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~ 314 (522)
+++ ........ . . .....||..|+++.+..+...+.+.|+||++.++.+|+.|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 32111110 0 1 12356999999999999999999999999999999999999999765433221111110
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
... ..... +.......+.++...+-..+...+|....+...|+.+....
T Consensus 253 ---~~~-----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 ---PRK-----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---hhh-----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 00000 11111234555666666689999999999999987765443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=211.27 Aligned_cols=169 Identities=21% Similarity=0.154 Sum_probs=127.1
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
|+|.+++.. ....+++.+++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 689999975 2456999999999999999999999875 999999999999999 9999864321
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
...||+.|+|||++.+..|+.++|||||||++|||+||+.||....... ..+..+. ..... . .+.. .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~----~~~~~---~-~~~~-~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILL----NGMPA---D-DPRD-R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHH----HHhcc---C-Cccc-c
Confidence 1258999999999999999999999999999999999999996542211 1111111 11000 0 0000 0
Q ss_pred CCChHHH--HHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 335 RYPMRGL--YQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 335 ~~~~~~~--~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..+.... ..+.+++.+||+.+|.+||++.++++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0111122 258899999999999999999999999977643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-24 Score=211.95 Aligned_cols=261 Identities=32% Similarity=0.420 Sum_probs=200.0
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCC-CcceeEEEEEcCCeeEEEEe
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHS-NLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hp-nIv~l~~~~~~~~~~~lV~E 170 (522)
|.+...||.|+|+.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +|+.+++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 678889999999999999997 78999999765433 256788999999999988 79999999988888899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DFGla~~~~~ 249 (522)
|+.+++|.+++...... ..+.......++.|++.+|.|+|..+ ++||||||+|||++..+ .++++|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777652111 36889999999999999999999999 99999999999999988 799999999985443
Q ss_pred CCCCc----ceecccCCccccChhhhhc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC-CcchHHHhhhhhhhcc
Q 009933 250 GDKTH----VSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPP-GEHNLVAWARPLFKDR 321 (522)
Q Consensus 250 ~~~~~----~~~~~~gt~~y~APE~l~~---~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~ 321 (522)
..... ......||..|+|||.+.. ..+....|+|++|++++++++|..||...... .......... ...
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL---ELP 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH---hcC
Confidence 33221 2356789999999999987 57889999999999999999999997654331 0111111111 111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.. .................+.+++..|+..+|..|.+..+....
T Consensus 232 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000000000002223567889999999999999988887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=228.37 Aligned_cols=176 Identities=18% Similarity=0.133 Sum_probs=134.8
Q ss_pred hhcCCcccceecccCceEEEEEEECC-CCcEEEEEEEccCCc-----cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLES-TGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-~g~~vAvK~i~~~~~-----~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~ 164 (522)
...+|.+.+.||+|+||+||+|++.. +++.||||++..... .....+.+|+.+|+.|+|+||+..+..+ ..
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence 46789999999999999999999875 678889998753311 1234588999999999999998533222 45
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeecCCCceeeeeecc
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL-KSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDL-Kp~NILld~~~~vkL~DFGl 243 (522)
.|||||||+|++|... .. .. ...++.|++.+|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 93 ~~LVmE~~~G~~L~~~-~~----~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP----HG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc----cc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 7999999999999632 11 11 1467899999999999999 999999 99999999999999999999
Q ss_pred eeeCCCCCCCcc------eecccCCccccChhhhhcCC------CCcchhhH
Q 009933 244 AKLGPVGDKTHV------STRVMGTYGYCAPEYAMTGQ------LTLKSDVY 283 (522)
Q Consensus 244 a~~~~~~~~~~~------~~~~~gt~~y~APE~l~~~~------~~~~sDVw 283 (522)
++.......... .+..++++.|+|||++.... .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 997543221111 13567889999999986542 23346666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=242.19 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=192.5
Q ss_pred cccceecccCceEEEEEEECCCCcEEEEEEEccC--Cccch----HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN--GLQGN----REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 96 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~--~~~~~----~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
....++|.|.||.|+.+......+.++.|..... ..... ..+..|+.+-..|+||||+..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998888888766666666654311 11111 12556788888899999988888777776666669
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||++ +|+.++.. ...+...++..++.||+.||+|||+.+ |.|||||++|+|++.++.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999976 357888999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCC--cceecccCCccccChhhhhcCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 250 GDKT--HVSTRVMGTYGYCAPEYAMTGQLTL-KSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 250 ~~~~--~~~~~~~gt~~y~APE~l~~~~~~~-~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.... ......+|+-.|+|||++....|++ ..||||.|++++.|++|+.||............ . .....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--~--~~~~~----- 543 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--N--NYSDQ----- 543 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--h--ccccc-----
Confidence 4443 4556788999999999999999986 579999999999999999999755443222100 0 00000
Q ss_pred cCCccccCCCCh--HHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 327 MADPLLQGRYPM--RGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 327 ~~d~~l~~~~~~--~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.....+.... ........+|.++|+.+|.+|.|+.+|++.
T Consensus 544 --~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 --RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred --cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000011110 112356679999999999999999999873
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=203.27 Aligned_cols=264 Identities=19% Similarity=0.262 Sum_probs=201.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
-+|++.++||+|+||.++.|...-+++.||||.-... ...-++..|....+.|. .+.|..+|.+...+.+-.||||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4699999999999999999999999999999986543 23456777888888886 88999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCceeeeeecceee
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-----GFHPKLSDFGLAKL 246 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-----~~~vkL~DFGla~~ 246 (522)
+ |-+|+|+..-+ ...|+..++.-|+.|++.-++|+|++. +|+|||||+|+||.. ...|.|+|||+|+.
T Consensus 106 L-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 77999888653 467999999999999999999999999 999999999999953 34689999999997
Q ss_pred CCCCCCC-----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 247 GPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 247 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
....... .......||..||+-....+...+...|+-|||-++++.|-|..||.+.........-.- +.+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK----IGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK----IGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH----hccc
Confidence 5433221 112346799999999999999999999999999999999999999998766543222111 1111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
... .-++. |...+| .++...+.-.-..+-.+-|...-+...+..+...
T Consensus 255 Kr~-T~i~~-Lc~g~P----~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 255 KRS-TPIEV-LCEGFP----EEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ccc-CCHHH-HHhcCH----HHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 110 11111 111122 4555556666667777888888777776665433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=192.64 Aligned_cols=263 Identities=20% Similarity=0.246 Sum_probs=203.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E 170 (522)
...|.+.+.||.|+||.+|+|..-.+|..||||+-+.. ....++..|..+...|+ ...|..+..|+.+..+-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46799999999999999999999999999999997543 23346778999999997 4678888888889999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCceeeeeecceeeC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---GFHPKLSDFGLAKLG 247 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---~~~vkL~DFGla~~~ 247 (522)
++ |-+|.+++.-. ...++..+++-++-|++.-|+|+|..+ +|||||||+|+|..- ...+.|+|||+++..
T Consensus 92 LL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 98 78999988653 456888999999999999999999999 999999999999953 346899999999874
Q ss_pred CCCCC-----CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhccc
Q 009933 248 PVGDK-----THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 322 (522)
Q Consensus 248 ~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 322 (522)
..... ........||..|.+-....+...+...|+-|+|.+|.++.-|..||++..+....+.-..+ .+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI---~Ek-- 239 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI---SEK-- 239 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---HHh--
Confidence 32211 11224567999999988888878889999999999999999999999987665443322211 111
Q ss_pred CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 323 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 323 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
++ ...-..+...+| .++.-.+.-|-...-++-|...-+-+.+..|-
T Consensus 240 K~-s~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 240 KM-STPIEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred hc-CCCHHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 11 111122223343 45666778888888888898888877776653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-24 Score=231.61 Aligned_cols=247 Identities=23% Similarity=0.221 Sum_probs=184.1
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-ccch---HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-LQGN---REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-~~~~---~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.. .... .+.+.|++ +..++|||++++.-+-+.....|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 67788999999999999999975 55 8999985443 2222 33344555 66678999999998888888889999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee--C
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--G 247 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~--~ 247 (522)
+|+.. +|+|.|.. ...+...+.+.|+.||+.||..+|..+ |+|+|||.+||||+.-..+.|+||-..+. +
T Consensus 101 qyvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 99966 99999965 456778889999999999999999999 99999999999999999999999987753 2
Q ss_pred CCCCCCc---ceecccCCccccChhhhhcC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 009933 248 PVGDKTH---VSTRVMGTYGYCAPEYAMTG----------Q-LTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVA 312 (522)
Q Consensus 248 ~~~~~~~---~~~~~~gt~~y~APE~l~~~----------~-~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~ 312 (522)
+..+... ...+...-.+|+|||.+... . .+++-||||+||+++||++ |+.+|.. .++..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHh
Confidence 2222222 12222334589999998642 1 5778999999999999998 5777752 22333
Q ss_pred hhhhh-hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 313 WARPL-FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 313 ~~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
+.... ......+.++-|. .+.++|..|++.||.+|.+++++|+.-
T Consensus 247 Yr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 32211 0001112222222 355899999999999999999999874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-23 Score=198.05 Aligned_cols=248 Identities=22% Similarity=0.359 Sum_probs=192.8
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
..+..+|.+...|..|+|++. |..+++|++..... ...+.|..|.-.|+.+.||||+.+++.|....++.+|..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 344556889999999999997 55677788764332 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeee--eecceeeCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS--DFGLAKLGPVG 250 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~--DFGla~~~~~~ 250 (522)
+.|+|+..|+. ...-.++..++.+++.+|++|+.|||+.. +-|.---|....|+||++.+.+|+ |--++..
T Consensus 270 p~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred cchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 99999999987 33456788899999999999999999985 324444689999999999887764 3222221
Q ss_pred CCCcceecccCCccccChhhhhcCCCC---cchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLT---LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~---~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.....-.|.||+||.+...+-+ .++|+|||.++||||.|...||....+.+....+.
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------------- 402 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------------- 402 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------------
Confidence 0112346889999999876533 57999999999999999999999877654432222
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
-.-+.-..|+.....+..|+.-|+..||.+||.+..|+-.|+.+
T Consensus 403 -leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 403 -LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 11122234444556788999999999999999999999999865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-23 Score=196.27 Aligned_cols=173 Identities=11% Similarity=0.107 Sum_probs=135.3
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHH---------HHHHHHHHHhCCCCCcceeEEEEE
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---------FLVEVLMLSLLHHSNLVNLIGYCA 160 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~---------~~~E~~~L~~l~hpnIv~l~~~~~ 160 (522)
....+|++.++||.|+||.||++.. ++..+|||++.......... +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3467899999999999999999765 36689999997543333222 578999999999999999999866
Q ss_pred cC--------CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC
Q 009933 161 DG--------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE 232 (522)
Q Consensus 161 ~~--------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~ 232 (522)
.. ...+|||||++|.+|.++.. +++ ..+.+|+.+|..||..+ |+|+||||.|||++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 43 35789999999999988732 222 24669999999999999 999999999999998
Q ss_pred CCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh
Q 009933 233 GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294 (522)
Q Consensus 233 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt 294 (522)
++ ++|+|||........... ..++....|..++|+|+||+++..+..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 88 999999988753211100 114555567889999999999876653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=190.33 Aligned_cols=138 Identities=17% Similarity=0.114 Sum_probs=108.5
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCcc--c-------h-----------------HHHHHHHHHHHhCCCCC
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--G-------N-----------------REFLVEVLMLSLLHHSN 151 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~-------~-----------------~~~~~E~~~L~~l~hpn 151 (522)
...||+|+||.||+|.+. +|+.||||+++..... . . .....|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 7999999999754211 0 0 11234999999998887
Q ss_pred cceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceee
Q 009933 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL-HDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 152 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~iiHrDLKp~NILl 230 (522)
+.....+.. ...+|||||+++++|...+.. ...+++..+..++.||+.+|.|| |+.+ |+||||||+|||+
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 644333222 223899999998777655322 35788999999999999999999 6888 9999999999999
Q ss_pred cCCCceeeeeecceee
Q 009933 231 DEGFHPKLSDFGLAKL 246 (522)
Q Consensus 231 d~~~~vkL~DFGla~~ 246 (522)
+ ++.++|+|||++..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-24 Score=221.95 Aligned_cols=233 Identities=27% Similarity=0.338 Sum_probs=185.2
Q ss_pred eecccCceEEEEEEE---CCCCcEEEEEEEccCCccch--HHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEeecC
Q 009933 100 LLGEGGFGRVYKGRL---ESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~---~~~g~~vAvK~i~~~~~~~~--~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
.+|+|.||.|++++- ...+..+|+|++.+...... .....|..++..++ ||.+|++...|+.+...+++++|+.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999987653 44578899999876543221 23445778888887 9999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~ 253 (522)
+|.|...+.. ...+++.....+...++.+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 9999998876 567788888999999999999999999 99999999999999999999999999986432221
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQ 333 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 333 (522)
.|||..|||||++. ....++|+||||++++||+||..||.. . ....++...
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~---~~~~Il~~~------------ 203 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------D---TMKRILKAE------------ 203 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------H---HHHHHhhhc------------
Confidence 28999999999998 678899999999999999999999975 1 111112211
Q ss_pred CCCChHHHHHHHHHHHHhcccCcCCCCCH--HHHHHHH
Q 009933 334 GRYPMRGLYQALAVAAMCLQEQAATRPLI--GDVVTAL 369 (522)
Q Consensus 334 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~--~evl~~L 369 (522)
-.+|......+..++..++..+|..|.-. ..+.+.+
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 12344445566689999999999999744 3444443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=183.04 Aligned_cols=139 Identities=19% Similarity=0.132 Sum_probs=110.5
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccc--------------------------hHHHHHHHHHHHhCCCCC
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--------------------------NREFLVEVLMLSLLHHSN 151 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--------------------------~~~~~~E~~~L~~l~hpn 151 (522)
...||+|+||.||+|.+. +|+.||||+++...... ...+..|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 89999999997642110 012357889999999998
Q ss_pred cceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceee
Q 009933 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILL 230 (522)
Q Consensus 152 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILl 230 (522)
|.....+... ..+|||||++++++...+.. ...++...+..++.|++.+|.+||. .+ |+||||||+|||+
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 7554443332 24899999998755443221 2457788999999999999999999 88 9999999999999
Q ss_pred cCCCceeeeeecceeeC
Q 009933 231 DEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~ 247 (522)
+ ++.++|+|||++...
T Consensus 152 ~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 152 H-DGKPYIIDVSQAVEL 167 (190)
T ss_pred E-CCCEEEEEcccceec
Confidence 9 789999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=190.34 Aligned_cols=235 Identities=20% Similarity=0.264 Sum_probs=148.4
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCC----------CCcceeEEEE-
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHH----------SNLVNLIGYC- 159 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~h----------pnIv~l~~~~- 159 (522)
.+.....||.|+|+.||.+++..|++.+|||++...... ..+.+.+|......+.+ -.++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456678999999999999999999999999998543321 22445555544444322 1122112221
Q ss_pred --------EcC---C-----eeEEEEeecCCCChhhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 009933 160 --------ADG---D-----QRLLVYEFMPLGSLEDHLHDLP---PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220 (522)
Q Consensus 160 --------~~~---~-----~~~lV~E~~~ggsL~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH 220 (522)
... . ..+++|+-+. ++|.+++..+. .....+.....+.+..|+++.+++||..+ |||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 1 2366788774 48887764321 11122334455667799999999999999 999
Q ss_pred cCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcC--------CCCcchhhHHHHHHHHHH
Q 009933 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--------QLTLKSDVYSFGVVFLEL 292 (522)
Q Consensus 221 rDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--------~~~~~sDVwSlGvll~eL 292 (522)
+||+|+|+|++.+|.++|+||+...... . .......+..|.+||+.... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g--~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAG--T---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETT--E---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecC--c---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999887522 1 11113456789999987542 478899999999999999
Q ss_pred HhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCC
Q 009933 293 ITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR 359 (522)
Q Consensus 293 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~R 359 (522)
+++..||+...+...... .+. .+. +....+..||..+|+.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~--------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW--------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG--------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc--------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999985533211110 111 122 444667789999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=180.06 Aligned_cols=187 Identities=19% Similarity=0.135 Sum_probs=142.0
Q ss_pred cccceecccCceEEEEEEECCCCcEEEEEEEccCCccch----HHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEe
Q 009933 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN----REFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 96 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~----~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.+...|++|+||+||.+.. .+..++.+.+........ ..+.+|+++|++|. |++|+.++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998776 478888888765543211 24788999999996 5889999886 44699999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeecCCCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL-KSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDL-Kp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|+.|.+|...+.. . ...++.|++.+|.+||+.+ |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999888754321 1 1357889999999999999 999999 79999999999999999999986432
Q ss_pred CCCC----cc-------eecccCCccccChhhhhcC-CCC-cchhhHHHHHHHHHHHhCCCCCCCC
Q 009933 250 GDKT----HV-------STRVMGTYGYCAPEYAMTG-QLT-LKSDVYSFGVVFLELITGRKAIDNT 302 (522)
Q Consensus 250 ~~~~----~~-------~~~~~gt~~y~APE~l~~~-~~~-~~sDVwSlGvll~eLltG~~Pf~~~ 302 (522)
.... .. ......++.|+.|+...-- ..+ ...++++.|+-+|.++|+..++...
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 2210 00 0112367888888865432 333 5679999999999999999887544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=179.99 Aligned_cols=137 Identities=21% Similarity=0.276 Sum_probs=109.3
Q ss_pred cccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-----CCCCcceeEEEEEcCC---e-eE
Q 009933 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-----HHSNLVNLIGYCADGD---Q-RL 166 (522)
Q Consensus 96 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-----~hpnIv~l~~~~~~~~---~-~~ 166 (522)
.-..+||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||++++++++++. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4457899999999995 6666665 69998765444567789999999999 5799999999998874 3 33
Q ss_pred EEEee--cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceeecC----CCceeee
Q 009933 167 LVYEF--MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL-EYLHDKANPPVIYRDLKSSNILLDE----GFHPKLS 239 (522)
Q Consensus 167 lV~E~--~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~~~~iiHrDLKp~NILld~----~~~vkL~ 239 (522)
+|||| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++ ||||||||+|||++. +..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557999999965 235555 35678888887 9999999 999999999999963 3479999
Q ss_pred ee-ccee
Q 009933 240 DF-GLAK 245 (522)
Q Consensus 240 DF-Gla~ 245 (522)
|| |...
T Consensus 152 Dg~G~~~ 158 (210)
T PRK10345 152 DNIGEST 158 (210)
T ss_pred ECCCCcc
Confidence 95 5433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=210.98 Aligned_cols=196 Identities=20% Similarity=0.233 Sum_probs=159.9
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC---CCCcceeEEEEEcCCeeEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~---hpnIv~l~~~~~~~~~~~l 167 (522)
....|.|.+.||+|+||+||+|...+ |+.||||+-+....... ..=.+++.+|+ -+-|..+..++.-.+..+|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 34568888999999999999999987 99999999876654432 22233444444 3456666666667778899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-------CCCceeeee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-------EGFHPKLSD 240 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-------~~~~vkL~D 240 (522)
|+||.+.|+|.+++.. .+.++|..++.|+.||+..|+.||..+ |||+||||+|+||. +.--++|+|
T Consensus 772 v~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999974 678999999999999999999999999 99999999999993 234589999
Q ss_pred ecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCC
Q 009933 241 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 297 (522)
Q Consensus 241 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~ 297 (522)
||.+.-...-.........++|-.+--+|...+..++...|.|.|..++|-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999864332222234556778999999999999999999999999999999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-21 Score=210.42 Aligned_cols=212 Identities=27% Similarity=0.407 Sum_probs=151.2
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
...+|..+++|..|+||.||.++++.+.+.+|+| |.++++ +++- +|.....|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-----------------
Confidence 3568999999999999999999999999999994 433321 1111 33333445444
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+-...++. .++++... +.+++|||+.+ |+|||+||+|.||+.-|++|++|||+++.....
T Consensus 136 ----gDc~tllk~----~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhccc----CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 333344433 23444322 78999999999 999999999999999999999999999864221
Q ss_pred CCCc-------------ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 251 DKTH-------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 251 ~~~~-------------~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
..+. ....++||+.|.|||++....|...+|+|++|+|+||.+-|..||....+..... .+
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~v 270 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QV 270 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hh
Confidence 1111 1234689999999999999999999999999999999999999998775533211 12
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 361 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs 361 (522)
+.+....++- |.. ...+..++|.+.|+.+|..|--
T Consensus 271 isd~i~wpE~-dea--------~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 271 ISDDIEWPEE-DEA--------LPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhhcccccc-CcC--------CCHHHHHHHHHHHHhChHhhcc
Confidence 2222222222 111 1246778999999999999973
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=190.85 Aligned_cols=217 Identities=27% Similarity=0.402 Sum_probs=163.7
Q ss_pred HHhCCCCCcceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecC
Q 009933 144 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV-IYRD 222 (522)
Q Consensus 144 L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i-iHrD 222 (522)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.. ....+++.....++++|+.||.|||.-. | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4568899999999999999999999999999999999976 3567899999999999999999999865 5 9999
Q ss_pred CCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCC-------CCcchhhHHHHHHHHHHHhC
Q 009933 223 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-------LTLKSDVYSFGVVFLELITG 295 (522)
Q Consensus 223 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-------~~~~sDVwSlGvll~eLltG 295 (522)
|+..|+++|..+.+||+|||+.................-..-|.|||++.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999988753211111111222345799999998641 46779999999999999999
Q ss_pred CCCCCCCCCCCc-chHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 296 RKAIDNTRPPGE-HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 296 ~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..||........ ..++.++.. . ....+.|.+.... +....+..++..||..+|..||++..|-..+..+-.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~---~---~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK---G---GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh---c---CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999986433222 223333221 1 1111222221100 222368899999999999999999999888876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6e-20 Score=182.97 Aligned_cols=198 Identities=21% Similarity=0.201 Sum_probs=140.6
Q ss_pred CCCCcceeEEEEEc---------------------------CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHH
Q 009933 148 HHSNLVNLIGYCAD---------------------------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 200 (522)
Q Consensus 148 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~ 200 (522)
+|||||.++.+|.+ ...+|+||...+. +|.+++.. ...+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 59999999987743 2356899998865 99999865 445666778899
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceee--cCC--CceeeeeecceeeCCCCC----CCcceecccCCccccChhhhh
Q 009933 201 AGAAKGLEYLHDKANPPVIYRDLKSSNILL--DEG--FHPKLSDFGLAKLGPVGD----KTHVSTRVMGTYGYCAPEYAM 272 (522)
Q Consensus 201 ~qi~~~L~yLH~~~~~~iiHrDLKp~NILl--d~~--~~vkL~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~l~ 272 (522)
.|+++|+.|||.++ |.|||||.+|||| |++ -.+.|+|||++-...... ........-|.-..||||++.
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999999 333 357899999986422210 000112244777899999986
Q ss_pred cCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHH
Q 009933 273 TGQ------LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALA 346 (522)
Q Consensus 273 ~~~------~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 346 (522)
..+ --.++|.|+.|.+.||++....||......... ...+ . ...++.+.+ .....+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-~r~Y-----q-e~qLPalp~---------~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-TRTY-----Q-ESQLPALPS---------RVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-hhhh-----h-hhhCCCCcc---------cCChHHHH
Confidence 432 135899999999999999999999763322111 1111 1 112222222 22346678
Q ss_pred HHHHhcccCcCCCCCHHHHHHHHH
Q 009933 347 VAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 347 Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
|+...|+.||.+|++..-....|+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999998876666664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=173.98 Aligned_cols=142 Identities=17% Similarity=0.129 Sum_probs=112.0
Q ss_pred CCcccceecccCceEEEEEE-ECCCCcEEEEEEEccCCccc------------------------hHHHHHHHHHHHhCC
Q 009933 94 NFRPECLLGEGGFGRVYKGR-LESTGQVVAVKQLDRNGLQG------------------------NREFLVEVLMLSLLH 148 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~-~~~~g~~vAvK~i~~~~~~~------------------------~~~~~~E~~~L~~l~ 148 (522)
-|.+.+.||+|+||.||+|. +..+|+.||||+++...... ...+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 66689999999997542110 022467999999997
Q ss_pred CCC--cceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 009933 149 HSN--LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 226 (522)
Q Consensus 149 hpn--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~ 226 (522)
+.. +..++++ ...+|||||+.+.+|..++.. ...+....+..++.||+.+|.+||..+. |+|+||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence 532 3444443 235899999999888776532 2345666778999999999999998864 999999999
Q ss_pred ceeecCCCceeeeeecceee
Q 009933 227 NILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 227 NILld~~~~vkL~DFGla~~ 246 (522)
|||++ ++.++|+|||++..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99999 88999999999875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=165.50 Aligned_cols=134 Identities=22% Similarity=0.306 Sum_probs=113.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccc--------hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--------~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
+.||+|++|.||+|.+ .+..++||+........ ...+.+|+.++..+.|++|.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999998 47789999875433211 1346789999999999998887777777788899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
|++|++|.+++... .+ ....++.+|+.+|.+||..+ |+|+||+|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998641 12 77899999999999999999 99999999999999 78899999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-18 Score=162.04 Aligned_cols=130 Identities=22% Similarity=0.320 Sum_probs=107.0
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEEccCCccc--------hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--------~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+||+|+||.||++.+ ++..|++|+........ ...+.+|+.++..+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999995 47889999865432211 24466899999999988766555556667778999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
++|++|.+++... . ..++.+++.+|.+||+.+ |+|+||+|.|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~----~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEG----N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhc----H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999987541 1 078999999999999999 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-19 Score=184.35 Aligned_cols=174 Identities=25% Similarity=0.353 Sum_probs=129.2
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
.++||.|++|.-.+|.++|... ......++...+.++.|++.+++| ++ .+|+|+||.||++..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 3678999999999999999742 334567788999999999999999 77 8999999999999999999999999
Q ss_pred ceeeCCCCC----CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhh
Q 009933 243 LAKLGPVGD----KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 243 la~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
+........ .....+...||..||+||.+.+..|+.++||||||+||+||+. =...|+....
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t------------- 468 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT------------- 468 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh-------------
Confidence 987543222 1223456789999999999999999999999999999999997 2222211100
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHH
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 363 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 363 (522)
+.+.+ .-.+++.+...+| .-..|+.+++...|.+||++.
T Consensus 469 ~~d~r--~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 469 LTDIR--DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhhhh--cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence 00000 1122222222232 334689999999999999433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.7e-18 Score=160.64 Aligned_cols=144 Identities=17% Similarity=0.085 Sum_probs=112.3
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc----------------------chHHHHHHHHH
Q 009933 86 RELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ----------------------GNREFLVEVLM 143 (522)
Q Consensus 86 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~----------------------~~~~~~~E~~~ 143 (522)
.++......|.+.+.||+|+||.||++... +|+.||||++...... ....+..|+.+
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 344444445888999999999999999886 6999999997643210 01125678888
Q ss_pred HHhCCCCC--cceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 009933 144 LSLLHHSN--LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 221 (522)
Q Consensus 144 L~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHr 221 (522)
+..+.|++ ++.+++. ...++||||+++++|.++... .....++.+|+.++.++|..+ |+|+
T Consensus 87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~ 149 (198)
T cd05144 87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHG 149 (198)
T ss_pred HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcC
Confidence 99888774 4445442 345899999999998765421 235678899999999999998 9999
Q ss_pred CCCCCceeecCCCceeeeeecceeeC
Q 009933 222 DLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 222 DLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+||||++++.++|+|||++...
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccC
Confidence 99999999999999999999999653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-18 Score=184.99 Aligned_cols=139 Identities=22% Similarity=0.322 Sum_probs=113.4
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--------chHHHHHHHHHHHhCCCCCcceeEEEEEc
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--------GNREFLVEVLMLSLLHHSNLVNLIGYCAD 161 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~ 161 (522)
.....|...++||+|+||+||++.+.. ..+++|+....... ....+.+|+.++..++|++|+..+.++..
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 334556778999999999999998864 34444443221111 12457789999999999999988888887
Q ss_pred CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
....++||||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ +++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999999884 34679999999999999999 9999999999999 5779999999
Q ss_pred cceee
Q 009933 242 GLAKL 246 (522)
Q Consensus 242 Gla~~ 246 (522)
|+++.
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 99985
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.4e-17 Score=143.50 Aligned_cols=135 Identities=22% Similarity=0.189 Sum_probs=114.0
Q ss_pred ccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC--CCcceeEEEEEcCCeeEEEEeecCC
Q 009933 97 PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH--SNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 97 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
+.+.||.|.++.||++... +..++||.+..... ...+..|+.++..+.| .++++++.++...+..+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4577999999999999986 37899999865432 4578889999999986 5899999998888899999999988
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
..+..+ +......++.+++.+|.+||......++|+||+|.|||+++.+.++|+|||++..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 776554 4456678899999999999986434499999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=148.93 Aligned_cols=134 Identities=22% Similarity=0.183 Sum_probs=97.6
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHH----------------------HHHHHHHHHhCCCCC--
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NRE----------------------FLVEVLMLSLLHHSN-- 151 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~----------------------~~~E~~~L~~l~hpn-- 151 (522)
.+.||+|+||+||+|.+. +++.||||++....... ... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 78999999987542211 111 124555666655432
Q ss_pred cceeEEEEEcCCeeEEEEeecCCCChhhh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcee
Q 009933 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDH-LHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNIL 229 (522)
Q Consensus 152 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NIL 229 (522)
+.+.+++ ...++||||++++.+... +... .. ...+..++.+++.++.+||. .+ |+|+||||+|||
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-----hh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4444443 245899999998544321 2110 01 15678899999999999999 88 999999999999
Q ss_pred ecCCCceeeeeecceee
Q 009933 230 LDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 230 ld~~~~vkL~DFGla~~ 246 (522)
++ ++.++|+|||++..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 88999999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.9e-18 Score=186.80 Aligned_cols=257 Identities=24% Similarity=0.283 Sum_probs=191.0
Q ss_pred cCCcccceecccCceEEEEEEECC-CCcEEEEEEEccCC--ccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLES-TGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~-~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV 168 (522)
..|.+.+.||+|+|+.|-...... ....+|+|.+.... ......+..|..+-..+. |.|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457777789999999999888743 34567777775543 111233445777777777 99999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceeecCCC-ceeeeeecceee
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-DKANPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKL 246 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~iiHrDLKp~NILld~~~-~vkL~DFGla~~ 246 (522)
++|..++++.+.+.. ......+...+..++.|+..+|.|+| ..+ +.|+||||+|.+++..+ .++++|||++..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999998832 12225666778899999999999999 888 99999999999999999 999999999997
Q ss_pred CCC-CCCCcceecccC-CccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 247 GPV-GDKTHVSTRVMG-TYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 247 ~~~-~~~~~~~~~~~g-t~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
... ..........+| ++.|+|||...+. ......|+||+|+++.-+++|..|+........ ....|.. ....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~----~~~~ 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKS----NKGR 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecc----cccc
Confidence 655 333334455678 9999999999885 446788999999999999999999875543221 1111211 1000
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
+... .-........+++..++..+|..|.+.+++..
T Consensus 250 ~~~~--------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 FTQL--------PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccC--------ccccCChhhhhcccccccCCchhccccccccc
Confidence 0000 11122245667888999999999998887743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.6e-16 Score=151.86 Aligned_cols=134 Identities=23% Similarity=0.245 Sum_probs=105.1
Q ss_pred ceec-ccCceEEEEEEECCCCcEEEEEEEccCCc-------------cchHHHHHHHHHHHhCCCCCc--ceeEEEEEcC
Q 009933 99 CLLG-EGGFGRVYKGRLESTGQVVAVKQLDRNGL-------------QGNREFLVEVLMLSLLHHSNL--VNLIGYCADG 162 (522)
Q Consensus 99 ~~LG-~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-------------~~~~~~~~E~~~L~~l~hpnI--v~l~~~~~~~ 162 (522)
.+|| .|+.|+||.+... +..++||.+..... .....+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4687 8899999999875 67899998854221 112457789999999998875 6677765433
Q ss_pred C----eeEEEEeecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcee
Q 009933 163 D----QRLLVYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK 237 (522)
Q Consensus 163 ~----~~~lV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vk 237 (522)
. ..+|||||++| .+|.+++.. ..+++. .+.+|+.+|.+||+.+ |+|+||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 2 22599999997 689988864 345543 3678999999999999 99999999999999888999
Q ss_pred eeeecceee
Q 009933 238 LSDFGLAKL 246 (522)
Q Consensus 238 L~DFGla~~ 246 (522)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999885
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.8e-15 Score=155.14 Aligned_cols=250 Identities=24% Similarity=0.234 Sum_probs=185.8
Q ss_pred cCCcccceecc--cCceEEEEEEE--CCCCcEEEEEEEcc--CCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCee
Q 009933 93 KNFRPECLLGE--GGFGRVYKGRL--ESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQR 165 (522)
Q Consensus 93 ~~y~~~~~LG~--G~fG~Vy~~~~--~~~g~~vAvK~i~~--~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~ 165 (522)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+. ........-.+|+.....++ |+|.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677788999 99999999999 78899999998432 22233334456777777776 99999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceeecCC-Cceeeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDLKSSNILLDEG-FHPKLSD 240 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~~~~iiHrDLKp~NILld~~-~~vkL~D 240 (522)
++-+|+|. .+|..+.+.. ...++...++.++.+... ||..+|..+ ++|-|+||.||++..+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 99999995 6888888762 234677778888888888 999999998 9999999999999888 8899999
Q ss_pred ecceeeCCCCCCCcce---ecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 241 FGLAKLGPVGDKTHVS---TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 241 FGla~~~~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
||+........-.... .+..|...|++||++.+ -++..+|||+||.++.+-.++-..+..... ..|.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~--- 336 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------SSWS--- 336 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------CCcc---
Confidence 9999876554432222 23367889999997655 789999999999999999998766543211 1111
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
..+ .+. +..++-......+..++..+++.+|-.|++.+.+..
T Consensus 337 -~~r----~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 -QLR----QGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccc----ccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 100 111222222334445899999999999998766544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-14 Score=141.08 Aligned_cols=207 Identities=24% Similarity=0.290 Sum_probs=144.3
Q ss_pred HHHHHhCCCCCcceeEEEEEcCC-----eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 009933 141 VLMLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215 (522)
Q Consensus 141 ~~~L~~l~hpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~ 215 (522)
+..|-++-|.|||+++.|+.+.. ...++.|||..|+|..+|++.......+....-.+|+.||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 44556667999999999987654 46899999999999999998766677788888899999999999999998 5
Q ss_pred CCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCc--ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHH
Q 009933 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELI 293 (522)
Q Consensus 216 ~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLl 293 (522)
|+|+|++|..+-|++..++-|||.----....+...... ......+-++|.+||.=...+.+.++|||+||...++|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 889999999999999999888875311111100000000 112234678999999876667888999999999999998
Q ss_pred hCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 294 TGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 294 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+..--........ ..... ...+.-+-+.+- ..++..|++..|..||++.+++-+
T Consensus 277 ilEiq~tnseS~~~-~ee~i-------a~~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE-VEENI-------ANVIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceee-hhhhh-------hhheeeccCccc------------cCcCcccccCCCCCCcchhhhhcC
Confidence 87643211110000 00000 001111111111 246789999999999999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.2e-13 Score=144.84 Aligned_cols=140 Identities=24% Similarity=0.166 Sum_probs=97.9
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccch----------------------------------------HHH
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN----------------------------------------REF 137 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~----------------------------------------~~~ 137 (522)
.+.||.|++|.||+|+.. +|+.||||+.+....... -.+
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999986 589999999865321100 013
Q ss_pred HHHHHHHHhCC----CCCcceeEEEE-EcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 009933 138 LVEVLMLSLLH----HSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK-GLEYLH 211 (522)
Q Consensus 138 ~~E~~~L~~l~----hpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~L~yLH 211 (522)
.+|+..+.++. |.+-+.+-.++ ......+|||||++|++|.++.... ...++ ...++.+++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHH
Confidence 44555555542 33223332222 2234579999999999999876431 11122 3456666665 478899
Q ss_pred hcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 212 ~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
..+ ++|+|+||.|||++.++.++|+|||++...
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 988 999999999999999999999999999864
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=8e-14 Score=150.24 Aligned_cols=145 Identities=19% Similarity=0.159 Sum_probs=96.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc----------------------------------hH---
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG----------------------------------NR--- 135 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~----------------------------------~~--- 135 (522)
..|+. +.||.|++|.||+|+++.+|+.||||++++..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 78999999999999999889999999997542100 01
Q ss_pred ---HHHHHHHHHHhCC----CCCcceeEEEEEc-CCeeEEEEeecCCCChhhhh--ccCCCCCCCCCHHHHHHHHHHHHH
Q 009933 136 ---EFLVEVLMLSLLH----HSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAK 205 (522)
Q Consensus 136 ---~~~~E~~~L~~l~----hpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~l--~~~~~~~~~l~~~~~~~i~~qi~~ 205 (522)
++.+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.|.++. .........+....+..++.||
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1334444444442 3444444443332 45678999999999998742 2210011123344444444444
Q ss_pred HHHHHHhcCCCCeEecCCCCCceeecCCC----ceeeeeecceeeCC
Q 009933 206 GLEYLHDKANPPVIYRDLKSSNILLDEGF----HPKLSDFGLAKLGP 248 (522)
Q Consensus 206 ~L~yLH~~~~~~iiHrDLKp~NILld~~~----~vkL~DFGla~~~~ 248 (522)
+..+ ++|+|+||.|||++.++ .++++|||++....
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3567 99999999999999887 99999999998654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-12 Score=137.13 Aligned_cols=170 Identities=19% Similarity=0.205 Sum_probs=131.8
Q ss_pred EEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCC
Q 009933 111 KGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP 190 (522)
Q Consensus 111 ~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~ 190 (522)
.|..+.++.+|.|+..+..+........+-++.|+.|+||||+++++.++.....|||+|.+. -|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------
Confidence 567777899999999987654334556777899999999999999999999999999999984 67777765
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhh
Q 009933 191 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270 (522)
Q Consensus 191 l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 270 (522)
+........+.||+.||.|||+.++ ++|++|.-+.|+|+..|..||.+|-++........ ......--..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 2356677789999999999997654 99999999999999999999999998865322221 0111112234666765
Q ss_pred hhcCCCCcchhhHHHHHHHHHHHhC
Q 009933 271 AMTGQLTLKSDVYSFGVVFLELITG 295 (522)
Q Consensus 271 l~~~~~~~~sDVwSlGvll~eLltG 295 (522)
+.... -..|.|-|||++++++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 44322 356999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.6e-13 Score=121.24 Aligned_cols=130 Identities=19% Similarity=0.093 Sum_probs=97.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcc-eeEEEEEcCCeeEEEEeecCCCCh
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV-NLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
+.|+.|.++.||++... +..|+||+...... ....+..|+.++..+.+.+++ +++.+. ....++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 56889999999999975 78899999754421 223467899999988765554 444443 2345899999999877
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
.+.. .....++.+++.+|..||..+ ...++|+|++|.|||++ ++.++|+||+.+..
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6531 011346788999999999986 12259999999999999 66899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.7e-13 Score=139.35 Aligned_cols=248 Identities=21% Similarity=0.207 Sum_probs=179.9
Q ss_pred hcCCcccceecccCceEEEEEEEC-CCCcEEEEEEEccCCccchHH--HHHHHHHHHhCC-CCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE-STGQVVAVKQLDRNGLQGNRE--FLVEVLMLSLLH-HSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~--~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~l 167 (522)
..+|..+..||.|.|+.|+.+... .++..|++|.+...-.....+ -+.|+.+...+. |.+++..+..+....+.||
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 446888899999999999998865 578899999886654333333 245777766665 9999999988888888899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-Cceeeeeecceee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG-FHPKLSDFGLAKL 246 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~-~~vkL~DFGla~~ 246 (522)
-.|||.++++...+.. ...+++...+++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||+...
T Consensus 344 p~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred chhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 9999999998877733 456778889999999999999999998 9999999999999765 8889999999864
Q ss_pred CCCCCCCcceecccCCcccc--ChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYC--APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~--APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
..... .....+-+++ +++......+..+.|+||||..+.+.+++...-... +.|.. +
T Consensus 417 ~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~~--------i 475 (524)
T KOG0601|consen 417 LAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSLT--------I 475 (524)
T ss_pred cceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc--------cccee--------e
Confidence 22111 1122333444 455555667889999999999999999986432211 11110 0
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..-.-+. .+. ...++..+...++..++..||.+.++..+....
T Consensus 476 ~~~~~p~----~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 RSGDTPN----LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ecccccC----CCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0000011 111 125566788889999999999999887766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.9e-13 Score=149.74 Aligned_cols=250 Identities=21% Similarity=0.207 Sum_probs=179.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.+.|.+.+-+-.|.++.++.+.-..++...++|+....... ..+....+-.++-...+|.++.....+......+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45567777888999999999988888877777776443221 122233344444445567777776666677888999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
++|+.+++|...|+.. ...+.+-+..++..+..+++|||... ++|+|++|.|+|+..+++.+++|||+.....
T Consensus 883 ~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999873 35566667778888999999999987 8999999999999999999999998433211
Q ss_pred CC----C-------------------------CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCC
Q 009933 249 VG----D-------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299 (522)
Q Consensus 249 ~~----~-------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf 299 (522)
.. + .........||+.|.+||.+.+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 000122356899999999999999999999999999999999999999
Q ss_pred CCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHH
Q 009933 300 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 363 (522)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 363 (522)
....+... +. .+....-+.. .-+........+++...+..+|.+|..+.
T Consensus 1036 na~tpq~~----------f~---ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQI----------FE---NILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhh----------hh---ccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 86544211 10 0001111111 11223445667888999999999997665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.8e-11 Score=112.77 Aligned_cols=136 Identities=14% Similarity=0.087 Sum_probs=98.8
Q ss_pred ceecccCceEEEEEEECC------CCcEEEEEEEccCCc---------------c------c-hHHH----HHHHHHHHh
Q 009933 99 CLLGEGGFGRVYKGRLES------TGQVVAVKQLDRNGL---------------Q------G-NREF----LVEVLMLSL 146 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~------~g~~vAvK~i~~~~~---------------~------~-~~~~----~~E~~~L~~ 146 (522)
..||.|--+.||.|.... .+..+|||+.+.... . . ...+ ..|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998753 357899998743110 0 0 1122 378999998
Q ss_pred CCC--CCcceeEEEEEcCCeeEEEEeecCCCChh-hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 009933 147 LHH--SNLVNLIGYCADGDQRLLVYEFMPLGSLE-DHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL-HDKANPPVIYRD 222 (522)
Q Consensus 147 l~h--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~iiHrD 222 (522)
+.. -++..++++ ...+|||||+.+..+. ..+.+ ..++..+...+..+++.+|..| |..+ |||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 863 456666654 4568999999764432 22322 2345566778889999999999 8888 99999
Q ss_pred CCCCceeecCCCceeeeeecceeeC
Q 009933 223 LKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 223 LKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|++.|||+++ +.+.|+|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.1e-11 Score=114.28 Aligned_cols=142 Identities=21% Similarity=0.247 Sum_probs=110.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCC--CCcceeEEEEEcCC---eeEEEEeec
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHH--SNLVNLIGYCADGD---QRLLVYEFM 172 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~h--pnIv~l~~~~~~~~---~~~lV~E~~ 172 (522)
+.|+.|.++.||++.... |..++||+...... .....+..|+.++..+.+ .++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998854 68899999765432 134567889999999976 34677777776542 568999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA-------------------------------------- 214 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------- 214 (522)
+|.+|.+.+.. ..+++.....++.+++..|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888876532 35677788888889999999998531
Q ss_pred ---------------CCCeEecCCCCCceeecC--CCceeeeeecceee
Q 009933 215 ---------------NPPVIYRDLKSSNILLDE--GFHPKLSDFGLAKL 246 (522)
Q Consensus 215 ---------------~~~iiHrDLKp~NILld~--~~~vkL~DFGla~~ 246 (522)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134899999999999988 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.1e-10 Score=119.22 Aligned_cols=170 Identities=19% Similarity=0.217 Sum_probs=133.2
Q ss_pred ceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc----CCeeEEEEeecCC-CChhhh
Q 009933 106 FGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPL-GSLEDH 180 (522)
Q Consensus 106 fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-gsL~~~ 180 (522)
-.+.|++...-+|..|++|+++.+..........-+++++++.|+|||+|.++|.. +..++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35789999999999999999965544444455567899999999999999998863 4568999999875 477776
Q ss_pred hccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 181 LHDLP-----------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 181 l~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
..... ..+..+++..+|.++.||..||.++|+.| +.-+-|.|.+||++.+.+|+|+-.|+..+...
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54322 22345788999999999999999999999 88899999999999999999998888776433
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK 297 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~ 297 (522)
... |.+. --.+-|.=.||.+++.|.||..
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 220 1111 1245688899999999999953
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.1e-10 Score=103.55 Aligned_cols=131 Identities=24% Similarity=0.314 Sum_probs=99.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccc--------hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--------~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.+|++|+-+.+|.+.+. |..+++|.=.+..... .....+|+.+|.++.--.|..-+=++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999999775 5556777532222211 1235679999998876555544555667777889999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
|++|..|.+++... ...++..+-.-+.-||..+ |||+||.++||++..+. +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999998761 2456777778888899999 99999999999998765 99999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.4e-10 Score=101.91 Aligned_cols=143 Identities=22% Similarity=0.248 Sum_probs=105.5
Q ss_pred ccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--------chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 97 PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 97 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.+.+|-+|+-+.|+++.+. |+.++||.=-..... ......+|+.+|.++.--.|.--.-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999986 888888853221111 123467899999988755554444456666677899
Q ss_pred EeecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---ceeeeeecce
Q 009933 169 YEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF---HPKLSDFGLA 244 (522)
Q Consensus 169 ~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~---~vkL~DFGla 244 (522)
|||++| .++.+++..... ..........++..|-..|.-||..+ |||+||..+||+|..++ .+.|+|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999977 488888876321 12222333678999999999999999 99999999999995543 4589999998
Q ss_pred ee
Q 009933 245 KL 246 (522)
Q Consensus 245 ~~ 246 (522)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 75
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.6e-09 Score=105.77 Aligned_cols=265 Identities=17% Similarity=0.189 Sum_probs=162.8
Q ss_pred cccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHh-CCCCCcceeEEE------EEcCC-eeEE
Q 009933 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL-LHHSNLVNLIGY------CADGD-QRLL 167 (522)
Q Consensus 96 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~-l~hpnIv~l~~~------~~~~~-~~~l 167 (522)
...+.||+|+-+.+|..-.-. -.+.|+..........+ .+.+|.. -.||-+..-+.| .-+.. ..-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhh---chhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 345679999999999754432 23457776543322222 2223333 246644331111 11222 2567
Q ss_pred EEeecCCCChhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 168 VYEFMPLGSLEDHLHDL---PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
+|..+.+..-...+..- ........|..+++.+..|+.+...||..| .+-+|+.++|||+.+++.|.|+|-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 88888765322222111 112235789999999999999999999999 899999999999999999999987665
Q ss_pred eeCCCCCCCcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCC------CCcchHHH
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITG-RKAIDNTRP------PGEHNLVA 312 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG-~~Pf~~~~~------~~~~~~~~ 312 (522)
.+. .........+|...|.+||... +..-+...|.|.||+++|+||.| ++||.+-.. +.+..+-.
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 543 2222334567899999999765 23456789999999999999987 899975432 11111111
Q ss_pred hhhhhhhcccCCCCcCCccccCCCChHHH-HHHHHHHHHhcccC--cCCCCCHHHHHHHHHHhhhcc
Q 009933 313 WARPLFKDRRKFPKMADPLLQGRYPMRGL-YQALAVAAMCLQEQ--AATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 313 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~-~~l~~Li~~cl~~d--P~~RPs~~evl~~L~~l~~~~ 376 (522)
................| ...|...+ ..+-.|..+|+..- +.-|||.+-++.+|..+..+.
T Consensus 242 -g~f~ya~~~~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 242 -GRFAYASDQRRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred -ceeeechhccCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00001110000000000 11222222 34556788888653 678999999999998886655
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=6e-09 Score=103.62 Aligned_cols=141 Identities=18% Similarity=0.134 Sum_probs=100.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCcc-----------chHHHHHHHHHHHhCCCCCc--ceeEEEEEc----
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-----------GNREFLVEVLMLSLLHHSNL--VNLIGYCAD---- 161 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-----------~~~~~~~E~~~L~~l~hpnI--v~l~~~~~~---- 161 (522)
+.+-+-....|+++... |+.|.||........ ....+.+|+..+..|..-+| ..++.+++.
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444557777663 788999977433211 11136788888888753333 344555543
Q ss_pred -CCeeEEEEeecCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-------
Q 009933 162 -GDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE------- 232 (522)
Q Consensus 162 -~~~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~------- 232 (522)
....+||||++++. +|.+++.... ..+.+......++.+|+..+.-||..| |+|+||++.||||+.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23578999999886 8999885421 234556777899999999999999999 999999999999975
Q ss_pred CCceeeeeecceee
Q 009933 233 GFHPKLSDFGLAKL 246 (522)
Q Consensus 233 ~~~vkL~DFGla~~ 246 (522)
+..+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 56899999998863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=9.2e-09 Score=96.79 Aligned_cols=124 Identities=23% Similarity=0.225 Sum_probs=80.8
Q ss_pred EEEEEEECCCCcEEEEEEEccCCc-------------c--------c-----hHHHHHHHHHHHhCCCC--CcceeEEEE
Q 009933 108 RVYKGRLESTGQVVAVKQLDRNGL-------------Q--------G-----NREFLVEVLMLSLLHHS--NLVNLIGYC 159 (522)
Q Consensus 108 ~Vy~~~~~~~g~~vAvK~i~~~~~-------------~--------~-----~~~~~~E~~~L~~l~hp--nIv~l~~~~ 159 (522)
.||.|... ++..+|||+.+.... . . .....+|+..|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999986 488999998743110 0 0 02246799999999866 456666542
Q ss_pred EcCCeeEEEEeecC--CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCceeecCCCce
Q 009933 160 ADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY-LHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 160 ~~~~~~~lV~E~~~--ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
..+|||||+. |..+..+... .++......++.+++..+.. +|..+ |||+||.+.|||++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 3479999998 5455443322 11133456778888885555 57888 9999999999999988 99
Q ss_pred eeeeecceee
Q 009933 237 KLSDFGLAKL 246 (522)
Q Consensus 237 kL~DFGla~~ 246 (522)
.|+|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999999885
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.1e-08 Score=91.67 Aligned_cols=105 Identities=26% Similarity=0.270 Sum_probs=82.6
Q ss_pred HHHHHHHHHHHhCCCC--CcceeEEEEEcC----CeeEEEEeecCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 009933 135 REFLVEVLMLSLLHHS--NLVNLIGYCADG----DQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207 (522)
Q Consensus 135 ~~~~~E~~~L~~l~hp--nIv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L 207 (522)
....+|...+..|..- .+...+.+.+.. ...+||+|++++. +|.+++... ..++......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 4567788887777533 345556655542 2458999999874 799998752 2256667889999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceeecCCC---ceeeeeecceee
Q 009933 208 EYLHDKANPPVIYRDLKSSNILLDEGF---HPKLSDFGLAKL 246 (522)
Q Consensus 208 ~yLH~~~~~~iiHrDLKp~NILld~~~---~vkL~DFGla~~ 246 (522)
.-||..+ |+|+||++.|||++.+. .+.|+||+-++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999998876 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.6e-07 Score=91.55 Aligned_cols=135 Identities=20% Similarity=0.119 Sum_probs=97.7
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCC-----------c-----------cchHHHHHHHHHHHhCCCC--
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-----------L-----------QGNREFLVEVLMLSLLHHS-- 150 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-----------~-----------~~~~~~~~E~~~L~~l~hp-- 150 (522)
+.+...||.|--+.||.|.+. .|..+|||.=+... . .......+|.++|..|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567789999999999999997 48999999642110 0 0012346799999998754
Q ss_pred CcceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 151 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
.|.+.+++ +.-.+||||++|-.|...- ++....-.|+..|+.-+.-+-..| |||+||++-|||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 66666654 4457999999986665432 122334455555666666566777 9999999999999
Q ss_pred cCCCceeeeeecceee
Q 009933 231 DEGFHPKLSDFGLAKL 246 (522)
Q Consensus 231 d~~~~vkL~DFGla~~ 246 (522)
+++|.+.|+||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.7e-07 Score=86.83 Aligned_cols=138 Identities=16% Similarity=0.141 Sum_probs=102.2
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccC---C---ccchHHHHHHHHHHHhCCCCC--cceeEEEEE-c----CCeeEE
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRN---G---LQGNREFLVEVLMLSLLHHSN--LVNLIGYCA-D----GDQRLL 167 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~---~---~~~~~~~~~E~~~L~~l~hpn--Iv~l~~~~~-~----~~~~~l 167 (522)
-|+||-+-|+..... |+.+-||.-... . ......|.+|+..|..|..-+ +.+++ ++. . ....+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 467999999998875 557888876421 1 224567999999999886332 44444 332 1 124689
Q ss_pred EEeecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--eeeeeecce
Q 009933 168 VYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH--PKLSDFGLA 244 (522)
Q Consensus 168 V~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~--vkL~DFGla 244 (522)
|+|-+.+ -+|.+++... .-.+.+......++.+|+..|.-||+.+ +.|+|+.+.|||++.++. |+++||--+
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9998753 4888887551 1235567778899999999999999999 999999999999986666 999999876
Q ss_pred ee
Q 009933 245 KL 246 (522)
Q Consensus 245 ~~ 246 (522)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 64
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.3e-08 Score=107.65 Aligned_cols=151 Identities=20% Similarity=0.228 Sum_probs=100.7
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcc-------eecccCCccccChhhhhc
Q 009933 201 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-------STRVMGTYGYCAPEYAMT 273 (522)
Q Consensus 201 ~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~-------~~~~~gt~~y~APE~l~~ 273 (522)
.+++.||.|+|...+ +||+.|.|++|.++.++..||+.|+++........... ..-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999998654 99999999999999999999999998865332111000 011223558999999999
Q ss_pred CCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhc
Q 009933 274 GQLTLKSDVYSFGVVFLELITGRKA-IDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCL 352 (522)
Q Consensus 274 ~~~~~~sDVwSlGvll~eLltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl 352 (522)
...+.++|+|||||++|.+..|.++ |............ ...+..-...++.....++.+-+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHHHHh
Confidence 8889999999999999999955444 4332221111111 111111111122233356777788899
Q ss_pred ccCcCCCCCHHHHHH
Q 009933 353 QEQAATRPLIGDVVT 367 (522)
Q Consensus 353 ~~dP~~RPs~~evl~ 367 (522)
..++..||++.+++.
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999997776654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-08 Score=108.76 Aligned_cols=185 Identities=17% Similarity=0.099 Sum_probs=139.3
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCC-cceeEEEEEcCCeeEEEEeecC
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN-LVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~ 173 (522)
|...+-++++++++++|.+...+...+ .+.+... ....-++++|.+++||| .+..++.++.+...+++++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 444556899999999999987655444 6666432 44556899999999999 7777777777889999999998
Q ss_pred CC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 174 LG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 174 gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++ +....+. .....+.+.+...+...-+++|+|||+.. =+|+| |||..+ +..++.||+....+....
T Consensus 318 ~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 318 TGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred CCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 76 2222221 11234445555667777888999999875 58998 888766 578999999987654332
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCC
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf 299 (522)
......+|+.++|||+.....+....|+|++++--.+|--|-.|-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 334567999999999999999999999999998777777776664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.8e-07 Score=100.81 Aligned_cols=140 Identities=19% Similarity=0.149 Sum_probs=90.3
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccch------------------------------H----------HHH
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN------------------------------R----------EFL 138 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~------------------------------~----------~~~ 138 (522)
+-|+.++-|.||+|+.+. |+.||||+.+++-.... + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 569999999999999985 99999999865311000 0 123
Q ss_pred HHHHHHHhCC-----CCCcceeEEEE-EcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 009933 139 VEVLMLSLLH-----HSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212 (522)
Q Consensus 139 ~E~~~L~~l~-----hpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 212 (522)
+|...+.++. .++ +.+=.+| +-.....|+|||++|-.+.+.... ....++...+.....++. +..+=.
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHHh
Confidence 4555454442 233 2222222 334667899999999998888432 113344333322222221 222223
Q ss_pred cCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 213 ~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
.+ ++|.|..|.||+++.++.+.+.|||+.....
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 56 9999999999999999999999999987643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.7e-06 Score=84.13 Aligned_cols=140 Identities=16% Similarity=0.151 Sum_probs=87.3
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCC--cceeEEEEEcCCeeEEEEeecCCCC
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN--LVNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
..||.|..+.||+.. +..+++|...... ....+.+|.+++..+..-. +.+++++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 568999999999842 4467888876432 3455788999999887443 4777888888888899999999863
Q ss_pred -hhhh---------------------hccCCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHhc-CCCCeEecC
Q 009933 177 -LEDH---------------------LHDLPPDKEPLDWNTRMKIAAG----------AAK-GLEYLHDK-ANPPVIYRD 222 (522)
Q Consensus 177 -L~~~---------------------l~~~~~~~~~l~~~~~~~i~~q----------i~~-~L~yLH~~-~~~~iiHrD 222 (522)
+... |+........++.. ...+..+ +.. ...+|... ..+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 2111 11111111111100 0001000 001 12222211 234589999
Q ss_pred CCCCceeecCCCceeeeeecceee
Q 009933 223 LKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 223 LKp~NILld~~~~vkL~DFGla~~ 246 (522)
+.|.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999998874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.8e-06 Score=81.22 Aligned_cols=137 Identities=13% Similarity=0.117 Sum_probs=92.4
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHH---------HHHHHHHHhCC---CCCcceeEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---------LVEVLMLSLLH---HSNLVNLIGY 158 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~---------~~E~~~L~~l~---hpnIv~l~~~ 158 (522)
...+|.+.+++-......|.+.... +..+++|..........+.| .+++..+..+. --.++.++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567888888888777777777664 78899998865432222222 23333333332 2233333333
Q ss_pred EE-----cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 009933 159 CA-----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG 233 (522)
Q Consensus 159 ~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~ 233 (522)
.+ .....+|||||++|..|.++.. +++ .+...|+.+|.-||..| ++|+|+.|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 22 2245578999999988877642 222 24456778899999999 9999999999999865
Q ss_pred Cceeeeeeccee
Q 009933 234 FHPKLSDFGLAK 245 (522)
Q Consensus 234 ~~vkL~DFGla~ 245 (522)
+ ++++||+..+
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 4 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.1e-06 Score=83.00 Aligned_cols=141 Identities=22% Similarity=0.217 Sum_probs=85.8
Q ss_pred ecccCc-eEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEeecCCCChh
Q 009933 101 LGEGGF-GRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLE 178 (522)
Q Consensus 101 LG~G~f-G~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 178 (522)
|-.|.+ ..||++... +..+.||+..... ...+..|+.++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 344544 789999764 4678888875432 345677998888885 444667788777767789999999997776
Q ss_pred hhh-------------------ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----c
Q 009933 179 DHL-------------------HDLPPDKEPLDWN--TRMKIAA--------------------GAAKGLEYLHD----K 213 (522)
Q Consensus 179 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~~L~yLH~----~ 213 (522)
... +.......++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1111111111100 0000000 01111122211 1
Q ss_pred CCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 214 ~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 134599999999999999987788999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.41 E-value=2e-06 Score=82.69 Aligned_cols=145 Identities=21% Similarity=0.228 Sum_probs=85.1
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCC--CcceeEEEEEc---CCeeEEEEeec
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLIGYCAD---GDQRLLVYEFM 172 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hp--nIv~l~~~~~~---~~~~~lV~E~~ 172 (522)
.+.|+.|..+.||++.... ..++||+.... .....+..|+.++..|... .+..++.++.. ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3578999999999999874 58999997543 3456677888888887633 35566664433 33568999999
Q ss_pred CCCChhh----------------hhc---cCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 009933 173 PLGSLED----------------HLH---DLPPDKEPLDWNT---------RMKI------------AAGAAK-GLEYLH 211 (522)
Q Consensus 173 ~ggsL~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~qi~~-~L~yLH 211 (522)
+|..+.. ++. ........+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 111 1111111111110 0000 111222 333444
Q ss_pred hc----CCCCeEecCCCCCceeec-CCCceeeeeecceee
Q 009933 212 DK----ANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKL 246 (522)
Q Consensus 212 ~~----~~~~iiHrDLKp~NILld-~~~~vkL~DFGla~~ 246 (522)
.. ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 31 233499999999999999 666668999988764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-05 Score=92.55 Aligned_cols=150 Identities=16% Similarity=0.246 Sum_probs=93.3
Q ss_pred cceecccCceEEEEEEECCCC--cEEEEEEEccCCc-cchHHHHHHHHHHHhCC-CCCc--ceeEEEEEcC---CeeEEE
Q 009933 98 ECLLGEGGFGRVYKGRLESTG--QVVAVKQLDRNGL-QGNREFLVEVLMLSLLH-HSNL--VNLIGYCADG---DQRLLV 168 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g--~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~-hpnI--v~l~~~~~~~---~~~~lV 168 (522)
.+.|+.|.+..+|+......+ ..+++|+...... .....+.+|+.+|+.|. |.+| .+++.+|.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567899999999998875432 4678887654322 23356889999999996 6664 7788888764 467899
Q ss_pred EeecCCCChhhh-----------------------hccCCCC-------CCCCC--HHHHHHHHH---------------
Q 009933 169 YEFMPLGSLEDH-----------------------LHDLPPD-------KEPLD--WNTRMKIAA--------------- 201 (522)
Q Consensus 169 ~E~~~ggsL~~~-----------------------l~~~~~~-------~~~l~--~~~~~~i~~--------------- 201 (522)
|||++|..+.+. |+..... ..+.. ..++..+..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988653321 1111100 01111 112211111
Q ss_pred HHHHHHHHHHhcCC--------CCeEecCCCCCceeecC-CC-ceeeeeecceeeC
Q 009933 202 GAAKGLEYLHDKAN--------PPVIYRDLKSSNILLDE-GF-HPKLSDFGLAKLG 247 (522)
Q Consensus 202 qi~~~L~yLH~~~~--------~~iiHrDLKp~NILld~-~~-~vkL~DFGla~~~ 247 (522)
.+...+.+|..+-. +.+||+|+++.|||++. +. .+-|.||.++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12334566644311 23999999999999975 33 3579999998753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.5e-05 Score=77.23 Aligned_cols=152 Identities=21% Similarity=0.178 Sum_probs=100.6
Q ss_pred ccccHHHHHHhhcCCccccee---cccCceEEEEEEECCCCcEEEEEEEccCCccc-------------------hHH--
Q 009933 81 QTFTFRELAAATKNFRPECLL---GEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-------------------NRE-- 136 (522)
Q Consensus 81 ~~~~~~~~~~~~~~y~~~~~L---G~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-------------------~~~-- 136 (522)
...+...+........+..+. ..|--+.||+|... ++..+|||+.......- ..+
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 344555666666676666654 46666789998874 48899999985432110 011
Q ss_pred ---HHHHHHHHHhCC--CCCcceeEEEEEcCCeeEEEEeecCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 009933 137 ---FLVEVLMLSLLH--HSNLVNLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210 (522)
Q Consensus 137 ---~~~E~~~L~~l~--hpnIv~l~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL 210 (522)
...|+..|.++. +=.+.+-+.+. ...|||||+... .-.-.|.+ -++...++..+..++++.+.-|
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHH
Confidence 234677777664 33344444443 347999998543 22222322 2333446777888888888888
Q ss_pred Hh-cCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 211 HD-KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 211 H~-~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
-. .+ +||+||+.-|||+. ++.+.|+||+-+..
T Consensus 183 ~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 183 YKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HHhcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 77 55 99999999999999 78999999998875
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.7e-05 Score=73.94 Aligned_cols=133 Identities=23% Similarity=0.262 Sum_probs=94.4
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCC----------------ccchHHHHHHHHHHHhCC------CCCccee
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG----------------LQGNREFLVEVLMLSLLH------HSNLVNL 155 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~----------------~~~~~~~~~E~~~L~~l~------hpnIv~l 155 (522)
..+||+|+.=.||.--+ .....||++.... .....+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 46799999999997543 4457899987655 122355666776665555 7899999
Q ss_pred EEEEEcCCeeEEEEeecCC------CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 009933 156 IGYCADGDQRLLVYEFMPL------GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 229 (522)
Q Consensus 156 ~~~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NIL 229 (522)
+|+.++....-+|+|.+.. -+|.+++.. ..++. .....+. .-..||-+.+ |+.+||+|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999998732 268888854 44655 4444444 4456777777 999999999999
Q ss_pred ecC---CC-ceeeee-eccee
Q 009933 230 LDE---GF-HPKLSD-FGLAK 245 (522)
Q Consensus 230 ld~---~~-~vkL~D-FGla~ 245 (522)
+.. .. .+.|+| ||...
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EEecCCCceEEEEEeCCCCcc
Confidence 942 22 578888 34433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.2e-05 Score=73.19 Aligned_cols=125 Identities=26% Similarity=0.391 Sum_probs=88.2
Q ss_pred cCCcccceecccCc-eEEEEEEECCCCcEEEEEEEcc---CC-------cc-----------chHHHHHHHHHHHhCC--
Q 009933 93 KNFRPECLLGEGGF-GRVYKGRLESTGQVVAVKQLDR---NG-------LQ-----------GNREFLVEVLMLSLLH-- 148 (522)
Q Consensus 93 ~~y~~~~~LG~G~f-G~Vy~~~~~~~g~~vAvK~i~~---~~-------~~-----------~~~~~~~E~~~L~~l~-- 148 (522)
.+++.++.||.|.- |.||++... |+.||||++.. .. .. ...-|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 77899999999999 999999986 88999999422 11 00 1123677877766664
Q ss_pred -CCCc--ceeEEEEEcC------------------CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 009933 149 -HSNL--VNLIGYCADG------------------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207 (522)
Q Consensus 149 -hpnI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L 207 (522)
+.++ |+.+||..-. ...-||.||++... .+. ..-+.+|.+-|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHH
Confidence 5566 8999987322 01246667664422 222 33455677778
Q ss_pred HHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 208 ~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8999999 999999999987 4489999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.2e-05 Score=73.98 Aligned_cols=129 Identities=20% Similarity=0.176 Sum_probs=91.4
Q ss_pred cccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcce-eEEEEEcCCeeEEEEeecCC
Q 009933 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN-LIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 96 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~-l~~~~~~~~~~~lV~E~~~g 174 (522)
+..+.|++|++|.||+|.+. |..+|+|+-..+. ....+..|+++|..+.--++.+ +|.|-. .++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 45678999999999999997 6789999876553 3466888999999998776644 444432 2456999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCceeecCCCceeeeeecceee
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK-SSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLK-p~NILld~~~~vkL~DFGla~~ 246 (522)
-.|.+.-.. .+... +..++..---|-..| |-|..|. |..++|..+..+.|+||.-|+.
T Consensus 97 ~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG-------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc-------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 888776532 12223 334445544566667 9999997 5544454445899999999874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.16 E-value=1e-05 Score=76.36 Aligned_cols=104 Identities=27% Similarity=0.300 Sum_probs=81.6
Q ss_pred HHHHHHHHhCCC-CCcceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 009933 138 LVEVLMLSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216 (522)
Q Consensus 138 ~~E~~~L~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 216 (522)
..|..+|+.+.+ +++.+++|+|- .++|.||+..+++....... ..-...+|..+.+|+.+++..+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358889999986 69999999993 36789999877665321000 0113468999999999999999999985433
Q ss_pred CeEecCCCCCceeecCCCceeeeeecceee
Q 009933 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 217 ~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
.+.-.|++++|+-+++++++|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 488899999999999999999999987764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=9.8e-06 Score=87.28 Aligned_cols=138 Identities=18% Similarity=0.126 Sum_probs=88.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccc-------------------------------------hHHHHHHH
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-------------------------------------NREFLVEV 141 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-------------------------------------~~~~~~E~ 141 (522)
+.|+.-+.|.||+|+.+. |+.||||+-+..-... +-+|..|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999986 9999999975421100 00134444
Q ss_pred HHHHh----CCCCC------cceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 009933 142 LMLSL----LHHSN------LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211 (522)
Q Consensus 142 ~~L~~----l~hpn------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH 211 (522)
+...+ +.|-+ |.++|-.+ .....|+||||+|..+.|.-.- ....++...+...+.++..-+-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf-- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIF-- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHH--
Confidence 43332 33444 33333222 3467899999999877765322 12445555544444443322222
Q ss_pred hcCCCCeEecCCCCCceeecC----CCceeeeeecceeeC
Q 009933 212 DKANPPVIYRDLKSSNILLDE----GFHPKLSDFGLAKLG 247 (522)
Q Consensus 212 ~~~~~~iiHrDLKp~NILld~----~~~vkL~DFGla~~~ 247 (522)
..| ++|+|=.|.|||+.. ++.+.|.|||+....
T Consensus 319 ~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 235 999999999999983 678999999998864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.7e-05 Score=76.01 Aligned_cols=73 Identities=14% Similarity=0.114 Sum_probs=46.1
Q ss_pred ceecccCce-EEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCC---CcceeEEEEEcCC---eeEEEEee
Q 009933 99 CLLGEGGFG-RVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS---NLVNLIGYCADGD---QRLLVYEF 171 (522)
Q Consensus 99 ~~LG~G~fG-~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hp---nIv~l~~~~~~~~---~~~lV~E~ 171 (522)
+.|+.|+.. .||+.. ..+++|..... .....+..|+.+|..|... .+..+++.....+ ..++||++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457766666 599762 34778875442 2345788899999888632 3444454443322 34889999
Q ss_pred cCCCChh
Q 009933 172 MPLGSLE 178 (522)
Q Consensus 172 ~~ggsL~ 178 (522)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.8e-05 Score=87.58 Aligned_cols=196 Identities=21% Similarity=0.195 Sum_probs=138.7
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEcCCeeE----EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 009933 138 LVEVLMLSLLHHSNLVNLIGYCADGDQRL----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213 (522)
Q Consensus 138 ~~E~~~L~~l~hpnIv~l~~~~~~~~~~~----lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 213 (522)
..|+..+.++.|+|++.++.|.......- +..|+|..-++...+.. ...++....+.+..++++||.|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 44677888889999999999876654333 44578888888888866 56788899999999999999999998
Q ss_pred CCCCeEecCCCCC---ceeecCCCceeee--eecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcc--hhhHHHH
Q 009933 214 ANPPVIYRDLKSS---NILLDEGFHPKLS--DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK--SDVYSFG 286 (522)
Q Consensus 214 ~~~~iiHrDLKp~---NILld~~~~vkL~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~--sDVwSlG 286 (522)
. ..|.-|... +...+..+.+.++ ||+.+..+....... ...-+..|.++|......+..+ .|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 6 666655555 4555666777777 999888654433221 2234567888888777665554 7999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 009933 287 VVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 366 (522)
Q Consensus 287 vll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl 366 (522)
.++..+..|..+-... .....+++.... ..+.+....|+..++++|+++.+++
T Consensus 380 ll~~~~~~~~~i~~~~-------------------~~~~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKS-------------------AVPVSLLDVLST--------SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCcccccc-------------------cchhhhhccccc--------hhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999886442211 111112221111 1455788899999999999999998
Q ss_pred HHHH
Q 009933 367 TALT 370 (522)
Q Consensus 367 ~~L~ 370 (522)
+..-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 8663
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00015 Score=73.53 Aligned_cols=76 Identities=13% Similarity=0.058 Sum_probs=56.6
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC---CCcceeEEEEEcC---CeeEEEEee
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH---SNLVNLIGYCADG---DQRLLVYEF 171 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h---pnIv~l~~~~~~~---~~~~lV~E~ 171 (522)
.+.||.|..+.||...... + .+.+|..+. ......+..|...|+.|.. -.+.+++++|..+ +..+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 4569999999999997643 3 467777532 1133578899999998863 3678889887653 568999999
Q ss_pred cCCCCh
Q 009933 172 MPLGSL 177 (522)
Q Consensus 172 ~~ggsL 177 (522)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00013 Score=71.01 Aligned_cols=143 Identities=22% Similarity=0.207 Sum_probs=81.7
Q ss_pred ceecccCceEEEEEEECC-CCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCC-cceeEEEEEcCCeeEEEEeecCCCC
Q 009933 99 CLLGEGGFGRVYKGRLES-TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN-LVNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~-~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
+.|..|-...||++.... .+..|++|+...... .......|+.++..+.... ..+++..+. + .+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 457778888999997653 356788997754321 1123346888888886433 445554432 2 48999999876
Q ss_pred hhhh-----------------hccCCCCC-------CCC-CHHHHHHHHHH----------------------HHHHHHH
Q 009933 177 LEDH-----------------LHDLPPDK-------EPL-DWNTRMKIAAG----------------------AAKGLEY 209 (522)
Q Consensus 177 L~~~-----------------l~~~~~~~-------~~l-~~~~~~~i~~q----------------------i~~~L~y 209 (522)
+... ++...... ... .+..+..+... +...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 11111111 011 12222222111 1111112
Q ss_pred H----Hhc-CCCCeEecCCCCCceeecC-CCceeeeeecceee
Q 009933 210 L----HDK-ANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKL 246 (522)
Q Consensus 210 L----H~~-~~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~ 246 (522)
| -.. ....++|+|+.+.|||++. +..+.|+||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 1234999999999999997 57899999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00016 Score=71.47 Aligned_cols=139 Identities=16% Similarity=0.066 Sum_probs=80.0
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCc-ceeEEEEEcCCeeEEEEeecCCCChhh
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFMPLGSLED 179 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ggsL~~ 179 (522)
|..|-...+|+... ++..+++|..........-....|..+|+.+....+ .+++.++. -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45677789998874 467888987654322211235678889988874433 34444332 368999999876542
Q ss_pred h-----------------hccCCCCCCCCCHH-HHHHHHHHH---------HHHHHHHHhc-----CCCCeEecCCCCCc
Q 009933 180 H-----------------LHDLPPDKEPLDWN-TRMKIAAGA---------AKGLEYLHDK-----ANPPVIYRDLKSSN 227 (522)
Q Consensus 180 ~-----------------l~~~~~~~~~l~~~-~~~~i~~qi---------~~~L~yLH~~-----~~~~iiHrDLKp~N 227 (522)
. |+.......+++.. .+..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 22222112222222 111211111 1112222211 02248999999999
Q ss_pred eeecCCCceeeeeecceee
Q 009933 228 ILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 228 ILld~~~~vkL~DFGla~~ 246 (522)
||+++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00014 Score=73.34 Aligned_cols=144 Identities=19% Similarity=0.152 Sum_probs=84.8
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCC--cceeEEE------EEcCCeeEEEE
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN--LVNLIGY------CADGDQRLLVY 169 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpn--Iv~l~~~------~~~~~~~~lV~ 169 (522)
.+.|..|....+|++... +..+++|+... .....+..|+.++..|.+.. +.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 445777877899998754 45789998754 23345667888887775332 4444431 23345668999
Q ss_pred eecCCCChhh----h----------hcc----CCCC---CCCCCHHHHH----------HHHHHHHHHHHHHHhc----C
Q 009933 170 EFMPLGSLED----H----------LHD----LPPD---KEPLDWNTRM----------KIAAGAAKGLEYLHDK----A 214 (522)
Q Consensus 170 E~~~ggsL~~----~----------l~~----~~~~---~~~l~~~~~~----------~i~~qi~~~L~yLH~~----~ 214 (522)
+|++|..+.. . ++. +... .....|.... .....+...+.++... .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 0 011 0000 0111121110 0111233344555431 1
Q ss_pred CCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 215 ~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
...+||+|+.|.|||++++..+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 22399999999999999887778999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00052 Score=72.06 Aligned_cols=76 Identities=18% Similarity=0.152 Sum_probs=53.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccC------C-ccchHHHHHHHHHHHhCC---CCCcceeEEEEEcCCeeEEE
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRN------G-LQGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~------~-~~~~~~~~~E~~~L~~l~---hpnIv~l~~~~~~~~~~~lV 168 (522)
+.||.|.+..||++.+...++.|+||+-... . ......+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999999753358999985321 1 112345667888888764 2356667765 44667899
Q ss_pred EeecCCCC
Q 009933 169 YEFMPLGS 176 (522)
Q Consensus 169 ~E~~~ggs 176 (522)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00046 Score=70.41 Aligned_cols=158 Identities=16% Similarity=0.100 Sum_probs=83.1
Q ss_pred cHHHHHHhhcCCcc-----cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCC--CcceeE
Q 009933 84 TFRELAAATKNFRP-----ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLI 156 (522)
Q Consensus 84 ~~~~~~~~~~~y~~-----~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hp--nIv~l~ 156 (522)
+..++......|.+ .+.|..|....+|.+... +..+++|++.. .....+..|+.++..|... .+.+++
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT--QGEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeC--CCcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 33444444455654 244667777899998864 33688998752 1223344455555555311 133333
Q ss_pred E------EEEcCCeeEEEEeecCCCChh-----------hhh---ccCCC----C---CCCCCH-HHHHH----------
Q 009933 157 G------YCADGDQRLLVYEFMPLGSLE-----------DHL---HDLPP----D---KEPLDW-NTRMK---------- 198 (522)
Q Consensus 157 ~------~~~~~~~~~lV~E~~~ggsL~-----------~~l---~~~~~----~---~~~l~~-~~~~~---------- 198 (522)
. +....+..+++|+|++|..+. ..| +.... . ...+.| .....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 123355678999999987432 111 11000 0 001111 11111
Q ss_pred --HHHH-HHHHHHHHHhc----CCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 199 --IAAG-AAKGLEYLHDK----ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 199 --i~~q-i~~~L~yLH~~----~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
.+.+ +...+..+... -...+||+|+.|.|||++.+...-|+||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122333211 122399999999999998765568999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.001 Score=67.66 Aligned_cols=157 Identities=17% Similarity=0.172 Sum_probs=87.1
Q ss_pred HHHHHhhcCCcc-----cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCC--CcceeEEE
Q 009933 86 RELAAATKNFRP-----ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLIGY 158 (522)
Q Consensus 86 ~~~~~~~~~y~~-----~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hp--nIv~l~~~ 158 (522)
+++......|.+ .+.|+.|....||++... +..+++|+..... ....+..|+.++..|... .+.+++..
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 344444445544 345777777899998753 3457889875421 234455677777766422 23444432
Q ss_pred ------EEcCCeeEEEEeecCCCChhh-----------h---hcc----CCCCCC---C-CCHHHHH------------H
Q 009933 159 ------CADGDQRLLVYEFMPLGSLED-----------H---LHD----LPPDKE---P-LDWNTRM------------K 198 (522)
Q Consensus 159 ------~~~~~~~~lV~E~~~ggsL~~-----------~---l~~----~~~~~~---~-l~~~~~~------------~ 198 (522)
....+..++||+|++|..+.. . ++. +..... . -.|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 122456789999998854321 0 111 000000 0 0111110 0
Q ss_pred HHHHHHHHHHHHHh----cCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 199 IAAGAAKGLEYLHD----KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 199 i~~qi~~~L~yLH~----~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
....+...+++|.. .....+||+|+.+.||+++.++.+.|+||+.+..
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 11123344555543 1123499999999999999887778999998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=1.3e-05 Score=93.06 Aligned_cols=160 Identities=13% Similarity=0.004 Sum_probs=120.2
Q ss_pred HHHHHHHHhCCCCCcceeEEEEEc--CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-
Q 009933 138 LVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA- 214 (522)
Q Consensus 138 ~~E~~~L~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~- 214 (522)
..|...++...|+++...+.=... ....+.+++|+.+|.+++.|.+-.....+++..-+.....+.+....-+|...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 345555666789888776654433 34568999999999999999775555555665555555555577777777653
Q ss_pred -CCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHH
Q 009933 215 -NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELI 293 (522)
Q Consensus 215 -~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLl 293 (522)
..-.+|++||+-|.+|..+.++|+.++|+.++.. ..........+++.|+.|++...-.++.++|+|..++.+|++.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2347999999999999999999999999999421 1122234456888999999998889999999999999999999
Q ss_pred hCCCCC
Q 009933 294 TGRKAI 299 (522)
Q Consensus 294 tG~~Pf 299 (522)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888776
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0014 Score=66.54 Aligned_cols=139 Identities=20% Similarity=0.269 Sum_probs=84.5
Q ss_pred ccceecccCceEEEEEEECCCCcEEEEEEEcc--CCccchHHHHHHHHHHHhCCC--CCcceeEEEEEcCC--eeEEEEe
Q 009933 97 PECLLGEGGFGRVYKGRLESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLHH--SNLVNLIGYCADGD--QRLLVYE 170 (522)
Q Consensus 97 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~--~~~~~~~~~~~E~~~L~~l~h--pnIv~l~~~~~~~~--~~~lV~E 170 (522)
+.+.+..|.--.+|..... ++.++|. ... ..........+|+.+|+.+.- --+...+++|.++. ..++||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3344433333344554443 7788888 331 222334556778888887653 23445567777766 6699999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHH-HHHHHHHHHHHh-------------------------------------
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIA-AGAAKGLEYLHD------------------------------------- 212 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~-~qi~~~L~yLH~------------------------------------- 212 (522)
|+.|..+.+.+.. .... ..++ ..++..|.-||+
T Consensus 106 ~veGe~~~~~~~~-----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 106 WVEGEVVWSALPP-----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EecceeccCcCCc-----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 9998544433322 0111 1111 244444444443
Q ss_pred -------------c-----CCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 213 -------------K-----ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 213 -------------~-----~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
. +.+.++|+|+.+.||+|+...-+=|.||+++.+.
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2 2346999999999999998888999999999863
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0019 Score=65.28 Aligned_cols=143 Identities=24% Similarity=0.258 Sum_probs=83.5
Q ss_pred ceecccCceEEEEEEECC------CCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCc-ceeEEEEEcCCeeEEEEee
Q 009933 99 CLLGEGGFGRVYKGRLES------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~------~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnI-v~l~~~~~~~~~~~lV~E~ 171 (522)
+.|..|-...||++.... .++.|++|+..... ........|+.++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345556667899988653 25789999975532 223455678888888864333 455555532 368999
Q ss_pred cCCCChhhh-----------------hccCCCCC--C---CCC--HHHHHH--------------------------HHH
Q 009933 172 MPLGSLEDH-----------------LHDLPPDK--E---PLD--WNTRMK--------------------------IAA 201 (522)
Q Consensus 172 ~~ggsL~~~-----------------l~~~~~~~--~---~l~--~~~~~~--------------------------i~~ 201 (522)
++|..+... +|...... . ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 11111110 0 111 111111 111
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCCCceeecCC----Cceeeeeecceee
Q 009933 202 GAAKGLEYLHD------KANPPVIYRDLKSSNILLDEG----FHPKLSDFGLAKL 246 (522)
Q Consensus 202 qi~~~L~yLH~------~~~~~iiHrDLKp~NILld~~----~~vkL~DFGla~~ 246 (522)
.+...+.+|-. .....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 123459999999999999874 7899999988763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0002 Score=71.78 Aligned_cols=147 Identities=15% Similarity=0.116 Sum_probs=98.3
Q ss_pred cccHHHHHHhhc---CCcccceecccCceEEEEEEECCCCcEEEEEEEccC-----Cccch-----------------HH
Q 009933 82 TFTFRELAAATK---NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN-----GLQGN-----------------RE 136 (522)
Q Consensus 82 ~~~~~~~~~~~~---~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~-----~~~~~-----------------~~ 136 (522)
-+.+-.+.+..+ -+.+.+.||-|--+-||.+.+.. |+.+++|.-... +.... -.
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla 156 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA 156 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence 344444444443 36778899999999999999874 889999863211 00001 12
Q ss_pred HHHHHHHHHhCC-CCC-cceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 009933 137 FLVEVLMLSLLH-HSN-LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214 (522)
Q Consensus 137 ~~~E~~~L~~l~-hpn-Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 214 (522)
...|+..|+.|. |-+ +.+.+++ +..++|||++.|-.|...-+- .+ ...+...+..-|.-|-..|
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d---~~~ly~~lm~~Iv~la~~G 222 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------ED---PPTLYDDLMGLIVRLANHG 222 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CC---hHHHHHHHHHHHHHHHHcC
Confidence 346888888876 332 4444444 345789999998777664322 11 2234444445556677778
Q ss_pred CCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 215 ~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||+|+.--||+|++++.++++||--+..
T Consensus 223 ---lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 223 ---LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ---ceecccchheeEEecCCCEEEeechHhhc
Confidence 99999999999999999999999976543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0031 Score=63.27 Aligned_cols=31 Identities=32% Similarity=0.450 Sum_probs=26.0
Q ss_pred CCeEecCCCCCceeecCCCc-eeeeeecceee
Q 009933 216 PPVIYRDLKSSNILLDEGFH-PKLSDFGLAKL 246 (522)
Q Consensus 216 ~~iiHrDLKp~NILld~~~~-vkL~DFGla~~ 246 (522)
+.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999987555 46999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0058 Score=63.12 Aligned_cols=74 Identities=19% Similarity=0.080 Sum_probs=47.2
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEEcc------CC-ccchHHHHHHHHHHHhCC--CCCcceeEEEEEcCCeeEEEEe
Q 009933 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDR------NG-LQGNREFLVEVLMLSLLH--HSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~------~~-~~~~~~~~~E~~~L~~l~--hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.||.|....||++.+...++.|+||+-.. .. .-.......|...|.... .|..|+-+. +.+.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence 47999999999999864336899997532 11 112244556778887664 454444332 334556679999
Q ss_pred ecCC
Q 009933 171 FMPL 174 (522)
Q Consensus 171 ~~~g 174 (522)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.011 Score=62.19 Aligned_cols=73 Identities=12% Similarity=0.051 Sum_probs=49.9
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCc-------cchHHHHHHHHHHHhCC---CCCcceeEEEEEcCCeeEE
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-------QGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-------~~~~~~~~E~~~L~~l~---hpnIv~l~~~~~~~~~~~l 167 (522)
.+.||.|....||++.+. +..|+||+-..... ........|+..|..+. -.++.++|.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 456899999999999874 45689998642111 12233445677776654 247788888876 45678
Q ss_pred EEeecCC
Q 009933 168 VYEFMPL 174 (522)
Q Consensus 168 V~E~~~g 174 (522)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0062 Score=61.36 Aligned_cols=74 Identities=22% Similarity=0.281 Sum_probs=49.0
Q ss_pred ccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC---CCCcceeEEEEEcCCeeEEEEeecC
Q 009933 97 PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 97 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~ 173 (522)
..+.|+-|....+|+.. .+++.+.||+-.. .....|..|+.-|+.|. --.+.+++.+....+..+|||||++
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 34568889999999988 4578899999762 33456788998888884 3457788998888778899999997
Q ss_pred CC
Q 009933 174 LG 175 (522)
Q Consensus 174 gg 175 (522)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.016 Score=59.96 Aligned_cols=143 Identities=20% Similarity=0.218 Sum_probs=83.3
Q ss_pred ceecccCceEEEEEEECC----CCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCc-ceeEEEEEcCCeeEEEEeecC
Q 009933 99 CLLGEGGFGRVYKGRLES----TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFMP 173 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~----~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 173 (522)
..|-.|-.-.+|++.... .++.|++|+..... ...-....|+.++..+..-++ .++++.+..+ .|++|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345557778899987532 24678999876543 222223678888888875444 3556655332 5899998
Q ss_pred CCChhhh-----------------hccCCCC--CCCCCHHHHHHHHHHH-----------------HHHHHHHH----h-
Q 009933 174 LGSLEDH-----------------LHDLPPD--KEPLDWNTRMKIAAGA-----------------AKGLEYLH----D- 212 (522)
Q Consensus 174 ggsL~~~-----------------l~~~~~~--~~~l~~~~~~~i~~qi-----------------~~~L~yLH----~- 212 (522)
+.+|... +|..... .....+..+..++.++ ...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 1221111 1122233333333222 11122221 1
Q ss_pred cCCCCeEecCCCCCceeecC-CCceeeeeecceee
Q 009933 213 KANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKL 246 (522)
Q Consensus 213 ~~~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~ 246 (522)
.....++|+||++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11234899999999999976 46899999988864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.019 Score=58.14 Aligned_cols=29 Identities=24% Similarity=0.306 Sum_probs=25.4
Q ss_pred CeEecCCCCCceeecCCCceeeeeecceee
Q 009933 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 217 ~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
.+||+|+.+.|||++. +.+.|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 4899999999999987 6789999997763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0093 Score=57.05 Aligned_cols=30 Identities=33% Similarity=0.387 Sum_probs=21.6
Q ss_pred CeEecCCCCCceee-cCCCceeeeeecceee
Q 009933 217 PVIYRDLKSSNILL-DEGFHPKLSDFGLAKL 246 (522)
Q Consensus 217 ~iiHrDLKp~NILl-d~~~~vkL~DFGla~~ 246 (522)
.++|.||.+.|||+ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999988864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0092 Score=62.41 Aligned_cols=75 Identities=19% Similarity=0.118 Sum_probs=49.5
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccC-----C-ccchHHHHHHHHHHHhCC--CCC-cceeEEEEEcCCeeEEE
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN-----G-LQGNREFLVEVLMLSLLH--HSN-LVNLIGYCADGDQRLLV 168 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~-----~-~~~~~~~~~E~~~L~~l~--hpn-Iv~l~~~~~~~~~~~lV 168 (522)
.+.||-|.-..||++.+...++.|+||+-... . .-.......|.+.|+.+. .|. +.++|. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 45789999999999998543567999975321 1 112345566888888764 454 444543 345566789
Q ss_pred EeecCC
Q 009933 169 YEFMPL 174 (522)
Q Consensus 169 ~E~~~g 174 (522)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.025 Score=57.56 Aligned_cols=30 Identities=23% Similarity=0.232 Sum_probs=27.7
Q ss_pred CeEecCCCCCceeecCCCceeeeeecceee
Q 009933 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 217 ~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
.+||+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.025 Score=58.18 Aligned_cols=142 Identities=21% Similarity=0.255 Sum_probs=80.6
Q ss_pred eecccCceEEEEEEECCC---CcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCc-ceeEEEEEcCCeeEEEEeecCCC
Q 009933 100 LLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 175 (522)
.|-.|-.-.+|++..... +..|++|+...... ..-...+|+.+++.+..-+| .++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 344477778998876432 23788998755322 22233578888888875555 4556555322 589999776
Q ss_pred Chhh-----------------hhccCCCC--CCCCCHHHHHHHHHHH----------------------HHHHHHHHh--
Q 009933 176 SLED-----------------HLHDLPPD--KEPLDWNTRMKIAAGA----------------------AKGLEYLHD-- 212 (522)
Q Consensus 176 sL~~-----------------~l~~~~~~--~~~l~~~~~~~i~~qi----------------------~~~L~yLH~-- 212 (522)
+|.. .+|..... ..+-.+..+..+..++ ..-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5521 11121111 1111233333333222 111222211
Q ss_pred --cC-CCCeEecCCCCCceeecC-CCceeeeeecceee
Q 009933 213 --KA-NPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKL 246 (522)
Q Consensus 213 --~~-~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~ 246 (522)
.+ ...++|.||.+.|||+++ ++.++|+||..+-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 224899999999999974 57899999988764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.024 Score=58.08 Aligned_cols=103 Identities=18% Similarity=0.155 Sum_probs=69.5
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
.+.|++|++- |+.| ..+ ....+.++..|+.+.+..|.-|..+- ++-||||...||||+ +|+|.|+||-
T Consensus 299 ~y~yl~~kdh-gt~i-s~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPI-SII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Ccee-eee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 4557777764 4444 223 22457889999999888887777654 489999999999999 9999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHH
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSF 285 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSl 285 (522)
+++.....+. .. -...--|-.+.+ .-+.+-+||-+
T Consensus 367 lsRl~~~q~~--is-----y~rldhp~lF~G-~dd~QFeIYrl 401 (488)
T COG5072 367 LSRLSYSQGI--IS-----YNRLDHPDLFNG-VDDYQFEIYRL 401 (488)
T ss_pred eeecccCCce--ee-----ccccCchhhhcC-ccceeeeHHHH
Confidence 9996322211 11 112334555553 33667778764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.031 Score=57.42 Aligned_cols=139 Identities=18% Similarity=0.159 Sum_probs=90.2
Q ss_pred ccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---------------------chHH-----HHHHHHHHHhCCCC
Q 009933 97 PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---------------------GNRE-----FLVEVLMLSLLHHS 150 (522)
Q Consensus 97 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---------------------~~~~-----~~~E~~~L~~l~hp 150 (522)
+--.|..|--+.||.|... +|..+|||+.+-.-+. ..+. ...|+..|.+|+..
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3346888999999999876 5888999987432110 0011 23477777777643
Q ss_pred CcceeEEEEEcCCeeEEEEeecCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 009933 151 NLVNLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 229 (522)
Q Consensus 151 nIv~l~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NIL 229 (522)
.|.----... ....|||+|+... --.-.|+ ...++...+..+-.|++.-+.-|-..+. +||.||.--|+|
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLL 297 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhhe
Confidence 3211100011 2336999999421 1122232 2456777788888888888888877654 999999999999
Q ss_pred ecCCCceeeeeecceee
Q 009933 230 LDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 230 ld~~~~vkL~DFGla~~ 246 (522)
+-+ |.+.|+|-+-+..
T Consensus 298 yhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 298 YHD-GKLYIIDVSQSVE 313 (520)
T ss_pred EEC-CEEEEEEcccccc
Confidence 965 5899999877653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.006 Score=64.84 Aligned_cols=49 Identities=27% Similarity=0.373 Sum_probs=39.4
Q ss_pred hHHHHHHHHHHHhCCCCCcceeEEEEEcC-CeeEEEEeecCCCChhhhhcc
Q 009933 134 NREFLVEVLMLSLLHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHD 183 (522)
Q Consensus 134 ~~~~~~E~~~L~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~ 183 (522)
..+++-...+++.+.|+|+...+++.... ....+|||++ +.+|++.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 45677788999999999999999877543 3467899998 5699998865
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.047 Score=56.06 Aligned_cols=141 Identities=21% Similarity=0.310 Sum_probs=82.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC---CCcce---eEE----EEEcCCeeEEEEe
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH---SNLVN---LIG----YCADGDQRLLVYE 170 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h---pnIv~---l~~----~~~~~~~~~lV~E 170 (522)
|.+ .--.||+....+ |+ +++|+.... ....++.-|+..|..|.- +-.++ +-| .+......+-|++
T Consensus 34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 556789988864 44 489988765 345566667777776642 22222 111 1111236778999
Q ss_pred ecCCCChhh-hh------------------ccCC----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhcC
Q 009933 171 FMPLGSLED-HL------------------HDLP----PDKEPLDWNT-------------RMKIAAGAAKGLEYLHDKA 214 (522)
Q Consensus 171 ~~~ggsL~~-~l------------------~~~~----~~~~~l~~~~-------------~~~i~~qi~~~L~yLH~~~ 214 (522)
|++|..+.. .- ..++ .......|.. ......++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999877762 11 0111 1111233331 1113344455555555431
Q ss_pred -----CCC--eEecCCCCCceeecCCCc-eeeeeecceee
Q 009933 215 -----NPP--VIYRDLKSSNILLDEGFH-PKLSDFGLAKL 246 (522)
Q Consensus 215 -----~~~--iiHrDLKp~NILld~~~~-vkL~DFGla~~ 246 (522)
..+ |||+|+.|.|||++.+.. +.++||+-+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 112 899999999999998874 89999998864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.27 Score=50.45 Aligned_cols=72 Identities=18% Similarity=0.123 Sum_probs=43.9
Q ss_pred ccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCC--CcceeE---E--EEEcCCeeEEEEeecCCC
Q 009933 103 EGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLI---G--YCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 103 ~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hp--nIv~l~---~--~~~~~~~~~lV~E~~~gg 175 (522)
.+.-..||++... ++..+++|+..... .....+..|+..+..|... .++..+ + +...++..+.|+++++|.
T Consensus 35 ~s~eN~vy~v~~~-~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 35 NSYENRVYQFGDE-DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred ccccceEEEEecC-CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 3455679998864 36779999875332 3455667787777766421 122211 1 223345678899999876
Q ss_pred C
Q 009933 176 S 176 (522)
Q Consensus 176 s 176 (522)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 4
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.097 Score=54.97 Aligned_cols=75 Identities=17% Similarity=0.193 Sum_probs=44.9
Q ss_pred ceecccCceEEEEEEECCC-CcE-----EEEEEEccCCccchHHHHHHHHHHHhCCCCCc-ceeEEEEEcCCeeEEEEee
Q 009933 99 CLLGEGGFGRVYKGRLEST-GQV-----VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~-g~~-----vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnI-v~l~~~~~~~~~~~lV~E~ 171 (522)
+.|..|-...+|++..... +.. |.+++.. ......-.-.+|+.+++.|...++ .++++.+.. ++|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 4555588889999976432 122 3333321 111112233568999999986655 455555532 599999
Q ss_pred cCCCChh
Q 009933 172 MPLGSLE 178 (522)
Q Consensus 172 ~~ggsL~ 178 (522)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.05 Score=52.22 Aligned_cols=152 Identities=16% Similarity=0.108 Sum_probs=89.7
Q ss_pred cCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCChhhhhc
Q 009933 104 GGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH 182 (522)
Q Consensus 104 G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~ 182 (522)
++.++.-.+..+- | ...+|++..-... ...-+..+..++.+++ .|+++..- +...+-+|.|+|.-..
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------ 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------ 140 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------
Confidence 4445544444432 3 3456666544333 3455677888888765 46666632 4456678999984311
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCC
Q 009933 183 DLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 262 (522)
Q Consensus 183 ~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt 262 (522)
-. . ..++..=+..|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+.... .+
T Consensus 141 -------i~---~-~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~ 194 (308)
T PF07387_consen 141 -------IN---F-SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQ 194 (308)
T ss_pred -------cc---h-hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------he
Confidence 01 0 112222256788889542 3399999999999999999999999665431 01
Q ss_pred ccccChhhhhcCCCCcchhhHHHHHHHHHHHhCC
Q 009933 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296 (522)
Q Consensus 263 ~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~ 296 (522)
..|.--| ....+.++.+=+|=.-++++....
T Consensus 195 V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 195 VNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred eeEEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 1121111 124566777777666666666543
|
The function of this family is unknown. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.12 Score=52.05 Aligned_cols=30 Identities=30% Similarity=0.298 Sum_probs=25.2
Q ss_pred CeEecCCCCCceeecCC--C---ceeeeeecceee
Q 009933 217 PVIYRDLKSSNILLDEG--F---HPKLSDFGLAKL 246 (522)
Q Consensus 217 ~iiHrDLKp~NILld~~--~---~vkL~DFGla~~ 246 (522)
.|+|+|++..|||+..+ + .++++||-+++.
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 49999999999999543 3 689999988874
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.24 Score=47.93 Aligned_cols=74 Identities=26% Similarity=0.316 Sum_probs=50.5
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC---CCCcceeEEEEEcCCeeEEEEeecCCCC
Q 009933 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 100 ~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
.+.-|..-..|...+. ...+-||+-.. .....|..|+.-|..|. .-.+.+++.+-....+.|+||||++.+.
T Consensus 23 ~v~gG~inea~~v~dg--~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 23 EVSGGDINEAWRLRDG--TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred ccCCccccceeEeecC--CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444555555543 45688887432 33456778887777664 4567888888888999999999998866
Q ss_pred hh
Q 009933 177 LE 178 (522)
Q Consensus 177 L~ 178 (522)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 55
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.21 Score=59.09 Aligned_cols=143 Identities=21% Similarity=0.234 Sum_probs=77.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-------CCCcceeE-----EEEEc-CC--
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-------HSNLVNLI-----GYCAD-GD-- 163 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-------hpnIv~l~-----~~~~~-~~-- 163 (522)
+.|+ |.+-.+|++... ++..+++|+..... ....+..|...|..|. -|.+++.. ..+.. ..
T Consensus 31 ~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~ 106 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTD-DGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP 106 (1013)
T ss_pred eecC-CcCCceEEEEeC-CCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence 4564 556788988764 47789999987542 2233334445554442 23333322 11111 22
Q ss_pred eeEEEEeecCCCChhhhhc---------------------cC--CCCCCCCCHHH-----------------HHHHHHHH
Q 009933 164 QRLLVYEFMPLGSLEDHLH---------------------DL--PPDKEPLDWNT-----------------RMKIAAGA 203 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~---------------------~~--~~~~~~l~~~~-----------------~~~i~~qi 203 (522)
..+.+|+|++|..|.+... .+ +.....+.|.. ...++.++
T Consensus 107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~ 186 (1013)
T PRK06148 107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF 186 (1013)
T ss_pred EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence 4577899999977765111 11 11111222321 12222333
Q ss_pred HHHHH-----HHHhcCCCCeEecCCCCCceeecCCC--cee-eeeecceee
Q 009933 204 AKGLE-----YLHDKANPPVIYRDLKSSNILLDEGF--HPK-LSDFGLAKL 246 (522)
Q Consensus 204 ~~~L~-----yLH~~~~~~iiHrDLKp~NILld~~~--~vk-L~DFGla~~ 246 (522)
+..+. .|... ...+||+|+.+.|||++.+. .+. |+|||-+..
T Consensus 187 ~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 187 LARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 33222 12111 12399999999999998775 555 999998874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 522 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-40 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 547 bits (1411), Expect = 0.0
Identities = 124/321 (38%), Positives = 175/321 (54%), Gaps = 9/321 (2%)
Query: 51 VSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVY 110
+ S SK+ N + A+ + +L AT NF + L+G G FG+VY
Sbjct: 1 MGSKYSKATNSIND----ALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVY 56
Query: 111 KGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170
KG L G VA+K+ QG EF E+ LS H +LV+LIG+C + ++ +L+Y+
Sbjct: 57 KGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115
Query: 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230
+M G+L+ HL+ + W R++I GAA+GL YLH +I+RD+KS NILL
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILL 172
Query: 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 290
DE F PK++DFG++K G D+TH+ST V GT GY PEY + G+LT KSDVYSFGVV
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232
Query: 291 ELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAM 350
E++ R AI + P NL WA + ++ DP L + L + A
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVK 291
Query: 351 CLQEQAATRPLIGDVVTALTY 371
CL + RP +GDV+ L Y
Sbjct: 292 CLALSSEDRPSMGDVLWKLEY 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 544 bits (1404), Expect = 0.0
Identities = 115/304 (37%), Positives = 163/304 (53%), Gaps = 20/304 (6%)
Query: 81 QTFTFRELAAATKNFRPEC------LLGEGGFGRVYKGRLESTGQVVAVKQL----DRNG 130
+F+F EL T NF +GEGGFG VYKG + VAVK+L D
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITT 70
Query: 131 LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEP 190
+ ++F E+ +++ H NLV L+G+ +DGD LVY +MP GSL D L P
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPP 129
Query: 191 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250
L W+ R KIA GAA G+ +LH+ I+RD+KS+NILLDE F K+SDFGLA+
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 310
+T +++R++GT Y APE + G++T KSD+YSFGVV LE+ITG A+D R L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLL 243
Query: 311 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370
+ + + + D + + +VA+ CL E+ RP I V L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 371 YLAS 374
+ +
Sbjct: 303 EMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 524 bits (1352), Expect = 0.0
Identities = 130/294 (44%), Positives = 180/294 (61%), Gaps = 6/294 (2%)
Query: 80 AQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN-REFL 138
+ F+ REL A+ NF + +LG GGFG+VYKGRL G +VAVK+L QG +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQ 75
Query: 139 VEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 198
EV M+S+ H NL+ L G+C +RLLVY +M GS+ L + P + PLDW R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 199 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 258
IA G+A+GL YLHD +P +I+RD+K++NILLDE F + DFGLAKL D THV+T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA 194
Query: 259 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH--NLVAWARP 316
V GT G+ APEY TG+ + K+DV+ +GV+ LELITG++A D R + L+ W +
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370
L K+++ + D LQG Y + Q + VA +C Q RP + +VV L
Sbjct: 255 LLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 3e-92
Identities = 80/315 (25%), Positives = 114/315 (36%), Gaps = 29/315 (9%)
Query: 83 FTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVL 142
L + + + G FG V+K +L + VAVK Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 143 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 198
L + H N++ IG G L+ F GSL D L + WN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 199 IAAGAAKGLEYLH-------DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251
IA A+GL YLH D P + +RD+KS N+LL ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 252 KTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 306
+ +GT Y APE L+ D+Y+ G+V EL + A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 307 EHNLVA--WARPLFKDRRKF--PKMADPLLQGRYPMRGLYQALA-VAAMCLQEQAATRPL 361
P +D ++ K P+L+ + L C A R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 362 IGDVVTALTYLASQT 376
G V +T + T
Sbjct: 306 AGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-69
Identities = 89/290 (30%), Positives = 133/290 (45%), Gaps = 30/290 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 158
+G G FG V++ G VAVK L EFL EV ++ L H N+V +G
Sbjct: 45 IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
+V E++ GSL LH +E LD R+ +A AKG+ YLH++ NPP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 278
++R+LKS N+L+D+ + K+ DFGL++L + S GT + APE
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 279 KSDVYSFGVVFLELITGRKAIDNTRP-PGEHNL-VAWARPLFKDRR-KFPKMADPLLQGR 335
KSDVYSFGV+ EL T ++ P + V A FK +R + P+ +P
Sbjct: 219 KSDVYSFGVILWELATLQQ------PWGNLNPAQVVAAV-GFKCKRLEIPRNLNP----- 266
Query: 336 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNL 385
+ + + C + RP ++ L L P S+L
Sbjct: 267 -QVAAIIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-69
Identities = 73/345 (21%), Positives = 124/345 (35%), Gaps = 56/345 (16%)
Query: 83 FTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFL--VE 140
E + N + L+G G +G VYKG L+ + VAVK + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSF---ANRQNFINEKN 57
Query: 141 VLMLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNT 195
+ + L+ H N+ I + LLV E+ P GSL +L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 196 RMKIAAGAAKGLEYLH------DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK---- 245
++A +GL YLH D P + +RDL S N+L+ +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 246 --LGPVGDKTHVSTRVMGTYGYCAPEYAM-------TGQLTLKSDVYSFGVVFLELITGR 296
L G++ + + +GT Y APE + D+Y+ G+++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 297 KAIDNTRPPGEHNL----VAWARPLFKDRRK----------FPKMADPLLQGRYPMRGLY 342
+ E+ + P F+D + FP+ ++
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 343 QALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSN 387
+ C + A R + L + S ++
Sbjct: 293 ED------CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 6e-68
Identities = 80/289 (27%), Positives = 133/289 (46%), Gaps = 45/289 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN-------REFLVEVLMLSLLHHSNLV 153
+G+GGFG V+KGRL VVA+K L +G +EF EV ++S L+H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
L G + +V EF+P G L L D P+ W+ ++++ A G+EY+ ++
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 214 ANPPVIYRDLKSSNILLDEG-----FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
NPP+++RDL+S NI L K++DFGL++ H + ++G + + AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 269 EYAMTGQL---TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP-LFKDRR-K 323
E + + T K+D YSF ++ ++TG D + + + R
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRPT 250
Query: 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372
P+ P +R + + +C RP +V L+ L
Sbjct: 251 IPEDCPP------RLRNVIE------LCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 6e-66
Identities = 87/304 (28%), Positives = 128/304 (42%), Gaps = 32/304 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+G G FG V K + + VA+KQ++ + + F+VE+ LS ++H N+V L G C
Sbjct: 16 VGRGAFGVVCKAKW--RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ LV E+ GSL + LH P M ++G+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 221 RDLKSSNILLDE-GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
RDLK N+LL G K+ DFG A D T G+ + APE + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 280 SDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR-KFPKMADPLLQGRYPM 338
DV+S+G++ E+IT RK D P + WA + R K P+
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA--VHNGTRPPLIKNLPK------PI 233
Query: 339 RGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRD 398
L C + + RP + ++V +T+L Y P A L S P D
Sbjct: 234 ESLMT------RCWSKDPSQRPSMEEIVKIMTHL--MRYFPGADEPLQYPCQHSLPPGED 285
Query: 399 DRRS 402
R
Sbjct: 286 GRVE 289
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-63
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 35/227 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 158
L E G ++KGR + G + VK L R+F E L + H N++ ++G
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 159 CADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
C + +MP GSL + LH+ +D + +K A A+G+ +LH P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ- 275
+ L S ++++DE ++S + + S M + APE A+ +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPE-ALQKKP 184
Query: 276 ---LTLKSDVYSFGVVFLELITGRK--------------AIDNTRPP 305
+D++SF V+ EL+T A++ RP
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-63
Identities = 74/300 (24%), Positives = 113/300 (37%), Gaps = 40/300 (13%)
Query: 95 FRPECL-----LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH 149
FRP L LG+G FG+ K TG+V+ +K+L R + R FL EV ++ L H
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
N++ IG + + E++ G+L + W+ R+ A A G+ Y
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAY 123
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL------------GPVGDKTHVST 257
LH +I+RDL S N L+ E + ++DFGLA+L
Sbjct: 124 LHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317
V+G + APE K DV+SFG+V E+I A P + + +
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRTMDFGLNV 236
Query: 318 FKDRRKF-PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376
++ P P + C RP + L L
Sbjct: 237 RGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-63
Identities = 69/208 (33%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+G GGFG+VY+ G VAVK D + Q E + ++L H N++ L
Sbjct: 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
G C LV EF G L L + + + + A A+G+ YLHD+A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 217 PVIYRDLKSSNILLDEGFHP--------KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
P+I+RDLKSSNIL+ + K++DFGLA+ +T + G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAP 183
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELITGR 296
E + SDV+S+GV+ EL+TG
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-59
Identities = 68/201 (33%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 158
+G G FG VYKG+ VAVK L+ + F EV +L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
Q +V ++ SL HLH + + + IA A+G++YLH K +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---YAMTGQ 275
I+RDLKS+NI L E K+ DFGLA +H ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 276 LTLKSDVYSFGVVFLELITGR 296
+ +SDVY+FG+V EL+TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 9e-59
Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 24/210 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 158
+G+G FG+VY GR VA++ +D + + F EV+ H N+V +G
Sbjct: 41 IGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218
C ++ +L + D K LD N +IA KG+ YLH +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+++DLKS N+ D G ++DFGL + G + G + APE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 276 L---------TLKSDVYSFGVVFLELITGR 296
+ SDV++ G ++ EL
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-58
Identities = 68/302 (22%), Positives = 119/302 (39%), Gaps = 37/302 (12%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFL--VEVLMLSLLHHSNLVNLIG 157
+G+G +G V+ G+ G+ VAVK + E+ L+ H N++ I
Sbjct: 44 QIGKGRYGEVWMGKWR--GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 158 YCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-- 211
G Q L+ ++ GSL D+L LD + +K+A + GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 212 ---DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYC 266
+ P + +RDLKS NIL+ + ++D GLA +GT Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 267 APE------YAMTGQLTLKSDVYSFGVVFLELITG---RKAIDNTRPPGEHNLVAWARPL 317
PE Q + +D+YSFG++ E+ ++ + P ++ + + P
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP--YHDLVPSDPS 271
Query: 318 FKDRRKF--PKMADPLLQGRYPMRGLYQALA-VAAMCLQEQAATRPLIGDVVTALTYLAS 374
++D R+ K P R+ + + + C A+R V L ++
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 375 QT 376
Sbjct: 332 SQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-57
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 29/224 (12%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFL--VEVLMLSLLHHSNLVNLIG 157
+G+G +G V++G + G+ VAVK + + + E+ +L H N++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 158 YCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-- 211
Q L+ + +GSL D+L LD + ++I A GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 212 ---DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV--STRVMGTYGYC 266
+ P + +RDLKS NIL+ + ++D GLA + + +GT Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 267 APE------YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 304
APE + D+++FG+V E+ +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-55
Identities = 72/301 (23%), Positives = 126/301 (41%), Gaps = 37/301 (12%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFL--VEVLMLSLLHHSNLVNLIG 157
+G+G FG V++G+ G+ VAVK + R + E+ +L H N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 158 YCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-- 211
+ Q LV ++ GSL D+L+ + + +K+A A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 212 ---DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYC 266
+ P + +RDLKS NIL+ + ++D GLA T +GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 267 APEYAMTGQL-------TLKSDVYSFGVVFLELITGRKAIDNTRPPGE--HNLVAWARPL 317
APE + + ++D+Y+ G+VF E+ R +I + + + + P
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 318 FKDRRKF--PKMADPLLQGRYPMRGLYQALA-VAAMCLQEQAATRPLIGDVVTALTYLAS 374
++ RK + P + R+ + +A + C A R + L+ L+
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
Query: 375 Q 375
Q
Sbjct: 337 Q 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 5e-44
Identities = 60/195 (30%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 159
+G G FG V+ GRL + +VAVK + +FL E +L H N+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
+V E + G L + L T +++ AA G+EYL K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 279
+RDL + N L+ E K+SDFG+++ G + APE G+ + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 280 SDVYSFGVVFLELIT 294
SDV+SFG++ E +
Sbjct: 296 SDVWSFGILLWETFS 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 72/205 (35%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 101 LGEGGFGRVYKGRL----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
LG+G FG V R ++TG+VVAVK+L + + R+F E+ +L L H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 157 GYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
G C +R L+ E++P GSL D+L KE +D ++ + KG+EYL K
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 269
I+RDL + NIL++ K+ DFGL K+ P + G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT 294
+ ++ SDV+SFGVV EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 101 LGEGGFGRVYKGRL----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
LG+G FG V R ++TG +VAVKQL +G R+F E+ +L LH +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 157 GYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
G ++ LV E++P G L D L + LD + + ++ KG+EYL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 269
++RDL + NIL++ H K++DFGLAKL P+ +V G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT 294
+ +SDV+SFGVV EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-43
Identities = 72/205 (35%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 101 LGEGGFGRVYKGRL----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
LG+G FG V R ++TG+VVAVK+L + + R+F E+ +L L H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 157 GYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
G C +R L+ E++P GSL D+L KE +D ++ + KG+EYL K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 269
I+RDL + NIL++ K+ DFGL K+ P + + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT 294
+ ++ SDV+SFGVV EL T
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 63/290 (21%), Positives = 106/290 (36%), Gaps = 38/290 (13%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
K++ LGEGGF V G A+K++ + Q E E M L +H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 153 VNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
+ L+ YC L+ F G+L + + L L + + + G +GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-------G 261
+H +RDLK +NILL + P L D G + + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 262 TYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 315
T Y APE + + + ++DV+S G V ++ G D G+ +A
Sbjct: 206 TISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA--- 259
Query: 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
+++ P+ R+ + + RP I +
Sbjct: 260 --VQNQLSIPQ------SPRHS----SALWQLLNSMMTVDPHQRPHIPLL 297
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQ----VVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LG G FG VYKG G+ VA+K+L + + N+E L E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+G C L+ + MP G L D++ + K+ + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+++RDL + N+L+ H K++DFGLAKL +K + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 276 LTLKSDVYSFGVVFLELIT-GRK 297
T +SDV+S+GV EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 101 LGEGGFGRVYKGRL----ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG+V R ++TG+ VAVK L +G + E+ +L L+H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 156 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G C + L+ EF+P GSL+++L +K ++ ++K A KG++YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAP 268
++RDL + N+L++ K+ DFGL K + + + AP
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAP 198
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELIT 294
E M + + SDV+SFGV EL+T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 69/206 (33%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 101 LGEGGFGRVYKGRL----ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG+V + TG++VAVK L G Q + E+ +L L+H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 156 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G C D LV E++PLGSL D+L + + + A +G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAP 268
I+RDL + N+LLD K+ DFGLAK P G + + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAP 206
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELIT 294
E + SDV+SFGV EL+T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-41
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQ----VVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LG G FG V+KG G+ V +K + D++G Q + +L + L H+++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+G C G LV +++PLGSL DH+ + L + AKG+ YL +
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+++R+L + N+LL +++DFG+A L P DK + + + A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 276 LTLKSDVYSFGVVFLELIT-GRK 297
T +SDV+S+GV EL+T G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-41
Identities = 70/278 (25%), Positives = 108/278 (38%), Gaps = 42/278 (15%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNL 152
+ + +G G F VYKG T VA +L L + + F E ML L H N+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 153 VNLIGYCAD---GDQRLLVY-EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
V G + +++ E M G+L+ +L + KGL+
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQ 143
Query: 209 YLHDKANPPVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
+LH + PP+I+RDLK NI + G K+ D GLA L + + V+GT +
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLK----RASFAKAVIGTPEFM 197
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDR--R 322
APE + DVY+FG+ LE+ T P N R +
Sbjct: 198 APEM-YEEKYDESVDVYAFGMCMLEMATS-------EYPYSECQNAAQIYRRVTSGVKPA 249
Query: 323 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
F K+A P ++ + C+++ R
Sbjct: 250 SFDKVAIPEVK------------EIIEGCIRQNKDERY 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G +G VY+G + VAVK L + EFL E ++ + H NLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
++ EFM G+L D+L + +++ + + +A + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 280
R+L + N L+ E K++DFGL++L GD + APE + ++KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 281 DVYSFGVVFLELIT 294
DV++FGV+ E+ T
Sbjct: 401 DVWAFGVLLWEIAT 414
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-40
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQ----VVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LG G FG VYKG G+ VA+K+L + + N+E L E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+G C L+ + MP G L D++ + K+ + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+++RDL + N+L+ H K++DFGLAKL +K + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 276 LTLKSDVYSFGVVFLELIT-GRK 297
T +SDV+S+GV EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+G G FG V+ G + +V A+K + R G +F+ E ++ L H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ LV EFM G L D+L + T + + +G+ YL + VI+
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 277
RDL + N L+ E K+SDFG+ + V D + T GT + +PE + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSFSRYS 183
Query: 278 LKSDVYSFGVVFLELIT-GRK 297
KSDV+SFGV+ E+ + G+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G +G VY+G + VAVK L + EFL E ++ + H NLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
++ EFM G+L D+L + +++ + + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 277
RDL + N L+ E K++DFGL++L + T+ + G + APE + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFS 190
Query: 278 LKSDVYSFGVVFLELIT 294
+KSDV++FGV+ E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-39
Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQV---VAVKQL---DRNGLQGNREFLVEVLMLSLLHHSNLVN 154
LG+G FG V +G ++ VAVK L + + +F+ EV + L H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
L G +V E PLGSL D L + T + A A+G+ YL K
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYA 271
I+RDL + N+LL K+ DFGL + P D +V + +CAPE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 272 MTGQLTLKSDVYSFGVVFLELIT-GRK 297
T + SD + FGV E+ T G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 67/311 (21%), Positives = 117/311 (37%), Gaps = 28/311 (9%)
Query: 59 RNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTG 118
S + P +P+ + L NFR E +G G F VY+ G
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDG 57
Query: 119 QVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175
VA+K++ L + + E+ +L L+H N++ + ++ +V E G
Sbjct: 58 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235
L + K + T K LE++H + V++RD+K +N+ +
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGV 174
Query: 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
KL D GL + KT + ++GT Y +PE KSD++S G + E+
Sbjct: 175 VKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 296 RKAIDNTRPPGEHNLVAWARPLFK-DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQE 354
+ P + + K ++ +P PL Y + + MC+
Sbjct: 233 -------QSPFYGDKMNLYSLCKKIEQCDYP----PLPSDHYS----EELRQLVNMCINP 277
Query: 355 QAATRPLIGDV 365
RP + V
Sbjct: 278 DPEKRPDVTYV 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 65/194 (33%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG+G FG V+ G T +V A+K L + G FL E ++ L H LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 248
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ +V E+M GSL D L + L + +AA A G+ Y+ ++
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 280
RDL+++NIL+ E K++DFGLA+L ++ + APE A+ G+ T+KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 281 DVYSFGVVFLELIT 294
DV+SFG++ EL T
Sbjct: 363 DVWSFGILLTELTT 376
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 41/220 (18%)
Query: 101 LGEGGFGRVYKGRLESTGQV-------VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
LG+G F +++KG G V +K LD+ + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G C GD+ +LV EF+ GSL+ +L +K ++ ++++A A + +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 214 ANPPVIYRDLKSSNILLDEGFHP--------KLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265
+I+ ++ + NILL KLSD G++ V+
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177
Query: 266 ------CAPEYAMTGQL-TLKSDVYSFGVVFLELIT-GRK 297
PE + L +D +SFG E+ + G K
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 98 ECLLGEGGFGRVYKGRLESTGQV--VAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLV 153
+ LG G FG V +G + VA+K L + G + E + E ++ L + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
LIG C + +LV E G L L +E + + ++ + G++YL +K
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCA 267
++RDL + N+LL + K+SDFGL+K D + + + A
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181
Query: 268 PEYAMTGQLTLKSDVYSFGVVFLELIT-GRK 297
PE + + +SDV+S+GV E ++ G+K
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 101 LGEGGFGRVYKGRLESTG-----QVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 154
LG+G FG VY+G + VA+K ++ R EFL E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHL------HDLPPDKEPLDWNTRMKIAAGAAKGLE 208
L+G + G L++ E M G L+ +L P P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV------MGT 262
YL+ ++RDL + N ++ E F K+ DFG+ + D + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+PE G T SDV+SFGVV E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 70/260 (26%), Positives = 108/260 (41%), Gaps = 18/260 (6%)
Query: 46 HHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGG 105
HH + + + + A P A RE+ A E ++G G
Sbjct: 4 HHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEA--SRIHIEKIIGSGD 61
Query: 106 FGRVYKGRLESTGQ---VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGYCAD 161
G V GRL GQ VA+K L + R +FL E ++ H N++ L G
Sbjct: 62 SGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121
Query: 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 221
G ++V E+M GSL+ L + + G G+ YL D ++R
Sbjct: 122 GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHR 175
Query: 222 DLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLTL 278
DL + N+L+D K+SDFGL+++ + D + G + APE +
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 279 KSDVYSFGVVFLELIT-GRK 297
SDV+SFGVV E++ G +
Sbjct: 234 ASDVWSFGVVMWEVLAYGER 253
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 63/265 (23%), Positives = 105/265 (39%), Gaps = 19/265 (7%)
Query: 36 SAKDGSIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNF 95
S G + + S S P+ E T + + +RE
Sbjct: 4 SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWM 60
Query: 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
+ +G G FG V++ + + TG AVK++ + E++ + L +V L
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPL 115
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
G +G + E + GSL + + E + A +GLEYLH +
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHTRR- 170
Query: 216 PPVIYRDLKSSNILLD-EGFHPKLSDFGLAK-LGPVGDKTHVSTR--VMGTYGYCAPEYA 271
+++ D+K+ N+LL +G L DFG A L P G + T + GT + APE
Sbjct: 171 --ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR 296
M K D++S + L ++ G
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+G+G FG V G G VAVK + + + FL E +++ L HSNLV L+G
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 161 DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
+ L +V E+M GSL D+L + L + +K + + +EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV----MGTYGYCAPEYAMTGQ 275
+RDL + N+L+ E K+SDFGL K T + ++ APE +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 362
Query: 276 LTLKSDVYSFGVVFLELIT 294
+ KSDV+SFG++ E+ +
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQV--VAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
LG G FG V KG + V VAVK L + N E L E ++ L + +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
G C + + +LV E LG L +L + +++ + G++YL +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCAPEY 270
++RDL + N+LL + K+SDFGL+K + + + + APE
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191
Query: 271 AMTGQLTLKSDVYSFGVVFLELIT-GRK 297
+ + KSDV+SFGV+ E + G+K
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-38
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V G+ + V AVK + + G EF E + L H LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDV-AVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+V E++ G L ++L + L+ + +++ +G+ +L I+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIH 127
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 277
RDL + N L+D K+SDFG+ + V D + +GT + APE + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 278 LKSDVYSFGVVFLELIT-GRK 297
KSDV++FG++ E+ + G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 101 LGEGGFGRVYKGRLESTG-----QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG+V+ + +VAVK L L ++F E +L+ L H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEPLDWNTRMKIAAGA 203
G C DGD ++V+E+M G L L K L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV---- 259
A G+ YL + ++RDL + N L+ K+ DFG+++ D V
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 260 --MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
M PE M + T +SDV+SFGV+ E+ T
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+G+G FG V G G VAVK + +N + FL E +++ L HSNLV L+G
Sbjct: 29 IGKGEFGDVMLGDYR--GNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 161 DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
+ L +V E+M GSL D+L + L + +K + + +EYL +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV----MGTYGYCAPEYAMTGQ 275
+RDL + N+L+ E K+SDFGL K T + ++ APE +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 190
Query: 276 LTLKSDVYSFGVVFLELIT-GRK 297
+ KSDV+SFG++ E+ + GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQ---VVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLI 156
+G+G FG VY G Q A+K L R +Q FL E L++ L+H N++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 157 GYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
G + ++ +M G L + + + A+G+EYL ++
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK- 144
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG------TYGYCAPE 269
++RDL + N +LDE F K++DFGLA+ + V T A E
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----ALE 198
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT 294
T + T KSDV+SFGV+ EL+T
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 8/212 (3%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLV-EVLMLSLLHHS 150
+++ +G G +GR K R +S G+++ K+LD + + ++ LV EV +L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 151 NLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
N+V D L V E+ G L + +++ LD +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 209 YLHDKANPP--VIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
H +++ V++RDLK +N+ LD + KL DFGLA++ + T + +GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYM 183
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELITGRKA 298
+PE KSD++S G + EL
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 101 LGEGGFGRVYKGRLESTG-----QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG+V+ + +VAVK L ++F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHL-----------HDLPPDKEPLDWNTRMKIAAGAA 204
G C +G L+V+E+M G L L PL + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV----- 259
G+ YL ++RDL + N L+ +G K+ DFG+++ D V R
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 260 -MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
M PE + + T +SDV+SFGVV E+ T
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 59/266 (22%), Positives = 92/266 (34%), Gaps = 27/266 (10%)
Query: 35 DSAKDGSIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKN 94
D + QS H + + + P P + ++
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFF-------------QQS 58
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN--GLQGNREFLVEV-LMLSLLHHSN 151
F+ LG G +G V+K R + G++ AVK+ G + L EV + H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
V L +G L E SL+ H L L +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLH 174
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ +++ D+K +NI L KL DFGL +G + G Y APE
Sbjct: 175 SQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE-L 227
Query: 272 MTGQLTLKSDVYSFGVVFLELITGRK 297
+ G +DV+S G+ LE+ +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNME 253
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQV---VAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLI 156
+G G FG VY G L AVK L+R + +FL E +++ H N+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 157 GYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
G C + L+V +M G L + + + + + AKG++YL K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLASKK- 148
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG------TYGYCAPE 269
++RDL + N +LDE F K++DFGLA+ + V + A E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALE 202
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT 294
T + T KSDV+SFGV+ EL+T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V G+ V A+K + + G EF+ E ++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDV-AIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
++ E+M G L ++L + + +++ + +EYL K ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 277
RDL + N L+++ K+SDFGL++ V D + T +G+ + PE M + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 278 LKSDVYSFGVVFLELIT 294
KSD+++FGV+ E+ +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 67/289 (23%), Positives = 113/289 (39%), Gaps = 50/289 (17%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
+F+ L+G GGFG+V+K + G+ +K++ N N + EV L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 153 VNLIGYCADGDQRL----------------LVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 196
V+ G D + EF G+LE + E LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLA 124
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 256
+++ KG++Y+H K +I RDLK SNI L + K+ DFGL
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178
Query: 257 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316
TR GT Y +PE + + D+Y+ G++ EL+
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------------CDT 220
Query: 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
F+ + F + D ++ + + + L ++ RP ++
Sbjct: 221 AFETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 62/262 (23%), Positives = 105/262 (40%), Gaps = 43/262 (16%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 151
+F +LG+G FG+V K R + A+K++ + L EV++L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 152 LVNLIGYCADGDQRL-------------LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK 198
+V + + + E+ G+L D +H + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120
Query: 199 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL------------ 246
+ + L Y+H + +I+RDLK NI +DE + K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 247 -GPVGDKTHVSTRVMGTYGYCAPE-YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 304
G ++++ + GT Y A E TG K D+YS G++F E+I
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------F 228
Query: 305 PGEHNLVAWARPLFKDRRKFPK 326
V + L +FP
Sbjct: 229 STGMERVNILKKLRSVSIEFPP 250
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 101 LGEGGFGRVYKGRL---ESTGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
LGEG FG V +G L + T VAVK + D + + EFL E + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 156 IGYCADGDQR-----LLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKGLE 208
+G C + + +++ FM G L +L L + + T +K A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--KTHVSTRV----MGT 262
YL ++ ++RDL + N +L + ++DFGL+K GD + ++ +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
A E T KSDV++FGV E+ T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQ---VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLI 156
+G G FG V GRL+ + VA+K L + R +FL E ++ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
G ++V E+M GSL+ L + + G A G++YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMT 273
++RDL + NIL++ K+SDFGL ++ + D + G + +PE
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 274 GQLTLKSDVYSFGVVFLELIT-GRK 297
+ T SDV+S+G+V E+++ G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQV---VAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLI 156
LGEG FG VY+G + VAVK ++ N+ +F+ E +++ L H ++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
G + + ++ E P G L +L +K L T + + K + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCAPEY 270
++RD+ NIL+ KL DFGL++ + D+ + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 271 AMTGQLTLKSDVYSFGVVFLELIT-GRK 297
+ T SDV+ F V E+++ G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQV----VAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVN 154
+G G FG VYKG L+++ VA+K L + G + +FL E ++ H N++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
L G + +++ E+M G+L+ L + + + G A G++YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYA 271
++RDL + NIL++ K+SDFGL+++ + D + G + APE
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 272 MTGQLTLKSDVYSFGVVFLELIT-GRK 297
+ T SDV+SFG+V E++T G +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 101 LGEGGFGRVYKGRL---ESTGQVVAVKQLDRNGLQGNR--EFLVEVLMLSLLHHSNLVNL 155
LG+G FG V + +L + + VAVK L + + + EFL E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 156 IGYCADGDQR------LLVYEFMPLGSLEDHL--HDLPPDKEPLDWNTRMKIAAGAAKGL 207
+G + +++ FM G L L + + L T ++ A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--KTHVSTRV----MG 261
EYL + I+RDL + N +L E ++DFGL++ GD + ++++ +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 262 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
A E T+ SDV++FGV E++T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-37
Identities = 66/197 (33%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V+ G +V AVK L + G FL E ++ L H LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ ++ E+M GSL D L P L N + +AA A+G+ ++ ++ I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 277
RDL+++NIL+ + K++DFGLA+L + D + T G + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFT 188
Query: 278 LKSDVYSFGVVFLELIT 294
+KSDV+SFG++ E++T
Sbjct: 189 IKSDVWSFGILLTEIVT 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 65/194 (33%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG+G FG V+ G T +V A+K L + G FL E ++ L H LV L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ +V E+M GSL D L + L + +AA A G+ Y+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 280
RDL+++NIL+ E K++DFGLA+L ++ + APE A+ G+ T+KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 281 DVYSFGVVFLELIT 294
DV+SFG++ EL T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHHSNLVNLI 156
LG+G FG VY R + + ++A+K L + L+ + EV + S L H N++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
GY D + L+ E+ PLG++ L L E T A L Y H K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR---TA-TYITELANALSYCHSKR-- 129
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 276
VI+RD+K N+LL K++DFG + P + + GT Y PE
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRT--D-LCGTLDYLPPEMIEGRMH 184
Query: 277 TLKSDVYSFGVVFLELITGR 296
K D++S GV+ E + G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 101 LGEGGFGRVYKGRLESTG-----QVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 154
LGE FG+VYKG L Q VA+K L D+ EF E ++ + L H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEPLDWNTRMKIAAG 202
L+G +++ + G L + L D K L+ + + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--KTHVSTRV- 259
A G+EYL V+++DL + N+L+ + + K+SD GL + D K ++ +
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 260 ---MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
M APE M G+ ++ SD++S+GVV E+ +
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
LG G FG V+ +V AVK + + G FL E ++ L H LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIY 220
+ ++ EFM GSL D L + + +A A+G+ ++ + I+
Sbjct: 254 -KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 221 RDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 277
RDL+++NIL+ K++DFGLA++ + D + T G + APE G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFGSFT 363
Query: 278 LKSDVYSFGVVFLELIT 294
+KSDV+SFG++ +E++T
Sbjct: 364 IKSDVWSFGILLMEIVT 380
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 45/219 (20%), Positives = 82/219 (37%), Gaps = 25/219 (11%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHS 150
+ + +G GG +V++ Q+ A+K ++ + E+ L+ L
Sbjct: 28 RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 151 NL--VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
+ + L Y +V E L L K+ +D R + +
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 141
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
+H +++ DLK +N L+ +G KL DFG+A + V +GT Y P
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 269 E-----------YAMTGQLTLKSDVYSFGVVFLELITGR 296
E +++ KSDV+S G + + G+
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQV---VAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLI 156
+G G FG VY G L AVK L+R + +FL E +++ H N+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 157 GYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
G C + L+V +M G L + + + + + AKG+++L K
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK- 212
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG------TYGYCAPE 269
++RDL + N +LDE F K++DFGLA+ + V + A E
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALE 266
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT 294
T + T KSDV+SFGV+ EL+T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 154
LG G FG VY+G++ + + VAVK L + Q +FL+E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---PLDWNTRMKIAAGAAKGLEYLH 211
IG R ++ E M G L+ L + P L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 212 DKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
+ I+RD+ + N LL G K+ DFG+A+ M + P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELIT 294
E M G T K+D +SFGV+ E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 100 LLGEGGFGRVYKGRLESTGQV--VAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLVNL 155
++GEG FG+V K R++ G A+K++ + +R+F E+ ++ L HH N++NL
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEPLDWNTRMKIAAGA 203
+G C L E+ P G+L D L L + AA
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV---- 259
A+G++YL K I+RDL + NIL+ E + K++DFGL++ V K R+
Sbjct: 152 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGRLPVRW 207
Query: 260 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
M A E T SDV+S+GV+ E+++
Sbjct: 208 M------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-36
Identities = 64/264 (24%), Positives = 103/264 (39%), Gaps = 28/264 (10%)
Query: 49 NRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECL-----LGE 103
+ + + G + A I + T+ + + E + +GE
Sbjct: 341 PSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGE 400
Query: 104 GGFGRVYKGRLESTGQV---VAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 159
G FG V++G S VA+K + +FL E L + H ++V LIG
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
+ ++ E LG L L K LD + + A + L YL K +
Sbjct: 461 -TENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FV 513
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPEYAMTG 274
+RD+ + N+L+ KL DFGL++ + D T+ G + APE
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKLPIKWMAPESINFR 567
Query: 275 QLTLKSDVYSFGVVFLELIT-GRK 297
+ T SDV+ FGV E++ G K
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVK 591
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 27/209 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQV---VAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNL 155
+GEG FG V++G S VA+K +N +FL E L + H ++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
IG + ++ E LG L L LD + + A + L YL K
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR- 136
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCAPE 269
++RD+ + N+L+ KL DFGL++ + D T+ + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 270 YAMTGQLTLKSDVYSFGVVFLELIT-GRK 297
+ T SDV+ FGV E++ G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 98 ECLLGEGGFGRVYKGRLESTGQV--VAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 154
+ LG G FG V +G + VA+K L E + E ++ L + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
LIG C + +LV E G L L +E + + ++ + G++YL +K
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYA 271
++R+L + N+LL + K+SDFGL+K D + + + APE
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECI 511
Query: 272 MTGQLTLKSDVYSFGVVFLELIT-GRK 297
+ + +SDV+S+GV E ++ G+K
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 44/220 (20%), Positives = 88/220 (40%), Gaps = 33/220 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-----------------EVLM 143
L +G F ++ + A+K+ +++ L+ R+F E+ +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 144 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE----PLDWNTRMKI 199
++ + + + G + D+ ++YE+M S+ + + I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 259
Y+H++ N + +RD+K SNIL+D+ KLSDFG ++ K S
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGS--- 210
Query: 260 MGTYGYCAPEYAMTGQLT---LKSDVYSFGVVFLELITGR 296
GTY + PE + + + K D++S G+ +
Sbjct: 211 RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 62/353 (17%), Positives = 126/353 (35%), Gaps = 39/353 (11%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLV-EVLMLSLLHHS 150
+ + +GEG FG+ + G+ +K+++ + + RE EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
N+V + +V ++ G L ++ + + L+++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHV 141
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
HD+ +++RD+KS NI L + +L DFG+A++ + ++ +GT Y +PE
Sbjct: 142 HDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEI 196
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330
KSD+++ G V EL T + A + + FP
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII--------SGSFPP---- 244
Query: 331 LLQGRYP--MRGLYQALAVAAMCLQEQAATRPLIGDVV-------TALTYLASQTYDPNA 381
+ Y +R L + RP + ++ +L+ Q
Sbjct: 245 -VSLHYSYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEF 297
Query: 382 ASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGR--VGRHGSPSTHKNSPDYR 432
++ G + P + ++G P +K D +
Sbjct: 298 CLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDKK 350
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 39/311 (12%), Positives = 86/311 (27%), Gaps = 76/311 (24%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE----------------------- 136
+LG+ + + TG+ V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 137 -----FLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLVYEFM--PLGSLEDHLHDLPPD 187
F+ ++ ++ + D R +Y M L + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 188 KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247
+ L + R+++ + L LH +++ L+ +I+LD+ L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 248 PVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVFLELITGR 296
+ + G+ PE +T D ++ G+V +
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA- 309
Query: 297 KAIDNTRPP-GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ 355
P + + + +F+ + P+ LL+G L+
Sbjct: 310 ------DLPITKDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYP 347
Query: 356 AATRPLIGDVV 366
R L +
Sbjct: 348 KEDRLLPLQAM 358
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 25/212 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLL--HHSNLVNL 155
+G GG +V++ Q+ A+K ++ + E+ L+ L H ++ L
Sbjct: 16 QIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
Y +V E L L K+ +D R + + +H
Sbjct: 75 YDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG- 128
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE------ 269
+++ DLK +N L+ +G KL DFG+A + V +GT Y PE
Sbjct: 129 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 270 -----YAMTGQLTLKSDVYSFGVVFLELITGR 296
+++ KSDV+S G + + G+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSN 151
+F P LG GGFG V++ + + A+K++ + RE + EV L+ L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 152 LVNLIGYCADGD---------QRLLVY---EFMPLGSLEDHLHDLPPDKEPLDWNTRMKI 199
+V + + ++ +Y + +L+D ++ +E + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHI 123
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL----------GPV 249
A+ +E+LH K +++RDLK SNI K+ DFGL
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
T +GT Y +PE + K D++S G++ EL+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 154
LG G FG VY+G++ + + VAVK L + Q +FL+E L++S +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---PLDWNTRMKIAAGAAKGLEYLH 211
IG R ++ E M G L+ L + P L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 212 DKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY--- 265
+ I+RD+ + N LL G K+ DFG+A+ D G
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPV 250
Query: 266 --CAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
PE M G T K+D +SFGV+ E+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 77/275 (28%), Positives = 120/275 (43%), Gaps = 38/275 (13%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHS 150
+ F +G+G FG V+KG T +VVA+K +D + E + E+ +LS
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
+ G + ++ E++ GS D L PLD I KGL+YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL 135
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE 269
H + I+RD+K++N+LL E KL+DFG+ +L K + +GT + APE
Sbjct: 136 HSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPE 189
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDRRKFPKM 327
K+D++S G+ +EL G PP H + + LF PK
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARG-------EPPHSELHPM----KVLF----LIPKN 234
Query: 328 ADPLLQGRY--PMRGLYQALAVAAMCLQEQAATRP 360
P L+G Y P++ CL ++ + RP
Sbjct: 235 NPPTLEGNYSKPLKEF------VEACLNKEPSFRP 263
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 101 LGEGGFGRVYKGRL-------ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSN 151
LGEG FG+V VAVK L D + + + E+ +M + H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEPLDWNTRMKI 199
++NL+G C ++ E+ G+L ++L +E + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--KTHVST 257
A+G+EYL + I+RDL + N+L+ E K++DFGLA+ D K +
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 258 RV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 49/264 (18%), Positives = 93/264 (35%), Gaps = 25/264 (9%)
Query: 48 VNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFG 107
V R S K + + + + A + ++ + + +G GG
Sbjct: 11 VPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSS 70
Query: 108 RVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNL--VNLIGYCADGD 163
+V++ Q+ A+K ++ + E+ L+ L + + L Y
Sbjct: 71 KVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129
Query: 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 223
+V E L L K+ +D R + + +H +++ DL
Sbjct: 130 YIYMVMECGN-IDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDL 181
Query: 224 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-----------YAM 272
K +N L+ +G KL DFG+A + V +G Y PE
Sbjct: 182 KPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240
Query: 273 TGQLTLKSDVYSFGVVFLELITGR 296
+++ KSDV+S G + + G+
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGK 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHHSNLVNLI 156
LG+G FG VY R + ++A+K L ++ L+ + E+ + S L H N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
Y D + L+ EF P G L L E + A L Y H++
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR---SA-TFMEELADALHYCHERK-- 134
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 276
VI+RD+K N+L+ K++DFG + P + GT Y PE
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 277 TLKSDVYSFGVVFLELITGR 296
K D++ GV+ E + G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 58/223 (26%), Positives = 90/223 (40%), Gaps = 44/223 (19%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLV 153
LG G FG+V + E VAVK L + E+ +M L H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR----------MKIAAGA 203
NL+G C G L++ E+ G L + L E + ++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
A+G+ +L K I+RD+ + N+LL G K+ DFGLA+ +M
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDS 218
Query: 264 GYC------------APEYAMTGQLTLKSDVYSFGVVFLELIT 294
Y APE T++SDV+S+G++ E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 101 LGEGGFGRVYKGRL-------ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSN 151
LGEG FG+V VAVK L D + + + E+ +M + H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEPLDWNTRMKI 199
++NL+G C ++ E+ G+L ++L +E + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--KTHVST 257
A+G+EYL + I+RDL + N+L+ E K++DFGLA+ D K +
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 258 RV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 70/284 (24%), Positives = 120/284 (42%), Gaps = 34/284 (11%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSN 151
++ + ++G G V + VA+K+++ Q + + L+ E+ +S HH N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWN-TRMKIAA---GAAKGL 207
+V+ D+ LV + + GS+ D + + E IA +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTR--VMGTYG 264
EYLH I+RD+K+ NILL E +++DFG+ A L GD T R +GT
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 265 YCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDR 321
+ APE + K+D++SFG+ +EL TG P + + L
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG-------AAPYHKYPPM----KVLM--- 237
Query: 322 RKFPKMADPLLQGRYPMRGLYQALAVA-----AMCLQEQAATRP 360
+ P L+ + + + + ++CLQ+ RP
Sbjct: 238 -LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHSNLVNL 155
LG GG VY VA+K + + E L EV S L H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
I + D LV E++ +L +++ PL +T + G+++ HD
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST-RVMGTYGYCAPEYAMTG 274
+++RD+K NIL+D K+ DFG+AK + + + T V+GT Y +PE A
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 275 QLTLKSDVYSFGVVFLELITGR 296
+D+YS G+V E++ G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-34
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 27/228 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 159
+LG+G +G VY GR S +A+K++ + ++ E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
++ + E +P GSL L D E +I +GL+YLHD
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI----LEGLKYLHDNQ-- 142
Query: 217 PVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---YA 271
+++RD+K N+L++ G K+SDFG +K + + GT Y APE
Sbjct: 143 -IVHRDIKGDNVLINTYSG-VLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 272 MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 319
G +D++S G +E+ TG +PP + L +FK
Sbjct: 199 PRG-YGKAADIWSLGCTIIEMATG-------KPP-FYELGEPQAAMFK 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-34
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 151
K + +G+G G VY +TGQ VA++Q++ + E+L++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+VN + GD+ +V E++ GSL D + + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEY 270
VI+RD+KS NILL KL+DFG A++ P K T V GT + APE
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWMAPEV 187
Query: 271 AMTGQLTLKSDVYSFGVVFLELITG 295
K D++S G++ +E+I G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 63/221 (28%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEV-LMLSLLHHSNLV 153
LG G FG+V + VAVK L + R + E+ ++ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHL--------------HDLPPDKEPLDWNTRMKI 199
NL+G C G L++ E+ G L + L + D+ LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST-- 257
+ AKG+ +L K I+RDL + NILL G K+ DFGLA+ V
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 258 ----RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ M APE T +SDV+S+G+ EL +
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-34
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGY 158
+LG+G V++GR + TG + A+K + + + E +L L+H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 159 CADGDQRL--LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+ R L+ EF P GSL L + P + L + + + G+ +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 217 PVIYRDLKSSNILLDEGFHP----KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--- 269
+++R++K NI+ G KL+DFG A+ + D + GT Y P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYE 188
Query: 270 -----YAMTGQLTLKSDVYSFGVVFLELITGR 296
+ D++S GV F TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 22/254 (8%)
Query: 46 HHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGG 105
HH + SS + + + A + + +GEG
Sbjct: 2 HHHHHHSSGVDLG--TENLYFQSGVVTHEQFKAALRMVVDQG--DPRLLLDSYVKIGEGS 57
Query: 106 FGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165
G V R + +G+ VAVK +D Q EV+++ H N+V + G++
Sbjct: 58 TGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA---GAAKGLEYLHDKANPPVIYRD 222
++ EF+ G+L D + + + E +IA + L YLH + VI+RD
Sbjct: 118 WVLMEFLQGGALTDIVSQVRLN-EE-------QIATVCEAVLQALAYLHAQG---VIHRD 166
Query: 223 LKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 281
+KS +ILL KLSDFG A++ K + V GT + APE + D
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISRSLYATEVD 223
Query: 282 VYSFGVVFLELITG 295
++S G++ +E++ G
Sbjct: 224 IWSLGIMVIEMVDG 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 154
+GEG FGRV++ R +VAVK L + +F E +++ + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHL--------------------HDLPPDKEPLDWN 194
L+G CA G L++E+M G L + L P PL
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 195 TRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--K 252
++ IA A G+ YL ++ ++RDL + N L+ E K++DFGL++ D K
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 253 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ + M PE + T +SDV+++GVV E+ +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 154
LGEG FG+V K + VAVK L N + L E +L ++H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHL--------------------HDLPPDKEPLDWN 194
L G C+ LL+ E+ GSL L PD+ L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 195 TRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--K 252
+ A ++G++YL + +++RDL + NIL+ EG K+SDFGL++ D
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 253 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
R+ M A E T +SDV+SFGV+ E++T
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 49/358 (13%), Positives = 95/358 (26%), Gaps = 78/358 (21%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE----------------------- 136
+LG+ + + TG+ V +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 137 -----FLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLVYEFM--PLGSLEDHLHDLPPD 187
F+ ++ ++ + D R +Y M L + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 188 KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247
+ L + R+++ + L LH +++ L+ +I+LD+ L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 248 PVGDKTHVSTRVMGTYGYCAPEY----------AMTGQLTLKSDVYSFGVVFLELITGRK 297
G S G+ PE +T D ++ G+ +
Sbjct: 260 RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD- 314
Query: 298 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAA 357
P + + + +F+ + P+ LL+G L+
Sbjct: 315 -----LPNTDDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYPKE 353
Query: 358 TRPLIGDVVTALTYLASQTYDPNAASNLSNRVGPSTPRNRDDRRSMADGQDSPDEHGR 415
R L + Y +T A P G PDE G
Sbjct: 354 DRLLPLQAMETPEYEQLRTELSAALPLYQ---TDGEPTREGGAP--PSGTSQPDEAGA 406
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLV 153
LG G FG+V + +T + VAVK L + +R + E+ +++ + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 154 NLIGYCADGDQ-RLLVYEFMPLGSLEDHL------------HDLPPDKEPLDWNTRMKIA 200
NL+G C +++ EF G+L +L K+ L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 201 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--KTHVSTR 258
AKG+E+L + I+RDL + NILL E K+ DFGLA+ R
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 259 V----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ M APE T++SDV+SFGV+ E+ +
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 41/345 (11%), Positives = 74/345 (21%), Gaps = 54/345 (15%)
Query: 59 RNGSDPKKEPAIPKEPTAHIA---AQTFTFR-ELAAATKNFRPECLLGEGGFGRVYKGRL 114
+ KEPA E T L+ + + L G V+ R
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83
Query: 115 ESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIGYC------------ 159
+ A+K E + L +
Sbjct: 84 VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143
Query: 160 --------------ADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 203
LL+ L L L + + + A
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
+ L K +++ N+ + L D VG + S+
Sbjct: 204 IRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS---VPV 255
Query: 264 GYCAPEYAM--TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321
Y E+ T T + + G+ + P +
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCL-------FLPFGLVTPGIKGSWKRPS 308
Query: 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 366
+ P P+ + L + L R L + +
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVKTL-IGRF-LNFDRRRRLLPLEAM 351
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 29/246 (11%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 151
+ F LGEG +G VYK + TGQ+VA+KQ+ +E + E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V G +V E+ GS+ D + + L + I KGLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLH 142
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEY 270
I+RD+K+ NILL+ H KL+DFG+ +L K + V+GT + APE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPEV 196
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDRRKFPKMA 328
+D++S G+ +E+ G +PP H + R +F P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEG-------KPPYADIHPM----RAIF----MIPTNP 241
Query: 329 DPLLQG 334
P +
Sbjct: 242 PPTFRK 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 20/212 (9%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM-----LSLLHH 149
P LG G +G V K R +GQ++AVK++ N + +LM + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLLMDLDISMRTVDC 65
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
V G + E M SL+ + + + + KIA K LE+
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAP 268
LH K + VI+RD+K SN+L++ K+ DFG+ L G Y AP
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAP 178
Query: 269 E----YAMTGQLTLKSDVYSFGVVFLELITGR 296
E ++KSD++S G+ +EL R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 101 LGEGGFGRVYKGRL-------ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSN 151
LGEG FG+V + VAVK L + + + E+ +M + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEPLDWNTRMKI 199
++NL+G C ++ E+ G+L ++L + +E L +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--KTHVST 257
A A+G+EYL K I+RDL + N+L+ E K++DFGLA+ D K +
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 258 RV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGY 158
+LG+G V++GR + TG + A+K + + + E +L L+H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 159 CADGDQRL--LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+ R L+ EF P GSL L + P + L + + + G+ +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 217 PVIYRDLKSSNILLDEGFHP----KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--- 269
+++R++K NI+ G KL+DFG A+ + D + GT Y P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYE 188
Query: 270 -----YAMTGQLTLKSDVYSFGVVFLELITGR 296
+ D++S GV F TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 151
+ + LG+G FG+VYK + + TG + A K ++ + +++VE+ +L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAA---GAAKGL 207
+V L+G + ++ EF P G+++ + +L EP +I + L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVVCRQMLEAL 130
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDK--THVSTRVMGTYG 264
+LH K +I+RDLK+ N+L+ +L+DFG+ AK K + + GT
Sbjct: 131 NFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPY 182
Query: 265 YCAPEYAMTGQLT-----LKSDVYSFGVVFLELITG 295
+ APE M + K+D++S G+ +E+
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 61/260 (23%), Positives = 104/260 (40%), Gaps = 22/260 (8%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLV 153
F LG G G V+K + +G V+A K + R ++ E+ +L + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
G + + E M GSL+ L E + K++ KGL YL +K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREK 150
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEY 270
+++RD+K SNIL++ KL DFG++ G + D + V GT Y +PE
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV-----GTRSYMSPER 201
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGR-----KAIDNTRPPGEHNLVAWARPLFKDRRKFP 325
+++SD++S G+ +E+ GR + A R
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 326 KMADPLLQGRYPMRGLYQAL 345
+ + P +++ L
Sbjct: 262 RPLNKFGMDSRPPMAIFELL 281
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 14/201 (6%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHHSNLVNLI 156
LG+GGF + ++ T +V A K + ++ L + +E+ + L H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
G+ D D +V E SL + EP R G +YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---AR-YYLRQIVLGCQYLHRNR-- 135
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
VI+RDLK N+ L+E K+ DFGLA K+ G++ V GT Y APE
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKG 191
Query: 276 LTLKSDVYSFGVVFLELITGR 296
+ + DV+S G + L+ G+
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 23/225 (10%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSN 151
R +L EGGF VY+ + +G+ A+K+L N + NR + EV M L H N
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 152 LVNLIGYCADGDQRLL--VYEFMPL-----GSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 204
+V + G + EF+ L G L + L + + PL +T +KI
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTC 146
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA---KLGPVGDKTHVSTRVM- 260
+ ++++H + PP+I+RDLK N+LL KL DFG A P + ++
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 261 ------GTYGYCAPE---YAMTGQLTLKSDVYSFGVVFLELITGR 296
T Y PE + K D+++ G + L +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 26/239 (10%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLI--- 156
LG GGFG V + + TG+ VA+KQ + NRE E+ ++ L+H N+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 157 ---GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
A D LL E+ G L +L+ + L + + + L YLH+
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 214 ANPPVIYRDLKSSNILLDEGFHP---KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
+I+RDLK NI+L G K+ D G AK + + V GT Y APE
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GTLQYLAPEL 194
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDRRKFPKM 327
+ T+ D +SFG + E ITG P V W + + + +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITG-------FRPFLPNWQPVQWHGKVREKSNEHIVV 246
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 63/248 (25%), Positives = 98/248 (39%), Gaps = 18/248 (7%)
Query: 53 SDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKG 112
+D K+ P I R + + LG+GGF + ++
Sbjct: 5 ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR----RRYVRGRFLGKGGFAKCFEI 60
Query: 113 RLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169
T +V A K + ++ L + +E+ + L H ++V G+ D D +V
Sbjct: 61 SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120
Query: 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 229
E SL + EP R G +YLH VI+RDLK N+
Sbjct: 121 ELCRRRSLLELHKRRKALTEPE---AR-YYLRQIVLGCQYLHRNR---VIHRDLKLGNLF 173
Query: 230 LDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 288
L+E K+ DFGLA K+ G++ V GT Y APE + + DV+S G +
Sbjct: 174 LNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
Query: 289 FLELITGR 296
L+ G+
Sbjct: 231 MYTLLVGK 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLV 153
LG G FG+V VAVK L ++ + E+ +M L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHL-------------------HDLPPDKEPLDWN 194
NL+G C L++E+ G L ++L + D L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 195 TRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD--K 252
+ A AKG+E+L K+ ++RDL + N+L+ G K+ DFGLA+
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 253 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294
+ R+ M APE G T+KSDV+S+G++ E+ +
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 50/221 (22%), Positives = 84/221 (38%), Gaps = 26/221 (11%)
Query: 92 TKNFRPECLLGEG--GFGRVYKGRLESTGQVVAVKQLD-RNGLQGNREFLV-EVLMLSLL 147
+ ++G+G V R + TG+ V V++++ FL E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 148 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD--KEPLDWNTRMKIAA---G 202
+H N+V ++ +V FM GS +D + D E IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IAYILQG 136
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG-LAKLGPVGDKTHV----ST 257
K L+Y+H ++R +K+S+IL+ LS + G + V
Sbjct: 137 VLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 258 RVMGTYGYCAPEYAMTGQL--TLKSDVYSFGVVFLELITGR 296
+ + +PE KSD+YS G+ EL G
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 43/253 (16%), Positives = 78/253 (30%), Gaps = 38/253 (15%)
Query: 64 PKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLES-----TG 118
K PAI + + ++ L LGEG F +VY+
Sbjct: 48 QCKLPAIKPKTEFQLGSKLVYVHHL------------LGEGAFAQVYEATQGDLNDAKNK 95
Query: 119 QVVAVKQLDRNGLQGNREFLVEVLMLSLL---HHSNLVNLIGYCADGDQRLLVYEFMPLG 175
Q +K EF + ++ L + + +LV E G
Sbjct: 96 QKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152
Query: 176 SLEDHLHDL-PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF 234
+L + ++ ++ + + A +E +HD +I+ D+K N +L GF
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGF 209
Query: 235 HP-----------KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVY 283
L D G + + K + T T G+ E + D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 284 SFGVVFLELITGR 296
++ G
Sbjct: 270 GVAATVYCMLFGT 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHH 149
++F+ LLG+G F VY+ TG VA+K +D+ + EV + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
+++ L Y D + LV E G + +L + K + R G+ Y
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEAR-HFMHQIITGMLY 127
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAP 268
LH +++RDL SN+LL + K++DFGLA +L +K + GT Y +P
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISP 181
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELITGR 296
E A L+SDV+S G +F L+ GR
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 21/214 (9%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM-----LSLLH 148
+ + +G G +G V K + +GQ++AVK++ + + ++LM +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRSSD 79
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEPLDWNTRMKIAAGAAKGL 207
+V G + E M S + + + + KI K L
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYC 266
+L + +I+RD+K SNILLD + KL DFG+ +L + TR G Y
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYM 192
Query: 267 APE----YAMTGQLTLKSDVYSFGVVFLELITGR 296
APE A ++SDV+S G+ EL TGR
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHH 149
F +LG GGFG V+ ++++TG++ A K+L++ L+ + + +VE +L+ +H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 150 SNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGL 207
+V+L Y + L LV M G + H++++ D R A GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGL 302
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 267
E+LH + +IYRDLK N+LLD+ + ++SD GLA G GT G+ A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMA 357
Query: 268 PEYAMTGQLTLKSDVYSFGVVFLELITGR 296
PE + + D ++ GV E+I R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 48/201 (23%), Positives = 75/201 (37%), Gaps = 13/201 (6%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHSNLVNL 155
L+G GG G VY+ ++VA+K + L + F E L ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
+ Q + + L L + PL + I L+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+RD+K NIL+ L DFG+A T + +GT Y APE
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESH 211
Query: 276 LTLKSDVYSFGVVFLELITGR 296
T ++D+Y+ V E +TG
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 82/312 (26%), Positives = 123/312 (39%), Gaps = 56/312 (17%)
Query: 42 IAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAA------TKNF 95
++ HH + D + N +P A + ++A K F
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRA----GSLKDPDVAELFFKDDPEKLF 56
Query: 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNL 152
+G G FG VY R +VVA+K++ +G Q N ++ + EV L L H N
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA---GAAKGLEY 209
+ G LV E+ GS D L +PL ++IAA GA +GL Y
Sbjct: 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQ---EVEIAAVTHGALQGLAY 169
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR--VMGTYGYCA 267
LH +I+RD+K+ NILL E KL DFG A + ++ +GT + A
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMA 218
Query: 268 PEYAMTGQLT---LKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDRR 322
PE + K DV+S G+ +EL +PP + + L+
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAER-------KPPLFNMNAM----SALY---- 263
Query: 323 KFPKMADPLLQG 334
+ P LQ
Sbjct: 264 HIAQNESPALQS 275
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 32/228 (14%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN--GLQGNREFLVEV-LMLSLLH 148
T F +G G FG V+K G + A+K+ + G + L EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
HS++V A+ D L+ E+ GSL D + + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG-----------LAKLGPVGDKTHVST 257
Y+H + +++ D+K SNI + P + + K+G +G T +S+
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 258 R--VMGTYGYCAPE-------YAMTGQLTLKSDVYSFGVVFLELITGR 296
G + A E + K+D+++ + +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAE 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHH 149
FR +LG+GGFG V ++ +TG++ A K+L++ ++ + L E +L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 150 SNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPD--KEPLDWNTRMKI-AAGAAK 205
+V+L Y + L LV M G L+ H++ + E R AA
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-----RAVFYAAEICC 297
Query: 206 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265
GLE LH + ++YRDLK NILLD+ H ++SD GLA P G RV GT GY
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGY 351
Query: 266 CAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
APE + T D ++ G + E+I G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 82/287 (28%), Positives = 121/287 (42%), Gaps = 48/287 (16%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLS-LLHHS 150
F L+G G +G+VYKGR TGQ+ A+K +D G E E+ ML HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 151 NLVNLIG-----YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA--- 201
N+ G D +L LV EF GS+ D + + + +W IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICR 136
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVM 260
+GL +LH VI+RD+K N+LL E KL DFG+ A+L + + +
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FI 190
Query: 261 GTYGYCAPEYAMTGQLT-----LKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAW 313
GT + APE + KSD++S G+ +E+ G PP H +
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-------APPLCDMHPM--- 240
Query: 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
R LF P+ P L+ + + + CL + + RP
Sbjct: 241 -RALF----LIPRNPAPRLKSKKWSKKFQSFIES---CLVKNHSQRP 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHSNLVNL 155
+LG GG V+ R + VAVK L R L + F + E + L+H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 156 --IGYCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
G A+ L Y E++ +L D +H + P+ +++ A A + L +
Sbjct: 78 YDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS 132
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCA 267
H +I+RD+K +NI++ K+ DFG+A+ + D + T+ V+GT Y +
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLS 187
Query: 268 PEYAMTGQLTLKSDVYSFGVVFLELITGR 296
PE A + +SDVYS G V E++TG
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 8e-30
Identities = 72/213 (33%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHH 149
+F ++G GGFG VY R TG++ A+K LD+ ++ + L E +MLSL+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 150 SN---LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAA 204
+ +V + Y +L + + M G L HL E M+ AA
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEII 302
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
GLE++H++ V+YRDLK +NILLDE H ++SD GLA K H V GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHG 355
Query: 265 YCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 296
Y APE G S D +S G + +L+ G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 31/245 (12%)
Query: 61 GSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQV 120
GS P E E T+ + +F P+ +LG G G + R +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKI----------SFCPKDVLGHGAEGTIVY-RGMFDNRD 50
Query: 121 VAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED 179
VAVK++ +RE V++L H N++ D + + E +L++
Sbjct: 51 VAVKRILPECFSFADRE--VQLLR-ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE 106
Query: 180 HLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-----GF 234
++ L+ T ++ GL +LH +++RDLK NIL+
Sbjct: 107 YVEQKDFAHLGLEPITLLQ---QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKI 160
Query: 235 HPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEY---AMTGQLTLKSDVYSFGVVFL 290
+SDFGL K L + V GT G+ APE T D++S G VF
Sbjct: 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFY 220
Query: 291 ELITG 295
+I+
Sbjct: 221 YVISE 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 20/220 (9%)
Query: 86 RELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV---EVL 142
+ A + +G G G+V+K R TG V+AVKQ+ R+G + + ++ +V+
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 143 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 202
+ +V G + E M + + P E + K+
Sbjct: 78 L-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI----LGKMTVA 132
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL-AKLGPVGDKTHVSTRVMG 261
K L YL +K VI+RD+K SNILLDE KL DFG+ +L R G
Sbjct: 133 IVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL----VDDKAKDRSAG 186
Query: 262 TYGYCAPE-----YAMTGQLTLKSDVYSFGVVFLELITGR 296
Y APE +++DV+S G+ +EL TG+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-29
Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 27/249 (10%)
Query: 57 KSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLES 116
+ S + + + F + ++ ++ LG G +G V R +
Sbjct: 4 HHHHSSGREN---LYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 117 TGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174
T A+K + + + + + EV +L LL H N++ L + D LV E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDLKSSNILL 230
G L D + E AA K G+ YLH +++RDLK N+LL
Sbjct: 121 GELFDEIIHRMKFNE--------VDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLL 169
Query: 231 ---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 287
++ K+ DFGL+ + K +GT Y APE + + K DV+S GV
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGV 225
Query: 288 VFLELITGR 296
+ L+ G
Sbjct: 226 ILFILLAGY 234
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 12/233 (5%)
Query: 68 PAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLD 127
A P+ + + ++F+ +LGEG F V R +T + A+K L+
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 128 RNGLQGNREF---LVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL 184
+ + + E ++S L H V L D ++ + G L ++
Sbjct: 65 KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-- 122
Query: 185 PPDKEPLDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243
K T + A LEYLH K +I+RDLK NILL+E H +++DFG
Sbjct: 123 ---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 176
Query: 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
AK+ K + +GT Y +PE SD+++ G + +L+ G
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 25/230 (10%)
Query: 77 HIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE 136
H F A + ++ + +LG+G FG V + + TGQ AVK + + ++ +
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 137 ---FLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDW 193
L EV +L L H N++ L + D LV E G L D + E
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE---- 125
Query: 194 NTRMKIAAGAAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKL 246
AA + G+ Y+H +++RDLK N+LL + + ++ DFGL+
Sbjct: 126 ----VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST- 177
Query: 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
+ + +GT Y APE + G K DV+S GV+ L++G
Sbjct: 178 --HFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 57/253 (22%), Positives = 94/253 (37%), Gaps = 35/253 (13%)
Query: 64 PKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAV 123
I + ++ +++ LG G +G V + ++ A+
Sbjct: 7 HSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66
Query: 124 KQLDRNGLQGNREFLV-------------EVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170
K + ++ R E+ +L L H N++ L D LV E
Sbjct: 67 KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDLKSS 226
F G L + + + E AA K G+ YLH +++RD+K
Sbjct: 127 FYEGGELFEQIINRHKFDE--------CDAANIMKQILSGICYLHKHN---IVHRDIKPE 175
Query: 227 NILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVY 283
NILL + + K+ DFGL+ K + +GT Y APE + + K DV+
Sbjct: 176 NILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVW 231
Query: 284 SFGVVFLELITGR 296
S GV+ L+ G
Sbjct: 232 SCGVIMYILLCGY 244
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-27
Identities = 46/204 (22%), Positives = 75/204 (36%), Gaps = 24/204 (11%)
Query: 100 LLGEGGFGRVYKGR-LESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNLIG 157
+ GG G +Y G+ V +K L +G + + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 158 YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
+ D+ +V E++ SL+ + L + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
++Y DLK NI+L E KL D G + GT G+ APE
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGY-LYGTPGFQAPEIV- 249
Query: 273 TGQLTLKSDVYSFGVVFLELITGR 296
T+ +D+Y+ G L
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDL 273
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 72/269 (26%), Positives = 110/269 (40%), Gaps = 20/269 (7%)
Query: 35 DSAKDGSIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAAT-K 93
++ ++ + + +D K + ++ P + + + + T
Sbjct: 91 ETPEEREEWTTAI--QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN 148
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHS 150
F LLG+G FG+V + ++TG+ A+K L + + E L E +L H
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 151 NLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLE 208
L L Y RL V E+ G L HL E R + A L+
Sbjct: 209 FLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALD 262
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCA 267
YLH + N V+YRDLK N++LD+ H K++DFGL K G T + GT Y A
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLA 317
Query: 268 PEYAMTGQLTLKSDVYSFGVVFLELITGR 296
PE D + GVV E++ GR
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 36/230 (15%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSN 151
E +LG G G V + G+ VAVK++ + E +++L S H N
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALME--IKLLTESD-DHPN 70
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA---GAAKGLE 208
++ + E +L+D + E L + A G+
Sbjct: 71 VIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 209 YLHDKANPPVIYRDLKSSNILLD-------------EGFHPKLSDFGLAKL---GPVGDK 252
+LH +I+RDLK NIL+ E +SDFGL K G +
Sbjct: 130 HLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 253 THVSTRVMGTYGYCAPE-------YAMTGQLTLKSDVYSFGVVFLELITG 295
T+++ GT G+ APE +LT D++S G VF +++
Sbjct: 187 TNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 158
LG+G FG V K + T Q AVK +++ + + EV +L L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKA 214
D +V E G L D + E AA K G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------HDAARIIKQVFSGITYMHKHN 141
Query: 215 NPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+++RDLK NILL ++ K+ DFGL+ + +GT Y APE
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPE-V 194
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR 296
+ G K DV+S GV+ L++G
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGT 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 26/254 (10%)
Query: 53 SDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKG 112
S + + K P +P I + + ++G G FG V++
Sbjct: 2 SFTMSNAPLNGVKLNP--LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQA 59
Query: 113 RLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY-----CADGDQRL- 166
+L + + VA+K++ LQ R E+ ++ ++ H N+V+L + + L
Sbjct: 60 KLVESDE-VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 226
LV E++P ++ K+ + + L Y+H + +RD+K
Sbjct: 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIG--ICHRDIKPQ 170
Query: 227 NILLDEGFHP-KLSDFGLAK-LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDV 282
N+LLD KL DFG AK L + +R Y Y APE T D+
Sbjct: 171 NLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIFGATNYTTNIDI 225
Query: 283 YSFGVVFLELITGR 296
+S G V EL+ G+
Sbjct: 226 WSTGCVMAELMQGQ 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
+G+G FG+V + T ++ A+K +++ E E+ ++ L H LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 157 GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKA 214
Y ++ + +V + + G L HL KE +K+ L+YL ++
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-----TVKLFICELVMALDYLQNQR 135
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--YAM 272
+I+RD+K NILLDE H ++DF +A + P + T + GT Y APE +
Sbjct: 136 ---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSR 189
Query: 273 TGQLTLKS-DVYSFGVVFLELITGR 296
G + D +S GV EL+ GR
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 151
F+ E + G+G FG V G+ +STG VA+K++ ++ NRE L + L++LHH N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 152 LVNLI------GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 204
+V L G D L +V E++P +L + +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 205 KGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHP-KLSDFGLAK-LGPVGDKTH-VSTRVM 260
+ + LH N V +RD+K N+L++E KL DFG AK L P + +R
Sbjct: 140 RSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR-- 195
Query: 261 GTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 296
Y Y APE Q T D++S G +F E++ G
Sbjct: 196 --Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 34/210 (16%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+GEG +G V+K R TGQ+VA+K+ D + + L E+ ML L H NLVNL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKHPNLVNLL 68
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+ LV+E+ ++ L + + I + + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYGYCAPEYAMT 273
I+RD+K NIL+ + KL DFG A+L GP V+TR Y +PE
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE---- 172
Query: 274 GQLTLKSDVYSFGV-------VFLELITGR 296
L + Y V VF EL++G
Sbjct: 173 --LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHSNLVNL 155
LLGEG +G+V + T AVK L + L+ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 156 --IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK------GL 207
+ Y + + +V E+ G E + D P+K R + GL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQAHGYFCQLIDGL 122
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 267
EYLH + ++++D+K N+LL G K+S G+A+ G+ +
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 268 PEYAMTGQL--TLKSDVYSFGVVFLELITGR 296
PE A K D++S GV + TG
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 67/274 (24%), Positives = 110/274 (40%), Gaps = 35/274 (12%)
Query: 33 RKDSAKDGSIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAAT 92
R S + S S+ ++GS A P +
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDR------------PQE 53
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
++ ++G G FG VY+ +L +G++VA+K++ LQ R E+ ++ L H N+
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNI 109
Query: 153 VNLIGY-CADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
V L + + G+++ LV +++P ++ K+ L +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHP-KLSDFGLAK-LGPVGDKTH-VSTRVMGTY 263
L Y+H + +RD+K N+LLD KL DFG AK L + +R Y
Sbjct: 169 LAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y 221
Query: 264 GYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 296
Y APE T DV+S G V EL+ G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 34/210 (16%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+GEG +G V K R + TG++VA+K+ D + + + E+ +L L H NLVNL+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQLRHENLVNLL 90
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
C + LV+EF+ ++ D L P LD+ K G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYGYCAPEYAMT 273
+I+RD+K NIL+ + KL DFG A+ P V+TR Y APE
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE---- 194
Query: 274 GQLTLKSDVYSFGV-------VFLELITGR 296
L + Y V + E+ G
Sbjct: 195 --LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHS 150
F LG G FGRV + + +G A+K LD+ + ++ L E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEY 209
LV L D +V E++ G + HL + EP + AA EY
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-----HARFYAAQIVLTFEY 156
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
LH +IYRDLK N+L+D+ + +++DFG AK V +T T + GT APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--T-LCGTPEALAPE 208
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGR 296
++ D ++ GV+ E+ G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 55/196 (28%), Positives = 81/196 (41%), Gaps = 19/196 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNLIGYC 159
LG G FG V+ S+G +K ++++ Q E E+ +L L H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKAN 215
D +V E G L + + + L A K L Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALS----EGYVAELMKQMMNALAYFHSQH- 144
Query: 216 PPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
V+++DLK NIL K+ DFGLA+L H + GT Y APE
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAA-GTALYMAPE-VF 198
Query: 273 TGQLTLKSDVYSFGVV 288
+T K D++S GVV
Sbjct: 199 KRDVTFKCDIWSAGVV 214
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 30/268 (11%)
Query: 34 KDSAKDGSIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATK 93
K+S S + + V S+ + K + A F R + A
Sbjct: 25 KNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAP-FDHRIVTAKQG 83
Query: 94 NFR------PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL 147
+LG G FG+V+K +TG +A K + G++ E E+ +++ L
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 148 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIAAGAAK 205
H+NL+ L + +LV E++ G L D + +D + + K
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---------IDESYNLTELDTILFMK 194
Query: 206 ----GLEYLHDKANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTHVSTRV 259
G+ ++H +++ DLK NIL + K+ DFGLA+ +K V
Sbjct: 195 QICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---N 248
Query: 260 MGTYGYCAPEYAMTGQLTLKSDVYSFGV 287
GT + APE ++ +D++S GV
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 32/212 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+GEG +G V+K + T ++VA+K++ D G+ L E+ +L L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLH 67
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+ LV+EF L+ + LD KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
V++RDLK N+L++ KL++FGLA+ PV + V+ T Y P+
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPD----- 171
Query: 275 QLTLKSDVYSFGV-------VFLELITGRKAI 299
+ + +YS + +F EL + +
Sbjct: 172 -VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 64/287 (22%), Positives = 106/287 (36%), Gaps = 61/287 (21%)
Query: 83 FTFRELAAATKNFRPECL---------LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG 133
F F +L ++ P+ L LG G G V T + VA++ + +
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175
Query: 134 NREFLV--------EVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP 185
E+ +L L+H ++ + + D + +V E M G L D +
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK 234
Query: 186 PDKEPLDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKL 238
KE ++YLH+ +I+RDLK N+LL +E K+
Sbjct: 235 RLKE--------ATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283
Query: 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---YAMTGQLTLKSDVYSFGVVFLELITG 295
+DFG +K+ +G+ + + T GT Y APE T D +S GV+ ++G
Sbjct: 284 TDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
Query: 296 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLY 342
PP F + R + D + G+Y
Sbjct: 341 -------YPP------------FSEHRTQVSLKDQITSGKYNFIPEV 368
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 57/287 (19%), Positives = 96/287 (33%), Gaps = 65/287 (22%)
Query: 58 SRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLEST 117
+ S ++ + + + + +G+G +G V T
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQ-KKYHLKGA------------IGQGSYGVVRVAIENQT 50
Query: 118 GQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172
+ A+K +++N ++ EV ++ LHH N+ L D LV E
Sbjct: 51 RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAG-----------------------------A 203
G L D L+ D +K
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170
Query: 204 AK-------GLEYLHDKANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKL---GPVGD 251
+ L YLH++ + +RD+K N L ++ F KL DFGL+K G+
Sbjct: 171 SNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE 227
Query: 252 KTHVSTRVMGTYGYCAPE--YAMTGQLTLKSDVYSFGVVFLELITGR 296
++T+ GT + APE K D +S GV+ L+ G
Sbjct: 228 YYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGY 158
LGEG +G V T + VAVK +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK-------GLEYLH 211
+G+ + L E+ G L D + + M A + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD-AQRFFHQLMAGVVYLH 122
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-- 269
+ +RD+K N+LLDE + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 270 ----YAMTGQLTLKSDVYSFGVVFLELITGR 296
+ + DV+S G+V ++ G
Sbjct: 180 KRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 71/250 (28%), Positives = 107/250 (42%), Gaps = 28/250 (11%)
Query: 61 GSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPEC-----LLGEGGFGRVYKGRLE 115
G +EP + A A + ++ + +P ++G+G FG+V R +
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 116 STGQVVAVKQLDRNGLQGNREF---LVE--VLMLSLLHHSNLVNLIGYCADGDQRL-LVY 169
+ AVK L + + +E + E VL+ ++ H LV L + +L V
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLH-FSFQTADKLYFVL 118
Query: 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDLKSSNI 228
+++ G L HL EP R + AA A L YLH ++YRDLK NI
Sbjct: 119 DYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSLN---IVYRDLKPENI 170
Query: 229 LLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTGQLTLKS-DVYSFG 286
LLD H L+DFGL K + T T GT Y APE + Q ++ D + G
Sbjct: 171 LLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLG 226
Query: 287 VVFLELITGR 296
V E++ G
Sbjct: 227 AVLYEMLYGL 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 66/204 (32%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
LLG+G FG+V R ++TG+ A+K L + + E + E +L H L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 157 GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKA 214
Y RL V E+ G L HL E R + A LEYLH +
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGAEIVSALEYLHSRD 125
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMT 273
V+YRD+K N++LD+ H K++DFGL K G T + GT Y APE +
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPE-VLE 178
Query: 274 GQLTLKS-DVYSFGVVFLELITGR 296
++ D + GVV E++ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 22/196 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 159
+LG G F V+ + TG++ A+K + ++ + E+ +L + H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKAN 215
LV + + G L D + + E K A+ + ++YLH+
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTE--------KDASLVIQQVLSAVKYLHENG- 126
Query: 216 PPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
+++RDLK N+L +E ++DFGL+K+ ++ + + GT GY APE
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLA 180
Query: 273 TGQLTLKSDVYSFGVV 288
+ D +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVI 196
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 60/197 (30%), Positives = 86/197 (43%), Gaps = 24/197 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 158
LG+G FG V K + T Q AVK +++ + + EV +L L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKA 214
D +V E G L D + E AA K G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------HDAARIIKQVFSGITYMHKHN 141
Query: 215 NPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+++RDLK NILL ++ K+ DFGL+ T + R+ GT Y APE
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAYYIAPE-V 194
Query: 272 MTGQLTLKSDVYSFGVV 288
+ G K DV+S GV+
Sbjct: 195 LRGTYDEKCDVWSAGVI 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 57/258 (22%), Positives = 93/258 (36%), Gaps = 27/258 (10%)
Query: 42 IAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRP---- 97
I R D + K + + + + + + +
Sbjct: 102 IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDI 161
Query: 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG 157
LG G FG V++ +TG A K + E+ +S+L H LVNL
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIAAGAAK----GLEYLH 211
D ++ +++YEFM G L + + D + +M A + GL ++H
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKV---------ADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 212 DKANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
+ ++ DLK NI+ KL DFGL V GT + APE
Sbjct: 273 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPE 326
Query: 270 YAMTGQLTLKSDVYSFGV 287
A + +D++S GV
Sbjct: 327 VAEGKPVGYYTDMWSVGV 344
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 64/257 (24%), Positives = 102/257 (39%), Gaps = 38/257 (14%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNLVNLIGY 158
+LGEG RV T Q AVK +++ EV ++ H N++ LI +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA----AKGLEYLHDKA 214
+ D+ LV+E M GS+ H+H E A+ A L++LH+K
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNE--------LEASVVVQDVASALDFLHNKG 131
Query: 215 NPPVIYRDLKSSNILL---DEGFHPKLSDFGLAK-LGPVGDKTHVSTRVM----GTYGYC 266
+ +RDLK NIL ++ K+ DF L + GD + +ST + G+ Y
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 267 APEYAMTGQLTLKS-----DVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFK 319
APE D++S GV+ L++G PP G
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSG-------YPPFVGRCGSDCGWDRGEA 241
Query: 320 DRRKFPKMADPLLQGRY 336
+ + + +G+Y
Sbjct: 242 CPACQNMLFESIQEGKY 258
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLHHSNLVNLIG 157
LG G + VYKG ++TG VA+K++ G + E+ ++ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKELKHENIVRLYD 70
Query: 158 YCADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
++ LV+EFM L D + L+ N +GL + H+
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPEYAMT 273
+++RDLK N+L+++ KL DFGLA+ PV + V+ T Y AP+
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPD---- 178
Query: 274 GQLTLKSDVYSFGV-------VFLELITGR 296
+ + S YS + + E+ITG+
Sbjct: 179 --VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 55/283 (19%), Positives = 97/283 (34%), Gaps = 57/283 (20%)
Query: 34 KDSAKDGSIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATK 93
S +D ++ + G++ ++ E A F +
Sbjct: 41 IRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQ------ 94
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVL---------ML 144
+ P+ ++G G V + +TG AVK ++ + + E L EV +
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 145 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG-- 202
+ H +++ LI LV++ M G L D+L
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-----------------TEKVAL 197
Query: 203 ----AAK-------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251
+ +LH +++RDLK NILLD+ +LSDFG + +
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEP 252
Query: 252 KTHVSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVV 288
+ GT GY APE + D+++ GV+
Sbjct: 253 GEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 50/195 (25%), Positives = 76/195 (38%), Gaps = 22/195 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+G G +G V + T A K++ + ++ F E+ ++ L H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKANP 216
D LV E G L + + +E AA K + Y H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRE--------SDAARIMKDVLSAVAYCHKLN-- 126
Query: 217 PVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 273
V +RDLK N L KL DFGLA + T+V GT Y +P+ +
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQ-VLE 181
Query: 274 GQLTLKSDVYSFGVV 288
G + D +S GV+
Sbjct: 182 GLYGPECDEWSAGVM 196
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGY 158
LGEG +G V T + VAVK +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK-------GLEYLH 211
+G+ + L E+ G L D + + M A + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD-AQRFFHQLMAGVVYLH 122
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-- 269
+ +RD+K N+LLDE + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 270 ----YAMTGQLTLKSDVYSFGVVFLELITGR 296
+ + DV+S G+V ++ G
Sbjct: 180 KRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 69/214 (32%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 94 NFRPECLLGEGGFGRVY---KGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM----LSL 146
F +LG+G FG+V+ K Q+ A+K L + L+ V M L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVE 82
Query: 147 LHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAA 204
++H +V L Y + +L L+ +F+ G L L E +K A A
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLAELA 136
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTY 263
L++LH +IYRDLK NILLDE H KL+DFGL+K +K GT
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTV 190
Query: 264 GYCAPEYAMTGQLTLKS-DVYSFGVVFLELITGR 296
Y APE + + +S D +SFGV+ E++TG
Sbjct: 191 EYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 71/202 (35%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 156
LG G FGRV+ R G+ A+K L + + ++ E LMLS++ H ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKAN 215
G D Q ++ +++ G L L K N K AA LEYLH K
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHSKD- 126
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
+IYRDLK NILLD+ H K++DFG AK V D T+ T + GT Y APE ++ +
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCGTPDYIAPE-VVSTK 178
Query: 276 LTLKS-DVYSFGVVFLELITGR 296
KS D +SFG++ E++ G
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGY 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+GEG +G VYK + +S G++VA+K++ + G+ + E+ +L LHH N+V+LI
Sbjct: 29 VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGI--PSTAIREISLLKELHHPNIVSLI 85
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
LV+EFM L+ L + L + +G+ + H
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR-- 139
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+++RDLK N+L++ KL+DFGLA+ PV TH V+ T Y AP+
Sbjct: 140 -ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPD----- 189
Query: 275 QLTLKS-------DVYSFGVVFLELITGR 296
+ + S D++S G +F E+ITG+
Sbjct: 190 -VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
+GEG +G VYK + + G+ A+K++ + G+ + E+ +L L HSN+V L
Sbjct: 10 IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLY 66
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
+ +LV+E + L+ L L+ T G+ Y HD+
Sbjct: 67 DVIHTKKRLVLVFEHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR-- 120
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
V++RDLK N+L++ K++DFGLA+ PV TH ++ T Y AP+
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPD----- 170
Query: 275 QLTLKSDVYSFGV-------VFLELITGR 296
+ + S YS + +F E++ G
Sbjct: 171 -VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYC 159
LGEG + VYKG+ + T +VA+K++ +G + EV +L L H+N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219
LV+E++ L+ +L D ++ + +GL Y H + V+
Sbjct: 70 HTEKSLTLVFEYLDK-DLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK---VL 122
Query: 220 YRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 277
+RDLK N+L++E KL+DFGLA+ P + V+ T Y P+ +
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPD------IL 172
Query: 278 LKSDVYSFGV-------VFLELITGR 296
L S YS + +F E+ TGR
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 158
+G+G F +V R TG+ VA+K +D+ L + EV ++ +L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK------GLEYLHD 212
L+ E+ G + D+L + RMK +K ++Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVA----------HGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--- 269
K +++RDLK+ N+LLD + K++DFG + VG K G Y APE
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQ 186
Query: 270 ---YAMTGQLTLKSDVYSFGVVFLELITGR 296
Y G + DV+S GV+ L++G
Sbjct: 187 GKKYD--GP---EVDVWSLGVILYTLVSGS 211
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVE--VLMLSLLHHSNLVN 154
+LG+G FG+V+ + T Q A+K L ++ + + + +VE VL L+ H L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTH 82
Query: 155 LIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHD 212
+ + L V E++ G L H+ R AA GL++LH
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILGLQFLHS 136
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYA 271
K ++YRDLK NILLD+ H K++DFG+ K +GD T GT Y APE
Sbjct: 137 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEIL 190
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR 296
+ + D +SFGV+ E++ G+
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 58/260 (22%), Positives = 101/260 (38%), Gaps = 30/260 (11%)
Query: 52 SSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYK 111
S + S + A + +E ++ LLG GGFG VY
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS 61
Query: 112 GRLESTGQVVAVKQLDRNGLQGNREFLV------EVLMLSLLHHS--NLVNLIGYCADGD 163
G S VA+K ++++ + E EV++L + ++ L+ + D
Sbjct: 62 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121
Query: 164 QRLLVYEF-MPLGSLEDHLHDLPPDKEPLDWNTRMK----IAAGAAKGLEYLHDKANPPV 218
+L+ E P+ L D + + +E L R + A + + H+ V
Sbjct: 122 SFVLILERPEPVQDLFDFITERGALQEEL---ARSFFWQVLEA-----VRHCHNCG---V 170
Query: 219 IYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 277
++RD+K NIL+D KL DFG L T + GT Y PE+ +
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYSPPEWIRYHRYH 226
Query: 278 -LKSDVYSFGVVFLELITGR 296
+ V+S G++ +++ G
Sbjct: 227 GRSAAVWSLGILLYDMVCGD 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 67/219 (30%), Positives = 97/219 (44%), Gaps = 49/219 (22%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLLHHSNLVNL 155
LGEG F VYK R ++T Q+VA+K++ ++ L E+ +L L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK--------GL 207
+ LV++FM DL + + + + + K GL
Sbjct: 78 LDAFGHKSNISLVFDFME--------TDL---EVIIK-DNSLVLTPSHIKAYMLMTLQGL 125
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYG 264
EYLH +++RDLK +N+LLDE KL+DFGLAK P TH V TR
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----W 177
Query: 265 YCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 296
Y APE L + +Y GV + EL+
Sbjct: 178 YRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 60/285 (21%), Positives = 101/285 (35%), Gaps = 31/285 (10%)
Query: 22 GGAVGAVKELNRKDSAKDGSIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQ 81
G + ++ D I N + K+ +P K + +
Sbjct: 15 DGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHRE 74
Query: 82 TFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FL 138
F ++ +G G FG V +L++ +V A+K L++ + E F
Sbjct: 75 DFEILKV------------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR 122
Query: 139 VEVLMLSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 196
E +L + L + A D + LV ++ G L L D+ P + R
Sbjct: 123 EERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM-AR 178
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 256
A ++ +H ++RD+K NIL+D H +L+DFG S
Sbjct: 179 F-YLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 257 TRVMGTYGYCAPEYAMTGQLTLKS-----DVYSFGVVFLELITGR 296
V GT Y +PE + D +S GV E++ G
Sbjct: 235 VAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 94 NFRPECLLGEGGFGRVY---KGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM-----LS 145
F +LG+GG+G+V+ K +TG++ A+K L + + N + L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK-DTAHTKAERNILE 76
Query: 146 LLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGA 203
+ H +V+LI Y +L L+ E++ G L L E A
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-----TACFYLAEI 130
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GT 262
+ L +LH K +IYRDLK NI+L+ H KL+DFGL K T GT
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGT 184
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
Y APE M D +S G + +++TG
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 51/196 (26%), Positives = 80/196 (40%), Gaps = 24/196 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+G G + + ++T AVK +D++ E +E+ +L H N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDVYD 86
Query: 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA----AKGLEYLHDKANP 216
DG +V E M G L D + E + A+ K +EYLH +
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKFFSE--------REASAVLFTITKTVEYLHAQG-- 136
Query: 217 PVIYRDLKSSNILL---DEGFHP-KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
V++RDLK SNIL ++ DFG AK + + T T + APE
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTANFVAPEVLE 193
Query: 273 TGQLTLKSDVYSFGVV 288
D++S GV+
Sbjct: 194 RQGYDAACDIWSLGVL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 55/258 (21%), Positives = 103/258 (39%), Gaps = 30/258 (11%)
Query: 40 GSIAQSHHVNRVSSDKSKSR-NGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPE 98
GS HH ++V + N D E K + + + + +
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYD------YYDIL 56
Query: 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 158
LG G FG V++ ++TG+V K ++ E+ +++ LHH L+NL
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIAAGAAK----GLEYLHD 212
D + +L+ EF+ G L D + + +M + GL+++H+
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI---------AAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 213 KANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
+ +++ D+K NI+ + K+ DFGLA + V T + APE
Sbjct: 168 HS---IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEI 221
Query: 271 AMTGQLTLKSDVYSFGVV 288
+ +D+++ GV+
Sbjct: 222 VDREPVGFYTDMWAIGVL 239
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 28/218 (12%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--------EVLML 144
+ + LG G FG V+ + + V VK + + + + E+ +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 145 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS-LEDHLHDLPPDKEPLDWNTRMK---IA 200
S + H+N++ ++ + LV E G L + P EPL +
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL---ASYIFRQLV 140
Query: 201 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 260
+ + YL K +I+RD+K NI++ E F KL DFG A G +
Sbjct: 141 SA----VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 261 GTYGYCAPEYAMTGQLTL--KSDVYSFGVVFLELITGR 296
GT YCAPE + G + +++S GV L+
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 45/200 (22%), Positives = 80/200 (40%), Gaps = 26/200 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EV-LMLSLLHHSNLVNLIG 157
LG G F V + +STGQ A K L + + + E+ ++ ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDK--EPLDWNTRMKIAAGAAK----GLEYLH 211
+ + +L+ E+ G + + E K G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYLH 148
Query: 212 DKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
+++ DLK NILL K+ DFG+++ +G + + GT Y AP
Sbjct: 149 QNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAP 202
Query: 269 EYAMTGQLTLKSDVYSFGVV 288
E +T +D+++ G++
Sbjct: 203 EILNYDPITTATDMWNIGII 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 50/220 (22%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 156
LGEG +G VYK T + VA+K++ + G+ + EV +L L H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQHRNIIELK 99
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA------KGLEYL 210
+ L++E+ +DL K+ +D N + + + G+ +
Sbjct: 100 SVIHHNHRLHLIFEYAE--------NDL---KKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHP-----KLSDFGLAKL--GPVGDKTHVSTRVMGTY 263
H + ++RDLK N+LL K+ DFGLA+ P+ TH ++ T
Sbjct: 149 HSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TL 201
Query: 264 GYCAPEYAMTGQLTLKSDVYSFGV-------VFLELITGR 296
Y PE + L S YS V ++ E++
Sbjct: 202 WYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 23/206 (11%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHH 149
+ N+ + LG+G F V + ++TG A K ++ L + E + L H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK---- 205
N+V L + LV++ + G L + + E A+ +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQQILE 116
Query: 206 GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 262
+ Y H +++R+LK N+LL +G KL+DFGLA V D GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GT 170
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVV 288
GY +PE + D+++ GV+
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 21/209 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLI 156
++G G F V +++ TGQV A+K +++ + E F E +L + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL- 126
Query: 157 GYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
+ A D + LV E+ G L L ++ P + R A ++ +H
Sbjct: 127 -HFAFQDENYLYLVMEYYVGGDLLTLLSK-FGERIPAEM-ARF-YLAEIVMAIDSVHRLG 182
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
++RD+K NILLD H +L+DFG V GT Y +PE
Sbjct: 183 ---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAV 238
Query: 275 QLTLKSDVY-------SFGVVFLELITGR 296
+ Y + GV E+ G+
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 69/267 (25%), Positives = 109/267 (40%), Gaps = 26/267 (9%)
Query: 43 AQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPEC--- 99
+ V S+ ++ + + + A T + + +
Sbjct: 286 YFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNF 345
Query: 100 --LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVE--VLMLSLLHHSNL 152
+LG+G FG+V + T ++ AVK L ++ + + + +VE VL L L
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF-L 404
Query: 153 VNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYL 210
L C RL V E++ G L H+ + KEP AA A GL +L
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFFL 458
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPE 269
K +IYRDLK N++LD H K++DFG+ K T T+ GT Y APE
Sbjct: 459 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE 512
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGR 296
D ++FGV+ E++ G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQL----DRNGLQGN-----REFLVEVL-MLSLLHHS 150
+G G +G VYK R +G VA+K + G G RE V +L L H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE--VALLRRLEAFEHP 74
Query: 151 NLVNLI----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK 205
N+V L+ D + ++ LV+E + DL + LD + A K
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL---RTYLDKAPPPGLPAETIK 123
Query: 206 --------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVST 257
GL++LH +++RDLK NIL+ G KL+DFGLA+ + ++
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTP 178
Query: 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
V+ T Y APE + D++S G +F E+ +
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 67/269 (24%), Positives = 102/269 (37%), Gaps = 24/269 (8%)
Query: 42 IAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTA--HIAAQTFTFRELAAATKNFRPEC 99
+A HH + S G+ + T + T +NF
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60
Query: 100 LLGEGGFGRVY---KGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM-----LSLLHHSN 151
+LG G +G+V+ K TG++ A+K L + + + +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 152 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEY 209
LV L Y + +L L+ +++ G L HL E ++I LE+
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIYVGEIVLALEH 174
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
LH +IYRD+K NILLD H L+DFGL+K + GT Y AP+
Sbjct: 175 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPD 230
Query: 270 YAMTGQLTLKSDV--YSFGVVFLELITGR 296
G V +S GV+ EL+TG
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 60/202 (29%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLHHSNLVN 154
LG G F V K R + TG+ A K + + L +R E EV +L + H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYL 210
L + +L+ E + G L D L +KE L T + A K G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFL----AEKESL---TEDE-ATQFLKQILDGVHYL 124
Query: 211 HDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
H K + + DLK NI+L KL DFG+A + GT +
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPEFV 178
Query: 267 APEYAMTGQLTLKSDVYSFGVV 288
APE L L++D++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVI 200
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVE--VLMLSLLHHSNLVN 154
+LG+G FG+V + T ++ AVK L ++ + + + +VE VL L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQ 85
Query: 155 LIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHD 212
L C RL V E++ G L H+ + KEP AA A GL +L
Sbjct: 86 LH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFFLQS 139
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYA 271
K +IYRDLK N++LD H K++DFG+ K T T+ GT Y APE
Sbjct: 140 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-I 192
Query: 272 MTGQLTLKS-DVYSFGVVFLELITGR 296
+ Q KS D ++FGV+ E++ G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 40/217 (18%)
Query: 101 LGEGGFGRVYKGR-LESTGQVVAVKQL----DRNGL--QGNREFLVEVL-MLSLLHHSNL 152
+GEG +G+V+K R L++ G+ VA+K++ G+ RE V VL L H N+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAVLRHLETFEHPNV 76
Query: 153 VNLI----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK-- 205
V L D + +L LV+E + DL LD + K
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVD--------QDL---TTYLDKVPEPGVPTETIKDM 125
Query: 206 ------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRV 259
GL++LH V++RDLK NIL+ KL+DFGLA+ + +++ V
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVV 180
Query: 260 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
+ T Y APE + D++S G +F E+ +
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVE--VLMLSLLHHSNLVN 154
+LG+G FG+V R++ TG + AVK L ++ + + + + E +L L+ +H L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 88
Query: 155 LIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHD 212
L C RL V EF+ G L H+ E R + AA L +LHD
Sbjct: 89 LF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEIISALMFLHD 142
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYA 271
K +IYRDLK N+LLD H KL+DFG+ K G T T GT Y APE
Sbjct: 143 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE-I 195
Query: 272 MTGQLTLKS-DVYSFGVVFLELITGR 296
+ L + D ++ GV+ E++ G
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 61/252 (24%), Positives = 99/252 (39%), Gaps = 23/252 (9%)
Query: 44 QSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGE 103
HH + V S + + + A + F E LG
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGR 63
Query: 104 GGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD 163
G VY+ + + T + A+K L + + E+ +L L H N++ L
Sbjct: 64 GATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121
Query: 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKANPPVI 219
+ LV E + G L D + + E + AA A K + YLH+ ++
Sbjct: 122 EISLVLELVTGGELFDRIVEKGYYSE--------RDAADAVKQILEAVAYLHENG---IV 170
Query: 220 YRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 276
+RDLK N+L K++DFGL+K+ V + + T GT GYCAPE
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRGCAY 227
Query: 277 TLKSDVYSFGVV 288
+ D++S G++
Sbjct: 228 GPEVDMWSVGII 239
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 53/223 (23%), Positives = 85/223 (38%), Gaps = 46/223 (20%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR--------NGLQGNREFL---VE 140
+N+ P+ +LG G V + + T + AVK +D +Q RE V+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 141 VLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--- 197
+L + H N++ L LV++ M G L D+ T
Sbjct: 76 ILR-KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTL 121
Query: 198 --KIAAGAAK----GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251
K + + LH +++RDLK NILLD+ + KL+DFG + +
Sbjct: 122 SEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDP 176
Query: 252 KTHVSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVV 288
+ GT Y APE + D++S GV+
Sbjct: 177 GEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 101 LGEGGFGRVYKGR--LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG- 157
+G G +G VYK + + A+KQ++ G+ + E+ +L L H N+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 158 YCADGDQRL-LVYEFMP--LGSLEDHLHDLPPDKEPLDWNTRM--KIAAGAAKGLEYLHD 212
+ + D+++ L++++ L + +K+P+ M + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 213 KANPPVIYRDLKSSNILLDEGFHP----KLSDFGLAKL--GPVGDKTHVSTRVMGTYGYC 266
V++RDLK +NIL+ K++D G A+L P+ + V+ T+ Y
Sbjct: 147 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 202
Query: 267 APEYAMTGQLTLKS-------DVYSFGVVFLELITGR 296
APE L L + D+++ G +F EL+T
Sbjct: 203 APE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLI 156
++G G FG V R +ST +V A+K L + + + F E +++ + +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134
Query: 157 GYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDK 213
+ A D +V E+MP G L + + + + A L+ +H
Sbjct: 135 -FYAFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVP-EKWARFYTAEVVLALDAIHSM 187
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---- 269
I+RD+K N+LLD+ H KL+DFG T V GT Y +PE
Sbjct: 188 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKS 243
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGR 296
G + D +S GV E++ G
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 62/202 (30%), Positives = 88/202 (43%), Gaps = 28/202 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLHHSNLVN 154
LG G F V K R +STG A K + + + +R E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYL 210
L + +L+ E + G L D L KE L + A K G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSFIKQILDGVNYL 131
Query: 211 HDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
H K + + DLK NI+L H KL DFGLA G + + GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFV 185
Query: 267 APEYAMTGQLTLKSDVYSFGVV 288
APE L L++D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVI 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 61/260 (23%), Positives = 97/260 (37%), Gaps = 64/260 (24%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--------EVLMLSLLHHSNL 152
LG G G V T + VA+K + + E+ +L L+H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLED------HLHDLPPDKEPLDWNTRMKIAAGAAK- 205
+ + + D + +V E M G L D L KE
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL------KE--------ATCKLYFYQ 122
Query: 206 ---GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRV 259
++YLH+ +I+RDLK N+LL +E K++DFG +K+ +G+ + + T
Sbjct: 123 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC 177
Query: 260 MGTYGYCAPE---YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316
GT Y APE T D +S GV+ ++G PP
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-------YPP----------- 218
Query: 317 LFKDRRKFPKMADPLLQGRY 336
F + R + D + G+Y
Sbjct: 219 -FSEHRTQVSLKDQITSGKY 237
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 49/196 (25%), Positives = 79/196 (40%), Gaps = 24/196 (12%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNLVNLIGYC 159
LGEG F K + + Q AVK + + ++ E+ + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKAN 215
D LV E + G L + + E A+ + + ++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSE--------TEASYIMRKLVSAVSHMHDVG- 126
Query: 216 PPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
V++RDLK N+L ++ K+ DFG A+L P ++ + T T Y APE
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPELLN 182
Query: 273 TGQLTLKSDVYSFGVV 288
D++S GV+
Sbjct: 183 QNGYDESCDLWSLGVI 198
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 48/235 (20%), Positives = 85/235 (36%), Gaps = 33/235 (14%)
Query: 70 IPKEPTAHIAAQTFTFRELAAATKNFR-----PECLLGEGGFGRVYKGRLESTGQVVAVK 124
+ H + F+ + +LG G G+V + TGQ A+K
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 125 QLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDH 180
L + +E V+ ++V ++ + L++ E M G L
Sbjct: 61 LLYDSPKAR-QE--VD-HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116
Query: 181 LHDLPPDKEPLDWNTRMKIAAGA----AKGLEYLHDKANPPVIYRDLKSSNILL---DEG 233
+ ++ + R AA +++LH + +RD+K N+L ++
Sbjct: 117 IQ----ERGDQAFTERE--AAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKD 167
Query: 234 FHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 288
KL+DFG AK + T T Y APE + D++S GV+
Sbjct: 168 AVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 23/260 (8%)
Query: 46 HHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGG 105
HH + D + N + +E + + + ++F ++G G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 106 FGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVE--VLMLSLLHHSNLVNLIGYCA 160
+ +V RL+ T ++ A++ + + + + + E V + +H LV L C
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLH-SCF 122
Query: 161 DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHDKANPPV 218
+ RL V E++ G L H+ E + +A + L YLH++ +
Sbjct: 123 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLHERG---I 174
Query: 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTGQLT 277
IYRDLK N+LLD H KL+D+G+ K G T T GT Y APE + G+
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-ILRGEDY 230
Query: 278 LKS-DVYSFGVVFLELITGR 296
S D ++ GV+ E++ GR
Sbjct: 231 GFSVDWWALGVLMFEMMAGR 250
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 62/202 (30%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLHHSNLVN 154
LG G F V K R +STG A K + + + +R E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYL 210
L + +L+ E + G L D L KE L + A K G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSFIKQILDGVNYL 131
Query: 211 HDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
H K + + DLK NI+L H KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 267 APEYAMTGQLTLKSDVYSFGVV 288
APE L L++D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVI 207
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---LVE--VLMLSLLHHSNLVN 154
++G G + +V RL+ T ++ A+K + + + + + E V + +H LV
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVG 74
Query: 155 LIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKI-AAGAAKGLEYLHD 212
L C + RL V E++ G L H+ E + +A + L YLH+
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLHE 128
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYA 271
+ +IYRDLK N+LLD H KL+D+G+ K G T T GT Y APE
Sbjct: 129 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-I 181
Query: 272 MTGQLTLKS-DVYSFGVVFLELITGR 296
+ G+ S D ++ GV+ E++ GR
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 40/214 (18%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-----EVLMLSLLHHSNLVN 154
LG G FG+V G + TG VAVK L+R ++ +V E+ L L H +++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIK 75
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK------GLE 208
L + +V E++ G L D++ + R++ ++
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICK----------HGRVEEMEARRLFQQILSAVD 125
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
Y H V++RDLK N+LLD + K++DFGL+ + G+ S G+ Y AP
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAP 179
Query: 269 E------YAMTGQLTLKSDVYSFGVVFLELITGR 296
E YA G + D++S GV+ L+ G
Sbjct: 180 EVISGRLYA--G---PEVDIWSCGVILYALLCGT 208
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 29/204 (14%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-----EVLMLSLLHHSNLVNL 155
+G+G F V + TGQ AVK +D + E + +L H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHL----HDLPPDKEPLDWNTRMKIAAGAAK----GL 207
+ + +V+EFM L + E +A+ + L
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--------AVASHYMRQILEAL 143
Query: 208 EYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
Y HD +I+RD+K +LL + KL FG+A +G+ V+ +GT
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPH 198
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVV 288
+ APE DV+ GV+
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 43/229 (18%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-------------------- 139
+G+G +G V E+ A+K L + L F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 140 ------EVLMLSLLHHSNLVNL--IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPL 191
E+ +L L H N+V L + + D +V+E + G + + P +PL
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPL 134
Query: 192 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251
+ KG+EYLH + +I+RD+K SN+L+ E H K++DFG++ D
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 252 KTHVSTRVMGTYGYCAPEYAMTGQLTL----KSDVYSFGVVFLELITGR 296
+S V GT + APE +++ + DV++ GV + G+
Sbjct: 192 A-LLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 23/206 (11%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHH 149
+ N+ + LG+G F V + ++TG A K ++ L + E + L H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK---- 205
N+V L + LV++ + G L + + E A+ +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQQILE 139
Query: 206 GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 262
+ Y H +++R+LK N+LL +G KL+DFGLA V D GT
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GT 193
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVV 288
GY +PE + D+++ GV+
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 28/202 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLHHSNLVN 154
LG G F V K R +STG A K + + + +R + EV +L + H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYL 210
L + +L+ E + G L D L + E + A K G+ YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 211 HDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
H + + DLK NI+L K+ DFGLA + GT +
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF-GTPEFV 184
Query: 267 APEYAMTGQLTLKSDVYSFGVV 288
APE L L++D++S GV+
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 35/196 (17%), Positives = 79/196 (40%), Gaps = 26/196 (13%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 159
LG G FG V++ S+ + K + G ++ + E+ +L++ H N+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESF 70
Query: 160 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRM--KIAAGAAK----GLEYLHDK 213
++ ++++EF+ + + + + + L++LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERI---------NTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 214 ANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ + D++ NI+ K+ +FG A+ GD + + Y APE
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 272 MTGQLTLKSDVYSFGV 287
++ +D++S G
Sbjct: 176 QHDVVSTATDMWSLGT 191
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 17/164 (10%)
Query: 145 SLLHHSNLVNLIGYCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 201
+ + N +G ++ +Y + +L+D ++ ++ + + I
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-EHGVCLHIFI 171
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK----------LGPVGD 251
A+ +E+LH K +++RDLK SNI K+ DFGL +
Sbjct: 172 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
T +GT Y +PE + K D++S G++ EL+
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 54/226 (23%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-F----LVEVLMLSLLHHSNLVNL 155
+G+G FG V+K R TGQ VA+K++ ++ +E F L E+ +L LL H N+VNL
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 156 IGYCADGDQRL--------LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK-- 205
I C LV++F HDL L N +K K
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-NVLVKFTLSEIKRV 129
Query: 206 ------GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVST 257
GL Y+H +++RD+K++N+L+ KL+DFGLA+ + + T
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 258 RVMGTYGYCAPEYAMTGQLTLKS-------DVYSFGVVFLELITGR 296
+ T Y PE L L D++ G + E+ T
Sbjct: 187 NRVVTLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 33/248 (13%)
Query: 64 PKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAV 123
+ PA P PT + E +R LLG+GGFG V+ G + VA+
Sbjct: 7 LQGPPAPPGTPTPPPGGKDREAFE-----AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAI 61
Query: 124 KQLDRNGL-------QGNREFLVEVLMLSLLH----HSNLVNLIGYCADGDQRLLVYEF- 171
K + RN + L EV +L + H ++ L+ + + +LV E
Sbjct: 62 KVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERP 120
Query: 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD 231
+P L D++ + P E +R +++ H + V++RD+K NIL+D
Sbjct: 121 LPAQDLFDYITEKGPLGEGP---SR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILID 173
Query: 232 -EGFHPKLSDFGLAKLGPVGD-KTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVV 288
KL DFG L GT Y PE+ Q L + V+S G++
Sbjct: 174 LRRGCAKLIDFGSGALLHDEPYTDFD-----GTRVYSPPEWISRHQYHALPATVWSLGIL 228
Query: 289 FLELITGR 296
+++ G
Sbjct: 229 LYDMVCGD 236
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 47/197 (23%), Positives = 78/197 (39%), Gaps = 22/197 (11%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 158
LG+G F V + GQ A ++ L + E + LL H N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK----GLEYLHDKA 214
++ L+++ + G L + + E A+ + + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSE--------ADASHCIQQILEAVLHCHQMG 130
Query: 215 NPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
V++R+LK N+LL +G KL+DFGLA V + GT GY +PE
Sbjct: 131 ---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYLSPEVL 185
Query: 272 MTGQLTLKSDVYSFGVV 288
D+++ GV+
Sbjct: 186 RKDPYGKPVDLWACGVI 202
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 53/213 (24%), Positives = 81/213 (38%), Gaps = 40/213 (18%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIG 157
+G G FG R + T ++VAVK ++R V E++ L H N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKE 83
Query: 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK------GLEYLH 211
++ E+ G L + + + R G+ Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICN----------AGRFSEDEARFFFQQLLSGVSYCH 133
Query: 212 DKANPPVIYRDLKSSNILLDEGFHP--KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
+ +RDLK N LLD P K+ DFG +K + + + V GT Y APE
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPE 187
Query: 270 ------YAMTGQLTLKSDVYSFGVVFLELITGR 296
Y G+ +DV+S GV ++ G
Sbjct: 188 VLLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLI 156
LGEG FG+V T Q VA+K + R L+ + + E+ L LL H +++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK------GLEYL 210
++V E+ G L D++ + RM G +EY
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYIVE----------KKRMTEDEGRRFFQQIICAIEYC 124
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE- 269
H +++RDLK N+LLD+ + K++DFGL+ + G+ S G+ Y APE
Sbjct: 125 HRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 178
Query: 270 -----YAMTGQLTLKSDVYSFGVVFLELITGR 296
YA G + DV+S G+V ++ GR
Sbjct: 179 INGKLYA--G---PEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLI 156
LG G FG+V G+ E TG VAVK L+R ++ E+ L L H +++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK------GLEYL 210
+ +V E++ G L D++ N R+ G++Y
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICK----------NGRLDEKESRRLFQQILSGVDYC 132
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE- 269
H V++RDLK N+LLD + K++DFGL+ + G+ S G+ Y APE
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEV 186
Query: 270 -----YAMTGQLTLKSDVYSFGVVFLELITGR 296
YA G + D++S GV+ L+ G
Sbjct: 187 ISGRLYA--G---PEVDIWSSGVILYALLCGT 213
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 54/247 (21%), Positives = 97/247 (39%), Gaps = 55/247 (22%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 151
+K + LG G FG V + +G+ A+K++ ++ NRE + ++ +L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 152 LVNLIGY-------------------------------------CADGDQRL-LVYEFMP 173
++ L+ Y ++ L ++ E++P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG 233
+L L + N + + ++H + +RD+K N+L++
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHRDIKPQNLLVNSK 177
Query: 234 FHP-KLSDFGLAK-LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVF 289
+ KL DFG AK L P + +R + Y APE + T D++S G VF
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 290 LELITGR 296
ELI G+
Sbjct: 233 GELILGK 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 58/266 (21%), Positives = 90/266 (33%), Gaps = 36/266 (13%)
Query: 41 SIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFR---- 96
S QS V + PA P P Q L
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK 64
Query: 97 -PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 155
+LG G G+V + + T + A+K L RE VE L ++V +
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-RE--VE-LHWRASQCPHIVRI 120
Query: 156 IGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDK--EPLDWNTRMKIAAGA----AK 205
+ + L+V E + G L + D E + A+ +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE--------REASEIMKSIGE 172
Query: 206 GLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 262
++YLH + +RD+K N+L KL+DFG AK + ++T T
Sbjct: 173 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YT 226
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVV 288
Y APE + D++S GV+
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 5e-20
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 148
K ++ +G G G V + VA+K+L R N R E++++ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 119
Query: 149 HSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 202
H N+++L+ + LV E M + +L + + LD +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI--QMELDHERMSYLLYQ 172
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVM 260
G+++LH A +I+RDLK SNI++ K+ DFGLA+ +V TR
Sbjct: 173 MLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 228
Query: 261 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
Y APE + D++S G + E++ +
Sbjct: 229 ----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 29/217 (13%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 148
K ++ +G G G V + VA+K+L R N R + E++++ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 149 HSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK-IAA 201
H N++ L+ + +V E M + +L + + LD + RM +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVI--QMELD-HERMSYLLY 134
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDKT-HVSTRV 259
G+++LH A +I+RDLK SNI++ K+ DFGLA G T +V TR
Sbjct: 135 QMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 260 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
Y APE + D++S G + E+I G
Sbjct: 192 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 62/266 (23%), Positives = 97/266 (36%), Gaps = 77/266 (28%)
Query: 101 LGEGGFGRVYKGRL-----ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLV 153
LG G FG+V + +T + VAVK L + +R + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 154 NLIG--------------YCADGDQRLLVY------------------------------ 169
NL+G +C G+ L Y
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 170 ---------------------EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
E L +E+ K+ L + + AKG+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
+L + I+RDL + NILL E K+ DFGLA+ + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 269 EYAMTGQLTLKSDVYSFGVVFLELIT 294
E T++SDV+SFGV+ E+ +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 148
K + +G G +G V + +G+ VA+K+L R + + R E+L+L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQ 81
Query: 149 HSNLVNLI-----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 202
H N++ L+ LV FM + L + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIM--GLKFSEEKIQYLVYQ 134
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTH-VSTRVMG 261
KGL+Y+H A V++RDLK N+ ++E K+ DFGLA+ + T V TR
Sbjct: 135 MLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTR--- 187
Query: 262 TYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 296
+ Y APE ++ D++S G + E++TG+
Sbjct: 188 -W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 61/324 (18%), Positives = 111/324 (34%), Gaps = 69/324 (21%)
Query: 36 SAKDGSIAQSHHVNRVSSDKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNF 95
S+ + + AQ H+ + + G K+ + + + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQ------IPDRY 55
Query: 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREF---------LVEVLMLSL 146
L+G G +G V + + +VVA+K++ R F L E+ +L+
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNR 108
Query: 147 LHHSNLVNL----IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 201
L+H ++V + I + L +V E + L L +
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLY 163
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 261
G++Y+H A +++RDLK +N L+++ K+ DFGLA+ + + +
Sbjct: 164 NLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 262 TYG-------------------------YCAPEYAMTGQL-TLKSDVYSFGVVFLELITG 295
Y APE + + T DV+S G +F EL+
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 296 RKAIDNTRPPGEHNLVAWARPLFK 319
K PLF
Sbjct: 281 IKENVAYHADR--------GPLFP 296
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 148
+R +G G +G V TG VA+K+L R + L R E+ +L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMR 82
Query: 149 HSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 202
H N++ L+ + D LV FM L L E L + +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLM-KHEKLGEDRIQFLVYQ 136
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 262
KGL Y+H A +I+RDLK N+ ++E K+ DFGLA+ +V TR
Sbjct: 137 MLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190
Query: 263 YGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 296
Y APE + T D++S G + E+ITG+
Sbjct: 191 --YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 36/226 (15%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR--NGLQGNREF---------LVE 140
+ + + G +G V G ++S G VA+K++ + + L E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 141 VLMLSLLHHSNLVNL----IGYCADGDQRL-LVYEFMPLGSLEDHLHD-LPPDKEPLDWN 194
+ +L+ HH N++ L + + +L LV E M L + + +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVIS-P 133
Query: 195 TRMK-IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA-KLGPVGDK 252
++ GL LH+ A V++RDL NILL + + DF LA + +K
Sbjct: 134 QHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 253 T-HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGR 296
T +V+ R Y APE M T D++S G V E+ +
Sbjct: 191 THYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLD--RNGLQGNREFLVEVLMLSLLHH 149
+ +GEG +G V VA+K++ + R L E+ +L H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRH 84
Query: 150 SNLVNLIG----YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK-IAAGA 203
N++ + + + + +V + M E L+ L + L N +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLL-KTQHLS-NDHICYFLYQI 137
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGT 262
+GL+Y+H AN V++RDLK SN+LL+ K+ DFGLA+ P D T T + T
Sbjct: 138 LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 263 YGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 296
Y APE + + T D++S G + E+++ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 27/216 (12%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 148
+ ++ +G G +G V TG VAVK+L R + + R E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMK 86
Query: 149 HSNLVNLI-----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAG 202
H N++ L+ + + LV M L+++ + L + +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIV-KCQKLTDDHVQFLIYQ 140
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT-HVSTRVMG 261
+GL+Y+H A+ +I+RDLK SN+ ++E K+ DFGLA+ + T +V+TR
Sbjct: 141 ILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVATRW-- 194
Query: 262 TYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 296
Y APE + D++S G + EL+TGR
Sbjct: 195 ---YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 31/241 (12%), Positives = 64/241 (26%), Gaps = 49/241 (20%)
Query: 59 RNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTG 118
++ A P + A+ R +R G + ++ +
Sbjct: 5 ALREPDRESSAPPDDVQLVPGARIANGR--------YRLLIFHGGVPPLQFWQALDTALD 56
Query: 119 QVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 175
+ VA+ +D G+ + +E L L LS + + ++ L+V E++ G
Sbjct: 57 RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG 116
Query: 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235
SL++ P ++ A + H V S + +
Sbjct: 117 SLQEVADTSPSPVG------AIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGD 167
Query: 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG 295
L+ + D+ G L+
Sbjct: 168 VVLAYPA----------------------TMPDA-------NPQDDIRGIGASLYALLVN 198
Query: 296 R 296
R
Sbjct: 199 R 199
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLVNLIGYC 159
LG G + V++ + + V VK L ++ E+ +L +L N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 160 ADGDQR--LLVYEFMPLGSLEDHLHDLPPD------KEPLDWNTRMKIAAGAAKGLEYLH 211
D R LV+E + + L E L K L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 212 DKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLG-PVGDKTH-VSTRVMGTYGYCAP 268
+++RD+K N+++D E +L D+GLA+ P + V++R + P
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 269 EYAMTGQLTLKS-DVYSFGVVFLELITGRKAI 299
E + Q+ S D++S G + +I ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLD--RNGLQGNREFLVEVLMLSLLHH 149
+ +F+ + LLGEG +G V + TG++VA+K+++ L R L E+ +L H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 150 SNLVNLIG-YCADGDQRL----LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK-----I 199
N++ + D + ++ E M + LH + + L + ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVI-STQMLS-DDHIQYFIYQT 121
Query: 200 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA----KLGPVGDKTHV 255
+ ++ LH +N VI+RDLK SN+L++ K+ DFGLA + +
Sbjct: 122 L----RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 256 STRVMGTY----GYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 296
M + Y APE +T + DV+S G + EL R
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 61/286 (21%), Positives = 106/286 (37%), Gaps = 56/286 (19%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 148
N+ + L+G G +G VY ++T + VA+K+++R + + R L E+ +L+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLK 83
Query: 149 HSNLVNL----IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMK----- 198
++ L I L +V E + L L L +K
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYN 137
Query: 199 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 258
+ G ++H+ + +I+RDLK +N LL++ K+ DFGLA+ T++
Sbjct: 138 LL----LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 259 VMGTYGYCAPEYAMTGQLT--------------LKS-------DVYSFGVVFLELITGRK 297
+ + QLT L D++S G +F EL+ +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 298 AIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQ 343
+ N PLF FP D + + Q
Sbjct: 251 SHINDPTNR--------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQ 288
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 28/223 (12%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLD-RNGLQGNREFLVEVLMLSLLHHS 150
+ LG GG G V+ + VA+K++ + L E+ ++ L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDHD 68
Query: 151 NLVNLIG-YCADGDQRL-------------LVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 196
N+V + G Q +V E+M E L ++ ++ PL
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVL-EQGPLLEEHA 122
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAK-LGPVGDKTH 254
+GL+Y+H AN V++RDLK +N+ ++ E K+ DFGLA+ + P
Sbjct: 123 RLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 255 VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGR 296
+ + T Y +P ++ T D+++ G +F E++TG+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 36/159 (22%), Positives = 59/159 (37%), Gaps = 30/159 (18%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNLVNLIGYC 159
LG G G+V + + T + A+K L EV L ++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 80
Query: 160 ADGDQR----LLVYEFMPLGSLEDHLHDLPPDK--EPLDWNTRMKIAAGA----AKGLEY 209
+ L+V E + G L + D E + A+ + ++Y
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE--------REASEIMKSIGEAIQY 132
Query: 210 LHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAK 245
LH + +RD+K N+L KL+DFG AK
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 45/158 (28%), Positives = 62/158 (39%), Gaps = 15/158 (9%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
NFR +G G FG + G+ T + VA+K L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIP 68
Query: 154 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
+ + G +V E LG SLED L DL L T + IA +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 213 KANPPVIYRDLKSSNILLDEGFHPK-----LSDFGLAK 245
K +IYRD+K N L+ + + DF LAK
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
+R +G G FG +Y G + G+ VA+K + + +E + ++ +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGI 67
Query: 154 -NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+ A+GD ++V E LG SLED L + K L T + +A +EY+H
Sbjct: 68 PTIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPK---LSDFGLAKL-GPVGDKTHVSTR----VMGTY 263
K I+RD+K N L+ G + DFGLAK H+ R + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 264 GYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 296
Y A G + + + D+ S G V + G
Sbjct: 180 RY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 24/216 (11%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
+++ +GEG FG +++G Q VA+K R + E LL +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGI 68
Query: 154 -NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
N+ + +G +LV + LG SLED L DL K + T A ++ +H
Sbjct: 69 PNVYYFGQEGLHNVLVIDL--LGPSLED-LLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPK-----LSDFGLAKL-GPVGDKTHVSTR----VMG 261
+K+ ++YRD+K N L+ + DFG+ K K H+ R + G
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 262 TYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 296
T Y G + + + D+ + G VF+ + G
Sbjct: 181 TARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 62/244 (25%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 148
+ + LG+G +G V+K TG+VVAVK++ N R E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELS 66
Query: 149 -HSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA- 204
H N+VNL+ AD D+ + LV+++M E LH + I A
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAV--------------IRANILE 107
Query: 205 ------------KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252
K ++YLH +++RD+K SNILL+ H K++DFGL++ +
Sbjct: 108 PVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 253 THVSTRVMGTYG-------------------YCAPEYAMTGQL-TLKSDVYSFGVVFLEL 292
+ + Y APE + T D++S G + E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 293 ITGR 296
+ G+
Sbjct: 225 LCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 34/219 (15%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH----------- 148
LG G F V+ + VA+K + R E+ +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 149 HSNLVNLIGY----CADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGA 203
++++ L+ + +G ++V+E LG +L + PL + +I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKYEHRGIPLI-YVK-QISKQL 140
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP------KLSDFGLAKLGPVGDKTHVST 257
GL+Y+H + +I+ D+K N+L++ P K++D G A + T
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 258 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
R Y +PE + +D++S + ELITG
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
FR +G G FG +Y G T + VA+K + + + L E + +L +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGI 65
Query: 154 -NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
N+ + +GD +LV + LG SLED L + K L T + +A +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDL--LGPSLED-LFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPK---LSDFGLAKL-GPVGDKTHVSTR----VMGTY 263
K+ ++RD+K N L+ G + DFGLAK H+ R + GT
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 264 GYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGR 296
Y A G + + + D+ S G V + + G
Sbjct: 178 RY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 6e-13
Identities = 42/264 (15%), Positives = 69/264 (26%), Gaps = 69/264 (26%)
Query: 81 QTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL--------DRNGLQ 132
F T+ + +GEG FG V++ VA+K + + + +
Sbjct: 9 GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 133 GNREFLVEVLMLSLLH---------HSNLVNLIG-YCADG-------------------- 162
E L E+++ L + L +C G
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 163 ---------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
DQ +V EF G + + + T I L
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEAS 180
Query: 214 ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV------STRVMGTYGYC- 266
+RDL N+LL + KL K + + + G
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 267 -----APEYAMTGQLTLKSDVYSF 285
E TG + D+Y
Sbjct: 239 FCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 34/175 (19%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQV--------VAVKQLDRNG-LQGNREFLV---- 139
+ ++ + G +Y+ ST ++K ++G L + F
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 140 --EVLMLSLLHHSNLV---NLIGY-CADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLD 192
+V L+ + L+ +G+ R LV LG SL+ L P K L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSP--KHVLS 157
Query: 193 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK--LSDFGLAK 245
+ +++A LE+LH+ ++ ++ + NI +D + L+ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 46/218 (21%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL------HHSNLV 153
++G+G FG+V K Q VA+K + RN + +R+ E+ +L L + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 154 NLIGY-------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKE----PLDWNTRMKIAAG 202
+++ C + +E + + +L + + K+ K A
Sbjct: 163 HMLENFTFRNHIC-------MTFELLSM-NLYELI------KKNKFQGFSLPLVRKFAHS 208
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP--KLSDFGLAKLGPVGDK--THVSTR 258
+ L+ LH +I+ DLK NILL + K+ DFG + + T++ +R
Sbjct: 209 ILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTYIQSR 263
Query: 259 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
Y APE + + + D++S G + EL+TG
Sbjct: 264 F-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 30/220 (13%), Positives = 63/220 (28%), Gaps = 48/220 (21%)
Query: 54 DKSKSRNGSDPKKEPAIPKEPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGR 113
+ + + + + +G GGFG +Y
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDM----EGNQWVLGKKIGSGGFGLIYLAF 57
Query: 114 LESTGQVVAVK----------QLDR-----NGLQGNREFLVEVLMLSLLHHSNLVNLIGY 158
+ + A L + ++ + + + L + + G
Sbjct: 58 PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDCIKKWIERKQLDYLGIPLFYGS 116
Query: 159 ----CADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRM------KIAAGAAKGL 207
R +V E LG L+ N ++ L
Sbjct: 117 GLTEFKGRSYRFMVMER--LGIDLQKI----------SGQNGTFKKSTVLQLGIRMLDVL 164
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPK--LSDFGLAK 245
EY+H+ ++ D+K++N+LL + L+D+GL+
Sbjct: 165 EYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL------HHSNLV 153
L+G+G FG+V K + VA+K + +N + +EV +L L+ +V
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 154 NLIGY-------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
+L + C LV+E + +L D L + + + N K A
Sbjct: 120 HLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNT--NFRGVSLNLTRKFAQQMCTA 169
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHP--KLSDFGLAKLGPVGDK--THVSTRVMGT 262
L +L +I+ DLK NILL K+ DFG + +G + ++ +R
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRF--- 223
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
Y +PE + L D++S G + +E+ TG
Sbjct: 224 --YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 34/174 (19%), Positives = 67/174 (38%), Gaps = 27/174 (15%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQV-----VAVKQLDRNGLQGNREF-----LVEVL 142
++ +G+GGFG +Y + S+ V VK + E +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 143 MLSLLHHSNLVNLIG-----YCADGDQRLLVYEFM---PLG-SLEDHLHDLPPDKEPLDW 193
+ + + +G D+ Y FM G L+ +++ +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKRFSR-- 151
Query: 194 NTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK--LSDFGLAK 245
T ++++ LEY+H+ ++ D+K+SN+LL+ + L D+GLA
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 51/259 (19%), Positives = 80/259 (30%), Gaps = 76/259 (29%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC- 159
LG G F V+ + VA+K + ++ L E+ +L + +S+ N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSD-PNDPNREM 102
Query: 160 ------------ADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
+G +V+E LG L + PL KI +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQQVLQG 158
Query: 207 LEYLHDKANPPVIYRDLKSSNILL------------------------------------ 230
L+YLH K +I+ D+K NILL
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 231 -------------DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 277
E K++D G A + TR Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 278 LKSDVYSFGVVFLELITGR 296
+D++S + EL TG
Sbjct: 272 TPADIWSTACMAFELATGD 290
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 57/242 (23%), Positives = 87/242 (35%), Gaps = 74/242 (30%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-----HHSNLVN 154
+G+G FGRV + + AVK + RN + R +E +L + +++N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 155 LIGY-------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207
G C L++E + SL + + + K L
Sbjct: 101 YHGKFMYYDHMC-------LIFEPLGP-SLYEIITR--NNYNGFHIEDIKLYCIEILKAL 150
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHP-------------------------KLSDFG 242
YL + + + DLK NILLD+ + KL DFG
Sbjct: 151 NYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 243 LAKLGPVGDKTH---VSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELI 293
A H ++TR Y APE + + SD++SFG V EL
Sbjct: 208 CATF---KSDYHGSIINTRQ-----YRAPEVILNLGWDV------SSDMWSFGCVLAELY 253
Query: 294 TG 295
TG
Sbjct: 254 TG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 57/243 (23%), Positives = 89/243 (36%), Gaps = 80/243 (32%)
Query: 100 LLGEGGFGRVYKGR-LESTGQVVAVKQLDRNGLQGNREF----LVEVLMLSLL------H 148
LGEG FG+V + ++ G+ VAVK + +N + E+ +L L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 149 HSNLVNLIGY-------CADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIA 200
V ++ + C +V+E LG S D + + P + K+A
Sbjct: 76 TFRCVQMLEWFEHHGHIC-------IVFE--LLGLSTYDFIKE--NGFLPFRLDHIRKMA 124
Query: 201 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-------------------KLSDF 241
K + +LH + + DLK NIL + + K+ DF
Sbjct: 125 YQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 242 GLAKLGPVGDKTH---VSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLEL 292
G A D+ H VSTR Y APE ++ DV+S G + +E
Sbjct: 182 GSATYD---DEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCILIEY 227
Query: 293 ITG 295
G
Sbjct: 228 YLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 49/242 (20%), Positives = 78/242 (32%), Gaps = 78/242 (32%)
Query: 100 LLGEGGFGRVYKGR-LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH------SNL 152
LGEG FG+V + VA+K + RN + +E+ +L +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 153 VNLIGY-------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKE----PLDWNTRMKIAA 201
V + + C + +E + + + L KE P +A
Sbjct: 85 VLMSDWFNFHGHMC-------IAFELLGK-NTFEFL------KENNFQPYPLPHVRHMAY 130
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP-------------------KLSDFG 242
L +LH+ + + DLK NIL +++DFG
Sbjct: 131 QLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 243 LAKLGPVGDKTH---VSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVFLELI 293
A + H V+TR Y PE +A DV+S G + E
Sbjct: 188 SATFD---HEHHTTIVATRH-----YRPPEVILELGWAQ------PCDVWSIGCILFEYY 233
Query: 294 TG 295
G
Sbjct: 234 RG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 522 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.9 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.68 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.44 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.65 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.56 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.46 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.34 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.21 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.38 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.1 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.87 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.39 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-57 Score=464.42 Aligned_cols=252 Identities=20% Similarity=0.340 Sum_probs=206.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++++.||+|+||+||+|++..+|+.||||+|....... .+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999999999999999998654432 3568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||+||+|.++|.. .....+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 104 y~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~- 177 (350)
T 4b9d_A 104 YCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS- 177 (350)
T ss_dssp CCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH-
T ss_pred CCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC-
Confidence 9999999999975 22456899999999999999999999999 99999999999999999999999999986421
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.....+..+||+.|||||++.+..|+.++||||||||||||+||+.||..... ......+.... ++.
T Consensus 178 -~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~--~~~---- 244 (350)
T 4b9d_A 178 -TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISGS--FPP---- 244 (350)
T ss_dssp -HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC--CCC----
T ss_pred -CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC--CCC----
Confidence 11233457899999999999999999999999999999999999999975422 12222222211 111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.+||.+||+.||++|||+.||++.
T Consensus 245 -----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 -----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112233578899999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-57 Score=454.87 Aligned_cols=253 Identities=25% Similarity=0.307 Sum_probs=215.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.++||+|+||+||+|++..+++.||||++.+... ...+.+.+|+.+|+.|+|||||+++++|.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 569999999999999999999999999999999975422 23467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||+||+|.++|.. ...+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999976 467999999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
..........+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ......+......+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~~~----- 253 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLEYDF----- 253 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC-----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCC-----
Confidence 4444445668999999999999999999999999999999999999999975321 11122222222112
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+......+.+||.+||+.||++|||+.|++..-.
T Consensus 254 -------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~ 287 (311)
T 4aw0_A 254 -------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 287 (311)
T ss_dssp -------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHH
T ss_pred -------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHH
Confidence 2223356889999999999999999999865443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=457.75 Aligned_cols=265 Identities=28% Similarity=0.420 Sum_probs=216.7
Q ss_pred hcCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.++|.+.+.||+|+||+||+|++. .++..||||+++.......+.|.+|+.+|++|+|||||+++++|.+.+.+|
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357889999999999999999975 357899999998765555678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcee
Q 009933 167 LVYEFMPLGSLEDHLHDLP---------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK 237 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vk 237 (522)
||||||++|+|.++|+... .....++|.+++.|+.||+.||.|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 23457999999999999999999999998 99999999999999999999
Q ss_pred eeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhh
Q 009933 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 238 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
|+|||+++.....+........+||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~--- 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIEC--- 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHH---
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---
Confidence 999999986543333333344679999999999999999999999999999999999 8999976432 112211
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
+... .. . ..|......+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 243 i~~~-~~-~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 243 ITQG-RV-L---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHT-CC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHcC-CC-C---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111 11 1 112223357889999999999999999999999999886543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=456.29 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=213.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
+.|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999998766566677899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
+||+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--
Confidence 99999999975 56999999999999999999999999 999999999999999999999999999875322
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
.......+||+.|||||++.+..|+.++||||||||||||++|+.||...... ..... +.... . +.+
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~---i~~~~---~----~~~ 290 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKM---IRDNL---P----PRL 290 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH---HHHSS---C----CCC
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHH---HHcCC---C----CCC
Confidence 22345678999999999999999999999999999999999999999754221 11111 11110 0 000
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.........+.+||.+||+.||++|||+.||+++
T Consensus 291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0112234678899999999999999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-57 Score=459.08 Aligned_cols=263 Identities=29% Similarity=0.470 Sum_probs=209.6
Q ss_pred cCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
++|.+.++||+|+||+||+|++. .+++.||||+++.......+.|.+|+.+|++|+|||||+++++|.+.+.+||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999975 3588999999987655556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCce
Q 009933 168 VYEFMPLGSLEDHLHDLPP-----------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
|||||++|+|.++|+.... ...+++|.+++.|+.||+.||.|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 2356999999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhh
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 315 (522)
||+|||+++.....+........+||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+...+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHH-
Confidence 9999999987544444444556789999999999999999999999999999999999 8999975432 1122111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
... ..+ ..|......+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 274 --~~g-~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 --TQG-REL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --HHT-CCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HcC-CCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111 111 11222335788999999999999999999999999988653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=450.67 Aligned_cols=258 Identities=20% Similarity=0.215 Sum_probs=212.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||+++++|.+.+.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3568889999999999999999999999999999976432 24699999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeeecceeeCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKLGPVG 250 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DFGla~~~~~~ 250 (522)
|+||+|.++|+. ...+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999976 467999999999999999999999999 99999999999999887 6999999999875432
Q ss_pred CCCc---ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 251 DKTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 251 ~~~~---~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.... ....++||+.|||||++.+..|+.++|||||||+||||+||+.||...........+ ......+.
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~~~~-- 276 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPPPIR-- 276 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSCCGGG--
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCCCCch--
Confidence 2111 123468999999999999999999999999999999999999999865443322111 11111111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.++......+.+||.+||+.||++|||+.||++.|.......
T Consensus 277 -------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 277 -------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 112223457889999999999999999999999998776543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-56 Score=447.09 Aligned_cols=263 Identities=29% Similarity=0.455 Sum_probs=206.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||+||+|++.. .||||+++.... ...+.|.+|+.+|++|+|||||+++++|.+ +.+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 4678899999999999999998753 599999975432 234678999999999999999999998865 5689999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||++|+|.++|+. ....+++.+++.|+.||+.||.|||+++ ||||||||+||||++++++||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999975 2457999999999999999999999998 99999999999999999999999999987544
Q ss_pred CCCCcceecccCCccccChhhhhc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
..........+||+.|||||++.. ..|+.++|||||||+||||+||+.||....... .+.. ........+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~~----~~~~~~~~p~ 258 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIF----MVGRGYASPD 258 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHH----HHHTTCCCCC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHHH----HHhcCCCCCC
Confidence 333344456789999999999974 359999999999999999999999997543211 1111 1111111111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
+. ..+......+.+||.+||+.||++|||+.+|+++|+.|....
T Consensus 259 -----~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 -----LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp -----ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred -----cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 10 122233467889999999999999999999999999886443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-55 Score=458.27 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=213.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
+.|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
+||+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-- 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--
Confidence 99999999975 56999999999999999999999999 999999999999999999999999999875332
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
.......+||+.|||||++.+..|+.++||||||||||||++|+.||...... ..... +.... . +.+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~---i~~~~---~----~~~ 367 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKM---IRDNL---P----PRL 367 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH---HHHSC---C----CCC
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHH---HHcCC---C----CCC
Confidence 22345678999999999999999999999999999999999999999754221 11111 11110 0 000
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. ........+.+||.+||+.||++|||+.||+++
T Consensus 368 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp S--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 111233578899999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-56 Score=448.18 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=212.6
Q ss_pred cCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.++++.+.||+|+||+||+|.+. .+++.||||+++.... ...+.|.+|+.+|++|+|||||+++++|.+.+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677889999999999999963 3578999999975432 23467999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 009933 167 LVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF 234 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~ 234 (522)
||||||++|+|.++|..... ....++|.+++.|+.||+.||.|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 1346999999999999999999999999 99999999999999999
Q ss_pred ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHh
Q 009933 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAW 313 (522)
Q Consensus 235 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~ 313 (522)
++||+|||+++.....+........+||+.|||||++.+..|+.++|||||||+||||+| |..||..... ..+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 999999999986544433334456789999999999999999999999999999999998 8999976432 122222
Q ss_pred hhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 314 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
+ ...... ..|......+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 260 i----~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 I----RNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H----HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H----HcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 111111 12223346788999999999999999999999999853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=432.20 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=195.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||+||+|++..+++.||||++++.... ....+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999999999999999999765432 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||| +|+|.+++.. ...+++.++..|+.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6799999976 467999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
. ......+||+.|||||++.+..| +.++|||||||+||+|+||+.||.... .......+......++
T Consensus 165 ~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~~~~p--- 232 (275)
T 3hyh_A 165 G---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGVYTLP--- 232 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCCC---
T ss_pred C---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCCCC---
Confidence 2 23345789999999999998876 579999999999999999999997532 1122222222222221
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+.+||.+||+.||++|||+.|+++.
T Consensus 233 ---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 233 ---------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---------CCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1223567899999999999999999999884
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-55 Score=436.75 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=201.2
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEc----CCeeEEE
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRLLV 168 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~----~~~~~lV 168 (522)
|++.+.||+|+||+||+|.+..++..||||++...... ..+.|.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36778899999999999999999999999999754332 23568899999999999999999999865 3568999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCceeeeeecceeeC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLG 247 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~vkL~DFGla~~~ 247 (522)
||||++|+|.++|.. ...+++..+..|+.||+.||+|||+++ ++||||||||+||||+ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999976 467999999999999999999999874 4599999999999997 4799999999999863
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.. ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ..+.. .+.... .+..
T Consensus 183 ~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~---~i~~~~--~~~~ 250 (290)
T 3fpq_A 183 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR---RVTSGV--KPAS 250 (290)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH---HHTTTC--CCGG
T ss_pred CC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHH---HHHcCC--CCCC
Confidence 22 23456789999999998865 6999999999999999999999999753221 11111 111110 0111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
++ ......+.+||.+||+.||++|||+.||+++
T Consensus 251 ~~--------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 FD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC--------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1122467899999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=438.46 Aligned_cols=248 Identities=27% Similarity=0.332 Sum_probs=200.5
Q ss_pred cCCcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
++|++.+.||+|+||+||+|++. .+++.||||++++.... ....+.+|+.+|+.|+|||||+++++|.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999984 46889999999764322 23467889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||||+||+|.++|.. ...+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999976 467999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... .......+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ......+......+
T Consensus 177 ~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~~~--- 245 (304)
T 3ubd_A 177 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAKLGM--- 245 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---
T ss_pred cCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCCCCC---
Confidence 322 2233457899999999999999999999999999999999999999975422 11222222222222
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCH-----HHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI-----GDVVT 367 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-----~evl~ 367 (522)
+......+.+||.+||+.||++|||+ +||++
T Consensus 246 ---------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 ---------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 12223567899999999999999984 56654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=445.00 Aligned_cols=273 Identities=26% Similarity=0.373 Sum_probs=220.3
Q ss_pred ccHHHHHHhhcCCcccceecccCceEEEEEEECCC-----CcEEEEEEEccCCcc-chHHHHHHHHHHHhCCC-CCccee
Q 009933 83 FTFRELAAATKNFRPECLLGEGGFGRVYKGRLEST-----GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHH-SNLVNL 155 (522)
Q Consensus 83 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~h-pnIv~l 155 (522)
+...+++...++|++.+.||+|+||+||+|.+..+ ++.||||++...... ..+.|.+|+.+|..+.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 44455666678999999999999999999998643 368999999765433 24568999999999965 899999
Q ss_pred EEEEEcC-CeeEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 009933 156 IGYCADG-DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 222 (522)
Q Consensus 156 ~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrD 222 (522)
+++|.+. +.+|||||||++|+|.++|+.... ....+++.+++.|+.||+.||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 578999999999999999975321 2356899999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 009933 223 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 301 (522)
Q Consensus 223 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~ 301 (522)
|||+||||++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987544443334456789999999999999999999999999999999998 8999976
Q ss_pred CCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 302 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..... .+... +.....+ ..|......+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 291 ~~~~~--~~~~~----i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 291 VKIDE--EFCRR----LKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCCSH--HHHHH----HHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH--HHHHH----HHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 53321 11111 1111111 1122233578899999999999999999999999988754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=431.18 Aligned_cols=269 Identities=25% Similarity=0.319 Sum_probs=202.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC----eeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD----QRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~----~~~lV 168 (522)
++|.+.+.||+|+||+||+|++. |+.||||+++.... ....+..|+.++..++|||||+++++|.+.+ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 46888999999999999999984 89999999965321 1122334566667889999999999998654 57999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA-----NPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
||||++|+|.++|+. ..++|..+++|+.|++.||.|||++. .++||||||||+||||+.++++||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999976 56999999999999999999999871 22399999999999999999999999999
Q ss_pred eeeCCCCCCC--cceecccCCccccChhhhhcC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--------
Q 009933 244 AKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE-------- 307 (522)
Q Consensus 244 a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~------~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~-------- 307 (522)
++........ ......+||+.|||||++.+. .|+.++|||||||+||||+||..||........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9875433221 122346799999999999764 367899999999999999999888754322111
Q ss_pred -chHHHhhhhhhhcccCCCCcCCccccCC-CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 308 -HNLVAWARPLFKDRRKFPKMADPLLQGR-YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 308 -~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.........+.. ...++.+... .+.+....+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 235 ~~~~~~~~~~~~~------~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 235 DPSVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTT------SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHHhc------ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 011111111111 1111111111 1234566788999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=419.68 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=191.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCC--------
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGD-------- 163 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-------- 163 (522)
++|++.+.||+|+||+||+|+++.+++.||||+++..... ..+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999999999999999999765433 2356889999999999999999999987544
Q ss_pred ----eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeee
Q 009933 164 ----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239 (522)
Q Consensus 164 ----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~ 239 (522)
.+|||||||++|+|.+++.... .....++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 3799999999999999997622 1234567778999999999999999999 9999999999999999999999
Q ss_pred eecceeeCCCCCCC----------cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 009933 240 DFGLAKLGPVGDKT----------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN 309 (522)
Q Consensus 240 DFGla~~~~~~~~~----------~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~ 309 (522)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||... .+
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----ME 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cH
Confidence 99999865332211 11234689999999999999999999999999999999996 77531 11
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.......+.. ..++ +. .......+.+||.+||+.||++|||+.||++
T Consensus 233 ~~~~~~~~~~--~~~p----~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLTDVRN--LKFP----PL-----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHT--TCCC----HH-----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhc--CCCC----CC-----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111100 0111 11 0122345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=423.04 Aligned_cols=268 Identities=23% Similarity=0.291 Sum_probs=204.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEc------CC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD------GD 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~------~~ 163 (522)
.++|++.+.||+|+||+||+|++..+|+.||||+|+..... ..+.+.+|+.+|+.|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999999999999999999754322 23567899999999999999999998764 36
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.+|||||||. |+|.+++.. ...+++.++..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 689999976 578999999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCC--CCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 244 AKLGPVGD--KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 244 a~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
++...... ........+||+.|||||++.+. .|+.++||||||||||||++|+.||...........+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98643221 12234567899999999998875 5699999999999999999999999765322111111000000000
Q ss_pred --------------ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 --------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 --------------~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...++......+. .........+.+||.+||+.||++|||+.|+|++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWE-TVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHH-HhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000 0000123578899999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=412.74 Aligned_cols=201 Identities=25% Similarity=0.345 Sum_probs=173.0
Q ss_pred HhhcCCcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCee
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~ 165 (522)
...++|++.+.||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|..+ +|||||+++++|.+.+++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999974 457899999996542 345678999999988 699999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-Cceeeeeecce
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG-FHPKLSDFGLA 244 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~-~~vkL~DFGla 244 (522)
|||||||++++|.+++. .+++.++..|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999984 4889999999999999999999999 9999999999999876 79999999999
Q ss_pred eeCCCCCC--------------------------CcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCC
Q 009933 245 KLGPVGDK--------------------------THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRK 297 (522)
Q Consensus 245 ~~~~~~~~--------------------------~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~ 297 (522)
+....... ....+..+||+.|+|||++.+. .|+.++||||+|||+|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86432111 1112346799999999999876 58999999999999999999999
Q ss_pred CCCCC
Q 009933 298 AIDNT 302 (522)
Q Consensus 298 Pf~~~ 302 (522)
||...
T Consensus 246 Pf~~~ 250 (361)
T 4f9c_A 246 PFYKA 250 (361)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 99644
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=434.67 Aligned_cols=254 Identities=23% Similarity=0.285 Sum_probs=212.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+...+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999999999999999999876655567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCceeeeeecceeeCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE--GFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~--~~~vkL~DFGla~~~~~ 249 (522)
|+||+|.++|.. ....+++.++..|+.||+.||+|||+++ |+||||||+||||+. .+.+||+|||+++....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999964 2457999999999999999999999999 999999999999975 48999999999997543
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. ......+||+.|||||++.+..|+.++|||||||||||||+|..||...... .. ...+......++.
T Consensus 310 ~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~---~~~i~~~~~~~~~--- 377 (573)
T 3uto_A 310 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ET---LRNVKSCDWNMDD--- 377 (573)
T ss_dssp T---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHHTTCCCCCS---
T ss_pred C---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HH---HHHHHhCCCCCCc---
Confidence 2 2345678999999999999999999999999999999999999999754221 11 1111111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+.. ......+.+||.+||+.||++||++.|++++
T Consensus 378 ~~~-----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAF-----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGG-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc-----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1123567899999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=398.18 Aligned_cols=284 Identities=42% Similarity=0.701 Sum_probs=245.1
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 87 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
++...+++|++.++||+|+||+||+|.+. +++.||||++........+.+.+|+.+|+.++||||++++++|...+..+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 44456789999999999999999999975 58999999998766566678899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999999999764444457999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
..............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|...... ...+..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 267 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQ 267 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCCS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHHH
Confidence 5443333334456689999999999999999999999999999999999999988777666666666544333 234566
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.+++.+....+......+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 6677666677788889999999999999999999999999999987643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=434.44 Aligned_cols=250 Identities=28% Similarity=0.364 Sum_probs=204.6
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHH---HHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVE---VLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E---~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
++|++.++||+|+||+||+|+++.+|+.||||+|++... .....+.+| +.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 579999999999999999999999999999999975422 122233344 56667788999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
||||||+||+|.++|.. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|+|||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999976 467999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
.... .....+||+.|||||++.. ..|+.++|||||||||||||+|..||..........+. .........
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---~~i~~~~~~-- 412 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTMAVE-- 412 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---HHHHHCCCC--
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhhcCCCCC--
Confidence 5332 2345789999999999975 57999999999999999999999999754333222211 112222111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 368 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~ 368 (522)
++......+.+||.+||+.||++|++ +.||+++
T Consensus 413 ----------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 413 ----------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ----------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 12223357889999999999999998 5777663
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=389.35 Aligned_cols=287 Identities=45% Similarity=0.761 Sum_probs=244.1
Q ss_pred cccccHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEE
Q 009933 80 AQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGY 158 (522)
Q Consensus 80 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~ 158 (522)
...|++.++....++|++.++||+|+||+||+|.+. +++.||||++...... ....+.+|+.++..++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 356788999999999999999999999999999865 5899999999765432 23468899999999999999999999
Q ss_pred EEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---CCCCeEecCCCCCceeecCCCc
Q 009933 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK---ANPPVIYRDLKSSNILLDEGFH 235 (522)
Q Consensus 159 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~~~~iiHrDLKp~NILld~~~~ 235 (522)
|......++||||+.+++|.+++.........+++..++.|+.||+.||.|||+. + |+|+||||+||||+.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 9999999999999999999999988665666799999999999999999999999 7 999999999999999999
Q ss_pred eeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--CCCcchHHHh
Q 009933 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR--PPGEHNLVAW 313 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~--~~~~~~~~~~ 313 (522)
+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .........|
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999998754322 223445669999999999999999999999999999999999999996321 2223345556
Q ss_pred hhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 314 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
....... ..+..+.+..+...++......+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus 252 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 252 VKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 5554443 345677777777788888999999999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=382.21 Aligned_cols=264 Identities=27% Similarity=0.377 Sum_probs=216.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.++||+|+||+||+|.+..+++.||||++........+.+.+|+.+|..++||||++++++|.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46799999999999999999999999999999999765555567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+++... ...+++.+++.|+.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999762 457999999999999999999999999 9999999999999999999999999998653322
Q ss_pred CCc------------ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh
Q 009933 252 KTH------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 319 (522)
Q Consensus 252 ~~~------------~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 319 (522)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.............. .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hcccc
Confidence 111 11146799999999999999999999999999999999999999876543222110000 00000
Q ss_pred cccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 320 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 320 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
. ..+......+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus 242 ~--------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 242 R--------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp H--------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred c--------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 011112235778999999999999999999999999886554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=374.93 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=212.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++........+.+.+|+.+++.++||||++++++|...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999999999999999999766556667789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999976 46899999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
. ......||+.|+|||++.+..|+.++|||||||++|+|++|..||....... .......... ...
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~--~~~---- 236 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT--PEL---- 236 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS--CCC----
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC--CCC----
Confidence 2 2345679999999999999999999999999999999999999997542211 1111111110 011
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+......+.+||.+||+.||++|||+.++++.
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 ---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0122233568899999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=387.09 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=208.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..|||||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999999999999999999754332 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999975 457999999999999999999999999 999999999999999999999999999865433
Q ss_pred CCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .....+... . ....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~-----~---~~~~ 229 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK-----K---TYLN 229 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT-----C---TTST
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc-----c---ccCC
Confidence 33333445789999999999988775 778999999999999999999997643321 112222111 0 0011
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+ .......+.+||.+||+.||++|||+.||++.
T Consensus 230 ~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 P------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 01223567899999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=383.44 Aligned_cols=273 Identities=27% Similarity=0.344 Sum_probs=211.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC----eeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD----QRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~----~~~l 167 (522)
.++|++.++||+|+||+||+|++. ++.||||++.... .....+..|+.+|..++||||+++++++.... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 468999999999999999999986 7999999996542 22344566888999999999999999998754 4699
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCceeecCCCcee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK----------ANPPVIYRDLKSSNILLDEGFHPK 237 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------~~~~iiHrDLKp~NILld~~~~vk 237 (522)
||||+++|+|.+++.. ..+++..++.|+.||+.||.|||+. + |+||||||+||||+.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999976 4599999999999999999999998 8 99999999999999999999
Q ss_pred eeeecceeeCCCCCCCcceecccCCccccChhhhhcC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 009933 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA 312 (522)
Q Consensus 238 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~ 312 (522)
|+|||+++...............||+.|+|||++.+. .++.++|||||||++|||+||+.||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999875443333333446799999999999873 45678899999999999999999998654432222211
Q ss_pred hhhhhhhc----ccCCCCcCCccccCC-CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 313 WARPLFKD----RRKFPKMADPLLQGR-YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 313 ~~~~~~~~----~~~~~~~~d~~l~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
........ .........+.+... ........+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 10000000 000001111111111 1123456789999999999999999999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=387.32 Aligned_cols=265 Identities=26% Similarity=0.391 Sum_probs=215.9
Q ss_pred hcCCcccceecccCceEEEEEEEC-------CCCcEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCcceeEEEEEcC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE-------STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADG 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~ 162 (522)
.++|++.+.||+|+||+||+|.+. .++..||||+++..... ....+.+|+.+|+.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999974 34568999999765322 235688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
+.+||||||+.+|+|.+++..... ....+++.+++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976321 1245899999999999999999999999 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~ 309 (522)
+.++.+||+|||+++...............+|+.|+|||++.+..|+.++|||||||++|||++ |..||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999987544333333344567889999999999999999999999999999999 99999764321 1
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
+.... ..... ...+......+.+||.+||+.||++||++.+|++.|+.+....
T Consensus 314 ~~~~~----~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 LFKLL----KEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHH----HTTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHH----hcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111 11100 0112223457889999999999999999999999999987544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=380.81 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=209.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4689999999999999999999999999999999976533 23456789999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999976 467999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCCcceecccCCccccChhhhhcCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.. .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ......+......+
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~---- 233 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKYRI---- 233 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC----
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC----
Confidence 22 33456899999999999988875 799999999999999999999975421 12222222221111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+......+.+|+.+||+.||.+|||+.++++.
T Consensus 234 --------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 --------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12233567899999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=383.56 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=211.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCc---EEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQ---VVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.++||+|+||+||+|.+..+++ .||||++..... ...+.+.+|+.+|..++||||++++++|.+.+..+|
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 4679999999999999999999975554 599999976432 234568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999965 2357999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 248 PVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 248 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .+.... ... ..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~---~~~-~~-- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSV---EEG-YR-- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHH---HTT-CC--
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH---HcC-CC--
Confidence 4332211 2223456788999999999999999999999999999999 99999654221 111111 111 00
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
...+......+.+||..||+.||++||++.+|++.|+.+....
T Consensus 273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 0112223357889999999999999999999999999987544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=368.17 Aligned_cols=284 Identities=40% Similarity=0.634 Sum_probs=229.7
Q ss_pred cccccHHHHHHhhcCCccc------ceecccCceEEEEEEECCCCcEEEEEEEccCC----ccchHHHHHHHHHHHhCCC
Q 009933 80 AQTFTFRELAAATKNFRPE------CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG----LQGNREFLVEVLMLSLLHH 149 (522)
Q Consensus 80 ~~~~~~~~~~~~~~~y~~~------~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~~L~~l~h 149 (522)
...|++.++..++++|... +.||+|+||+||+|.+ +++.||||++.... ....+.+.+|+.+|+.++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4668899999999998877 8999999999999987 47899999996532 1234568899999999999
Q ss_pred CCcceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 009933 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 229 (522)
Q Consensus 150 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NIL 229 (522)
|||+++++++.+.+..++||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+|+||||+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999752 12356999999999999999999999999 999999999999
Q ss_pred ecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 009933 230 LDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN 309 (522)
Q Consensus 230 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~ 309 (522)
|+.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||.........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~- 243 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL- 243 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-
Confidence 99999999999999987544333333345679999999998865 5899999999999999999999999865443222
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
..+..........+...++..+ ...+......+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 -LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp -THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred -HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1121112222222222333322 2345567788999999999999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=379.56 Aligned_cols=253 Identities=26% Similarity=0.299 Sum_probs=209.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------chHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.+|..++||||++++++|.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 56899999999999999999999999999999999765432 236788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----ceeeeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF----HPKLSDF 241 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~----~vkL~DF 241 (522)
+|||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999965 467999999999999999999999999 99999999999998776 7999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
|++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ......+....
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITAVS 234 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTC
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC
Confidence 9998754322 23456799999999999999999999999999999999999999975422 11111111111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+ ++... ......+.+||.+||+.||++|||+.++++.
T Consensus 235 ~~~----~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YDF----DEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCC----CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCC----Cchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 10000 1123567899999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=379.26 Aligned_cols=250 Identities=27% Similarity=0.330 Sum_probs=209.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.++||+|+||+||+|+++.+++.||||++++.. ......+..|+.+|..++||||++++++|...+.+|||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997542 23345688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999976 467999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ......+......
T Consensus 157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~----- 223 (337)
T 1o6l_A 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEIR----- 223 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC-----
T ss_pred cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC-----
Confidence 22 1223456899999999999999999999999999999999999999975321 1111122222111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
++......+.+||.+||+.||++|| ++.+|+++
T Consensus 224 -------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 -------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1222335778999999999999999 89998875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=384.55 Aligned_cols=275 Identities=26% Similarity=0.394 Sum_probs=219.0
Q ss_pred cccHHHHHHhhcCCcccceecccCceEEEEEE-----ECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCcce
Q 009933 82 TFTFRELAAATKNFRPECLLGEGGFGRVYKGR-----LESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVN 154 (522)
Q Consensus 82 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~-----~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~ 154 (522)
.+...++....++|++.+.||+|+||.||+|. ...+++.||||++...... ..+.+.+|+.+|..+ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 34455666667899999999999999999999 4556789999999764332 235688999999999 7999999
Q ss_pred eEEEEEcCC-eeEEEEeecCCCChhhhhccCCCC----------------------------------------------
Q 009933 155 LIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPD---------------------------------------------- 187 (522)
Q Consensus 155 l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~---------------------------------------------- 187 (522)
++++|.+.+ .+++||||+.+|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998765 489999999999999999764321
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 188 ----------------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 188 ----------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999999 9999999999999999999999999998654433
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||....... .+... .......
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~~------ 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR----LKEGTRM------ 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHH----HHHTCCC------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHH----HHcCCCC------
Confidence 3333445678999999999999999999999999999999998 999997643321 11111 1111100
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+......+.+|+..||+.||.+||++.+|+++|+.+...
T Consensus 316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 01112235688999999999999999999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=372.04 Aligned_cols=264 Identities=32% Similarity=0.448 Sum_probs=204.4
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
...+|++.+.||+|+||+||+|.+. ++.||||++....... ...+.+|+.+|+.++||||+++++++.+....++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3568999999999999999999884 8899999997654332 35688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999997621 1123899999999999999999999875 459999999999999999999999999998532
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...... ..... .
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~---~~~~~-~---- 257 (309)
T 3p86_A 191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAV---GFKCK-R---- 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHH---HHSCC-C----
T ss_pred cc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhcCC-C----
Confidence 21 11234467999999999999999999999999999999999999999754321 111111 00000 0
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
...+......+.+||.+||+.||++||++.+|++.|+.+....
T Consensus 258 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 -----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 0112223356889999999999999999999999999886543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=369.40 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=217.3
Q ss_pred cccccHHHHHHhhcC----------CcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC
Q 009933 80 AQTFTFRELAAATKN----------FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH 149 (522)
Q Consensus 80 ~~~~~~~~~~~~~~~----------y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h 149 (522)
...+++.++..+++. |...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|+.++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 345777777776654 7778899999999999999998999999999987666666788999999999999
Q ss_pred CCcceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 009933 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNIL 229 (522)
Q Consensus 150 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NIL 229 (522)
|||++++++|...+..+|||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 9999999999999999999999999999999865 46999999999999999999999999 999999999999
Q ss_pred ecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 009933 230 LDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN 309 (522)
Q Consensus 230 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~ 309 (522)
|+.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~ 248 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---Q 248 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---H
T ss_pred ECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence 9999999999999998643321 1234567999999999999999999999999999999999999999754221 1
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
... .+.... .+.+. ........+.+|+.+||+.||++||++.+|++.-
T Consensus 249 ~~~---~~~~~~--~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 249 AMK---RLRDSP--PPKLK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHH---HHHHSS--CCCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHH---HHhcCC--CCCcC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 111 111110 00100 1112235678999999999999999999998854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=382.53 Aligned_cols=249 Identities=28% Similarity=0.385 Sum_probs=203.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.++||+|+||+||+|+++.+++.||||++.+.. ......+..|+.+|..+ +||||++++++|.+.+.+||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999999999999999997542 12335677899999988 69999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||||.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999976 467999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ......+......+
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~~--- 243 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEVVY--- 243 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCC---
Confidence 222 2233457899999999999999999999999999999999999999975422 11222222222111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCH------HHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI------GDVVT 367 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~------~evl~ 367 (522)
+......+.+||.+||+.||++||++ .+|++
T Consensus 244 ---------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 ---------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 22233567899999999999999998 66665
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=365.75 Aligned_cols=264 Identities=25% Similarity=0.330 Sum_probs=210.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.++..++||||+++++++...+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999999999999999986543322 35688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999976 457999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .......... ..+..
T Consensus 163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~--~~~~~- 232 (294)
T 4eqm_A 163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQD--SVPNV- 232 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSS--CCCCH-
T ss_pred ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhc--cCCCc-
Confidence 221 1123346799999999999999999999999999999999999999975422 1111111111 11110
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHHHhhhcc
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-LIGDVVTALTYLASQT 376 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~evl~~L~~l~~~~ 376 (522)
... ........+.++|.+||+.||++|| ++.++++.|+.+....
T Consensus 233 ~~~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 TTD----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHH----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred chh----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 001 1112235688999999999999999 9999999998765433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=383.80 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=204.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.++||+|+||+||+|+++.+++.||||++++.... ....+..|+.+|..+ +|||||+++++|.+.+.+||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46799999999999999999999999999999999764322 234577899999876 89999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||||++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999976 467999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc--c-hHHHhhhhhhhcccCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE--H-NLVAWARPLFKDRRKF 324 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~--~-~~~~~~~~~~~~~~~~ 324 (522)
.. ........+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ . ........+......
T Consensus 204 ~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 280 (396)
T 4dc2_A 204 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 280 (396)
T ss_dssp CC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-
T ss_pred cc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-
Confidence 22 22234567899999999999999999999999999999999999999975432211 1 111111222222211
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 362 (522)
++......+.+||.+||+.||++||++
T Consensus 281 -----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 -----------IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 222233577899999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=369.72 Aligned_cols=253 Identities=26% Similarity=0.325 Sum_probs=208.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------chHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+|+.++||||++++++|.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45699999999999999999999999999999999765332 246788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----ceeeeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF----HPKLSDF 241 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~----~vkL~DF 241 (522)
+|||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999965 467999999999999999999999999 99999999999998877 8999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
|++....... .....+||+.|+|||++....++.++|||||||++|+|++|..||...... .... .+....
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~~~~~~ 233 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA---NVSAVN 233 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHHHTC
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHH---HHHhcC
Confidence 9998754322 233467999999999999999999999999999999999999999754221 1111 111111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+ ..... ......+.+||.+||+.||++|||+.++++.
T Consensus 234 ~~~---~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YEF---EDEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCC---CHHHH-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCc---Ccccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 00000 1123567899999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=378.24 Aligned_cols=257 Identities=22% Similarity=0.251 Sum_probs=207.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC-----ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG-----LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.+.|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999999999999999996421 123567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---eeeeeecc
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH---PKLSDFGL 243 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~---vkL~DFGl 243 (522)
||||||++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888653333456899999999999999999999999 999999999999976554 99999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
+...... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.... ..+. ..+......
T Consensus 180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~---~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF---EGIIKGKYK 250 (351)
T ss_dssp CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH---HHHHHTCCC
T ss_pred eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH---HHHHcCCCC
Confidence 9875432 222345679999999999999999999999999999999999999997531 1111 111111110
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+ .+.... .....+.+||.+||+.||++||++.++++.
T Consensus 251 ~----~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 M----NPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C----CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C----Cccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000000 123567899999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=370.62 Aligned_cols=255 Identities=16% Similarity=0.234 Sum_probs=210.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+|+.++||||++++++|.+.+.++|||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999999999999999997543 3345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCceeeeeecceeeCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE--GFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~--~~~vkL~DFGla~~~~~ 249 (522)
|++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999965 2357999999999999999999999999 999999999999987 78999999999987543
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+......+. .
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~---~ 224 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTFD---E 224 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCCC---H
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCCCC---h
Confidence 22 33456799999999999998899999999999999999999999975422 111111111111110 0
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
... ......+.+||.+||+.||.+|||+.++++.-.
T Consensus 225 ~~~-----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 225 EAF-----KEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHH-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred hhh-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 000 012356889999999999999999999998554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=376.97 Aligned_cols=260 Identities=27% Similarity=0.451 Sum_probs=204.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcE----EEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQV----VAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~----vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.++|++.++||+|+||+||+|++..+++. ||+|.+.... ......+.+|+.+|..++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 46799999999999999999999877765 4777775432 234567899999999999999999999998765 78
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||||+.+|+|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999999762 457999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..............+|+.|+|||++.+..++.++|||||||++|||++ |..||....... +.... ......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~~~- 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGERL- 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCCC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHH----HcCCCC-
Confidence 544433333344567889999999999999999999999999999999 999997643321 11111 111100
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+......+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11222345788999999999999999999999999988643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=373.32 Aligned_cols=260 Identities=28% Similarity=0.454 Sum_probs=208.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcE----EEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQV----VAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~----vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.++|++.++||+|+||+||+|.+..+++. ||+|++.... ......+.+|+.++..++||||++++++|. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 46799999999999999999999887776 7777775432 233356778999999999999999999986 46689
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||||+.+++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999762 357889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+... .....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~ 239 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-----ERLAQP 239 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-----CBCCCC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----CCCCCC
Confidence 655444444455678889999999999999999999999999999999 99999865432211111100 011111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.. ....+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 240 ~~------------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 240 QI------------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TT------------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred Cc------------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11 112456899999999999999999999999988543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=366.08 Aligned_cols=274 Identities=21% Similarity=0.271 Sum_probs=216.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCC--eeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~--~~~lV 168 (522)
.++|++.++||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++.... ..+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999999999999999999975432 33466789999999999999999999998765 78999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCceeeeeecce
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLA 244 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl----d~~~~vkL~DFGla 244 (522)
|||+++++|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997632 2234999999999999999999999999 9999999999999 78888999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhh--------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAM--------TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||...........+ ...
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~ 238 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MYK 238 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH--HHH
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH--HHH
Confidence 8754332 223467999999999987 468899999999999999999999999754432221111 111
Q ss_pred hhhccc-CC----CCcC--------CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 317 LFKDRR-KF----PKMA--------DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 317 ~~~~~~-~~----~~~~--------d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
+..... .. .... .......++......+.+|+.+||+.||++||++.|+++..+..+-
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 111100 00 0000 0001123445666788899999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=368.13 Aligned_cols=265 Identities=20% Similarity=0.234 Sum_probs=215.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+..|+.+|+.| +||||+++++++......+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 468999999999999999999999999999999997543 234688999999999 89999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-----eeeeeeccee
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH-----PKLSDFGLAK 245 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~-----vkL~DFGla~ 245 (522)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 89999999763 467999999999999999999999999 999999999999998887 9999999998
Q ss_pred eCCCCCCCc-----ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 246 LGPVGDKTH-----VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 246 ~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
......... .....+||+.|+|||++.+..++.++|||||||++|||++|..||............... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~~ 235 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---GDT 235 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH---HHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH---Hhh
Confidence 754332211 124567999999999999999999999999999999999999999876443332222211 111
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
....+ ...+...+ ..+.+|+..||+.||.+||++.+|++.|+.+....
T Consensus 236 ~~~~~---~~~~~~~~-----p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 236 KRATP---IEVLCENF-----PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHSC---HHHHTTTC-----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hccCC---HHHHhccC-----hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00000 00111111 27889999999999999999999999999876554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=370.76 Aligned_cols=247 Identities=29% Similarity=0.400 Sum_probs=208.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||+||+|++..+++.||||++.+.. ....+.+.+|+.+|+.++||||++++++|.+...+|||
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997542 23345678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999976 467999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..... ......+......+
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~---- 222 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELRF---- 222 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCCC----
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC----
Confidence 2 22346799999999999999999999999999999999999999975321 11122222221111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
+......+.+||.+||+.||++|| ++.+|+++
T Consensus 223 --------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 223 --------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 122235778999999999999999 88888764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=370.29 Aligned_cols=264 Identities=28% Similarity=0.413 Sum_probs=214.6
Q ss_pred hcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|.+.+.||+|+||.||+|.+ ..++..||||++..... ...+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 57899999999999999999998 34568999999975432 2335688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 009933 166 LLVYEFMPLGSLEDHLHDLPP--------------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 225 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp 225 (522)
++||||+.+++|.+++..... ....+++.+++.++.||+.||.|||+.+ |+|+||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999986432 1234899999999999999999999999 99999999
Q ss_pred CceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 009933 226 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRP 304 (522)
Q Consensus 226 ~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~ 304 (522)
+||||+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987544333222334567889999999999999999999999999999999 9999976533
Q ss_pred CCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 305 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.. +.... ..... . ..+......+.+||.+||+.||++||++.+|++.|+.+...
T Consensus 259 ~~---~~~~~----~~~~~-~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ER---LFNLL----KTGHR-M---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG---HHHHH----HTTCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH---HHHHh----hcCCc-C---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 21 11111 11100 0 11122335788999999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=362.92 Aligned_cols=265 Identities=21% Similarity=0.275 Sum_probs=204.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||+||+|.+..+++.||||++....... ...+.+|+.+|+.++||||+++++++.+.+..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999999999999999997654332 3567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 66666544 2467999999999999999999999999 999999999999999999999999999874322
Q ss_pred CCCcceecccCCccccChhhhhcCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc--------
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR-------- 321 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------- 321 (522)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ...............
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhh
Confidence 22234567899999999998765 89999999999999999999988643322 111111111000000
Q ss_pred cCCCC------cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPK------MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~------~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..... .................+.+||.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 000000011122344678899999999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=387.33 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=211.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|.+.+.||+|+||.||+|.+..+++.||||+++..... ....+.+|+.+|+.++||||++++++|...+..+||||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 46799999999999999999999988999999999754222 23467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999975 2346899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
..........+++.|+|||++....++.++|||||||++|||++ |..||...... ...... .....+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~----- 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFV----EKGGRL----- 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHH----HTTCCC-----
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC-----
Confidence 11111112235678999999999999999999999999999998 99999754221 111111 111110
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+......+.+||.+||+.||++|||+.+|++.|+.+..+
T Consensus 335 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 -----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11122235678999999999999999999999999988643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=374.42 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=208.8
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+|+.|+||||++++++|.+.+..|||
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356799999999999999999999999999999999765432 235688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---Cceeeeeeccee
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG---FHPKLSDFGLAK 245 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~---~~vkL~DFGla~ 245 (522)
|||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999975 467999999999999999999999999 9999999999999764 459999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ..+. ..+......++
T Consensus 180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~---~~i~~~~~~~~ 250 (362)
T 2bdw_A 180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLY---AQIKAGAYDYP 250 (362)
T ss_dssp CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHTCCCCC
T ss_pred EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHhCCCCCC
Confidence 643222 23356799999999999999999999999999999999999999975421 1111 11111111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.. ......+.+||.+||+.||++||++.++++.
T Consensus 251 ---~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 ---SPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---TTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---cccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1100 1123568899999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=366.20 Aligned_cols=269 Identities=29% Similarity=0.432 Sum_probs=210.1
Q ss_pred hcCCcccceecccCceEEEEEE----ECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcC--Cee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGR----LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~ 165 (522)
.++|++.+.||+|+||+||+|+ +..+++.||||++........+.+.+|+.+|..++||||++++++|... ..+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4689999999999999999999 4567999999999866555557789999999999999999999998653 568
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
+|||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999762 345999999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCC-cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC---------CCcchHHHhhh
Q 009933 246 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP---------PGEHNLVAWAR 315 (522)
Q Consensus 246 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~---------~~~~~~~~~~~ 315 (522)
........ .......++..|+|||++.+..++.++|||||||++|+|++|..||..... ...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 65332211 122334577889999999999999999999999999999999998864211 00000011111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
........ ...+......+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 243 ~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELLKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhccCc----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111111 1112233467889999999999999999999999999987543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=384.92 Aligned_cols=265 Identities=26% Similarity=0.396 Sum_probs=211.1
Q ss_pred hcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||+||+|.+ ..+++.||||++..... .....+.+|+.+|..++||||++++++|.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46799999999999999999994 45678999999965432 3345688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---ceeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLP---PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF---HPKLS 239 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~---~vkL~ 239 (522)
+||||||.+++|.+++.... .....+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997632 22346999999999999999999999999 99999999999998544 59999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |..||..... ..+.... .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i---~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV---T 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHH---H
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---H
Confidence 9999975322222223344668999999999999999999999999999999998 9999975422 1111111 1
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
... .. ..+......+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus 301 ~~~-~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 301 SGG-RM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp TTC-CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred cCC-CC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 110 00 011122356889999999999999999999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=373.62 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=204.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.+.||+|+||+||+|+++.+++.||||++.+..... ...+..|+.+|..+ +||||++++++|.+...+||
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367999999999999999999999999999999997654322 34577899999887 89999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999976 457999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc--hHHH-hhhhhhhcccCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH--NLVA-WARPLFKDRRKF 324 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~--~~~~-~~~~~~~~~~~~ 324 (522)
... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... .... ....+......
T Consensus 161 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 237 (345)
T 3a8x_A 161 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 237 (345)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-
T ss_pred cCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-
Confidence 221 12334578999999999999999999999999999999999999999753322111 1111 11111222111
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 362 (522)
++......+.+||.+||+.||++||++
T Consensus 238 -----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 -----------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 122233578899999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=366.45 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=200.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--------------------------chHHHHHHHHHHH
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--------------------------GNREFLVEVLMLS 145 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--------------------------~~~~~~~E~~~L~ 145 (522)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999999754321 1245789999999
Q ss_pred hCCCCCcceeEEEEEc--CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 009933 146 LLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDL 223 (522)
Q Consensus 146 ~l~hpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDL 223 (522)
.++||||+++++++.+ ...++|||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999987 5689999999999999887643 57999999999999999999999999 999999
Q ss_pred CCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCC---CCcchhhHHHHHHHHHHHhCCCCCC
Q 009933 224 KSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVFLELITGRKAID 300 (522)
Q Consensus 224 Kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~sDVwSlGvll~eLltG~~Pf~ 300 (522)
||+||||+.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999998753322 2234567999999999998765 3788999999999999999999997
Q ss_pred CCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 301 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.... ..+...+......++. .......+.+||.+||+.||++||++.+|++.
T Consensus 242 ~~~~------~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 242 DERI------MCLHSKIKSQALEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CSSH------HHHHHHHHHCCCCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CccH------HHHHHHHhcccCCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 5321 1111111111111110 01123568899999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=383.06 Aligned_cols=255 Identities=21% Similarity=0.261 Sum_probs=208.5
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
..++|++.+.||+|+||+||+|.+..+++.||+|++...... ..+.+.+|+.+|+.++||||++++++|.+.+..|||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 357899999999999999999999999999999999765433 235688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCceeeeeeccee
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAK 245 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld---~~~~vkL~DFGla~ 245 (522)
||||.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999976 467999999999999999999999999 99999999999998 56789999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ......+......++
T Consensus 162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~ 233 (444)
T 3soa_A 162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAYDFP 233 (444)
T ss_dssp CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCCCC
T ss_pred EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCCCCC
Confidence 643322 223456799999999999999999999999999999999999999965321 111111111111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.. ......+.+||.+||+.||++||++.++++.
T Consensus 234 ---~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 ---SPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---TTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---cccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110 1123568899999999999999999999884
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=378.71 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=208.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+|+.++|||||+++++|.+...+|||
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999999999999999996532 22346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+|+|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999976 467999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCcceecccCCccccChhhhhc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
... .....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||..........+.... ......
T Consensus 167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~-- 238 (384)
T 4fr4_A 167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---ETTVVT-- 238 (384)
T ss_dssp TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---HHCCCC--
T ss_pred CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hhcccC--
Confidence 322 3345789999999999974 45899999999999999999999999765443322222211 111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC-HHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-IGDVVT 367 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~evl~ 367 (522)
++......+.+||.+||+.||.+||+ +.+|+.
T Consensus 239 ----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 239 ----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 22223357889999999999999998 666554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=375.78 Aligned_cols=268 Identities=25% Similarity=0.435 Sum_probs=214.3
Q ss_pred HHhhcCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcC
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADG 162 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~ 162 (522)
....++|++.+.||+|+||.||+|.+. .+++.||||+++..... ....+.+|+.+|+.++||||++++++|.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344678999999999999999999996 34589999999765332 245688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPD--------------------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 222 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrD 222 (522)
+..+|||||+++++|.+++...... ...+++.+++.|+.||+.||.|||+.+ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999999999999999999763221 257999999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 009933 223 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 301 (522)
Q Consensus 223 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~ 301 (522)
|||+||||+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999976432222222334568999999999999999999999999999999999 9999975
Q ss_pred CCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 302 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
... ..+... +... .... .+......+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus 280 ~~~---~~~~~~---~~~~--~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 280 MAH---EEVIYY---VRDG--NILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp SCH---HHHHHH---HHTT--CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCh---HHHHHH---HhCC--CcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 422 111111 1111 1111 11223357889999999999999999999999999876443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=375.08 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=209.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.+|..++||||++++++|.+...++|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999999999999999999766544556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCceeeeeecceeeCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE--GFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~--~~~vkL~DFGla~~~~~ 249 (522)
+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+. .+.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999865 2357999999999999999999999999 999999999999974 57899999999987533
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .... ..+......+..
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~---~~i~~~~~~~~~--- 271 (387)
T 1kob_A 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETL---QNVKRCDWEFDE--- 271 (387)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHH---HHHHHCCCCCCS---
T ss_pred Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCCCCCCc---
Confidence 22 23445799999999999999999999999999999999999999975422 1111 111111111110
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. ........+.+||.+||+.||++||++.++++.
T Consensus 272 ~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 D-----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp S-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 111223578899999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=383.44 Aligned_cols=259 Identities=23% Similarity=0.292 Sum_probs=211.0
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC
Q 009933 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD 163 (522)
Q Consensus 87 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~ 163 (522)
++....++|++.++||+|+||+||+|+++.+++.||||++.+.. ......+.+|+.+|..++|||||+++++|.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999999999999999996532 122345788999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.+|||||||++|+|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999976 46899999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 319 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 319 (522)
++...... .......+||+.|+|||++.... |+.++|||||||+||||++|+.||..... ......+..
T Consensus 215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~ 287 (410)
T 3v8s_A 215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMN 287 (410)
T ss_dssp CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHT
T ss_pred eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHHh
Confidence 98643322 11234578999999999998765 88999999999999999999999975422 111111111
Q ss_pred cc--cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHHHH
Q 009933 320 DR--RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTALT 370 (522)
Q Consensus 320 ~~--~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~evl~~L~ 370 (522)
.. ..++. . ......+.+||.+||+.+|.+ ||++.||+++-.
T Consensus 288 ~~~~~~~p~--~--------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 288 HKNSLTFPD--D--------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HHHHCCCCT--T--------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred ccccccCCC--c--------ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 11 11111 0 112357889999999999998 999999988643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=378.68 Aligned_cols=269 Identities=27% Similarity=0.389 Sum_probs=217.9
Q ss_pred hcCCcccceecccCceEEEEEEECC-------CCcEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCcceeEEEEEcC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES-------TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADG 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~ 162 (522)
.++|.+.+.||+|+||+||+|.+.. .+..||||++...... ....+.+|+.+|+.+ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4689999999999999999999753 3367999999765332 235688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
+..+|||||+.+++|.+++..... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976331 1246999999999999999999999999 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~ 309 (522)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 9999999999999986544333333444567899999999999999999999999999999999 9999975422 11
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccCCCC
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPN 380 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~ 380 (522)
+.... ...... ..+......+.+||.+||+.||++||++.+|++.|+.+........
T Consensus 302 ~~~~~----~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 302 LFKLL----KEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHH----HTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHH----HcCCCC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 11111 111100 0112233578899999999999999999999999999876664433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=360.67 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=211.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|.+.. ++.||||++.... ...+.+.+|+.+|+.++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4679999999999999999999974 7889999997654 3356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999975 2456899999999999999999999999 9999999999999999999999999998643211
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .... .+... ....
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~---~~~~~---~~~~--- 227 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE---DISTG---FRLY--- 227 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHTT---CCCC---
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHH---HHhcC---ccCC---
Confidence 111223456788999999999999999999999999999999 99999754221 1111 11111 0000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.+......+.+|+..||+.||++||++.+++++|+.+...
T Consensus 228 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 228 -----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1111235688999999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=376.00 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=207.1
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCee
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~ 165 (522)
...++|++.++||+|+||+||+|+++.+++.||||++++.. ......+..|..+|..+ +||||++++++|.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999999999999999997542 12345677899998876 899999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
||||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999976 457999999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||..... ......+......+
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~- 237 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDNPFY- 237 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC-
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHhCCCCC-
Confidence 532222 223457899999999999999999999999999999999999999975422 11111112221111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHH-HHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG-DVVT 367 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-evl~ 367 (522)
+......+.+||.+||+.||++||++. +|++
T Consensus 238 -----------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 238 -----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 122235778999999999999999987 5543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=370.12 Aligned_cols=265 Identities=23% Similarity=0.354 Sum_probs=196.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCc---EEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee-
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQ---VVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR- 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~- 165 (522)
.++|++.+.||+|+||+||+|.+..++. .||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 5689999999999999999999877665 89999997643 23346788999999999999999999999887665
Q ss_pred -----EEEEeecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceee
Q 009933 166 -----LLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 238 (522)
Q Consensus 166 -----~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL 238 (522)
++||||+.+++|.+++.... .....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 99999999999999996421 22236899999999999999999999999 999999999999999999999
Q ss_pred eeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhh
Q 009933 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 239 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||....... +....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~--- 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNYL--- 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH---
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHHH---
Confidence 99999986544333333334557889999999999999999999999999999999 899997643321 11111
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.... . . ..+......+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus 253 ~~~~-~-~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 IGGN-R-L---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HTTC-C-C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcCC-C-C---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1110 0 0 111223357889999999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=372.73 Aligned_cols=267 Identities=25% Similarity=0.385 Sum_probs=212.1
Q ss_pred hhcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCC-ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCC
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD 163 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~ 163 (522)
..++|++.+.||+|+||+||+|.+ ..++..||||++.... ....+.+.+|+.+|..+ +||||++++++|...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357899999999999999999997 3356789999997542 23346788999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhhhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPD-------------------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLK 224 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLK 224 (522)
..+|||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|+|||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999763211 134899999999999999999999999 9999999
Q ss_pred CCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 009933 225 SSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTR 303 (522)
Q Consensus 225 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~ 303 (522)
|+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986543333333344567889999999999999999999999999999998 999997653
Q ss_pred CCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 304 PPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
... .+.... ..... ...+......+.+||.+||+.||.+||++.+|++.|+.+....
T Consensus 280 ~~~--~~~~~~----~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDA--NFYKLI----QNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSH--HHHHHH----HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHH--HHHHHH----hcCCC----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 321 111111 11100 0111222357889999999999999999999999999876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=357.85 Aligned_cols=266 Identities=18% Similarity=0.206 Sum_probs=216.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+|+.++..+ +|+||+.+++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 568999999999999999999999999999999996543 335678899999999 79999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-----eeeeeeccee
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH-----PKLSDFGLAK 245 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~-----vkL~DFGla~ 245 (522)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++.
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 99999999762 346999999999999999999999999 999999999999987766 9999999998
Q ss_pred eCCCCCCC-----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 246 LGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 246 ~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 75433221 1234567999999999999999999999999999999999999999876543332222211110000
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
... +.+.. .....+.+|+.+||+.||++||++.+|++.|+.+..+.
T Consensus 240 -~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 240 -TPL-----RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp -SCH-----HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -ccH-----HHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 000 00011 12257889999999999999999999999999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=386.53 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=213.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC-CCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH-SNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h-pnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..|+| ++|..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4789999999999999999999999999999999875432 3457889999999987 556666677788889999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCceeeeeecceeeC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl---d~~~~vkL~DFGla~~~ 247 (522)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 89999999752 357999999999999999999999999 9999999999999 68899999999999875
Q ss_pred CCCCCC-----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhccc
Q 009933 248 PVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 322 (522)
Q Consensus 248 ~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 322 (522)
...... .......||+.|+|||++.+..++.++||||||||||||++|+.||....................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 233 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH---
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc---
Confidence 433221 112356799999999999999999999999999999999999999987655433332222111000
Q ss_pred CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 323 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 323 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
...+.. +...+ ...+.+||..||+.+|++||++.+|++.|+.+....
T Consensus 234 --~~~~~~-l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 234 --ATSIEA-LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp --HSCHHH-HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --cccHHH-HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 000111 00112 257889999999999999999999999999885544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=380.17 Aligned_cols=261 Identities=25% Similarity=0.416 Sum_probs=201.2
Q ss_pred hcCCcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.++||+|+||.||+|++. .++..||||+++.... ...+.+.+|+.+|..++||||++++++|.+....+|
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999986 4577899999976432 234578899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++.. ....+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999976 2457999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 248 PVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 248 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.... ......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i----~~~~~~- 269 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAV----DEGYRL- 269 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHH----HTTEEC-
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCC-
Confidence 3322111 1122345778999999999999999999999999999998 9999975422 1111111 111000
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+......+.+||.+||+.||++||++.+|++.|+.+...
T Consensus 270 ---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 ---------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ---------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11122346788999999999999999999999999988654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.31 Aligned_cols=247 Identities=25% Similarity=0.310 Sum_probs=208.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+|..++||||++++++|.+...+|||
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357999999999999999999999999999999996542 23345688899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999976 357999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.. ....+||+.|+|||++.+..|+.++|||||||++|||++|..||..... ......+......
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~----- 256 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKVR----- 256 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC-----
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCCC-----
Confidence 21 2346799999999999999999999999999999999999999975422 1111222222111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~ 368 (522)
++......+.+||.+||+.||.+||+ +.+|+++
T Consensus 257 -------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 -------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 12223357889999999999999998 7888764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=361.52 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=203.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHh--CCCCCcceeEEEEEc----CCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL--LHHSNLVNLIGYCAD----GDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~--l~hpnIv~l~~~~~~----~~~~ 165 (522)
.++|++.+.||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 57899999999999999999998 4899999999653 34556667777766 789999999998754 3468
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCceeecCCCcee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH--------DKANPPVIYRDLKSSNILLDEGFHPK 237 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiHrDLKp~NILld~~~~vk 237 (522)
++||||+++++|.+++.. ..+++..++.|+.||+.||.||| +.+ |+||||||+||||+.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 999999999999999964 57999999999999999999999 777 99999999999999999999
Q ss_pred eeeecceeeCCCCCCCc--ceecccCCccccChhhhhcC------CCCcchhhHHHHHHHHHHHhC----------CCCC
Q 009933 238 LSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVFLELITG----------RKAI 299 (522)
Q Consensus 238 L~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~------~~~~~sDVwSlGvll~eLltG----------~~Pf 299 (522)
|+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997643322211 12234799999999999876 455799999999999999999 7777
Q ss_pred CCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 300 DNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.......... .... .........+.+. ...++......+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 234 ~~~~~~~~~~-~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSF-EDMR-KVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCH-HHHH-HHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcch-hhhh-HHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 6543322211 1111 1111111111111 1112334567899999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=364.19 Aligned_cols=267 Identities=23% Similarity=0.299 Sum_probs=202.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||+||+|.+. +++.||||++....... ...+.+|+.+|+.++||||+++++++.+....+|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 478999999999999999999996 48999999997543222 356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 99 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99975 88888865 2456999999999999999999999999 99999999999999999999999999987432
Q ss_pred CCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh-----hhcccC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL-----FKDRRK 323 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~-----~~~~~~ 323 (522)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...... +.....
T Consensus 172 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 172 P--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp C--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred C--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 2 122344578999999999986 56899999999999999999999999865443322111100000 000000
Q ss_pred C-------CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 324 F-------PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 324 ~-------~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+ ...................+.+||.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 00000000000011123578899999999999999999999873
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=373.52 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=207.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.++||+|+||+||+|+++.+++.||||++++.. ......+..|..+|..+ +||||++++++|.+.+.+||
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 578999999999999999999999999999999997542 12345678899999887 79999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999976 357999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ......+......
T Consensus 172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---- 239 (353)
T 2i0e_A 172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNVA---- 239 (353)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC----
T ss_pred ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCCC----
Confidence 221 1233457899999999999999999999999999999999999999975321 1112222222211
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~ 368 (522)
++......+.+||.+||+.||.+||+ +.+|+++
T Consensus 240 --------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 --------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 12223357889999999999999995 4666553
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=372.21 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=207.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+|+.++||||+++++++......+||
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999996532 12235788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+ +|+|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6799999876 467999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... .+
T Consensus 160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i 220 (336)
T 3h4j_B 160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KV 220 (336)
T ss_dssp TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CC
T ss_pred CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HH
Confidence 32 22345679999999999988776 689999999999999999999997543221110 00
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.... ...+......+.+||.+||+.||.+|||+.+|++.-.
T Consensus 221 ~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 221 NSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp CSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred HcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 0000 0122223457789999999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=385.91 Aligned_cols=264 Identities=21% Similarity=0.244 Sum_probs=213.1
Q ss_pred cHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEE
Q 009933 84 TFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCA 160 (522)
Q Consensus 84 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~ 160 (522)
.+.++....++|++.++||+|+||+||+|++..+++.||||++.+... .....+..|+.+|..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 344555667899999999999999999999999999999999965321 12234788999999999999999999999
Q ss_pred cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeee
Q 009933 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSD 240 (522)
Q Consensus 161 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~D 240 (522)
+.+.+|||||||++|+|.+++... ...+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999762 467999999999999999999999999 99999999999999999999999
Q ss_pred ecceeeCCCCCCCcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh
Q 009933 241 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 241 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~ 315 (522)
||+++...... .......+||+.|+|||++. ...|+.++|||||||+||||++|+.||...... ....
T Consensus 219 FGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~ 291 (437)
T 4aw2_A 219 FGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYG 291 (437)
T ss_dssp CTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH
T ss_pred hhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHH
Confidence 99998643322 22234568999999999997 457899999999999999999999999754221 1111
Q ss_pred hhhhc--ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCC--CCCHHHHHHHH
Q 009933 316 PLFKD--RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT--RPLIGDVVTAL 369 (522)
Q Consensus 316 ~~~~~--~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~evl~~L 369 (522)
.+... ...++.... .....+.+||.+||+.+|++ ||++.||++.-
T Consensus 292 ~i~~~~~~~~~p~~~~---------~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 292 KIMNHKERFQFPTQVT---------DVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHHTHHHHCCCCSSCC---------CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred hhhhccccccCCcccc---------cCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 11111 111121111 12356789999999998888 99999998743
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=366.26 Aligned_cols=266 Identities=27% Similarity=0.401 Sum_probs=215.5
Q ss_pred hcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~ 164 (522)
.++|++.+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|+.+|..+ +||||++++++|...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999996 45678999999976543 2346788999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPP--------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976321 1235899999999999999999999999 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~ 309 (522)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 9999999999999987544333223334567889999999999999999999999999999999 999997653221 1
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
..... .... ... .+......+.+||.+||+.||.+||++.+|++.|+.+....
T Consensus 257 ~~~~~----~~~~--~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 FYKMI----KEGF--RML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHH----HHTC--CCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHh----ccCC--CCC--------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11111 1110 000 11122357889999999999999999999999999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=361.26 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=206.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCC-------cEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTG-------QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g-------~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~ 164 (522)
.++|++.+.||+|+||+||+|.+..++ ..||+|++........+.+.+|+.+|+.++||||++++++|.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999998776 4799999976655556789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--------e
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH--------P 236 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~--------v 236 (522)
.+|||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999762 334899999999999999999999999 999999999999988877 9
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~ 315 (522)
||+|||++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|+..... .....
T Consensus 161 kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~~---- 228 (289)
T 4fvq_A 161 KLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRKL---- 228 (289)
T ss_dssp EECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHH----
T ss_pred eeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hHHHH----
Confidence 999999987431 1223568999999999987 6799999999999999999996655432211 11111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
........++... ...+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 229 ~~~~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 229 QFYEDRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHHHTTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred HHhhccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111111222211 124668999999999999999999999999875433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.39 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=211.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|.+. ++..||||++..... ....+.+|+.+|..++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 567999999999999999999887 477899999976543 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999762 345899999999999999999999999 9999999999999999999999999998753332
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .....+.... ....
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~----~~~~- 226 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGH----RLYR- 226 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTC----CCCC-
T ss_pred h-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCC----CCCC-
Confidence 1 12233456778999999999899999999999999999999 99999754221 1111111110 0011
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
+......+.+|+..||+.||++|||+.+|++.|+.+..+
T Consensus 227 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 ------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111224688999999999999999999999999987644
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=365.90 Aligned_cols=260 Identities=23% Similarity=0.304 Sum_probs=199.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCe----
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQ---- 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~---- 164 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++..++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 578999999999999999999999999999999997654332 2467889999999999999999999876543
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.||||||+++++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999976 457999999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCC-cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 245 KLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 245 ~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCC
Confidence 864332211 1223467999999999999999999999999999999999999999754221 111111111100
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH-HHHHh
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT-ALTYL 372 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~-~L~~l 372 (522)
. ..... ......+.+||.+||+.||++||+..+++. .|..+
T Consensus 238 ~----~~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 P----PSARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp C----HHHHS----TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C----ccccc----CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 00000 112356789999999999999996666554 45443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=371.01 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=193.9
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ..+.+.+|+.+|..++||||++++++|......+||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999999999999999997542 34567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCceeeeeecceeeC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---GFHPKLSDFGLAKLG 247 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---~~~vkL~DFGla~~~ 247 (522)
|+++++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999976 466999999999999999999999999 999999999999975 889999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+. ..+..... ..
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~---~~i~~~~~---~~ 270 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMF---RRILNCEY---YF 270 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHH---HHHHTTCC---CC
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHH---HHHHhCCC---cc
Confidence 321 1234567999999999999999999999999999999999999999654321 1111 11111111 11
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+ ........+.+||.+||+.||++||++.++++.
T Consensus 271 ~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111233578899999999999999999999873
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=367.36 Aligned_cols=268 Identities=24% Similarity=0.320 Sum_probs=193.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++...+..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4679999999999999999999999999999999976532 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 171 FMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|+. ++|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886421 22346899999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh--------
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK-------- 319 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~-------- 319 (522)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhh
Confidence 221 123345789999999999864 689999999999999999999999975432111 111100000
Q ss_pred cccCCCCcCC-----------ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 320 DRRKFPKMAD-----------PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 320 ~~~~~~~~~d-----------~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....+..... ..+...........+.+||.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000 000000111223578899999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.98 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=216.5
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..++|++.+.||+|+||+||+|.+..++..||||++.... ...+.+.+|+.+|+.++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999999999999999997543 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999762 3456999999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .+..... ...
T Consensus 165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~----~~~------- 229 (288)
T 3kfa_A 165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE----KDY------- 229 (288)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH----TTC-------
T ss_pred c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----ccC-------
Confidence 2 222334557889999999999999999999999999999999 99999764322 1111111 100
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
....+......+.+|+..||+.||.+||++.+|++.|+.+...
T Consensus 230 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 230 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 0011122235788999999999999999999999999887544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=372.02 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=201.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||++++..+++.||||++.... .....+.+|+.+++.++||||++++++|.....++|||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999999999999999997643 3346688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--eeeeeecceeeCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH--PKLSDFGLAKLGPV 249 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~--vkL~DFGla~~~~~ 249 (522)
+.+++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999975 457999999999999999999999999 999999999999987765 99999999974322
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLK-SDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
. ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ .......+......++.
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~-- 243 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKYSIPD-- 243 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCCCCCT--
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCCCCCC--
Confidence 1 12334679999999999998888765 8999999999999999999986544322 12222222221111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.......+.+||.+||+.||++|||+.+|+++-..
T Consensus 244 --------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 244 --------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp --------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred --------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 01123577899999999999999999999986543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=356.95 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=206.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch-------HHHHHHHHHHHhCCCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN-------REFLVEVLMLSLLHHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~-------~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~ 164 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4689999999999999999999999999999999965433221 56889999999999999999999997655
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc-----eeee
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH-----PKLS 239 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~-----vkL~ 239 (522)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ .+|+|+||||+||||+.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999999865 2457999999999999999999999875 45999999999999987776 9999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhh--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||........ .+....
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~ 242 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMI 242 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHH
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHH
Confidence 9999985321 234567999999999984 45678999999999999999999999976543211 111111
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.... .. + .++......+.+||.+||+.||++||++.+|++.|+.+
T Consensus 243 ~~~~--~~----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEG--LR----P----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSC--CC----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccC--CC----C----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1110 00 1 11222335788999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=356.44 Aligned_cols=254 Identities=30% Similarity=0.440 Sum_probs=197.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc----chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ----GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~----~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.++||+|+||.||+|.+. ++.||||++...... ..+.+.+|+.+++.++||||++++++|.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 467999999999999999999985 889999998754322 23568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--------CCceeee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE--------GFHPKLS 239 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~--------~~~vkL~ 239 (522)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+..+|+|+||||+||||+. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999864 57999999999999999999999987555889999999999986 7789999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 319 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 319 (522)
|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+ ....
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~--~~~~ 228 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----AVAY--GVAM 228 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHH--HHHT
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH--hhhc
Confidence 999998543221 22457999999999999999999999999999999999999999754211 1110 1111
Q ss_pred cccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 320 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 320 ~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
.. . ....+......+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 229 ~~--~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NK--L--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SC--C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC--C--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 10 0 0011222335788999999999999999999999999753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=368.61 Aligned_cols=260 Identities=27% Similarity=0.453 Sum_probs=204.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEE----EEEEEccC-CccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVV----AVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~v----AvK~i~~~-~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.++|++.++||+|+||+||+|.+..+++.| |+|.+... .......+.+|+.+|+.++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999998877765 66666433 2334567899999999999999999999998765 78
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||||+.+++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999762 456999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..............+|+.|+|||++.+..|+.++|||||||++|||++ |..||....... +.... ......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~----~~~~~~- 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGERL- 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCCC-
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCCC-
Confidence 543333333344557889999999999999999999999999999999 999997653321 11111 111100
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+......+.+||.+||+.||.+||++.+|++.|+.+...
T Consensus 239 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 ---------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11122335688999999999999999999999999988644
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=365.50 Aligned_cols=250 Identities=28% Similarity=0.379 Sum_probs=198.4
Q ss_pred hcCCcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCc----cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~----~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~ 164 (522)
.++|++.++||+|+||+||+|++. .+++.||||+++.... .....+.+|+.+|+.++||||++++++|...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999985 5799999999976532 223457789999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
+||||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999976 457899999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
...... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+......+
T Consensus 169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~ 240 (327)
T 3a62_A 169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCKLNL 240 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCCC
T ss_pred cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCC
Confidence 753221 1223456799999999999999999999999999999999999999975421 11111222221111
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
+......+.+||.+||+.||++|| ++.+++++
T Consensus 241 ------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 241 ------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 122235678999999999999999 67787764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=361.81 Aligned_cols=269 Identities=22% Similarity=0.335 Sum_probs=206.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
..+|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+|+.++||||++++++|...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999999989999999999754322 235688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++.........+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999754334567999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... .......|++.|+|||++.+..++.++|||||||++|+|++|..||..... +.......+... .++...
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~--~~~~~~ 259 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQC--DYPPLP 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTT--CSCCCC
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcc--cCCCCc
Confidence 221 122345689999999999999999999999999999999999999975422 111111111111 111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccCCC
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDP 379 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~ 379 (522)
. ......+.+|+.+||+.||++||++.+|++.|+.+......+
T Consensus 260 ----~----~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 260 ----S----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp ----T----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred ----c----cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 1 112356889999999999999999999999999997766543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=390.33 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=214.8
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
...+|++.+.||+|+||.||+|.+..++..||||+++... ...+.|.+|+.+|+.++|||||+++++|.....++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3567899999999999999999999889999999997654 345779999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||.+|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999762 2356899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. ........+++.|+|||++....++.++|||||||+||||++ |..||...... .+.... .....
T Consensus 372 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~~------ 437 (495)
T 1opk_A 372 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKDYR------ 437 (495)
T ss_dssp C-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTTCC------
T ss_pred c-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCC------
Confidence 1 112223456789999999999999999999999999999999 99999764321 111111 11100
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
...+......+.+||.+||+.||++||++.+|++.|+.+.
T Consensus 438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1112223367889999999999999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=383.90 Aligned_cols=196 Identities=25% Similarity=0.347 Sum_probs=157.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEc-----CCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-----GDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-----~~~ 164 (522)
.++|++.++||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+|+.++|||||+++++|.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4789999999999999999999999999999999965422 234568899999999999999999999944 357
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
+||||||+ +++|.+++.. ...+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 4699999976 467999999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCC-------------------------cceecccCCccccChhhhh-cCCCCcchhhHHHHHHHHHHHhC
Q 009933 245 KLGPVGDKT-------------------------HVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITG 295 (522)
Q Consensus 245 ~~~~~~~~~-------------------------~~~~~~~gt~~y~APE~l~-~~~~~~~sDVwSlGvll~eLltG 295 (522)
+........ ...+..+||+.|+|||++. ...|+.++||||||||||||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 865322110 1234567899999999874 56799999999999999999993
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=371.05 Aligned_cols=249 Identities=23% Similarity=0.300 Sum_probs=201.2
Q ss_pred ccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCC
Q 009933 97 PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 97 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
..++||+|+||.||+|.+..+++.||||++........+.+.+|+.+|..++||||++++++|...+.++|||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 36789999999999999999999999999987665566788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee--cCCCceeeeeecceeeCCCCCCCc
Q 009933 177 LEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTH 254 (522)
Q Consensus 177 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl--d~~~~vkL~DFGla~~~~~~~~~~ 254 (522)
|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++.......
T Consensus 173 L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 173 LFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp EHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 9999865 2356899999999999999999999999 9999999999999 677899999999998754332
Q ss_pred ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccC
Q 009933 255 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQG 334 (522)
Q Consensus 255 ~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 334 (522)
.....+||+.|+|||++....++.++|||||||++|||++|..||...... .....+......+. ....
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~~~---~~~~-- 312 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWDLE---DEEF-- 312 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCSC---SGGG--
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCCC---hhhh--
Confidence 223457999999999999989999999999999999999999999754221 11111112111111 1111
Q ss_pred CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 335 RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 335 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+.+||.+||+.||.+||++.++++.
T Consensus 313 ---~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 313 ---QDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1123578899999999999999999999984
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=359.42 Aligned_cols=258 Identities=23% Similarity=0.384 Sum_probs=208.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||++.+. ++..||||++..... ..+.+.+|+.+|..++||||++++++|.+....++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 568999999999999999999987 578899999976543 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999752 356999999999999999999999999 9999999999999999999999999998643211
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .... .+... ....
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~---~~~~~---~~~~--- 241 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE---HIAQG---LRLY--- 241 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH---HHHTT---CCCC---
T ss_pred -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHH---HHhcc---cCCC---
Confidence 111223456788999999999999999999999999999998 99999754321 1111 11111 0000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.+......+.+|+.+||+.||++||++.+|++.|+.+..+
T Consensus 242 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 242 -----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111235688999999999999999999999999987643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.06 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=209.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEE----cCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA----DGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~----~~~~~~l 167 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 468999999999999999999999899999999997665555677889999999999999999999987 3457899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+.+++|.+++.........+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999765445678999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCCc-------ceecccCCccccChhhhhcCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 248 PVGDKTH-------VSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 248 ~~~~~~~-------~~~~~~gt~~y~APE~l~~~~---~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||......... +....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~--- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAV--- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHh---
Confidence 2111100 012345799999999987654 789999999999999999999999532111110 11100
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
.....++ .+......+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 261 -~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 -QNQLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -HCC--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -hccCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0100000 111223578899999999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=384.51 Aligned_cols=250 Identities=27% Similarity=0.334 Sum_probs=200.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccC---CccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.++||+|+||.||+|.+..+++.||||++... .......+..|+.+|+.++||||++++++|...+.+|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999999753 222335677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||++++|.+++.. ...+++..+..++.||+.||.|||+ .+ ||||||||+||||+.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999976 4679999999999999999999998 88 999999999999999999999999999853
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ......+......+
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~--- 368 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEIRF--- 368 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCCC---
Confidence 222 2233457899999999999999999999999999999999999999965422 11111122221111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
+......+.+||.+||+.||.+|| ++.+|+++
T Consensus 369 ---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 369 ---------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 122235678999999999999999 99999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=365.29 Aligned_cols=263 Identities=23% Similarity=0.237 Sum_probs=205.0
Q ss_pred HHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccC-----CccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN-----GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD 163 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~-----~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~ 163 (522)
....++|++.+.||+|+||+||+|.+..+++.||||++... .....+.+.+|+.+|+.++||||++++++|.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 44567899999999999999999999999999999999653 2234467889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhccCCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPD------------------------------------KEPLDWNTRMKIAAGAAKGL 207 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~~L 207 (522)
..+||||||++++|.+++...... ...+++..++.|+.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998631111 12246778899999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceeecCCC--ceeeeeecceeeCCCCCCC--cceecccCCccccChhhhhc--CCCCcchh
Q 009933 208 EYLHDKANPPVIYRDLKSSNILLDEGF--HPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMT--GQLTLKSD 281 (522)
Q Consensus 208 ~yLH~~~~~~iiHrDLKp~NILld~~~--~vkL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~--~~~~~~sD 281 (522)
.|||+.+ |+|+||||+||||+.++ .+||+|||++......... .......||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999 99999999999998766 8999999999864322211 12345679999999999975 67899999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC
Q 009933 282 VYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL 361 (522)
Q Consensus 282 VwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs 361 (522)
||||||++|||++|+.||...... .....+......+ ..+.. ......+.+||.+||+.||.+||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~---~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCF---ENPNY-----NVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCT---TSGGG-----GGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccccc---CCccc-----ccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999754321 1111112211111 11111 112357889999999999999999
Q ss_pred HHHHHHH
Q 009933 362 IGDVVTA 368 (522)
Q Consensus 362 ~~evl~~ 368 (522)
+.++++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999884
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=371.75 Aligned_cols=270 Identities=19% Similarity=0.213 Sum_probs=207.1
Q ss_pred hcCCcccceeccc--CceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEG--GFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G--~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.++||+| +||+||+|++..+++.||||++...... ....+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 9999999999999999999999765322 23567789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||||++++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999762 2356999999999999999999999999 999999999999999999999999998653
Q ss_pred CCCCC-----CcceecccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh-
Q 009933 248 PVGDK-----THVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK- 319 (522)
Q Consensus 248 ~~~~~-----~~~~~~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~- 319 (522)
..... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......... .......+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCc
Confidence 21111 111223478999999999987 57999999999999999999999999765432211 110000000
Q ss_pred --cccC------------------CCCcC---------CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 320 --DRRK------------------FPKMA---------DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 320 --~~~~------------------~~~~~---------d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.... +.... .......++......+.+||.+||+.||++|||+.++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000 00000 0000001222334578899999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=366.47 Aligned_cols=211 Identities=26% Similarity=0.319 Sum_probs=183.8
Q ss_pred ccccHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-----CCCccee
Q 009933 81 QTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----HSNLVNL 155 (522)
Q Consensus 81 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-----hpnIv~l 155 (522)
..+++.+.....++|++.++||+|+||+||+|++..+++.||||++... ......+..|+.+|+.+. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3445555556678999999999999999999999999999999999642 233456778999999986 9999999
Q ss_pred EEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---
Q 009933 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE--- 232 (522)
Q Consensus 156 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~--- 232 (522)
+++|...+..+|||||+ +++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 99999999999999999 88999999762 2345999999999999999999999999 999999999999975
Q ss_pred ----------------------CCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHH
Q 009933 233 ----------------------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFL 290 (522)
Q Consensus 233 ----------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~ 290 (522)
++.+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 78999999999986432 223467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC
Q 009933 291 ELITGRKAIDNTR 303 (522)
Q Consensus 291 eLltG~~Pf~~~~ 303 (522)
+|++|+.||....
T Consensus 251 ell~g~~pf~~~~ 263 (360)
T 3llt_A 251 ELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHSSCSCCCSS
T ss_pred HHHHCCCCCCCCc
Confidence 9999999997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=365.22 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=200.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD------- 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------- 163 (522)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+|+.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4679999999999999999999999999999999975433 23467899999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEeecCCCChhhhhccCCCCCCCCCH
Q 009933 164 --------------------------------------------------QRLLVYEFMPLGSLEDHLHDLPPDKEPLDW 193 (522)
Q Consensus 164 --------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~ 193 (522)
..++|||||++++|.+++.... .....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3799999999999999998632 2244677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC----------cceecccCCc
Q 009933 194 NTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT----------HVSTRVMGTY 263 (522)
Q Consensus 194 ~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~gt~ 263 (522)
..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......... ......+||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 789999999999999999999 999999999999999999999999999875433211 1223457999
Q ss_pred cccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHH
Q 009933 264 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQ 343 (522)
Q Consensus 264 ~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 343 (522)
.|+|||++.+..++.++|||||||++|||++|..|+.. .......... ..++. ........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~~~~--~~~~~---------~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITDVRN--LKFPL---------LFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHHHHT--TCCCH---------HHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHHhhc--cCCCc---------ccccCChh
Confidence 99999999999999999999999999999998765421 1111100000 00000 01123356
Q ss_pred HHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 344 ALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 344 l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+.+||.+||+.||++||++.+|++.
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7899999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=358.30 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=200.6
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||+||+|.+ .+++.||||++...... ....+.+|+.+|+.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999999 56899999999754322 23678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9976 999998752 357899999999999999999999999 999999999999999999999999999764321
Q ss_pred CCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh-------hhccc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL-------FKDRR 322 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~-------~~~~~ 322 (522)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ +....... +....
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGG
T ss_pred --ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhh
Confidence 1122345789999999999764 589999999999999999999999975432111 11110000 00000
Q ss_pred CCCCcCCcccc-------CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 323 KFPKMADPLLQ-------GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 323 ~~~~~~d~~l~-------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.++. .++.+. ..+.......+.+||.+||+.||++|||+.++++.
T Consensus 230 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 230 ELPK-YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GSTT-CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccc-cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 000000 00111234577899999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.60 Aligned_cols=253 Identities=22% Similarity=0.242 Sum_probs=209.3
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+|+.++||||++++++|.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35679999999999999999999999999999999987655667789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCceeeeeecceeeC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl---d~~~~vkL~DFGla~~~ 247 (522)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||| +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999876 466899999999999999999999999 9999999999999 78899999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... . ....+......++.
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~~~~~~~~~- 228 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS---E---VMLKIREGTFTFPE- 228 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHCCCCCCH-
T ss_pred cCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH---H---HHHHHHhCCCCCCc-
Confidence 3322 2334579999999999876 4999999999999999999999999754221 1 11111111111000
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
... . .....+.+||.+||+.||++||++.++++.
T Consensus 229 --~~~-~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 --KDW-L----NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp --HHH-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --hhh-h----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 123578899999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=365.81 Aligned_cols=251 Identities=23% Similarity=0.279 Sum_probs=182.9
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEeecCCCC
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
.++||+|+||+||+|.+..+++.||||++... ....+.+|+.+|..+. ||||++++++|.+....||||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999999999999999999653 3456788999999997 9999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---ceeeeeecceeeCCCCCCC
Q 009933 177 LEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF---HPKLSDFGLAKLGPVGDKT 253 (522)
Q Consensus 177 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~---~vkL~DFGla~~~~~~~~~ 253 (522)
|.+++.. ...+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||++.......
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-- 163 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-- 163 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--
Confidence 9999986 467999999999999999999999999 99999999999997665 89999999998643322
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHhhhhhhhcccCCCCcCCccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH-NLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......... ........+......+ ..+.
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~---~~~~- 239 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF---EGEA- 239 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC---CSHH-
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC---Cccc-
Confidence 2234567899999999999999999999999999999999999999765432111 1111111111111000 0000
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.......+.+||.+||+.||++||++.+|++.
T Consensus 240 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 ----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 01123578899999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=368.90 Aligned_cols=257 Identities=23% Similarity=0.262 Sum_probs=206.7
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
..++|++.+.||+|+||+||+|.++.+++.||||++..... ...+|+++|..+ +||||++++++|.+....||||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 35679999999999999999999999999999999976542 234678888777 7999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC----Cceeeeeeccee
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG----FHPKLSDFGLAK 245 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~----~~vkL~DFGla~ 245 (522)
|||.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||.+. +.+||+|||++.
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999976 467999999999999999999999999 9999999999998432 359999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........+... +......+.
T Consensus 169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~~~~~~~~ 243 (342)
T 2qr7_A 169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---IGSGKFSLS 243 (342)
T ss_dssp ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH---HHHCCCCCC
T ss_pred cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH---HccCCcccC
Confidence 753322 223456799999999999988899999999999999999999999975432222222221 111111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
..+.......+.+||.+||+.||++||++.+|++.-..
T Consensus 244 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 244 --------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp --------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred --------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 11112234678899999999999999999999986543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=379.52 Aligned_cols=255 Identities=29% Similarity=0.403 Sum_probs=209.7
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC-eeEEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-QRLLVY 169 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-~~~lV~ 169 (522)
..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|+.++||||+++++++.... .++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3467899999999999999999986 7899999997653 4577999999999999999999999987765 789999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999762 2234799999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
. .....+++.|+|||++.+..++.++|||||||+||||++ |..||........ ...+ .....
T Consensus 342 ~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i----~~~~~----- 404 (450)
T 1k9a_A 342 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKGYK----- 404 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHH----HTTCC-----
T ss_pred c-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCCC-----
Confidence 1 122357889999999999999999999999999999998 9999976543221 1111 11100
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
...+......+.+||.+||+.||++|||+.+|++.|+.+....
T Consensus 405 -----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 405 -----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 0112223467889999999999999999999999999886543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=359.17 Aligned_cols=253 Identities=26% Similarity=0.301 Sum_probs=208.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------chHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+|..++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999999999999999999764332 246788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----ceeeeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF----HPKLSDF 241 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~----~vkL~DF 241 (522)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999976 467899999999999999999999999 99999999999999887 7999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .... ..+....
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~---~~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETL---ANITSVS 234 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHH---HHHHTTC
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHhcc
Confidence 9998754322 22346799999999999999999999999999999999999999975421 1111 1111111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.. .++.+.. .....+.+||.+||+.||++||++.++++.
T Consensus 235 ~~----~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YD----FDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC----CCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc----cChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 1111111 122567899999999999999999999873
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=374.90 Aligned_cols=248 Identities=25% Similarity=0.307 Sum_probs=198.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHH-HHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLM-LSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~-L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.++||+|+||+||+|+++.+++.||||++.+.... ....+..|..+ ++.++||||++++++|.+.+.+||
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 46799999999999999999999999999999999765432 22345667666 577899999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999976 467899999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||..... ......+......+
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~~--- 258 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPLQL--- 258 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSCCCC---
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcccCC---
Confidence 222 1233457899999999999999999999999999999999999999975321 11122222221111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 366 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl 366 (522)
+......+.+||.+||+.||.+||++.+.+
T Consensus 259 ---------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 259 ---------KPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ---------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ---------CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 112235678999999999999999986433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=358.50 Aligned_cols=261 Identities=29% Similarity=0.443 Sum_probs=196.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||+||+|.+.. .||||++...... ..+.+.+|+.+|+.++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 5689999999999999999998753 5999999755332 235688999999999999999999965 556789999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999965 2467999999999999999999999999 99999999999999999999999999986443
Q ss_pred CCCCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
...........||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ..+.... ... .+..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~~-~~~~ 245 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMV----GRG-SLSP 245 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHH----HHT-SCCC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHh----ccc-ccCc
Confidence 33333344567999999999997 567889999999999999999999999754321 1111111 111 1111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
.... ........+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 246 ~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLSK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chhh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111 111233678899999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=365.75 Aligned_cols=266 Identities=26% Similarity=0.383 Sum_probs=213.3
Q ss_pred hcCCcccceecccCceEEEEEEEC-------CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE-------STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~ 162 (522)
.++|++.+.||+|+||+||+|.+. .++..||||++..... .....+.+|+.+|+.+ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999985 3567899999976532 2335688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPD------------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
+..+|||||+.+++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|+||||+||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999863321 235899999999999999999999999 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~ 309 (522)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence 9999999999999987544332222334567889999999999999999999999999999999 9999975422 11
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
+.... ... .. . ..+......+.+||.+||+.||.+||++.+|++.|+.+.....
T Consensus 268 ~~~~~---~~~-~~-~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 LFKLL---KEG-HR-M---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHH---HHT-CC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHH---hcC-CC-C---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 11111 111 00 0 0112233578899999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=359.65 Aligned_cols=262 Identities=24% Similarity=0.289 Sum_probs=202.7
Q ss_pred hcCCccc-ceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPE-CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.+.|++. ++||+|+||+||+|.+..+++.||||++..........+.+|+.+|.++ +||||+++++++.+.+.++|||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678884 7899999999999999999999999999876555567889999999884 7999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---eeeeeecceee
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH---PKLSDFGLAKL 246 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~---vkL~DFGla~~ 246 (522)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999976 357899999999999999999999999 999999999999988766 99999999875
Q ss_pred CCCCCC-----CcceecccCCccccChhhhhc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH------
Q 009933 247 GPVGDK-----THVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL------ 310 (522)
Q Consensus 247 ~~~~~~-----~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~------ 310 (522)
...... .......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 432111 111224569999999999975 4689999999999999999999999986543221100
Q ss_pred ---HHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 311 ---VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 311 ---~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+......++ .... ......+.+||.+||+.||++||++.++++.
T Consensus 244 ~~~~~~~~~i~~~~~~~~---~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFP---DKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHCCCCCC---HHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHHhccCcccC---chhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000111111110000 0000 0123568899999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.29 Aligned_cols=268 Identities=25% Similarity=0.334 Sum_probs=202.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++....... .+.+.+|+.+|+.++||||++++++|...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999999999999999996654322 355788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999998865 466999999999999999999999999 99999999999999999999999999987432
Q ss_pred CCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh--------hhhhhc
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA--------RPLFKD 320 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~--------~~~~~~ 320 (522)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... ...+..
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 155 P--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 2 122345678999999999986 57899999999999999999999999765332111111100 000000
Q ss_pred ccCCCCcCCccccCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 RRKFPKMADPLLQGRYP-----MRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...+.....+......+ ......+.+||.+||+.||++|||+.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000000000 1233568899999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=364.47 Aligned_cols=275 Identities=26% Similarity=0.384 Sum_probs=217.9
Q ss_pred ccHHHHHHhhcCCcccceecccCceEEEEEEE-----CCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCccee
Q 009933 83 FTFRELAAATKNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNL 155 (522)
Q Consensus 83 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~l 155 (522)
+...++....++|++.+.||+|+||+||+|.+ ..+++.||||++...... ....+.+|+.+|..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555678999999999999999999985 346789999999765432 235688999999999 69999999
Q ss_pred EEEEEcCC-eeEEEEeecCCCChhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 009933 156 IGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPD------------KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 222 (522)
Q Consensus 156 ~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrD 222 (522)
+++|...+ .+++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|+|
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987754 589999999999999999863221 223889999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 009933 223 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDN 301 (522)
Q Consensus 223 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~ 301 (522)
|||+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986543333233344568899999999999999999999999999999998 9999976
Q ss_pred CCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 302 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
..... .+.... ..... .. .+......+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus 254 ~~~~~--~~~~~~----~~~~~-~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDE--EFCRRL----KEGTR-MR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSH--HHHHHH----HHTCC-CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhH--HHHHHh----ccCcc-CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 43221 111111 11100 00 11122356889999999999999999999999999886543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=369.12 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=212.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCc-----EEEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQ-----VVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~-----~vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~ 164 (522)
.++|++.+.||+|+||+||+|.+..+++ .||||++..... .....+.+|+.+|..+ +||||++++++|...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 5789999999999999999999976654 799999976532 2345688999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPP----------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF 234 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~ 234 (522)
.+|||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 9999999999999999964210 1346899999999999999999999999 99999999999999999
Q ss_pred ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHh
Q 009933 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAW 313 (522)
Q Consensus 235 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~ 313 (522)
.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|+| |..||....... .+...
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~ 279 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYKL 279 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHHH
Confidence 999999999986433332222334557889999999999999999999999999999999 999997543221 11111
Q ss_pred hhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 314 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
. ...... ..+......+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 280 ~----~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 280 V----KDGYQM----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp H----HHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----hcCCCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1 111100 01111235678999999999999999999999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=356.77 Aligned_cols=266 Identities=27% Similarity=0.404 Sum_probs=209.1
Q ss_pred hcCCcccceecccCceEEEEEE----ECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcC--Ce
Q 009933 92 TKNFRPECLLGEGGFGRVYKGR----LESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~----~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~ 164 (522)
..+|++.+.||+|+||.||+|+ +..+++.||||++..... .....+.+|+.+|..++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3568999999999999999999 466799999999975432 3346788999999999999999999999877 67
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
+++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999955 2356999999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCC-cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------CCCcchHHHhhh
Q 009933 245 KLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR--------PPGEHNLVAWAR 315 (522)
Q Consensus 245 ~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~--------~~~~~~~~~~~~ 315 (522)
......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+.... +...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 875433221 12334568889999999999999999999999999999999998864321 000111111111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
....... ....+......+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 254 ~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111 01122233467889999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.20 Aligned_cols=256 Identities=20% Similarity=0.235 Sum_probs=197.7
Q ss_pred hcCCccc-ceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHH-HhCCCCCcceeEEEEEc----CCee
Q 009933 92 TKNFRPE-CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLVNLIGYCAD----GDQR 165 (522)
Q Consensus 92 ~~~y~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L-~~l~hpnIv~l~~~~~~----~~~~ 165 (522)
.++|.+. ++||+|+||+||+|.+..+++.||||++.. ...+.+|+.++ +.++||||++++++|.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 789999999999999999999999999953 34567888887 45689999999999875 5678
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCceeeeeec
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---GFHPKLSDFG 242 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---~~~vkL~DFG 242 (522)
|||||||.+|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999762 2346999999999999999999999999 999999999999987 7899999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch-HHHhhhhhhhcc
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN-LVAWARPLFKDR 321 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~ 321 (522)
+++..... ......+||+.|+|||++.+..|+.++||||||||||||++|..||.......... ..... ....
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~~~~ 283 (400)
T 1nxk_A 210 FAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMGQ 283 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---HHTC
T ss_pred cccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---HcCc
Confidence 99864322 12345679999999999999999999999999999999999999997654332211 11111 1111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
..++ .+.. ......+.+||.+||+.||++|||+.+|++.-..
T Consensus 284 ~~~~---~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 284 YEFP---NPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp CCCC---TTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ccCC---Cccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 1111 0000 1223568899999999999999999999987554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=385.55 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=208.7
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.++||+|+||+||+|+++.+++.||||++.+... .....+..|+.+|..++||||++++++|.+...+||||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 679999999999999999999999999999999965432 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||++||+|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+||||+.++++||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999875444567999999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ .......+......
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~~~------ 411 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQAVT------ 411 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCCCC------
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcccC------
Confidence 221 23346899999999999999999999999999999999999999986533221 11122222222111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 362 (522)
++......+.+||.+||+.||++||++
T Consensus 412 ------~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 412 ------YPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ------CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ------CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 222233577899999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=349.67 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=208.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999999999999999999754332 2356789999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---eeeeeecceee
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH---PKLSDFGLAKL 246 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~---vkL~DFGla~~ 246 (522)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||||+.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999876 467999999999999999999999999 999999999999976655 99999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.......+
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~- 227 (284)
T 3kk8_A 158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYDYP- 227 (284)
T ss_dssp CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCC-
T ss_pred cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhccccCC-
Confidence 43322 223467999999999999999999999999999999999999999653221 11111111111111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+.. ......+.+|+.+||+.||++||++.++++.-
T Consensus 228 --~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 228 --SPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp --TTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred --chhh-----cccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 1100 11235678999999999999999999999854
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=357.55 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=199.2
Q ss_pred hcCCcccceecccCceEEEEEEECCC---CcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.+.||+|+||.||+|.+..+ +..||||++...... ..+.+.+|+.+|+.++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 46799999999999999999999653 457999998754322 2356889999999999999999999984 567899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999752 346899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
..... .......+|+.|+|||++....++.++|||||||++|||++ |..||...... ...... ... .. .
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i---~~~-~~-~- 236 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---ENG-ER-L- 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH---HTT-CC-C-
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH---HcC-CC-C-
Confidence 33221 12233457789999999999999999999999999999997 99999754322 111111 110 00 0
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+......+.+|+.+||+.||++||++.+|++.|+.+..+
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01122335788999999999999999999999999987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=358.20 Aligned_cols=266 Identities=25% Similarity=0.318 Sum_probs=202.1
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-----cchHHHHHHHHHHHhCC---CCCcceeEEEEEcC
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLH---HSNLVNLIGYCADG 162 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-----~~~~~~~~E~~~L~~l~---hpnIv~l~~~~~~~ 162 (522)
..++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.+++.++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46789999999999999999999999999999999964321 12345677887777665 99999999999876
Q ss_pred C-----eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcee
Q 009933 163 D-----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK 237 (522)
Q Consensus 163 ~-----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vk 237 (522)
. ..++||||+. ++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 5799999997 5999999762 2344999999999999999999999999 99999999999999999999
Q ss_pred eeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 238 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~ 234 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDL 234 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHH
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence 9999999864322 223456799999999999999999999999999999999999999975432111 1111110
Q ss_pred hhc--ccCCCCc---CCccccC--C-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 FKD--RRKFPKM---ADPLLQG--R-----YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ~~~--~~~~~~~---~d~~l~~--~-----~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
... ....+.. ....+.. . ........+.+||.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 0000000 0000000 0 001233578899999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=377.10 Aligned_cols=262 Identities=23% Similarity=0.234 Sum_probs=209.2
Q ss_pred cHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEE
Q 009933 84 TFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCA 160 (522)
Q Consensus 84 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~ 160 (522)
.+.+.....++|++.++||+|+||+||+|+++.+++.||||++.+... .....+..|+.+|..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 344555567899999999999999999999999999999999975321 12345788999999999999999999999
Q ss_pred cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeee
Q 009933 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSD 240 (522)
Q Consensus 161 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~D 240 (522)
+.+.+|||||||++|+|.+++... ...+++..++.++.||+.||.|||+.+ ||||||||+||||+.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999752 347999999999999999999999999 99999999999999999999999
Q ss_pred ecceeeCCCCCCCcceecccCCccccChhhhh-------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHh
Q 009933 241 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-------TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 313 (522)
Q Consensus 241 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-------~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~ 313 (522)
||+++...... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...... ..
T Consensus 206 FGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~ 278 (412)
T 2vd5_A 206 FGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ET 278 (412)
T ss_dssp CTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH
T ss_pred chhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HH
Confidence 99998753322 11223468999999999998 356899999999999999999999999754221 11
Q ss_pred hhhhhhc--ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCC---CCHHHHHHH
Q 009933 314 ARPLFKD--RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR---PLIGDVVTA 368 (522)
Q Consensus 314 ~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~R---Ps~~evl~~ 368 (522)
...+... ...++. + +......+.+||.+||+ +|.+| |++.+|+++
T Consensus 279 ~~~i~~~~~~~~~p~-----~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 279 YGKIVHYKEHLSLPL-----V----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHTHHHHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHhcccCcCCCc-----c----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1111111 111111 0 11123578899999999 99998 588888764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=357.29 Aligned_cols=269 Identities=25% Similarity=0.322 Sum_probs=204.9
Q ss_pred HHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC--CCCCcceeEEEEEcC---
Q 009933 88 LAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL--HHSNLVNLIGYCADG--- 162 (522)
Q Consensus 88 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l--~hpnIv~l~~~~~~~--- 162 (522)
.....++|++.+.||+|+||.||+|.+. ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3344678999999999999999999986 899999999643 234455566666554 899999999999887
Q ss_pred -CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEecCCCCCceeecCC
Q 009933 163 -DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK--------ANPPVIYRDLKSSNILLDEG 233 (522)
Q Consensus 163 -~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~~~~iiHrDLKp~NILld~~ 233 (522)
...+|||||+++++|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+||||+.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN 178 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred CCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence 789999999999999999976 4699999999999999999999998 7 9999999999999999
Q ss_pred CceeeeeecceeeCCCCCCCc--ceecccCCccccChhhhhcCCCCcc------hhhHHHHHHHHHHHhC----------
Q 009933 234 FHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTGQLTLK------SDVYSFGVVFLELITG---------- 295 (522)
Q Consensus 234 ~~vkL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~------sDVwSlGvll~eLltG---------- 295 (522)
+.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999997643322111 1124579999999999988766665 9999999999999999
Q ss_pred CCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCC-CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 296 RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR-YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 296 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..||.......... ... ...... ....+.+... .+......+.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 259 ~~p~~~~~~~~~~~-~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 259 QLPYHDLVPSDPSY-EDM-REIVCI-----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CCTTTTTSCSSCCH-HHH-HHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccHhhhcCCCCch-hhh-HHHHhh-----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 55554433222111 111 000110 0011111111 112556779999999999999999999999999999875
Q ss_pred cc
Q 009933 375 QT 376 (522)
Q Consensus 375 ~~ 376 (522)
..
T Consensus 332 ~~ 333 (337)
T 3mdy_A 332 SQ 333 (337)
T ss_dssp TT
T ss_pred hc
Confidence 43
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=371.27 Aligned_cols=272 Identities=15% Similarity=0.174 Sum_probs=208.7
Q ss_pred hcCCcccceecccCceEEEEEEECCC-----CcEEEEEEEccCCccch-----------HHHHHHHHHHHhCCCCCccee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST-----GQVVAVKQLDRNGLQGN-----------REFLVEVLMLSLLHHSNLVNL 155 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~-----------~~~~~E~~~L~~l~hpnIv~l 155 (522)
.++|++.++||+|+||+||+|.+..+ ++.||||++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 56899999999999999999999764 57899999876532111 123456667788899999999
Q ss_pred EEEEEcC----CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 009933 156 IGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD 231 (522)
Q Consensus 156 ~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld 231 (522)
++++... ...+|||||+ +++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998764 4589999999 9999999976 2467999999999999999999999999 99999999999998
Q ss_pred --CCCceeeeeecceeeCCCCCCC-----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 009933 232 --EGFHPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP 304 (522)
Q Consensus 232 --~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~ 304 (522)
.++.+||+|||+++........ ......+||+.|+|||++.+..++.++|||||||+||||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999864322111 111345699999999999999999999999999999999999999985322
Q ss_pred CCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 305 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
. ...+........ ..+..++++.+.. ......+.+|+..||+.+|++||++.+|++.|+.+.....
T Consensus 267 ~--~~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 267 D--PKYVRDSKIRYR--ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp C--HHHHHHHHHHHH--HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred C--HHHHHHHHHHhh--hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1 112211111111 1122222222210 1123578899999999999999999999999998866543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=376.12 Aligned_cols=266 Identities=24% Similarity=0.319 Sum_probs=194.7
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCC--ee
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGD--QR 165 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~--~~ 165 (522)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+|..+. ||||++++++|...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4678999999999999999999999999999999996532 223456788999999997 999999999997554 78
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
|||||||. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 589999976 57899999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCC-------------------CCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 009933 246 LGPVGD-------------------KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 305 (522)
Q Consensus 246 ~~~~~~-------------------~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~ 305 (522)
...... .....+..+||+.|+|||++.+ ..|+.++||||||||||||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 643211 1112345689999999999987 67999999999999999999999999764321
Q ss_pred CcchHHHhhhhhhhc----------------------------ccCCCCcCCc----cccCCCChHHHHHHHHHHHHhcc
Q 009933 306 GEHNLVAWARPLFKD----------------------------RRKFPKMADP----LLQGRYPMRGLYQALAVAAMCLQ 353 (522)
Q Consensus 306 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~d~----~l~~~~~~~~~~~l~~Li~~cl~ 353 (522)
.....+ ...+.. ......++.. .............+.+|+.+||+
T Consensus 238 ~~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 111110 000000 0000000000 00000000223568899999999
Q ss_pred cCcCCCCCHHHHHHH
Q 009933 354 EQAATRPLIGDVVTA 368 (522)
Q Consensus 354 ~dP~~RPs~~evl~~ 368 (522)
.||++|||+.|++++
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=368.89 Aligned_cols=269 Identities=29% Similarity=0.405 Sum_probs=212.8
Q ss_pred hcCCcccceecccCceEEEEEEE----CCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEE--cCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA--DGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~--~~~~~ 165 (522)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|+.+|+.++||||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46799999999999999999994 6678999999998765555567899999999999999999999987 45678
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
+|||||+++++|.+++... ...+++..++.|+.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999752 246899999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC--------cchHHHhhhh
Q 009933 246 LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG--------EHNLVAWARP 316 (522)
Q Consensus 246 ~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~--------~~~~~~~~~~ 316 (522)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 754332211 2234568889999999999999999999999999999999999986432100 0000000000
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
..... .....+......+.+||.+||+.||++||++.+|++.|+.+....
T Consensus 256 ~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 256 LLEEG----------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred Hhhcc----------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11110 111122334467889999999999999999999999999876544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=364.33 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=205.8
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--------chHHHHHHHHHHHhCCCCCcceeEEEEEcC
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--------GNREFLVEVLMLSLLHHSNLVNLIGYCADG 162 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~ 162 (522)
..++|++.+.||+|+||+||+|.+..+++.||||++...... ....+.+|+.+|+.++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356899999999999999999999999999999999765322 223567899999999999999999999999
Q ss_pred CeeEEEEeecCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 163 DQRLLVYEFMPLG-SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 163 ~~~~lV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
+.+++||||+.+| +|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999766 99999976 457999999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ....
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~ 239 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TVEA 239 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------GTTT
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------HHhh
Confidence 9998754322 2344679999999999998876 7899999999999999999999964211 0000
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
... .+......+.+||..||+.||++||++.+|++.
T Consensus 240 ~~~------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 AIH------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccC------------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011123568899999999999999999999885
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=363.12 Aligned_cols=267 Identities=25% Similarity=0.359 Sum_probs=202.7
Q ss_pred hhcCCcccceecccCceEEEEEEECC---CCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCC--
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLES---TGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD-- 163 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~---~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~-- 163 (522)
..++|.+.+.||+|+||.||+|.+.. ++..||||++...... ..+.+.+|+.+|+.++||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45789999999999999999998864 4568999999765332 2356889999999999999999999998765
Q ss_pred ---eeEEEEeecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceee
Q 009933 164 ---QRLLVYEFMPLGSLEDHLHDLP--PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 238 (522)
Q Consensus 164 ---~~~lV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL 238 (522)
..++||||+.+++|.+++.... .....+++..++.|+.||+.||.|||+.+ |+|+||||+||||+.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 3599999999999999985321 23467999999999999999999999998 999999999999999999999
Q ss_pred eeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhh
Q 009933 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 239 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .+....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~--- 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYL--- 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH---
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHH---
Confidence 99999986543332223334567889999999999999999999999999999999 88898754321 111111
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
... . .. ..+......+.+||.+||+.||.+||++.+|++.|+.+....+
T Consensus 263 ~~~-~-~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 263 LHG-H-RL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HTT-C-CC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HcC-C-CC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111 0 00 0112233578899999999999999999999999999876553
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=350.64 Aligned_cols=267 Identities=21% Similarity=0.282 Sum_probs=210.5
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEE-EcCCeeEEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC-ADGDQRLLVY 169 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~-~~~~~~~lV~ 169 (522)
..++|++.+.||+|+||+||+|++..+++.||||++..... ...+..|+.++..++|++++..+.++ ......+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45789999999999999999999999999999999765432 34578899999999988877776655 6778889999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCceeeeeecceee
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKL 246 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl---d~~~~vkL~DFGla~~ 246 (522)
||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 89999999752 356999999999999999999999999 9999999999999 7899999999999987
Q ss_pred CCCCCCC-----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh-hhhhhc
Q 009933 247 GPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA-RPLFKD 320 (522)
Q Consensus 247 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~-~~~~~~ 320 (522)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 5443221 1223567999999999999999999999999999999999999999876554433332221 111110
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
. .+.+...+ ...+.+||..||+.||++||++.+|++.|+.+.....
T Consensus 238 ~-------~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 238 P-------IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp C-------HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred h-------hhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0 00011111 2468899999999999999999999999998866553
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.67 Aligned_cols=250 Identities=27% Similarity=0.399 Sum_probs=205.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||+||+|.+..++..||||++..... .....+.+|+.+++.++||||++++++|.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4679999999999999999999999999999999965322 2235688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999976 356899999999999999999999998 9999999999999999999999999986532
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+......
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~----- 225 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVEFT----- 225 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC-----
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHhCCCC-----
Confidence 21 22346789999999999999999999999999999999999999975321 1111111111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
++......+.+||.+||+.||++||++.+|++.-.
T Consensus 226 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 226 -------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp -------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred -------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 11122356789999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=368.20 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=199.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCC--CCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHH--SNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~h--pnIv~l~~~~~~~~~~~l 167 (522)
.++|++.+.||+|+||+||++.+. +++.||||++...... ....+.+|+.+|..++| |||+++++++.....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467999999999999999999985 5899999999765432 23568899999999986 999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||| .+++|.+++.. ...+++.++..|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||++...
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9995 57899999986 467999999999999999999999999 99999999999997 578999999999865
Q ss_pred CCCCCCcceecccCCccccChhhhhc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~-----------~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~ 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHH
Confidence 43333333445679999999999975 6789999999999999999999999964321 1111111
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.... .....++......+.+||..||+.||.+|||+.+|++....
T Consensus 233 ~~~~----------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 233 IIDP----------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp HHCT----------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HhcC----------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 1111 11111222223567899999999999999999999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=352.65 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=209.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 4679999999999999999999999999999999975432 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999975 457999999999999999999999999 999999999999999999999999999864333
Q ss_pred CCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ..+..+.. ... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~~~----~~~ 229 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE----KKT----YLN 229 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHT----TCT----TST
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhh----ccc----ccC
Confidence 22223345679999999999987765 779999999999999999999997643321 11222211 000 000
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+ .......+.+||.+||+.||++|||+.+|++.
T Consensus 230 ~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 P------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0 01223567899999999999999999999763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=379.92 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=208.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|.+.+.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.+|+.++||||+++++++...+..|||
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999975422 2345688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999975 467999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .+ ...+......
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~---~~~i~~~~~~---- 234 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TL---FKKICDGIFY---- 234 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HH---HHHHHTTCCC----
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HH---HHHHhcCCcC----
Confidence 322 2345679999999999998766 68999999999999999999999754221 11 1111111111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+.+||.+||+.||++|||+.+|++.
T Consensus 235 --------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 --------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 111123567899999999999999999999984
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=353.68 Aligned_cols=254 Identities=25% Similarity=0.302 Sum_probs=202.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|.+.+.||+|+||+||+|.+..++..||||++..... ...+.+.+|+.+|+.++||||++++++|.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 4679999999999999999999999999999999976532 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCceeeeeecceeeC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl---d~~~~vkL~DFGla~~~ 247 (522)
|+++++|.+++.........+++..++.|+.||+.||.|||+.+ |+|+||||+|||| +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998653233467999999999999999999999999 9999999999999 45678999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||...... .... ............
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~---~~~~~~~~~~~~ 247 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQ---KATYKEPNYAVE 247 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCCCCCC-
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHh---hhccCCcccccc
Confidence 322 2234567999999999886 57899999999999999999999999754221 1111 111111111100
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.. . ....+.+||.+||+.||++||++.||++
T Consensus 248 ~~-----~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 CR-----P----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -C-----C----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cC-----c----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1 2256789999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=370.54 Aligned_cols=276 Identities=21% Similarity=0.265 Sum_probs=216.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCC--eeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~--~~~lV 168 (522)
.++|++.++||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++.... ..+||
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999999999999999999975432 33466789999999999999999999998765 78999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCceeeeeecce
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKLSDFGLA 244 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl----d~~~~vkL~DFGla 244 (522)
||||++++|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999997621 1234999999999999999999999999 9999999999999 77888999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhc--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMT--------GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
+..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||............ ...
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~--~~~ 238 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MYK 238 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH--HHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH--HHH
Confidence 874332 22334679999999999875 56788999999999999999999999755433222111 111
Q ss_pred hhhccc-CCC----C-------cC-CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 317 LFKDRR-KFP----K-------MA-DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 317 ~~~~~~-~~~----~-------~~-d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
+..... ... . +. .......++......+.+|+.+||+.||++||++.++++.|..+....
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 111100 000 0 00 000112234566678889999999999999999999999999886543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=351.52 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=211.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 467999999999999999999997 578899999976543 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999762 356899999999999999999999999 9999999999999999999999999998642211
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
........+++.|+|||++....++.++|||||||++|+|++ |..||...... .... .+... ....
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~i~~~---~~~~--- 225 (267)
T 3t9t_A 159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE---DISTG---FRLY--- 225 (267)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHTT---CCCC---
T ss_pred -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHH---HHhcC---CcCC---
Confidence 111223457789999999999999999999999999999999 89999754221 1111 11111 0000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.+......+.+|+.+||+.||++||++.++++.|+.+...
T Consensus 226 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 226 -----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1112235678999999999999999999999999988653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.95 Aligned_cols=250 Identities=28% Similarity=0.419 Sum_probs=186.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4679999999999999999999988999999999965321 2236688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999975 2367999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .....
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~-------- 227 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVLA-------- 227 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSS--------
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhhc--------
Confidence 2221 2234578999999999999899999999999999999999999997543321100 00000
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
+ ...+......+.+||.+||+.||++||++.+|++
T Consensus 228 ~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 D----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0 0112223357789999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=362.13 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=209.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEE--EEEEEccCC-ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVV--AVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~v--AvK~i~~~~-~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.+.||+|+||.||+|++..++..+ |||.+.... ....+.+.+|+.+|..+ +||||+++++++.+.+..+|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367999999999999999999998888765 999987532 23345688999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc
Q 009933 168 VYEFMPLGSLEDHLHDLP------------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH 235 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~ 235 (522)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999997632 22357999999999999999999999999 999999999999999999
Q ss_pred eeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhh
Q 009933 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~ 314 (522)
+||+|||++..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .+..
T Consensus 181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~-- 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE-- 252 (327)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH--
T ss_pred EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHH--
Confidence 99999999974221 111233457889999999999899999999999999999998 99999754221 1111
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.+... .. ...+......+.+||.+||+.||.+||++.+|++.|+.+....
T Consensus 253 -~~~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 -KLPQG-YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -HGGGT-CC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -HhhcC-CC----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111 00 0112223357889999999999999999999999999887654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=364.96 Aligned_cols=264 Identities=21% Similarity=0.291 Sum_probs=196.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.++||+|+||+||+|.+..+++.||||++....... ...+.+|+.+|+.++||||+++++++.+.+.++|||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 568999999999999999999999999999999997543322 345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-----cCCCceeeeeecce
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL-----DEGFHPKLSDFGLA 244 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl-----d~~~~vkL~DFGla 244 (522)
||+.+ +|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +..+.+||+|||++
T Consensus 113 e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99975 99999976 456999999999999999999999999 9999999999999 45566999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh--hh--
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL--FK-- 319 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~--~~-- 319 (522)
...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||........ +....... ..
T Consensus 185 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTT
T ss_pred cccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCchh
Confidence 864322 1223445789999999999875 589999999999999999999999975432111 11111000 00
Q ss_pred ---cc-------cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 320 ---DR-------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 320 ---~~-------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.. ..++......+...++......+.+||.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 0000000000000001112357789999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=347.97 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=213.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEE-EcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC-ADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~-~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..++|++++..+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 578999999999999999999999999999999987543 235688999999999988877666655 66778899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCceeeeeecceeeC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl---d~~~~vkL~DFGla~~~ 247 (522)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||| +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 89999999742 357999999999999999999999999 9999999999999 58899999999999875
Q ss_pred CCCCCCc-----ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh-hhhhhcc
Q 009933 248 PVGDKTH-----VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA-RPLFKDR 321 (522)
Q Consensus 248 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~ 321 (522)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4432211 123567999999999999999999999999999999999999999875544333322211 1111100
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
.+.+...+ ...+.+|+.+||+.||++||++.+|++.|+.+.....
T Consensus 239 -------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 239 -------IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -------HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -------hHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 00011112 2568899999999999999999999999998865543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=359.25 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=209.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
..+|.+.++||+|+||.||++.+..+++.||+|++..... ...+.+.+|+.+++.++||||++++++|.+.+..+||
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999975432 2345688899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999876 467999999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+......+
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~---- 260 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEYSI---- 260 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCC----
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcCCCCC----
Confidence 222 123346799999999999999999999999999999999999999975321 11111111111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+......+.+||.+||+.||++||++.+|++.-.
T Consensus 261 --------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 261 --------PKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred --------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1122246778999999999999999999998543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=358.60 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=207.8
Q ss_pred HHHHHHhhcCCccc-ceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCC-CCCcceeEEEEE
Q 009933 85 FRELAAATKNFRPE-CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLH-HSNLVNLIGYCA 160 (522)
Q Consensus 85 ~~~~~~~~~~y~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~ 160 (522)
|.......+.|.+. +.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|..+. ||||++++++|.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445556778887 899999999999999999999999999975432 23467889999999995 699999999999
Q ss_pred cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCcee
Q 009933 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---GFHPK 237 (522)
Q Consensus 161 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---~~~vk 237 (522)
+....+|||||+.+++|.+++.. .....+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999865 23467999999999999999999999999 999999999999987 78999
Q ss_pred eeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 238 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ..+
T Consensus 175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i 245 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETY---LNI 245 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHH
T ss_pred EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHH---HHH
Confidence 99999998753222 223467999999999999999999999999999999999999999754221 111 111
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....... ..+ ........+.+||.+||+.||++||++.+|++.
T Consensus 246 ~~~~~~~---~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQVNVDY---SEE-----TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHTCCCC---CTT-----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred Hhccccc---Cch-----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111111 011 111223568899999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.10 Aligned_cols=261 Identities=21% Similarity=0.229 Sum_probs=202.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.++..++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999999999999999997643322 35688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999976 357999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...............
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~- 256 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPST- 256 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGGG-
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCccc-
Confidence 3221 1223457999999999999989999999999999999999999999753211 111111111100000
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHHHhhhc
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-LIGDVVTALTYLASQ 375 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~evl~~L~~l~~~ 375 (522)
.+......+.+||.+||+.||++|| ++.++++.|+.+...
T Consensus 257 -------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 257 -------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 1111224677899999999999999 999999999876433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=353.75 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=207.2
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..++|.+.+.||+|+||.||+|.+..+++.||||++..........+.+|+.+|+.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 35679999999999999999999999999999999986654455678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCceeeeeecceeeC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl---d~~~~vkL~DFGla~~~ 247 (522)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999875 357899999999999999999999999 9999999999999 78899999999999753
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+. ..+......+.
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~---~~i~~~~~~~~-- 227 (304)
T 2jam_A 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLF---EKIKEGYYEFE-- 227 (304)
T ss_dssp CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---HHHHHCCCCCC--
T ss_pred CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHcCCCCCC--
Confidence 221 22345699999999999999999999999999999999999999975422 1111 11111111111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+ ........+.+||.+||+.||++||++.++++.-
T Consensus 228 -~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 228 -SP-----FWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp -TT-----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred -cc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 11 1112235788999999999999999999999854
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=384.16 Aligned_cols=255 Identities=29% Similarity=0.413 Sum_probs=210.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.++||+|+||.||+|++..+++.||||++.+... .....+.+|+.+|..++|||||+++++|.+.+.+|||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 4579999999999999999999999999999999965322 2345678999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ ||||||||+||||+.++++||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999762 2345999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||...........+ ...+......
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i--~~~i~~~~~~----- 407 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ERLVKEVPEE----- 407 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH--HHHHHHCCCC-----
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH--HHHhhccccc-----
Confidence 322 234568999999999999989999999999999999999999999865432221111 1111111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
++......+.+||.+||+.||.+|| ++.||+++
T Consensus 408 -------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 -------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1222335788999999999999999 77888764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=362.53 Aligned_cols=247 Identities=22% Similarity=0.220 Sum_probs=195.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.++||+|+||+||+|.+..+++.||||++....... ...+..|+..+..+ +||||++++++|.+...++||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999999999999999986543222 23445555555544 899999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 66999988762 356999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..||... ....... . ...
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~~~-----~-----~~~ 269 (311)
T 3p1a_A 209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQLR-----Q-----GYL 269 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHHHT-----T-----TCC
T ss_pred cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHh-----c-----cCC
Confidence 222 2344569999999998876 7999999999999999999997766432 1111110 0 001
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.+. ......+.+||.+||+.||++|||+.+|++.
T Consensus 270 ~~~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 270 PPEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Ccccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11111 1223578899999999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=350.30 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=209.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4679999999999999999999999999999999975432 2335678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999876 457999999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+......
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~----- 233 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEYS----- 233 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCCC-----
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhccCC-----
Confidence 222 123346799999999999998999999999999999999999999975321 1111111111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
++......+.+|+.+||+.||++||++.++++.-.
T Consensus 234 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 234 -------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred -------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 11122356789999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=372.96 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=199.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCC--CCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLH--HSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~--hpnIv~l~~~~~~~~~~~l 167 (522)
..+|++.+.||+|+||+||+|.+.. ++.||||++...... ....+.+|+.+|..|. ||||+++++++...+.+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3569999999999999999999875 899999999765432 3356889999999996 5999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||| +.+++|.+++.. ...+++.+++.|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||++...
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 557899999986 457899999999999999999999999 99999999999996 578999999999865
Q ss_pred CCCCCCcceecccCCccccChhhhhc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~-----------~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
............+||+.|+|||++.+ ..|+.++||||||||||||++|+.||..... .......
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~ 279 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA 279 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHH
Confidence 43332223345679999999999975 3689999999999999999999999964321 1111111
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+.... ....++......+.+||.+||+.||++||++.+|++.-.
T Consensus 280 ~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 280 IIDPN----------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHCTT----------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HhCcc----------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 11111 111111122356789999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=354.04 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=207.2
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc---------
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--------- 161 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--------- 161 (522)
...+|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+|..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3567999999999999999999999899999999997542 456789999999999999999998864
Q ss_pred -------CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 009933 162 -------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF 234 (522)
Q Consensus 162 -------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~ 234 (522)
...+++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 44589999999999999999752 2357999999999999999999999999 99999999999999999
Q ss_pred ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh
Q 009933 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 235 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~ 314 (522)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~ 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFF 228 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHH
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHH
Confidence 99999999998754322 223456999999999999999999999999999999999999887421 1111
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+ .. ..+ ...+ ...+.+||.+||+.||.+||++.+|++.|+.+...
T Consensus 229 ~~~-~~-~~~--------~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 229 TDL-RD-GII--------SDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHH-HT-TCC--------CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHh-hc-ccc--------cccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111 10 011 1112 24577999999999999999999999999987533
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=364.99 Aligned_cols=259 Identities=18% Similarity=0.172 Sum_probs=210.3
Q ss_pred hhcCCcccceecccCceEEEEEE-----ECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC---CCCcceeEEEEEcC
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGR-----LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSNLVNLIGYCADG 162 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~-----~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~---hpnIv~l~~~~~~~ 162 (522)
..++|.+.++||+|+||+||+|. +..+++.||||++... ....+..|+.++..++ |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35779999999999999999994 6677999999999754 3456778888888887 99999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---------
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPP-DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE--------- 232 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~--------- 232 (522)
+..|||||||++|+|.+++..... ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999974222 2467999999999999999999999999 999999999999988
Q ss_pred --CCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH
Q 009933 233 --GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 310 (522)
Q Consensus 233 --~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~ 310 (522)
++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||+||||+||+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999976443333444556789999999999999999999999999999999999999986432110
Q ss_pred HHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCC-CCHHHHHHHHHHhhhccC
Q 009933 311 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATR-PLIGDVVTALTYLASQTY 377 (522)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~R-Ps~~evl~~L~~l~~~~~ 377 (522)
..+...+.. ++ ....+.+|+..||+.+|.+| |++.++.+.|+.+..+..
T Consensus 293 -----------~~~~~~~~~-----~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 293 -----------CKPEGLFRR-----LP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp -----------EEECSCCTT-----CS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----------eeechhccc-----cC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 000111111 11 23466789999999999999 588899999988765543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.18 Aligned_cols=268 Identities=25% Similarity=0.405 Sum_probs=213.5
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEE
Q 009933 87 ELAAATKNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCA 160 (522)
Q Consensus 87 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~ 160 (522)
++....++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999886 3578899999975432 23346889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCChhhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC
Q 009933 161 DGDQRLLVYEFMPLGSLEDHLHDLP------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF 234 (522)
Q Consensus 161 ~~~~~~lV~E~~~ggsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~ 234 (522)
+.+..++||||+.+++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 9999999999999999999997521 11246789999999999999999999999 99999999999999999
Q ss_pred ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHh
Q 009933 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAW 313 (522)
Q Consensus 235 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~ 313 (522)
.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..+...
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~ 252 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRF 252 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHHH
Confidence 999999999985432222122233457889999999999999999999999999999999 8899875422 111111
Q ss_pred hhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 314 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
+... .... .+......+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 253 ---~~~~--~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 ---VMEG--GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---HHTT--CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---HHcC--CcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111 0101 112233568899999999999999999999999987644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=347.78 Aligned_cols=258 Identities=25% Similarity=0.316 Sum_probs=207.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------chHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.+|+.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 35799999999999999999999999999999999764322 246788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----ceeeeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF----HPKLSDF 241 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~----~vkL~DF 241 (522)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999975 457999999999999999999999999 99999999999998877 8999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... .+....
T Consensus 157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~~~~ 227 (283)
T 3bhy_A 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLT---NISAVN 227 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHTTC
T ss_pred ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHH---HhHhcc
Confidence 9998643322 223456999999999999999999999999999999999999999754221 1111 111110
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH--HHHhh
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA--LTYLA 373 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~--L~~l~ 373 (522)
.. ...... ......+.+|+.+||+.||++||++.++++. ++.+.
T Consensus 228 ~~----~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 228 YD----FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CC----CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred cC----Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 00 010000 1123567899999999999999999999983 44443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=353.33 Aligned_cols=257 Identities=30% Similarity=0.442 Sum_probs=201.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.++||+|+||+||+|.+. ++.||||++... ...+.+.+|+.+|+.++||||+++++++.+ ..+|||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 357999999999999999999986 789999999643 345678899999999999999999998864 48999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---cCCCCeEecCCCCCceeecCCCc-eeeeeecceeeC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD---KANPPVIYRDLKSSNILLDEGFH-PKLSDFGLAKLG 247 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~~~~iiHrDLKp~NILld~~~~-vkL~DFGla~~~ 247 (522)
+++++|.+++.... ....+++..++.++.||+.||.|||+ .+ |+||||||+||||+.++. +||+|||++...
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999997621 12347899999999999999999999 66 999999999999988876 799999999753
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+. .... .....
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~--~~~~--~~~~~ 225 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWA--VHNG--TRPPL 225 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHHH--HHTT--CCCCC
T ss_pred cc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHHH--HhcC--CCCCc
Confidence 21 1233569999999999999999999999999999999999999997543211 111111 1110 01111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccCC
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD 378 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~ 378 (522)
+......+.+|+.+||+.||++||++.+|++.|+.+......
T Consensus 226 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 226 ---------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ---------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ---------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 111225678999999999999999999999999998765543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=363.11 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=204.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCC----cEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTG----QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g----~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.++|.+.++||+|+||+||+|.+..++ ..||||++...... ....+.+|+.+|..++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 457888999999999999999986543 45999999754322 2346889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
|||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999975 2357999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 247 GPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 247 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+.... ......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~----~~~~~~ 269 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAI----NDGFRL 269 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HTTCCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----HCCCcC
Confidence 43322111 1123346789999999999999999999999999999999 9999965422 1111111 111111
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
..+......+.+||.+||+.||++||++.+|++.|+.+....
T Consensus 270 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 270 ----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011223357889999999999999999999999999886543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=382.06 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=210.4
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
...++|++.+.||+|+||+||+|.+.. +..||||+++... ...+.+.+|+.+|+.++|||||++++++. .+..+|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 345789999999999999999999974 7889999997654 34678999999999999999999999986 56789999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||.+|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 262 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999751 1236889999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.. ........+|+.|+|||++....++.++|||||||+||||+| |+.||...... .+.... .. ...+
T Consensus 337 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i---~~-~~~~---- 404 (454)
T 1qcf_A 337 NE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL---ER-GYRM---- 404 (454)
T ss_dssp HH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH---HH-TCCC----
T ss_pred Cc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hc-CCCC----
Confidence 11 111123446789999999999999999999999999999999 99999754221 111111 11 1111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+......+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 405 ------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 ------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 01122335788999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.30 Aligned_cols=268 Identities=26% Similarity=0.394 Sum_probs=205.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.++||+|+||.||+|.+..+++.||||++....... ...+.+|+.+|+.++||||++++++|.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999999999999999986543322 345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999888765 456999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH-h-------hhhhhhc
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA-W-------ARPLFKD 320 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~-~-------~~~~~~~ 320 (522)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||............. . ....+..
T Consensus 177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 2 1223446799999999999875 78999999999999999999999997653211111000 0 0000111
Q ss_pred ccCCCCcCCccccCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 RRKFPKMADPLLQGRYP-----MRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...+.....+.+....+ ......+.+||.+||+.||++|||+.||++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111111111111111 1234678899999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=350.89 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=206.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcC--CeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~--~~~~l 167 (522)
.++|++.+.||+|+||+||+|++. ++.||||++...... ..+.+.+|+.+|+.++||||++++++|.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 467999999999999999999996 889999999765432 235688999999999999999999999887 78899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++... ....+++..++.|+.||+.||.|||+.+ ++|+|+||||+|||++.++.++|+|||+....
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999862 2336899999999999999999999874 45999999999999999999999999887642
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL---KSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~---~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
. .....||+.|+|||++.+..++. ++|||||||++|||++|+.||...... ...........
T Consensus 164 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-- 228 (271)
T 3kmu_A 164 Q-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGL-- 228 (271)
T ss_dssp S-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCC--
T ss_pred c-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCC--
Confidence 1 12356899999999998765544 899999999999999999999754221 11111111110
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
.+ ..+......+.+|+..||+.||++|||+.+|++.|+.+..
T Consensus 229 ----~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 ----RP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00 1112233568899999999999999999999999998753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=352.76 Aligned_cols=262 Identities=27% Similarity=0.364 Sum_probs=207.4
Q ss_pred CCcccceecccCceEEEEEEECCCCc---EEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee-EEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQ---VVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR-LLV 168 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~-~lV 168 (522)
.|.+.++||+|+||+||+|.+..++. .||||++..... ...+.+.+|+.+|+.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999999755444 799999975432 2346788999999999999999999999876655 999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999976 2467899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCC--CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 249 VGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 249 ~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+..... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~----~~~~~-- 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA----QGRRL-- 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH----TTCCC--
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh----cCCCC--
Confidence 2211 1122345678999999999999999999999999999999997666543222 111111111 10000
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
..+......+.+|+.+||+.||.+|||+.+|++.|+.+.....
T Consensus 248 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 248 --------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred --------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 0111223568899999999999999999999999999876654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=360.93 Aligned_cols=262 Identities=25% Similarity=0.323 Sum_probs=192.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEE--------cC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCA--------DG 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~--------~~ 162 (522)
..+|++.++||+|+||.||+|.+..+++.||||++..........+.+|+.+|..+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999999999999999997665555677889999999996 999999999994 33
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
..+++||||+. |+|.+++.... ....+++..++.|+.||+.||.|||+.+ ++|+|+||||+||||+.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45799999996 69999886422 2356999999999999999999999874 349999999999999999999999999
Q ss_pred ceeeCCCCCCCc----------ceecccCCccccChhhh---hcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 009933 243 LAKLGPVGDKTH----------VSTRVMGTYGYCAPEYA---MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN 309 (522)
Q Consensus 243 la~~~~~~~~~~----------~~~~~~gt~~y~APE~l---~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~ 309 (522)
++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 998654322111 11135689999999998 566789999999999999999999999975322110
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
. ...... .........+.+||.+||+.||.+||++.+|++.|+.+....
T Consensus 262 -~-------~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 262 -V-------NGKYSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ------------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -h-------cCcccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 000000 000111134678999999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=378.12 Aligned_cols=265 Identities=23% Similarity=0.263 Sum_probs=198.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcC------C
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------D 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------~ 163 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+|+.++|||||+++++|... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999999999999999997542 22345688999999999999999999999654 4
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.+|||||||.+ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999976 57777643 4899999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH-Hh---------
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-AW--------- 313 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~-~~--------- 313 (522)
++..... ...+..+||+.|+|||++.+..|+.++||||||||||||++|+.||...........+ ..
T Consensus 211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9864322 2334578999999999999999999999999999999999999999764321111000 00
Q ss_pred ------hhhhhhcccCCC-----CcCCccccCCC---ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 314 ------ARPLFKDRRKFP-----KMADPLLQGRY---PMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 314 ------~~~~~~~~~~~~-----~~~d~~l~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
............ ..+...+.... .......+.+||.+||+.||++|||+.|++++-
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000000000000 00000000000 011245789999999999999999999998853
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=364.88 Aligned_cols=267 Identities=15% Similarity=0.155 Sum_probs=202.3
Q ss_pred hcCCcccceecccCceEEEEEEECC---CCcEEEEEEEccCCcc-----------chHHHHHHHHHHHhCCCCCcceeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES---TGQVVAVKQLDRNGLQ-----------GNREFLVEVLMLSLLHHSNLVNLIG 157 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~---~g~~vAvK~i~~~~~~-----------~~~~~~~E~~~L~~l~hpnIv~l~~ 157 (522)
.++|++.+.||+|+||+||+|.+.. ++..||||++...... ....+..|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999987 7889999999765321 1123567888999999999999999
Q ss_pred EEEc----CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC
Q 009933 158 YCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG 233 (522)
Q Consensus 158 ~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~ 233 (522)
++.. ....||||||+ +++|.+++.. ...+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9988 77899999999 9999999976 347999999999999999999999999 9999999999999887
Q ss_pred C--ceeeeeecceeeCCCCCC-----CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 009933 234 F--HPKLSDFGLAKLGPVGDK-----THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG 306 (522)
Q Consensus 234 ~--~vkL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~ 306 (522)
+ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999986532211 111134579999999999999999999999999999999999999996432211
Q ss_pred cchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 307 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
. .......... ..++..+..... .......+.+||.+||+.||++||++.+|++.|+.+.
T Consensus 268 ~-~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 V-AVQTAKTNLL---DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp H-HHHHHHHHHH---HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred H-HHHHHHHhhc---ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1 1111111111 111111111000 0022357889999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=362.34 Aligned_cols=264 Identities=27% Similarity=0.408 Sum_probs=206.0
Q ss_pred hcCCcccceecccCceEEEEEE-----ECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGR-----LESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~-----~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||.||+|. +..++..||||++..... .....+.+|+.+|+.++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4689999999999999999999 556788999999965432 2345688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCceeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPP---DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---GFHPKLS 239 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---~~~vkL~ 239 (522)
+|||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986322 1245899999999999999999999999 999999999999984 4569999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..+.... .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~---~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV---T 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHH---H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHH---h
Confidence 9999975433222223344568999999999999999999999999999999998 9999975422 1111111 1
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.. .. . ..+......+.+||.+||+.||.+||++.+|++.|+.+...
T Consensus 260 ~~-~~-~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 260 SG-GR-M---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TT-CC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cC-CC-C---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11 00 0 01112235688999999999999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.40 Aligned_cols=260 Identities=26% Similarity=0.382 Sum_probs=206.9
Q ss_pred hcCCcccc-eecccCceEEEEEEE--CCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPEC-LLGEGGFGRVYKGRL--ESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~-~LG~G~fG~Vy~~~~--~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.++|.+.+ .||+|+||+||+|.+ ..+++.||||++...... ..+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999955 556789999999765322 245788999999999999999999999 567789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999976 456999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 247 GPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 247 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
........ ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...... .+.... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAML----EKGER- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTCC-
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCCC-
Confidence 54332211 1223446789999999999899999999999999999999 99999754321 111111 11100
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
. ..+......+.+||.+||+.||++||++.+|++.|+.+-...
T Consensus 239 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 239 M---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 0 112223357889999999999999999999999999875443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.72 Aligned_cols=270 Identities=25% Similarity=0.354 Sum_probs=212.0
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHh--CCCCCcceeEEEEEcCC-
Q 009933 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL--LHHSNLVNLIGYCADGD- 163 (522)
Q Consensus 87 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~--l~hpnIv~l~~~~~~~~- 163 (522)
......++|++.+.||+|+||.||+|.+. ++.||||++... ....+..|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 34455678999999999999999999984 899999999643 34567788888887 78999999999998876
Q ss_pred ---eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCceeecC
Q 009933 164 ---QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH--------DKANPPVIYRDLKSSNILLDE 232 (522)
Q Consensus 164 ---~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiHrDLKp~NILld~ 232 (522)
..++||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+ |+|+||||+||||+.
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred ccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 78999999999999999976 46899999999999999999999 777 999999999999999
Q ss_pred CCceeeeeecceeeCCCCCCCc--ceecccCCccccChhhhhcCC------CCcchhhHHHHHHHHHHHhC---------
Q 009933 233 GFHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTGQ------LTLKSDVYSFGVVFLELITG--------- 295 (522)
Q Consensus 233 ~~~vkL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~------~~~~sDVwSlGvll~eLltG--------- 295 (522)
++.+||+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 9999999999998643332211 123457999999999998752 34689999999999999999
Q ss_pred -CCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCC-CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 296 -RKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGR-YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 296 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
..||........ ....+...+... ...+.+... ........+.+|+.+||+.||++||++.+|++.|+.+.
T Consensus 263 ~~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 263 YQLPYYDLVPSDP-SVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCTTTTTSCSSC-CHHHHHHHHTTS------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCccccCcCcc-cHHHHHHHHHHH------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 677765433221 111111111111 111111111 12355678899999999999999999999999999987
Q ss_pred hcc
Q 009933 374 SQT 376 (522)
Q Consensus 374 ~~~ 376 (522)
.+.
T Consensus 336 ~~~ 338 (342)
T 1b6c_B 336 QQE 338 (342)
T ss_dssp HTT
T ss_pred HHh
Confidence 654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=352.38 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=210.8
Q ss_pred hcCCcccc-eecccCceEEEEEEEC--CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPEC-LLGEGGFGRVYKGRLE--STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~-~LG~G~fG~Vy~~~~~--~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|.+.. .||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+|..++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35677766 9999999999999864 4578899999976532 2346688999999999999999999999 4567899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999964 2456999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCC-cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 248 PVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 248 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .+..... .. . .
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~---~~-~-~- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE---QG-K-R- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHH---TT-C-C-
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHh---cC-C-c-
Confidence 432221 11223456889999999998899999999999999999998 99999764321 1111111 11 0 0
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccCC
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYD 378 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~ 378 (522)
..++......+.+||..||+.||++||++.+|++.|+.+......
T Consensus 232 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 232 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 011223346788999999999999999999999999998665543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=361.92 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=198.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
++|++.+.||+|+||+||+|.+..+++.||||++....... ...+.+|+.+|+.++||||+++++++...+..+|||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999996543221 12455799999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+. ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 97 5999998762 456999999999999999999999999 999999999999999999999999999864322
Q ss_pred CCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc--cCCCCcC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR--RKFPKMA 328 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 328 (522)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ............ ...+...
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhh
Confidence 222334578999999999986 578999999999999999999999997643221 111111111100 0000000
Q ss_pred Cc---------cccC----CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 329 DP---------LLQG----RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 329 d~---------~l~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.. .... .........+.+||.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 0000 0001223567899999999999999999999884
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=353.47 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=200.5
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--------cchHHHHHHHHHHHhCCCCCcceeEEEEEcC
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--------QGNREFLVEVLMLSLLHHSNLVNLIGYCADG 162 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--------~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~ 162 (522)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 35679999999999999999999999999999999975432 1223578899999999999999999999776
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---eeee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH---PKLS 239 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~---vkL~ 239 (522)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999999865 467999999999999999999999999 999999999999987654 9999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||........ +.....
T Consensus 160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~- 233 (322)
T 2ycf_A 160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT- 233 (322)
T ss_dssp CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH-
T ss_pred cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH-
Confidence 99999864321 1233467999999999985 45789999999999999999999999976543221 111110
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
..... . .+... ......+.+||.+||+.||++||++.++++
T Consensus 234 --~~~~~---~-~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 --SGKYN---F-IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HTCCC---C-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hCccc---c-Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 10000 0 00000 012357889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=370.72 Aligned_cols=201 Identities=26% Similarity=0.350 Sum_probs=170.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcC-----Ce
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~-----~~ 164 (522)
.++|++.++||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 5789999999999999999999999999999999975422 2345788999999999999999999999776 57
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
+||||||+. ++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 599999976 467999999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCC--------------------cceecccCCccccChhhh-hcCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 009933 245 KLGPVGDKT--------------------HVSTRVMGTYGYCAPEYA-MTGQLTLKSDVYSFGVVFLELITGRKAID 300 (522)
Q Consensus 245 ~~~~~~~~~--------------------~~~~~~~gt~~y~APE~l-~~~~~~~~sDVwSlGvll~eLltG~~Pf~ 300 (522)
+........ ...+..+||+.|+|||++ ....|+.++||||||||||||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 875432211 123567899999999986 45679999999999999999998655553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=348.54 Aligned_cols=255 Identities=22% Similarity=0.257 Sum_probs=204.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC----ccchHHHHHHHHHHHhCCCCCcceeEEEEE--cCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG----LQGNREFLVEVLMLSLLHHSNLVNLIGYCA--DGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~--~~~~~ 165 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+|+.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 578999999999999999999999999999999996542 233467889999999999999999999984 45688
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
+|||||+.++ |.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999875 77777653 2457999999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
...............||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~~~~ 231 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGKGSYA 231 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhcCCCC
Confidence 754333333344567999999999998654 37899999999999999999999975321 1111111111111
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
++......+.+||.+||+.||.+||++.+|++.-.
T Consensus 232 ------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 232 ------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp ------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred ------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 11122356789999999999999999999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=346.47 Aligned_cols=248 Identities=20% Similarity=0.255 Sum_probs=201.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.++..+ +||||+++++++.+.+..+||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 5679999999999999999999999999999999976432 2345678899999999 899999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC----------------
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---------------- 232 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---------------- 232 (522)
|||+++++|.+++.........+++..++.|+.||+.||.|||+.+ |+|+||||+||||+.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999763222367899999999999999999999999 999999999999984
Q ss_pred ---CCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 009933 233 ---GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH 308 (522)
Q Consensus 233 ---~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~ 308 (522)
...+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..++... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----D 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----H
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----h
Confidence 447999999999874332 224589999999999876 5678999999999999999998776432 1
Q ss_pred hHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 309 NLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...... . ..++. ++......+.+||.+||+.||++||++.++++.
T Consensus 236 ~~~~~~----~--~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 QWHEIR----Q--GRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHHH----T--TCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHH----c--CCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111111 1 01111 111223578899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=355.42 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=207.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEc--CCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~~l 167 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999999999999999999765432 33568899999999999999999998854 578999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
||||+++++|.+++.........+++..++.++.||+.||.|||+.+ ..+|+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999764334456999999999999999999999976 2349999999999999999999999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+.. .+... ...
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~i~~~--~~~ 234 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG---KIREG--KFR 234 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHT--CCC
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHH---HHhhc--ccc
Confidence 64322 1122345789999999999999999999999999999999999999975421 11111 11111 111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
. .+......+.+||.+||+.||++||++.+|++.+..
T Consensus 235 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 R---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred c---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 111233578899999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=361.67 Aligned_cols=265 Identities=29% Similarity=0.401 Sum_probs=208.6
Q ss_pred CcccceecccCceEEEEEEE----CCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEc--CCeeEE
Q 009933 95 FRPECLLGEGGFGRVYKGRL----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLL 167 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~~l 167 (522)
|++.+.||+|+||+||++.+ ..+++.||||++..... .....+.+|+.+|+.++||||+++++++.+ ...++|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 49999999999999988865 34789999999976532 224568899999999999999999999987 467899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+++++|.+++.. ..+++..++.|+.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999976 45999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCC-cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC------cchH--HHhhhhhh
Q 009933 248 PVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPG------EHNL--VAWARPLF 318 (522)
Q Consensus 248 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~------~~~~--~~~~~~~~ 318 (522)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... .... ........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 443221 12234568889999999999999999999999999999999999986431100 0000 00000111
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
... .....+......+.+||.+||+.||++||++.+|++.|+.+..+..
T Consensus 265 ~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 265 ERG----------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcc----------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111 1111222334678899999999999999999999999998866553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=366.13 Aligned_cols=267 Identities=21% Similarity=0.283 Sum_probs=202.7
Q ss_pred HHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc-------
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD------- 161 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~------- 161 (522)
....++|++.+.||+|+||+||+|.+..+++.||||++..... ...+|+.+|+.++|||||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999999999999999999965432 23469999999999999999999844
Q ss_pred -------------------------------CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 009933 162 -------------------------------GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210 (522)
Q Consensus 162 -------------------------------~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL 210 (522)
...++|||||++ ++|.+++.........+++..++.|+.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999998 488887765434467899999999999999999999
Q ss_pred HhcCCCCeEecCCCCCceeec-CCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHH
Q 009933 211 HDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVV 288 (522)
Q Consensus 211 H~~~~~~iiHrDLKp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvl 288 (522)
|+.+ |+||||||+||||+ .++.+||+|||++....... ......||+.|+|||++.+. .|+.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 99999999999997 68899999999998653322 23345789999999998875 59999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchHHHhhhh--------hhhc-----ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccC
Q 009933 289 FLELITGRKAIDNTRPPGEHNLVAWARP--------LFKD-----RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQ 355 (522)
Q Consensus 289 l~eLltG~~Pf~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~d 355 (522)
+|||++|+.||........ +...... +... ...++.+....+...++......+.+||.+||+.|
T Consensus 232 l~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999976432111 1111100 0000 00111111111111122334467889999999999
Q ss_pred cCCCCCHHHHHHH
Q 009933 356 AATRPLIGDVVTA 368 (522)
Q Consensus 356 P~~RPs~~evl~~ 368 (522)
|++|||+.|+++.
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=347.79 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=208.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999996532 12245688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999976 356899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||..... ......+......
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~----- 230 (284)
T 2vgo_A 166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNVDLK----- 230 (284)
T ss_dssp SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCCC-----
T ss_pred cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhccccC-----
Confidence 22 12345799999999999999999999999999999999999999975321 1111111111111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
++......+.+||.+||+.||.+||++.+|++.-
T Consensus 231 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 231 -------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred -------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 1122235678999999999999999999999853
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=357.50 Aligned_cols=270 Identities=25% Similarity=0.340 Sum_probs=200.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHH--HHhCCCCCcceeEEEEEc-----CCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLM--LSLLHHSNLVNLIGYCAD-----GDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~--L~~l~hpnIv~l~~~~~~-----~~~ 164 (522)
.++|++.++||+|+||+||+|.+ +++.||||++... ....+..|.++ +..++||||+++++++.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46899999999999999999987 4899999999653 23344445444 445899999999986542 236
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCCCceeecCCCc
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK---------ANPPVIYRDLKSSNILLDEGFH 235 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~~~~iiHrDLKp~NILld~~~~ 235 (522)
++|||||+++++|.+++.. ..+++..++.|+.||+.||.|||+. + |+||||||+||||+.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 7899999999999999976 4468999999999999999999998 7 999999999999999999
Q ss_pred eeeeeecceeeCCCCCC------CcceecccCCccccChhhhhc-------CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 009933 236 PKLSDFGLAKLGPVGDK------THVSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVFLELITGRKAIDNT 302 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDVwSlGvll~eLltG~~Pf~~~ 302 (522)
+||+|||++........ .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999986533211 112234579999999999986 35677899999999999999998877543
Q ss_pred CCCCcch-H-HH---------hhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 303 RPPGEHN-L-VA---------WARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 303 ~~~~~~~-~-~~---------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
....... . .. ............+.+ .... .........+.+||.+||+.||++|||+.+|++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF-PEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC-CTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCC-Cccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 3322111 0 00 000001111111111 1111 0122355679999999999999999999999999999
Q ss_pred hhhccC
Q 009933 372 LASQTY 377 (522)
Q Consensus 372 l~~~~~ 377 (522)
+.....
T Consensus 316 ll~~~~ 321 (336)
T 3g2f_A 316 LMMIWE 321 (336)
T ss_dssp HHHCCC
T ss_pred HHHHHH
Confidence 876553
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=352.21 Aligned_cols=253 Identities=27% Similarity=0.380 Sum_probs=210.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.+.|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+|..++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 4579999999999999999999999999999999976543 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999864 57999999999999999999999999 999999999999999999999999999864332
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... +... . .+
T Consensus 173 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---~~~~--~-----~~ 237 (303)
T 3a7i_A 173 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL---IPKN--N-----PP 237 (303)
T ss_dssp B--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH---HHHS--C-----CC
T ss_pred c--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH---hhcC--C-----CC
Confidence 2 1223467899999999999999999999999999999999999999754221 11111 1111 0 01
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.+... ....+.+||..||+.||++||++.+|++....
T Consensus 238 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 238 TLEGN----YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp CCCSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred CCccc----cCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 11112 23568899999999999999999999986654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=369.78 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=196.4
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--------cchHHHHHHHHHHHhCCCCCcceeEEEEEc
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--------QGNREFLVEVLMLSLLHHSNLVNLIGYCAD 161 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--------~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~ 161 (522)
...++|.+.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.++||||++++++|..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 346789999999999999999999999999999999975421 112347899999999999999999999864
Q ss_pred CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---Cceee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG---FHPKL 238 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~---~~vkL 238 (522)
+..||||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.+ ..+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 568999999999999999875 467999999999999999999999999 9999999999999654 45999
Q ss_pred eeecceeeCCCCCCCcceecccCCccccChhhhhc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh
Q 009933 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 239 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~ 315 (522)
+|||+++.... .......+||+.|+|||++.. ..|+.++|||||||++|+|++|..||........ +.....
T Consensus 284 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~ 358 (419)
T 3i6u_A 284 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 358 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHH
T ss_pred eecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHh
Confidence 99999986432 223345779999999999863 5788999999999999999999999975433211 111110
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.... ....... ......+.+||.+||+.||++||++.++++.
T Consensus 359 ---~~~~---~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 ---SGKY---NFIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ---TTCC---CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---cCCC---CCCchhh-----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 0000000 0123568899999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=363.06 Aligned_cols=257 Identities=26% Similarity=0.337 Sum_probs=206.8
Q ss_pred hcCCcccceecccCceEEEEEEEC---CCCcEEEEEEEccCCc----cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~i~~~~~----~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~ 163 (522)
.++|++.++||+|+||+||+|++. .+++.||||+++.... .....+..|+.+|..+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 367999999999999999999994 4799999999975422 2335567899999999 6999999999999999
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.++|||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999976 357999999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
++..... ........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||......... ......+....
T Consensus 206 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~ 282 (355)
T 1vzo_A 206 SKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE 282 (355)
T ss_dssp EEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC
T ss_pred CeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC
Confidence 9864322 1222345679999999999986 35789999999999999999999999755432221 11222222211
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTALT 370 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~L~ 370 (522)
.. ++......+.+||.+||+.||++|| ++.+|++...
T Consensus 283 ~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 283 PP------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CC------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 11 1222335678999999999999999 9999988654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=349.03 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=209.9
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.+|+.++||||+++++++.. +..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3568999999999999999999986 47789999997653 345678899999999999999999999864 56899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++......
T Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999651 1126899999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.. .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .+.... ... ...
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~---~~~---~~~--- 229 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL---ERG---YRM--- 229 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH---HTT---CCC---
T ss_pred cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHH---hcc---cCC---
Confidence 21 11223457889999999999899999999999999999999 89999754221 111111 111 000
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
..+......+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus 230 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 230 -----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 011122357889999999999999999999999999886544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=351.35 Aligned_cols=263 Identities=28% Similarity=0.400 Sum_probs=205.0
Q ss_pred hcCCcccceecccCceEEEEEEECCC---CcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEE-cCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCA-DGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~-~~~~~~ 166 (522)
..+|++.++||+|+||+||+|.+..+ ...||||.+..... ...+.+.+|+.+|+.++||||++++++|. .....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 34689999999999999999997543 34689999975432 23456889999999999999999999864 456889
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+||||+.+++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999975 2456899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCC--cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 247 GPVGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITG-RKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 247 ~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++| ..||........ .... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~---~~~~~- 250 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL---LQGRR- 250 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHH---HTTCC-
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHH---hcCCC-
Confidence 4332211 122345678899999999999999999999999999999995 555554332211 1111 11110
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
.. .+......+.+|+.+||+.||++||++.+|++.|+.+.....
T Consensus 251 --~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 251 --LL--------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp --CC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred --CC--------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 011122468899999999999999999999999999876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=351.62 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=205.4
Q ss_pred hcCCcccceecccCceEEEEEEECC---CCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES---TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~---~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.+.||+|+||+||+|.+.. ++..||||++..... ...+.+.+|+.+|+.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 5689999999999999999999753 345699999976532 334678899999999999999999999875 45689
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999975 2356899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||....... ..... ...... .
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~~~-~ 234 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGDRL-P 234 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTCCC-C
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCCCC-C
Confidence 33221 12233457889999999999999999999999999999998 999997543221 11111 111100 0
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
.+......+.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 235 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 235 ---------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 111123568899999999999999999999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=363.85 Aligned_cols=265 Identities=18% Similarity=0.184 Sum_probs=206.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC--------CCCcceeEEEEE---
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH--------HSNLVNLIGYCA--- 160 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~--------hpnIv~l~~~~~--- 160 (522)
.++|++.++||+|+||+||+|++..+++.||||++... ......+.+|+.+|+.++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999999999999999999643 233456788999999885 788999999997
Q ss_pred -cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCC----
Q 009933 161 -DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGF---- 234 (522)
Q Consensus 161 -~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~---- 234 (522)
....++|||||+ +++|.+++.. .....+++..++.|+.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 566899999999 5677777654 2235699999999999999999999998 8 99999999999998775
Q ss_pred ---------------------------------------------ceeeeeecceeeCCCCCCCcceecccCCccccChh
Q 009933 235 ---------------------------------------------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269 (522)
Q Consensus 235 ---------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 269 (522)
.+||+|||++..... .....+||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCCh
Confidence 799999999986432 123457999999999
Q ss_pred hhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhh---------------------hcccCCCCcC
Q 009933 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF---------------------KDRRKFPKMA 328 (522)
Q Consensus 270 ~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~ 328 (522)
++.+..|+.++|||||||+||||++|+.||.................+. .....+..+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999998655433221111111100 0000010110
Q ss_pred Ccc---------ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 329 DPL---------LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 329 d~~---------l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
... -...++......+.+||.+||+.||++|||+.+|++.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 0012345666789999999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=358.00 Aligned_cols=268 Identities=30% Similarity=0.448 Sum_probs=212.1
Q ss_pred hcCCcccceecccCceEEEEEEE----CCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC--ee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD--QR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~--~~ 165 (522)
.++|++.+.||+|+||.||+|.+ ..+++.||||++........+.+.+|+.+|+.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45799999999999999999994 5679999999998765555677899999999999999999999987654 78
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999762 356999999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCC-cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC---------CCcchHHHhhh
Q 009933 246 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP---------PGEHNLVAWAR 315 (522)
Q Consensus 246 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~---------~~~~~~~~~~~ 315 (522)
........ .......++..|+|||++.+..++.++|||||||++|+|+||..||..... ...........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 75433221 112234577889999999998999999999999999999999998863210 00000010111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+...... ..+......+.+||.+||+.||++||++.+|++.|+.+..+
T Consensus 274 ~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKNNGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHTTCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcCCCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111111110 11222346788999999999999999999999999988654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=373.83 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=202.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||+||+|++..++..||||++..... .....+.+|+.+|+.++|||||+++++|.+...+||||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4579999999999999999999999999999999976532 33567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCceeeeeecceee
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---GFHPKLSDFGLAKL 246 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---~~~vkL~DFGla~~ 246 (522)
|||.+++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999876 467999999999999999999999999 999999999999976 45599999999987
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||...... .+. ..+......
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~~~~--- 255 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EIL---RKVEKGKYT--- 255 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTCCC---
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCCC---
Confidence 54322 234567999999999886 47999999999999999999999999754321 111 111111111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...+... .....+.+||.+||+.||.+|||+.++++.
T Consensus 256 ~~~~~~~-----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 FDSPEWK-----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSGGGT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCchhcc-----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111111 123567899999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=391.17 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=208.8
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~ 166 (522)
..++|++.++||+|+||+||+|++..+++.||||++++.. ....+.+..|..+|..+ +||||+.++++|.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999999999999999997532 23345678899999987 6999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
|||||+++|+|.+++.. ...+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999976 467999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
..... ......+||+.|+|||++.+..|+.++||||||||||||++|+.||..... ......+......
T Consensus 492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~--- 560 (674)
T 3pfq_A 492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNVA--- 560 (674)
T ss_dssp CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCCC---
T ss_pred cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCCC---
Confidence 33222 234567899999999999999999999999999999999999999975422 1122222222211
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCH-----HHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI-----GDVVT 367 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-----~evl~ 367 (522)
++......+.+||..||+.||++||++ .+|++
T Consensus 561 ---------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 ---------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 222334678899999999999999997 66654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=373.88 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=209.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.++||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.++||||++++++|.+...+++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999976532 3356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---cCCCceeeeeeccee
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL---DEGFHPKLSDFGLAK 245 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl---d~~~~vkL~DFGla~ 245 (522)
|||+.+++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999976 467999999999999999999999999 9999999999999 567899999999998
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... .+.. .+......+
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~i~~~~~~~- 246 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILK---KVEKGKYTF- 246 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCCCC-
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHcCCCCC-
Confidence 643322 2345679999999999876 7999999999999999999999999754221 1111 111111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
..+.. ......+.+||.+||+.||.+|||+.+++++-.
T Consensus 247 --~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 247 --ELPQW-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp --CSGGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred --CCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 00100 122357889999999999999999999998543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=376.76 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=205.2
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.++||||+++++++.+ +..+||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 35679999999999999999999975 5679999997654 335678999999999999999999999876 67899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999641 1346899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. ........+++.|+|||++....++.++|||||||+||||++ |..||...... .+...+ .....+
T Consensus 334 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~~~----- 400 (452)
T 1fmk_A 334 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----ERGYRM----- 400 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTCCC-----
T ss_pred c-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC-----
Confidence 1 112233457889999999999999999999999999999999 99999754221 111111 111000
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..+......+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 401 -----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 401 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1122233578899999999999999999999999998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=353.00 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=191.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-h-HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-N-REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-~-~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++....... . ..+..+..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 578999999999999999999999999999999997543222 2 23444555688899999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
||+++ +|.+++.........+++..++.|+.||+.||.|||+. + |+|+||||+||||+.++.+||+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99975 88888765433457899999999999999999999998 8 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhh----hcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYA----MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||...... ..... ...... .
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~--~ 231 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQLK-QVVEEP--S 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHHHH-HHHHSC--C
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHHHH-HHhccC--C
Confidence 221 22335699999999996 4567899999999999999999999999753221 11111 111111 0
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..... ......+.+||.+||+.||++|||+.+|++.
T Consensus 232 ~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 232 PQLPA--------DKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CCCCT--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCccc--------ccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11111 1123568899999999999999999999983
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=357.52 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=208.1
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--------hHHHHHHHHHHHhC-CCCCcceeEE
Q 009933 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLL-HHSNLVNLIG 157 (522)
Q Consensus 87 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--------~~~~~~E~~~L~~l-~hpnIv~l~~ 157 (522)
......++|++.+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+|..+ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455678999999999999999999999899999999997643211 24567899999999 7999999999
Q ss_pred EEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCcee
Q 009933 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPK 237 (522)
Q Consensus 158 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vk 237 (522)
+|......||||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||||+.++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999975 457999999999999999999999999 99999999999999999999
Q ss_pred eeeecceeeCCCCCCCcceecccCCccccChhhhhcC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 009933 238 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV 311 (522)
Q Consensus 238 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~ 311 (522)
|+|||++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~ 314 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILML 314 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHH
Confidence 99999998754322 23456799999999998743 588999999999999999999999975321 1111
Q ss_pred HhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 312 AWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 312 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. .+..... ....+... .....+.+||.+||+.||++||++.+|++.
T Consensus 315 ~---~i~~~~~---~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 R---MIMEGQY---QFSSPEWD-----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H---HHHHTCC---CCCHHHHS-----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H---HHHhCCC---CCCCcccc-----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1111110 00001000 112468899999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=362.25 Aligned_cols=250 Identities=30% Similarity=0.409 Sum_probs=204.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
+.|++.+.||+|+||+||+|++..+++.||||++....... .+.+.+|+.+|+.++||||++++++|...+..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999997653322 246789999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+. |+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 588888854 2467999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCcceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+.... .+.
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~--~~~ 272 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE--SPA 272 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC--CCC
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC--CCC
Confidence 23457999999999985 46789999999999999999999999975422 11111111111 111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
... . .....+.+||.+||+.||++||++.+|++....
T Consensus 273 ~~~----~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 273 LQS----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp CCC----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CCC----C----CCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 111 1 122567899999999999999999999986543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=357.98 Aligned_cols=269 Identities=27% Similarity=0.312 Sum_probs=201.2
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-----hHHHHHHHHHHHhCCCCCcceeEEEEEcCCe
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-----NREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-----~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~ 164 (522)
...++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+|..++||||++++++|.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999999999999999997533221 2467899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 89888865 2356888999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhh-----
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF----- 318 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~----- 318 (522)
...... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||........ +........
T Consensus 160 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEE 235 (346)
T ss_dssp STTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTT
T ss_pred eeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChh
Confidence 864322 2233456789999999999764 589999999999999999999999875432111 111110000
Q ss_pred --hcccCCCCcCCccccCCCC-----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 319 --KDRRKFPKMADPLLQGRYP-----MRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 319 --~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.....+...+........+ ......+.+||.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000000100000000011 12236788999999999999999999998854
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=357.03 Aligned_cols=270 Identities=23% Similarity=0.315 Sum_probs=204.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEc--------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD-------- 161 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-------- 161 (522)
.++|++.+.||+|+||+||+|++..+++.||||++...... ....+.+|+.+|+.++||||++++++|..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999999999999999998654332 23567899999999999999999999987
Q ss_pred CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
.+.++|||||+.+ +|.+.+... ...+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 4568999999975 787777652 356999999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCC--CcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhh
Q 009933 242 GLAKLGPVGDK--THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 242 Gla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......+
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99986542221 122345678999999999986 468999999999999999999999997643221111111100000
Q ss_pred hcccCCCCc--------CCccccCCCCh-HH------HHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 319 KDRRKFPKM--------ADPLLQGRYPM-RG------LYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 319 ~~~~~~~~~--------~d~~l~~~~~~-~~------~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.. ...+.. ........... .. ...+.+||.+||+.||++|||+.|+++.-
T Consensus 249 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 249 TP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp CT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred Ch-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 00 000000 00000000011 11 23578999999999999999999998853
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=362.08 Aligned_cols=268 Identities=22% Similarity=0.275 Sum_probs=206.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+|+.++||||++++++|...+..+||||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4579999999999999999999999999999999976532 223568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|+++++|.+++.. ...+++..+..++.||+.||.|||+. + |+|+||||+||||+.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999976 45789999999999999999999996 8 99999999999999999999999999864321
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh---------hhhhhc
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA---------RPLFKD 320 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~---------~~~~~~ 320 (522)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ......
T Consensus 185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 1223457999999999999999999999999999999999999999754321100000000 000000
Q ss_pred ccC-------------CCCcCCcccc----CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 321 RRK-------------FPKMADPLLQ----GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 321 ~~~-------------~~~~~d~~l~----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
... ....++.... ..........+.+||.+||+.||++|||+.++++.-.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 000 0000000000 0001112356889999999999999999999998654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=376.03 Aligned_cols=255 Identities=23% Similarity=0.299 Sum_probs=205.2
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-------------cchHHHHHHHHHHHhCCCCCcceeEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-------------QGNREFLVEVLMLSLLHHSNLVNLIG 157 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-------------~~~~~~~~E~~~L~~l~hpnIv~l~~ 157 (522)
..++|++.++||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 46789999999999999999999999999999999976432 22356889999999999999999999
Q ss_pred EEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC---
Q 009933 158 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF--- 234 (522)
Q Consensus 158 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~--- 234 (522)
+|.+...+|||||||.+++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999976 467999999999999999999999999 99999999999998765
Q ss_pred ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh
Q 009933 235 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 235 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~ 314 (522)
.+||+|||++....... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||...... .+..
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~-- 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIK-- 257 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH--
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH--
Confidence 69999999998754322 234567999999999987 47999999999999999999999999754221 1111
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.+......+. .+.. ......+.+||.+||+.||.+|||+.++++.-.
T Consensus 258 -~i~~~~~~~~---~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 258 -KVEKGKYYFD---FNDW-----KNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp -HHHHCCCCCC---HHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -HHHcCCCCCC---cccc-----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 1111110000 0000 012356889999999999999999999998543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=360.94 Aligned_cols=268 Identities=16% Similarity=0.189 Sum_probs=210.3
Q ss_pred hcCCcccceecccCceEEEEEEECCC--------CcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcce---------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST--------GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN--------- 154 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~--------g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~--------- 154 (522)
.++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+|..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 36899999999999999999999873 889999999654 46788999999999999987
Q ss_pred ------eEEEEEc-CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009933 155 ------LIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSN 227 (522)
Q Consensus 155 ------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~N 227 (522)
+++++.. ....+|||||+ +++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6777776 78899999999 99999999862 1367999999999999999999999999 9999999999
Q ss_pred eeecCCC--ceeeeeecceeeCCCCCCC-----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 009933 228 ILLDEGF--HPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 300 (522)
Q Consensus 228 ILld~~~--~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~ 300 (522)
|||+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 9999999999864322111 11234579999999999999999999999999999999999999998
Q ss_pred CCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 301 NTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
...... ..+......+.... ..+...... .......+.+||.+||+.||++||++.+|++.|+.+.....
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDKP---GPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHSC---CCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCH-HHHHHHHHhccCCh---hhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 653221 11222222111111 111111110 01123678899999999999999999999999999876553
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.99 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=198.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999999899999999996532 22345788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999976 356899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ......+......
T Consensus 163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---- 229 (276)
T 2h6d_A 163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRGGVFY---- 229 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC----
T ss_pred CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCccc----
Confidence 321 2234568999999999988765 6899999999999999999999975321 1111111111111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
++......+.+||.+||+.||.+||++.+|++.
T Consensus 230 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 --------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111123567899999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=348.83 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=201.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcC-CeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG-DQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~-~~~~lV~E 170 (522)
.++|++.+.||+|+||+||++.+. ++.||||++.... ..+.+.+|+.+++.++||||+++++++... +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467999999999999999999985 8899999997542 456788999999999999999999997654 47899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999751 1123889999999999999999999999 999999999999999999999999999753221
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .+.... .... .
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~----~~~~------~ 232 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGY------K 232 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTC------C
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hcCC------C
Confidence 123457889999999999999999999999999999998 99999754221 111111 0000 0
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
. ..+......+.+||..||+.||++||++.+|++.|+.+....
T Consensus 233 ~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 233 M----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 0 112223357889999999999999999999999999886543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.82 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=205.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC--ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.++||+|+||+||+|.+..+++.||||++.... ......+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999999999999999996432 233567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCceeeeeecceee
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKL 246 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld---~~~~vkL~DFGla~~ 246 (522)
|||.+++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999876 467999999999999999999999999 99999999999994 566799999999985
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... .+.. .+......+.
T Consensus 174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~i~~~~~~~~- 242 (486)
T 3mwu_A 174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK---RVETGKYAFD- 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHTCCCSC-
T ss_pred CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCCCCC-
Confidence 4322 12345679999999999876 6999999999999999999999999754221 1111 1111111100
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.+.. ......+.+||.+||+.||.+|||+.++++.-.
T Consensus 243 --~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 243 --LPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp --SGGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred --Cccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 0100 122356889999999999999999999998643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=344.63 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=202.6
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
.+|....+||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||++++++|...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555669999999999999999999999999998765555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCceeeeeecceeeCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-~~~vkL~DFGla~~~~~~~ 251 (522)
++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+|+||||+||||+. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999997621 2245678999999999999999999999 999999999999987 8999999999998643322
Q ss_pred CCcceecccCCccccChhhhhcCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||...... ....+.........
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~------- 245 (295)
T 2clq_A 178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMFKVHP------- 245 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHHHHHCCCC-------
T ss_pred --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhhccccccc-------
Confidence 1223457899999999998653 899999999999999999999999643221 11111111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.++......+.+||.+||+.||++||++.++++.
T Consensus 246 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 -----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122233577899999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.46 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=198.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCC------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------ 163 (522)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 57899999999999999999999999999999999654322 2356789999999999999999999997763
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.+||||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7899999975 56899999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc--
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD-- 320 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-- 320 (522)
++.... ..+..++|+.|+|||++.+ ..|+.++|||||||++|||++|+.||........ ...+......
T Consensus 175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~~~ 246 (367)
T 1cm8_A 175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPP 246 (367)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCC
T ss_pred cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCC
Confidence 987432 2344678999999999987 6899999999999999999999999975432111 1100000000
Q ss_pred ---------------ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 ---------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ---------------~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...++......+. .........+.+|+.+||+.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0001111111111 0111234678899999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=370.67 Aligned_cols=244 Identities=16% Similarity=0.173 Sum_probs=191.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHH---HHHhCCCCCcceeE-------EE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVL---MLSLLHHSNLVNLI-------GY 158 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~---~L~~l~hpnIv~l~-------~~ 158 (522)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999998899999999997532 233467889994 55555799999998 77
Q ss_pred EEcCCe-----------------eEEEEeecCCCChhhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 009933 159 CADGDQ-----------------RLLVYEFMPLGSLEDHLHDLP---PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218 (522)
Q Consensus 159 ~~~~~~-----------------~~lV~E~~~ggsL~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 218 (522)
+...+. .||||||+ +|+|.+++.... .....+++..++.|+.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 766543 78999999 679999997521 11223445888899999999999999999 9
Q ss_pred EecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcC-----------CCCcchhhHHHHH
Q 009933 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----------QLTLKSDVYSFGV 287 (522)
Q Consensus 219 iHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~sDVwSlGv 287 (522)
+||||||+||||+.++.+||+|||+++... ......+| +.|+|||++.+. .|+.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998622 13345678 999999999987 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 288 VFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 288 ll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
+||||++|+.||...........+ ... . ..+ ...+.+||.+||+.||++||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~----------------~~~-~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI----------------FRS-C-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG----------------GSS-C-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhhh----------------hhh-c-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999754332111100 000 0 111 256789999999999999999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=343.15 Aligned_cols=253 Identities=26% Similarity=0.310 Sum_probs=206.4
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---------cchHHHHHHHHHHHhCC-CCCcceeEEEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---------QGNREFLVEVLMLSLLH-HSNLVNLIGYCA 160 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---------~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~ 160 (522)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+|..+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35789999999999999999999999999999999976431 11245778999999996 999999999999
Q ss_pred cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeee
Q 009933 161 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSD 240 (522)
Q Consensus 161 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~D 240 (522)
.....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999976 457999999999999999999999999 99999999999999999999999
Q ss_pred ecceeeCCCCCCCcceecccCCccccChhhhh------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh
Q 009933 241 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM------TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 241 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~ 314 (522)
||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||..... ....
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~ 238 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLML 238 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHH
Confidence 99998653322 233467899999999986 44688999999999999999999999965321 1111
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
..+......+ ..+. .......+.+||.+||+.||++||++.+|++
T Consensus 239 ~~~~~~~~~~---~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNYQF---GSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCCCC---CTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCccc---Cccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111111 0110 0122357889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=349.44 Aligned_cols=260 Identities=18% Similarity=0.236 Sum_probs=204.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEc--CCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCAD--GDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~--~~~~~lV 168 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++... ....+.+|+.+|+.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999999999999999999743 3467889999999997 9999999999988 6788999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeeecceeeC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKLG 247 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DFGla~~~ 247 (522)
|||+.+++|.+++.. +++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||++...
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999999853 788999999999999999999999 99999999999999766 8999999999865
Q ss_pred CCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh--------hh
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP--------LF 318 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~--------~~ 318 (522)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+...... .+
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHH
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHH
Confidence 4332 2234578999999999987 6799999999999999999999999964332111 11110000 00
Q ss_pred h-cccC------------CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 319 K-DRRK------------FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 319 ~-~~~~------------~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. .... .............+......+.+||.+||+.||++|||+.++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000 000111111111222234678999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=368.53 Aligned_cols=265 Identities=24% Similarity=0.307 Sum_probs=199.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcC------Cee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------DQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------~~~ 165 (522)
..+|++.++||+|+||+||+|++..+++.||||++.... ..+.+|+.+|+.|+|||||+++++|... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346999999999999999999999999999999996542 2234699999999999999999988542 246
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-Cceeeeeecce
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG-FHPKLSDFGLA 244 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~-~~vkL~DFGla 244 (522)
+|||||+.+ +|.+++.........+++..++.|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999975 777766543334578999999999999999999999999 9999999999999954 67899999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh------
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL------ 317 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~------ 317 (522)
+...... .....+||+.|+|||++.+. .|+.++||||||||||||++|+.||...... ..+......+
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHH
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 8753322 22346789999999999765 7999999999999999999999999764321 1111111100
Q ss_pred --hhcccCCCCcCCcccc-----CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 318 --FKDRRKFPKMADPLLQ-----GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 318 --~~~~~~~~~~~d~~l~-----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.........+.-+.+. ..++......+.+||.+||+.||++||++.|++++-
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 0000011111111110 011222346788999999999999999999998743
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=351.40 Aligned_cols=267 Identities=25% Similarity=0.368 Sum_probs=189.5
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
..++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.++..++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 46789999999999999999999988899999999865432 23456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 170 EFMPLGSLEDHLHDL----PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 170 E~~~ggsL~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
||+++++|.+++... ......+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998631 112456999999999999999999999999 9999999999999999999999999997
Q ss_pred eCCCCCC---CcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 246 LGPVGDK---THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 246 ~~~~~~~---~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
....... ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||........ ..... ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~---~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLTL---QNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHH---TSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHHh---ccCC
Confidence 6432211 112234579999999999976 5789999999999999999999999976533211 11100 0110
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...................+.+||.+||+.||.+||++.+|++.
T Consensus 245 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 245 ---PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp ---CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111111111112233578899999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=363.15 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=198.4
Q ss_pred CCcccceecccCceEEEEEEECCC---CcEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEc-CCeeEEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQRLLV 168 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-~~~~~lV 168 (522)
.|.+.++||+|+||+||+|.+..+ ...||||.+.... ....+.+.+|+.+|+.++||||++++++|.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 477889999999999999998533 2468999986532 2334678899999999999999999998754 4678999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999975 2456889999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCC--cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 249 VGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 249 ~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||........ .... .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~---~~~~~--- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL---LQGRR--- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHH---HTTCC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHH---HcCCC---
Confidence 22211 11233557889999999999999999999999999999999 6677765433221 1111 11100
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhccC
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTY 377 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 377 (522)
... +......+.+|+.+||+.||++||++.+|++.|+.+.....
T Consensus 315 -~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 315 -LLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000 11223568899999999999999999999999999876554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=345.95 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=204.1
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+|..++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3568999999999999999999999999999999997642 35678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999863 2467999999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ....... .....
T Consensus 179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~~~--~~~~~-- 246 (314)
T 3com_A 179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAI---FMIPTNP--PPTFR-- 246 (314)
T ss_dssp B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHHSC--CCCCS--
T ss_pred c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHH---HHHhcCC--CcccC--
Confidence 1 1223457899999999999989999999999999999999999999754221 111 0111110 00110
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+......+.+||.+||+.||.+||++.+|++.-
T Consensus 247 -----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 247 -----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp -----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred -----CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 1112235788999999999999999999998844
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=352.60 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=200.5
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEc------C
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCAD------G 162 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~------~ 162 (522)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+|..+ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34678999999999999999999999899999999997543 3456788999999998 79999999999987 5
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
...+|||||+.+++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 6889999999999999999762 2357899999999999999999999999 9999999999999999999999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 317 (522)
++...... ........||+.|+|||++. ...++.++|||||||++|+|++|..||...... .... .+
T Consensus 175 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~ 246 (326)
T 2x7f_A 175 VSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALF---LI 246 (326)
T ss_dssp TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HH
T ss_pred CceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHH---Hh
Confidence 98764321 11223457999999999997 567899999999999999999999999654221 1111 11
Q ss_pred hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
... ..+.... . .....+.+||.+||+.||.+||++.+|++.
T Consensus 247 ~~~--~~~~~~~----~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 PRN--PAPRLKS----K----KWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHS--CCCCCSC----S----CSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hcC--ccccCCc----c----ccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 1111111 1 122578899999999999999999999884
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.65 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=201.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEc----CCeeE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRL 166 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~----~~~~~ 166 (522)
..|++.+.||+|+||+||+|.+..++..||+|++...... ....+.+|+.+|+.++||||++++++|.. ...++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4588889999999999999999999999999999754332 34568899999999999999999999875 45689
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCceeeeeeccee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAK 245 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~vkL~DFGla~ 245 (522)
+||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.+ .+|+|+||||+||||+ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999976 367899999999999999999999875 3499999999999997 78999999999997
Q ss_pred eCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 246 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ......+... .
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~-~--- 246 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSG-V--- 246 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTT-C---
T ss_pred ccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhcc-C---
Confidence 53222 2334679999999998864 6999999999999999999999999754221 1111111111 0
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....+ +......+.+||..||+.||.+||++.+|++.
T Consensus 247 --~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 247 --KPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --CCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --Ccccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00111 11122468899999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.65 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=201.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+|..++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 57899999999999999999999999999999999876656667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 169 (302)
T 2j7t_A 98 CPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-- 169 (302)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence 9999999998652 356999999999999999999999999 99999999999999999999999998753111
Q ss_pred CCcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 252 KTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.........||+.|+|||++. ...++.++|||||||++|+|++|..||..... ........... ...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~--~~~ 241 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSD--PPT 241 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC--CCC
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccC--Ccc
Confidence 011123356899999999984 56789999999999999999999999975422 11111111111 011
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.. .+......+.+||.+||+.||++||++.+|++
T Consensus 242 ~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 10 11122356889999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=367.62 Aligned_cols=200 Identities=23% Similarity=0.306 Sum_probs=175.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC------CCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL------HHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l------~hpnIv~l~~~~~~~~~~ 165 (522)
..+|++.++||+|+||+||+|.+..+++.||||++.... .....+..|+.+|..+ +|+||+.++++|.....+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999999999999999996532 2235677788888877 577999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc--eeeeeecc
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH--PKLSDFGL 243 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~--vkL~DFGl 243 (522)
+|||||+. ++|.+++... ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 5999999762 2345999999999999999999999999 999999999999999887 99999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 303 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~ 303 (522)
+..... .....+||+.|+|||++.+..|+.++||||||||||||++|..||....
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 986322 2234679999999999999999999999999999999999999997653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=383.72 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=205.0
Q ss_pred cCCcccc-eecccCceEEEEEEEC--CCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 93 KNFRPEC-LLGEGGFGRVYKGRLE--STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~-~LG~G~fG~Vy~~~~~--~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
++|.+.. .||+|+||.||+|.+. .++..||||+++.... ...+.+.+|+.+|+.++|||||+++++|.. +.++||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3455555 7999999999999885 3467799999976532 345779999999999999999999999986 568999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
||||.+|+|.+++.. ....+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999965 2467999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 249 VGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 249 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
...... ......+++.|+|||++....|+.++|||||||+||||++ |+.||...... .+...+ .....
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i----~~~~~--- 557 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI----EQGKR--- 557 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHH----HTTCC---
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCC---
Confidence 322111 1122345689999999999999999999999999999998 99999765332 122111 11110
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
...+......+.+||..||+.||++||++.+|++.|+.+....
T Consensus 558 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 558 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0122233467889999999999999999999999999875444
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=354.83 Aligned_cols=267 Identities=22% Similarity=0.272 Sum_probs=204.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcC-----Cee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~-----~~~ 165 (522)
..+|++.++||+|+||.||+|.+..+++.||||++...... ....+.+|+.+|..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999999999999999999754322 235688999999999999999999999765 468
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
|+||||+. ++|.+++.. ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 499999976 56999999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCC-CcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHh-hhhhhhc--
Q 009933 246 LGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW-ARPLFKD-- 320 (522)
Q Consensus 246 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~-- 320 (522)
....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.. .......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 6432211 111244679999999998765 4589999999999999999999999976543222111110 0000000
Q ss_pred -----------ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 -----------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 -----------~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...++......+ ..+.......+.+||.+||+.||++|||+.++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPW-NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCH-HHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCH-HHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 00001123568899999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=362.11 Aligned_cols=255 Identities=11% Similarity=-0.007 Sum_probs=184.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhC--CCCCcceeE-------EEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL--HHSNLVNLI-------GYC 159 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l--~hpnIv~l~-------~~~ 159 (522)
..+|++.+.||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.++..| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34589999999999999999999999999999999875432 234566775555544 699988755 555
Q ss_pred EcC-----------------CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 009933 160 ADG-----------------DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR------MKIAAGAAKGLEYLHDKANP 216 (522)
Q Consensus 160 ~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~~~ 216 (522)
... ..+|||||||. ++|.+++... ...+.+..+ +.++.||+.||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 433 33799999998 7999999752 123444455 677899999999999999
Q ss_pred CeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHh
Q 009933 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELIT 294 (522)
Q Consensus 217 ~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLlt 294 (522)
|+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..|+.++|||||||+||||++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999986421 2224567899999999987 689999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 295 GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 295 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
|+.||....+........ . .........+...........+.+||.+||+.||++||++.++++
T Consensus 289 g~~Pf~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKR---P------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCCCB---C------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccchhh---h------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999998654321111000 0 000000001110111123467889999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=355.76 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=196.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCC------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------ 163 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.++||||++++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4789999999999999999999999999999999975432 22356789999999999999999999997765
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
..||||||+.+ +|.+++.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 78888853 4889999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH---------h-
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA---------W- 313 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~---------~- 313 (522)
+...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+. +
T Consensus 174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9864321 12344679999999999999999999999999999999999999997643211000000 0
Q ss_pred ------hhhhhhcccCCC-----CcCCccccCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 314 ------ARPLFKDRRKFP-----KMADPLLQGR---YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 314 ------~~~~~~~~~~~~-----~~~d~~l~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
..........+. .......... ........+.+||.+||+.||++|||+.++++.-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000000000000 0000000000 01122467889999999999999999999998543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=381.62 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=208.3
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..++|++.++||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|+.|+|||||++++++.+ +..|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 35678999999999999999999975 5679999997654 345679999999999999999999999876 67899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||.+|+|.++|... ....+++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999999641 1245899999999999999999999999 999999999999999999999999999864321
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. ........++..|+|||++....++.++|||||||+||||++ |+.||...... .+...+ .....+
T Consensus 417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~~~----- 483 (535)
T 2h8h_A 417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----ERGYRM----- 483 (535)
T ss_dssp H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHH----HTTCCC-----
T ss_pred c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC-----
Confidence 1 111123456789999999999999999999999999999999 99999754221 111111 111100
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
..+......+.+||.+||+.||++||++.+|++.|+.+.
T Consensus 484 -----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 112223357889999999999999999999999999764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=385.78 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=200.1
Q ss_pred ceecccCceEEEEEEE--CCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRL--ESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~--~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
+.||+|+||+||+|.+ ..+++.||||+++.... ...+.+.+|+.+|..|+|||||+++++|.. +..+||||||.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 45678999999976432 224678999999999999999999999975 558899999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC-
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT- 253 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~- 253 (522)
|+|.+++.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999976 467999999999999999999999999 999999999999999999999999999865432221
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
.......+|+.|+|||++....|+.++|||||||+||||++ |+.||...... .+...+ .....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i----~~~~~--------- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAML----EKGER--------- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTCC---------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCC---------
Confidence 12233457889999999999999999999999999999998 99999754321 111111 11110
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
...+......+.+||..||+.||++||++.+|++.|+.+..
T Consensus 591 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01122233678899999999999999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=348.54 Aligned_cols=260 Identities=29% Similarity=0.423 Sum_probs=198.3
Q ss_pred hcCCcccceecccCceEEEEEEECC-CCc--EEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES-TGQ--VVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~-~g~--~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||+||+|.+.. +++ .||||+++.... ...+.+.+|+.++..++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4679999999999999999998743 333 689999876432 23467889999999999999999999998765 8
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999999752 356899999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 246 LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 246 ~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..+. ..+......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~---~~~~~~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQIL---HKIDKEGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH---HHHHTSCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHH---HHHHccCCC
Confidence 754332211 1234557889999999999899999999999999999999 9999975422 1111 111111111
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
. ..+......+.+||.+||+.||++||++.+|++.|+.+..
T Consensus 244 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 L----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred C----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1 0111233578899999999999999999999999988753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.06 Aligned_cols=275 Identities=22% Similarity=0.256 Sum_probs=201.0
Q ss_pred ccHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-----------hHHHHHHHHHHHhCCCCC
Q 009933 83 FTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-----------NREFLVEVLMLSLLHHSN 151 (522)
Q Consensus 83 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-----------~~~~~~E~~~L~~l~hpn 151 (522)
..+.++....++|++.+.||+|+||.||+|.+.. ++.||||++....... .+.+.+|+.+|+.++|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456788889999999999999999999999865 8999999996532211 256889999999999999
Q ss_pred cceeEEEEEc-----CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 009933 152 LVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSS 226 (522)
Q Consensus 152 Iv~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~ 226 (522)
|++++++|.. ...+||||||+. ++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+|+||||+
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 163 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPG 163 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChH
Confidence 9999999854 346899999997 588888875 2457999999999999999999999999 999999999
Q ss_pred ceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 009933 227 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 305 (522)
Q Consensus 227 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~ 305 (522)
||||+.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp GEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999753222 12344678999999999987 67999999999999999999999999764321
Q ss_pred CcchHH-Hhhhh-hhh---------cccCCCCcCCccccC---CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 306 GEHNLV-AWARP-LFK---------DRRKFPKMADPLLQG---RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 306 ~~~~~~-~~~~~-~~~---------~~~~~~~~~d~~l~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.....+ ..... ... ....+.......... .........+.+||.+||+.||++|||+.++++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111100 00000 000 000000000000000 0111223568899999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=358.97 Aligned_cols=259 Identities=23% Similarity=0.303 Sum_probs=186.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcC------C
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG------D 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------~ 163 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|+.++||||++++++|... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 5789999999999999999999999999999999965422 2345678999999999999999999999754 5
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
..|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6799998864 56999999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc-
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR- 321 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 321 (522)
++.... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||........ +..+.......
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~ 250 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPG 250 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCC
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence 986322 2344679999999999987 6899999999999999999999999976432111 11110000000
Q ss_pred ----------------cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 ----------------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ----------------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+.......+.. ........+.+||.+||+.||++|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHH-HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHH-HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000000 001123568899999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=350.17 Aligned_cols=261 Identities=20% Similarity=0.265 Sum_probs=206.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch-----------------HHHHHHHHHHHhCCCCCcce
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN-----------------REFLVEVLMLSLLHHSNLVN 154 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~-----------------~~~~~E~~~L~~l~hpnIv~ 154 (522)
.++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+|+.+|..++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 699999999965322111 77899999999999999999
Q ss_pred eEEEEEcCCeeEEEEeecCCCChhhh------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCc
Q 009933 155 LIGYCADGDQRLLVYEFMPLGSLEDH------LHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSN 227 (522)
Q Consensus 155 l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~N 227 (522)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+|+||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999999 433 225679999999999999999999999 88 9999999999
Q ss_pred eeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCCCC
Q 009933 228 ILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTL-KSDVYSFGVVFLELITGRKAIDNTRPP 305 (522)
Q Consensus 228 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~-~sDVwSlGvll~eLltG~~Pf~~~~~~ 305 (522)
|||+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999874322 33456799999999999887 6766 999999999999999999999764331
Q ss_pred CcchHHHhhhhhhhcccCCCC----cCCcccc---CCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 306 GEHNLVAWARPLFKDRRKFPK----MADPLLQ---GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~----~~d~~l~---~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+.... ......++. ...+... ..........+.+||.+||+.||.+||++.++++.
T Consensus 259 --~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 --VELFNNI---RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp --HHHHHHH---TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHH---hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111 111111111 0000000 00012234578899999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=353.61 Aligned_cols=272 Identities=24% Similarity=0.278 Sum_probs=195.0
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe--
Q 009933 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ-- 164 (522)
Q Consensus 87 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~-- 164 (522)
......++|++.++||+|+||+||+|.+..+++.||||++.... .....+..|+..+..++||||++++++|.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556789999999999999999999999999999999986543 223456678888999999999999999966433
Q ss_pred -----eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCceeecC-CCce
Q 009933 165 -----RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH--DKANPPVIYRDLKSSNILLDE-GFHP 236 (522)
Q Consensus 165 -----~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~~~~iiHrDLKp~NILld~-~~~v 236 (522)
++|||||+.+ +|.+.+.........+++..+..++.||+.||.||| +.+ |+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999976 665555433334577899999999999999999999 888 999999999999986 8999
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhhcCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~ 315 (522)
||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ +.....
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHH
Confidence 999999998643322 233467899999999997654 89999999999999999999999976432111 111110
Q ss_pred hh-------hhcccCCCCcCC---------ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 316 PL-------FKDRRKFPKMAD---------PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 316 ~~-------~~~~~~~~~~~d---------~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.. +..........+ ..+...........+.+||.+||+.||.+|||+.||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000000000000 000011222345789999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=346.20 Aligned_cols=269 Identities=22% Similarity=0.295 Sum_probs=198.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEE-----------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA----------- 160 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~----------- 160 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999999999999999997665555577889999999999999999999874
Q ss_pred ---cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCce
Q 009933 161 ---DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHP 236 (522)
Q Consensus 161 ---~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~v 236 (522)
.....++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||||+ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 4467899999997 599999864 56899999999999999999999999 99999999999997 56799
Q ss_pred eeeeecceeeCCCCCC-CcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh
Q 009933 237 KLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 237 kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~ 314 (522)
||+|||++........ ........+|..|+|||++.. ..++.++|||||||++|||++|+.||...........+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999986432111 112234567999999999876 67999999999999999999999999765321111100000
Q ss_pred hhhhh--cc----cCCCCcCCcccc-CC-----CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 315 RPLFK--DR----RKFPKMADPLLQ-GR-----YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 315 ~~~~~--~~----~~~~~~~d~~l~-~~-----~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.+... .. ..++..+..... .. ........+.+||.+||+.||++||++.++++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 00000 00 000000000000 00 0012235788999999999999999999998853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.57 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=196.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCC------ee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD------QR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------~~ 165 (522)
..+|++.++||+|+||+||+|++..+++ ||+|++..... ...+|+.+|+.++||||++++++|.... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4579999999999999999999987655 88888754322 2236999999999999999999996543 37
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCceeeeeecce
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLA 244 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~vkL~DFGla 244 (522)
+|||||+.+ +|.+.+.........+++..++.|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||++
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 899999976 444444322223567999999999999999999999999 99999999999998 7999999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh------
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL------ 317 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~------ 317 (522)
+...... ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||....... .+......+
T Consensus 190 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 190 KILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSRE 264 (394)
T ss_dssp EECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred ccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 8753322 22346789999999999765 59999999999999999999999997643211 111111000
Q ss_pred ----hhc---ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 ----FKD---RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ----~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
... ...++......+...++......+.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 001111111111111222234678999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=347.45 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=204.5
Q ss_pred hcCCcccceecccCceEEEEEEE-CCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCC------CcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRL-ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS------NLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hp------nIv~l~~~~~~~~~ 164 (522)
.++|++.+.||+|+||+||+|.+ ..+++.||||++.... .....+.+|+.++..++|+ +|++++++|...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 56899999999999999999999 5578999999996432 2345678899999988765 49999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC------------
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE------------ 232 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~------------ 232 (522)
.+|||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 88999999762 2346899999999999999999999999 999999999999987
Q ss_pred -------CCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 009933 233 -------GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 305 (522)
Q Consensus 233 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~ 305 (522)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999864321 23457999999999999999999999999999999999999999754321
Q ss_pred CcchHHHhhhh-----hhhcccC----------CC----------CcCCcccc-CCCChHHHHHHHHHHHHhcccCcCCC
Q 009933 306 GEHNLVAWARP-----LFKDRRK----------FP----------KMADPLLQ-GRYPMRGLYQALAVAAMCLQEQAATR 359 (522)
Q Consensus 306 ~~~~~~~~~~~-----~~~~~~~----------~~----------~~~d~~l~-~~~~~~~~~~l~~Li~~cl~~dP~~R 359 (522)
.....+..... ++..... .. ....+... ...+......+.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 11111110000 0000000 00 00000000 11223456788999999999999999
Q ss_pred CCHHHHHHH
Q 009933 360 PLIGDVVTA 368 (522)
Q Consensus 360 Ps~~evl~~ 368 (522)
||+.||++.
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=351.78 Aligned_cols=263 Identities=20% Similarity=0.287 Sum_probs=200.4
Q ss_pred ccHHHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCC--CCCcceeEEE
Q 009933 83 FTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLH--HSNLVNLIGY 158 (522)
Q Consensus 83 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~--hpnIv~l~~~ 158 (522)
+.+..+....++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+|..++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 333334445678999999999999999999986 4899999999754332 3356889999999997 5999999999
Q ss_pred EEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceee
Q 009933 159 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 238 (522)
Q Consensus 159 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL 238 (522)
+......+|||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||||++ +.+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence 999999999999 557899999976 457899999999999999999999999 999999999999975 89999
Q ss_pred eeecceeeCCCCCCCcceecccCCccccChhhhhc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 009933 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 307 (522)
Q Consensus 239 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----------~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~ 307 (522)
+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 244 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--- 244 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS---
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH---
Confidence 99999986543322222344679999999999875 4788999999999999999999999965321
Q ss_pred chHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 308 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
. ........... ....++......+.+||.+||+.||++||++.+|++.-.
T Consensus 245 -~-~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 245 -Q-ISKLHAIIDPN----------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp -H-HHHHHHHHCTT----------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -H-HHHHHHHHhcc----------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 1 11111111110 011111122356789999999999999999999998653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.31 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=201.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcC-----Cee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~-----~~~ 165 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 5789999999999999999999999999999999965332 2235678999999999999999999988764 678
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 599999876 56999999999999999999999999 9999999999999999999999999998
Q ss_pred eCCCCCCCc--------ceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh
Q 009933 246 LGPVGDKTH--------VSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 246 ~~~~~~~~~--------~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
......... .....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHH
Confidence 753221111 1223578999999998875 679999999999999999999999997643211 1100000
Q ss_pred hhhccc------------------CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 317 LFKDRR------------------KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 317 ~~~~~~------------------~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...... .++......+. .........+.+||.+||+.||++|||+.+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00000000000 0001223567899999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=354.50 Aligned_cols=265 Identities=17% Similarity=0.223 Sum_probs=202.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-----------CCCcceeEEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----------HSNLVNLIGYCA 160 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-----------hpnIv~l~~~~~ 160 (522)
..+|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+|..++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999999999999999997432 23456788999988886 899999999997
Q ss_pred cCC----eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeec----
Q 009933 161 DGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLD---- 231 (522)
Q Consensus 161 ~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld---- 231 (522)
... .+++||||+ +++|.+++... ....+++..++.|+.||+.||.|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 654 789999999 88999999763 234589999999999999999999998 8 99999999999994
Q ss_pred --CCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 009933 232 --EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHN 309 (522)
Q Consensus 232 --~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~ 309 (522)
..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 445899999999986432 2234578999999999999999999999999999999999999998654321111
Q ss_pred HHHhhhhhh---------------------hcccCCCCcCC-------cc--ccCCCChHHHHHHHHHHHHhcccCcCCC
Q 009933 310 LVAWARPLF---------------------KDRRKFPKMAD-------PL--LQGRYPMRGLYQALAVAAMCLQEQAATR 359 (522)
Q Consensus 310 ~~~~~~~~~---------------------~~~~~~~~~~d-------~~--l~~~~~~~~~~~l~~Li~~cl~~dP~~R 359 (522)
.......+. .....+..+.. .. ....++......+.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111000000 00000000000 00 0113455667789999999999999999
Q ss_pred CCHHHHHHH
Q 009933 360 PLIGDVVTA 368 (522)
Q Consensus 360 Ps~~evl~~ 368 (522)
||+.+|++.
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.05 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=195.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc----------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD---------- 161 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~---------- 161 (522)
.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+|+.++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46799999999999999999999989999999999643 2334668899999999999999999998865
Q ss_pred ---CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceee
Q 009933 162 ---GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKL 238 (522)
Q Consensus 162 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL 238 (522)
....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 3567999999999999999975 2356788999999999999999999999 999999999999999999999
Q ss_pred eeecceeeCCCCC------------CCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 009933 239 SDFGLAKLGPVGD------------KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPP 305 (522)
Q Consensus 239 ~DFGla~~~~~~~------------~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~ 305 (522)
+|||++....... .........||+.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 9999998643211 01122345689999999999865 78999999999999999998 54321
Q ss_pred CcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 306 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.........+......++ ..++......+.+||.+||+.||.+||++.+|++.
T Consensus 232 --~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 --MERVNILKKLRSVSIEFP--------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHHHHHHHSTTCCCC--------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhHHHHHHhccccccccC--------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111111111111 12233344667899999999999999999999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=336.85 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=205.2
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
...++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++......++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 345789999999999999999999998999999999965432 345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC---Cceeeeeecce
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG---FHPKLSDFGLA 244 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~---~~vkL~DFGla 244 (522)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||||+.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999875 357899999999999999999999999 9999999999999654 47999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ..+. ..+......+
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~---~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDIL---KRVETGKYAF 241 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHCCCCC
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHcCCCCC
Confidence 8643222 2233468999999998876 589999999999999999999999975422 1111 1111111100
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. .+.. ......+.+||.+||+.||++||++.++++.
T Consensus 242 ~---~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 D---LPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp C---SGGG-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred C---chhh-----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 0000 1123568899999999999999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=350.54 Aligned_cols=258 Identities=23% Similarity=0.327 Sum_probs=199.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCee----
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQR---- 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~---- 165 (522)
.++|.+.+.||+|+||+||+|.+..+++.||||++....... ...+.+|+.+|+.++||||++++++|......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 578999999999999999999999999999999997643322 35678999999999999999999999887655
Q ss_pred --EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 166 --LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 166 --~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 58888874 34899999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc-
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR- 321 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 321 (522)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...........
T Consensus 191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~ 262 (371)
T 4exu_A 191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPG 262 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCc
Confidence 985322 2234678999999999987 6899999999999999999999999975432111 11000000000
Q ss_pred ----------------cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 ----------------RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ----------------~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+.......+. .+.......+.+||.+||+.||++|||+.++++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000000 0011224678899999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=342.95 Aligned_cols=265 Identities=24% Similarity=0.336 Sum_probs=202.3
Q ss_pred hhcCCcccceecccCceEEEEEEEC-CCCcEEEEEEEccCCc--cchHHHHHHHHHHHhC---CCCCcceeEEEEE----
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLE-STGQVVAVKQLDRNGL--QGNREFLVEVLMLSLL---HHSNLVNLIGYCA---- 160 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~-~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l---~hpnIv~l~~~~~---- 160 (522)
..++|++.+.||+|+||+||+|.+. .+++.||||++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999965322 1223566777777666 8999999999987
Q ss_pred -cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeee
Q 009933 161 -DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239 (522)
Q Consensus 161 -~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~ 239 (522)
.....++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5667899999997 5999999763 2345899999999999999999999999 9999999999999999999999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK 319 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 319 (522)
|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..........
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcC
Confidence 9999986422 122344678999999999999999999999999999999999999997543211 1111100000
Q ss_pred c--ccCCC-----------CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 320 D--RRKFP-----------KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 320 ~--~~~~~-----------~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. ..... ......+ ..+.......+.+||.+||+.||++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000 0000000 01112234577899999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=345.90 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=195.4
Q ss_pred HHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------chHHHHHHHHHHHhC----CCCCcceeEE
Q 009933 88 LAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLL----HHSNLVNLIG 157 (522)
Q Consensus 88 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~~L~~l----~hpnIv~l~~ 157 (522)
.....++|++.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.++..+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344568899999999999999999999989999999999765432 223456789999988 8999999999
Q ss_pred EEEcCCeeEEEEee-cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCc
Q 009933 158 YCADGDQRLLVYEF-MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFH 235 (522)
Q Consensus 158 ~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~ 235 (522)
++...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 99999999999999 789999999976 457999999999999999999999999 99999999999998 8899
Q ss_pred eeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhh
Q 009933 236 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWA 314 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~ 314 (522)
+||+|||++...... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.... .
T Consensus 179 ~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~----- 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E----- 244 (312)
T ss_dssp EEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-----
T ss_pred EEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H-----
Confidence 999999999875332 22345699999999999887764 58999999999999999999996421 0
Q ss_pred hhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 315 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....... ++......+.+||.+||+.||++||++.+|++.
T Consensus 245 --~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 --ILEAELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HHHTCCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --HhhhccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 112223567899999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=344.96 Aligned_cols=260 Identities=23% Similarity=0.302 Sum_probs=183.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHH-HHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVL-MLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~-~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+..|+. +++.++||||+++++++...+..+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46899999999999999999999999999999999765322 2234555655 777889999999999999999999999
Q ss_pred eecCCCChhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 170 EFMPLGSLEDHLHDLP-PDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
||+.+ +|.+++.... .....+++..+..++.|++.||.|||+. + |+|+||||+||||+.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 8888775211 1246789999999999999999999998 8 999999999999999999999999999864
Q ss_pred CCCCCCcceecccCCccccChhhh----hcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYA----MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||....... .........
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~--- 245 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVVKG--- 245 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCS---
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHhcC---
Confidence 3221 22334699999999998 45678999999999999999999999997542210 000000000
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
..+.+...........+.+||.+||+.||++||++.+|++.-.
T Consensus 246 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 246 ----DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp ----CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred ----CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 0011111111123457889999999999999999999988543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=352.54 Aligned_cols=203 Identities=25% Similarity=0.322 Sum_probs=174.4
Q ss_pred HHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CC-----CcceeEEEEEcC
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HS-----NLVNLIGYCADG 162 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hp-----nIv~l~~~~~~~ 162 (522)
....++|++.++||+|+||+||+|.+..+++.||||++.... .....+..|+.++..++ |+ +|+.++++|...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 334678999999999999999999999999999999997432 22356677888888875 55 499999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCCeEecCCCCCceee--cCCCceee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD--KANPPVIYRDLKSSNILL--DEGFHPKL 238 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--~~~~~iiHrDLKp~NILl--d~~~~vkL 238 (522)
+..+|||||+.+ +|.+++... ....+++..++.++.||+.||.|||. .+ ||||||||+|||| +.++.+||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred CceEEEEecCCC-CHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence 999999999964 999999762 23468999999999999999999994 56 9999999999999 45788999
Q ss_pred eeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 009933 239 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTR 303 (522)
Q Consensus 239 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~ 303 (522)
+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus 203 ~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 203 VDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999987432 1234679999999999999999999999999999999999999998653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=347.22 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=203.6
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------chHHHHHHHHHHHhCC--CCCcceeEEE
Q 009933 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLH--HSNLVNLIGY 158 (522)
Q Consensus 87 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~~L~~l~--hpnIv~l~~~ 158 (522)
+.....++|++.++||+|+||.||+|.+..+++.||||++...... ....+..|+.+|+.++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3444568899999999999999999999999999999999764332 2245678999999996 5999999999
Q ss_pred EEcCCeeEEEEeecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCce
Q 009933 159 CADGDQRLLVYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHP 236 (522)
Q Consensus 159 ~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~v 236 (522)
+...+..++||||+.+ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+ +++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999976 899999976 467999999999999999999999999 99999999999998 78999
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~ 315 (522)
||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .
T Consensus 190 kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~------ 254 (320)
T 3a99_A 190 KLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E------ 254 (320)
T ss_dssp EECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------
T ss_pred EEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----h------
Confidence 99999999875322 2234579999999999988776 688999999999999999999996421 0
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....... ++......+.+||.+||+.||++||++.+|++.
T Consensus 255 -~~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 -IIRGQVF------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHHCCCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hhccccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111 111123567899999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=346.14 Aligned_cols=256 Identities=20% Similarity=0.216 Sum_probs=177.7
Q ss_pred hcCCcccc-eecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc----CCeeE
Q 009933 92 TKNFRPEC-LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRL 166 (522)
Q Consensus 92 ~~~y~~~~-~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~----~~~~~ 166 (522)
.++|.+.+ +||+|+||+||+|.+..+++.||||++... ..........+..+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 57899854 699999999999999999999999999643 1222233345677899999999999876 45689
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCceeeeeecc
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---GFHPKLSDFGL 243 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---~~~vkL~DFGl 243 (522)
|||||+.+++|.+++... ....+++.+++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999862 2357999999999999999999999999 999999999999976 45599999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
+...... ......||+.|+|||++....++.++|||||||++|+|++|..||............ ...+......
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~ 251 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRIRLGQYG 251 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------C
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhhhccccc
Confidence 9864321 223457899999999998888999999999999999999999999754332111000 0000000000
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
+ ..+ ........+.+||.+||+.||++|||+.+|++.-.
T Consensus 252 ~---~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 252 F---PNP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp C---CTT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred c---Cch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0 000 01123357889999999999999999999998543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=354.70 Aligned_cols=271 Identities=22% Similarity=0.289 Sum_probs=186.1
Q ss_pred cCCcc-cceecccCceEEEEEEEC--CCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc--CCeeEE
Q 009933 93 KNFRP-ECLLGEGGFGRVYKGRLE--STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLL 167 (522)
Q Consensus 93 ~~y~~-~~~LG~G~fG~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~~l 167 (522)
+.|++ .++||+|+||+||+|++. .+++.||||++.... ....+.+|+.+|+.|+|||||+++++|.. ...+||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 458999999999999976 468899999997543 23568899999999999999999999954 678999
Q ss_pred EEeecCCCChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----cCCCceee
Q 009933 168 VYEFMPLGSLEDHLHDLP-----PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL----DEGFHPKL 238 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl----d~~~~vkL 238 (522)
||||+.+ +|.+++.... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999964 8888875311 12235999999999999999999999999 9999999999999 77899999
Q ss_pred eeecceeeCCCCCC-CcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC------cchH
Q 009933 239 SDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPG------EHNL 310 (522)
Q Consensus 239 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~------~~~~ 310 (522)
+|||+++....... .......+||+.|+|||++.+. .|+.++||||||||||+|++|+.||....... ....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999986432211 1223456799999999999874 59999999999999999999999997543210 0011
Q ss_pred HHhhhhhhhccc--------CCCC-------cCCccccC--------CCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 311 VAWARPLFKDRR--------KFPK-------MADPLLQG--------RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 311 ~~~~~~~~~~~~--------~~~~-------~~d~~l~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
+......+.... .++. +....... .........+.+||.+||+.||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111100000000 0000 00000000 000011346789999999999999999999987
Q ss_pred HH
Q 009933 368 AL 369 (522)
Q Consensus 368 ~L 369 (522)
.-
T Consensus 334 hp 335 (405)
T 3rgf_A 334 DP 335 (405)
T ss_dssp SG
T ss_pred Ch
Confidence 54
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=343.05 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=199.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEcCCe-----
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQ----- 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~----- 164 (522)
.++|.+.+.||+|+||.||+|.+..+|+.||||++....... ...+.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999997643222 3567899999999999999999999987654
Q ss_pred -eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 165 -RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 165 -~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58888874 34899999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc--
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD-- 320 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-- 320 (522)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ...........
T Consensus 173 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~ 244 (353)
T 3coi_A 173 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPG 244 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCC
T ss_pred ccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 985321 1234578999999999987 678999999999999999999999997643211 11100000000
Q ss_pred ---------------ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 ---------------RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ---------------~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...++......+. .........+.+||.+||+.||++||++.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000010011110 1112334678899999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.96 Aligned_cols=262 Identities=19% Similarity=0.265 Sum_probs=202.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCC-cEEEEEEEccCCccchHHHHHHHHHHHhCCCCC------cceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTG-QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN------LVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g-~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpn------Iv~l~~~~~~~~~ 164 (522)
.++|++.+.||+|+||+||+|.+..++ +.||||+++... .....+..|+.+|+.++|++ |+.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999998776 789999996432 33456788999999987665 9999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee--------------
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL-------------- 230 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl-------------- 230 (522)
.+|||||+ +++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 99999999 66787777652 2356999999999999999999999998 9999999999999
Q ss_pred -----cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 009933 231 -----DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 305 (522)
Q Consensus 231 -----d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~ 305 (522)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5678999999999986332 223467999999999999999999999999999999999999999754321
Q ss_pred CcchHHHhhhhhhhc--------ccC----------CCC----------cCCccc-cCCCChHHHHHHHHHHHHhcccCc
Q 009933 306 GEHNLVAWARPLFKD--------RRK----------FPK----------MADPLL-QGRYPMRGLYQALAVAAMCLQEQA 356 (522)
Q Consensus 306 ~~~~~~~~~~~~~~~--------~~~----------~~~----------~~d~~l-~~~~~~~~~~~l~~Li~~cl~~dP 356 (522)
.. .......... ... ... ...+.. ...........+.+||.+||+.||
T Consensus 246 ~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 246 EH---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp HH---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HH---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 11 1111100000 000 000 000000 001122345678899999999999
Q ss_pred CCCCCHHHHHHH
Q 009933 357 ATRPLIGDVVTA 368 (522)
Q Consensus 357 ~~RPs~~evl~~ 368 (522)
++|||+.+|++.
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=345.75 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=200.1
Q ss_pred hhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
..++|++.+.||+|+||.||+|.+.. .||||++..... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 35789999999999999999999864 499999875432 2235577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++ ++.+||+|||++....
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999976 2346899999999999999999999999 99999999999998 6799999999987542
Q ss_pred CCC---CCcceecccCCccccChhhhhc---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh
Q 009933 249 VGD---KTHVSTRVMGTYGYCAPEYAMT---------GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316 (522)
Q Consensus 249 ~~~---~~~~~~~~~gt~~y~APE~l~~---------~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~ 316 (522)
... .........||+.|+|||++.. ..++.++|||||||++|+|++|+.||...... ... ..
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~---~~ 254 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII---WQ 254 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH---HH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HH
Confidence 211 1112233568999999999974 35789999999999999999999999754221 111 11
Q ss_pred hhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 317 LFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 317 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
+... ..+..... .+ ...+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus 255 ~~~~--~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 255 MGTG--MKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHTT--CCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred hccC--CCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 00111110 11 235779999999999999999999999999876554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=372.89 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=205.5
Q ss_pred hhcCCcccceecccCceEEEEEEECCC---CcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 91 ATKNFRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 91 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
..++|++.+.||+|+||+||+|.+..+ +..||||++...... ..+.+.+|+.+|+.++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 356799999999999999999998643 467999998754322 2367889999999999999999999985 46789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
|||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..
T Consensus 467 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999975 2346899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
...... .......+|+.|+|||++....++.++|||||||++|||++ |..||...... ...... ... ...
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i---~~~-~~~- 611 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---ENG-ERL- 611 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HHT-CCC-
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH---HcC-CCC-
Confidence 433221 12233457889999999999999999999999999999997 99999754221 111111 111 100
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..+......+.+||.+||+.||++||++.+|++.|+.+..
T Consensus 612 ---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 612 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0112233578899999999999999999999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=333.63 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=183.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-h-HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-N-REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-~-~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||.||+|.+..+++.||||++....... . +.+..+..+++.++||||+++++++...+..+|||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999999899999999997654322 2 23344556788889999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
||+ ++.+..++.. ....+++..++.++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5555555543 135789999999999999999999995 8 9999999999999999999999999997543
Q ss_pred CCCCCcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...... .............
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~ 248 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEPP 248 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCCC
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCCC
Confidence 221 223457999999999994 457899999999999999999999999753221 1111111111110
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L 369 (522)
.... .......+.+||.+||+.||.+||++.+|++.-
T Consensus 249 ---~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 249 ---LLPG------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp ---CCCS------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred ---CCCc------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 0000 011235688999999999999999999999843
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.07 Aligned_cols=235 Identities=14% Similarity=0.088 Sum_probs=187.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.+.||+|+||.||+|++..+++.||||++....... .+.+.+|+.++..++||||+++++++.+.+..|||
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999999999999999997654332 25688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
|||+++++|.+++.. . ....++..|+.||+.||.|||+.+ |+||||||+||||+.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999954 2 355678999999999999999999 9999999999999999999998443
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
|++ .++.++|||||||++|||+||+.||............ ...... ..
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~------~~ 222 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAG------QP 222 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTS------CB
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhcc------CC
Confidence 333 3789999999999999999999999865432211000 000000 00
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.+. ..........+.+||.+||+.||++| |+.++++.|+.+....
T Consensus 223 ~~~--~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 223 IEP--ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CCH--HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCh--hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000 00011123568899999999999999 9999999999886544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=347.69 Aligned_cols=254 Identities=23% Similarity=0.269 Sum_probs=187.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEee
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
+.|.+.++||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.+|..+ +|||||++++++.+....||||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4566678999999999987644 46999999998653 235678899999876 899999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCC-------------Cc
Q 009933 172 MPLGSLEDHLHDLPPDKEP---LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEG-------------FH 235 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~-------------~~ 235 (522)
|. ++|.+++......... .++..++.|+.||+.||.|||+.+ |+||||||+||||+.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 5999999763222111 133456789999999999999999 9999999999999654 48
Q ss_pred eeeeeecceeeCCCCCCCc--ceecccCCccccChhhhhc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCC
Q 009933 236 PKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPP 305 (522)
Q Consensus 236 vkL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~-------~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~ 305 (522)
+||+|||++.......... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998754332211 1234679999999999976 578999999999999999999 99999643221
Q ss_pred CcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 306 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.... ......+... ....+......+.+||.+||+.||.+||++.+|++
T Consensus 247 ----~~~i----~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ----ESNI----IRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHH----HHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHH----hcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111 1111111111 11123345578899999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.80 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=186.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
..+|.+.++||+|+||+||... ..+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+....|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3568999999999999976433 34689999999975432 3356799999999 79999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCceeeeeeccee
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-----GFHPKLSDFGLAK 245 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-----~~~vkL~DFGla~ 245 (522)
||. ++|.+++... ...+.+..++.|+.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 996 5999999762 233455567899999999999999999 999999999999943 3357899999998
Q ss_pred eCCCCCCC-cceecccCCccccChhhhh---cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 246 LGPVGDKT-HVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 246 ~~~~~~~~-~~~~~~~gt~~y~APE~l~---~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
........ ......+||+.|+|||++. ...++.++|||||||++|||++ |..||..... ...... ..
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----~~~~~~---~~- 243 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANIL---LG- 243 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----HHHHHH---TT-
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----HHHHHH---hc-
Confidence 65432211 2234567999999999998 4577889999999999999999 8999864321 111100 00
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
..... .. .........+.+||.+||+.||++||++.+|++
T Consensus 244 ~~~~~-~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSLD-CL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCCT-TS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCcc-cc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000 00 011234456789999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=362.19 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=195.1
Q ss_pred hcCCcccceecccCceEEEEEEECC-CCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCe-----
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES-TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ----- 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~-~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~----- 164 (522)
.++|++.++||+|+||+||+|.+.. +++.||||++..... .....+..|+.+|..++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999975 689999999865432 233567899999999999999999999987665
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.||||||+++++|.+++.. .+++.+++.|+.||+.||.|||+++ ||||||||+||||+.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987643 6999999999999999999999999 9999999999999886 8999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
+..... ...+||+.|+|||++.+. ++.++|||||||+||+|++|..||...... .+
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~ 284 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GL 284 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SC
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------cc
Confidence 874322 345799999999999875 589999999999999999998887642110 00
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHHHhh
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-LIGDVVTALTYLA 373 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~evl~~L~~l~ 373 (522)
. ...........+.+||.+||+.||++|| +++++...|..+.
T Consensus 285 ~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 P-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp C-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 0000012235678999999999999999 5666777776654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.33 Aligned_cols=244 Identities=18% Similarity=0.193 Sum_probs=183.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc---chHHHHHHHHHHHhCCC-CCcc---------e----
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHH-SNLV---------N---- 154 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~~L~~l~h-pnIv---------~---- 154 (522)
..+|.+.++||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.++..+.| +|+. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 44588889999999999999999999999999999743322 24678899999999987 3211 1
Q ss_pred --------eEEEEEc-----CCeeEEEEeecCCCChhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 009933 155 --------LIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDL---PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPV 218 (522)
Q Consensus 155 --------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 218 (522)
++.++.. ...++++|+++ +++|.+++... ......+++..++.|+.||+.||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1111111 22456777766 67999998521 123456888899999999999999999999 9
Q ss_pred EecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhh----------hcCCCCcchhhHHHHHH
Q 009933 219 IYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA----------MTGQLTLKSDVYSFGVV 288 (522)
Q Consensus 219 iHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~~~~sDVwSlGvl 288 (522)
|||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++ ....|+.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999986321 2345678 999999999 44468889999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 289 FLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 289 l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
||||++|+.||......... ...+... ..++ ..+.+||.+||+.||++||++.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~------~~~~~~~------------~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGS------EWIFRSC------------KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCS------GGGGSSC------------CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhhH------HHHHhhc------------ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999754321110 0001100 0122 56889999999999999999877755
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=319.85 Aligned_cols=229 Identities=21% Similarity=0.277 Sum_probs=183.4
Q ss_pred hcCCccc-ceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHH-HhCCCCCcceeEEEEEc----CCee
Q 009933 92 TKNFRPE-CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLVNLIGYCAD----GDQR 165 (522)
Q Consensus 92 ~~~y~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L-~~l~hpnIv~l~~~~~~----~~~~ 165 (522)
.++|.+. ++||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||++++++|.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567777 789999999999999999999999999953 35677888887 66789999999999987 6788
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCceeeeeec
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---GFHPKLSDFG 242 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---~~~vkL~DFG 242 (522)
+|||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999862 2347999999999999999999999999 999999999999987 7899999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhccc
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 322 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 322 (522)
++.... +..|+.++|||||||++|+|++|..||.........
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------- 207 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------- 207 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------------
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--------------
Confidence 987521 235788999999999999999999999754321110
Q ss_pred CCCCcCCccccC--CCC----hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 323 KFPKMADPLLQG--RYP----MRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 323 ~~~~~~d~~l~~--~~~----~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
..+....... .++ ......+.+||.+||+.||.+||++.++++.-.
T Consensus 208 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 208 --PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp --CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 0000000000 111 122357889999999999999999999998544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=357.12 Aligned_cols=272 Identities=25% Similarity=0.310 Sum_probs=206.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-cchHHHHHHHHHHHhCCCCCcceeEEEEEc------CCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCAD------GDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~------~~~ 164 (522)
.++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|..++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3689999999999999999999999999999999875422 234568899999999999999999998765 677
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCc---eeeeee
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFH---PKLSDF 241 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~---vkL~DF 241 (522)
.+||||||++++|.+++.... ....+++..++.|+.||+.||.|||+.+ |+|+||||+||||+.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999998632 2346889999999999999999999999 999999999999986664 999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....|...+....
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~ 240 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKS 240 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC---
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhccc
Confidence 9998653322 2345679999999999999999999999999999999999999996531 1112211111000
Q ss_pred cC----------CCCcCCc-cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHH-----HHHHHHHhhhc
Q 009933 322 RK----------FPKMADP-LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGD-----VVTALTYLASQ 375 (522)
Q Consensus 322 ~~----------~~~~~d~-~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e-----vl~~L~~l~~~ 375 (522)
.. ...+... .....+.......+.+||..||+.||++||++.+ +.+.+..+...
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00 0000000 0011234456778999999999999999999988 55666665443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=327.13 Aligned_cols=241 Identities=17% Similarity=0.143 Sum_probs=184.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--------chHHHHHHHHHHHhCC---------CCCcce
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--------GNREFLVEVLMLSLLH---------HSNLVN 154 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--------~~~~~~~E~~~L~~l~---------hpnIv~ 154 (522)
.++|++.+.||+|+||+||+|++ +++.||||++...... ..+.+.+|+.+|+.++ |||||.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 5899999999765321 2267889999998886 777777
Q ss_pred eEEEEE------------------------------cCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHH
Q 009933 155 LIGYCA------------------------------DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 204 (522)
Q Consensus 155 l~~~~~------------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~ 204 (522)
+++++. ....+|||||||++|+|.+.+.. ..+++..++.|+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 776643 26789999999999987777743 5689999999999999
Q ss_pred HHHHHHH-hcCCCCeEecCCCCCceeecCCC--------------------ceeeeeecceeeCCCCCCCcceecccCCc
Q 009933 205 KGLEYLH-DKANPPVIYRDLKSSNILLDEGF--------------------HPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263 (522)
Q Consensus 205 ~~L~yLH-~~~~~~iiHrDLKp~NILld~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~ 263 (522)
.||.||| +.+ |+||||||+||||+.++ .+||+|||+++.... ...+||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 899 99999999999998876 899999999986432 1347999
Q ss_pred cccChhhhhcCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCCCCcchHHHhh-hhhhhcccCCCCcCCccccCCCChHHH
Q 009933 264 GYCAPEYAMTGQLTLKSDVYSFGVV-FLELITGRKAIDNTRPPGEHNLVAWA-RPLFKDRRKFPKMADPLLQGRYPMRGL 341 (522)
Q Consensus 264 ~y~APE~l~~~~~~~~sDVwSlGvl-l~eLltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~ 341 (522)
.|+|||++.+.. +.++|||||+++ .+++++|..||... ...... ..+... ...... ..........
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~s 309 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQ-MTFKTK----CNTPAMKQIK 309 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHT-CCCSSC----CCSHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhh-hccCcc----cchhhhhhcC
Confidence 999999998765 899999998777 77889999988421 000001 111111 011100 0011123456
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHH
Q 009933 342 YQALAVAAMCLQEQAATRPLIGDVV 366 (522)
Q Consensus 342 ~~l~~Li~~cl~~dP~~RPs~~evl 366 (522)
..+.+||.+||+.| |+.|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 78999999999977 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-33 Score=305.38 Aligned_cols=186 Identities=18% Similarity=0.123 Sum_probs=134.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEEccCCcc----------chHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEEE
Q 009933 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ----------GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 101 LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~----------~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++.|++|.+..++..-.|+.||||++...... ..++|.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56677777777777667999999999764321 124688999999999 6999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||+|++|.++|.. ..+++.. .|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999986 4667654 58999999999999999 99999999999999999999999999986432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf 299 (522)
. .......+||+.|||||++.+ .+..++|+||+|+++++|+++..+|
T Consensus 392 ~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 D--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred C--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 223456789999999999876 5778899999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-29 Score=268.82 Aligned_cols=185 Identities=19% Similarity=0.244 Sum_probs=145.6
Q ss_pred cccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--------hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 96 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--------~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
...++||+|+||+||+|.. .+..+++|++....... .+.+.+|+.+|+.++||||+.+..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 4467899999999999954 47889999875433221 2347899999999999999966666667788899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||||++++|.+++.. +..|+.||+.+|.|||+++ |+||||||+||||+. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999864 4689999999999999999 999999999999998 9999999999975
Q ss_pred CCCCCCc-----ceecccCCccccChhhhhc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 009933 248 PVGDKTH-----VSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVFLELITGRKAI 299 (522)
Q Consensus 248 ~~~~~~~-----~~~~~~gt~~y~APE~l~~--~~~~~~sDVwSlGvll~eLltG~~Pf 299 (522)
....... .....+||+.|||||++.. ..|+..+|+|+..+-.++.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3321111 1235689999999999987 57888999999999998888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=222.72 Aligned_cols=163 Identities=15% Similarity=0.052 Sum_probs=128.3
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------------------chHHHHHHHHHHHhCC
Q 009933 87 ELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------------------GNREFLVEVLMLSLLH 148 (522)
Q Consensus 87 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------------------~~~~~~~E~~~L~~l~ 148 (522)
.+......|.+.+.||+|+||.||+|.+ .+++.||||+++..... ....+.+|+.+|+.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3344455677889999999999999999 78999999999643211 2345789999999999
Q ss_pred CCCcceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 009933 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNI 228 (522)
Q Consensus 149 hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NI 228 (522)
| +++++++.. +..|+||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 4 666665544 55699999999999998 422 134579999999999999999 99999999999
Q ss_pred eecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhc----------CCCCcchhhHH
Q 009933 229 LLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT----------GQLTLKSDVYS 284 (522)
Q Consensus 229 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~----------~~~~~~sDVwS 284 (522)
||+ ++.+||+|||+++. +..|+|||++.. ..|...+|+|.
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999 99999999999974 345789998754 34555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.8e-21 Score=189.16 Aligned_cols=137 Identities=17% Similarity=0.088 Sum_probs=107.7
Q ss_pred CCcccceecccCceEEEEEEECCCCcE--EEEEEEccCCccc------------------------hHHHHHHHHHHHhC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQV--VAVKQLDRNGLQG------------------------NREFLVEVLMLSLL 147 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~--vAvK~i~~~~~~~------------------------~~~~~~E~~~L~~l 147 (522)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++...... ...+.+|+.+|..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999999667889 9999975432110 12577899999999
Q ss_pred CCCCc--ceeEEEEEcCCeeEEEEeecCC-C----ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 009933 148 HHSNL--VNLIGYCADGDQRLLVYEFMPL-G----SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH-DKANPPVI 219 (522)
Q Consensus 148 ~hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~ii 219 (522)
.|++| ..++++ ...+|||||+.+ | +|.+++.. +++..+..++.||+.+|.||| +.+ ||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88864 444442 356899999942 3 66666532 224467889999999999999 888 99
Q ss_pred ecCCCCCceeecCCCceeeeeecceee
Q 009933 220 YRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 220 HrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
||||||+||||+. .++|+|||++..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999998 999999999985
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-18 Score=176.48 Aligned_cols=137 Identities=13% Similarity=0.090 Sum_probs=99.4
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc-----cc---------hHH--------HHHHHHHHHhCCCCC
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-----QG---------NRE--------FLVEVLMLSLLHHSN 151 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-----~~---------~~~--------~~~E~~~L~~l~hpn 151 (522)
-|++...||.|+||.||+|.+. +|+.||||+++.... .. ... ...|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999986 599999999854211 00 011 124666666665444
Q ss_pred cceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec
Q 009933 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD 231 (522)
Q Consensus 152 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld 231 (522)
+....-+... ..+|||||+.|++|..+... .....++.||+.+|.|||+.+ ||||||||.||||+
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 3211111111 23799999999888765422 134578899999999999999 99999999999998
Q ss_pred CCC----------ceeeeeecceee
Q 009933 232 EGF----------HPKLSDFGLAKL 246 (522)
Q Consensus 232 ~~~----------~vkL~DFGla~~ 246 (522)
+++ .+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 766 389999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3e-13 Score=132.18 Aligned_cols=146 Identities=16% Similarity=0.067 Sum_probs=116.0
Q ss_pred HhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEE
Q 009933 90 AATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 90 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV 168 (522)
.....|++...++.|+++.||++... +..++||+...........+.+|+.+|+.|. +..+.++++++...+..|+|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34567999999999999999999854 6889999986532233446888999999985 67788999999998999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA---------------------------------- 214 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------- 214 (522)
|||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999876421 1123478889999999999810
Q ss_pred ----------------------CCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 215 ----------------------NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 215 ----------------------~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13399999999999998766667999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=7.3e-12 Score=121.35 Aligned_cols=138 Identities=17% Similarity=0.096 Sum_probs=102.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCC--cceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN--LVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpn--Iv~l~~~~~~~~~~~lV~E 170 (522)
..|.+..+.+.|.++.||++.. .+|..++||+.... ....+..|+.+|+.+.+.+ +.+++.++...+..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3455555445666799999975 35778999997653 2345778999999886544 5568888888888999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA------------------------------------ 214 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------ 214 (522)
|++|.+|. ... .+ ...++.+++..|..||...
T Consensus 96 ~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99998884 211 11 2356778888888888743
Q ss_pred -------------------CCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 215 -------------------NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 215 -------------------~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
...++|+||+|.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=4.2e-11 Score=122.60 Aligned_cols=143 Identities=15% Similarity=0.184 Sum_probs=108.2
Q ss_pred cccceecccCceEEEEEEECCCCcEEEEEEEc--cCC-ccchHHHHHHHHHHHhCC--CCCcceeEEEEEcC---CeeEE
Q 009933 96 RPECLLGEGGFGRVYKGRLESTGQVVAVKQLD--RNG-LQGNREFLVEVLMLSLLH--HSNLVNLIGYCADG---DQRLL 167 (522)
Q Consensus 96 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~--~~~-~~~~~~~~~E~~~L~~l~--hpnIv~l~~~~~~~---~~~~l 167 (522)
...+.|+.|.++.||++... +..+++|+.. ... ......+.+|+.+|+.|. +..+.+++.++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34567999999999999875 4678889875 322 122456788999999997 45678899988776 45799
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--------------------------------- 214 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------- 214 (522)
||||++|..|.+.. ...++..+...++.+++..|..||...
T Consensus 119 vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 99999998775422 134678888999999999999999831
Q ss_pred ----------------------CCCeEecCCCCCceeecCCCc--eeeeeecceee
Q 009933 215 ----------------------NPPVIYRDLKSSNILLDEGFH--PKLSDFGLAKL 246 (522)
Q Consensus 215 ----------------------~~~iiHrDLKp~NILld~~~~--vkL~DFGla~~ 246 (522)
...+||+|+++.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 235999999999999987653 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=4.9e-11 Score=119.30 Aligned_cols=183 Identities=19% Similarity=0.187 Sum_probs=123.6
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCC--cceeEEEEEcCC---eeEEEEee
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSN--LVNLIGYCADGD---QRLLVYEF 171 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpn--Iv~l~~~~~~~~---~~~lV~E~ 171 (522)
.+.|+.|.+..||++. ..++||+.... .....+..|+.+|+.+. +.. +..++.+..... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999863 45889986432 23456888999998874 332 344554443333 34889999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA------------------------------------- 214 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------- 214 (522)
++|.+|.+... ..++..+...++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988875432 24677788889999999999999621
Q ss_pred ------------------CCCeEecCCCCCceeecC--CCceeeeeecceeeCCCCCCCcceecccCCccc---cChhhh
Q 009933 215 ------------------NPPVIYRDLKSSNILLDE--GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY---CAPEYA 271 (522)
Q Consensus 215 ------------------~~~iiHrDLKp~NILld~--~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y---~APE~l 271 (522)
.+.++|+|++|.|||+++ ...+.|+||+.+....... .......+ ..|+.+
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHH
Confidence 134899999999999988 5567899999987632110 00011111 233322
Q ss_pred hc-----CC---------CCcchhhHHHHHHHHHHHhCCCCC
Q 009933 272 MT-----GQ---------LTLKSDVYSFGVVFLELITGRKAI 299 (522)
Q Consensus 272 ~~-----~~---------~~~~sDVwSlGvll~eLltG~~Pf 299 (522)
.. .. ...-.+.|+++.++|.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 01 122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=1.5e-07 Score=91.74 Aligned_cols=141 Identities=18% Similarity=0.171 Sum_probs=102.6
Q ss_pred CCcccceecccCce-EEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEee
Q 009933 94 NFRPECLLGEGGFG-RVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 94 ~y~~~~~LG~G~fG-~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.|+.. .+..|..+ .||+......+..++||+-... ....+..|+.+|+.|. +--+.+++.++.+.+..++|||+
T Consensus 26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 34433 34445444 7999888777788999987532 3456788999998885 33467889999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-------------------------------------- 213 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-------------------------------------- 213 (522)
++|.++.+..... ......++.+++..|..||..
T Consensus 102 l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 102 IPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp CCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred eCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9998887765431 122345666777777777751
Q ss_pred -----------------CCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 214 -----------------ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 214 -----------------~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012389999999999999877777999998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.5e-07 Score=92.54 Aligned_cols=136 Identities=20% Similarity=0.147 Sum_probs=97.4
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCC---CcceeEEEEE-cCCeeEEEEeecC
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS---NLVNLIGYCA-DGDQRLLVYEFMP 173 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hp---nIv~l~~~~~-~~~~~~lV~E~~~ 173 (522)
.+.|+.|....||+. +..++||+-.. ......+..|+.+|..|.+. .+..++.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356888988999988 46688898532 12345688999999999753 3566676664 4456789999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 009933 174 LGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--------------------------------------- 214 (522)
Q Consensus 174 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------------- 214 (522)
|..|.+... ..++..+...++.++...|..||+..
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988876422 22455566666777777777666532
Q ss_pred ------------------CCCeEecCCCCCceeecC---CCc-eeeeeecceee
Q 009933 215 ------------------NPPVIYRDLKSSNILLDE---GFH-PKLSDFGLAKL 246 (522)
Q Consensus 215 ------------------~~~iiHrDLKp~NILld~---~~~-vkL~DFGla~~ 246 (522)
.+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224799999999999987 455 48999998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=3.8e-07 Score=92.76 Aligned_cols=82 Identities=7% Similarity=-0.012 Sum_probs=57.0
Q ss_pred ccee-cccCceEEEEEEEC---C---CCcEEEEEEEccCC---ccchHHHHHHHHHHHhCC-C--CCcceeEEEEEcC--
Q 009933 98 ECLL-GEGGFGRVYKGRLE---S---TGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLH-H--SNLVNLIGYCADG-- 162 (522)
Q Consensus 98 ~~~L-G~G~fG~Vy~~~~~---~---~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~-h--pnIv~l~~~~~~~-- 162 (522)
.+.| +.|....+|++... . ++..+++|+..... ......+..|+.+|+.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998763 0 15678899865432 112345778888888885 3 3567788887665
Q ss_pred -CeeEEEEeecCCCChhh
Q 009933 163 -DQRLLVYEFMPLGSLED 179 (522)
Q Consensus 163 -~~~~lV~E~~~ggsL~~ 179 (522)
...++||||++|..|.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.5e-06 Score=89.91 Aligned_cols=76 Identities=16% Similarity=0.075 Sum_probs=50.0
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCc-------cchHHHHHHHHHHHhCCC--CCcc-eeEEEEEcCCeeEE
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL-------QGNREFLVEVLMLSLLHH--SNLV-NLIGYCADGDQRLL 167 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~-------~~~~~~~~E~~~L~~l~h--pnIv-~l~~~~~~~~~~~l 167 (522)
.+.||.|.++.||++....+++.|+||....... .....+..|+.+|..+.. +.++ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4679999999999997765578899998653211 123456778888887742 4444 55543 3455689
Q ss_pred EEeecCCC
Q 009933 168 VYEFMPLG 175 (522)
Q Consensus 168 V~E~~~gg 175 (522)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=7.2e-06 Score=82.23 Aligned_cols=142 Identities=16% Similarity=0.266 Sum_probs=80.2
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-----CCCcceeE-E--EEEcCCeeEEEEe
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----HSNLVNLI-G--YCADGDQRLLVYE 170 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-----hpnIv~l~-~--~~~~~~~~~lV~E 170 (522)
+.|+.|....||++... +..+++|+.... ...+..|+.++..|. .|.++... + +....+..++||+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666788999999875 345899998652 233444555555543 24443311 0 1234667899999
Q ss_pred ecCCCChh--------------hhhccCCC----C-C-----CCCCHHHH------------------------------
Q 009933 171 FMPLGSLE--------------DHLHDLPP----D-K-----EPLDWNTR------------------------------ 196 (522)
Q Consensus 171 ~~~ggsL~--------------~~l~~~~~----~-~-----~~l~~~~~------------------------------ 196 (522)
|++|..+. ..++.... . . ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11111000 0 0 01122211
Q ss_pred -HHHHHHHHHHHHHHHh--------c--CCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 197 -MKIAAGAAKGLEYLHD--------K--ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 197 -~~i~~qi~~~L~yLH~--------~--~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
..+..++..++.+|+. . ....+||+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112224445666763 0 123499999999999998888899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.00 E-value=3.4e-05 Score=77.32 Aligned_cols=139 Identities=18% Similarity=0.181 Sum_probs=91.7
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC---CCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
.+.|+.|.+..+|+... ++..++||+.... ....+..|+..|+.|. ...+.+++.++...+..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 45789999999999985 3678889987542 2456788999888884 35688899988888889999999998
Q ss_pred CChhh-----------hhccCCC-C-----------------CCCCCHHHHH---HHH----------------HHHHHH
Q 009933 175 GSLED-----------HLHDLPP-D-----------------KEPLDWNTRM---KIA----------------AGAAKG 206 (522)
Q Consensus 175 gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~----------------~qi~~~ 206 (522)
..+.. .|+.... . ...-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76421 2232211 0 0011344321 111 111111
Q ss_pred H-HHHHh-cCCCCeEecCCCCCceeecCCCceeeeeec
Q 009933 207 L-EYLHD-KANPPVIYRDLKSSNILLDEGFHPKLSDFG 242 (522)
Q Consensus 207 L-~yLH~-~~~~~iiHrDLKp~NILld~~~~vkL~DFG 242 (522)
+ ..|.. ...+.+||+|+.+.|||++.++ +.|+||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 23321 1245699999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.88 E-value=5.1e-05 Score=79.05 Aligned_cols=77 Identities=17% Similarity=0.235 Sum_probs=47.8
Q ss_pred CCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccC--CccccChhhhhcCC---CCcchhhHHHHHHHH
Q 009933 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG--TYGYCAPEYAMTGQ---LTLKSDVYSFGVVFL 290 (522)
Q Consensus 216 ~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~g--t~~y~APE~l~~~~---~~~~sDVwSlGvll~ 290 (522)
..++|+||++.|||++.++ ++|+||+.+......-. . ..... ...|++|+...... -....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--l-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--I-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--H-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--H-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3499999999999998776 99999999886321100 0 00111 13466666553211 112345567888888
Q ss_pred HHHhCC
Q 009933 291 ELITGR 296 (522)
Q Consensus 291 eLltG~ 296 (522)
+++++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00016 Score=71.02 Aligned_cols=79 Identities=22% Similarity=0.222 Sum_probs=57.5
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCC---CcceeEEEEEcCCeeEEEEe
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS---NLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hp---nIv~l~~~~~~~~~~~lV~E 170 (522)
...-.+.+|.|..+.||+++.. +|+.|+||+...........|..|+..|+.|.-- .+.+++.+. ..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 4555678999999999999986 5899999987655444445678899999988522 345555542 2478999
Q ss_pred ecCCCCh
Q 009933 171 FMPLGSL 177 (522)
Q Consensus 171 ~~~ggsL 177 (522)
|+.++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0005 Score=68.38 Aligned_cols=160 Identities=14% Similarity=0.105 Sum_probs=87.6
Q ss_pred ccHHHHHHhhcCCcc-----cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCC--ccee
Q 009933 83 FTFRELAAATKNFRP-----ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN--LVNL 155 (522)
Q Consensus 83 ~~~~~~~~~~~~y~~-----~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpn--Iv~l 155 (522)
++..++......|.+ .+.|+.|....||++.... + .+++|+.... .....+..|+.++..|.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 444555555566765 2346778889999998753 3 6889998652 12334556777776664211 2233
Q ss_pred EE------EEEcCCeeEEEEeecCCCChhh--------------hhcc----CCCCC-CCC---CHHHHHH---------
Q 009933 156 IG------YCADGDQRLLVYEFMPLGSLED--------------HLHD----LPPDK-EPL---DWNTRMK--------- 198 (522)
Q Consensus 156 ~~------~~~~~~~~~lV~E~~~ggsL~~--------------~l~~----~~~~~-~~l---~~~~~~~--------- 198 (522)
+. +....+..++||+|++|..+.. .++. +.... ... .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 31 1123456789999999865421 0111 11000 001 1222100
Q ss_pred ---HHHHHHHHHHHHHhc----CCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 199 ---IAAGAAKGLEYLHDK----ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 199 ---i~~qi~~~L~yLH~~----~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+...+...+.+|+.. ....+||+|+.+.|||++.+..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455666542 123499999999999998876668999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00025 Score=70.17 Aligned_cols=139 Identities=9% Similarity=0.026 Sum_probs=76.0
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCc-ceeEEEEEcCCeeEEEEeec-CCC
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFM-PLG 175 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnI-v~l~~~~~~~~~~~lV~E~~-~gg 175 (522)
.+.|+.|....+|++ ..+++|+..... ........|+.+++.+....+ .+++.++ .+.-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 677889999999999 458889876432 111223568877777753333 4555443 33457899999 665
Q ss_pred Chhh------------------hhccCCCC-CCCCC-HHHHHHHHHH--------------HHHHHHH----HHh-cCCC
Q 009933 176 SLED------------------HLHDLPPD-KEPLD-WNTRMKIAAG--------------AAKGLEY----LHD-KANP 216 (522)
Q Consensus 176 sL~~------------------~l~~~~~~-~~~l~-~~~~~~i~~q--------------i~~~L~y----LH~-~~~~ 216 (522)
+|.. .++..... ...+. +..+..+... +...+.. |.. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4431 11111100 00011 1111111111 1111111 111 1123
Q ss_pred CeEecCCCCCceeecCCCceeeeeecceee
Q 009933 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 217 ~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5566789999998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00042 Score=72.45 Aligned_cols=74 Identities=18% Similarity=0.248 Sum_probs=50.5
Q ss_pred cceecccCceEEEEEEECC-------CCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCc-ceeEEEEEcCCeeEEEE
Q 009933 98 ECLLGEGGFGRVYKGRLES-------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVY 169 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnI-v~l~~~~~~~~~~~lV~ 169 (522)
.+.|+.|-...||++.... ++..|++|+.... .....+..|+.++..|...+| .++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998753 2578999988432 111455679988888863333 567766543 3899
Q ss_pred eecCCCCh
Q 009933 170 EFMPLGSL 177 (522)
Q Consensus 170 E~~~ggsL 177 (522)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00055 Score=70.35 Aligned_cols=143 Identities=17% Similarity=0.198 Sum_probs=85.0
Q ss_pred ceecccCceEEEEEEECC-------CCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEEe
Q 009933 99 CLLGEGGFGRVYKGRLES-------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~E 170 (522)
+.|..|-...+|++.... +++.|+||+... .......+.+|..+++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 457678888899998742 357899998632 2233456678999988875 3334667766643 29999
Q ss_pred ecCCCChhhh-----------------hccCCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 009933 171 FMPLGSLEDH-----------------LHDLPP-DKEPL--DWNTRMKIAAGAAK-------------------GLEYLH 211 (522)
Q Consensus 171 ~~~ggsL~~~-----------------l~~~~~-~~~~l--~~~~~~~i~~qi~~-------------------~L~yLH 211 (522)
|++|.+|..- |+.... ..... -+.++.+++.++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9988655311 111111 11112 24555556554422 233333
Q ss_pred h----c-CCCCeEecCCCCCceeecCC----Cceeeeeecceee
Q 009933 212 D----K-ANPPVIYRDLKSSNILLDEG----FHPKLSDFGLAKL 246 (522)
Q Consensus 212 ~----~-~~~~iiHrDLKp~NILld~~----~~vkL~DFGla~~ 246 (522)
+ . ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 2 12349999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.001 Score=66.24 Aligned_cols=143 Identities=15% Similarity=0.106 Sum_probs=80.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCC--CcceeEEE-----EEcCCeeEEEEee
Q 009933 99 CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLIGY-----CADGDQRLLVYEF 171 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hp--nIv~l~~~-----~~~~~~~~lV~E~ 171 (522)
..|+ |....||++... +|+.+++|+..... .....+..|+.++..|... .++.++.. ....+..++||+|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 4576 888899988764 36679999986432 2345666788887776422 23444432 2234566889999
Q ss_pred cCCCChhh-----------h---hcc----CCC-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc
Q 009933 172 MPLGSLED-----------H---LHD----LPP-DKEPLDWNTR----MKI---------------AAGAAKGLEYLHDK 213 (522)
Q Consensus 172 ~~ggsL~~-----------~---l~~----~~~-~~~~l~~~~~----~~i---------------~~qi~~~L~yLH~~ 213 (522)
++|..+.. . ++. ... ....+++... ..+ ...+-..+..|...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98754321 0 111 000 0111222111 001 11111223333321
Q ss_pred ----CCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 214 ----ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 214 ----~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 123489999999999999 4 899999988875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0012 Score=66.11 Aligned_cols=143 Identities=16% Similarity=0.096 Sum_probs=72.8
Q ss_pred ceecccCceE-EEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC--CCcceeEEEEEcCCeeEEEEeecCCC
Q 009933 99 CLLGEGGFGR-VYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH--SNLVNLIGYCADGDQRLLVYEFMPLG 175 (522)
Q Consensus 99 ~~LG~G~fG~-Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~gg 175 (522)
+.|+.|.... +|+.... ++..+++|....... ..+..|+.++..|.. -.+.+++.+..... ++|||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 3465554444 6677542 256677776543211 234456676666642 23556666543333 7899999776
Q ss_pred Chhhhhcc---------------------CCCC-CCCCCHHHHH-------H-H------------HHHHHHHHHHHHh-
Q 009933 176 SLEDHLHD---------------------LPPD-KEPLDWNTRM-------K-I------------AAGAAKGLEYLHD- 212 (522)
Q Consensus 176 sL~~~l~~---------------------~~~~-~~~l~~~~~~-------~-i------------~~qi~~~L~yLH~- 212 (522)
.+.+++.. .... -..++..... . + ...+...+..|..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 66544321 0000 0112221110 0 0 0011122223311
Q ss_pred --cCCCCeEecCCCCCceeecCC----CceeeeeecceeeC
Q 009933 213 --KANPPVIYRDLKSSNILLDEG----FHPKLSDFGLAKLG 247 (522)
Q Consensus 213 --~~~~~iiHrDLKp~NILld~~----~~vkL~DFGla~~~ 247 (522)
.....++|+|+.+.|||++.+ ..+.|+||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 122359999999999999874 67899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0014 Score=69.05 Aligned_cols=75 Identities=13% Similarity=0.025 Sum_probs=49.0
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCc-ceeEEEEEcCCeeEEEEeecCCCC
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFMPLGS 176 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ggs 176 (522)
.+.|+.|-...+|++.....+..|++|+..... ...-....|+.+|..|...+| .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 346778888999999986445788899874422 111123578999998875555 56777663 2 35999998754
Q ss_pred h
Q 009933 177 L 177 (522)
Q Consensus 177 L 177 (522)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00095 Score=67.93 Aligned_cols=75 Identities=9% Similarity=0.026 Sum_probs=44.8
Q ss_pred cceecccCceEEEEEEECC--------CCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCC-cceeEEEEEcCCeeEEE
Q 009933 98 ECLLGEGGFGRVYKGRLES--------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN-LVNLIGYCADGDQRLLV 168 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpn-Iv~l~~~~~~~~~~~lV 168 (522)
.+.|+.|..-.||++.... .+..+++|+..... ........|+.+|+.|...+ +.++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3467788888999998753 12678888865421 11122457888888775333 44666554 2 3689
Q ss_pred EeecCCCCh
Q 009933 169 YEFMPLGSL 177 (522)
Q Consensus 169 ~E~~~ggsL 177 (522)
|||++|.+|
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0039 Score=62.79 Aligned_cols=31 Identities=16% Similarity=0.180 Sum_probs=27.6
Q ss_pred CCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 216 ~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999988775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0037 Score=58.72 Aligned_cols=98 Identities=14% Similarity=0.103 Sum_probs=65.0
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCCcc
Q 009933 176 SLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV 255 (522)
Q Consensus 176 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 255 (522)
+|.+.|.. .+.+|+++++|.++.|.+..|.-+-.... -..+=+.|..|+|..+|+|-+.+ ..+.
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 78898876 36899999999999999998877622111 11334557999999999887764 1111
Q ss_pred eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh
Q 009933 256 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT 294 (522)
Q Consensus 256 ~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt 294 (522)
.....+.|||.+. ...+.+.=|||||++||.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122466888763 345678899999999999885
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.04 E-value=0.042 Score=57.07 Aligned_cols=143 Identities=16% Similarity=0.177 Sum_probs=85.5
Q ss_pred cceecccCceEEEEEEECCC-------CcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCeeEEEE
Q 009933 98 ECLLGEGGFGRVYKGRLEST-------GQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~-------g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.+.|..|-...+|++..... +..|++++.... ........+|..+++.|. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 34577788889999987521 577899986432 222223457888888775 333455665432 27899
Q ss_pred eecCCCChhh--h---------------hcc-------CCC--CCCCCCHHHHHHHHHHH-------------------H
Q 009933 170 EFMPLGSLED--H---------------LHD-------LPP--DKEPLDWNTRMKIAAGA-------------------A 204 (522)
Q Consensus 170 E~~~ggsL~~--~---------------l~~-------~~~--~~~~l~~~~~~~i~~qi-------------------~ 204 (522)
||++|.+|.. + |+. +.. ...+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 0 011 011 12222355554444332 1
Q ss_pred HHHHHHHhc---------------------CCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 205 KGLEYLHDK---------------------ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 205 ~~L~yLH~~---------------------~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
..+.+|.+. ....++|+|+.+.||| +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223333211 1234899999999999 7888999999998874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.38 E-value=0.31 Score=49.92 Aligned_cols=29 Identities=31% Similarity=0.344 Sum_probs=25.1
Q ss_pred eEecCCCCCceee------cCCCceeeeeecceee
Q 009933 218 VIYRDLKSSNILL------DEGFHPKLSDFGLAKL 246 (522)
Q Consensus 218 iiHrDLKp~NILl------d~~~~vkL~DFGla~~ 246 (522)
++|+|+.+.|||+ +++..+.|+||-++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998874
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.10 E-value=0.38 Score=44.87 Aligned_cols=123 Identities=11% Similarity=0.114 Sum_probs=82.1
Q ss_pred HHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 009933 140 EVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVI 219 (522)
Q Consensus 140 E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ii 219 (522)
|+.+|. ..||+++.. .+-.+.+.+.|.++.-..+.=+..+ ..++....++++.+|+....+++. -+
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~ 101 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNRT-----RY 101 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGGS-----SE
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhcC-----ce
Confidence 444443 368988877 5666777777777655422222223 346778999999999987755543 37
Q ss_pred ecCCCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCC
Q 009933 220 YRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAI 299 (522)
Q Consensus 220 HrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf 299 (522)
|--|.|+||+++.++.++|.-.|+-...+ |. .++...=+-.+=|++..+++++..|
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEEecceEEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 88899999999999999998877644211 11 1111111336778999999999888
Q ss_pred C
Q 009933 300 D 300 (522)
Q Consensus 300 ~ 300 (522)
+
T Consensus 158 e 158 (215)
T 4ann_A 158 D 158 (215)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.87 E-value=1.3 Score=41.32 Aligned_cols=115 Identities=11% Similarity=0.064 Sum_probs=77.6
Q ss_pred CCCCcceeEEEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 009933 148 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE-YLHDKANPPVIYRDLKSS 226 (522)
Q Consensus 148 ~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~-yLH~~~~~~iiHrDLKp~ 226 (522)
.||++ -...-.+++.+.|.++.-+++.-+..++ .++..+.++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 68888 3344477788777777654443334443 3677889999988887655 4432 477889999
Q ss_pred ceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 009933 227 NILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAID 300 (522)
Q Consensus 227 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~ 300 (522)
||++|.++.++|.-.|+-...++ .=+.+|-+ +-.+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lpP--------------~e~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLPP--------------DEWDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBSS--------------CSCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccCCC--------------CCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999998776442211 11122222 2267788999999988775
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.39 E-value=0.18 Score=52.93 Aligned_cols=62 Identities=5% Similarity=0.011 Sum_probs=18.4
Q ss_pred cccceecccCceEEEEEEECCCCcEEEE------EEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEE
Q 009933 96 RPECLLGEGGFGRVYKGRLESTGQVVAV------KQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCA 160 (522)
Q Consensus 96 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAv------K~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~ 160 (522)
.+.+.|| ||.||++.+......||| |.+...... ....+.+|..++..++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456776 999999999765567888 766543222 2245778889999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 522 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-77 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-65 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-59 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-50 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-48 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 7e-77
Identities = 81/285 (28%), Positives = 127/285 (44%), Gaps = 27/285 (9%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSN 151
+G G FG VYKG+ VAVK L+ Q + F EV +L H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
++ +GY Q +V ++ SL HLH + + + + IA A+G++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
K +I+RDLKS+NI L E K+ DFGLA + +H ++ G+ + APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 272 MT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328
+ +SDVY+FG+V EL+TG+ N + + L D K
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373
++ + A CL+++ RPL ++ ++ LA
Sbjct: 239 PKAMK------------RLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (558), Expect = 4e-68
Identities = 78/316 (24%), Positives = 128/316 (40%), Gaps = 41/316 (12%)
Query: 82 TFTFRELAAATKNFRPEC---------LLGEGGFGRVYKGRLESTGQ---VVAVKQLDRN 129
FTF + A + F E ++G G FG V G L+ G+ VA+K L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 130 GLQGN-REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 188
+ R+FL E ++ H N+++L G +++ EFM GSL+ L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---ND 122
Query: 189 EPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248
+ + G A G++YL + ++RDL + NIL++ K+SDFGL++
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 249 VGDKTHVSTRV---MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP 305
T + APE + T SDV+S+G+V E+++ + RP
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPY 234
Query: 306 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
+ + +D R P PM + C Q+ RP G +
Sbjct: 235 WDMTNQDVINAIEQDYRLPP-----------PMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 366 VTALTYLASQTYDPNA 381
V L + +PN+
Sbjct: 284 VNTLDKMIR---NPNS 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 9e-68
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNL 152
+F LG G G V+K + +G V+A K + R + E+ +L + +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
V G + + E M GSL+ L + K++ KGL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
K +++RD+K SNIL++ KL DFG++ ++ +GT Y +PE
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAID 300
+++SD++S G+ +E+ GR I
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-67
Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 29/279 (10%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
+ + LG G FG V+ G VAVK L + G FL E ++ L H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
V L + ++ E+M GSL D L P L N + +AA A+G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
+ I+RDL+++NIL+ + K++DFGLA+L ++ + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE--HNLVAWARPLFKDRRKFPKMADP 330
G T+KSDV+SFG++ E++T + E NL R + D P+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--NCPE---- 237
Query: 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369
+ + +C +E+ RP + + L
Sbjct: 238 ------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 7e-67
Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 25/279 (8%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSN 151
++ +G G +GR K R +S G+++ K+LD + + + EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 152 LVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
+V D L V E+ G L + +++ LD +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 210 LHDK--ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 267
H + V++RDLK +N+ LD + KL DFGLA++ + T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 268 PEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327
PE KSD++S G + EL + R+ P
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGKIREGKFRRIPYR 237
Query: 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 366
+ + L + RP + +++
Sbjct: 238 YSD------------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-66
Identities = 66/296 (22%), Positives = 112/296 (37%), Gaps = 29/296 (9%)
Query: 101 LGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 160
+G+G FG V++G+ G+ VAVK + + E+ +L H N++ I
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 161 DGD----QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA-- 214
+ Q LV ++ GSL D+L+ + + +K+A A GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 215 ---NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPE 269
P + +RDLKS NIL+ + ++D GLA T +GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 270 YAMT------GQLTLKSDVYSFGVVFLELITGRKAIDNT----RPPGEHNLVAWARPLFK 319
+ ++D+Y+ G+VF E+ P + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 320 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375
K+ + L + C A R + L+ L+ Q
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 4e-66
Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 27/278 (9%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
K+ LG G FG V G+ VA+K + EF+ E ++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKL 61
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
V L G C ++ E+M G L ++L + +++ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
K ++RDL + N L+++ K+SDFGL++ D+ S + PE M
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLM 174
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE-HNLVAWARPLFKDRRKFPKMADPL 331
+ + KSD+++FGV+ E+ + K E +A L++ K+
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT-- 232
Query: 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369
+ C E+A RP +++ +
Sbjct: 233 ---------------IMYSCWHEKADERPTFKILLSNI 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 6e-66
Identities = 72/281 (25%), Positives = 114/281 (40%), Gaps = 25/281 (8%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
+G G FG V+ G VA+K + R G +F+ E ++ L H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
V L G C + LV+EFM G L D+L + T + + +G+ YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
VI+RDL + N L+ E K+SDFG+ + D+ ST + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332
+ + KSDV+SFGV+ E+ + K R E + +D ++ P L
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL 226
Query: 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373
+ C +E+ RP ++ L +A
Sbjct: 227 AST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (540), Expect = 1e-65
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 23/296 (7%)
Query: 81 QTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVE 140
+ + + + + LG G +G VY+G + VAVK L + ++ EFL E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 141 VLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIA 200
++ + H NLV L+G C ++ EFM G+L D+L + +++ + + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMA 121
Query: 201 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 260
+ +EYL K I+RDL + N L+ E K++DFGL++L GD
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 177
Query: 261 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320
+ APE + ++KSDV++FGV+ E+ T P D
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGI----------D 221
Query: 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376
+ ++ + + P + + C Q + RP ++ A + ++
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 5e-65
Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 32/277 (11%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHH 149
++F LG+G FG VY R + + ++A+K L + L+ + EV + S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
N++ L GY D + L+ E+ PLG++ L D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSY 121
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
H K VI+RD+K N+LL K++DFG + P + T + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 174
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329
K D++S GV+ E + G+ P + + + + FP
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDFVT 228
Query: 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 366
A + + L+ + RP++ +V+
Sbjct: 229 E------------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 8e-65
Identities = 66/276 (23%), Positives = 109/276 (39%), Gaps = 26/276 (9%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSN 151
+++ LGEG +G V T + VAVK +D E E+ + +L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V G+ +G+ + L E+ G L D + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ +RD+K N+LLDE + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 272 MTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPG-EHNLVAWARPLFKDRRKFPKMAD 329
+ DV+S G+V ++ G D E++ + +K
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
LL L E + R I D+
Sbjct: 238 ALLHK----------------ILVENPSARITIPDI 257
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 9e-65
Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 31/284 (10%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
K + +G+G FG V G G VAVK + + + FL E +++ L HSNL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 153 VNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
V L+G + L +V E+M GSL D+L + L + +K + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
++RDL + N+L+ E K+SDFGL K + + + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 172
Query: 272 MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331
+ + KSDV+SFG++ E+ + R P + P + K
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFG------RVPYPRIPLKDVVPRVEKGYKMD------ 220
Query: 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375
P V C AA RP + L ++ +
Sbjct: 221 ----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (535), Expect = 1e-64
Identities = 68/307 (22%), Positives = 112/307 (36%), Gaps = 49/307 (15%)
Query: 94 NFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLL 147
N +GEG FGRV++ R +VAVK L + +F E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 148 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD--------------------LPPD 187
+ N+V L+G CA G L++E+M G L + L P
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 188 KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247
PL ++ IA A G+ YL ++RDL + N L+ E K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPP-- 305
D + PE + T +SDV+++GVV E+ + P
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG------LQPYY 244
Query: 306 GEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
G + + P+ + + +C + A RP +
Sbjct: 245 GMAHEEVIYYVRDGNILACPENCPL------------ELYNLMRLCWSKLPADRPSFCSI 292
Query: 366 VTALTYL 372
L +
Sbjct: 293 HRILQRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-64
Identities = 81/288 (28%), Positives = 127/288 (44%), Gaps = 29/288 (10%)
Query: 100 LLGEGGFGRVYKGRL---ESTGQVVAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNL 155
++G G FG VY G L + AVK L+R G +FL E +++ H N+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 156 IGYCADGDQR-LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
+G C + L+V +M G L + + + + AKG+++L
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA--- 147
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPEYAM 272
+ ++RDL + N +LDE F K++DFGLA+ D H T + A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332
T + T KSDV+SFGV+ EL+T P + N L + RR LL
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRR--------LL 254
Query: 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPN 380
Q Y LY+ V C +A RP ++V+ ++ + S +
Sbjct: 255 QPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 7e-64
Identities = 72/302 (23%), Positives = 114/302 (37%), Gaps = 44/302 (14%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQ-----VVAVKQLDRNGLQGNRE-FLVEV-LMLSL 146
N +LG G FG+V + VAVK L RE + E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 147 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------------------DLPPD 187
H N+VNL+G C L++E+ G L ++L + D
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 188 KEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247
L + + A AKG+E+L K ++RDL + N+L+ G K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE 307
V + APE G T+KSDV+S+G++ E+ + P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----NPYPG 269
Query: 308 HNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367
+ A L ++ K P + + C + RP ++ +
Sbjct: 270 IPVDANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 368 AL 369
L
Sbjct: 320 FL 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 3e-63
Identities = 64/286 (22%), Positives = 112/286 (39%), Gaps = 36/286 (12%)
Query: 92 TKNFRPE------CLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLS 145
T++ PE LG+G FG+VYK + + T + A K +D + +++VE+ +L+
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 64
Query: 146 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK 205
H N+V L+ + ++ EF G+++ + +L + PL + +
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLD 121
Query: 206 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265
L YLHD +I+RDLK+ NIL KL+DFG++ +GT +
Sbjct: 122 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYW 176
Query: 266 CAPEYAMTGQL-----TLKSDVYSFGVVFLELITGRKAIDNTRPPGE-HNLVAWARPLFK 319
APE M K+DV+S G+ +E+ P + P
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 320 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
++ L+ CL++ R +
Sbjct: 237 QPSRWSSNFKDFLKK----------------CLEKNVDARWTTSQL 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-62
Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 40/300 (13%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTG--QVVAVKQLDRNGL-QGNREFLVEV-LMLSLLH 148
+ + + ++GEG FG+V K R++ G A+K++ +R+F E+ ++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD------------LPPDKEPLDWNTR 196
H N++NL+G C L E+ P G+L D L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 256
+ AA A+G++YL K I+RDL + NIL+ E + K++DFGL++ V K
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 257 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP 316
T + A E T SDV+S+GV+ E+++ P
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238
Query: 317 LFKDRR-KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375
L + R + P D + + C +E+ RP ++ +L + +
Sbjct: 239 LPQGYRLEKPLNCDD------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 2e-62
Identities = 76/298 (25%), Positives = 113/298 (37%), Gaps = 39/298 (13%)
Query: 100 LLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLS-LLHHSNL 152
LG G FG+V + VAVK L + RE + E+ +LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHD--------------LPPDKEPLDWNTRMK 198
VNL+G C G L++ E+ G L + L + D+ LD +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 199 IAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTR 258
+ AKG+ +L K I+RDL + NILL G K+ DFGLA+ V
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 259 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF 318
+ APE T +SDV+S+G+ EL + + P
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----------- 255
Query: 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376
KF KM + P + + C RP +V + S++
Sbjct: 256 ----KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-62
Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 36/283 (12%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHS 150
+ + + +G G F VYKG T VA +L L + + F E ML L H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 151 NLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
N+V + +LV E M G+L+ +L + + KG
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKG 124
Query: 207 LEYLHDKANPPVIYRDLKSSNILL-DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265
L++LH + PP+I+RDLK NI + K+ D GLA L + + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 266 CAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE--HNLVAWARPLFKDRRK 323
APE + DVY+FG+ LE+ T + + + + +P D+
Sbjct: 180 MAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 366
P++ + + C+++ R I D++
Sbjct: 239 IPEVKE-----------------IIEGCIRQNKDERYSIKDLL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-62
Identities = 80/325 (24%), Positives = 141/325 (43%), Gaps = 35/325 (10%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQV----VAVKQLDR-NGLQGNREFLVEVLMLSLLHH 149
F+ +LG G FG VYKG G+ VA+K+L + N+E L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
++ L+G C +L + + MP G L D++ + K+ + + AKG+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
L D+ +++RDL + N+L+ H K++DFGLAKL +K + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR-KFPKMA 328
+ T +SDV+S+GV EL+T +P + L K R P +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDGIPASEISSILEKGERLPQPPIC 238
Query: 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSN- 387
+ C A +RP +++ + +A DP +
Sbjct: 239 TI------------DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR---DPQRYLVIQGD 283
Query: 388 -RVGPSTPRNRDDRRSMADGQDSPD 411
R+ +P + + R++ D +D D
Sbjct: 284 ERMHLPSPTDSNFYRALMDEEDMDD 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 7e-62
Identities = 72/281 (25%), Positives = 109/281 (38%), Gaps = 35/281 (12%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLH 148
K F +G G FG VY R +VVA+K++ +G Q N ++ + EV L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 149 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLE 208
H N + G LV E+ + + K+PL + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 209 YLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 268
YLH +I+RD+K+ NILL E KL DFG A + + +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAP 180
Query: 269 EYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325
E + GQ K DV+S G+ +EL + + N +A +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVV 366
+ + CLQ+ RP ++
Sbjct: 241 EYFRNFVDS----------------CLQKIPQDRPTSEVLL 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-61
Identities = 77/307 (25%), Positives = 131/307 (42%), Gaps = 36/307 (11%)
Query: 92 TKNFRPEC-----LLGEGGFGRVYKGRLESTGQ----VVAVKQLDRNGLQGNR-EFLVEV 141
T P C ++G G FG VYKG L+++ VA+K L + R +FL E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 142 LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 201
++ H N++ L G + +++ E+M G+L+ L + + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLR 117
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVM 260
G A G++YL N ++RDL + NIL++ K+SDFGL++ L + T+ ++
Sbjct: 118 GIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 261 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320
+ APE + T SDV+SFG+V E++T + E
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------- 221
Query: 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPN 380
K + + PM + C Q++ A RP D+V+ L L P+
Sbjct: 222 ---VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR---APD 275
Query: 381 AASNLSN 387
+ L++
Sbjct: 276 SLKTLAD 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-61
Identities = 68/275 (24%), Positives = 106/275 (38%), Gaps = 31/275 (11%)
Query: 101 LGEGGFGRVYKGRLE--STGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLI 156
LG G FG V KG + + VAVK L E L E ++ L + +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANP 216
G C + + +LV E LG L +L + +++ + G++YL +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
++RDL + N+LL + K+SDFGL+K L + T + APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 276 LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR-KFPKMADPLLQG 334
+ KSDV+SFGV+ E + + +P L K R P
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGERMGCPAGCPR---- 237
Query: 335 RYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369
+ + +C RP V L
Sbjct: 238 --------EMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 6e-61
Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 30/290 (10%)
Query: 86 RELAAATKNFRP-ECLLGEGGFGRVYKG--RLESTGQVVAVKQLDRNGLQGNRE-FLVEV 141
++L N + LG G FG V +G R+ VA+K L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 142 LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAA 201
++ L + +V LIG C + +LV E G L L +E + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 202 GAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVM 260
+ G++YL +K ++RDL + N+LL + K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 261 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRP-PGEHNLVAWARPLFK 319
+ APE + + +SDV+S+GV E ++ + +P A
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQG 228
Query: 320 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369
R + P P + A+ + C + RP V +
Sbjct: 229 KRMECPPECPP------------ELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 7e-61
Identities = 76/277 (27%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 152
++ R E LG+G FG V+ G T +V A+K L + G FL E ++ L H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 153 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD 212
V L + +V E+M GSL D L + L + +AA A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 213 KANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 272
++RDL+++NIL+ E K++DFGLA+L ++ + APE A+
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 273 TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332
G+ T+KSDV+SFG++ EL T + PG N + R P
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPE-- 241
Query: 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369
+ C +++ RP + L
Sbjct: 242 ----------SLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-60
Identities = 65/275 (23%), Positives = 112/275 (40%), Gaps = 27/275 (9%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 151
K + +G+G G VY +TGQ VA++Q++ + E+L++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+VN + GD+ +V E++ GSL D + + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
VI+RD+KS NILL KL+DFG + + + ++GT + APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVV 188
Query: 272 MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGE-HNLVAWARPLFKDRRKFPKMADP 330
K D++S G++ +E+I G N P + + P ++ K +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
L CL R ++
Sbjct: 249 FLNR----------------CLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-59
Identities = 77/285 (27%), Positives = 112/285 (39%), Gaps = 29/285 (10%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGL---QGNREFLVEVLMLSL 146
K+ R LG+G FG V +G ++ VAVK L + L + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 147 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
L H NL+ L G ++ V E PLGSL D L + T + A A+G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 207 LEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGY 265
+ YL K I+RDL + N+LL K+ DFGL + P D +V + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 266 CAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325
CAPE T + SD + FGV E+ T + P N + K+ + P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLP 235
Query: 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370
+ P V C + RP + L
Sbjct: 236 R----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-57
Identities = 71/299 (23%), Positives = 115/299 (38%), Gaps = 38/299 (12%)
Query: 94 NFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQG-NREFLVEV-LMLSL 146
+ LG G FG+V + +T + VAVK L +R + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 147 LHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHD------------LPPDKEPLDW 193
HH N+VNL+G C G +++ EF G+L +L K+ L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 194 NTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT 253
+ + AKG+E+L + I+RDL + NILL E K+ DFGLA+
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAW 313
+ APE T++SDV+SFGV+ E+ + P +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEE 245
Query: 314 ARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372
K+ + P + C + + RP ++V L L
Sbjct: 246 FCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-57
Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 31/289 (10%)
Query: 93 KNFRPECLLGEGGFGRVYKGRL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSL 146
+ LG+G FG VY+G + VA+K ++ R EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 147 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------PLDWNTRMKIA 200
+ ++V L+G + G L++ E M G L+ +L L P P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 201 AGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVM 260
A G+ YL+ ++RDL + N ++ E F K+ DFG+ + D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 261 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320
+ +PE G T SDV+SFGVV E+ T + G N +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY----QGLSNEQVLRFVMEGG 252
Query: 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 369
P + MC Q RP ++++++
Sbjct: 253 LLDKPDNCPD------------MLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-56
Identities = 67/282 (23%), Positives = 108/282 (38%), Gaps = 32/282 (11%)
Query: 100 LLGEGGFGRVYKGRL---ESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNL 155
+GEG FG V++G E+ VA+K RE FL E L + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 156 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKAN 215
IG + + ++ E LG L L K LD + + A + L YL K
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 216 PPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 275
++RD+ + N+L+ KL DFGL++ + +++ + APE +
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 185
Query: 276 LTLKSDVYSFGVVFLELITGRKAIDNTRPP--GEHNLVAWARPLFKDRRKFPKMADPLLQ 333
T SDV+ FGV E++ P G N R +R P P
Sbjct: 186 FTSASDVWMFGVCMWEILMHG------VKPFQGVKNNDVIGRIENGERLPMPPNCPP--- 236
Query: 334 GRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375
++ C + RP ++ L+ + +
Sbjct: 237 ---------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-56
Identities = 65/270 (24%), Positives = 102/270 (37%), Gaps = 28/270 (10%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHS 150
+F+ +LGEG F V R +T + A+K L++ + E ++S L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
V L D ++ + G L ++ D A LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
H +I+RDLK NILL+E H +++DFG AK+ K + +GT Y +PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330
SD+++ G + +L+ G P N + + K FP+ P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
+A + L A R
Sbjct: 236 ------------KARDLVEKLLVLDATKRL 253
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-55
Identities = 73/304 (24%), Positives = 116/304 (38%), Gaps = 40/304 (13%)
Query: 94 NFRPECLLGEGGFGRVYKGRLEST-------GQVVAVKQLDRNGLQGN-REFLVEV-LML 144
LGEG FG+V VAVK L + + + + + E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 145 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLD 192
+ H N++NL+G C ++ E+ G+L ++L P +E L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 193 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252
+ A A+G+EYL K I+RDL + N+L+ E K++DFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA 312
+T + APE T +SDV+SFGV+ E+ T P V
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSPYPGVPVE 244
Query: 313 WARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372
L K+ + P + + C + RP +V L +
Sbjct: 245 ELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
Query: 373 ASQT 376
+ T
Sbjct: 295 VALT 298
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 184 bits (468), Expect = 3e-54
Identities = 73/249 (29%), Positives = 108/249 (43%), Gaps = 19/249 (7%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLH-- 148
+F ++G GGFG VY R TG++ A+K LD+ + QG L E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 149 -HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207
+V + D+ + + M G L HL E AA GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAAEIILGL 120
Query: 208 EYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 267
E++H++ V+YRDLK +NILLDE H ++SD GLA +GT+GY A
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 268 PEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-AWARPLFKDRRKFP 325
PE G +D +S G + +L+ G + +H + + F
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 326 KMADPLLQG 334
LL+G
Sbjct: 234 PELRSLLEG 242
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (459), Expect = 5e-53
Identities = 62/269 (23%), Positives = 99/269 (36%), Gaps = 25/269 (9%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
++ LG G FG V++ +TG A K + E+ +S+L H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
NL D ++ +++YEFM G L + + D + + + ++ KGL ++H+
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 214 ANPPVIYRDLKSSNILL--DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
++ DLK NI+ KL DFGL D GT + APE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVA 197
Query: 272 MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331
+ +D++S GV+ L++G P G N R + A
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 332 LQGRYPMRGLYQALAVAAMCLQEQAATRP 360
+ L TR
Sbjct: 252 ISE--------DGKDFIRKLLLADPNTRM 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-52
Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 31/271 (11%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSL-LHH 149
+F +LG+G FG+V+ + T Q A+K L ++ + + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
L ++ + V E++ G L H+ D + AA GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQF 118
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
LH K ++YRDLK NILLD+ H K++DFG+ K +GD GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329
+ + D +SFGV+ E++ G+ P + + D +P+ +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYPRWLE 227
Query: 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
+A + + R
Sbjct: 228 K------------EAKDLLVKLFVREPEKRL 246
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (455), Expect = 2e-52
Identities = 68/336 (20%), Positives = 137/336 (40%), Gaps = 33/336 (9%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
+ LG G FG V++ ++TG+V K ++ E+ +++ LHH L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
NL D + +L+ EF+ G L D + + + + A +GL+++H+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 214 ANPPVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+++ D+K NI+ + + K+ DFGLA + T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIV 200
Query: 272 MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331
+ +D+++ GV+ L++G P + + + + + +F + A
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTYDPNAASNLSNRVGP 391
+ +A LQ++ R + D + +L SNL++R+ P
Sbjct: 255 VSP--------EAKDFIKNLLQKEPRKRLTVHDAL-EHPWLKGDH------SNLTSRI-P 298
Query: 392 STPRNRDDRRSMADGQDSPDEHGRVGRHGSPSTHKN 427
S+ N+ ++ D P +GR + S+ +
Sbjct: 299 SSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRK 334
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (444), Expect = 3e-51
Identities = 57/270 (21%), Positives = 95/270 (35%), Gaps = 22/270 (8%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHS 150
+ +LG G F V + T ++VA+K + + L+G E+ +L + H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
N+V L G L+ + + G L D + + K ++ ++YL
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYL 123
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
HD + LDE +SDFGL+K+ D V + GT GY APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEV 180
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330
+ D +S GV+ L+ G P + N + K +F
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
+ A +++ R
Sbjct: 235 DISD--------SAKDFIRHLMEKDPEKRF 256
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 175 bits (445), Expect = 3e-51
Identities = 69/244 (28%), Positives = 108/244 (44%), Gaps = 21/244 (8%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHH 149
++F+ LG G FGRV+ R G+ A+K L + + ++ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
++ + G D Q ++ +++ L L + AA LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
LH K +IYRDLK NILLD+ H K++DFG AK P V+ + GT Y APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329
T D +SFG++ E++ G P + N + + +FP +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT------PFYDSNTMKTYEKILNAELRFPPFFN 225
Query: 330 PLLQ 333
++
Sbjct: 226 EDVK 229
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 174 bits (441), Expect = 4e-51
Identities = 65/277 (23%), Positives = 111/277 (40%), Gaps = 29/277 (10%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLH 148
+ + +LG GG V+ R + VAVK L + + F E + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 149 HSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 204
H +V + G +V E++ +L D +H + P+ +++ A A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTY 263
+ L + H +I+RD+K +NI++ K+ DFG+A+ + G+ + V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 264 GYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323
Y +PE A + +SDVYS G V E++TG P + V+ A ++
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVREDPI 232
Query: 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
P L AV L + R
Sbjct: 233 PPSARHEGLSA--------DLDAVVLKALAKNPENRY 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (440), Expect = 4e-51
Identities = 65/288 (22%), Positives = 102/288 (35%), Gaps = 40/288 (13%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---------QGNREFLVEV-LM 143
N+ P+ +LG G V + + T + AVK +D G + L EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 144 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 203
+ H N++ L LV++ M G L D+L +K L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 263
+ + LH +++RDLK NILLD+ + KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 264 GYCAPEYAMTGQL------TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL 317
Y APE + D++S GV+ L+ G P + R +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRMI 227
Query: 318 FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
+F + + L Q R +
Sbjct: 228 MSGNYQFGSPEWDDYSD--------TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 9e-50
Identities = 45/274 (16%), Positives = 102/274 (37%), Gaps = 26/274 (9%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
+ LG G FG V++ S+ + K + G E+ +L++ H N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
+L ++ ++++EF+ + + ++ L+ + + L++LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 214 ANPPVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ + D++ NI+ K+ +FG A+ GD + + Y APE
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 272 MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331
++ +D++S G + L++G + A F D F +++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-DEEAFKEISI-- 232
Query: 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
+A+ L ++ +R +
Sbjct: 233 -----------EAMDFVDRLLVKERKSRMTASEA 255
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-48
Identities = 72/281 (25%), Positives = 110/281 (39%), Gaps = 33/281 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-----NREFLVEVLMLSLLHHSNLVN 154
LGEG F VYK R ++T Q+VA+K++ NR L E+ +L L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 155 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
L+ LV++FM D + + L + +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 215 NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 274
+++RDLK +N+LLDE KL+DFGLAK G T + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 275 QL-TLKSDVYSFGVVFLELITGR------------KAIDNT--RPPGEHNLVAWARPLFK 319
++ + D+++ G + EL+ I T P E + P +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 320 DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
+ FP + + L + R
Sbjct: 236 TFKSFPGIPLHHIFSAAGD----DLLDLIQGLFLFNPCARI 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 30/286 (10%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 153
++ ++G G FG VY+ +L +G++VA+K++ ++ NR E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 154 NLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGL 207
L + ++ LV +++P H K+ L + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 208 EYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 266
Y+H + +RD+K N+LLD + KL DFG AK + + + Y
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRA 190
Query: 267 APEYAMTGQLTLKSDVYSFGVVFLELITGR------------KAIDNTRPPGEHNLVAWA 314
T DV+S G V EL+ G+ I +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 315 RPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
P + + KFP++ + R +A+A+ + L+ R
Sbjct: 251 NPNYTE-FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 7e-47
Identities = 59/290 (20%), Positives = 106/290 (36%), Gaps = 20/290 (6%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHS 150
+ +GEG +G V VA+K++ Q + L E+ +L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
N++ + + ++ + L+ L + L + +GL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL-LKTQHLSNDHICYFLYQILRGLKYI 125
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPE 269
H V++RDLK SN+LL+ K+ DFGLA+ P D T T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 270 YAMTGQLTLKS-DVYSFGVVFLELITGR-------------KAIDNTRPPGEHNLVAWAR 315
+ + KS D++S G + E+++ R + P + +L
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
++ + + R +AL + L R +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-46
Identities = 64/278 (23%), Positives = 103/278 (37%), Gaps = 38/278 (13%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLHHSNLV 153
LG G F V K R +STG A K + + + +R + EV +L + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 154 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
L + +L+ E + L D +KE L + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 214 ANPPVIYRDLKSSNILLDE----GFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
+ + DLK NI+L + K+ DFGLA G++ + GT + APE
Sbjct: 133 ---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR--KFPKM 327
L L++D++S GV+ L++G V+ F+D +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
A ++ L + R I D
Sbjct: 247 AKDFIRR----------------LLVKDPKKRMTIQDS 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (409), Expect = 2e-46
Identities = 49/304 (16%), Positives = 93/304 (30%), Gaps = 37/304 (12%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSN 151
+++ +GEG FG +++G Q VA+K R + E LL +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+ N+ + +G +LV + + L T A ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 212 DKANPPVIYRDLKSSNILLDEGFHP-----KLSDFGLAKL-----GPVGDKTHVSTRVMG 261
+K ++YRD+K N L+ + DFG+ K + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 262 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321
T Y + + + + + D+ + G VF+ + G + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------ERIG 229
Query: 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-------LIGDVVTALTYLAS 374
K L +P + P L V+ L
Sbjct: 230 EKKQSTPLRELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
Query: 375 QTYD 378
+ +D
Sbjct: 286 ENFD 289
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-46
Identities = 67/244 (27%), Positives = 98/244 (40%), Gaps = 18/244 (7%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHH 149
+F LLG+G FG+V R ++TG+ A+K L + + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
L L D+ V E+ G L HL + A LEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 120
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
LH + V+YRD+K N++LD+ H K++DFGL K G T GT Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPE 175
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329
D + GVV E++ GR P + + + +FP+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRTLS 229
Query: 330 PLLQ 333
P +
Sbjct: 230 PEAK 233
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-45
Identities = 61/281 (21%), Positives = 107/281 (38%), Gaps = 44/281 (15%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE------FLVEVLMLSLLH 148
++ LLG GGFG VY G S VA+K ++++ + E +EV++L +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 149 --HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKG 206
S ++ L+ + D +L+ E L D ++ L +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEA 122
Query: 207 LEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 265
+ + H+ V++RD+K NIL+D KL DFG L K V T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVY 175
Query: 266 CAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324
PE+ + + V+S G++ +++ G P + + F+ R
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFFRQR--V 227
Query: 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
L++ CL + + RP ++
Sbjct: 228 SSECQHLIRW----------------CLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 1e-45
Identities = 52/275 (18%), Positives = 95/275 (34%), Gaps = 28/275 (10%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 154
+R +G G FG +Y G + G+ VA+K + + +E + ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66
Query: 155 LIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK 213
I +C A+GD ++V E + + T + +A +EY+H K
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 214 ANPPVIYRDLKSSNIL---LDEGFHPKLSDFGLAKL-----GPVGDKTHVSTRVMGTYGY 265
I+RD+K N L +G + DFGLAK + + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 266 CAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325
+ + + + + D+ S G V + G + + + K
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------ERISEKKM 233
Query: 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
+L YP + C + +P
Sbjct: 234 STPIEVLCKGYPS----EFATYLNFCRSLRFDDKP 264
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 7e-45
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 31/296 (10%)
Query: 91 ATKNFRPECLLGEGGFGRVYKGR-LESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLL 147
A + + +GEG +G+V+K R L++ G+ VA+K++ + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 148 ---HHSNLVNLIGYCADGDQRLLVYEFMPLGSL--EDHLHDLPPDKEPLDWNTRMKIAAG 202
H N+V L C + + + + + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGT 262
+GL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 263 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR-------------KAIDNTRPPGEHN 309
Y APE + D++S G +F E+ + K +D PGE +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
W R + R+ F + ++ ++ + CL A R
Sbjct: 239 ---WPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-44
Identities = 63/287 (21%), Positives = 110/287 (38%), Gaps = 24/287 (8%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSN 151
NF+ +GEG +G VYK R + TG+VVA+K++ + + E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V L+ ++ LV+EF+ + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
V++RDLK N+L++ KL+DFGLA+ V +T+ + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILL 175
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR-------------KAIDNTRPPGEHNLVAWARPLF 318
+ D++S G +F E++T R + P E +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-MP 234
Query: 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
+ FPK A P ++ + L R
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDE-DGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 54/274 (19%), Positives = 92/274 (33%), Gaps = 31/274 (11%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNLVNLIGY 158
+LG G G+V + + T + A+K L + EV L ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 159 C----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA 214
A L+V E + G L + D + +I + ++YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 215 NPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
+ +RD+K N+L KL+DFG AK + T Y APE
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 272 MTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331
+ D++S GV+ L+ G H L + R + +P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPF-----YSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDV 365
+ + L+ + R I +
Sbjct: 241 WSEVSE-----EVKMLIRNLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-42
Identities = 61/294 (20%), Positives = 104/294 (35%), Gaps = 34/294 (11%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSN 151
+ +G+G FG V+K R TGQ VA+K++ + L E+ +L LL H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 152 LVNLIGYCADGDQR--------LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGA 203
+VNLI C LV++F + L + ++
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQML 126
Query: 204 AKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS--TRVMG 261
GL Y+H +++RD+K++N+L+ KL+DFGLA+ + + + T +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 262 TYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTR--------------PPG 306
T Y PE + + D++ G + E+ T +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 307 EHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP 360
E L++ + AL + L A R
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-42
Identities = 57/266 (21%), Positives = 101/266 (37%), Gaps = 10/266 (3%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHS 150
+ + +GEG +G V+K + T ++VA+K++ + L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
N+V L + LV+EF +D LD KGL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
H + V++RDLK N+L++ KL++FGLA+ + + + S V+ +
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVL 173
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330
+ D++S G +F EL + + + + ++P M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 331 LLQGRYPMRGLYQALAVAAMCLQEQA 356
YPM +L L
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATG 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (377), Expect = 7e-42
Identities = 46/205 (22%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSN 151
+ +GEG +G VYK + + G+ A+K++ ++ + E+ +L L HSN
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 152 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH 211
+V L + +LV+E + + + L+ T G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH 117
Query: 212 DKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 271
D+ V++RDLK N+L++ K++DFGLA+ + + + ++ +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 272 MTGQLTLKSDVYSFGVVFLELITGR 296
+ + + D++S G +F E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 1e-41
Identities = 60/243 (24%), Positives = 95/243 (39%), Gaps = 21/243 (8%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHS 150
F LG G FGRV + + +G A+K LD+ + ++ L E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 151 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
LV L D +V E++ G + HL AA EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 211 HDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 270
H +IYRDLK N+L+D+ + +++DFG AK T + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 271 AMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330
++ D ++ GV+ E+ G P + + + +FP
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFSS 263
Query: 331 LLQ 333
L+
Sbjct: 264 DLK 266
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 59/303 (19%), Positives = 103/303 (33%), Gaps = 28/303 (9%)
Query: 83 FTFRELAAAT----KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--RE 136
F +E+ +R +G G +G V TG VA+K+L R +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 137 FLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTR 196
E+ +L + H N++ L+ + +F + E L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 197 MKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVS 256
+ KGL Y+H +RDLK N+ ++E K+ DFGLA+ + ++
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMT 176
Query: 257 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR------------KAIDNT-- 302
V+ + + T D++S G + E+ITG+ K I
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 303 RPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362
PP E + + P++ A+ + L A R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP-LAVNLLEKMLVLDAEQRVTA 295
Query: 363 GDV 365
G+
Sbjct: 296 GEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-37
Identities = 66/251 (26%), Positives = 105/251 (41%), Gaps = 20/251 (7%)
Query: 93 KNFRPECLLGEGGFGRVYKGRL---ESTGQVVAVKQLDRNGL----QGNREFLVEVLMLS 145
+NF +LG G +G+V+ R TG++ A+K L + + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 146 LL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 204
+ LV L + L+ +++ G L HL +E +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIV 139
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
LE+LH +IYRD+K NILLD H L+DFGL+K V D+T + GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 265 YCAPEYAMTGQ--LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 322
Y AP+ G D +S GV+ EL+TG +++ +R + K
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSEP 253
Query: 323 KFPKMADPLLQ 333
+P+ L +
Sbjct: 254 PYPQEMSALAK 264
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 136 bits (344), Expect = 7e-37
Identities = 41/208 (19%), Positives = 82/208 (39%), Gaps = 21/208 (10%)
Query: 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNL 152
+++ LG G + V++ + + V VK L + + E+ ++ +L N+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 153 VNLIGYCADGDQRL--LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYL 210
+ L D R LV+E + + L K L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYC 145
Query: 211 HDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
H +++RD+K N+++D E +L D+GLA+ G + + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 270 YAMTGQL-TLKSDVYSFGVVFLELITGR 296
+ Q+ D++S G + +I +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 9/207 (4%)
Query: 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHH 149
+ ++ +G G +G V TG VAVK+L R + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 150 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEY 209
N++ L+ + + L + + L + + +GL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 210 LHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 269
+H +RDLK SN+ ++E K+ DFGLA+ +V+TR +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEI 189
Query: 270 YAMTGQLTLKSDVYSFGVVFLELITGR 296
D++S G + EL+TGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 21/212 (9%)
Query: 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHS 150
K ++ +G G G V + VA+K+L R + E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 151 NLVNLIGYCA------DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAA 204
N+++L+ + LV E M + LD +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQML 129
Query: 205 KGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 264
G+++LH + +I+RDLK SNI++ K+ DFGLA+ + + T + T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRY 183
Query: 265 YCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
Y APE + D++S G + E++ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (311), Expect = 5e-32
Identities = 40/215 (18%), Positives = 78/215 (36%), Gaps = 16/215 (7%)
Query: 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 154
+ LG G F V+ + VA+K + + + E+ +L ++ ++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTK 73
Query: 155 LIGYCADGDQRLL-VYEFMPLGSLEDHLHDLPPDKEPLD-----------WNTRMKIAAG 202
A+ +LL + + + + L +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 203 AAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 261
GL+Y+H + +I+ D+K N+L++ L +A LG T +
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 262 TYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR 296
T Y +PE + +D++S + ELITG
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 5e-19
Identities = 23/160 (14%), Positives = 45/160 (28%), Gaps = 30/160 (18%)
Query: 100 LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL----------QGNREFLVEVLMLSLLHH 149
L+GEG V+ E VK G+ F V + +
Sbjct: 7 LMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 150 SNLVNLIGYCA----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAK 205
L L G + ++ E + L ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDMILE 114
Query: 206 GLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245
+ + + +++ DL N+L+ E + DF +
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 522 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.79 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.03 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.98 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=434.40 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=208.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||+||+|+++.+++.||||++...... ..+.+.+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35799999999999999999999999999999999765432 34568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
||++|+|.+++.. ...+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+++.....
T Consensus 84 y~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999975 567999999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
......+..+||+.|||||++.+..| +.++|||||||+||||+||+.||........ .+..+. ..... ..
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~-----~~~~~---~~ 227 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-----EKKTY---LN 227 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHH-----TTCTT---ST
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHHh-----cCCCC---CC
Confidence 44444556789999999999998876 5789999999999999999999975433211 111111 11100 00
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
+ .......+.+||.+||+.||++|||+.||++
T Consensus 228 ~------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 P------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0112356779999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=427.42 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=212.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999998765556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++|+|.+++.. ..+++.+++.|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+++......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998875 56999999999999999999999999 9999999999999999999999999998753322
Q ss_pred CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 253 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
......+||+.|+|||++.+..|+.++|||||||++|+|+||+.||...... ... ........ +.+
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~---~~~~~~~~--~~~----- 236 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RAL---YLIATNGT--PEL----- 236 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHHHCS--CCC-----
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHH---HHHHhCCC--CCC-----
Confidence 2334568999999999999999999999999999999999999999754221 111 11111110 111
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+......+.+||.+||+.||++|||+.|++++
T Consensus 237 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112233578899999999999999999999763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=431.79 Aligned_cols=255 Identities=24% Similarity=0.305 Sum_probs=210.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.++||+|+||+||+|+++.+++.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999975322 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||++|+|.+++.. ...+++..++.++.||+.||+|||+.+ ||||||||+||||++++.+||+|||+++....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999876 467999999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
..........+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ......+......
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~~------ 228 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIKLEYD------ 228 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCCC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHcCCCC------
Confidence 4433344567899999999999999999999999999999999999999975421 1111112221111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
++......+.+||.+||+.||++|||++|++....-+
T Consensus 229 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~ 265 (288)
T d1uu3a_ 229 ------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265 (288)
T ss_dssp ------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHH
T ss_pred ------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHH
Confidence 1222335688999999999999999999987655433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=423.28 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=209.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||+||+|+++.+++.||||++.+.. ......+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999996532 223456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||++|+|.+++.. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999976 467999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+......+
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~----- 223 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVEFTF----- 223 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCCCC-----
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCCC-----
Confidence 2 23456799999999999999999999999999999999999999975422 11111111211111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+......+.+||.+||+.||++|||+.||++.
T Consensus 224 -------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 -------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 12223577899999999999999999999873
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=425.82 Aligned_cols=262 Identities=30% Similarity=0.451 Sum_probs=205.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
.++|++.+.||+|+||+||+|++. ..||||+++.... ...+.|.+|+.+|.+++|||||++++++.. ..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 468999999999999999999864 3599999975432 334678899999999999999999998754 5689999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999975 2457999999999999999999999998 99999999999999999999999999987544
Q ss_pred CCCCcceecccCCccccChhhhhcC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
...........||+.|||||++... .|+.++|||||||+||||+||+.||........ +... .......+.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~----~~~~~~~p~ 230 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFM----VGRGYLSPD 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHH----HHHTSCCCC
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHH----HhcCCCCCc
Confidence 4443444567899999999999743 589999999999999999999999976433111 1111 111111111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
. . . .+......+.+||.+||+.||++|||+.+|++.|+.++..
T Consensus 231 ~-~-~----~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 L-S-K----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp G-G-G----SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred c-h-h----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0 0 1 1122335788999999999999999999999999988754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=429.15 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=198.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc--hHHHHHHHHHHHhCCCCCcceeEEEEEc--CCeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~~L~~l~hpnIv~l~~~~~~--~~~~~lV 168 (522)
++|++.+.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+ ...+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999999999999999997764432 3568899999999999999999999865 4568999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
||||++|+|.+++.........+++..++.|+.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999753334568999999999999999999999864 23499999999999999999999999999987
Q ss_pred CCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ..+. ..+... .+..
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~---~~i~~~--~~~~ 233 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA---GKIREG--KFRR 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHHT--CCCC
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHH---HHHHcC--CCCC
Confidence 5322 2233457899999999999999999999999999999999999999975422 1111 111111 1111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
.+......+.+||.+||+.||++|||+.||++
T Consensus 234 ---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122357889999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-54 Score=431.79 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=215.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|++..+++.||||+++.+. ...+.|.+|+.+|+.++|||||+++++|.+.+.++|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 567999999999999999999999999999999997654 3456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
|++|+|.+++.. .....+++..++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+++.....
T Consensus 95 ~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (287)
T d1opja_ 95 MTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 168 (287)
T ss_dssp CTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-
T ss_pred ccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC-
Confidence 999999999975 23467999999999999999999999999 999999999999999999999999999864332
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
.........||+.|+|||++.+..|+.++|||||||++|||++|..||..... ...+...+ ....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~i----~~~~--------- 233 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELL----EKDY--------- 233 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHH----HTTC---------
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHHH----hcCC---------
Confidence 22233445689999999999999999999999999999999998877653322 11111111 1111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
....+......+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 234 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011222233578899999999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=424.31 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=209.9
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeec
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 172 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 172 (522)
+.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999999999999999998776666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++|+|.+++.. ....+++.++..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||++..... .
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 99999999865 2457999999999999999999999999 99999999999999999999999999975321 1
Q ss_pred CcceecccCCccccChhhhh-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 253 THVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 253 ~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.......+||+.|+|||++. ...|+.++|||||||+||||+||+.||....+.. ... .+..... +.+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~~~~~--~~~ 235 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIAKSEP--PTL 235 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHHSCC--CCC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHcCCC--CCC
Confidence 11233567999999999984 4568999999999999999999999997653321 111 1111110 111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
..+......+.+||.+||+.||++|||+.||++
T Consensus 236 -------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 -------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223467889999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-53 Score=427.34 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=200.8
Q ss_pred cCCcccceecccCceEEEEEEECCCCc---EEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQ---VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
++|++.++||+|+||+||+|+++.+++ .||||++...... ..+.|.+|+.+|+.|+|||||+++++|.+.+.++||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467888999999999999999976654 6899988654333 345789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
||||++|+|.+++.. ....+++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998875 2457999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCcc---eecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCC
Q 009933 249 VGDKTHV---STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKF 324 (522)
Q Consensus 249 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (522)
....... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+...+ ... ..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i---~~~-~~~ 252 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAI---EQD-YRL 252 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH---HTT-CCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHH---HcC-CCC
Confidence 3222111 122457999999999999999999999999999999998 8999975432 1222211 111 111
Q ss_pred CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 325 PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 325 ~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..+......+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 253 ----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 253 ----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1122334678899999999999999999999999988754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=418.20 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=202.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|+.++|||||+++++|...+.++|||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 367999999999999999999997 47889999997654 3457799999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
|++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999875 2467899999999999999999999999 9999999999999999999999999998653322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
. .......||+.|+|||++.+..|+.++|||||||+||||+|+..|+..... ...+...+ ... . ...
T Consensus 156 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i---~~~-~---~~~--- 222 (263)
T d1sm2a_ 156 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDI---STG-F---RLY--- 222 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHH---HHT-C---CCC---
T ss_pred c-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHH---Hhc-C---CCC---
Confidence 2 223346789999999999999999999999999999999996555432211 11122211 111 0 011
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
.+......+.+||.+||+.||++|||+.+|++.|+.++.
T Consensus 223 ----~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 ----KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 111223567899999999999999999999999998864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=432.04 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=207.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||+||+|++..+|+.||||+++..... ....+.+|+.+|+.++|||||+++++|.+.+++|||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999999999999999999765332 24578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||++|+|.+++.. ...+++..++.++.||+.||.|||+. + |+||||||+||||+.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999976 46799999999999999999999974 8 99999999999999999999999999986421
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC------
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK------ 323 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------ 323 (522)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... .. +..........
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE-LM-FGCQVEGDAAETPPRPR 231 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHH-HH-C----------------
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HH-HHHHhcCCcccCCcccc
Confidence 1234578999999999999999999999999999999999999999764321110 00 00000000000
Q ss_pred -----C--------C-----CcCCccccC---CCC-hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 324 -----F--------P-----KMADPLLQG---RYP-MRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 324 -----~--------~-----~~~d~~l~~---~~~-~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
. + ...+..... ..+ ......+.+||.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 0 000000000 000 1123578899999999999999999999984
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-52 Score=422.32 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=194.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
.+.|++.++||+|+||+||+|+++.+++.||||++....... ...+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999999999999999997654332 3457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCceeeeeecceeeC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLG 247 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld---~~~~vkL~DFGla~~~ 247 (522)
||+||+|.++|.. ...+++.++..|+.||+.||.|||+++ ||||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999976 567999999999999999999999999 99999999999994 5789999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+. ..+......+..
T Consensus 161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~---~~i~~~~~~~~~- 230 (307)
T d1a06a_ 161 DPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLF---EQILKAEYEFDS- 230 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHHTTCCCCCT-
T ss_pred cCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHH---HHHhccCCCCCC-
Confidence 322 2334578999999999999999999999999999999999999999753221 111 111121111111
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.........+.+||.+||+.||++|||+.|+++.
T Consensus 231 -------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 -------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111223578899999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.6e-52 Score=425.82 Aligned_cols=254 Identities=23% Similarity=0.272 Sum_probs=212.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+.+||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999999999999999999876655567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCceeeeeecceeeCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld--~~~~vkL~DFGla~~~~~ 249 (522)
|++|+|.+++.. ....+++.+++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999864 2457999999999999999999999999 99999999999995 467899999999987533
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. .......||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+......+.....
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~ 249 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNMDDSAF 249 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCSCCGGG
T ss_pred c---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCCcccc
Confidence 2 234457899999999999999999999999999999999999999975422 1111111121111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+.+||.+||+.||++|||+.||+++
T Consensus 250 --------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 --------SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --------cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223568899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.6e-52 Score=425.01 Aligned_cols=254 Identities=21% Similarity=0.269 Sum_probs=212.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|++..+|+.||||+++.........+.+|+.+|+.|+|||||+++++|.+++.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999876555566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec--CCCceeeeeecceeeCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD--EGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld--~~~~vkL~DFGla~~~~~ 249 (522)
|++|+|.+++.. ...++++.+++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||++.....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999998765 2457999999999999999999999999 99999999999997 678999999999987543
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. .......||+.|+|||++.+..|+.++|||||||+||||+||+.||...... .+ ...+......++..
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~---~~~i~~~~~~~~~~-- 250 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ET---LQNVKRCDWEFDED-- 250 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHHHCCCCCCSS--
T ss_pred C---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCCCCCCcc--
Confidence 2 2345578999999999999999999999999999999999999999754221 11 11111111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
........+.+||.+||+.||++|||+.||+++
T Consensus 251 ------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 ------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223578899999999999999999999763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=425.69 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=209.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCc-----EEEEEEEccCC-ccchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQ-----VVAVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~-----~vAvK~i~~~~-~~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~ 164 (522)
.++|++.++||+|+||+||+|++..+++ .||||++.... ......+.+|+.+|..+ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4679999999999999999999865443 69999986543 23346788999999988 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPP-------------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 225 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp 225 (522)
+|||||||++|+|.++|+.... ....+++..++.|+.||+.||.|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999976321 1245899999999999999999999999 99999999
Q ss_pred CceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 009933 226 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRP 304 (522)
Q Consensus 226 ~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~ 304 (522)
+|||++.++++||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |..||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986544443334445678999999999999999999999999999999998 8999976533
Q ss_pred CCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q 009933 305 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 370 (522)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~ 370 (522)
.. .+... ......+ ..+......+.+||.+||+.||++|||++||+++|.
T Consensus 273 ~~--~~~~~----~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA--NFYKL----IQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH--HHHHH----HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHHHH----HhcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 11111 1111111 122223457889999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=414.62 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=200.0
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEc----CCeeEEE
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRLLV 168 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~----~~~~~lV 168 (522)
|++.+.||+|+||+||+|++..+++.||||++...... ..+.+.+|+++|+.++|||||+++++|.+ ...+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 36777899999999999999999999999999764332 23568899999999999999999999865 3568999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec-CCCceeeeeecceeeC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD-EGFHPKLSDFGLAKLG 247 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld-~~~~vkL~DFGla~~~ 247 (522)
||||++|+|.+++.. ...+++..++.|+.||+.||+|||+++ ++||||||||+||||+ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999976 467999999999999999999999874 4599999999999996 5789999999999863
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCc
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKM 327 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (522)
.. ......+||+.|||||++.+ .|+.++|||||||+||||++|+.||...... ..+.. .+.... . +
T Consensus 166 ~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~---~i~~~~-~-~-- 231 (270)
T d1t4ha_ 166 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR---RVTSGV-K-P-- 231 (270)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH---HHTTTC-C-C--
T ss_pred cC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHH---HHHcCC-C-C--
Confidence 22 22345789999999998865 6999999999999999999999999754221 11111 111110 0 0
Q ss_pred CCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 328 ADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 328 ~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
..+ +......+.+||.+||+.||++|||+.||++
T Consensus 232 --~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 --ASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 1112346789999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=412.66 Aligned_cols=252 Identities=25% Similarity=0.310 Sum_probs=208.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc------chHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||+||+|+++.+|+.||||++++.... ..+.+.+|+.+|+.|+|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999999999999999999764322 246789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC----ceeeeee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF----HPKLSDF 241 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~----~vkL~DF 241 (522)
|||||||++|+|.++|.. ...+++..++.++.||+.||+|||+.+ ||||||||+||||+.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999976 467999999999999999999999999 99999999999998766 5999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR 321 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 321 (522)
|++....... ......||+.|+|||++.+..|+.++|||||||+||||++|+.||..... .... ..+....
T Consensus 162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~---~~i~~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETL---ANVSAVN 232 (293)
T ss_dssp TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHTTC
T ss_pred hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HHHH---HHHHhcC
Confidence 9998754332 33456799999999999999999999999999999999999999975422 1111 1111111
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
..+... . +......+.+||.+||+.||++|||+.||++
T Consensus 233 ~~~~~~----~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YEFEDE----Y----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCHH----H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCch----h----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111100 0 0112356789999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=414.19 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=208.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|.++ +++.||||+++... ...+.|.+|+.+|.+++|||||++++++.+ +.++|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 467999999999999999999986 47889999997654 345679999999999999999999998855 567999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
|++|+|.+++.. .....+++..++.|+.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 89 ~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999998865 22346999999999999999999999998 9999999999999999999999999999754322
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
........||+.|+|||++....|+.++|||||||+||||+||..|+..... ...+...+ ... .. +
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i---~~~-~~------~- 229 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNL---ERG-YR------M- 229 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH---HTT-CC------C-
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHH---Hhc-CC------C-
Confidence 2223456789999999999999999999999999999999997766543321 11122111 111 00 0
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
..+......+.+||.+||+.||++|||+.+|++.|+.+-
T Consensus 230 ---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 230 ---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 011122356889999999999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-52 Score=421.94 Aligned_cols=247 Identities=30% Similarity=0.394 Sum_probs=205.3
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccch---HHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
+.|++.+.||+|+||+||+|++..+++.||||+++....... +.+.+|+.+|+.|+|||||+++++|.+.+.+||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 349999999999999999999999999999999986654332 45889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||.+|+|..++.. ...+++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999877655 467999999999999999999999999 99999999999999999999999999986322
Q ss_pred CCCCcceecccCCccccChhhhhc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
....+||+.|||||++.+ ..|+.++|||||||++|||++|..||...... .....+... ..+.
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~--~~~~ 233 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN--ESPA 233 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS--CCCC
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC--CCCC
Confidence 234679999999999964 46899999999999999999999999754221 111111111 1111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
... . .....+.+||.+||+.||++|||+.+|+++
T Consensus 234 ~~~----~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 LQS----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CSC----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC----C----CCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 1 123578899999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=413.30 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=208.4
Q ss_pred hcCCcccce-ecccCceEEEEEEECC--CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECL-LGEGGFGRVYKGRLES--TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~-LG~G~fG~Vy~~~~~~--~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|.+.++ ||+|+||+||+|.++. ++..||||+++..... ..+.|.+|+.+|++++|||||+++++|.. +.+||
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 356777775 9999999999998754 3558999999765432 34678999999999999999999999975 46899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||||++|+|.+++.. ....+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999864 2467999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCC-cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 248 PVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 248 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
...... .......||+.|+|||++....|+.++|||||||++|||+| |+.||...... .+...+ ..... .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i----~~~~~-~ 231 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI----EQGKR-M 231 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHH----HTTCC-C
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCC-C
Confidence 443322 12234568999999999999999999999999999999998 89999765332 122211 11111 1
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
..+......+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 232 ---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 232 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112223357889999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=406.54 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=212.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|+++ +++.||||+++.... ..++|.+|+.++..++|||||+++++|.+.+.+++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 468999999999999999999996 688999999987544 456899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
+.+|+|.+++.. ....+++..+++|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999765 2467899999999999999999999999 9999999999999999999999999998654332
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
.. ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||...... .+.. .+... . ...
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~---~i~~~-~---~~~-- 221 (258)
T d1k2pa_ 155 YT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE---HIAQG-L---RLY-- 221 (258)
T ss_dssp CC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH---HHHTT-C---CCC--
T ss_pred ce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHH---HHHhC-C---CCC--
Confidence 22 2334678999999999999999999999999999999998 89999765321 1111 11111 1 111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHH
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTY 371 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~ 371 (522)
.|......+.+||.+||+.||++|||+.+|++.|..
T Consensus 222 -----~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 -----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -----CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111223578899999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=420.16 Aligned_cols=250 Identities=28% Similarity=0.332 Sum_probs=211.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
.++|++.++||+|+||+||+|+++.+++.||||++++.. ......+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999999999999999997542 22346688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
||||++|+|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
.. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ......+......+
T Consensus 157 ~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~~~~~---- 224 (337)
T d1o6la_ 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEIRF---- 224 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC----
T ss_pred cC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcCCCCC----
Confidence 22 2234457899999999999999999999999999999999999999976432 11122222222222
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 368 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~ 368 (522)
|......+.+||.+||+.||++||+ +.+|+++
T Consensus 225 --------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 --------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 2223356789999999999999995 7787763
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=412.41 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=204.1
Q ss_pred hcCCcccceecccCceEEEEEEECCCC----cEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTG----QVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g----~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
.+.|++.++||+|+||+||+|.++.++ ..||||++....... ...|.+|+.+|+.++|||||+++++|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 356889999999999999999987654 479999997543332 346889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
+|||||.+++|.+++.. ....+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998865 2467999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCC-CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
...... ........||+.|+|||++.+..|+.++|||||||+||||+++..||..... ...+...+ .....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i----~~~~~-- 231 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAI----NDGFR-- 231 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHH----HTTCC--
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHHH----hccCC--
Confidence 533222 1222345689999999999999999999999999999999997766653322 11122211 11111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
...+......+.+||.+||+.||++||++.+|++.|+.+..
T Consensus 232 --------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11222234578899999999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=410.04 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=199.1
Q ss_pred ceecccCceEEEEEEEC--CCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEeecCC
Q 009933 99 CLLGEGGFGRVYKGRLE--STGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 174 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~--~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 174 (522)
++||+|+||+||+|.+. .+++.||||+++..... ..+.+.+|+.+|++++|||||+++++|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999874 34578999999754332 23578999999999999999999999965 457899999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCCC-
Q 009933 175 GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDKT- 253 (522)
Q Consensus 175 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~- 253 (522)
|+|.+++.. ...+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999976 567999999999999999999999998 999999999999999999999999999875433222
Q ss_pred cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCccc
Q 009933 254 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPLL 332 (522)
Q Consensus 254 ~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 332 (522)
.......||+.|+|||++.+..|+.++|||||||++|||+| |+.||..... ..+...+ .....+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i----~~~~~~-------- 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAML----EKGERM-------- 229 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHH----HTTCCC--------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHH----HcCCCC--------
Confidence 12234578999999999999999999999999999999998 8999975432 1112111 111110
Q ss_pred cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 333 QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 333 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
..+......+.+||.+||+.||++|||+.+|++.|+..
T Consensus 230 --~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11222335788999999999999999999999988754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.6e-51 Score=403.20 Aligned_cols=261 Identities=24% Similarity=0.322 Sum_probs=206.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---hHHHHHHHHHHHhCCCCCcceeEEEEEcCC----e
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGD----Q 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~----~ 164 (522)
.++|++.+.||+|+||+||+|++..+++.||||+++...... ...+.+|+.+|+.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999997654433 346889999999999999999999987654 4
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
+|||||||+|++|.+++.. ...+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.++|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7999999999999999876 467999999999999999999999999 999999999999999999999999998
Q ss_pred eeCCCCCC-CcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 245 KLGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 245 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
........ .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||....+ .............
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCC
Confidence 76433222 2233456799999999999999999999999999999999999999975422 1111112222111
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHHHhh
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRP-LIGDVVTALTYLA 373 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~evl~~L~~l~ 373 (522)
.+....+ .....+.+||.+||+.||++|| ++++++..|..+.
T Consensus 233 ~~~~~~~--------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PPSARHE--------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CGGGTSS--------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCchhcc--------CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111111 1235788999999999999999 8999999988764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-51 Score=412.77 Aligned_cols=246 Identities=29% Similarity=0.403 Sum_probs=209.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++.+.||+|+||+||+|+++.+|+.||||++++.. ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999999999999999997532 233467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
|||.||+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999999997432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.....+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ......+......++
T Consensus 157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~~p---- 221 (316)
T d1fota_ 157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELRFP---- 221 (316)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCCCC----
T ss_pred -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCCCCCC----
Confidence 23457899999999999999999999999999999999999999975422 111222222221111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~~ 368 (522)
......+.+++.+||+.||.+|+ ++++|+++
T Consensus 222 --------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 --------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 12235678999999999999996 88998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=412.31 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=205.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCc----EEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQ----VVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.+|++.++||+|+||+||+|.+..+|+ .||||+++... ....+.|.+|+.+|++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999987776 58888886532 33456799999999999999999999999875 5678
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
+|||+.+++|.+++.. ....+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876 3567999999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.............||+.|+|||++.+..|+.++|||||||+||||+| |..||....... +...+ .....+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i----~~~~~~-- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGERL-- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH----HHTCCC--
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCCC--
Confidence 55444444455678999999999999999999999999999999999 788887543221 11111 111111
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhh
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 374 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~ 374 (522)
..+......+.+|+.+||+.||++|||+.+|++.|..+..
T Consensus 233 --------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1122233578899999999999999999999999988754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=407.21 Aligned_cols=253 Identities=17% Similarity=0.231 Sum_probs=209.6
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|.++.+++.||||+++... .....+.+|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999999999999999997654 2345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC--CCceeeeeecceeeCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE--GFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~--~~~vkL~DFGla~~~~~ 249 (522)
|+||+|.++|.. ....+++.+++.|+.||+.||+|||+++ |+||||||+||||+. ...+||+|||++.....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999975 2347999999999999999999999999 999999999999974 45899999999987533
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
. ......++|+.|+|||++.+..|+.++|||||||++|+|++|..||..... ......+......++....
T Consensus 157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~ 227 (321)
T d1tkia_ 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCCCHHHH
T ss_pred C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCChhhc
Confidence 2 234456799999999999999999999999999999999999999975422 1111122222111111000
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
+ .....+.+||.+||+.||++|||+.|++++
T Consensus 228 ~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 K--------EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp T--------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c--------CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 123467899999999999999999999884
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.2e-50 Score=397.17 Aligned_cols=253 Identities=26% Similarity=0.295 Sum_probs=208.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc---------hHHHHHHHHHHHhCC-CCCcceeEEEEEc
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG---------NREFLVEVLMLSLLH-HSNLVNLIGYCAD 161 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~---------~~~~~~E~~~L~~l~-hpnIv~l~~~~~~ 161 (522)
.++|++.+.||+|+||+||+|++..+++.||||++++..... .+.+.+|+.+|++|+ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999997654321 135788999999997 9999999999999
Q ss_pred CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
.+..|||||||++|+|.++|.. ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999976 468999999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT------GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~ 315 (522)
|+++...... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||...... .. ..
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~---~~ 225 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LM---LR 225 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HH
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HH---HH
Confidence 9998754322 3345789999999999874 35788999999999999999999999754321 11 11
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+......+... ........+.+|+.+||+.||++|||+.||++.
T Consensus 226 ~i~~~~~~~~~~--------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 226 MIMSGNYQFGSP--------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHTCCCCCTT--------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhCCCCCCCc--------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 112221111111 111233578899999999999999999998763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-50 Score=413.22 Aligned_cols=245 Identities=26% Similarity=0.316 Sum_probs=208.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~ 169 (522)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+...+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999999999999999996532 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPV 249 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~ 249 (522)
||+.+|+|.+++.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999976 467999999999999999999999999 99999999999999999999999999987432
Q ss_pred CCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 250 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 250 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
.....+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ......+......+
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~~----- 257 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKVRF----- 257 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC-----
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCCCCC-----
Confidence 22346799999999999999999999999999999999999999975421 11122222221111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRP-----LIGDVVT 367 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~evl~ 367 (522)
+......+.+||.+||+.||.+|+ ++++|++
T Consensus 258 -------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 -------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112235788999999999999994 8999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-51 Score=409.65 Aligned_cols=265 Identities=25% Similarity=0.429 Sum_probs=212.8
Q ss_pred HHhhcCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcC
Q 009933 89 AAATKNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADG 162 (522)
Q Consensus 89 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~ 162 (522)
+...++|++.+.||+|+||+||+|+++ .+++.||||+++...... .+.|.+|+.+|+.++||||++++++|...
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 334578999999999999999999985 346789999997654332 45689999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLP--------------------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 222 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrD 222 (522)
+..++||||+.+|+|.+++.... .....+++..++.|+.||+.||+|||+++ |||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence 99999999999999999996421 11235899999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCC-CCCCC
Q 009933 223 LKSSNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR-KAIDN 301 (522)
Q Consensus 223 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~-~Pf~~ 301 (522)
|||+||||+.++++||+|||+++...........+...||+.|+|||++....|+.++|||||||+||||++|. .||..
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999998654433333445677899999999999999999999999999999999996 56654
Q ss_pred CCCCCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 302 TRPPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.... .+...+ . ... .+. .+......+.+||.+||+.+|++|||+.+|+++|+.+.
T Consensus 246 ~~~~---e~~~~v---~-~~~-~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAHE---EVIYYV---R-DGN-ILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCHH---HHHHHH---H-TTC-CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHH---HHHHHH---H-cCC-CCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 4221 111111 1 111 111 12223357889999999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=404.83 Aligned_cols=257 Identities=28% Similarity=0.409 Sum_probs=203.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.++|++.+.||+|+||+||+|++..+ +.||||+++... ...+.|.+|+.+|++++|||||+++++|.+ +.+++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 36799999999999999999999764 679999997554 345779999999999999999999999854 568999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
|++|+|..++.. .....++|.+++.|+.||+.||+|||+++ |+||||||+||||+.++++||+|||+++......
T Consensus 93 ~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999865 22356999999999999999999999999 9999999999999999999999999998643222
Q ss_pred CCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCcc
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADPL 331 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 331 (522)
........||+.|+|||++....++.++|||||||+||||+||..||..... ...+...+. . ....
T Consensus 168 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~---~-~~~~------- 233 (285)
T d1fmka3 168 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE---R-GYRM------- 233 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH---T-TCCC-------
T ss_pred -ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH---h-cCCC-------
Confidence 2223446799999999999999999999999999999999998777654322 112222221 1 1000
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 332 LQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 332 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
..+......+.+||.+||+.||++||++.+|+++|+...
T Consensus 234 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 234 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 111222357889999999999999999999999998654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=401.01 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=200.2
Q ss_pred hcCCcccceecccCceEEEEEEECCC---CcEEEEEEEccCCccc-hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST---GQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 167 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~i~~~~~~~-~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~l 167 (522)
.++|++.+.||+|+||+||+|++..+ +..||||+++...... .+.+.+|+.+|+.++|||||+++++|. .+.+||
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 46799999999999999999998654 3568999986543332 356889999999999999999999996 467899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeC
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLG 247 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~ 247 (522)
|||||++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998765 2467999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCC
Q 009933 248 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPK 326 (522)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (522)
.... ....+...||+.|+|||++....|+.++|||||||+||||+| |..||...... .+...+. .....
T Consensus 159 ~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~----~~~~~-- 228 (273)
T d1mp8a_ 159 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE----NGERL-- 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTCCC--
T ss_pred cCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cCCCC--
Confidence 3322 223345678999999999999999999999999999999998 88898765332 1221111 11110
Q ss_pred cCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 327 MADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 327 ~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
..+......+.+||.+||+.||++|||+.+|++.|+.+..+
T Consensus 229 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11222335788999999999999999999999999887543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=401.49 Aligned_cols=259 Identities=25% Similarity=0.304 Sum_probs=197.9
Q ss_pred ccceecccCceEEEEEEECCCCcEEEEEEEccCCccc-----hHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEee
Q 009933 97 PECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG-----NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 171 (522)
Q Consensus 97 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~-----~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E~ 171 (522)
.+++||+|+||+||+|+++.+|+.||||+++...... .+.+.+|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999999999999999997543322 24688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCC
Q 009933 172 MPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGD 251 (522)
Q Consensus 172 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~ 251 (522)
|.++++..++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 998777766543 567899999999999999999999999 9999999999999999999999999998643322
Q ss_pred CCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc--ccCCC---
Q 009933 252 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD--RRKFP--- 325 (522)
Q Consensus 252 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~--- 325 (522)
......+||+.|+|||++... .|+.++|||||||++|||+||..||......+ ....+...... .....
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTT
T ss_pred --ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchh
Confidence 223456799999999998754 68999999999999999999999997543211 11111111000 00000
Q ss_pred CcCCccccC---CCCh-----HHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 326 KMADPLLQG---RYPM-----RGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 326 ~~~d~~l~~---~~~~-----~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
......... ..+. .....+.+||.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000 0111 22357889999999999999999999976
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.3e-50 Score=410.87 Aligned_cols=250 Identities=27% Similarity=0.350 Sum_probs=203.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc---cchHHHHH---HHHHHHhCCCCCcceeEEEEEcCCeeE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL---QGNREFLV---EVLMLSLLHHSNLVNLIGYCADGDQRL 166 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~---E~~~L~~l~hpnIv~l~~~~~~~~~~~ 166 (522)
++|++.++||+|+||+||+|++..+|+.||||++.+... .....+.+ |+.+++.++|||||+++++|.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 679999999999999999999999999999999965322 11223344 466777788999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
||||||++|+|.++|.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999976 467899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCC
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFP 325 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (522)
.... .....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||..........+.. ........
T Consensus 157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~~~~~~-- 227 (364)
T d1omwa3 157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMAVE-- 227 (364)
T ss_dssp CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---HSSSCCCC--
T ss_pred cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcccCCCC--
Confidence 5332 2334679999999999975 568999999999999999999999998654432221111 11111111
Q ss_pred CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHHH
Q 009933 326 KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVTA 368 (522)
Q Consensus 326 ~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~~ 368 (522)
++......+.+||.+||+.||++||+ +++|+++
T Consensus 228 ----------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 228 ----------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11122356889999999999999999 5777763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=406.87 Aligned_cols=269 Identities=26% Similarity=0.366 Sum_probs=202.2
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCcceeEEE
Q 009933 86 RELAAATKNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGY 158 (522)
Q Consensus 86 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~l~~~ 158 (522)
.++....++|++.++||+|+||+||+|.+.. +++.||||+++..... ..+.+..|+.++.++ +|+|||.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3443445789999999999999999999854 3578999999754332 335577777777766 68999999998
Q ss_pred EEcC-CeeEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 009933 159 CADG-DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKS 225 (522)
Q Consensus 159 ~~~~-~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp 225 (522)
+... ..+++|||||++|+|.++|..... ....+++.+++.|+.||+.||.|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8664 568999999999999999965221 2346899999999999999999999999 99999999
Q ss_pred CceeecCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCC
Q 009933 226 SNILLDEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR-KAIDNTRP 304 (522)
Q Consensus 226 ~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~-~Pf~~~~~ 304 (522)
+||||++++++||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+||. .||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998654443333344567999999999999999999999999999999999975 56764432
Q ss_pred CCcchHHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 305 PGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.. .+... +..... .. .+......+.+||.+||+.||++|||+.+|+++|+.+.
T Consensus 243 ~~--~~~~~----~~~~~~-~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 243 DE--EFCRR----LKEGTR-MR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp SH--HHHHH----HHHTCC-CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH--HHHHH----HhcCCC-CC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 11111 111111 11 11222356889999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-51 Score=399.82 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=200.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEc-CCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-~~~~~lV~E 170 (522)
.++|++.+.||+|+||.||+|+++ |..||||+++.. ...+.+.+|+.+|++++|||||+++++|.+ .+.++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 457899999999999999999995 789999999754 345778999999999999999999999865 456899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+++|+|.++|... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-
Confidence 99999999999651 1235899999999999999999999998 99999999999999999999999999986322
Q ss_pred CCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMAD 329 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 329 (522)
......+|+.|+|||++.+..|+.++|||||||++|||+| |+.||..... .++..++. . .. .+
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~---~-~~-~~---- 219 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE---K-GY-KM---- 219 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHT---T-TC-CC----
T ss_pred ----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH---c-CC-CC----
Confidence 2234568999999999999999999999999999999998 6777764322 22232221 1 10 01
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 330 PLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 330 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.++......+.+||.+||+.||++|||+.+|+++|+.+...
T Consensus 220 -----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 220 -----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 12222335788999999999999999999999999988643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=407.23 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=205.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCC---ccchHHHHHHHHHHH-hCCCCCcceeEEEEEcCCeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLS-LLHHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~~L~-~l~hpnIv~l~~~~~~~~~~~lV 168 (522)
++|++.+.||+|+||+||+|+++.+++.||||++++.. ....+.+..|+.++. .++|||||+++++|.+.+.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999997532 123345666776655 68999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCC
Q 009933 169 YEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGP 248 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~ 248 (522)
||||++|+|.+++.. ...+++.+++.++.||+.||+|||+++ ||||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999976 467899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcC
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMA 328 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (522)
... ...+..+||+.|+|||++.+..|+.++|||||||++|||+||+.||...... .+ ...+......++
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~~~i~~~~~~~p--- 223 (320)
T d1xjda_ 155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL---FHSIRMDNPFYP--- 223 (320)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCCCCCC---
T ss_pred ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HH---HHHHHcCCCCCC---
Confidence 322 2334568999999999999999999999999999999999999999754221 11 111112211111
Q ss_pred CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHH-HHHH
Q 009933 329 DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG-DVVT 367 (522)
Q Consensus 329 d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-evl~ 367 (522)
......+.+||.+||+.||++||++. +|++
T Consensus 224 ---------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 ---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12235678999999999999999985 6754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=403.87 Aligned_cols=265 Identities=27% Similarity=0.400 Sum_probs=210.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCC-------cEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCcceeEEEEEcC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTG-------QVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADG 162 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g-------~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~ 162 (522)
.++|++.+.||+|+||.||+|++..++ ..||||+++.+... ...++.+|+.++.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 467999999999999999999986543 47999999765433 236688898888887 799999999999999
Q ss_pred CeeEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 163 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 163 ~~~~lV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
...++|||||.+|+|.++|..... ....+++.+++.++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975321 2356899999999999999999999999 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHN 309 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~ 309 (522)
+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++ |..||...... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence 9999999999999987554444444455779999999999999999999999999999999998 67888654321 1
Q ss_pred HHHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 310 LVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
+... +.....+ ..+......+.+||.+||+.||++|||+.||++.|+.+.+.+
T Consensus 246 ~~~~----i~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 246 LFKL----LKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp HHHH----HHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHH----HHcCCCC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 1111 1111111 111222357889999999999999999999999999987644
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=405.37 Aligned_cols=254 Identities=20% Similarity=0.228 Sum_probs=201.1
Q ss_pred hcCCcccc-eecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHH-hCCCCCcceeEEEEEc----CCee
Q 009933 92 TKNFRPEC-LLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLS-LLHHSNLVNLIGYCAD----GDQR 165 (522)
Q Consensus 92 ~~~y~~~~-~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~-~l~hpnIv~l~~~~~~----~~~~ 165 (522)
.++|.+.. +||+|+||+||+|++..+++.||||+++. ...+.+|+.++. .++|||||+++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46798864 69999999999999999999999999953 356778998865 4589999999999875 4678
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC---CCceeeeeec
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE---GFHPKLSDFG 242 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~---~~~vkL~DFG 242 (522)
|||||||+||+|.++|... ....+++.+++.|+.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999762 2357999999999999999999999999 999999999999975 5679999999
Q ss_pred ceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhccc
Q 009933 243 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 322 (522)
Q Consensus 243 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 322 (522)
+++...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||............ ...+.....
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--~~~i~~~~~ 234 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KTRIRMGQY 234 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSS
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH--HHHHhcCCC
Confidence 998754332 234567999999999999999999999999999999999999999755332211100 000000000
Q ss_pred CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 323 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 323 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.++ . .........+.+||.+||+.||++|||+.||+++
T Consensus 235 ~~~---~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFP---N-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCC---T-----THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC---C-----cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 0 0001234578899999999999999999999885
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=401.25 Aligned_cols=261 Identities=27% Similarity=0.415 Sum_probs=208.5
Q ss_pred cCCcccceecccCceEEEEEEECCCCcE--EEEEEEccCCc-cchHHHHHHHHHHHhC-CCCCcceeEEEEEcCCeeEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQV--VAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLV 168 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~--vAvK~i~~~~~-~~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~~~lV 168 (522)
++|++.++||+|+||+||+|+++.++.. ||||+++.... ...+.+.+|+.+|..+ +|||||+++++|.+.+.++||
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6799999999999999999999887764 67788754332 3345789999999998 799999999999999999999
Q ss_pred EeecCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCce
Q 009933 169 YEFMPLGSLEDHLHDLP------------PDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 169 ~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
|||+++|+|.++|+... .....+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997531 23467999999999999999999999999 9999999999999999999
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCCCCcchHHHhhh
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRK-AIDNTRPPGEHNLVAWAR 315 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~-Pf~~~~~~~~~~~~~~~~ 315 (522)
||+|||+++..... .......||..|+|||.+....|+.++|||||||++|||++|.. ||..... ..+...+
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKL- 239 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHG-
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHH-
Confidence 99999999853221 12234568999999999999999999999999999999999765 5654321 1122111
Q ss_pred hhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 316 PLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 316 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.. ... ...+......+.+||.+||+.||++|||+.+|++.|+.+..+.
T Consensus 240 --~~-~~~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 --PQ-GYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp --GG-TCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred --Hh-cCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11 111 1122223467889999999999999999999999999987544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=400.92 Aligned_cols=266 Identities=27% Similarity=0.378 Sum_probs=213.6
Q ss_pred hcCCcccceecccCceEEEEEEEC-----CCCcEEEEEEEccCCcc-chHHHHHHHHHHHhC-CCCCcceeEEEEEcCCe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLE-----STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l-~hpnIv~l~~~~~~~~~ 164 (522)
.++|++.++||+|+||.||+|++. .+++.||||+++..... ....+.+|+.++..+ +|||||+++++|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467999999999999999999873 45679999999765433 335688999999999 69999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPP--------------DKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILL 230 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILl 230 (522)
.+||||||++|+|.+++..... ....+++..+..|+.||+.||+|||+++ ||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999975321 2346999999999999999999999999 9999999999999
Q ss_pred cCCCceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH
Q 009933 231 DEGFHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL 310 (522)
Q Consensus 231 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~ 310 (522)
+.++.+||+|||+++..............+||+.|+|||++....++.++|||||||++|||+|+..||........ .+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999999999976554444444567899999999999999999999999999999999995555443322111 11
Q ss_pred HHhhhhhhhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 311 VAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
... ..... .. ..+......+.+||.+||+.||++|||+.+|+++|+.+.++
T Consensus 258 ~~~----i~~~~--~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKM----IKEGF--RM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHH----HHHTC--CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----HhcCC--CC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111 11111 00 11112235688999999999999999999999999876544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=397.44 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=202.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||+||+|++..+++.||||+++..... ....+.+|+.+|+.++|||||+++++|.+...+|||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999999999999999999754332 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.+ ++.+++.. .....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9975 55555543 23567999999999999999999999999 999999999999999999999999999864332
Q ss_pred CCCcceecccCCccccChhhhhcCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH-Hhhhh----hhhcccCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-AWARP----LFKDRRKF 324 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~-~~~~~----~~~~~~~~ 324 (522)
. .......||+.|+|||++.... ++.++|||||||++|+|++|+.||............ ..... .+......
T Consensus 156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 2 2334457999999999988765 578999999999999999999999754321110000 00000 00000000
Q ss_pred CCcCCc---cccCCC---ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 325 PKMADP---LLQGRY---PMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 325 ~~~~d~---~l~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...... .....+ .......+.+|+.+||+.||++|||+.||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 000000 01223578899999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=394.95 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=201.0
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccc------hHHHHHHHHHHHhCC--CCCcceeEEEEEcCC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQG------NREFLVEVLMLSLLH--HSNLVNLIGYCADGD 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~------~~~~~~E~~~L~~l~--hpnIv~l~~~~~~~~ 163 (522)
.++|++.++||+|+||+||+|++..+++.||||++.+..... ...+.+|+.+|++++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999999999999999997543221 234678999999987 899999999999999
Q ss_pred eeEEEEeecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-CCceeeeee
Q 009933 164 QRLLVYEFMPL-GSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-GFHPKLSDF 241 (522)
Q Consensus 164 ~~~lV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-~~~vkL~DF 241 (522)
..++||||+.+ ++|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+||||||+||||+. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999976 578888865 467999999999999999999999999 999999999999985 579999999
Q ss_pred cceeeCCCCCCCcceecccCCccccChhhhhcCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 242 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 242 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
|+++..... ..+...||+.|+|||++.+..+ +.++|||||||+||||+||+.||.... . +...
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------i~~~ 219 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------IIRG 219 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------HHHC
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-------Hhhc
Confidence 999864322 2345789999999999998776 567899999999999999999996421 1 1111
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
...+ +......+.+||.+||+.||++|||++|+++.
T Consensus 220 ~~~~------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 QVFF------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCC------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCC------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 11123578899999999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=395.07 Aligned_cols=258 Identities=29% Similarity=0.420 Sum_probs=197.4
Q ss_pred hcCCcccceecccCceEEEEEEECCC-C--cEEEEEEEccCCc---cchHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST-G--QVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-g--~~vAvK~i~~~~~---~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||.||+|++..+ + ..||||++++... ...+.|.+|+.+|+.++|||||+++++|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 36799999999999999999987432 2 4689999976433 223578999999999999999999999976 467
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeeccee
Q 009933 166 LLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAK 245 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~ 245 (522)
+||||||++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999998865 2356999999999999999999999998 9999999999999999999999999999
Q ss_pred eCCCCCCCc-ceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHhhhhhhhcccC
Q 009933 246 LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELIT-GRKAIDNTRPPGEHNLVAWARPLFKDRRK 323 (522)
Q Consensus 246 ~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 323 (522)
......... ......|+..|+|||++.+..++.++|||||||++|||+| |..||..... .....+ +......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~---i~~~~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHK---IDKEGER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH---HHTSCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHH---HHhCCCC
Confidence 754433222 2234568889999999999999999999999999999998 8999974422 112221 1122111
Q ss_pred CCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHh
Q 009933 324 FPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 372 (522)
Q Consensus 324 ~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l 372 (522)
+ . .+......+.+||.+||+.||++|||+.+|++.|..+
T Consensus 234 ~-~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 L-P---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C-C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-C---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 0 1112235688999999999999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=396.39 Aligned_cols=269 Identities=26% Similarity=0.349 Sum_probs=202.1
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHH--HHHHHHhCCCCCcceeEEEEEcCC----eeE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGYCADGD----QRL 166 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~--E~~~L~~l~hpnIv~l~~~~~~~~----~~~ 166 (522)
.+|.+.+.||+|+||+||+|++. |+.||||+++.. ....+.. |+..+..++|||||+++++|.+.+ .+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 46888999999999999999974 899999999643 2333444 455556789999999999997654 679
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeecCCCceeeeee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA-----NPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
||||||++|+|.++|+. ..++|..++.++.|++.||.|||+.. ..+||||||||+||||+.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 99999999999999986 46999999999999999999999741 123999999999999999999999999
Q ss_pred cceeeCCCCCCCc--ceecccCCccccChhhhhcCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcc-----
Q 009933 242 GLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTGQ------LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEH----- 308 (522)
Q Consensus 242 Gla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~------~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~----- 308 (522)
|+++......... .....+||+.|+|||++.... ++.++|||||||+||||+||..||.........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9998754332211 234567999999999987643 577899999999999999999887543321110
Q ss_pred ---hHHHhhhhhhhcccCCCCcCCccccCCC-ChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 309 ---NLVAWARPLFKDRRKFPKMADPLLQGRY-PMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 309 ---~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
............ ....+.+...+ +......+.+|+.+||+.||++|||+.||++.|+.+..+.
T Consensus 233 ~~~~~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CSSCCHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 001111111111 11111111111 2345567889999999999999999999999999887554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=392.98 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=204.6
Q ss_pred cceecccCceEEEEEEECCCC---cEEEEEEEccCC-ccchHHHHHHHHHHHhCCCCCcceeEEEEEc-CCeeEEEEeec
Q 009933 98 ECLLGEGGFGRVYKGRLESTG---QVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQRLLVYEFM 172 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~i~~~~-~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-~~~~~lV~E~~ 172 (522)
.++||+|+||+||+|++..++ ..||||+++... ....+.|.+|+++|++++|||||++++++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 578999999999999986543 369999997532 2334679999999999999999999999875 56889999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCCCC
Q 009933 173 PLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVGDK 252 (522)
Q Consensus 173 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~ 252 (522)
++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999876 3456788999999999999999999999 99999999999999999999999999987543322
Q ss_pred C--cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcccCCCCcCCc
Q 009933 253 T--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRRKFPKMADP 330 (522)
Q Consensus 253 ~--~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 330 (522)
. .......||+.|+|||++....++.++|||||||+||||+||..||...... ..+..++ ..... ..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i---~~g~~----~~-- 254 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQGRR----LL-- 254 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTCC----CC--
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH---HcCCC----CC--
Confidence 2 1223457899999999999999999999999999999999998888654321 1122211 11111 01
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhcc
Q 009933 331 LLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQT 376 (522)
Q Consensus 331 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~~ 376 (522)
.+......+.+||.+||+.||++||++.||++.|+.+....
T Consensus 255 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 255 -----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 11122356889999999999999999999999999987553
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=390.35 Aligned_cols=268 Identities=23% Similarity=0.286 Sum_probs=199.8
Q ss_pred hcCCcccceecccCceEEEEEEECCC-CcEEEEEEEccCCcc--chHHHHHHHHHHHhC---CCCCcceeEEEEEc----
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLEST-GQVVAVKQLDRNGLQ--GNREFLVEVLMLSLL---HHSNLVNLIGYCAD---- 161 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l---~hpnIv~l~~~~~~---- 161 (522)
.++|++++.||+|+||+||+|++..+ ++.||||+++..... ....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57899999999999999999999655 678999999654322 233566777777665 79999999999853
Q ss_pred -CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeee
Q 009933 162 -GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSD 240 (522)
Q Consensus 162 -~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~D 240 (522)
...++++|||+.++.+...... ....+++..++.++.||+.||+|||+++ ||||||||+|||++..+.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3478999999988766544433 3467899999999999999999999999 99999999999999999999999
Q ss_pred ecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh-h---
Q 009933 241 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR-P--- 316 (522)
Q Consensus 241 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~-~--- 316 (522)
||++.... ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.... .
T Consensus 160 fg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99988532 2223456789999999999999999999999999999999999999997543211111110000 0
Q ss_pred -hhhcccCCCCcC----CccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 317 -LFKDRRKFPKMA----DPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 317 -~~~~~~~~~~~~----d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.+.......... .......+.......+.+||.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 0000001112234567899999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-48 Score=384.99 Aligned_cols=265 Identities=21% Similarity=0.272 Sum_probs=201.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||+||+|+++ +++.||||+++..... ..+.+.+|+.+|+.++|||||+++++|...+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999996 6899999999765332 24678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
|+.++.+..+... ...+++..+..|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9988766666654 577999999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhh-----hhhhcccCC
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWAR-----PLFKDRRKF 324 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 324 (522)
. .......|++.|+|||++.+. .++.++|||||||++|||++|+.||...........+.... ..+......
T Consensus 154 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 2 223345689999999999765 56899999999999999999999997543211111000000 000000000
Q ss_pred CCcCCccc------cCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 325 PKMADPLL------QGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 325 ~~~~d~~l------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
........ ...........+.+||.+||+.||++|||+.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11000000 00111123457889999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=395.31 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=210.4
Q ss_pred hcCCcccceecccCceEEEEEEECC-----CCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCCee
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 165 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~ 165 (522)
.++|++.+.||+|+||+||+|.+.. +++.||||+++..... ....|.+|+.+|++++|||||+++++|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4788999999999999999999852 3578999999754322 234688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeee
Q 009933 166 LLVYEFMPLGSLEDHLHDL------PPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLS 239 (522)
Q Consensus 166 ~lV~E~~~ggsL~~~l~~~------~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~ 239 (522)
++|||||.+|+|.+++... ......+++..+..|+.||+.||.|||+.+ |+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998641 112245789999999999999999999998 9999999999999999999999
Q ss_pred eecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCcchHHHhhhhhh
Q 009933 240 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGR-KAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 240 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~-~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
|||+++...............||+.|+|||.+.+..++.++|||||||+||||+||. .||..... ......+.
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~i~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVM 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH
Confidence 999998654333333334557899999999999999999999999999999999985 66654321 11111111
Q ss_pred hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 319 KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 319 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
.. . ... .+......+.+||.+||+.+|++|||+.+|+++|+...
T Consensus 250 ~~-~-~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 EG-G-LLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TT-C-CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred hC-C-CCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 1 111 11122357889999999999999999999999997653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=382.33 Aligned_cols=268 Identities=23% Similarity=0.291 Sum_probs=198.9
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCc--cchHHHHHHHHHHHhCCCCCcceeEEEEEc--------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-------- 161 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~-------- 161 (522)
.++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.+|+.++||||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3689999999999999999999999999999999865432 234678899999999999999999999865
Q ss_pred CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeee
Q 009933 162 GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDF 241 (522)
Q Consensus 162 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DF 241 (522)
...+|+||||+.++.+..+... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 3468999999987766655433 567899999999999999999999999 999999999999999999999999
Q ss_pred cceeeCCCCCCC--cceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhh
Q 009933 242 GLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLF 318 (522)
Q Consensus 242 Gla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 318 (522)
|++......... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+... ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~--~~ 239 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL--CG 239 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH--HC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh--cC
Confidence 999865432221 122345799999999999865 6899999999999999999999999754321111111110 00
Q ss_pred hcccC-CCCc--------CCccccCCCChH-------HHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 319 KDRRK-FPKM--------ADPLLQGRYPMR-------GLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 319 ~~~~~-~~~~--------~d~~l~~~~~~~-------~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..... .... ............ ....+.+||.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 0000 000000011111 12356789999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=386.02 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=197.3
Q ss_pred CCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcceeEEEEEcC------CeeEE
Q 009933 94 NFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------DQRLL 167 (522)
Q Consensus 94 ~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~------~~~~l 167 (522)
+|+..++||+|+||+||+|++..+++.||||++..... .+.+|+.+|+.++|||||+++++|... .++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 58889999999999999999999999999999976432 234699999999999999999998542 35789
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeeecceee
Q 009933 168 VYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKL 246 (522)
Q Consensus 168 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DFGla~~ 246 (522)
|||||+++ +.+.+.........+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999765 43333322223567999999999999999999999999 99999999999998765 899999999987
Q ss_pred CCCCCCCcceecccCCccccChhhhhc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHH-H--------hhhh
Q 009933 247 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLV-A--------WARP 316 (522)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~-~--------~~~~ 316 (522)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...........+ . +...
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 54332 2344679999999999875 47899999999999999999999999754321111100 0 0000
Q ss_pred hhh--cccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 317 LFK--DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 317 ~~~--~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
... ....++......+...........+.+||.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0001111111111111122334578899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=384.48 Aligned_cols=262 Identities=24% Similarity=0.306 Sum_probs=197.5
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCC------
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~------ 163 (522)
.++|++.+.||+|+||+||+|.+..+|+.||||+++..... ..+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57899999999999999999999999999999999764332 2356889999999999999999999997654
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
.+||||||| +.+|..+++. ..+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 579999999 5678887764 57999999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhh-----h
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARP-----L 317 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~-----~ 317 (522)
++.... ..+...||+.|+|||++.+. .++.++|||||||++|+|++|+.||................. .
T Consensus 168 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 987432 23456799999999999864 568999999999999999999999976532111100000000 0
Q ss_pred ---------hhcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 318 ---------FKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 318 ---------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
......+.......+.. ........+.+||.+||+.||++|||+.|||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000011111111110 111223567899999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=372.49 Aligned_cols=265 Identities=21% Similarity=0.247 Sum_probs=208.0
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcCCeeEEEEe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~~~~lV~E 170 (522)
++|++.+.||+|+||+||+|++..+++.||||+++..... ....+.+|+.+|+.++|||||+++++|.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999999999999999999765432 24678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceeeCCCC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKLGPVG 250 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~~~~~ 250 (522)
++.+++|..++.. ...+++..++.++.|++.||+|||+++ ||||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998888765 567899999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCcceecccCCccccChhhhhcCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhcc--------
Q 009933 251 DKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDR-------- 321 (522)
Q Consensus 251 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------- 321 (522)
.. ......+++.|+|||++.... ++.++|||||||++|||++|+.||...... ......+.......
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTG
T ss_pred Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhh
Confidence 22 233456788999999988765 689999999999999999999998543221 11111111000000
Q ss_pred cCC------CCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 322 RKF------PKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 322 ~~~------~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
..+ ...................+.+|+.+||+.||++|||++||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000000011222334678899999999999999999999763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=383.38 Aligned_cols=268 Identities=21% Similarity=0.243 Sum_probs=199.4
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-chHHHHHHHHHHHhCCCCCcceeEEEEEcCC----eeE
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGD----QRL 166 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~~----~~~ 166 (522)
+.+|+++++||+|+||+||+|++..+|+.||||+++..... ..+.+++|+.+|+.|+||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999999999999999999764422 2356889999999999999999999997643 235
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 167 LVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 167 lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
++++|+.+++|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55666779999999975 46999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCC-cceecccCCccccChhhhh-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhh-----
Q 009933 247 GPVGDKT-HVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFK----- 319 (522)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~APE~l~-~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~----- 319 (522)
....... ......+||+.|+|||++. ...|+.++||||+||++|+|++|+.||....................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 4332211 1234567999999999985 45678999999999999999999999976532111111100000000
Q ss_pred ---------cccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 320 ---------DRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 320 ---------~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
....+.......+. .........+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHH-HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000000 0001122468899999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.4e-46 Score=376.62 Aligned_cols=259 Identities=17% Similarity=0.241 Sum_probs=200.2
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEc--CCeeEEEE
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCAD--GDQRLLVY 169 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~--~~~~~lV~ 169 (522)
++|++.++||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+|+.++ ||||++++++|.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999999753 3467889999999996 9999999999974 45689999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCC-ceeeeeecceeeCC
Q 009933 170 EFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGF-HPKLSDFGLAKLGP 248 (522)
Q Consensus 170 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~-~vkL~DFGla~~~~ 248 (522)
|||.+++|..+. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||++....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987764 35899999999999999999999999 99999999999998654 69999999998754
Q ss_pred CCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH--HH---------hhhh
Q 009933 249 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL--VA---------WARP 316 (522)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~--~~---------~~~~ 316 (522)
... .....++|+.|+|||++.+. .|+.++|||||||++|||++|+.||........... .. +...
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 332 23456799999999998865 579999999999999999999999975533211100 00 0000
Q ss_pred h-hhcccCCC--------CcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q 009933 317 L-FKDRRKFP--------KMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVT 367 (522)
Q Consensus 317 ~-~~~~~~~~--------~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~ 367 (522)
. ......+. ..................+.+||.+||+.||++|||++|+|+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000000 000011111111223457889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-46 Score=372.18 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=202.7
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCcc-eeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV-NLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnIv-~l~~~~~~~~~~~lV~E 170 (522)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+..|+++++.++|+|++ .+..++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357999999999999999999999999999999987643 234578899999999877655 55566678889999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeec---CCCceeeeeecceeeC
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLD---EGFHPKLSDFGLAKLG 247 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld---~~~~vkL~DFGla~~~ 247 (522)
|+ +++|.+.+.. ....+++..+..++.||+.||+|||+++ ||||||||+|||++ .+..+||+|||+++..
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 4577766654 2467999999999999999999999999 99999999999985 4567999999999975
Q ss_pred CCCCCC-----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH-hhhhhhhcc
Q 009933 248 PVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA-WARPLFKDR 321 (522)
Q Consensus 248 ~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~ 321 (522)
...... ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||............. +.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~- 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-
Confidence 433221 12345679999999999999999999999999999999999999998665433322221 11110000
Q ss_pred cCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhh
Q 009933 322 RKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLA 373 (522)
Q Consensus 322 ~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~ 373 (522)
. .+.+...+ ...+.+|+..||+.+|++||++.+|.+.|+.+.
T Consensus 236 -~-----~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 236 -P-----IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -C-----HHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -C-----hhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 01111112 246789999999999999999999999888763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-45 Score=369.44 Aligned_cols=265 Identities=18% Similarity=0.234 Sum_probs=212.3
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC-CCcceeEEEEEcCCeeEEEEe
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH-SNLVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h-pnIv~l~~~~~~~~~~~lV~E 170 (522)
.++|++.++||+|+||+||+|++..+++.||||++.... ....+.+|++++..|.| +||+.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999999999999999986542 33457789999999975 899999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecC-----CCceeeeeeccee
Q 009933 171 FMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDE-----GFHPKLSDFGLAK 245 (522)
Q Consensus 171 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~-----~~~vkL~DFGla~ 245 (522)
|+ +++|.+++... ...+++..+..++.|++.||+|||+++ ||||||||+||||+. .+.+||+|||+++
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 68999998762 457999999999999999999999999 999999999999964 5789999999998
Q ss_pred eCCCCCCC-----cceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhc
Q 009933 246 LGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKD 320 (522)
Q Consensus 246 ~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 320 (522)
........ ......+||+.|||||++.+..|+.++|||||||++|||+||..||................... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-Q 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-H
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-C
Confidence 75432211 12335679999999999999999999999999999999999999998655443332222111100 0
Q ss_pred ccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHHhhhc
Q 009933 321 RRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQ 375 (522)
Q Consensus 321 ~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~L~~l~~~ 375 (522)
.... +.+...+| .++.+|+..|++.+|++||+++.+.+.|+.+..+
T Consensus 234 ~~~~-----~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 234 STPL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HSCH-----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCh-----HHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 0000 01111122 4678899999999999999999999988876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=377.52 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=205.3
Q ss_pred cCCcccceecccCceEEEEEEE---CCCCcEEEEEEEccCCc----cchHHHHHHHHHHHhCCC-CCcceeEEEEEcCCe
Q 009933 93 KNFRPECLLGEGGFGRVYKGRL---ESTGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLHH-SNLVNLIGYCADGDQ 164 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~---~~~g~~vAvK~i~~~~~----~~~~~~~~E~~~L~~l~h-pnIv~l~~~~~~~~~ 164 (522)
++|++.+.||+|+||+||+|++ +.+|+.||||++++... ...+.+.+|+.+|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999998 44689999999975432 234567889999999976 899999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
+++||||+.+++|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999976 457788999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhhhhccc
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPLFKDRR 322 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 322 (522)
+....... .......|++.|+|||.+... .++.++|||||||+||+|++|+.||...........+. ........
T Consensus 177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~~~~ 253 (322)
T d1vzoa_ 177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKSEP 253 (322)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHCCC
T ss_pred hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcccCCC
Confidence 86533222 223456799999999999765 47889999999999999999999998765543322221 11111111
Q ss_pred CCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q 009933 323 KFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPL-----IGDVVT 367 (522)
Q Consensus 323 ~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~evl~ 367 (522)
. ++......+.+|+.+||+.||++||+ ++|+++
T Consensus 254 ~------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 P------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1 22233467889999999999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=377.94 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=193.2
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEc------CC
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD------GD 163 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~------~~ 163 (522)
.++|++.++||+|+||+||+|++..+|+.||||++...... ....+.+|+.+|+.++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 46899999999999999999999999999999999765432 23467899999999999999999999964 46
Q ss_pred eeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecc
Q 009933 164 QRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGL 243 (522)
Q Consensus 164 ~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGl 243 (522)
++|+|||||.++ |.+.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 889999999764 445543 35899999999999999999999999 99999999999999999999999999
Q ss_pred eeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHH---------hh
Q 009933 244 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVA---------WA 314 (522)
Q Consensus 244 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~---------~~ 314 (522)
++..... ...+..++|+.|+|||++.+..++.++||||+||++|+|++|+.||...........+. +.
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 8864332 23355679999999999999999999999999999999999999997543211100000 00
Q ss_pred -------hhhhhcccCC-----CCcCCccccCC---CChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 315 -------RPLFKDRRKF-----PKMADPLLQGR---YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 315 -------~~~~~~~~~~-----~~~~d~~l~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.......... ........... ........+.+||.+||+.||++|||++|||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000110000 00111111100 112345678999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=374.06 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=197.8
Q ss_pred hcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc--chHHHHHHHHHHHhCCCCCcceeEEEEEcC-----Ce
Q 009933 92 TKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQ 164 (522)
Q Consensus 92 ~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~~L~~l~hpnIv~l~~~~~~~-----~~ 164 (522)
.++|++.+.||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.+|+.|+|||||+++++|... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999999999999999999765332 235678999999999999999999998643 34
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCceeeeeecce
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHPKLSDFGLA 244 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~vkL~DFGla 244 (522)
.++||+|+.+|+|.+++.. ..+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4667788889999999964 56999999999999999999999999 999999999999999999999999999
Q ss_pred eeCCCCCCCcceecccCCccccChhhhhcC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchHHHhhhhh-----h
Q 009933 245 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNLVAWARPL-----F 318 (522)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~~~~~~~~-----~ 318 (522)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...... .
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 7532 223456789999999998775 4689999999999999999999999754321111111000000 0
Q ss_pred ---------hcccCCCCcCCccccCCCChHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q 009933 319 ---------KDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTA 368 (522)
Q Consensus 319 ---------~~~~~~~~~~d~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~evl~~ 368 (522)
.....+.......+.. ........+.+||.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000000000 001123567899999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-41 Score=342.15 Aligned_cols=265 Identities=19% Similarity=0.198 Sum_probs=192.4
Q ss_pred cCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-----------CCCcceeEEEEEc
Q 009933 93 KNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----------HSNLVNLIGYCAD 161 (522)
Q Consensus 93 ~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-----------hpnIv~l~~~~~~ 161 (522)
.+|+++++||+|+||+||+|++..+|+.||||+++.... ..+.+.+|+.+|+.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 359999999999999999999999999999999976432 2356778888888775 5789999998754
Q ss_pred --CCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeecCCC----
Q 009933 162 --GDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDLKSSNILLDEGF---- 234 (522)
Q Consensus 162 --~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLKp~NILld~~~---- 234 (522)
....+++|+++..+........ ......+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 3566777777655443333222 1235678999999999999999999998 77 99999999999997654
Q ss_pred --ceeeeeecceeeCCCCCCCcceecccCCccccChhhhhcCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCcchH--
Q 009933 235 --HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNTRPPGEHNL-- 310 (522)
Q Consensus 235 --~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDVwSlGvll~eLltG~~Pf~~~~~~~~~~~-- 310 (522)
.++|+|||.+..... .....+||+.|+|||++....|+.++|||||||++++|++|+.||...........
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 399999999986432 22456799999999999999999999999999999999999999975433211111
Q ss_pred --HHhhhhh-------hhc---------ccCCCCcCCcc----------ccCCCChHHHHHHHHHHHHhcccCcCCCCCH
Q 009933 311 --VAWARPL-------FKD---------RRKFPKMADPL----------LQGRYPMRGLYQALAVAAMCLQEQAATRPLI 362 (522)
Q Consensus 311 --~~~~~~~-------~~~---------~~~~~~~~d~~----------l~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 362 (522)
......+ ... .......+... ............+.+||.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 1100000 000 00000000000 0122344567789999999999999999999
Q ss_pred HHHHH
Q 009933 363 GDVVT 367 (522)
Q Consensus 363 ~evl~ 367 (522)
.|+|+
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=7.4e-25 Score=203.61 Aligned_cols=164 Identities=14% Similarity=0.033 Sum_probs=120.5
Q ss_pred CcccceecccCceEEEEEEECCCCcEEEEEEEccCCcc-----c-------------hHHHHHHHHHHHhCCCCCcceeE
Q 009933 95 FRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQ-----G-------------NREFLVEVLMLSLLHHSNLVNLI 156 (522)
Q Consensus 95 y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~-----~-------------~~~~~~E~~~L~~l~hpnIv~l~ 156 (522)
+.+.++||+|+||+||+|.+. +|+.||||+++..... . ...+..|+..|..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 456789999999999999986 5899999987532110 0 12235688899999999999988
Q ss_pred EEEEcCCeeEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeecCCCce
Q 009933 157 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGFHP 236 (522)
Q Consensus 157 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLKp~NILld~~~~v 236 (522)
++.. .+|||||+++..+.++ +...+..++.||+.+|.|||+.+ |+||||||+|||++++ .+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEET----TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred EecC----CEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 7642 3799999988655442 22345689999999999999999 9999999999999965 48
Q ss_pred eeeeecceeeCCCCCCCcceecccCCccccC------hhhhhcCCCCcchhhHHHHHHH
Q 009933 237 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA------PEYAMTGQLTLKSDVYSFGVVF 289 (522)
Q Consensus 237 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~A------PE~l~~~~~~~~sDVwSlGvll 289 (522)
+|+|||++......... .|.. .+ +....|+.++||||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcH----------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence 99999999864322111 1111 11 1245788999999976444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.79 E-value=1.5e-08 Score=96.12 Aligned_cols=150 Identities=17% Similarity=0.083 Sum_probs=106.8
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCC-CCCcceeEEEEEcCCe
Q 009933 86 RELAAATKNFRPECLLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ 164 (522)
Q Consensus 86 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~-hpnIv~l~~~~~~~~~ 164 (522)
.++......|++.+..+-++...||+... +++.++||+...........+.+|+.+|..|. +--+.+++.++..++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 35666667888877765566679998864 36678899887654444556778998888775 4346778888888899
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 009933 165 RLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLHDKA------------------------------ 214 (522)
Q Consensus 165 ~~lV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------ 214 (522)
.++||++++|.++.+.... . . ....++.+++..|..||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~-----~-~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED-----E-Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT-----C-S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccc-----c-c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999999887665432 1 1 12334555566666666410
Q ss_pred --------------------------CCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 215 --------------------------NPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 215 --------------------------~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999876677999998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=6.6e-06 Score=76.80 Aligned_cols=130 Identities=18% Similarity=0.136 Sum_probs=85.0
Q ss_pred ecccC-ceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC--CCcceeEEEEEcCCeeEEEEeecCCCCh
Q 009933 101 LGEGG-FGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH--SNLVNLIGYCADGDQRLLVYEFMPLGSL 177 (522)
Q Consensus 101 LG~G~-fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~ggsL 177 (522)
+..|. ...||+.... .+..+++|...... ...+..|+..|+.|.. -.+.+++.++.+.+..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 4689998865 46778899875432 2346678887777653 3367788888888899999999988665
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 009933 178 EDHLHDLPPDKEPLDWNTRMKIAAGAAKGLEYLH---------------------------------------------- 211 (522)
Q Consensus 178 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH---------------------------------------------- 211 (522)
.+.. +.. ..++.++...|.-||
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 4321 111 111223333333333
Q ss_pred -----hc----CCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 212 -----DK----ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 212 -----~~----~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
.. ..+.+||+|+.|.|||++++..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 112389999999999999876678999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.03 E-value=6.9e-06 Score=82.55 Aligned_cols=77 Identities=14% Similarity=0.054 Sum_probs=49.0
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEEccC------Cc-cchHHHHHHHHHHHhCC-C-C-CcceeEEEEEcCCeeEE
Q 009933 98 ECLLGEGGFGRVYKGRLESTGQVVAVKQLDRN------GL-QGNREFLVEVLMLSLLH-H-S-NLVNLIGYCADGDQRLL 167 (522)
Q Consensus 98 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~i~~~------~~-~~~~~~~~E~~~L~~l~-h-p-nIv~l~~~~~~~~~~~l 167 (522)
.+.||.|....||++.+..+++.|+||.-... .. ........|+..|..+. + | .+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 34689999999999998777888999975421 11 12234556888887664 2 3 34555543 4556689
Q ss_pred EEeecCCCC
Q 009933 168 VYEFMPLGS 176 (522)
Q Consensus 168 V~E~~~ggs 176 (522)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.25 E-value=0.00023 Score=69.02 Aligned_cols=137 Identities=15% Similarity=0.103 Sum_probs=77.8
Q ss_pred ceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCCc-----ceeE--EEEEcCCeeEEEEeecCCCChh
Q 009933 106 FGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-----VNLI--GYCADGDQRLLVYEFMPLGSLE 178 (522)
Q Consensus 106 fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpnI-----v~l~--~~~~~~~~~~lV~E~~~ggsL~ 178 (522)
--.||++... +|..|++|+.+.. ....+++..|...|..|....| +..- ..+......+.|++++.|..+.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 3589999985 4888999998654 3345677788888877652221 1111 1234566788999999764321
Q ss_pred h------------------hhccCC-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHhc----CCC
Q 009933 179 D------------------HLHDLP-PDKEPLDWN-------------------TRMKIAAGAAKGLEYLHDK----ANP 216 (522)
Q Consensus 179 ~------------------~l~~~~-~~~~~l~~~-------------------~~~~i~~qi~~~L~yLH~~----~~~ 216 (522)
. ...... .....++.. ....+...+...++.+... ...
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 0 000100 011111211 1111222223333333332 123
Q ss_pred CeEecCCCCCceeecCCCceeeeeecceee
Q 009933 217 PVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 217 ~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
.+||+|+.+.|||++++ ..|+||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 48999999999999754 45899998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.06 E-value=0.0013 Score=62.89 Aligned_cols=160 Identities=14% Similarity=0.036 Sum_probs=82.8
Q ss_pred ccHHHHHHhhcCCccccee-----cccCceEEEEEEECCCCcEEEEEEEccCCccchHHHHHHHHHHHhCCC-----CCc
Q 009933 83 FTFRELAAATKNFRPECLL-----GEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH-----SNL 152 (522)
Q Consensus 83 ~~~~~~~~~~~~y~~~~~L-----G~G~fG~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~h-----pnI 152 (522)
++..++.....+|.+.++. ..|---+.|++.... | .+++|+..... ...++..|+.+|..|.. |..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 4567788888889876543 355567889998763 4 58999986432 23344556666666542 222
Q ss_pred ceeEE---EEEcCCeeEEEEeecCCCChhhh--------------hc----cCCCC-CCCCCHH----------------
Q 009933 153 VNLIG---YCADGDQRLLVYEFMPLGSLEDH--------------LH----DLPPD-KEPLDWN---------------- 194 (522)
Q Consensus 153 v~l~~---~~~~~~~~~lV~E~~~ggsL~~~--------------l~----~~~~~-~~~l~~~---------------- 194 (522)
+...+ +.........++.++.+..+... ++ ..... .......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 22110 12234455667777765432210 00 00000 0000000
Q ss_pred --HHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceeecCCCceeeeeecceee
Q 009933 195 --TRMKIAAGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDEGFHPKLSDFGLAKL 246 (522)
Q Consensus 195 --~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLKp~NILld~~~~vkL~DFGla~~ 246 (522)
.....+..+...+...+.. -...|||+|+.++|||++.+...-|+||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1111122222222222211 012399999999999999887778999998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.98 E-value=0.0013 Score=65.34 Aligned_cols=73 Identities=16% Similarity=0.220 Sum_probs=49.6
Q ss_pred ceecccCceEEEEEEECC-------CCcEEEEEEEccCCccchHHHHHHHHHHHhCCCCC-cceeEEEEEcCCeeEEEEe
Q 009933 99 CLLGEGGFGRVYKGRLES-------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN-LVNLIGYCADGDQRLLVYE 170 (522)
Q Consensus 99 ~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~E~~~L~~l~hpn-Iv~l~~~~~~~~~~~lV~E 170 (522)
+.|+-|-.=.+|++.... ..+.|.+++.-. ........+|..+++.+.-.+ ..+++++|.+ .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 567778888999998753 235677777642 223345667888888886334 4577777643 68999
Q ss_pred ecCCCCh
Q 009933 171 FMPLGSL 177 (522)
Q Consensus 171 ~~~ggsL 177 (522)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|